Audit Information |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Audit Information [Abstract] | |
| Auditor Name | PricewaterhouseCoopers LLP |
| Auditor Location | New York, New York |
| Auditor Firm ID | 238 |
Consolidated Statements of Financial Position (Parenthetical) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
||
|---|---|---|---|---|
| Fixed Maturities, AFS, allowance for credit losses | $ 183 | $ 331 | ||
| Fixed Maturities, available-for-sale, Amortized Cost | 357,996 | 341,004 | ||
| Fixed Maturities, Trading, amortized cost | 15,536 | 13,631 | ||
| Equity securities, AFS, amortized cost | 8,303 | 7,043 | ||
| Commercial mortgage and other loans, allowance for credit losses | 469 | 574 | ||
| Commercial mortgage and other loans | [1] | 64,715 | 62,341 | |
| Other invested assets, allowance for credit losses | [1] | 27,294 | 26,351 | |
| Reinsurance recoverables and deposit receivables, allowance for credit losses | 14 | 12 | ||
| Reinsurance recoverable and deposit receivables, embedded derivatives at fair value | 573 | 849 | ||
| Other assets, assets at fair value | 0 | 0 | ||
| Reinsurance and funds withheld payables, embedded derivatives at fair value | 174 | (118) | ||
| Other Liabilities, derivatives at fair value | 6,215 | 4,751 | ||
| Notes Issued by Consolidated Variable Interest Entities | [1] | $ 2,659 | $ 1,430 | |
| Preferred Stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||
| Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | ||
| Preferred Stock, Shares Issued | 0 | 0 | ||
| Common Stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||
| Common Stock, Shares Authorized | 1,500,000,000 | 1,500,000,000 | ||
| Common Stock, Shares, Issued | 666,305,189 | 666,305,189 | ||
| Treasury Stock, Shares | 318,361,498 | 311,738,187 | ||
| Fair value option | ||||
| Commercial mortgage and other loans | $ 1,056 | $ 702 | ||
| Other invested assets, allowance for credit losses | 26 | 19 | ||
| Notes Issued by Consolidated Variable Interest Entities | 767 | 60 | ||
| Leveraged lease loans | ||||
| Other invested assets, allowance for credit losses | 2 | 2 | ||
| Other invested assets, at fair value | 8,286 | 7,574 | ||
| ASU 2016-13 | ||||
| Short term investments, allowance for credit losses | 0 | 0 | ||
| Other assets, allowance for credit losses | 1 | 2 | ||
| Other liabilities, allowance for credit losses | $ 16 | $ 14 | ||
| ||||
Consolidated Statements of Operations - USD ($) $ in Millions |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||
| REVENUES | |||||||
| Premiums (includes $122, $73 and $323 of gains (losses) from changes in estimates on deferred profit liability amortization for the year ended December 31, 2025, 2024 and 2023, respectively) | [1] | $ 30,797 | $ 42,897 | $ 27,364 | |||
| Policy charges and fee income | 4,666 | 4,298 | 4,527 | ||||
| Net Investment Income | 21,473 | 19,909 | 17,865 | ||||
| Asset management and service fees | [1] | 4,019 | 4,090 | 3,717 | |||
| Other income (loss) | [1] | 4,426 | 3,037 | 4,065 | |||
| Realized investment gains (losses), net | [1],[2] | (4,132) | (3,429) | (3,615) | |||
| Change in value of market risk benefits, net of related hedging gains (losses) | (475) | (397) | 56 | ||||
| Total revenues | 60,774 | 70,405 | 53,979 | ||||
| BENEFITS AND EXPENSES | |||||||
| Policyholders’ benefits | [1] | 35,224 | 47,119 | 30,931 | |||
| Change in estimates of liability for future policy benefits | [1] | 103 | (37) | 337 | |||
| Interest credited to policyholders’ account balances | 5,068 | 4,582 | 3,983 | ||||
| Dividends to policyholders | 1,076 | 698 | 1,069 | ||||
| Amortization of deferred policy acquisition costs | [1] | 1,635 | 1,492 | 1,459 | |||
| Goodwill impairment | 0 | 0 | 177 | ||||
| General and administrative expenses | [1] | 13,012 | 13,342 | 12,951 | |||
| Total benefits and expenses | 56,118 | 67,196 | 50,907 | ||||
| INCOME (LOSS) BEFORE INCOME TAXES AND EQUITY IN EARNINGS OF JOINT VENTURES AND OTHER OPERATING ENTITIES | 4,656 | 3,209 | 3,072 | ||||
| Total income tax expense (benefit) | 1,053 | 507 | 613 | ||||
| INCOME (LOSS) BEFORE EQUITY IN EARNINGS OF JOINT VENTURES AND OTHER OPERATING ENTITIES | 3,603 | 2,702 | 2,459 | ||||
| Equity in earnings of joint ventures and other operating entities, net of taxes | 129 | 144 | 49 | ||||
| NET INCOME (LOSS) | 3,732 | 2,846 | 2,508 | ||||
| Less: Income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests | 156 | 119 | 20 | ||||
| NET INCOME (LOSS) ATTRIBUTABLE TO PRUDENTIAL FINANCIAL, INC. | $ 3,576 | $ 2,727 | $ 2,488 | ||||
| Basic earnings per share-Common Stock: | |||||||
| Net income (loss) attributable to Prudential Financial, Inc. (in dollars per share) | $ 10.05 | $ 7.54 | $ 6.76 | ||||
| Diluted earnings per share-Common Stock: | |||||||
| Net income (loss) attributable to Prudential Financial, Inc. (in dollars per share) | $ 9.99 | $ 7.50 | $ 6.74 | ||||
| |||||||
Consolidated Statements of Comprehensive Income - USD ($) $ in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||
| Statement of Comprehensive Income [Abstract] | |||||
| Net income (loss) | $ 3,732 | $ 2,846 | $ 2,508 | ||
| Other comprehensive income (loss), before tax: | |||||
| Foreign currency translation adjustments for the period | 446 | (852) | (264) | ||
| Net unrealized investment gains (losses) | (653) | (10,125) | 6,219 | ||
| Interest rate remeasurement of future policy benefits | [1] | 5,385 | 11,804 | (8,770) | |
| Gain (loss) from changes in non-performance risk on market risk benefits | (195) | (466) | (693) | ||
| Defined benefit pension and postretirement unrecognized periodic benefit (cost) | (346) | (204) | (27) | ||
| Total | 4,637 | 157 | (3,535) | ||
| Less: Income tax expense (benefit) related to other comprehensive income (loss) | 1,003 | 364 | (837) | ||
| Other comprehensive income (loss), net of taxes | 3,634 | (207) | (2,698) | ||
| Comprehensive income (loss) | 7,366 | 2,639 | (190) | ||
| Less: Comprehensive income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests | 156 | 119 | 20 | ||
| Comprehensive income (loss) attributable to Prudential Financial, Inc. | $ 7,210 | $ 2,520 | $ (210) | ||
| |||||
Consolidated Statements of Equity - USD ($) $ in Millions |
Total |
Common Stock |
Additional Paid-in Capital |
Retained Earnings |
Common Stock Held in Treasury
Common Stock
|
Accumulated Other Comprehensive Income (Loss) |
Total Prudential Financial, Inc. Equity |
Noncontrolling Interests |
redeemable noncontrolling interest |
|---|---|---|---|---|---|---|---|---|---|
| Beginning Balance at Dec. 31, 2022 | $ 30,934 | $ 6 | $ 25,747 | $ 31,714 | $ (23,068) | $ (3,806) | $ 30,593 | $ 341 | $ 985 |
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
| Common Stock acquired | (1,006) | (1,006) | (1,006) | ||||||
| Contributions from noncontrolling interests | 19 | 19 | 190 | ||||||
| Distributions to noncontrolling interests | (40) | (40) | (15) | ||||||
| Consolidations/(deconsolidations) of noncontrolling interests | (36) | (36) | 592 | ||||||
| Stock-based compensation programs | 293 | (1) | 294 | 293 | |||||
| Dividends declared on Common Stock | (1,850) | (1,850) | (1,850) | ||||||
| Comprehensive income: | |||||||||
| Net income (loss) | 2,508 | 2,488 | 2,488 | 6 | 14 | ||||
| Other Comprehensive Income (Loss), Net of Tax | (2,698) | (2,698) | (2,698) | 0 | 0 | ||||
| Total comprehensive income (loss) | (190) | 2,488 | (2,698) | (210) | 6 | 14 | |||
| Ending Balance at Dec. 31, 2023 | 28,110 | 6 | 25,746 | 32,352 | (23,780) | (6,504) | 27,820 | 290 | 1,766 |
| Comprehensive income: | |||||||||
| Net Income (Loss), excluding portion attributable to redeemable noncontrolling interest | 2,494 | ||||||||
| Total comprehensive income (loss) excluding portion attributable to redeemable noncontrolling interest | (204) | ||||||||
| Common Stock acquired | (1,006) | (1,006) | (1,006) | ||||||
| Contributions from noncontrolling interests | 15 | 15 | 203 | ||||||
| Distributions to noncontrolling interests | (63) | (63) | (120) | ||||||
| Consolidations/(deconsolidations) of noncontrolling interests | (3) | (3) | 47 | ||||||
| Stock-based compensation programs | 430 | 155 | 275 | 430 | |||||
| Dividends declared on Common Stock | (1,892) | (1,892) | (1,892) | ||||||
| Net income (loss) | 2,846 | 2,727 | 2,727 | 76 | 43 | ||||
| Other Comprehensive Income (Loss), Net of Tax | (207) | (207) | (207) | 0 | 0 | ||||
| Total comprehensive income (loss) | 2,639 | 2,727 | (207) | 2,520 | 76 | 43 | |||
| Ending Balance at Dec. 31, 2024 | 28,187 | 6 | 25,901 | 33,187 | (24,511) | (6,711) | 27,872 | 315 | 1,939 |
| Comprehensive income: | |||||||||
| Net Income (Loss), excluding portion attributable to redeemable noncontrolling interest | 2,803 | ||||||||
| Total comprehensive income (loss) excluding portion attributable to redeemable noncontrolling interest | 2,596 | ||||||||
| Common Stock acquired | (1,007) | (1,007) | (1,007) | ||||||
| Contributions from noncontrolling interests | 65 | 65 | 435 | ||||||
| Distributions to noncontrolling interests | (68) | (68) | (119) | ||||||
| Consolidations/(deconsolidations) of noncontrolling interests | 30 | 30 | 390 | ||||||
| Stock-based compensation programs | 295 | 112 | 183 | 295 | |||||
| Dividends declared on Common Stock | (1,932) | (1,932) | (1,932) | ||||||
| Net income (loss) | 3,732 | 3,576 | 3,576 | 7 | 149 | ||||
| Other Comprehensive Income (Loss), Net of Tax | 3,634 | 3,634 | 3,634 | 0 | 0 | ||||
| Total comprehensive income (loss) | 7,366 | 3,576 | 3,634 | 7,210 | 7 | 149 | |||
| Ending Balance at Dec. 31, 2025 | 32,787 | $ 6 | $ 26,013 | $ 34,831 | $ (25,335) | $ (3,077) | $ 32,438 | $ 349 | $ 2,794 |
| Comprehensive income: | |||||||||
| Net Income (Loss), excluding portion attributable to redeemable noncontrolling interest | 3,583 | ||||||||
| Total comprehensive income (loss) excluding portion attributable to redeemable noncontrolling interest | $ 7,217 |
Consolidated Statements of Cash Flows - USD ($) $ in Millions |
12 Months Ended | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
||||||||||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||||||||||||||||
| Net income (loss) | $ 3,732 | $ 2,846 | $ 2,508 | |||||||||||||||||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||||||||||||||||
| Realized investment gains(losses), net | [1],[2] | 4,132 | 3,429 | 3,615 | ||||||||||||||||||
| Change in value of market risk benefits, net of related hedging (gains) losses | 475 | 397 | (56) | |||||||||||||||||||
| Policy charges and fee income | (2,028) | (2,128) | (2,186) | |||||||||||||||||||
| Interest credited to policyholders' account balances | 5,068 | 4,582 | 3,983 | |||||||||||||||||||
| Goodwill impairment | 0 | 0 | 177 | |||||||||||||||||||
| Depreciation and amortization | 128 | 383 | ||||||||||||||||||||
| Depreciation and amortization | (70) | |||||||||||||||||||||
| (Gains) losses on assets supporting experience-rated contractholder liabilities, net | (648) | (595) | (503) | |||||||||||||||||||
| Change in: | ||||||||||||||||||||||
| Deferred policy acquisition costs | [2] | (1,215) | (1,111) | (869) | ||||||||||||||||||
| Future policy benefits and other insurance liabilities | 3,493 | 4,803 | 5,489 | |||||||||||||||||||
| Reinsurance related-balances | [2] | (2,263) | (2,731) | (683) | ||||||||||||||||||
| Income Taxes | (493) | (146) | (442) | |||||||||||||||||||
| Derivatives, net | 377 | 897 | (746) | |||||||||||||||||||
| Other, net | [2] | (4,487) | (2,124) | (3,707) | ||||||||||||||||||
| Cash flows from (used in) operating activities | 6,271 | 8,502 | 6,510 | |||||||||||||||||||
| Proceeds from the sale/maturity/prepayment of: | ||||||||||||||||||||||
| Fixed maturities, available-for-sale | 45,218 | 59,059 | 44,097 | |||||||||||||||||||
| Fixed maturities, held-to-maturity | 0 | 0 | 22 | |||||||||||||||||||
| Fixed maturities, trading | 4,151 | 3,398 | 1,559 | |||||||||||||||||||
| Assets supporting experience-rated contractholder liabilities | 1,356 | 1,474 | 2,286 | |||||||||||||||||||
| Equity securities | 7,741 | 5,790 | 4,348 | |||||||||||||||||||
| Commercial mortgage and other loans | 7,762 | 5,466 | 3,985 | |||||||||||||||||||
| Policy loans | 1,846 | 1,972 | 1,806 | |||||||||||||||||||
| Other invested assets | 2,784 | 1,936 | 1,260 | |||||||||||||||||||
| Short-term investments | 33,226 | 33,316 | 32,684 | |||||||||||||||||||
| Payments for the purchase/origination of: | ||||||||||||||||||||||
| Fixed maturities, available-for-sale | (67,592) | (72,997) | (47,580) | |||||||||||||||||||
| Fixed maturities, trading | (6,339) | (7,041) | (4,174) | |||||||||||||||||||
| Assets supporting experience-rated contractholder liabilities | (1,895) | (1,773) | (2,290) | |||||||||||||||||||
| Equity securities | (8,473) | (6,576) | (4,296) | |||||||||||||||||||
| Commercial mortgage and other loans | (9,572) | (9,134) | (6,359) | |||||||||||||||||||
| Policy loans | (1,610) | (1,601) | (1,544) | |||||||||||||||||||
| Other invested assets | (3,074) | (3,884) | (3,049) | |||||||||||||||||||
| Short-term investments | (31,039) | (37,244) | (32,872) | |||||||||||||||||||
| Derivatives, net | (175) | (696) | (1,329) | |||||||||||||||||||
| Other, net | [2] | (207) | (50) | (676) | ||||||||||||||||||
| Cash flows from (used in) investing activities | (25,892) | (28,585) | (12,122) | |||||||||||||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||||||||||||||||
| Policyholders’ account deposits | 39,889 | 35,913 | 28,521 | |||||||||||||||||||
| Policyholders’ account withdrawals | (20,251) | (19,388) | (18,307) | |||||||||||||||||||
| Net change in securities sold under agreements to repurchase and cash collateral for loaned securities | 1,881 | 3,884 | (156) | |||||||||||||||||||
| Cash dividends paid on Common Stock | (1,926) | (1,891) | (1,846) | |||||||||||||||||||
| Net change in financing arrangements (maturities 90 days or less) | 449 | (583) | 10 | |||||||||||||||||||
| Common Stock acquired | (1,000) | (1,000) | (1,012) | |||||||||||||||||||
| Common Stock reissued for exercise of stock options | 109 | 201 | 126 | |||||||||||||||||||
| Proceeds from the issuance of debt (maturities longer than 90 days) | 1,195 | 1,423 | 716 | |||||||||||||||||||
| Repayments of debt (maturities longer than 90 days) | (1,546) | (814) | (1,982) | |||||||||||||||||||
| Proceeds from notes issued by consolidated VIEs | 1,564 | 1,436 | 1,360 | |||||||||||||||||||
| Repayments of notes issued by consolidated VIEs | (439) | (617) | (336) | |||||||||||||||||||
| Other, net | [2] | 848 | 830 | 645 | ||||||||||||||||||
| Cash flows from (used in) financing activities | 20,773 | 19,394 | 7,739 | |||||||||||||||||||
| Effect of foreign exchange rate changes on cash balances | 77 | (254) | 37 | |||||||||||||||||||
| NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS | 1,229 | (943) | 2,164 | |||||||||||||||||||
| CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, BEGINNING OF YEAR | 18,520 | 19,463 | 17,299 | |||||||||||||||||||
| CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, END OF YEAR | 19,749 | 18,520 | 19,463 | |||||||||||||||||||
| SUPPLEMENTAL CASH FLOW INFORMATION | ||||||||||||||||||||||
| Income taxes paid, net of refunds | 1,398 | [3] | 756 | 895 | ||||||||||||||||||
| Interest paid | 1,907 | 1,995 | 1,555 | |||||||||||||||||||
| NON-CASH TRANSACTIONS DURING THE YEAR | ||||||||||||||||||||||
| Treasury Stock shares issued for stock-based compensation programs | 187 | 217 | 282 | |||||||||||||||||||
| Assets transferred upon surrender of IRA contracts | 0 | 0 | 2,019 | [4] | ||||||||||||||||||
| RECONCILIATION TO THE CONSOLIDATED STATEMENTS OF FINANCIAL POSITION | ||||||||||||||||||||||
| Cash and cash equivalents | 19,712 | [5] | 18,497 | [5] | 19,419 | |||||||||||||||||
| Restricted cash and restricted cash equivalents (included in “Other assets”) | 37 | 23 | 44 | |||||||||||||||||||
| Total cash, cash equivalents, restricted cash and restricted cash equivalents | 19,749 | 18,520 | 19,463 | |||||||||||||||||||
| Novation of annuity contracts from FLIAC | ||||||||||||||||||||||
| NON-CASH TRANSACTIONS DURING THE YEAR | ||||||||||||||||||||||
| Novation of contracts under reinsurance agreement | 0 | 0 | 491 | [6] | ||||||||||||||||||
| Novation of investment contracts to Empower | ||||||||||||||||||||||
| NON-CASH TRANSACTIONS DURING THE YEAR | ||||||||||||||||||||||
| Novation of contracts under reinsurance agreement | 2,157 | [7] | 0 | 0 | ||||||||||||||||||
| Significant pension risk transfer transactions: | ||||||||||||||||||||||
| NON-CASH TRANSACTIONS DURING THE YEAR | ||||||||||||||||||||||
| Assets received, excluding Cash and cash equivalents | 108 | 11,693 | 2,264 | |||||||||||||||||||
| Liabilities assumed | 489 | 16,020 | 3,257 | |||||||||||||||||||
| Net cash received / (paid) | 381 | 4,327 | 993 | |||||||||||||||||||
| Prismic Re | ||||||||||||||||||||||
| NON-CASH TRANSACTIONS DURING THE YEAR | ||||||||||||||||||||||
| Net assets transferred, excluding Cash and cash equivalent | 0 | 0 | [8] | 1,351 | [8] | |||||||||||||||||
| Payables established under coinsurance with funds withheld | 0 | 102 | [8] | 8,185 | [8] | |||||||||||||||||
| Reinsurance recoverables established for Future policy benefits ceded | 0 | 0 | [8] | (5,584) | [8] | |||||||||||||||||
| Deposit assets established for Policyholders' account balances ceded | 0 | 0 | [8] | (3,723) | [8] | |||||||||||||||||
| Unwind of Deferred policy acquisition costs ceded | 0 | 0 | [8] | 23 | [8] | |||||||||||||||||
| Deferred reinsurance loss | 0 | (102) | [8] | (240) | [8] | |||||||||||||||||
| Net cash received / (paid) | 0 | 0 | [8] | 12 | [8] | |||||||||||||||||
| Somerset Re | ||||||||||||||||||||||
| NON-CASH TRANSACTIONS DURING THE YEAR | ||||||||||||||||||||||
| Reinsurance recoverable | 0 | (578) | [8] | 0 | ||||||||||||||||||
| Unwind of Deferred policy acquisition costs ceded | 0 | 284 | [8] | 0 | ||||||||||||||||||
| Deferred reinsurance gain | 0 | 363 | [8] | 0 | ||||||||||||||||||
| Net cash received / (paid) | 0 | 69 | [8] | 0 | ||||||||||||||||||
| Wilton Re | ||||||||||||||||||||||
| NON-CASH TRANSACTIONS DURING THE YEAR | ||||||||||||||||||||||
| Net assets transferred, excluding Cash and cash equivalent | 0 | 6,679 | [8] | 0 | ||||||||||||||||||
| Policy loans ceded | 0 | 44 | [8] | 0 | ||||||||||||||||||
| Reinsurance recoverable | 0 | (7,362) | [8] | 0 | ||||||||||||||||||
| Unwind of Deferred policy acquisition costs ceded | 0 | 699 | [8] | 0 | ||||||||||||||||||
| Deferred reinsurance loss | 0 | (980) | [8] | 0 | ||||||||||||||||||
| Reinsurance payables | 0 | 175 | [8] | 0 | ||||||||||||||||||
| Net cash received / (paid) | 0 | (745) | [8] | 0 | ||||||||||||||||||
| Prismic Re International | ||||||||||||||||||||||
| NON-CASH TRANSACTIONS DURING THE YEAR | ||||||||||||||||||||||
| Net assets transferred, excluding Cash and cash equivalent | 6,069 | [8] | 0 | 0 | ||||||||||||||||||
| Deposit assets established for Policyholders' account balances ceded | (6,366) | [8] | 0 | 0 | ||||||||||||||||||
| Unwind of Deferred policy acquisition costs ceded | 219 | [8] | 0 | 0 | ||||||||||||||||||
| Net cash received / (paid) | $ (78) | [8] | $ 0 | $ 0 | ||||||||||||||||||
| ||||||||||||||||||||||
Unaudited Interim Consolidated Statements of Operations (Parenthetical) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Income Statement [Abstract] | |||
| Gain (loss) from changes in estimates on deferred profit liability amortization | $ 122 | $ 73 | $ 323 |
Business and Basis of Presentation |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| Business and Basis of Presentation | BUSINESS AND BASIS OF PRESENTATION Prudential Financial, Inc. (“Prudential Financial”) and its subsidiaries (collectively, “Prudential” or the “Company”) provide a wide range of insurance, investment management, and other financial products and services to both individual and institutional customers throughout the United States and in many other countries. Principal products and services provided include life insurance, annuities, retirement solutions, mutual funds and investment management. The Company’s principal operations consist of PGIM (the Company’s global investment management business), the U.S. Businesses (consisting of the Retirement Strategies, Group Insurance and Individual Life businesses), the International Businesses, the Closed Block division, and the Company’s Corporate and Other operations. The Closed Block division is accounted for as a divested business that is reported separately from the Divested and Run-off Businesses that are included within Corporate and Other operations. Divested and Run-off Businesses consist of businesses that have been, or will be, sold or exited, including businesses that have been placed in wind-down status that do not qualify for “discontinued operations” accounting treatment under U.S. GAAP. The Company’s Corporate and Other operations include corporate items and initiatives that are not allocated to business segments as well as the Divested and Run-off Businesses described above. Effective in the first quarter of 2025, consistent with changes to the Company’s internal management structure, the Company’s International Businesses are reflected as a single operating and reportable segment, which is how the chief operating decision maker (“CODM”) now assesses its performance and allocates resources. Prior to the first quarter of 2025, International Businesses consisted of the Life Planner and Gibraltar Life and Other operating segments, each of which was a reportable segment under U.S. GAAP. The change has been applied retrospectively and did not have any impact on the Company’s Consolidated Financial Statements contained herein or to any previously issued financial statements. See Note 23 for additional information regarding the Company’s segments. In the third quarter of 2023, the Company, through its Corporate and Other operations, acquired a 20% equity interest as a limited partner, in Prismic Life Holding Company LP (“Prismic”), a Bermuda-exempted limited partnership that owns all of the outstanding capital stock of Prismic Life Reinsurance, Ltd. (“Prismic Re”) and Prismic Life Reinsurance International, Ltd. (“Prismic Re International”), which are licensed Bermuda-based life and annuity reinsurance companies. Beginning with the fourth quarter of 2023, the operating results of Corporate and Other reflect the Company’s share of earnings in Prismic on a quarter lag. As this investment is accounted for under the equity method, Prismic, Prismic Re, and Prismic Re International are considered related parties. For additional information regarding related party transactions, see Note 24. For information regarding the Company’s reinsurance transactions with Prismic Re and Prismic Re International, see Note 15. As part of its continuous improvement process, the Company is working to become a leaner and more agile company by simplifying its management structure, empowering its employees with faster decision-making processes and investing in technology and data platforms. As part of this, the Company recorded charges of $135 million in the fourth quarter of 2025 and $200 million in the fourth quarter of 2023 to “” within its Corporate and Other operations. These actions, primarily related to its domestic operations and PGIM, reflect management’s ongoing efforts in evaluating the optimal workforce structure required to deliver on its long-term growth strategy. The Company expects these continued actions will create operating efficiencies, and provide reinvestment capacity to build capabilities, realize additional efficiencies, strengthen its competitiveness and fuel future growth. In February 2026, in conjunction with its previously announced internal investigation into employee misconduct in Japan, the Company voluntarily suspended new sales activity at Prudential of Japan for a 90-day period, commencing February 9, 2026. See “—Litigation and Regulatory Matters—Regulatory” within Note 25 for additional information. Basis of Presentation The Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). The Consolidated Financial Statements include the accounts of Prudential Financial, entities over which the Company exercises control, including majority-owned subsidiaries and minority-owned entities such as limited partnerships in which the Company is the general partner and variable interest entities (“VIEs”) in which the Company is considered the primary beneficiary. See Note 4 for additional information regarding the Company’s consolidated variable interest entities. Intercompany balances and transactions have been eliminated. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The most significant estimates include those used in determining future policy benefits; policyholders’ account balances related to the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products; market risk benefits; the measurement of goodwill and any related impairment; the valuation of investments including derivatives, the measurement of allowance for credit losses, and the recognition of other-than-temporary impairments (“OTTI”); pension and other postretirement benefits; any provision for income taxes and valuation of deferred tax assets; and accruals for contingent liabilities, including estimates for losses in connection with unresolved legal and regulatory matters. Out of Period Adjustments In the first quarter of 2025, the Company recorded out of period adjustments resulting in a net charge of $150 million to “Income (loss) from operations before income taxes and equity in earnings of joint ventures and other operating entities” for the year ended 2025. The adjustments included an overstatement of “Reinsurance recoverables and deposit receivables” and an understatement of “Deferred policy acquisition costs.” The impact of these adjustments, individually and in the aggregate, was not material to any previously reported annual financial statements and is not material to the 2025 annual financial statements.
|
Significant Accounting Policies and Pronouncements |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Significant Accounting Policies and Pronouncements | SIGNIFICANT ACCOUNTING POLICIES AND PRONOUNCEMENTS ASSETS Fixed maturities, available-for-sale, at fair value (“AFS debt securities”) includes bonds, notes and redeemable preferred stock that are carried at fair value. See Note 6 for additional information regarding the determination of fair value. The purchased cost of fixed maturities is adjusted for amortization of premiums and accretion of discounts to maturity or, if applicable, call date. AFS debt securities, where fair value is below amortized cost, are reviewed quarterly to determine whether the amortized cost basis of the security is recoverable. For mortgage-backed and asset-backed AFS debt securities, a credit impairment will be recognized in earnings as an allowance for credit losses and reported in “Realized investment gains (losses), net,” to the extent the amortized cost exceeds the net present value of projected future cash flows (the “net present value”) for the security. For all other AFS debt securities, qualitative factors are first considered including, but not limited to, the extent of the decline and the reasons for the decline in value (e.g., credit events, currency or interest-rate related, including general credit spread widening), and the financial condition of the issuer. If analysis of these qualitative factors results in the security needing to be impaired, a credit impairment will be recognized in earnings as an allowance for credit losses and reported in “Realized investment gains (losses), net,” to the extent the amortized cost exceeds the net present value of projected future cash flows (the “net present value”) for the security. A credit impairment recorded cannot exceed the difference between the amortized cost and fair value of the respective security. The net present value used to measure a credit impairment is calculated by discounting the Company’s best estimate of projected future cash flows at the effective interest rate implicit in the AFS debt security at the date of acquisition. Once the Company has deemed all or a portion of the amortized cost uncollectible, the allowance is removed from the balance sheet by writing down the amortized cost basis of the AFS debt security. Any amount of an AFS debt security’s change in fair value not recorded as an allowance for credit losses will be recorded in Other Comprehensive Income (loss) (“OCI”). When an AFS debt security’s fair value is below amortized cost and the Company has the intent to sell the AFS debt security, or it is more likely than not the Company will be required to sell the AFS debt security before its anticipated recovery, the amortized cost basis of the AFS debt security is written down to fair value and any previously recognized allowance is reversed. The write-down is reported in “Realized investment gains (losses), net.” Interest income, including amortization of premium and accretion of discount, are included in “Net investment income” under the effective yield method. Prepayment premiums are also included in “Net investment income.” For high credit quality mortgage-backed and asset-backed AFS debt securities (those rated AA or above), the amortized cost and effective yield of the securities are adjusted as necessary to reflect historical prepayment experience and changes in estimated future prepayments. The adjustments to amortized cost are recorded as a charge or credit to “Net investment income” in accordance with the retrospective method. For mortgage-backed and asset-backed AFS debt securities rated below AA, the effective yield is adjusted prospectively for any changes in the estimated timing and amount of cash flows unless the investment is purchased with credit deterioration or an allowance is currently recorded for the respective security. If an investment is impaired, any changes in the estimated timing and amount of cash flows will be recorded as the credit impairment, as opposed to a yield adjustment. If the asset is purchased with credit deterioration (or previously impaired), the effective yield will be adjusted if there are favorable changes in cash flows subsequent to the allowance being reduced to zero. For mortgage-backed and asset-backed AFS debt securities, cash flow estimates consider the payment terms of the underlying assets backing a particular security, including interest rate and prepayment assumptions based on data from widely accepted third-party data sources or internal estimates. In addition to interest rate and prepayment assumptions, cash flow estimates also include other assumptions regarding the underlying collateral including default rates and recoveries, which vary based on the asset type and geographic location, as well as the vintage year of the security. These assumptions can significantly impact income recognition, unrealized gains and loss recorded in OCI, and the amount of impairment recognized in earnings. The payment priority of the respective security is also considered. For all other AFS debt securities, cash flow estimates are driven by assumptions regarding probability of default and estimates regarding timing and amount of recoveries associated with a default. The Company has developed these estimates using information based on its historical experience as well as using market observable data, such as industry analyst reports and forecasts, sector credit ratings and other data relevant to the collectability of a security, such as the general payment terms of the security and the security’s position within the capital structure of the issuer. Fixed maturities, trading, at fair value (“Trading debt securities”) includes debt securities that are carried at fair value, such as fixed maturities with embedded features that are considered derivatives and assets contained within consolidated variable interest entities. See Note 6 for additional information regarding the determination of fair value. Realized and unrealized gains and losses for these investments are reported in “Other income (loss),” and interest income from these investments is reported in “Net investment income.” Assets supporting experience-rated contractholder liabilities, at fair value includes invested assets that consist of fixed maturities, equity securities, short-term investments and cash equivalents, that support certain products which are experience-rated, meaning that the investment results associated with these products are expected to ultimately accrue to contractholders. Realized and unrealized gains and losses for these investments are reported in “Other income (loss).” Interest and dividend income from these investments is reported in “Net investment income.” Equity securities, at fair value consists of common stock, mutual fund shares and non-redeemable preferred stock carried at fair value. Realized and unrealized gains and losses on these investments are reported in “Other income (loss),” and dividend income is reported in “Net investment income” on the ex-dividend date. Commercial mortgage and other loans consists of commercial mortgage loans, agricultural property loans, residential mortgage loans, as well as certain other collateralized and uncollateralized loans. Uncollateralized loans primarily represent reverse dual currency loans and corporate loans held by the Company’s international insurance operations. Commercial mortgage and other loans originated and held for investment are generally carried at unpaid principal balance, net of unamortized deferred loan origination fees and expenses, and net of any current expected credit loss (“CECL”) allowance. Certain off-balance sheet credit exposures (e.g., indemnification of serviced mortgage loans, and certain unfunded mortgage loan commitments where the Company cannot unconditionally cancel the commitment) are also subject to a CECL allowance. See Note 25 for additional information. The Company carries certain commercial mortgage loans originated within the Company’s commercial mortgage operations at fair value where the fair value option has been elected. Loans held for sale where the Company has not elected the fair value option are carried at the lower of cost or fair value. Commercial mortgage and other loans acquired, including those related to the acquisition of a business, are recorded at fair value when purchased, reflecting any premiums or discounts to unpaid principal balances. Interest income, and the amortization of the related premiums or discounts, are included in “Net investment income” under the effective yield method. Prepayment fees are also included in “Net investment income.” The CECL allowance represents the Company’s best estimate of expected credit losses over the remaining life of the assets or off-balance sheet credit exposures. The determination of the allowance considers historical credit loss experience, current conditions, and reasonable and supportable forecasts. The allowance is calculated separately for commercial mortgage loans, agricultural property loans, residential mortgage loans, and other collateralized and uncollateralized loans. For commercial mortgage and agricultural property loans, the allowance is calculated using an internally developed CECL model that pools together loans that share similar risk characteristics. Similar risk characteristics used to create the pools include, but are not limited to, vintage, maturity, credit rating, and collateral type. Key inputs to the CECL model include unpaid principal balances, internal credit ratings, annual expected loss factors, average lives of the loans adjusted for prepayment considerations, current and historical interest rate assumptions, and other factors influencing the Company’s view of the current stage of the economic cycle and future economic conditions. Subjective considerations include a review of whether historical loss experience is representative of current market conditions and the Company’s view of the credit cycle. Model assumptions and factors are reviewed and updated as appropriate. Information about certain key inputs is detailed below. Key factors in determining the internal credit ratings for commercial mortgage and agricultural property loans include loan-to-value and debt-service-coverage ratios. Other factors include amortization, loan term, and estimated market value growth rate and volatility for the property type and region. The loan-to-value ratio compares the carrying amount of the loan to the fair value of the underlying property or properties collateralizing the loan, and is commonly expressed as a percentage. Loan-to-value ratios greater than 100% indicate that the carrying amount of the loan exceeds the collateral value. A loan-to-value ratio less than 100% indicates an excess of collateral value over the carrying amount of the loan. The debt service coverage ratio is a property’s net operating income as a percentage of its debt service payments. Debt service coverage ratios less than 1.0 indicates that property operations do not generate enough income to cover the loan’s current debt payments. A debt service coverage ratio greater than 1.0 indicates an excess of net operating income over the debt service payments. The values utilized in calculating these ratios are developed as part of the Company’s periodic review of the commercial mortgage loan and agricultural property loan portfolios, which includes an internal appraisal of the underlying collateral value. The Company’s periodic review also includes a quality re-rating process, whereby the internal quality rating originally assigned at underwriting is updated based on current loan, property and market information using a proprietary quality rating system. See Note 3 for additional information related to the loan-to-value ratios and debt service coverage ratios related to the Company’s commercial mortgage and agricultural property loan portfolios. Annual expected loss rates are based on historical default and loss experience factors. Using average lives, the annual expected loss rates are converted into life-of-loan loss expectations. When individual loans no longer have the credit risk characteristics of the commercial mortgage or agricultural property loan pools, they are removed from the pools and are evaluated individually for an allowance. The allowance is determined based on the outstanding loan balance less the present value of expected future cash flows discounted at the loan’s effective interest rate or the fair value of the collateral if the loan is collateral dependent. For residential mortgage loans, the allowance is calculated using an internally developed CECL model that pools together loans that share similar risk characteristics. The estimated lifetime loss of the pool is calculated from the risk profiles of the loans, including borrower credit score, loan-to-value ratio, property type, and several key attributes of the loan and property including: loan type, loan age, loan performance history, and current performing or nonperforming status. Estimated lifetime loss rates are calculated by weighting projected losses in multiple economic scenarios based on the Company’s view of the current stage of the economic cycle and future economic conditions. The scenario losses are calibrated to industry historical experience of defaults, loss severities, and prepayment rates in multiple economic cycles, reflective of similar loan characteristics. When individual loans become nonperforming, the allowance is determined based on annual expected loss rates for nonperforming loans or the fair value of the collateral if the loan is collateral dependent. The Company defines nonperforming residential mortgage loans as those that are 90 days or more past due and/or in nonaccrual status. The CECL allowance for other collateralized and uncollateralized loans (e.g., corporate loans) carried at amortized cost is determined based on probability of default and loss given default assumptions by sector, credit quality and average lives of the loans. The CECL allowance on commercial mortgage and other loans can increase or decrease from period to period based on the factors noted above. The change in allowance is reported in “Realized investment gains (losses), net.” As it relates to unfunded commitments that are in scope of this guidance, the CECL allowance is reported in “Other liabilities,” and the change in the allowance is reported in “Realized investment gains (losses), net.” Once the Company has deemed a portion of the amortized cost to be uncollectible, the uncollectible portion of allowance is removed from the balance sheet by writing down the amortized cost basis of the loan. The carrying amount of the loan is not adjusted for subsequent recoveries in value. Interest received on loans that are past due is either applied against the principal or reported as net investment income based on the Company’s assessment as to the collectability of the principal. The Company defines “past due” as principal or interest not collected at least 30 days past the scheduled contractual due date. See Note 3 for additional information about the Company’s past due loans. The Company discontinues accruing interest on loans after the loans become 90 days delinquent as to principal or interest payments, or earlier when the Company has doubts about collectability. When the Company discontinues accruing interest on a loan, any accrued but uncollectible interest on the loan and other loans backed by the same collateral, if any, is charged against interest income in the same period. Generally, a loan is restored to accrual status only after all delinquent interest and principal are brought current and, in the case of loans where the payment of interest has been interrupted for a substantial period, or the loan has been modified, a regular payment performance has been established. Commercial mortgage and other loans are occasionally restructured. These restructurings generally include one or more of the following: full or partial payoffs outside of the original contract terms; changes to interest rates; extensions of maturity; or additions or modifications to covenants. Additionally, the Company may accept assets in full or partial satisfaction of the debt. All restructurings are evaluated under the modification guidance in ASC 310-20. When a loan is modified, the Company evaluates whether the restructuring results in a continuation of the existing loan or a new loan. For modifications that result in a continuation of the existing loan, the CECL allowance of the loan is remeasured using the modified terms, including the loan’s post-modification effective yield, and the allowance is adjusted accordingly. For modifications that result in a new loan, any CECL allowance is reversed and a direct write-down of the loan is recorded for the amount of the allowance, and any additional loss, net of recoveries, or any gain is recorded for the difference between the fair value of the new loan and the recorded investment in the loan. The new loan is evaluated prospectively for credit impairment based on the CECL allowance process noted above. The Company’s PGIM business provides commercial mortgage origination, underwriting and servicing for certain government sponsored entities (“GSEs”). The Company has agreed to indemnify the GSEs for a portion of the credit risk associated with certain of the mortgages it services. Management has established a CECL allowance that factors in historical loss information, current conditions and reasonable and supportable forecasts. The allowance also considers the remaining lives of the loans subject to the indemnification. The CECL allowance is included in “Other liabilities” and changes in the CECL allowance are reported in “Realized investment gains (losses), net.” See Note 25 for additional information. Policy loans represents funds loaned to policyholders up to the cash surrender value of the associated insurance policies and are carried at the unpaid principal balances due to the Company from the policyholders. Interest income on policy loans is recognized in “Net investment income” at the contract interest rate when earned. Policy loans are fully collateralized by the cash surrender value of the associated insurance policies. Other invested assets consists of the Company’s non-coupon investments in limited partnerships and limited liability companies (“LPs/LLCs”), other than joint ventures and other operating entities, as well as wholly-owned investment real estate, derivative assets and other investments. LPs/LLCs interests are accounted for using either the equity method of accounting, or at fair value with changes in fair value reported in “Other income (loss).” The Company’s income from investments in LPs/LLCs accounted for using the equity method, other than the Company’s investments in joint ventures and other operating entities, is included in “Net investment income.” The carrying value of these investments is written down, or impaired, to fair value when a decline in value is considered to be other-than-temporary. In applying the equity method (including assessment for OTTI), the Company uses financial information provided by the investee, generally on a one to three-month lag. The Company consolidates LPs/LLCs in certain other instances where it is deemed to exercise control, or is considered the primary beneficiary of a variable interest entity. See Note 4 for additional information about VIEs. The Company’s wholly-owned investment real estate consists of real estate which the Company has the intent to hold for the production of income as well as real estate held for sale. Real estate which the Company has the intent to hold for the production of income is carried at depreciated cost less any write-downs to fair value for impairment losses and is reviewed for impairment whenever events or circumstances indicate that the carrying value may not be recoverable. Real estate held for sale is carried at the lower of depreciated cost or fair value less estimated selling costs and is not further depreciated once classified as such. An impairment loss is recognized when the carrying value of the investment real estate exceeds the estimated undiscounted future cash flows (excluding interest charges) from the investment. At that time, the carrying value of the investment real estate is written down to fair value. Decreases in the carrying value of investment real estate held for the production of income due to OTTI are recorded in “Realized investment gains (losses), net.” Depreciation on real estate held for the production of income is computed using the straight-line method over the estimated useful lives of the properties and is included in “Net investment income.” Short-term investments primarily consists of highly liquid debt instruments with a maturity of twelve months or less and greater than three months when purchased, other than those debt instruments meeting this definition that are included in “Assets supporting experience-rated contractholder liabilities, at fair value.” These investments are generally carried at fair value or amortized cost that approximates fair value and include certain money market investments, funds managed similar to regulated money market funds, short-term debt securities issued by government-sponsored entities and other highly liquid debt instruments. Cash and cash equivalents includes cash on hand, amounts due from banks, certain money market investments, funds managed similar to regulated money market funds, other debt instruments with maturities of three months or less when purchased, other than cash equivalents that are included in “Assets supporting experience-rated contractholder liabilities, at fair value,” and receivables related to securities purchased under agreements to resell (see also “Securities sold under agreements to repurchase” below). These assets are generally carried at fair value or amortized cost which approximates fair value. Accrued investment income primarily includes accruals of interest and dividend income from investments that have been earned but not yet received. Deferred policy acquisition costs (“DAC”) represents costs directly related to the successful acquisition of new and renewal insurance and annuity business. Such DAC primarily includes commissions, costs of policy issuance and underwriting, and certain other expenses that are directly related to successfully acquired contracts. In each reporting period, previously capitalized DAC is amortized and included in “Amortization of deferred policy acquisition costs.” DAC for most long-duration contracts is amortized on a constant-level basis at a grouped contract level over the expected life of the underlying insurance contracts. Contracts are grouped consistent with the groupings used to estimate the liability for future policy benefits (or other related balances) for the corresponding contracts. Since contracts within a grouping may be of different sizes, contracts within a group are weighted to achieve appropriate amortization and to ensure that DAC is derecognized when a policy is no longer in force. The constant-level basis used to weight contracts within a grouping and amortize DAC is generally defined as follows: •Life insurance contracts – DAC associated with life insurance contracts is generally amortized in proportion to the initial face amount of life insurance in force. This is applicable to traditional and universal life insurance products in the Individual Life and International Businesses segments and Closed Block division, and group corporate- and bank-owned life insurance contracts in the Group Insurance segment. •Payout annuity contracts – DAC associated with payout annuity contracts in the Retirement Strategies segment is amortized in proportion to annual benefit payments. •Deferred annuity contracts – DAC associated with fixed and variable deferred annuity contracts in the Retirement Strategies and International Businesses segments is amortized in proportion to deposits. •Health contracts – DAC associated with health contracts in the International Businesses segment is generally amortized in proportion to maximum lifetime benefits. For funding agreement note contracts, single premium structured settlement contracts without life contingencies, and single premium immediate annuities without life contingencies, acquisition expenses are deferred and amortized over the expected life of the contracts using the interest method. For other group life and disability insurance contracts and guaranteed investment contracts (“GICs”), acquisition costs are expensed as incurred. Current period DAC amortization reflects the impact of changes in actual insurance in force during the period and changes in future assumptions effected as of the end of the quarter, where applicable. The Company typically updates actuarial assumptions annually in the second quarter, unless a material change is observed in an interim period that is indicative of a long-term trend. Generally, the Company does not expect trends to change significantly in the short-term and, to the extent these trends may change, the Company expects such changes to be gradual over the long-term. Assumptions used for DAC are consistent with those used in estimating the liability for future policy benefits (or any other related balance) for the corresponding contract. Determining the level of aggregation and actuarial assumptions used in projecting in-force terminations requires judgment. Internal criteria are developed to determine the level of aggregation by considering both qualitative and quantitative materiality thresholds. The assumptions used in projecting in-force terminations are mortality, mortality improvement, and lapse assumptions. These assumptions are generally based on the Company’s experience, industry experience and/or other factors, as applicable. For variable deferred annuity contracts, lapse rates are adjusted at the contract level based on the in-the-moneyness of the living benefits and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. For some products, policyholders can elect to modify product benefits, features, rights or coverages by exchanging a contract for a new contract or by amendment, endorsement, or rider to a contract, or by the election of a feature or coverage within a contract. These transactions are known as internal replacements. If policyholders surrender traditional life insurance policies in exchange for life insurance policies that do not have fixed and guaranteed terms, the Company immediately charges to expense the remaining unamortized DAC on the surrendered policies. For other internal replacement transactions, except those that involve the addition of a non-integrated contract feature that does not change the existing base contract, the unamortized DAC is immediately charged to expense if the terms of the new policies are not substantially similar to those of the former policies. If the new terms are substantially similar to those of the earlier policies, the DAC is retained with respect to the new policies and amortized over the expected life of the new policies. See Note 7 for additional information regarding DAC. Value of business acquired (“VOBA”) represents identifiable intangible assets to which a portion of the purchase price in a business acquisition is attributed under the application of purchase accounting. VOBA represents an adjustment to the stated value of in-force insurance contract liabilities to present them at fair value, determined as of the acquisition date. VOBA balances are subject to recoverability testing in the manner in which they were acquired. The Company has established a VOBA asset primarily for its acquired life insurance products and accident and health products with fixed benefits. As of December 31, 2025, the majority of the VOBA balance relates to the 2011 acquisition of AIG Star Life Insurance Co., Ltd, AIG Edison Life Insurance Company, AIG Financial Assurance Japan K.K. and AIG Edison Service Co., Ltd. (collectively, the “Star and Edison Businesses”). The Company records amortization of VOBA in “General and administrative expenses” and amortizes it over the anticipated life of the acquired contracts using the same methodology, factors, and assumptions used to amortize DAC and deferred sales inducements (“DSI”). See Note 7 for additional information regarding VOBA. Market risk benefit assets represents market risk benefits (“MRBs”) in an asset position and are presented separately from MRBs in a liability position. See “Market risk benefit liabilities” below. MRB assets also reflect ceded MRBs resulting from reinsurance of the Company’s Prudential Defined Income (“PDI”) traditional variable annuity contracts. See Note 15 for additional information regarding the reinsurance of PDI. Reinsurance recoverables and deposit receivables includes amounts recoverable under reinsurance agreements and receivables that follow the deposit method of accounting (see “Reinsurance” below). Other assets consists primarily of prepaid pension benefit costs (see Note 19), certain restricted assets (e.g., cash and cash equivalents), trade receivables, goodwill and other intangible assets, “right-of-use” lease assets (see “Other liabilities” below), DSI, the Company’s investments in joint ventures and other operating entities, property and equipment, deferred reinsurance losses (“DRL”) (see “Reinsurance” below) and receivables resulting from sales of securities that had not yet settled at the balance sheet date. Property and equipment are carried at cost less accumulated depreciation. Depreciation is determined using the straight-line method over the estimated useful lives of the related assets, which generally range from 3 to 40 years. As a result of certain acquisitions, the Company recognizes an asset for goodwill representing the excess of cost over the net fair value of the assets acquired and liabilities assumed. Goodwill is assigned to reporting units at the date the goodwill is initially recorded. A reporting unit is an operating segment, or a unit one level below the operating segment if discrete financial information is prepared and regularly reviewed by management at that level. Once goodwill has been assigned to reporting units, it no longer retains its association with a particular acquisition, and all of the activities within a reporting unit, whether acquired or organically grown, are available to support the value of the goodwill. The Company tests goodwill for impairment annually as of December 31 and more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Accounting guidance provides for an optional qualitative assessment for testing goodwill impairment that may allow companies to skip the quantitative test. As part of the annual goodwill impairment test, the Company estimates the fair value of the reporting units by applying the quantitative test, which involves comparing each reporting unit’s fair value to its carrying value including goodwill. If the fair value of a reporting unit exceeds its carrying value, the applicable goodwill is considered not to be impaired. If the carrying value exceeds fair value, goodwill is reduced and an impairment charge to income is recognized for the excess. The measurement of a goodwill impairment loss includes the related income tax effect from any tax deductible goodwill. The impairment loss cannot exceed the amount of goodwill assigned to a reporting unit, and the loss establishes a new basis in the goodwill. Subsequent reversal of goodwill impairment losses is not permitted. Management is required to make significant estimates in determining the fair value of a reporting unit including, but not limited to: projected revenues and operating margins, applicable discount and growth rates, and comparative market multiples. See Note 10 for additional information regarding goodwill. Deferred Sales Inducements are amounts that are credited to a policyholders’ account balance primarily as an inducement to purchase fixed and/or variable deferred annuity contracts. The Company defers sales inducements and amortizes them over the expected life of the policy using the same methodology, factors and assumptions used to amortize DAC. The Company records amortization of DSI in “Interest credited to policyholders’ account balances.” Unlike DAC, DSI are considered contractual cash flows and, as a result, are subject to periodic recoverability testing. See Note 7 for additional information regarding DSI. Identifiable intangible assets primarily include customer relationships and mortgage servicing rights and are recorded net of accumulated amortization. The Company tests identifiable intangible assets for impairment on an annual basis as of December 31 of each year or whenever events or circumstances suggest that the carrying value of an identifiable intangible asset may exceed the sum of the undiscounted cash flows expected to result from its use and eventual disposition. If this condition exists and the carrying value of an identifiable intangible asset exceeds its fair value, the excess is recognized as an impairment and is recorded as a charge against net income. Measuring intangible assets requires the use of estimates. Significant estimates include the projected net cash flow attributable to the intangible asset and the rate at which future net cash flows are discounted for purposes of estimating fair value, as applicable. See Note 10 for additional information regarding identifiable intangible assets. Investments in joint ventures and other operating entities are generally accounted for under the equity method. The carrying value of these investments is written down, or impaired, to fair value when a decline in value is considered to be other-than-temporary. See Note 9 for additional information regarding investments in joint ventures and other operating entities. Leases are recorded on the balance sheet as “right-of-use” assets and lease liabilities within “Other assets” and “Other liabilities” respectively. Leases are classified as either operating or finance leases and lease expense is recognized within “General and administrative expenses.” As a lessee, for operating leases, total lease expense is recognized using a straight-line method. Finance leases are treated as the purchase of an asset on a financing basis. Additionally, as a lessor, for sales-type and direct financing leases, the Company derecognizes the carrying value of the leased asset that is considered to have been transferred to a lessee and records a lease receivable and residual asset (“receivable and residual” approach). See Note 11 for additional information regarding leases. Separate account assets represents segregated funds that are invested for certain policyholders, pension funds and other customers. The assets consist primarily of equity securities, fixed maturities, real estate-related investments, real estate mortgage loans, short-term investments and derivative instruments and are reported at fair value. The assets of each account are legally segregated and are not subject to claims that arise out of any other business of the Company. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. The investment income and realized investment gains or losses from separate account assets generally accrue to the policyholders and are not included in the Company’s results of operations. Mortality, policy administration and surrender charges assessed against the accounts are included in “Policy charges and fee income.” Asset management fees charged to the accounts are included in “Asset management and service fees.” Seed money that the Company invests in separate accounts is reported in the appropriate general account asset line. Investment income and realized investment gains or losses from seed money invested in separate accounts accrue to the Company and are included in the Company’s results of operations. See Note 8 for additional information regarding separate account arrangements with contractual guarantees. See also “Separate account liabilities” below. LIABILITIES Future policy benefits primarily consists of the present value of expected future payments to or on behalf of policyholders, where the timing and amount of such payments depend on policyholder mortality or morbidity, less the present value of expected future net premiums (where net premiums are gross premiums multiplied by the Net-To-Gross (“NTG”) ratio discussed below). The liability for future policy benefits is accrued over time as premium revenue is recognized. See Note 12 for additional information regarding future policy benefits. The reserving methodology used for non-participating traditional and limited-payment contracts include the following: •Cash Flow Assumptions. In measuring the liability for future policy benefits, the net premium valuation methodology is utilized. Under this methodology, a liability for future policy benefits is established using current best estimate insurance assumptions and interest rate assumptions locked-in at contract issuance date. The NTG ratio is calculated as the ratio of the present value of expected policy benefits and non-level claim settlement expenses divided by the present value of expected gross premiums. The NTG ratio is applied to gross premiums, as premium revenue is recognized, to determine net premiums. The liability is then determined as the present value of expected future policy benefits and non-level claim settlement expenses less the present value of expected future net premiums. The result of the net premium valuation methodology is that the liability at any point in time represents an accumulation of the portion of premiums received to date expected to fund future benefits (i.e., net premiums received to date), less any benefits and expenses already paid. The liability does not necessarily reflect the full policyholder obligation the Company expects to pay at the conclusion of the contract since a portion of that obligation would be funded by net premiums received in the future and would be recognized in the liability at that time. For purposes of liability measurement, contracts are grouped into cohorts based primarily on issue year, reportable segment and major product line. The NTG ratio is generally updated quarterly for actual experience and annually in the second quarter of each year for future cash flow assumption updates during the Company’s annual assumptions review process unless a material change is observed in an interim period that is indicative of a long-term trend, with the exception of claim settlement expense assumptions which the Company has made an entity-wide election to lock-in as of contract issuance. The NTG ratio is subject to a retrospective unlocking method whereby the Company updates its best estimate of cash flows expected over the life of the cohort using actual historical experience and updated future cash flow assumptions. These updated cash flows are used to calculate the revised NTG ratio, which is used to derive an updated liability for future policy benefits as of the beginning of the current reporting period, discounted at the original contract issuance discount rate. The updated liability for future policy benefit amount as of the beginning of the quarter is then compared to the carrying amount of the liability as of that same date, before the updates for actual experience or future cash flow assumptions, to determine the current period change in liability estimate. This current period change in the liability is the liability remeasurement gain or loss that is recorded through current period earnings in “Change in estimates of liability for future policy benefits.” In subsequent periods, the revised NTG ratio is used to measure the liability for future policy benefits, subject to future revisions. If a cohort is in a loss position where the liability for future policy benefits plus the present value of expected future gross premiums are determined to be insufficient to provide for expected future policy benefits and non-level claim settlement expenses, the NTG ratio is capped at 100%. In these instances, all changes in expected benefits resulting from both actual experience deviations and changes in future assumptions are recognized immediately. While the liability for future policy benefits cannot be less than zero (i.e., a contra-liability) at the cohort level and thus the balance is floored at zero (i.e., “flooring”), the NTG ratio may be negative. This would be the case whereby conditions have improved such that the present value of future net premiums plus the existing liability for future policy benefits as of the valuation date exceed the present value of expected future policy benefits and non-level claim settlement expenses. In this case, the negative NTG ratio would be applied going forward to gross premiums received, effectively amortizing the gain into income and reducing the liability over time. In addition, for limited-payment contracts, the liability for future policy benefits also includes a Deferred Profit Liability (“DPL”) representing gross premiums received in excess of net premiums and is generally recognized in revenue in a constant relationship with insurance in force for life contracts or with the amount of expected future benefit payments for annuity contracts. The DPL is subject to a retrospective unlocking adjustment consistent with the liability for future policy benefits discussed above. The DPL cannot be less than zero (i.e., a contra-liability) at the cohort level and thus the balance is floored at zero (i.e., “flooring”). •Discount Rate Assumption. The locked-in discount rate is generally based on expected investment returns at contract inception for contracts issued prior to January 1, 2021 and the upper-medium grade fixed income corporate instrument yield (i.e., global single A) at contract inception for contracts issued on or after January 1, 2021. The discount rate in effect at contract inception is locked-in for the calculation of the NTG ratio and accretion of interest cost on the liability through net income. However, for balance sheet remeasurement purposes, the discount rate is updated using the current single A rate at each reporting period, with the effect on the liability resulting from such update recorded in “Interest rate remeasurement of future policy benefits” in OCI. The methodology used in constructing the single A discount rate curve for discounting cash flows used to calculate the liability for future policy benefits is intended to be reflective of the characteristics of the applicable insurance liabilities. The single A discount rate curve is developed by reference to upper-medium grade (low credit risk) fixed- income instrument yields that reflect the duration characteristics of the applicable insurance liabilities. The single A discount curve for the United States and foreign economies, such as Japan, with observable corporate A spreads, is developed using government bond rates, plus globally equivalent public corporate A spreads in the observable periods. The definition of upper medium grade is based on Moody's Investor Service, Inc. (“Moody’s”) definition which includes the spectrum of A (i.e., A- to A+). The rate used in foreign operations (with the exception of certain emerging markets, as discussed below) is based on the equivalent of a single A rate from a global rating agency for corporate bonds issued in the same currency and country in which the insurance contract is written. Liquidity is considered in defining the observable period and linear extrapolation is performed to the Company’s ultimate long-term economic assumptions. Annually, the Company performs a comprehensive review of the economic assumptions, including long-term interest rate assumptions and equity return assumptions, generally utilizing relevant economic outlook information and industry surveys as the primary basis. The Company has foreign currency denominated insurance obligations to policyholders in certain emerging markets where there is limited or no observable market data on upper-medium grade (low credit risk) fixed-income instrument yields. As a proxy for the upper-medium grade fixed-income instrument yield, the Company estimates an equivalent global single A yield in the currency of the emerging economy by converting a global single A U.S. dollar bond yield curve based on the relationship between market observable U.S. Treasury and foreign sovereign yield curves of similar duration as the insurance liability cash flows. The derived global single A curves in the foreign currency are evaluated against available evidence of observable global single A corporate bond rates in similar emerging economies. The Company uses interpolation and extrapolation techniques to complete the discount rate construction for the duration of the insurance liabilities to calculate the liability for future policy benefits denominated in the local currencies. The Company’s liability for future policy benefits also includes net liabilities for guaranteed benefits related to certain long-duration life contracts, such as no-lapse guarantee contract features (Additional Insurance Reserves or “AIR” liability), for which a liability is established when associated assessments are recognized (which include investment margin on policyholders’ account balances deposited to fixed and indexed funds and all policy charges including charges for administration, mortality, expense, surrender and other charges). This liability is established using current best estimate assumptions and is based on the ratio of the present value of total expected excess payments (i.e., payments in excess of account value) over the life of the contract divided by the present value of total expected assessments (i.e., benefit ratio). The liability equals the current benefit ratio multiplied by cumulative assessments recognized to date, plus interest, less cumulative excess payments to date. The liability does not necessarily reflect the full policyholder obligation the Company expects to pay at the conclusion of the contract since a portion of that excess payment would be funded by assessments received in the future and would be recognized in the liability at that time. The reserves are subject to adjustments based on annual reviews of assumptions and quarterly adjustments for experience as described below, including market performance. These adjustments reflect the impact on the benefit ratio of using actual historical experience from the issuance date to the balance sheet date plus updated estimates of future experience. The updated benefit ratio is then applied to all prior periods’ assessments to derive an adjustment to the reserve recognized through a benefit or charge to current period earnings. Any adjustments to this liability related to net unrealized gains (losses) on securities classified as available-for-sale are included in AOCI. For universal life type contracts and participating contracts, the Company performs premium deficiency tests using best estimate assumptions as of the testing date, at a minimum, on an annual basis, and on a quarterly basis for business whose profitability is closely tied to equity market performance. If the liabilities determined based on these best estimate assumptions are greater than the net reserves (i.e., GAAP reserves including unearned revenue reserves (“URR”), net of reinsurance, and any DSI or VOBA asset), the existing net reserves are adjusted by first reducing assets such as DSI, VOBA or deferred reinsurance loss by the amount of the deficiency or to zero through a charge to current period earnings. If the deficiency is more than these asset balances for insurance contracts, the net reserves are increased by the excess through a charge to current period earnings included in “Policyholders’ benefits.” Since investment yields are used as the discount rate, the premium deficiency test is also performed using a discount rate based on the market yield (i.e., assuming what would be the impact if any unrealized gains (losses) were realized as of the testing date). In the event that by using the market yield a deficiency occurs, an adjustment is established for the deficiency and is included in AOCI. The Company’s liability for future policy benefits also includes a liability for unpaid claims and claim adjustment expenses. The Company does not establish claim liabilities until a loss has been incurred. However, unpaid claims and claim adjustment expenses include estimates of claims that the Company believes have been incurred but have not yet been reported as of the balance sheet date. Expense assumptions included in the liability only include claim related expenses and exclude acquisition costs and non-claim related costs such as costs relating to investments, general administration, policy maintenance, product development, market research, and general overhead. Policyholders’ account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date. This liability is primarily associated with the accumulated account deposits, plus interest credited, less policyholder withdrawals and other charges assessed against the account balance, as applicable. These policyholders’ account balances also include provision for benefits under non-life contingent payout annuities and certain unearned revenues. The unearned revenue liability represents policy charges for services to be provided in future periods. The charges are deferred as incurred and are generally amortized over the expected life of the contract using the same methodology, factors, and assumption used to amortize DAC. See Note 13 for additional information regarding policyholders’ account balances. Policyholders’ account balances also include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products. The changes in the fair value of the embedded derivatives are recorded in net income. For additional information regarding the valuation of these embedded derivatives, see Note 6. Market risk benefit liabilities represents contracts or contract features that provide protection to the contractholder and exposes the Company to other than nominal capital market risk, primarily related to deferred annuities with guaranteed minimum benefits in the Retirement Strategies segment including guaranteed minimum death benefits (“GMDB”), guaranteed minimum income benefits (“GMIB”), guaranteed minimum accumulation benefits (“GMAB”), guaranteed minimum withdrawal benefits (“GMWB”) and guaranteed minimum income and withdrawal benefits (“GMIWB”). The benefits are accounted for using a fair value measurement framework. If a contract contains multiple market risk benefits, the benefits are bundled together and accounted for as a single compound market risk benefit. Market risk benefits in an asset position are presented separately from those in a liability position as there is no legal right of offset between contracts. The fair value of market risk benefits is calculated as the present value of expected future benefit payments to contractholders less the present value of expected future rider fees attributable to the market risk benefits. The fair value of market risk benefits is based on assumptions a market participant would use in valuing market risk benefits. For additional information regarding the valuation of market risk benefits, see Note 6. On a quarterly basis, changes in the fair value of market risk benefits are recorded in net income, net of related hedges, in “Change in value of market risk benefits, net of related hedging gains (losses),” except for the portion of the change attributable to changes in the Company’s non-performance risk (“NPR”) which is recorded in OCI. See Note 14 for additional information regarding market risk benefits. See “Reinsurance” below for information regarding the reinsurance of MRBs. Policyholders’ dividends includes dividends payable to policyholders and the policyholder dividend obligation associated with the participating policies included in the Closed Block. The dividends payable for participating policies included in the Closed Block are determined at the end of each year for the following year by the Board of Directors of The Prudential Insurance Company of America (“PICA”) based on its statutory results, capital position, ratings, and the emerging experience of the Closed Block. The policyholder dividend obligation represents amounts expected to be paid to Closed Block policyholders as an additional policyholder dividend unless otherwise offset by future Closed Block performance. Any adjustments to the policyholder dividend obligation related to net unrealized gains (losses) on securities classified as available- for-sale are included in AOCI. For additional information regarding the policyholder dividend obligation, see Note 16. The dividends payable for policies other than the participating policies included in the Closed Block include dividends payable in accordance with certain group and individual insurance policies. Securities sold under agreements to repurchase represents liabilities associated with securities repurchase agreements that are used primarily to earn spread income. As part of securities repurchase agreements, the Company transfers U.S. government and government agency securities to a third party and receives cash as collateral. For securities repurchase agreements, the cash received is typically invested in cash equivalents, short-term investments or fixed maturities. Receivables associated with securities purchased under agreements to resell are generally reflected as cash equivalents. As part of securities resale agreements, the Company invests cash and receives as collateral U.S. government securities or other debt securities. Securities repurchase and resale agreements that satisfy certain criteria are treated as secured borrowing or secured lending arrangements. These agreements are carried at the amounts at which the securities will be subsequently resold or reacquired, as specified in the respective transactions. For securities purchased under agreements to resell, the Company’s policy is to take possession or control of the securities either directly or through a third-party custodian. These securities are valued daily, and additional securities or cash collateral is received, or returned, when appropriate to protect against credit exposure. Securities to be resold are the same, or substantially the same, as the securities received. The majority of these transactions are with large brokerage firms and large banks. For securities sold under agreements to repurchase, the market value of the securities to be repurchased is monitored, and additional collateral is obtained where appropriate, to protect against credit exposure. The Company obtains collateral in an amount at least equal to 95% of the fair value of the securities sold. Securities to be repurchased are the same, or substantially the same, as those sold. The majority of these transactions are with highly rated money market funds. Income and expenses related to these transactions executed within the insurance companies used to earn spread income are reported as “Net investment income.” Cash collateral for loaned securities represents liabilities to return cash proceeds from security lending transactions. Securities lending transactions are used primarily to earn spread income. As part of securities lending transactions, the Company transfers U.S. and foreign debt and equity securities, as well as U.S. government and government agency securities, and receives cash as collateral. Cash proceeds from securities lending transactions are primarily used to earn spread income, and are typically invested in cash equivalents, short-term investments or fixed maturities. Securities lending transactions are treated as financing arrangements and are recorded at the amount of cash received. The Company obtains collateral in an amount equal to 102% and 105% of the fair value of the domestic and foreign securities, respectively. The Company monitors the market value of the securities loaned on a daily basis with additional collateral obtained as necessary. Substantially all of the Company’s securities lending transactions are with large brokerage firms and large banks. Income and expenses associated with securities lending transactions used to earn spread income are reported as “Net investment income.” The Company also enters into securities lending transactions where non-cash collateral, typically U.S. government, Japanese government, or other sovereign bonds are received. The collateral received is not reported on the Company’s Consolidated Statements of Financial Position. In these transactions, the Company receives a fee and obtains collateral in an amount equal to 102% to 105% of the fair value of the loaned securities. The Company monitors the market value of the securities loaned on a daily basis with additional collateral obtained as necessary. Substantially all of these transactions are with large brokerage firms and large banks. Income is reported as “Net investment income.” Reinsurance and funds withheld payables represents amounts payable under reinsurance agreements (see “Reinsurance” below). Short-term and long-term debt liabilities are primarily carried at an amount equal to unpaid principal balance, net of unamortized discount or premium and debt issuance costs. Original-issue discount or premium and debt-issue costs are recognized as a component of interest expense over the period the debt is expected to be outstanding, using the interest method of amortization. Interest expense is generally presented within “General and administrative expenses” in the Company’s Consolidated Statements of Operations. Interest expense may also be reported within “Net investment income” for certain activity, as prescribed by specialized industry guidance. Short-term debt is debt coming due in the next twelve months, including that portion of debt otherwise classified as long-term. The short-term debt caption may exclude short-term debt items for which the Company has the intent and ability to refinance on a long-term basis in the near-term. See Note 18 for additional information regarding short-term and long-term debt. Other liabilities consists primarily of trade payables, lease liabilities (see “Other assets” above), pension and other employee benefit liabilities (see Note 19), derivative liabilities (see “Derivative Financial Instruments” below), deferred reinsurance gains (“DRG”) (see “Reinsurance” below) and payables resulting from purchases of securities that had not yet settled at the balance sheet date. Notes issued by consolidated variable interest entities represents notes issued by certain asset-backed investment vehicles, primarily collateralized loan obligations (“CLOs”) and rated feeder funds, which the Company is required to consolidate. The creditors of these VIEs do not have recourse to the Company in excess of the assets contained within the VIEs. The Company has elected the fair value option for certain of these notes. Changes in fair value are reported in “Other income (loss).” Separate account liabilities primarily represents the contractholders’ account balances in separate account assets and to a lesser extent borrowings of the separate account, and will be equal and offsetting to total separate account assets. See also “Separate account assets” above. Commitments and contingent liabilities are accrued if it is probable that a liability has been incurred and an amount is reasonably estimable. Management evaluates whether there are incremental legal or other costs directly associated with the ultimate resolution of the matter that are reasonably estimable and, if so, they are included in the accrual. These accruals are generally reported in “Other liabilities.” MEZZANINE EQUITY Redeemable noncontrolling interests includes redeemable noncontrolling interests associated with certain consolidated PGIM-managed entities. These redeemable noncontrolling interests are classified as “Mezzanine equity” because their redemption is at the option of the holder and not within the control of the Company. Income (loss) attributable to redeemable noncontrolling interests is reported in “Income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests.” REVENUES, BENEFITS AND EXPENSES Insurance Revenue and Expense Recognition Premiums from individual life products, other than universal and variable life contracts, and health insurance and long-term care products are recognized when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any gross premium in excess of the net premium (i.e., the portion of the gross premium required to provide for all expected future policy benefits and non-level claim settlement expenses) is generally deferred and recognized into revenue in a constant relationship to insurance in force. Benefits are recorded as an expense when they are incurred. A liability for future policy benefits is recorded when premiums are recognized as described in “Future policy benefits” above. Premiums from non-participating group annuities with life contingencies, single premium structured settlements with life contingencies and single premium immediate annuities with life contingencies are recognized when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any gross premium in excess of the net premium is generally deferred and recognized into revenue based on expected future benefit payments. Benefits are recorded as an expense when they are incurred. A liability for future policy benefits is recorded when premiums are recognized as described in “Future policy benefits” above. Certain individual annuity contracts provide the contractholder a guarantee that the benefit received upon death or annuitization will be no less than a minimum prescribed amount. These benefits are generally accounted for as market risk benefits (see “Market risk benefits” above). Amounts received from policyholders as payment for universal or variable group and individual life contracts, deferred fixed or variable annuities, structured settlements and other contracts without life contingencies, and participating group annuities are reported as deposits to “Policyholders’ account balances” and/or “Separate account liabilities.” Revenues from these contracts are reflected in “Policy charges and fee income” consisting primarily of fees assessed during the period against the policyholders’ account balances for mortality and other benefit charges, policy administration charges and surrender charges. In addition to fees, the Company earns investment income from the investment of deposits in the Company’s general account portfolio. Fees assessed that represent compensation to the Company for services to be provided in future periods and certain other fees are generally deferred and amortized into revenue over the life of the related contracts using the same methodology, factors, and assumption used to amortize DAC as described above. Benefits and expenses for these products include claims in excess of related account balances, expenses of contract administration, interest credited to policyholders’ account balances and amortization of DAC, DSI and VOBA. Policyholders’ account balances also include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products where changes in the value of the embedded derivatives are recorded through “Realized investment gains (losses), net.” For additional information regarding the valuation of these embedded derivatives, see Note 6. For group life, other than universal and variable group life contracts, and disability insurance, premiums are generally recognized over the period to which the premiums relate in proportion to the amount of insurance protection provided. Claim and claim adjustment expenses are recognized when incurred. Asset management and service fees principally includes asset-based asset management fees, which are recognized in the period in which the services are performed. In certain asset management fee arrangements, the Company is entitled to receive performance-based incentive fees when the return on assets under management exceeds certain benchmark returns or other performance targets. The Company may be required to return all, or part, of such performance-based incentive fees depending on future performance of these assets relative to performance benchmarks. The Company records performance-based incentive fee revenue when the contractual terms of the asset management fee arrangement have been satisfied and it is probable that a significant reversal in the amount of the fee will not occur. Under this principle, the Company records a deferred performance-based incentive fee liability to the extent it receives cash related to the performance-based incentive fee prior to meeting the revenue recognition criteria delineated above. Other income (loss) includes realized and unrealized gains or losses from investments classified “Fixed maturities, trading, at fair value,” “Assets supporting experience-rated contractholder liabilities, at fair value,” “Equity securities, at fair value,” and “Other invested assets” that are measured at fair value and consolidated entities that follow specialized investment company fair value accounting. “Other income (loss)” also includes gains and losses primarily related to the remeasurement of foreign currency denominated assets and liabilities, as discussed in more detail under “Foreign Currency” below, as well as gains and losses related to business dispositions. Realized investment gains (losses), net includes realized gains or losses from sales and maturities of investments, changes to the allowance for credit losses, other impairments, fair value changes on mortgage loans where the fair value option has been elected, and derivative gains or losses. The derivative gains or losses include the impact of maturities, terminations and changes in fair value of the derivative instruments, including embedded derivatives, and other hedging instruments. Realized investment gains (losses) from the sales of securities are generally calculated using the specific identification method, with the exception of some of the Company’s International Businesses portfolios where the average cost method is used. OTHER ACCOUNTING POLICIES Income taxes receivable (payable) primarily represents the net deferred tax asset or liability and the Company’s estimated taxes receivable or payable for the current year and open audit years. The Company and its includable domestic subsidiaries file a consolidated federal income tax return that includes both life insurance companies and non-life insurance companies. Subsidiaries operating outside the U.S. are taxed, and income tax expense is recorded, based on applicable foreign statutes. See Note 17 for a discussion of certain non-U.S. jurisdictions for which the Company assumes repatriation of earnings. The application of U.S. GAAP requires the Company to evaluate the recoverability of the Company’s deferred tax assets and establish a valuation allowance if necessary to reduce the Company’s deferred tax assets to an amount that is more likely than not expected to be realized. Considerable judgment is required in determining whether a valuation allowance is necessary, and if so, the amount of such valuation allowance. See Note 17 for a discussion of factors considered when evaluating the need for a valuation allowance. The Company has elected to treat taxes related to Global Intangible Low-Taxed Income (“GILTI”) as a period cost and records such amounts in income tax expense in the period incurred. U.S. GAAP prescribes a comprehensive model for how a company should recognize, measure, present, and disclose in its financial statements uncertain tax positions that a company has taken or expects to take on tax returns. The application of this guidance is a two-step process. First, the Company determines whether it is more likely than not, based on the technical merits, that the tax position will be sustained upon examination. If a tax position does not meet the more likely than not recognition threshold, the benefit of that position is not recognized in the financial statements. The second step is measurement. The Company measures the tax position as the largest amount of benefit that is greater than 50% likely to be realized upon ultimate resolution with a taxing authority that has full knowledge of all relevant information. This measurement considers the amounts and probabilities of the outcomes that could be realized upon ultimate settlement using the facts, circumstances, and information available at the reporting date. The Company accrues a liability for unrecognized tax benefits, interest and penalties which relate to tax years still subject to review by the Internal Revenue Service (“IRS”) or other taxing jurisdictions. Audit periods remain open for review until the statute of limitations has passed. Generally, for tax years which produce net operating losses, capital losses or tax credit carryforwards (“tax attributes”), the statute of limitations does not close, to the extent of these tax attributes, until the expiration of the statute of limitations for the tax year in which they are fully utilized. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the liability for income taxes. The Company classifies all interest and penalties related to tax uncertainties as income tax expense. See Note 17 for additional information regarding income taxes. Share-Based Payments The Company applies the fair value-based measurement method in accounting for share-based payment transactions with employees except for equity instruments held by employee share ownership plans. Excess tax benefits (deficits) are recorded in earnings and represent the cumulative difference between the actual tax benefit realized and the amount of deferred tax assets recorded attributable to shared-based payment transactions. The Company accounts for non-employee stock options using the fair value method in accordance with authoritative guidance and related interpretations on accounting for equity instruments that are issued to other than employees for acquiring, or in conjunction with selling, goods or services. Earnings Per Share Earnings per share of Common Stock reflects the consolidated earnings of Prudential Financial. Basic earnings per share is computed by dividing available income attributable to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share includes the effect of all dilutive potential common shares that were outstanding during the period. See Note 21 for additional information. Foreign Currency The currency in which the Company prepares its financial statements (the “reporting currency”) is the U.S. dollar. Assets, liabilities and results of foreign operations are recorded based on the functional currency of each foreign operation. The determination of the functional currency is based on economic facts and circumstances pertaining to each foreign operation. The local currencies of the Company’s foreign operations are typically their functional currencies with the most significant exception being the Company’s Japanese operations where multiple functional currencies exist. There are two distinct processes for expressing these foreign transactions and balances in the Company’s financial statements: foreign currency measurement and foreign currency translation. Foreign currency measurement is the process by which transactions in foreign currencies are expressed in the functional currency. Gains and losses resulting from foreign currency measurement are reported in current earnings in “Other income (loss).” Foreign currency translation is the process of expressing a foreign entity’s functional currency financial statements in the reporting currency. Assets and liabilities of foreign operations and subsidiaries reported in currencies other than U.S. dollars are translated at the exchange rate in effect at the end of the period. Revenues, benefits and other expenses are translated at the average rate prevailing during the period. The effects of translating the statements of operations and financial position of non-U.S. entities with functional currencies other than the U.S. dollar are included, net of related qualifying hedge gains and losses and income taxes, in “Foreign currency translation adjustment,” a component of AOCI. Derivative Financial Instruments Derivatives are financial instruments whose values are derived from interest rates, foreign exchange rates, financial indices, values of securities or commodities, credit spreads, market volatility, expected returns, and liquidity. Values can also be affected by changes in estimates and assumptions, including those related to counterparty behavior and NPR used in valuation models. Derivative financial instruments generally used by the Company include swaps, futures, forwards and options and may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (OTC-cleared), while others are bilateral contracts between two counterparties (OTC-bilateral). Derivative positions are carried at fair value, generally by obtaining quoted market prices or through the use of valuation models. Derivatives are used to manage the interest rate and currency characteristics of assets or liabilities and to mitigate volatility of expected non-functional currency earnings and net investments in foreign operations resulting from changes in currency exchange rates. Additionally, derivatives may be used to reduce exposure to risks such as interest rate, credit, foreign currency and equity associated with assets held or expected to be purchased or sold, and liabilities incurred or expected to be incurred. As discussed in detail below, and in Note 5, all realized and unrealized changes in fair value of derivatives are recorded in current earnings, with the exception of cash flow hedges and hedges of net investments in foreign operations. The Company may also enter into intercompany derivatives, the results of which ultimately eliminate in consolidation over the term of the instrument. Cash flows from derivatives are reported in the operating, investing, or financing activities sections in the Consolidated Statements of Cash Flows based on the nature and purpose of the derivative. Derivatives are recorded either as assets, within “Other invested assets,” or as liabilities, within “Other liabilities,” except for embedded derivatives which are recorded with the associated host contract. The Company nets the fair value of all derivative financial instruments with counterparties for which a master netting arrangement has been executed. The Company designates derivatives as either (1) a hedge of the fair value of a recognized asset or liability or unrecognized firm commitment (“fair value” hedge); (2) a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability (“cash flow” hedge); (3) a foreign currency fair value or cash flow hedge (“foreign currency” hedge); (4) a hedge of a net investment in a foreign operation; or (5) a derivative that does not qualify for hedge accounting. To qualify for hedge accounting treatment, a derivative must be highly effective in mitigating the designated risk of the hedged item. Effectiveness of the hedge is formally assessed at inception and throughout the life of the hedging relationship. The Company formally documents at inception all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking various hedge transactions. This process includes linking all derivatives designated as fair value, cash flow, or foreign currency hedges to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. Hedges of a net investment in a foreign operation are linked to the specific foreign operation. When a derivative is designated as a fair value hedge and is determined to be highly effective, changes in its fair value, along with changes in the fair value of the hedged asset or liability (including losses or gains on firm commitments), are reported on a net basis in the Consolidated Statements of Operations, generally in “Realized investment gains (losses), net.” When swaps are used in hedge accounting relationships, periodic settlements are recorded in the same Consolidated Statements of Operations line as the related settlements of the hedged items. When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in its fair value are recorded in AOCI until earnings are affected by the variability of cash flows being hedged (e.g., when periodic settlements on a variable-rate asset or liability are recorded in earnings). At that time, the related portion of deferred gains or losses on the derivative instrument is reclassified and reported in the Consolidated Statements of Operations line item associated with the hedged item. When a derivative is designated as a foreign currency hedge and is determined to be highly effective, changes in its fair value are recorded either in current period earnings if the hedge transaction is a fair value hedge (e.g., a hedge of a recognized foreign currency asset or liability) or in AOCI if the hedge transaction is a cash flow hedge (e.g., a foreign currency denominated forecasted transaction). When a derivative is used as a hedge of a net investment in a foreign operation, its change in fair value is accounted for in the same manner as a translation adjustment (i.e., reported in the cumulative translation adjustment account within AOCI). If it is determined that a derivative no longer qualifies as an effective fair value or cash flow hedge or management removes the hedge designation, the derivative will continue to be carried on the balance sheet at its fair value, with changes in fair value recognized currently in “Realized investment gains (losses), net.” In this scenario, the hedged asset or liability under a fair value hedge will no longer be adjusted for changes in fair value associated with the hedged risk and the existing basis adjustment is amortized to the Consolidated Statements of Operations line associated with the asset or liability. The component of AOCI related to discontinued cash flow hedges is reclassified to the Consolidated Statements of Operations line associated with the hedged cash flows consistent with the earnings impact of the original hedged cash flows. When hedge accounting is discontinued because the hedged item no longer meets the definition of a firm commitment, or because it is probable that the forecasted transaction will not occur by the end of the specified time period, the derivative will continue to be carried on the balance sheet at its fair value, with changes in fair value recognized currently in “Realized investment gains (losses), net.” Any asset or liability that was recorded pursuant to recognition of the firm commitment is removed from the balance sheet and recognized currently in “Realized investment gains (losses), net.” Gains and losses that were in AOCI pursuant to the cash flow hedge of a forecasted transaction are recognized immediately in “Realized investment gains (losses), net.” If a derivative does not qualify for hedge accounting, all changes in its fair value, including net receipts and payments, are included in “Realized investment gains (losses), net” without considering changes in the fair value of the economically associated assets or liabilities. The Company is a party to financial instruments that contain derivative instruments that are “embedded” in the financial instruments. At inception, the Company assesses whether the economic characteristics of the embedded instrument are clearly and closely related to the economic characteristics of the remaining component of the financial instrument (i.e., the host contract) and whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. When it is determined that (1) the embedded instrument possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract and (2) a separate instrument with the same terms would qualify as a derivative instrument, the embedded instrument qualifies as an embedded derivative that is separated from the host contract, carried at fair value, and changes in its fair value are included in “Realized investment gains (losses), net.” For certain financial instruments that contain an embedded derivative that otherwise would need to be bifurcated and reported at fair value, the Company may elect to carry the entire instrument at fair value and report it within “Other invested assets” or “Other liabilities.” Reinsurance For each of its reinsurance contracts, the Company determines if the contract provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. The Company reviews all contractual features, particularly those that may limit the amount of insurance risk to which the reinsurer is subject, or features that delay the timely reimbursement of claims. The Company participates in reinsurance arrangements in various capacities as either the ceding entity or as the reinsurer (i.e., assuming entity). See Note 15 for additional information regarding the Company’s reinsurance arrangements. Reinsurance assumed business is generally accounted for consistent with direct business. Amounts currently recoverable under reinsurance agreements are included in “Reinsurance recoverables and deposit receivables” and amounts payable are included in “Reinsurance and funds withheld payables.” “Reinsurance recoverables and deposit receivables” also includes (1) an embedded derivative on deposit receivables where the Company has ceded fixed indexed annuities; and (2) embedded derivatives associated with receivables from modified coinsurance arrangements where the Company is the reinsurer, and net receivables from modified coinsurance arrangements where the Company is the cedant, and generally reflect the fair value of the invested assets retained by the cedant. “Reinsurance and funds withheld payables” also includes amounts payable to the reinsurer under coinsurance with funds withheld or net payables from modified coinsurance arrangements where the Company is the cedant, and generally reflect the fair value of the invested assets retained by the Company and contain an embedded derivative that is bifurcated and accounted for at fair value separately from the host contract, with changes in fair value recorded through “Realized investment gains (losses), net.” Revenues and benefits and expenses include amounts assumed under reinsurance agreements and are reflected net of reinsurance ceded. Reinsurance ceded arrangements do not discharge the Company as the primary insurer. Ceded balances would represent a liability of the Company in the event the reinsurers were unable to meet their obligations to the Company under the terms of the reinsurance agreements. Reinsurance recoverables are reported net of the CECL allowance. The CECL allowance considers the credit quality of the reinsurance counterparty and is generally determined based on the probability of default and loss given default assumptions, after considering any applicable collateral arrangements. Additions to or releases of the allowance are reported in “Policyholders’ benefits.” Reinsurance premiums, commissions, expense reimbursements, benefits and reserves related to reinsured long-duration contracts under coinsurance arrangements are accounted for over the life of the underlying reinsured contracts using assumptions consistent with those used to account for the underlying contracts. For reinsurance of in- force blocks of non-participating traditional and limited-payment contracts, the current value of the direct liability as of inception of the reinsurance agreement is used to calculate the reinsurance recoverable and cost of reinsurance such that there is no immediate other comprehensive income or loss from recognition of the reinsurance recoverable at inception. Consistent with the direct liability, the reinsurance recoverable for non-participating traditional and limited-payment contracts is remeasured each period using current single A rates with the effect on the reinsurance recoverable resulting from such updates recorded in “Interest rate remeasurement of future policy benefits” in OCI. For reinsurance of limited-payment contracts, the Company establishes a cost of reinsurance asset relating to the direct DPL and amortizes this balance through “Premiums” using the same methodology and assumptions used to amortize the direct DPL. For reinsurance of existing in-force blocks of long-duration contracts that transfer significant insurance risk, the difference between the fair value of the net consideration exchanged and the net liabilities ceded related to the underlying reinsured contracts is considered the net cost of reinsurance at the inception of the reinsurance agreement. This initial net cost of reinsurance is deferred and amortized into income over the remaining life of the reinsured policies on a basis consistent with the methodologies and assumptions used for amortizing DAC. This initial net cost of reinsurance may result in a deferred reinsurance gain which is recorded in “Other liabilities” and amortized through “Other income (loss),” or a deferred reinsurance loss which is recorded in “Other assets” and amortized through “General and administrative expenses.” Consistent with direct contracts, reinsurance arrangements may also include features that meet the definition of MRBs and, if so, are accounted for at fair value. The fair value of direct or assumed MRBs reflects the Company’s NPR, while the fair value of ceded MRBs reflects the counterparty credit risk of the reinsurer. Changes in the fair value of ceded MRBs, including the impact of changes in counterparty credit risk, are recorded in net income in “Change in value of market risk benefits, net of related hedging gains (losses).” Coinsurance arrangements contrast with the Company’s yearly renewable term arrangements, where only mortality risk is transferred to the reinsurer and premiums are paid to the reinsurer to reinsure that risk. The mortality risk that is reinsured under yearly renewable term arrangements represents the difference between the stated death benefits in the underlying reinsured contracts and the corresponding reserves or account value carried by the Company on those same contracts. The premiums paid to the reinsurer are based upon negotiated amounts, not on the actual premiums paid by the underlying contractholders to the Company. As yearly renewable term arrangements are usually entered into by the Company with the expectation that the contracts will be in force for the lives of the underlying policies, they are considered to be long-duration reinsurance contracts. The cost of reinsurance for universal life products is generally recognized based on the gross assessments of the underlying direct policies. The cost of reinsurance for term insurance products is generally recognized in proportion to direct premiums over the life of the underlying policies. The cost of reinsurance related to short-duration reinsurance contracts is accounted for over the reinsurance contract period. If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in “Reinsurance and funds withheld payables” and deposits made are included in “Reinsurance recoverables and deposit receivables.” As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as “Other income (loss)” or “General and administrative expenses,” as appropriate. RECENT ACCOUNTING PRONOUNCEMENTS Changes to U.S. GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates (“ASUs”) to the FASB Accounting Standards Codification (“ASC”). The Company considers the applicability and impact of all ASUs. ASUs listed below include those that have been adopted during the current fiscal year and/or those that have been issued but not yet adopted as of December 31, 2025, and as of the date of this filing. ASUs not listed below were assessed and determined to be either not applicable or not material. ASUs adopted during the year ended December 31, 2025
ASUs issued but not yet adopted as of December 31, 2025
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments | INVESTMENTS Fixed Maturity Securities The following tables set forth the composition of fixed maturity securities (excluding investments classified as trading), as of the dates indicated:
(1)Excludes notes with amortized cost of $15,744 million (fair value, $15,744 million), which have been offset with the associated debt under a netting agreement. (2)Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans, education loans and other asset types. (3)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.
__________ (1)Excludes notes with amortized cost of $14,748 million (fair value, $14,748 million), which have been offset with the associated debt under a netting agreement. (2)Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans, education loans and other asset types. (3)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations. The following tables set forth the fair value and gross unrealized losses on available-for-sale fixed maturity securities without an allowance for credit losses aggregated by investment category and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of the dates indicated:
As of December 31, 2025 and 2024, the gross unrealized losses on fixed maturity available-for-sale securities without an allowance of $32,392 million and $33,437 million, respectively, related to “1” highest quality or “2” high quality securities based on the National Association of Insurance Commissioners (“NAIC”) or equivalent rating and $809 million and $1,151 million, respectively, related to other than high or highest quality securities based on NAIC or equivalent rating. As of December 31, 2025, the $32,225 million of gross unrealized losses of twelve months or more were concentrated in the consumer non-cyclical, finance and utility sectors within corporate securities, as well as in foreign government securities. As of December 31, 2024, the $32,158 million of gross unrealized losses of twelve months or more were concentrated in the finance, consumer non-cyclical and utility sectors within corporate securities, as well as in foreign government securities. In accordance with its policy described in Note 2, the Company concluded that an adjustment to earnings for credit losses related to these fixed maturity securities was not warranted at December 31, 2025. This conclusion was based on detailed analysis of the underlying credit and cash flows for each security. Gross unrealized losses are primarily attributable to increases in interest rates, general credit spread widening and foreign currency exchange rate movements. As of December 31, 2025, the Company did not intend to sell these securities, and it was not more likely than not that the Company would be required to sell these securities before the anticipated recovery of the amortized cost basis. The following table sets forth the amortized cost and fair value of fixed maturities by contractual maturities, as of the date indicated:
__________ (1)Excludes notes with amortized cost of $15,744 million (fair value, $15,744 million), which have been offset with the associated debt under a netting agreement. Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. Asset-backed, commercial mortgage-backed and residential mortgage-backed securities are shown separately in the table above, as they do not have a single maturity date. The following table sets forth the sources of fixed maturity proceeds and related investment gains (losses), as well as losses on write-downs and the allowance for credit losses of fixed maturities, for the periods indicated:
__________ (1)Excludes activity from non-cash related proceeds due to the timing of trade settlements of $104 million, $(100) million and $(74) million for the years ended December 31, 2025, 2024 and 2023, respectively. (2)Amounts represent securities actively marketed for sale, securities where it is more likely than not the Company will be required to sell prior to the recovery of the amortized cost basis and write-downs on credit adverse securities. (3)Excludes activity from non-cash related proceeds due to the timing of trade settlements of $1 million for the year ended December 31, 2023. There were no fixed maturities, held-to-maturity assets during 2025 and 2024. The following tables set forth the balance of and changes in the allowance for credit losses for fixed maturity securities, as of and for the periods indicated:
See Note 2 for additional information about the Company’s methodology for developing its allowance and expected losses. For the year ended December 31, 2025, the net decrease in the allowance for credit losses on available-for-sale securities was primarily related to write-downs of distressed securities, partially offset by net additions in the basic industry and transportation sectors within corporate securities, due to adverse projected cash flows. For the year ended December 31, 2024, the net increase in the allowance for credit losses on available-for-sale securities was primarily related to net additions in the consumer cyclical, capital goods and energy sectors within corporate securities, due to adverse projected cash flows. The Company did not have any fixed maturity securities purchased with credit deterioration as of both December 31, 2025 and 2024.Assets Supporting Experience-Rated Contractholder Liabilities The following table sets forth the composition of “Assets supporting experience-rated contractholder liabilities,” as of the dates indicated:
(1)As a percentage of amortized cost, 99% of the portfolio was considered high or highest quality based on NAIC or equivalent ratings, as of both December 31, 2025 and 2024. (2)As a percentage of amortized cost, 100% of the portfolio consisted of public securities as of both December 31, 2025 and 2024. The net change in unrealized gains (losses) from assets supporting experience-rated contractholder liabilities still held at period end, recorded within “Other income (loss),” was $613 million, $495 million and $440 million during the years ended December 31, 2025, 2024 and 2023, respectively. Fixed Maturities, Trading The net change in unrealized gains (losses) from fixed maturities, trading still held at period end, recorded within “Other income (loss),” was $461 million, $(551) million and $518 million during the years ended December 31, 2025, 2024 and 2023, respectively. Equity Securities The net change in unrealized gains (losses) from equity securities still held at period end, recorded within “Other income (loss),” was $750 million, $735 million and $612 million during the years ended December 31, 2025, 2024 and 2023, respectively. Concentrations of Financial Instruments The Company monitors its concentrations of financial instruments and mitigates credit risk by maintaining a diversified investment portfolio which limits exposure to any single issuer. As of the dates indicated, the Company’s exposure to concentrations of credit risk of single issuers greater than 10% of the Company’s equity included securities of the U.S. government and certain U.S. government agencies and securities guaranteed by the U.S. government, as well as the securities disclosed below:
Commercial Mortgage and Other Loans The following table sets forth the composition of “Commercial mortgage and other loans,” as of the dates indicated:
__________ (1)Prior period amounts have been updated to conform to current period presentation. (2)Includes loans which are carried at fair value under the fair value option and are collateralized primarily by apartment complexes. As of December 31, 2025 and 2024, the net carrying value of these loans was $1,056 million and $702 million, respectively. As of December 31, 2025, the commercial mortgage and agricultural property loans were secured by properties geographically dispersed throughout the United States with the largest concentrations in California (28%), Florida (6%) and Texas (6%) and included loans secured by properties in Europe (6%), Mexico (2%), Japan (1%) and Australia (1%). As of December 31, 2025, the residential mortgage loans were secured by properties geographically dispersed throughout the United States with the largest concentrations in Florida (13%), California (10%) and New York (9%). The following table sets forth the balance of and changes in the allowance for credit losses for commercial mortgage and other loans, as of and for the periods ended:
See Note 2 for additional information about the Company’s methodology for developing the allowance and expected losses. For the year ended December 31, 2025, net reductions to the allowance for credit losses on commercial mortgage and other loans were primarily related to write-downs against loan-specific reserves within agricultural property loans and commercial mortgage loans in the retail sector, partially offset by an increase in loan-specific reserves within the retail sector. For the year ended December 31, 2024, net additions to the allowance for credit losses on commercial mortgage and other loans were primarily related to increases in loan-specific reserves within agricultural property loans and commercial mortgage loans within the retail and office sectors along with the establishment of general reserves for both the collateralized and uncollateralized loan portfolios. The following table sets forth the write-downs of commercial mortgage and agricultural property loans by origination year for the year ended December 31, 2025:
For the year ended December 31, 2024, there were $137 million of write-downs of which $132 million was related to a loan originated in 2016 and $5 million related to a loan originated in 2015. The following tables set forth key credit quality indicators based upon the recorded investment gross of allowance for credit losses, as of the dates indicated:
Residential mortgage loans primarily include fixed-rate, amortizing mortgage loans on rental properties owned by borrowers with FICO scores typically considered prime or above. The primary credit quality indicator is whether a loan is performing or nonperforming. The Company defines nonperforming residential mortgage loans as those that are 90 days or more past due and/or in nonaccrual status.
See Note 2 for additional information about the Company’s commercial mortgage and other loans credit quality monitoring process. The Company may grant loan modifications in its commercial mortgage and other loan portfolios to borrowers experiencing financial difficulties. These loan modifications may be in the form of principal forgiveness, interest rate reduction, other-than-insignificant payment delay, term extension or some combination thereof. The amount, timing and extent of modifications granted and subsequent performance are considered in determining any allowance for credit losses. The following tables set forth the amortized cost basis of loan modifications made to borrowers experiencing financial difficulties during the periods indicated:
During the year ended December 31, 2024, the modifications added less than one year to the weighted average life in both the commercial mortgage and agricultural property loan portfolios. The Company did not have any commitments to lend additional funds to borrowers experiencing financial difficulties on modified loans as of both December 31, 2025 and 2024. The following tables set forth an aging of past due commercial mortgage and other loans based upon the recorded investment gross of allowance for credit losses, as well as the amount of commercial mortgage and other loans on non-accrual status, as of the dates indicated:
__________ (1)As of December 31, 2025, there were no loans in this category accruing interest. (2)Includes loans for which no credit losses are expected due to U.S. agency guarantees. (3)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2.
__________ (1)As of December 31, 2024, there were no loans in this category accruing interest. (2)Includes loans for which no credit losses are expected due to U.S. agency guarantees. (3)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2. Loans on non-accrual status recognized interest of $5 million and $16 million for the years ended December 31, 2025 and 2024, respectively. Loans on non-accrual status that did not have a related allowance for credit losses were $442 million and $207 million as of December 31, 2025 and 2024, respectively. For the years ended December 31, 2025 and 2024, there were $1,618 million and $0 million, respectively, of residential mortgage loans acquired. For the years ended December 31, 2025 and 2024, there were no residential mortgage loans sold. The Company did not have any commercial mortgage and other loans purchased with credit deterioration as of both December 31, 2025 and 2024.Other Invested Assets The following table sets forth the composition of “Other invested assets,” as of the dates indicated:
__________ (1)As of December 31, 2025 and 2024, real estate held through direct ownership had mortgage debt of $217 million and $185 million, respectively. (2)Includes structured debt investments in feeder funds that are consolidated, resulting in the Company reporting the consolidated feeder funds’ proportionate share of the net assets of the master fund within Other invested assets. (3)Primarily includes equity investments accounted for under the measurement alternative, tax advantaged investments, strategic investments made by investment management operations, leveraged leases and member and activity stock held in the Federal Home Loan Bank of New York. For additional information regarding the Company’s holdings in the Federal Home Loan Bank of New York, see Note 18. In certain investment structures, the Company’s asset management business invests with other co-investors in an investment fund referred to as a feeder fund. In these structures, the invested capital of several feeder funds is pooled together and used to purchase ownership interests in another fund, referred to as a master fund. The master fund utilizes this invested capital and, in certain cases, other debt financing, to purchase various classes of assets on behalf of its investors. Specialized industry accounting for investment companies calls for the feeder fund to reflect its investment in the master fund as a single net asset equal to its proportionate share of the net assets of the master fund, regardless of its level of interest in the master fund. In cases where the Company consolidates the feeder fund, it retains the feeder fund’s net asset presentation and reports the consolidated feeder fund’s proportionate share of the net assets of the master fund in “Other long-term investments,” with any unaffiliated investors’ noncontrolling interests in the feeder fund reported in “Other liabilities” or “Noncontrolling interests.” The consolidated feeder funds’ investments in these master funds, reflected on this net asset basis, totaled $781 million and $788 million as of December 31, 2025 and 2024, respectively. There were $500 million and $450 million of unaffiliated interests in the consolidated feeder funds as of December 31, 2025 and 2024, respectively, and the master funds had gross assets of $44,434 million and $43,004 million, respectively, and gross liabilities of $42,644 million and $41,370 million, respectively, which are not included on the Company’s Consolidated Statements of Financial Position. Equity Method Investments The following tables set forth summarized combined financial information for significant LP/LLC interests accounted for under the equity method, including the Company’s investments in joint ventures and other operating entities that are described in more detail in Note 9. Changes between periods in the tables below reflect changes in the activities within the joint ventures and other operating entities and LPs/LLCs, as well as changes in the Company’s level of investment in such entities:
__________ (1)Amount represents gross assets of each fund where the Company has a significant investment. These assets consist primarily of investments in real estate, investments in securities and other miscellaneous assets. (2)Amount represents gross liabilities of each fund where the Company has a significant investment. These liabilities consist primarily of third-party borrowed funds, securities repurchase agreements and other miscellaneous liabilities.
__________ (1)Amount represents gross revenue of each fund where the Company has a significant investment. This revenue consists of income from investments in real estate, investments in securities and other income. (2)Amount represents gross expenses of each fund where the Company has a significant investment. These expenses consist primarily of interest expense, investment management fees, salary expenses and other expenses. Accrued Investment Income The following table sets forth the composition of “Accrued investment income,” as of the dates indicated:
Write-downs on accrued investment income were $1 million and $2 million for the years ended December 31, 2025 and 2024, respectively. Net Investment Income The following table sets forth “Net investment income” by investment type, for the periods indicated:
__________ (1)Includes income on credit-linked notes which are reported on the same financial statement line as related surplus notes, as conditions are met for right to offset. The carrying value of non-income producing assets included $82 million in fixed maturities, available-for-sale, $8 million in fixed maturities, trading, and $7 million in commercial mortgage and other loans as of December 31, 2025. Non-income producing assets represent investments that had not produced income for the twelve months preceding December 31, 2025. Realized Investment Gains (Losses), Net The following table sets forth “Realized investment gains (losses), net” by investment type, for the periods indicated:
__________ (1)Excludes fixed maturity securities classified as trading. (2)Prior period amounts have been updated to conform to current period presentation. (3)Includes changes in the value of reinsurance and funds withheld payables, primarily reflecting the impact of net investment income on withheld assets that are ceded to certain reinsurance counterparties. Net Unrealized Gains (Losses) on Investments within AOCI The following table sets forth net unrealized gains (losses) on investments, as of the dates indicated:
(1)For additional information regarding cash flow and fair value hedges, see Note 5. (2)Includes net unrealized gains (losses) on certain joint ventures that are strategic in nature and are included in “Other assets.”Repurchase Agreements and Securities Lending In the normal course of business, the Company sells securities under agreements to repurchase and enters into securities lending transactions. The following table sets forth the composition of “Securities sold under agreements to repurchase,” as of the dates indicated:
The following table sets forth the composition of “Cash collateral for loaned securities” which represents the liability to return cash collateral received for the following types of securities loaned, as of the dates indicated:
__________ (1)The Company did not have any agreements with remaining contractual maturities greater than thirty days, as of the dates indicated. Securities Pledged The Company pledges as collateral investment securities it owns to unaffiliated parties through certain transactions, including securities lending, securities sold under agreements to repurchase, collateralized borrowings and postings of collateral with derivative counterparties. The following table sets forth the carrying value of investments pledged to third parties, as of the dates indicated:
__________ (1)These assets are reported on the Company's Consolidated Statements of Financial Position. The following table sets forth the carrying amount of the associated liabilities supported by the pledged collateral, as of the dates indicated:
__________ (1)Includes funding agreements issued to the Federal Home Loan Bank of New York. (2)Primarily includes liabilities associated with derivative counterparties. In the normal course of its business activities, the Company accepts collateral that can be sold or repledged. The primary sources of this collateral are securities in customer accounts, securities purchased under agreements to resell and postings of collateral from OTC derivative counterparties. The fair value of this collateral was $1,532 million as of December 31, 2025 (the largest components of which included $637 million of securities and $895 million of cash from OTC derivative counterparties) and $1,920 million as of December 31, 2024 (the largest components of which included $265 million of securities and $1,655 million of cash from OTC derivative counterparties). A portion of the aforementioned securities, for both periods, had either been sold or repledged. Assets on Deposit, Held in Trust, and Restricted as to Sale The following table provides assets on deposit, assets held in trust, and securities restricted as to sale, as of the dates indicated:
__________ (1)Represents assets held in voluntary trusts established primarily to fund guaranteed dividends to certain policyholders and to fund certain employee benefits. (2)Represents assets held in trust related to reinsurance agreements excluding reinsurance agreements between wholly-owned subsidiaries. Assets valued at $15.0 billion and $16.0 billion were held in trust related to reinsurance agreements between wholly-owned subsidiaries as of December 31, 2025 and 2024, respectively. (3)Includes member and activity stock associated with membership in the Federal Home Loan Bank of New York.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Variable Interest Entities |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Variable Interest Entity, Measure of Activity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Variable Interest Entities | VARIABLE INTEREST ENTITIES In the normal course of its activities, the Company enters into relationships with various special-purpose entities and other entities that are deemed to be VIEs. A VIE is an entity that either (1) has equity investors that lack certain essential characteristics of a controlling financial interest (including the ability to control activities of the entity, the obligation to absorb the entity’s expected losses and the right to receive the entity’s expected residual returns) or (2) lacks sufficient equity to finance its own activities without financial support provided by other entities, which in turn would be expected to absorb at least some of the expected losses of the VIE. The Company is the primary beneficiary if the Company has (1) the power to direct the activities of the VIE that most significantly impact the economic performance of the entity and (2) the obligation to absorb losses of the entity that could be potentially significant to the VIE or the right to receive benefits from the entity that could be potentially significant. If the Company determines that it is the VIE’s primary beneficiary, it consolidates the VIE. Consolidated Variable Interest Entities The Company is the investment manager of certain asset-backed investment vehicles, commonly referred to as CLOs, and certain other vehicles for which the Company earns fee income for investment management services. The Company may sell or syndicate investments through these vehicles, principally as part of the strategic investing activity of the Company’s investment management businesses. Additionally, the Company may invest in securities issued by these vehicles. The Company is also the investment manager of certain investment structures whose beneficial interests are wholly-owned by consolidated subsidiaries. The Company has analyzed these relationships and determined that for certain CLOs and other investment structures it is the primary beneficiary and consolidates these entities. This analysis includes a review of (1) the Company’s rights and responsibilities as investment manager and (2) variable interests (if any) held by the Company. The assets of these VIEs are restricted and must be used first to settle liabilities of the VIE. The Company is not required to provide, and has not provided, material financial or other support to any of these VIEs. Additionally, the Company is the primary beneficiary of certain VIEs in which the Company has invested, as part of its investment activities, but for which it is not the investment manager. These include structured investments issued by a VIE that manages yen-denominated investments coupled with cross-currency coupon swap agreements thereby creating synthetic dual currency investments. The Company’s involvement in the structuring of these investments combined with its economic interest indicates that the Company is the primary beneficiary. The Company has not provided material financial support or other support that was not contractually required to these VIEs. The table below reflects the carrying amount and balance sheet caption in which the assets and liabilities of consolidated VIEs are reported. The liabilities primarily comprise obligations under debt instruments issued by the VIEs. The creditors of these VIEs do not have recourse to the Company in excess of the assets contained within the VIEs.
__________ (1)Total assets of consolidated VIEs reflect $4,801 million and $3,835 million as of December 31, 2025 and 2024, respectively, related to VIEs whose beneficial interests are wholly-owned by consolidated subsidiaries. (2)Recourse is limited to the assets of the respective VIE and does not extend to the general credit of the Company. As of December 31, 2025, the maturities of these obligations were between 0 and 14 years. Unconsolidated Variable Interest Entities The Company has determined that it is not the primary beneficiary of certain VIEs for which it may or may not be the investment manager. These VIEs consist primarily of CLOs and investment funds for which the Company has determined that it is not the primary beneficiary as it does not have both (1) the power to direct the activities of the VIE that most significantly impact the economic performance of the entity and (2) the obligation to absorb losses of the entity that could be potentially significant to the VIE or the right to receive benefits from the entity that could be potentially significant. The Company’s maximum exposure to loss resulting from its relationship with unconsolidated VIEs is limited to its investment in the VIEs, which was $1,484 million and $1,529 million at December 31, 2025 and 2024, respectively. These investments are reflected in “Fixed maturities, available-for-sale,” “Fixed maturities, trading,” “Equity securities” and “Other invested assets.” There are no liabilities associated with these unconsolidated VIEs on the Company’s Consolidated Statements of Financial Position. In addition, in the normal course of its activities, the Company will invest in structured investments including VIEs for which it is not the investment manager. These structured investments typically invest in fixed income investments and are managed by third parties and include asset-backed securities, commercial mortgage-backed securities and residential mortgage-backed securities. The Company’s maximum exposure to loss on these structured investments, both VIEs and non-VIEs, is limited to the amount of its investment. See Note 3 for details regarding the carrying amounts and classification of these assets. The Company has not provided material financial or other support that was not contractually required to these structures. The Company has determined that it is not the primary beneficiary of these structures due to the fact that it does not control these entities. Limited Partnerships and Limited Liability Companies In the normal course of its activities, the Company will invest in LPs/LLCs which include hedge funds, private equity funds and real estate-related funds and may or may not be VIEs. The Company classifies these investments as “Other invested assets” and its maximum exposure to loss associated with these VIE and non-VIE entities is limited to the amount of its investment, which was $20,509 million and $21,847 million as of December 31, 2025 and 2024, respectively. The Company has determined that it is not required to consolidate these entities because either (1) it does not control them or (2) it does not have the obligation to absorb losses of these entities that could be potentially significant to the entities or the right to receive benefits from the entities that could be potentially significant.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments | DERIVATIVES AND HEDGING Types of Derivative and Hedging Instruments Interest Rate Contracts Interest rate swaps, interest rate total return swaps, options and futures are used by the Company to reduce risks from changes in interest rates, manage interest rate exposures arising from mismatches between assets and liabilities and to hedge against changes in their values it owns or anticipates acquiring or selling. Swaps may be attributed to specific assets or liabilities or to a portfolio of assets or liabilities. Under interest rate swaps, the Company agrees with counterparties to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts calculated by reference to an agreed upon notional principal amount. Under interest rate total return swaps, the Company agrees with counterparties to exchange, at specified intervals, the difference between the return on a fixed income market index and Secured Overnight Financing Rate (“SOFR”) plus an associated funding spread based on a notional amount. The Company also uses interest rate swaptions, caps, and floors to manage interest rate risk. A swaption is an option to enter into a swap with a forward starting effective date. The Company pays a premium for purchased swaptions and receives a premium for written swaptions. In an interest rate cap, the buyer receives payments at the end of each period in which the interest rate exceeds the agreed strike price. Similarly, in an interest rate floor, the buyer receives payments at the end of each period in which the interest rate is below the agreed strike price. Swaptions, caps and floors are included in interest rate options. In standardized exchange-traded interest rate futures transactions, the Company purchases or sells a specified number of contracts, the values of which are determined by the daily market values of underlying referenced investments. The Company enters into exchange-traded futures with regulated futures commission’s merchants who are members of a trading exchange. Equity Contracts Equity options, equity total return swaps, and futures are used by the Company to manage its exposure to the equity markets which impacts the value of assets and liabilities it owns or anticipates acquiring or selling. Equity index options are contracts which will settle in cash based on differentials in the underlying indices at the time of exercise and the strike price. The Company uses combinations of purchases and sales of equity index options to hedge the effects of adverse changes in equity indices within a predetermined range. Equity total return swaps are contracts whereby the Company agrees with counterparties to exchange, at specified intervals, the difference between the return on an equity asset (or equity market index) and SOFR plus an associated funding spread based on a notional amount. The Company generally uses equity total return swaps to hedge the effect of adverse changes in equity indices. In standardized exchange-traded equity futures transactions, the Company purchases or sells a specified number of contracts, the values of which are determined by the daily market values of underlying referenced equity indices. The Company enters into exchange-traded futures with regulated futures commission’s merchants who are members of a trading exchange. Foreign Exchange Contracts Currency derivatives, including currency futures, options, forwards and swaps, and foreign currency denominated debts are used by the Company to reduce risks from changes in currency exchange rates with respect to investments denominated in foreign currencies that the Company either holds or intends to acquire or sell, and to hedge the currency risk associated with net investments in foreign operations and anticipated earnings of its foreign operations. Under currency forwards, the Company agrees with counterparties to deliver a specified amount of an identified currency at a specified future date. Typically, the price is agreed upon at the time of the contract and payment for such a contract is made at the specified future date. As noted above, the Company uses currency forwards to mitigate the impact of changes in currency exchange rates on U.S. dollar-equivalent earnings generated by certain of its non-U.S. businesses, primarily its international insurance and investment operations. The Company executes forward sales of the hedged currency in exchange for U.S. dollars at a specified exchange rate. The maturities of these currency forwards correspond with the future periods in which the non-U.S. dollar-denominated earnings are expected to be generated. Under currency swaps, the Company agrees with counterparties to exchange, at specified intervals, the difference between one currency and another at an exchange rate and calculated by reference to an agreed principal amount. Generally, the principal amount of each currency is exchanged at the beginning and termination of the currency swap by each party. Under foreign currency denominated debts, the Company uses a portion of its foreign currency denominated debt (same functional currency of its foreign subsidiaries) to hedge the risk of change in the net investment in a foreign subsidiary due to changes in exchange rates. These debt obligations reduce the Company’s foreign currency exposure from equity investment and act as hedge of the investment. Credit Contracts The Company writes credit default swaps to gain exposure similar to investment in public fixed maturity cash instruments. With these derivatives the Company sells credit protection on a single name reference, or certain index reference, and in return receives a quarterly premium. This premium or credit spread generally corresponds to the difference between the yield on the referenced name (or an index’s referenced names) public fixed maturity cash instruments and swap rates, at the time the agreement is executed. If there is an event of default by the referenced name or one of the referenced names in the index, as defined by the agreement, then the Company is obligated to pay the referenced amount of the contract to the counterparty and receive in return the referenced defaulted security or similar security (in the case of a credit default index) or pay the referenced amount less the auction recovery rate. See credit derivatives section for further discussion of guarantees. In addition to selling credit protection, the Company purchases credit protection using credit derivatives to hedge specific credit exposures in the Company’s investment portfolio. Other Contracts “To Be Announced” (“TBA”) Forward Contracts. The Company uses TBA forward contracts to gain exposure to the investment risk and return of mortgage-backed securities. TBA transactions can help the Company enhance the return on its investment portfolio, and can provide a more liquid and cost-effective method of achieving these goals than purchasing or selling individual mortgage-backed pools. Typically, the price is agreed upon at the time of the contract and payment for such a contract is made at a specified future date. Additionally, pursuant to the Company’s mortgage dollar roll program, TBAs or mortgage-backed securities are transferred to counterparties with a corresponding agreement to repurchase them at a future date. These transactions do not qualify as secured borrowings and are accounted for as derivatives. Loan Commitments. In its mortgage operations, the Company enters into commitments to fund commercial mortgage loans at specified interest rates and other applicable terms within specified periods of time. These commitments are legally binding agreements to extend credit to a counterparty. Loan commitments for loans that will be held for sale are recognized as derivatives and recorded at fair value. The determination of the fair value of loan commitments accounted for as derivatives considers various factors including, among others, terms of the related loan, the intended exit strategy for the loans based upon either securitization valuation models or investor purchase commitments, prevailing interest rates, origination income or expense, and the value of service rights. Loan commitments that relate to the origination of mortgage loans that will be held for investment are not accounted for as derivatives and accordingly are not recognized in the Company’s financial statements. See Note 25 for additional information. Embedded Derivatives. The Company offers certain products (for example, indexed universal life) which may include features that are accounted for as embedded derivatives. These embedded derivatives are carried at fair value through “Realized investment gains (losses), net” based on the change in value of the underlying contractual features, which are determined using valuation models. As part of certain funds withheld reinsurance and modified coinsurance arrangements that are described in Note 15, the reinsurance arrangements may contain embedded derivatives, which would also be carried at fair value through “Realized investment gains (losses), net” based on the total return of the underlying asset portfolio. Primary Risks Managed by Derivatives The table below provides a summary of the gross notional amount and fair value of derivative contracts by the primary underlying risks they are utilized to manage, excluding embedded derivatives. Many derivative instruments contain multiple underlying risks. The fair value amounts below represent the value of derivative contracts prior to taking into account the netting effects of master netting agreements and cash collateral. These netting impacts resulted in total derivative assets of $1,671 million and $1,601 million as of December 31, 2025 and 2024, respectively, and total derivative liabilities of $6,215 million and $4,751 million as of December 31, 2025 and 2024, respectively, reflected in the Consolidated Statements of Financial Position.
__________ (1)“Other” primarily includes derivative contracts used to improve the balance of the Company’s tail longevity and mortality risk. Under these contracts, the Company’s gains (losses) are capped at the notional amount. (2)Excludes embedded derivatives which contain multiple underlying risks. The fair value of these embedded derivatives was a net liability of $18,404 million (including the Prismic funds withheld-related embedded derivative net liability of $194 million) and $11,783 million (including the Prismic funds withheld-related embedded derivative net liability of $(91) million) as of December 31, 2025, and 2024, respectively, primarily included in “Policyholders’ account balances” and “Reinsurance and funds withheld payables.” (3)Recorded in “Other invested assets” and “Other liabilities” on the Consolidated Statements of Financial Position. As of December 31, 2025, the following amounts were recorded on the Consolidated Statements of Financial Position related to the carrying amount of the hedged assets (liabilities) and cumulative basis adjustments included in the carrying amount for fair value hedges:
__________ (1)There were no material fair value hedging adjustments for hedged assets and liabilities for which hedge accounting has been discontinued. Most of the Company’s derivatives do not qualify for hedge accounting for various reasons. For example: (i) derivatives that economically hedge embedded derivatives do not qualify for hedge accounting because changes in the fair value of the embedded derivatives are already recorded in net income; (ii) derivatives that are utilized as macro hedges of the Company’s exposure to various risks typically do not qualify for hedge accounting because they do not meet the criteria required under portfolio hedge accounting rules; and (iii) synthetic GICs, which are product standalone derivatives, do not qualify as hedging instruments under hedge accounting rules. Offsetting Assets and Liabilities The following tables present recognized derivative instruments (excluding embedded derivatives), and repurchase and reverse repurchase agreements that are offset in the Consolidated Statements of Financial Position, and/or are subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in the Consolidated Statements of Financial Position:
__________ (1)Amounts exclude the excess of collateral received/pledged from/to the counterparty.For information regarding the rights of offset associated with the derivative assets and liabilities in the table above, see “—Counterparty Credit Risk” below. For securities purchased under agreements to resell and securities sold under agreements to repurchase, the Company monitors the value of the securities and maintains collateral, as appropriate, to protect against credit exposure. Where the Company has entered into repurchase and resale agreements with the same counterparty, in the event of default, the Company would generally be permitted to exercise rights of offset. For additional information regarding the Company’s accounting policy for securities repurchase and resale agreements, see Note 2. Cash Flow, Fair Value and Net Investment Hedges The primary derivative and non-derivative instruments used by the Company in its fair value, cash flow and net investment hedge accounting relationships are interest rate swaps, currency swaps, currency forwards, and foreign currency denominated debts. These instruments are only designated for hedge accounting in instances where the appropriate criteria are met. The Company does not use futures, options, credit, or equity derivatives in any of its fair value, cash flow or net investment hedge accounting relationships. The following tables provide the financial statement classification and impact of derivatives used in qualifying and non-qualifying hedge relationships, including the offset of the hedged item in fair value hedge relationships.
(2)Includes the Prismic funds withheld-related embedded derivative realized gain (loss) of $(284) million, $598 million, and $(508) million for the years ended December 31, 2025, 2024, and 2023 respectively. Presented below is a rollforward of current period cash flow hedges in AOCI before taxes:
The changes in fair value of cash flow hedges are deferred in AOCI and are included in “Net unrealized investment gains (losses)” in the Consolidated Statements of Comprehensive Income; these amounts are then reclassified to earnings when the hedged item affects earnings. Using December 31, 2025 values, it is estimated that a pre-tax gain of approximately $281 million is expected to be reclassified from AOCI to earnings during the subsequent twelve months ending December 31, 2026. The exposures the Company is hedging with these qualifying cash flow hedges include the variability of future cash flows from forecasted transactions denominated in foreign currencies, the purchases of invested assets, and the receipt or payment of variable interest on existing financial instruments. The maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for forecasted transactions is 26 years. There were no material amounts reclassified from AOCI into earnings relating to instances in which the Company discontinued cash flow hedge accounting because the forecasted transaction did not occur by the anticipated date or within the additional time period permitted by the authoritative guidance for the accounting for derivatives and hedging. In addition, there were no instances in which the Company discontinued fair value hedge accounting due to a hedged firm commitment no longer qualifying as a fair value hedge. For net investment hedges, in addition to derivatives, the Company uses foreign currency denominated debt to hedge the risk of change in the net investment in a foreign subsidiary due to changes in exchange rates. For effective net investment hedges, the amounts, before applicable taxes, recorded in the cumulative translation adjustment within AOCI were $(49) million for the year ended December 31, 2025, $104 million for the year ended December 31, 2024, and $39 million for the year ended December 31, 2023. Credit Derivatives The following tables provide a summary of the notional and fair value of written credit protection, presented as assets (liabilities). The Company’s maximum amount at risk under these credit derivatives, assuming the value of the underlying referenced securities become worthless, is equal to the notional amounts. These credit derivatives have maturities of less than 10 years for index reference.
__________ (1)The NAIC rating designations are based on availability and the lowest ratings among “Moody's, Standard & Poor’s Rating Services (“S&P”) and Fitch Ratings Inc. (“Fitch”). If no rating is available from a rating agency, an NAIC 6 rating is used. (2)The NAIC rating designation is due to approximately 3% and 4% of the index reference name rated as NAIC 6 as of December 31, 2025, and 2024, respectively. (3)Single name credit default swaps may make reference to the credit of corporate debt, sovereign debt, and structured finance. Index reference NAIC designations are based on the lowest rated single name reference included in the index. The Company has no exposure on purchased credit protection as of December 31, 2025, and 2024. Counterparty Credit Risk The Company is exposed to losses in the event of non-performance by counterparties to financial derivative transactions with a positive fair value. The Company manages credit risk by: (i) entering into derivative transactions with highly rated major financial institutions and other creditworthy counterparties governed by master netting agreements, as applicable; (ii) trading through central clearing and OTC parties; (iii) obtaining collateral, such as cash and securities, when appropriate; and (iv) setting limits on single party credit exposures which are subject to periodic management review. Substantially all of the Company’s derivative agreements have zero thresholds which require daily full collateralization by the party in a liability position. In addition, certain of the Company’s derivative agreements contain credit-risk related contingent features; if the credit rating of one of the parties to the derivative agreement is to fall below a certain level, the party with positive fair value could request termination at the then fair value or demand immediate full collateralization from the party whose credit rating fell and is in a net liability position. As of December 31, 2025, there were no net liability derivative positions with counterparties with credit risk-related contingent features. All derivatives have been appropriately collateralized by the Company or the counterparty in accordance with the terms of the derivative agreements.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Assets and Liabilities |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value of Assets and Liabilities | FAIR VALUE OF ASSETS AND LIABILITIES Fair Value Measurement—Fair value represents the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The authoritative fair value guidance establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows: Level 1—Fair value is based on unadjusted quoted prices in active markets that are accessible to the Company for identical assets or liabilities. The Company’s Level 1 assets and liabilities primarily include certain cash equivalents and short-term investments, equity securities and derivative contracts that trade on an active exchange market. Level 2—Fair value is based on significant inputs, other than quoted prices included in Level 1, that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability through corroboration with observable market data. Level 2 inputs include quoted prices in active markets for similar assets and liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, and other market observable inputs. The Company’s Level 2 assets and liabilities include: fixed maturities (corporate public and private bonds, most government securities, certain asset-backed and mortgage-backed securities, etc.), certain equity securities (mutual funds, which do not trade in active markets because they are not publicly available), certain commercial mortgage loans, short-term investments, certain cash equivalents (primarily commercial paper), and certain OTC derivatives. Level 3—Fair value is based on at least one significant unobservable input for the asset or liability. The assets and liabilities in this category may require significant judgment or estimation in determining the fair value. The Company’s Level 3 assets and liabilities primarily include: certain private fixed maturities and equity securities, certain manually priced public equity securities and fixed maturities, certain highly structured OTC derivative contracts, certain consolidated real estate funds for which the Company is the general partner, contracts or contract features pertaining to living benefit features (market risk benefits) of the Company’s variable annuity contracts and embedded derivatives associated with the index-linked features of certain universal life and annuity products. Assets and Liabilities by Hierarchy Level—The tables below present the balances of assets and liabilities reported at fair value on a recurring basis, as of the dates indicated:
__________ (1)“Netting” amounts represent cash collateral of $(8,496) million and $(8,049) million as of December 31, 2025 and 2024, respectively, and the impact of offsetting asset and liability positions held with the same counterparty, subject to master netting agreements. (2)Excludes notes with fair value of $15,744 million (carrying amount of $15,744 million) and $14,748 million (carrying amount of $14,748 million) as of December 31, 2025 and 2024, respectively, which have been offset with the associated debt under a netting agreement. (3)Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans, education loans and other asset types. (4)Other invested assets excluded from the fair value hierarchy include certain hedge funds, private equity funds and other funds for which fair value is measured at net asset value (“NAV”) per share (or its equivalent) as a practical expedient. As of December 31, 2025 and 2024, the fair value of such investments was $5,526 million and $5,021 million, respectively. (5)Separate account assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate, hedge funds and other invested assets. As of December 31, 2025 and 2024, the fair value of such investments was $27,506 million and $26,700 million, respectively. (6)Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company’s Consolidated Statements of Financial Position. The methods and assumptions the Company uses to estimate the fair value of assets and liabilities measured at fair value on a recurring basis are summarized below. Fixed Maturity Securities—The fair values of the Company’s public fixed maturity securities are generally based on prices obtained from independent pricing services. Prices for each security are generally sourced from multiple pricing vendors, and a vendor hierarchy is maintained by asset type based on historical pricing experience and vendor expertise. The Company ultimately uses the price from the pricing service highest in the vendor hierarchy based on the respective asset type. The pricing hierarchy is updated for new financial products and recent pricing experience with various vendors. Consistent with the fair value hierarchy described above, securities with validated quotes from pricing services are generally reflected within Level 2, as they are primarily based on observable pricing for similar assets and/or other market observable inputs. Typical inputs used by these pricing services include but are not limited to, reported trades, benchmark yields, issuer spreads, bids, offers, and/or estimated cash flow, prepayment speeds and default rates. If the pricing information received from third-party pricing services is deemed not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process with the pricing service or classify the securities as Level 3. If the pricing service updates the price to be more consistent with the presented market observations, the security remains within Level 2. Internally-developed valuations or indicative broker quotes are also used to determine fair value in circumstances where vendor pricing is not available, or where the Company ultimately concludes that pricing information received from the independent pricing services is not reflective of market activity. If the Company concludes the values from both pricing services and brokers are not reflective of market activity, it may override the information with an internally-developed valuation. As of December 31, 2025 and 2024, overrides on a net basis were not material. Pricing service overrides, internally-developed valuations and indicative broker quotes are generally included in Level 3 in the fair value hierarchy. The Company conducts several specific price monitoring activities. Daily analyses identify price changes over predetermined thresholds defined at the financial instrument level. Various pricing integrity reports are reviewed on a daily and monthly basis to determine if pricing is reflective of market activity or if it would warrant any adjustments. Other procedures performed include, but are not limited to, reviews of third-party pricing services methodologies, reviews of pricing trends and back testing. The fair values of private fixed maturities, which are originated by internal private asset managers, are primarily determined using discounted cash flow models. These models primarily use observable inputs that include Treasury or similar base rates plus estimated credit spreads to value each security. The credit spreads are obtained through a survey of private market intermediaries who are active in both primary and secondary transactions, and consider, among other factors, the credit quality and the reduced liquidity associated with private placements. Internal adjustments are made to reflect variation in observed sector spreads. Since most private placements are valued using standard market observable inputs and inputs derived from, or corroborated by, market observable data including, but not limited to observed prices and spreads for similar publicly-traded issues, they have been reflected within Level 2. For certain private fixed maturities, the discounted cash flow model may incorporate significant unobservable inputs, which reflect the Company’s own assumptions about the inputs that market participants would use in pricing the asset. To the extent management determines that such unobservable inputs are significant to the price of a security, a Level 3 classification is made. Assets Supporting Experience-Rated Contractholder Liabilities—Assets supporting experience-rated contractholder liabilities consist primarily of fixed maturity securities, equity securities and derivatives whose fair values are determined consistent with similar instruments described above under “Fixed Maturity Securities” and below under “Equity Securities” and “Derivative Instruments.” Equity Securities—Equity securities consist principally of investments in common and preferred stock of publicly-traded companies, perpetual preferred stock, privately-traded securities, as well as mutual fund shares. The fair values of most publicly-traded equity securities are based on quoted prices in active markets for identical assets and are classified within Level 1 in the fair value hierarchy. Estimated fair values for most privately traded equity securities are determined using discounted cash flow, earnings multiple and other valuation models that require a substantial level of judgment around inputs and therefore are classified within Level 3. The fair values of mutual fund shares that transact regularly (but do not trade in active markets because they are not publicly available) are based on transaction prices of identical fund shares and are classified within Level 2 in the fair value hierarchy. The fair values of perpetual preferred stock are based on inputs obtained from independent pricing services that are primarily based on indicative broker quotes. As a result, the fair values of perpetual preferred stock are classified as Level 3. Commercial Mortgage and Other Loans—The fair value of loans held and accounted for using the fair value option is determined utilizing pricing indicators from the whole loan market, where investors are committed to purchase these loans at a predetermined price, which is considered the principal exit market for these loans. The Company evaluates the valuation inputs used for these assets, including the existence of predetermined exit prices, the terms of the loans, prevailing interest rates and credit risk, and deems the primary pricing inputs are Level 2 inputs in the fair value hierarchy. Other Invested Assets—Other invested assets primarily include investments in LPs/LLCs, derivatives and certain limited partnerships which are consolidated because the Company is either deemed to exercise control or considered the primary beneficiary of a variable interest entity. These entities are primarily investment companies and follow specialized industry accounting whereby their assets are carried at fair value. The investments held by these entities include various feeder fund investments in underlying master funds (whose underlying holdings generally include public fixed maturities, equity securities and mutual funds), as well as wholly-owned real estate held within other investment funds. For the unconsolidated fund investments, the fair value is primarily determined by the fund managers and is measured at NAV as a practical expedient. Reinsurance Recoverables and Deposit Receivables—Reinsurance recoverables and deposit receivables primarily include (1) an embedded derivative on deposit receivables where the Company has ceded fixed indexed annuities; and (2) embedded derivatives associated with receivables from modified coinsurance arrangements where the Company is the reinsurer, and net receivables from modified coinsurance arrangements where the Company is the cedant, and generally reflect the fair value of the invested assets retained by the cedant. Other Assets—Other assets reflected in Level 3 includes the fair value of strategic investments held and accounted for using the fair value option. Derivative Instruments—Derivatives are recorded at fair value either as assets, within “Other invested assets” or as liabilities, within “Other liabilities,” except for embedded derivatives which are recorded with the associated host contract. The fair values of derivative contracts can be affected by changes in interest rates, foreign exchange rates, commodity prices, credit spreads, market volatility, expected returns, NPR, liquidity and other factors. For derivative positions included within Level 3 of the fair value hierarchy, liquidity valuation adjustments are made to reflect the cost of exiting significant risk positions, and consider the bid-ask spread, maturity, complexity and other specific attributes of the underlying derivative position. The Company’s exchange-traded futures and options include Treasury futures, Eurodollar futures, commodity futures, Eurodollar options and commodity options. Exchange-traded futures and options are valued using quoted prices in active markets and are classified within Level 1 in the fair value hierarchy. The majority of the Company’s derivative positions are traded in the OTC derivative market and are classified within Level 2 in the fair value hierarchy. OTC derivatives classified within Level 2 are valued using models that utilize actively quoted or observable market inputs from external market data providers, third-party pricing vendors and/or recent trading activity. The Company’s policy is to use mid-market pricing in determining its best estimate of fair value. The fair values of most OTC derivatives, including interest rate and cross-currency swaps, currency forward contracts, commodity forward contracts, credit default swaps, loan commitments held for sale and to be announced (“TBA”) forward contracts on highly rated mortgage-backed securities issued by U.S. government sponsored entities are determined using discounted cash flow models. The fair values of European style option contracts are determined using Black-Scholes option pricing models. These models’ key inputs include the contractual terms of the respective contract, along with significant observable inputs, including interest rates, currency rates, credit spreads, equity prices, index dividend yields, NPR, volatility and other factors. The Company’s cleared interest rate swaps and credit derivatives linked to an index are valued using models that utilize actively quoted or observable market inputs, including SOFR, obtained from external market data providers, third-party pricing vendors and/or recent trading activity. These derivatives are classified as Level 2 in the fair value hierarchy. The majority of the Company’s derivative agreements are with highly rated major international financial institutions. To reflect the market’s perception of its own and the counterparty’s NPR, the Company incorporates additional spreads over SOFR into the discount rate used in determining the fair value of OTC derivative liabilities after netting of collateral. Rates used to discount expected cash flows to value OTC derivative assets reflect the terms of the Credit Support Annex (“CSA”). Derivatives classified as Level 3 include look-back equity options and other structured products. These derivatives are valued based upon models, such as Monte Carlo simulation models and other techniques that utilize significant unobservable inputs. Level 3 methodologies are validated through periodic comparison of the Company’s fair values to external broker-dealer values. Cash Equivalents and Short-Term Investments—Cash equivalents and short-term investments include money market instruments, commercial paper and other highly liquid debt instruments. Certain money market instruments are valued using unadjusted quoted prices in active markets that are accessible for identical assets and are primarily classified as Level 1. The remaining instruments in this category are generally fair valued based on market observable inputs and these investments have primarily been classified within Level 2. Separate Account Assets—Separate account assets include mutual funds, fixed maturity securities, treasuries, equity securities, real estate and commercial mortgage loans for which values are determined consistent with similar instruments described above under “Fixed Maturity Securities,” “Equity Securities” and “Commercial Mortgage and Other Loans.” Market Risk Benefits—Market risk benefit liabilities (or assets) represent contracts or contract features that provide protection to the contractholder and expose the insurance entity to other than nominal capital market risk, primarily related to deferred annuities with guaranteed minimum benefits in the Retirement Strategies segment including GMDB, GMIB, GMAB, GMWB and GMIWB. The benefits are bundled together and accounted for as single compound market risk benefits using a fair value measurement framework. The fair value of these market risk benefits is calculated as the present value of expected future benefit payments to contract holders less the present value of expected future rider fees attributable to the market risk benefits. The fair value of these benefit features is based on assumptions a market participant would use in valuing market risk benefits. This methodology could result in either a liability or asset balance, given changing capital market conditions and various actuarial assumptions. Since there is no observable active market for the transfer of these obligations, the valuations are calculated using internally-developed models with option pricing techniques. The models are based on a risk neutral valuation framework and incorporate premiums for risks inherent in valuation techniques, inputs, and the general uncertainty around the timing and amount of future cash flows. The determination of these risk premiums requires the use of management’s judgment. The significant inputs to the valuation models for these market risk benefits include capital market assumptions, such as interest rate levels and volatility assumptions, the Company’s market-perceived NPR, as well as actuarially determined assumptions, including contractholder behavior, such as lapse rates, benefit utilization rates, withdrawal rates, and mortality rates. Since many of these assumptions are unobservable and are considered to be significant inputs to the valuations, the assets and liabilities included in market risk benefits have been reflected within Level 3 in the fair value hierarchy. Capital market inputs and actual policyholders’ account values are updated each quarter based on capital market conditions as of the end of the quarter, including interest rates, equity markets and volatility. In the risk neutral valuation, the initial swap curve drives the total return used to grow the policyholders’ account values. The Company’s discount rate assumption is based on the SOFR swap curve adjusted for an additional spread relative to SOFR to reflect the Company’s market-perceived NPR, which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with the Company issued funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because funding agreements, living benefit guarantees, and index-linked interest crediting guarantees are insurance liabilities and are therefore senior to debt. Actuarial assumptions, including contractholder behavior and mortality, are reviewed at least annually, and updated based upon Company emerging experience and industry studies, future expectations and other data, including any observable market data. These assumptions are generally updated annually unless a material change that the Company feels is indicative of a long-term trend is observed in an interim period. Policyholders’ Account Balances—The liability for policyholders’ account balances is related to certain embedded derivative instruments associated with certain universal life and annuity products that provide policyholders with index-linked interest credited over contract specified term periods. The fair values of these liabilities are determined using discounted cash flow models which include capital market assumptions such as interest rates and equity index volatility assumptions, the Company’s market-perceived NPR and actuarially determined assumptions for mortality, lapses and projected hedge costs. As there is no observable active market for these liabilities, the fair value is determined as the present value of account balances paid to policyholders in excess of contractually guaranteed minimums using option pricing techniques for index term periods that contain deposits as of the valuation date, and the expected option cost for future index term periods, where the terms of index crediting rates have not yet been declared by the Company. Premiums for risks inherent in valuation techniques, inputs, and the general uncertainty around the timing and amount of future cash flows are also incorporated in the fair value of these liabilities. Since the valuation of these liabilities require the use of management’s judgement to determine these risk premiums and the use of unobservable inputs, these liabilities are reflected within Level 3 in the fair value hierarchy. Capital market inputs, including interest rates and equity market volatility, and actual policyholders’ account values are updated each quarter. Actuarial assumptions are reviewed at least annually and updated based upon emerging experience, future expectations and other data, including any observable market data. Aside from these annual updates, assumptions are generally updated only if a material change is observed in an interim period that the Company believes is indicative of a long-term trend. Reinsurance and Funds Withheld Payables—Reinsurance and funds withheld payables primarily includes an embedded derivative associated with certain funds withheld reinsurance arrangements that are described in Note 15 which represents a total return swap associated with the assets supporting the liability to the reinsurer. The fair value is determined based on the valuation of the underlying funds withheld assets identified to support the payable due to the applicable reinsurance counterparties. Other Liabilities—Other liabilities include certain derivative instruments. The fair values of derivative instruments are determined consistent with those described above under “Derivative Instruments.” Notes issued by Consolidated VIEs—These notes are based on the fair values of corresponding bank loan collateral. Since the notes are valued based on reference collateral, they are classified as Level 3. See Note 4 and “Fair Value Option” below for additional information. Quantitative Information Regarding Internally-Priced Level 3 Assets and Liabilities—The tables below present quantitative information regarding significant internally-priced Level 3 assets and liabilities:
__________ (1)Conversely, the impact of a decrease in input would have the opposite impact on fair value as that presented in the table. (2)Includes assets classified as fixed maturities available-for-sale, assets supporting experience-rated contractholder liabilities and fixed maturities, trading. (3)Excludes notes which have been offset with the associated debt under a netting agreement. (4)Represents multiple of earnings before interest, taxes, depreciation and amortization (“EBITDA”), and are amounts used when the Company has determined that market participants would use such multiples when valuing the investments. (5)For these investments, a range of discount rates is typically used and is therefore a more meaningful representation of the unobservable inputs used in the valuation rather than a weighted average. (6)Market risk benefits primarily represent fair value for all living benefit guarantees including accumulation, withdrawal and income benefits. Since the valuation methodology for these assets and liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (7)Policyholders’ account balances primarily represent general account liabilities for the index-linked interest credited on certain of the Company’s life and annuity products that are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (8)Lapse rates for contracts with living benefit guarantees are adjusted at the contract level based on the in-the-moneyness of the living benefit and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates for contracts with index-linked crediting guarantees may be adjusted at the contract level based on the applicability of any surrender charges, product type, and market related factors such as interest rates. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. For any given contract, lapse rates vary throughout the period over which cash flows are projected for the purposes of valuing these balances. (9)The spread over the SOFR swap curve represents the premium added to the proxy for the risk-free rate (SOFR) to reflect the Company’s estimates of rates that a market participant would use to value the living benefits in both the accumulation and payout phases and index-linked interest crediting guarantees as of December 31, 2025 and 2024, respectively. This spread includes an estimate of NPR, which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with issuing funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because funding agreements are insurance liabilities and are therefore senior to debt. Effective April 2023, the Company entered into an agreement with The Ohio National Life Insurance Company, now known as AuguStar Life Insurance Company (“AuguStar”), an affiliate of Constellation Insurance Holdings, Inc., to reinsure approximately $10 billion of account values of PDI traditional variable annuity contracts with guaranteed living benefits. See Note 15 for additional information regarding this transaction. As a result of this transaction, a ceded MRB asset balance was established to fair value the reinsurance reimbursements to the Company. The establishment of the fair value also required an estimate of NPR for AuguStar, which may differ from the Company’s; however, the NPR spreads for AuguStar were developed using a methodology similar to that of the Company. (10)The utilization rate assumption estimates the percentage of contracts that will utilize the benefit during the contract duration, and begin lifetime withdrawals at various time intervals from contract inception. The remaining contractholders are assumed to either begin lifetime withdrawals immediately or never utilize the benefit. Utilization assumptions may vary by product type, tax status and age. The impact of changes in these assumptions is highly dependent on the product type, the age of the contractholder at the time of the sale, and the timing of the first lifetime income withdrawal. Range reflects the utilization rate for the vast majority of business with living benefits. (11)The withdrawal rate assumption estimates the magnitude of annual contractholder withdrawals relative to the maximum allowable amount under the contract. These assumptions vary based on the age of the contractholder, the tax status of the contract and the duration since the contractholder began lifetime withdrawals. As of both December 31, 2025 and 2024, the minimum withdrawal rate assumption is 78% and the maximum withdrawal rate assumption may be greater than 100%. The fair value of the liability will generally increase the closer the withdrawal rate is to 100% and decrease as the withdrawal rate moves further away from 100%. (12)The range reflects the mortality rates for the vast majority of business with living benefits and other contracts, with policyholders ranging from 50 to 90 years old. While the majority of living benefits have a minimum age requirement, certain other contracts do not have an age restriction. This results in contractholders with mortality rates approaching 0% for certain benefits. Mortality rates may vary by product, age and duration. A mortality improvement assumption is also incorporated into the overall mortality table. (13)Option budget estimates the expected long-term cost of options used to hedge exposures associated with equity price and interest rate changes. The level of option budget determines future costs of the options, which impacts the growth in account value and the valuation of embedded derivatives. Interrelationships Between Unobservable Inputs—In addition to the sensitivities of fair value measurements to changes in each unobservable input in isolation, as reflected in the table above, interrelationships between these inputs may also exist, such that a change in one unobservable input may give rise to a change in another or multiple inputs. Examples of such interrelationships for significant internally-priced Level 3 assets and liabilities are as follows: Corporate Securities—The rate used to discount future cash flows reflects current risk-free rates plus credit and liquidity spread requirements that market participants would use to value an asset. The discount rate may be influenced by many factors, including market cycles, expectations of default, collateral, term and asset complexity. Each of these factors can influence discount rates, either in isolation, or in response to other factors. During weaker economic cycles, as the expectations of default increase, credit spreads widen, which results in a decrease in fair value. Commercial Mortgage-backed Securities—Interrelationships may exist between the prepayment rate, the default rate and/or loss severity, depending on specific market conditions. In stronger economic cycles, prepayment rates are generally driven by underlying property appreciation and subsequent cash-out refinances, while default rates and loss severity may be lower. During weaker economic cycles, prepayment rates may decline, while default rates and loss severity increase. Generally, a change in the assumption used for the probability of default would be accompanied by a directionally similar change in the assumption used for the loss severity and a directionally opposite change in the assumption used for prepayment rates. The impact of these factors on average life and economics varies with the deal structure and tranche subordination. Market Risk Benefits—The Company expects efficient benefit utilization and withdrawal rates to generally be correlated with lapse rates. However, behavior is generally highly dependent on the facts and circumstances surrounding the individual contractholder, such as their liquidity needs or tax situation, which could drive lapse behavior independent of other contractholder behavior assumptions. To the extent more efficient contractholder behavior results in greater in-the-moneyness at the contract level, lapse rates may decline for those contracts. Similarly, to the extent that increases in equity volatility are correlated with overall declines in the capital markets, lapse rates may decline as contracts become more in-the-money. Changes in Level 3 Assets and Liabilities––The following tables describe changes in fair values of Level 3 assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods (excluding MRBs disclosed in Note 14). When a determination is made to classify assets and liabilities within Level 3, the determination is based on significance of the unobservable inputs in the overall fair value measurement. All transfers are based on changes in the observability of the valuation inputs, including the availability of pricing service information that the Company can validate. Transfers into Level 3 are generally the result of unobservable inputs utilized within valuation methodologies and the use of indicative broker quotes for assets that were previously valued using observable inputs. Transfers out of Level 3 are generally due to the use of observable inputs in valuation methodologies as well as the availability of pricing service information for certain assets that the Company can validate.
__________ (1)“Other” includes additional activity not allocated to the specific categories within the rollforward of Level 3 Assets and Liabilities. (2)Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts. (3)Includes U.S. corporate public, U.S. corporate private, foreign corporate public and foreign corporate private securities. (4)Includes asset-backed, commercial mortgage-backed and residential mortgage-backed securities. (5)Issuances and settlements for Policyholders’ account balances are presented net in the rollforward. (6)Excludes MRB assets of $2,330 million and $2,331 million and MRB liabilities of $4,623 million and $4,455 million as of December 31, 2025 and 2024, respectively. See Note 14 for additional information. (7)Transfers into or out of Level 3 are generally reported at the value as of the beginning of the quarter in which the transfers occur for any such positions still held at the end of the quarter. Derivative Fair Value Information The following tables present the balances of certain derivative assets and liabilities measured at fair value on a recurring basis, as of the dates indicated, by the primary underlying risks they are used to manage. These tables include NPR and exclude embedded derivatives. The derivative assets and liabilities shown below are included in “Other invested assets” or “Other liabilities” in the tables contained within the sections “—Assets and Liabilities by Hierarchy Level” and “—Changes in Level 3 Assets and Liabilities,” above.
__________ (1)“Netting” amounts represent cash collateral and the impact of offsetting asset and liability positions held with the same counterparty, subject to master netting agreements. Changes in Level 3 Derivative Assets and Liabilities—The following tables provide a summary of the changes in fair value of Level 3 derivative assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods:
__________ (1)Total realized and unrealized gains (losses) as well as unrealized gains (losses) for assets still held at the end of the period are recorded in “Realized investment gains (losses), net.” (2)Transfers into or out of Level 3 are generally reported at the value as of the beginning of the quarter in which the transfers occur for any such positions still held at the end of the quarter. Nonrecurring Fair Value Measurements—The following tables represent information for assets measured at fair value on a nonrecurring basis. The fair value measurement is nonrecurring as these assets are measured at fair value only when there is a triggering event (e.g., an evidence of impairment). Assets included in the table are those that were adjusted to fair value during the respective reporting periods and that are still held as of the reporting date. The estimated fair values for these amounts were determined using significant unobservable inputs (Level 3).
__________ (1)Commercial mortgage loans are valued based on discounted cash flows utilizing market rates or the fair value of the underlying real estate collateral. (2)Reported carrying values for 2025 include values as of the measurement periods of March 31, 2025 for “Investment real estate,” December 31, 2025 for “Investment in JV/LP and Other” and September 30, 2025 and December 31, 2025 for “Equity securities.” Reported carrying values for 2024 include values as of the measurement periods of March 31, 2024 for “Investment in JV/LP and Other” and June 30, 2024 and September 30, 2024 for “Investment real estate.” (3)The Company recognized a goodwill impairment charge for Assurance IQ (“AIQ”) in 2023. The fair value was determined using weighting of an income approach, based on discounted cash flow valuation techniques and a market valuation approach based on a forward sales multiple. Fair Value Option The fair value option allows the Company to elect fair value as an alternative measurement for selected financial assets and financial liabilities not otherwise reported at fair value. Such elections have been made by the Company to help mitigate volatility in earnings that result from different measurement attributes. Electing the fair value option also allows the Company to achieve consistent accounting for certain assets and liabilities. Changes in fair value are reflected in “Realized investment gains (losses), net” for commercial mortgage and other loans and “Other income (loss)” for other assets and notes issued by consolidated VIEs. Changes in fair value due to instrument-specific credit risk are estimated using changes in credit spreads and quality ratings for the period reported. Interest income on commercial mortgage and other loans is included in “Net investment income.” Interest income on these loans is recorded based on the effective interest rate as determined at the closing of the loan. The following tables present information regarding assets and liabilities where the fair value option has been elected:
__________ (1)As of December 31, 2025, for loans for which the fair value option has been elected, none of the loans were 90 days or more past due. Fair Value of Financial Instruments The tables below present the carrying amount and fair value by fair value hierarchy level of certain financial instruments that are not reported at fair value. The financial instruments presented below are reported at carrying value on the Company’s Consolidated Statements of Financial Position. In some cases, as described below, the carrying amount equals or approximates fair value.
__________ (1)Carrying values presented herein differ from those in the Company’s Consolidated Statements of Financial Position because certain items within the respective financial statement captions are not considered financial instruments or are out of scope under authoritative guidance relating to disclosures of the fair value of financial instruments. (2)Includes contracts reinsured through coinsurance with funds withheld agreement with Prismic Re with a fair value of $7,513 million (carrying amount of $7,513 million) and $7,887 million (carrying amount of $7,887 million), a portion of which relates to insurance contracts as of December 31, 2025 and December 31, 2024, respectively. See Note 15 for additional information regarding the reinsurance arrangement with Prismic Re. (3)Excludes debt with fair value of $15,744 million (carrying amount of $15,744 million) and $14,748 million (carrying amount of $14,748 million) as of December 31, 2025 and December 31, 2024, respectively, which have been offset with the associated notes under a netting agreement. The fair values presented above have been determined by using available market information and by applying market valuation methodologies, as described in more detail below. Commercial Mortgage and Other Loans The fair value of most commercial mortgage loans is based upon the present value of the expected future cash flows discounted at the appropriate U.S. Treasury rate or foreign government bond rate (for non-U.S. dollar-denominated loans) plus an appropriate credit spread for loans of similar quality, average life and currency. The quality ratings for these loans, a primary determinant of the credit spreads and a significant component of the pricing process, are based on an internally-developed methodology. Certain commercial mortgage loans are valued incorporating other factors, including the terms of the loans, the relative strength of the underlying collateral, the principal exit strategies for the loans, prevailing interest rates and credit risk. Policy Loans The Company’s valuation technique for policy loans is to discount cash flows at the current policy loan coupon rate. Policy loans are fully collateralized by the cash surrender value of underlying insurance policies. As a result, the carrying value of the policy loans approximates the fair value. Short-Term Investments, Cash and Cash Equivalents, Accrued Investment Income and Other Assets The Company believes that due to the short-term nature of certain assets, the carrying value approximates fair value. These assets include: certain short-term investments, which are not securities, recorded at amortized cost; cash and cash equivalent instruments; accrued investment income; and other assets that meet the definition of financial instruments, including receivables, such as unsettled trades, accounts receivable and restricted cash. Reinsurance Recoverables and Deposit Receivables Reinsurance recoverables and deposit receivables includes receivables from modified coinsurance arrangements where the Company is the reinsurer and generally reflect the fair value of the invested assets retained by the cedant. Deposits made are included in “Reinsurance recoverables and deposit receivables.” The deposit assets are adjusted as amounts are paid, consistent with the underlying contracts. Policyholders’ Account Balances—Investment Contracts Only the portion of policyholders’ account balances related to products that are investment contracts (those without significant mortality or morbidity risk) are reflected in the table above. For fixed deferred annuities, single premium endowments, payout annuities and other similar contracts without life contingencies, fair values are generally derived using discounted projected cash flows based on interest rates that are representative of the Company’s financial strength ratings, and hence reflect the Company’s NPR. For GICs, funding agreements, structured settlements without life contingencies and other similar products, fair values are generally derived using discounted projected cash flows based on interest rates being offered for similar contracts with maturities consistent with those of the contracts being valued. For those balances that can be withdrawn by the customer at any time without prior notice or penalty, the fair value is the amount estimated to be payable to the customer as of the reporting date, which is generally the carrying value. For defined contribution and defined benefit contracts and certain other products, the fair value is the market value of the assets supporting the liabilities. Securities Sold Under Agreements to Repurchase The Company receives collateral for selling securities under agreements to repurchase, or pledges collateral under agreements to resell. Repurchase and resale agreements are also generally short-term in nature and, therefore, the carrying amounts of these instruments approximate fair value. Cash Collateral for Loaned Securities Cash collateral for loaned securities represents the collateral received or paid in connection with loaning or borrowing securities, similar to the securities sold under agreement to repurchase above. Due to the short-term nature of these transactions, the carrying value approximates fair value. Reinsurance and Funds Withheld Payables Reinsurance and funds withheld payables includes amounts payable to the reinsurer under coinsurance with funds withheld arrangements where the Company is the cedant. Deposits received are included in “Reinsurance and funds withheld payables.” The deposit liabilities are adjusted as amounts are received, consistent with the underlying contracts. Debt The fair value of short-term and long-term debt, as well as notes issued by consolidated VIEs, is generally determined by either prices obtained from independent pricing services, which are validated by the Company, or discounted cash flow models. With the exception of the notes issued by consolidated VIEs for which recourse is limited to the assets of the respective VIE and does not extend to the general credit of the Company, the fair values of these instruments consider the Company’s NPR. Discounted cash flow models predominately use market observable inputs such as the borrowing rates currently available to the Company for debt and financial instruments with similar terms and remaining maturities. For commercial paper issuances and other debt with a maturity of less than 90 days, the carrying value approximates fair value. Other Liabilities Other liabilities are primarily payables, such as unsettled trades, drafts and accrued expense payables. Due to the short-term until settlement of most of these liabilities, the Company believes that carrying value approximates fair value. Separate Account Liabilities—Investment Contracts Only the portion of separate account liabilities related to products that are investment contracts are reflected in the table above. Separate account liabilities are recorded at the amount credited to the contractholder, which reflects the change in fair value of the corresponding separate account assets including contractholder deposits less withdrawals and fees; therefore, carrying value approximates fair value.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Separate Accounts |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Separate Accounts Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Separate Account | SEPARATE ACCOUNTS The Company issues variable annuity and variable life insurance contracts through its separate accounts for which investment income and investment gains and losses accrue directly to, and investment risk is borne by, the contractholder. Most variable annuity and variable life insurance contracts are offered with both separate and general account options. See Note 13 for additional information. The assets supporting the variable portion of variable annuity and variable life insurance contracts are carried at fair value and reported as “Separate account assets” with an equivalent amount reported as “Separate account liabilities.” The liabilities related to the net amount at risk are reflected within “Future policy benefits” or “Market risk benefit liabilities” (or “assets,” if applicable). Amounts assessed against the contractholders for mortality, administration, and other services are included within revenue in “Policy charges and fee income” and changes in liabilities for minimum guarantees are generally included in “Policyholders’ benefits” or “Change in value of market risk benefits, net of related hedging gains (losses).” Separate Account Assets The aggregate fair value of assets, by major investment asset category, supporting separate accounts is as follows:
For the periods ended December 31, 2025, 2024 and 2023, there were no transfers of assets, other than cash, from the general account to a separate account; therefore, no gains or losses were recorded. Separate Account Liabilities The balances of and changes in separate account liabilities as of and for the periods ended are as follows:
__________ (1)Primarily represents activity from the Company’s intercompany eliminations as well as Divested and Run-off Businesses. There are no associated cash surrender charges. (2)“Cash surrender value” represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. There are no cash surrender charges for the PGIM and Institutional Retirement Strategies segments.
__________ (1)Primarily represents activity from the Company’s intercompany eliminations as well as Divested and Run-off Businesses. There are no associated cash surrender charges. (2)“Cash surrender value” represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. There are no cash surrender charges for the PGIM and Institutional Retirement Strategies segments.
__________ (1)Primarily represents activity from the Company’s intercompany eliminations as well as Divested and Run-off Businesses. There are no associated cash surrender charges. (2)“Cash surrender value” represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. There are no cash surrender charges for the PGIM and Institutional Retirement Strategies segments.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Policy Acquisition Costs, Deferred Reinsurance, Deferred Sales Inducements and Value of Business Acquired |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Charges, Insurers [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Policy Acquisition Costs, Deferred Reinsurance, Deferred Sales Inducements and Value of Business Acquired | DEFERRED POLICY ACQUISITION COSTS, DEFERRED REINSURANCE, DEFERRED SALES INDUCEMENTS AND VALUE OF BUSINESS ACQUIRED Deferred Policy Acquisition Costs The following tables show a rollforward for the lines of business that contain material DAC balances, along with a reconciliation to the Company’s total DAC balance:
__________ (1)Includes the impact of the reinsurance transaction with Prismic Re International in International Businesses. See Note 15 for additional information.
__________ (1)Prior period amounts have been updated to conform to current presentation. (2)Includes the impacts of the reinsurance transactions with Wilton Re and Somerset Re in Individual Life (Universal Life). See Note 15 for additional information
__________ (1)Prior period amounts have been updated to conform to current presentation. (2)Includes the impact of the reinsurance transaction with AuguStar in Individual Retirement Strategies. See Note 15 for additional information. Deferred Reinsurance Losses The following tables show a rollforward for the lines of business that contain DRL balances, along with a reconciliation to the Company's total DRL balance:
__________ (1)Includes the impacts of the reinsurance transaction with Wilton Re. See Note 15 for additional information.
__________ (1)Includes the impacts of the reinsurance transaction with Prismic Re. See Note 15 for additional information. Deferred Reinsurance Gains The following tables show a rollforward for the lines of business that contain DRG balances, along with a reconciliation to the Company's total DRG balance:
__________ (1)Includes the impacts of the reinsurance transaction with Somerset Re. See Note 15 for additional information.
__________ (1)Includes the impacts of the reinsurance transaction with AuguStar. See Note 15 for additional information. Deferred Sales Inducements The following table shows a rollforward of DSI balances for variable annuity products within Individual Retirement Strategies, which is the only line of business that contains a material DSI balance, along with a reconciliation to the Company’s total DSI balance:
Value of Business Acquired The following table shows a rollforward of VOBA balances for the acquisition of the Star and Edison Businesses for International Businesses, along with a reconciliation to the Company’s total VOBA balance:
__________ (1)Represents Aoba Life business. The following table provides estimated future amortization for the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments In Operating Joint Ventures |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Method Investments and Joint Ventures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments In Operating Joint Ventures | INVESTMENTS IN JOINT VENTURES AND OTHER OPERATING ENTITIES The Company has made investments in certain joint ventures and other operating entities that are strategic in nature and are made for other than the sole purpose of generating investment income. These investments are primarily accounted for under the equity method of accounting and are included in “Other assets” in the Company’s Consolidated Statements of Financial Position. The earnings from these investments are primarily included on an after-tax basis in “Equity in earnings of joint ventures and other operating entities, net of taxes” in the Company’s Consolidated Statements of Operations. The summarized financial information for the Company’s investments in joint ventures and other operating entities has been included in the summarized combined financial information for all significant equity method investments shown in Note 3. The following table sets forth information related to the Company’s investments in joint ventures and other operating entities as of and for the years ended December 31:
__________ (1)In September of 2023, the Company acquired a 20% equity interest as a limited partner in Prismic. See Note 1 for additional information. For the years ended December 31, 2025, 2024 and 2023, the Company recognized $61 million, $31 million and $10 million, respectively, of asset management fee income for services the Company provided to these joint ventures and other operating entities.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Other Intangibles |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill and Other Intangibles | GOODWILL AND OTHER INTANGIBLES The changes in the carrying value of goodwill by reportable segment are as follows:
__________ (1)During 2023, PGIM acquired a majority stake in Deerpath Capital Management, LP, a leading U.S.-based private credit and direct lending manager. The goodwill associated with that acquisition includes a measurement period adjustment made during 2024. (2)Corporate and Other includes the impairment of the remaining goodwill allocated with Assurance IQ. (3)Corporate and Other includes a sale of a foreign operation classified as a divested business. The Company tests goodwill for impairment annually, as of December 31, and more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount, as discussed in further detail in Note 2. The Company performed the annual goodwill impairment test using the quantitative approach for its reporting units at December 31, 2025. The estimated fair values of both PGIM and International Businesses incorporated a market approach based on an earnings multiple and exceeded their carrying values, resulting in no goodwill impairment as of December 31, 2025. Other Intangibles Other intangible balances at December 31, are as follows:
The fair values of net mortgage servicing rights were $271 million and $269 million at December 31, 2025 and 2024, respectively. Amortization expense for other intangibles was $73 million, $80 million and $89 million for the years ending December 31, 2025, 2024 and 2023, respectively. The amortization expense amounts for 2025, 2024 and 2023 do not include impairments recorded for mortgage servicing rights or other intangibles. See the nonrecurring fair value measurements section of Note 6 for additional information regarding these impairments. The following table provides estimated future amortization for the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Leases [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Operating Leases, Lessee | LEASES The Company occupies leased office space and other facilities in many locations under various long-term leases and has entered into numerous leases covering the long-term use of computers and other equipment. The leases, depending on their specific terms, are classified as either operating or finance with the vast majority of leases falling under the operating classification. The leases in the Company’s portfolio have remaining lease terms from less than one year to 23 years, some of which include options to extend the leases for up to 15 years, and some of which include options to terminate the leases within 12 years. An analysis of all economic and non-economic factors associated with leases containing certain options, including factors such as the existence of cancellation penalties, leasehold improvements made to the underlying assets and location of the underlying assets, is conducted to determine whether those leases are reasonably certain to renew, and hence, should be included in the lease term that is used to establish the right-of-use assets and lease liabilities for those arrangements. The Company does not have residual guarantees associated with its lessee arrangements, nor are there any restrictions or covenants associated with its lease arrangements. Lessee Supplemental balance sheet information related to leases where the Company is the lessee is included below. Right-of-use assets and lease liabilities are included within “Other assets” and “Other liabilities” respectively.
Maturities of operating lease liabilities are as follows:
Lease expense is included in “General and administrative expenses,” which consisted of operating lease and short-term costs. Operating lease costs were $121 million, $123 million, and $121 million for the years ended December 31, 2025, 2024, and 2023, respectively. Short-term lease costs were $70 million, $68 million, and $74 million for the years ended December 31, 2025, 2024, and 2023, respectively. Short-term lease costs relate to those leases with terms of twelve months or less that do not include an option to purchase the underlying asset that is reasonably certain of exercise. Lessor The Company directly owns certain real estate properties that are primarily reported within the investment portfolio. Such real estate is leased to third parties, with the Company serving as the lessor. The terms of the leases vary depending on property type (e.g., commercial or residential). In most cases, the lessee has an option to renew the lease contract based on market rates but does not have an option to purchase the property. The terms of the leases may also include provisions for the use of common areas. Such non-lease components are not separately accounted for by the Company, as a result of applying a practical expedient. Lease income included in “Net investment income” was $64 million, $69 million, and $79 million for the years ended December 31, 2025, 2024, and 2023, respectively. Lease income included in “Other income” was $12 million, $11 million, and $11 million for the years ended December 31, 2025, 2024, and 2023, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Operating Leases, Lessor | LEASES The Company occupies leased office space and other facilities in many locations under various long-term leases and has entered into numerous leases covering the long-term use of computers and other equipment. The leases, depending on their specific terms, are classified as either operating or finance with the vast majority of leases falling under the operating classification. The leases in the Company’s portfolio have remaining lease terms from less than one year to 23 years, some of which include options to extend the leases for up to 15 years, and some of which include options to terminate the leases within 12 years. An analysis of all economic and non-economic factors associated with leases containing certain options, including factors such as the existence of cancellation penalties, leasehold improvements made to the underlying assets and location of the underlying assets, is conducted to determine whether those leases are reasonably certain to renew, and hence, should be included in the lease term that is used to establish the right-of-use assets and lease liabilities for those arrangements. The Company does not have residual guarantees associated with its lessee arrangements, nor are there any restrictions or covenants associated with its lease arrangements. Lessee Supplemental balance sheet information related to leases where the Company is the lessee is included below. Right-of-use assets and lease liabilities are included within “Other assets” and “Other liabilities” respectively.
Maturities of operating lease liabilities are as follows:
Lease expense is included in “General and administrative expenses,” which consisted of operating lease and short-term costs. Operating lease costs were $121 million, $123 million, and $121 million for the years ended December 31, 2025, 2024, and 2023, respectively. Short-term lease costs were $70 million, $68 million, and $74 million for the years ended December 31, 2025, 2024, and 2023, respectively. Short-term lease costs relate to those leases with terms of twelve months or less that do not include an option to purchase the underlying asset that is reasonably certain of exercise. Lessor The Company directly owns certain real estate properties that are primarily reported within the investment portfolio. Such real estate is leased to third parties, with the Company serving as the lessor. The terms of the leases vary depending on property type (e.g., commercial or residential). In most cases, the lessee has an option to renew the lease contract based on market rates but does not have an option to purchase the property. The terms of the leases may also include provisions for the use of common areas. Such non-lease components are not separately accounted for by the Company, as a result of applying a practical expedient. Lease income included in “Net investment income” was $64 million, $69 million, and $79 million for the years ended December 31, 2025, 2024, and 2023, respectively. Lease income included in “Other income” was $12 million, $11 million, and $11 million for the years ended December 31, 2025, 2024, and 2023, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for Future Policy Benefits |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Liability for Future Policy Benefits | LIABILITY FOR FUTURE POLICY BENEFITS Liability for Future Policy Benefits primarily consists of the following sub-components, which are discussed in greater detail below. •Benefit Reserves; •Deferred Profit Liability; and •Additional Insurance Reserves In 2025, the Company recognized a favorable impact to net income attributable to its annual reviews and update of assumptions and other refinements for Liability for Future Policy Benefits. The impact was favorable for direct and assumed Benefit Reserves and DPL, net of the impact of flooring these liabilities at zero for each issue year cohort, primarily due to updates to mortality assumptions in Individual Life Insurance, partially offset by unfavorable updates for morbidity in Long-Term Care and mortality in Institutional Retirement Strategies. Additionally, there was a favorable impact for direct and assumed AIR, primarily due to offsetting impacts from updated policyholder behavior assumptions and mortality assumptions on universal life policies. In 2024, the Company recognized a favorable impact to net income attributable to its annual reviews and update of assumptions and other refinements for Liability for Future Policy Benefits. The impact was favorable for direct and assumed Benefit Reserves and DPL, net of the impact of flooring these liabilities at zero for each issue year cohort, primarily due to updates to mortality assumptions in Institutional Retirement Strategies and Long-Term Care, partially offset by unfavorable updates to policyholder behavior assumptions on certain life policies in International Businesses. Additionally, there was an unfavorable impact for direct and assumed AIR, primarily due to updates to policyholder behavior assumptions on universal life polices with secondary guarantees in Individual Life. In 2023, the Company recognized an unfavorable impact to net income attributable to its annual reviews and update of assumptions and other refinements for Liability for Future Policy Benefits. The impact was unfavorable for direct and assumed Benefit Reserves and DPL, net of the impact of flooring these liabilities at zero for each issue year cohort, primarily due to updates to policyholder behavior and claim assumptions in Long-Term Care. Additionally, there was an unfavorable impact for direct and assumed AIR, primarily due to unfavorable model refinements, partially offset by updates to economic assumptions, including expected future rates of returns on universal life policies with secondary guarantees in Individual Life. Benefit Reserves The balances of and changes in Benefit Reserves as of and for the periods indicated consist of the three tables presented below: Present Value of Expected Net Premiums rollforward, Present Value of Expected Future Policy Benefits rollforward, and Net Liability for Future Policy Benefits.
__________ (1)Reflects balance after reinsurance recoverable of $55 million, $60 million, and $69 million at December 31, 2025, 2024 and 2023, respectively. (2)Prior period amounts have been updated to conform to current period presentation. The following tables provide supplemental information related to the balances of and changes in Benefit Reserves included in the disaggregated tables above, on a gross (direct and assumed) basis, as of and for the period indicated:
(1)Prior period amounts have been updated to conform to current period presentation. For additional information regarding observable market information and the techniques used to determine the interest rate assumptions seen above, see Note 2. For non-participating traditional and limited-payment products, if a cohort is in a loss position where the liability for future policy benefits plus the present value of expected future gross premiums are determined to be insufficient to provide for the present value of expected future policy benefits and non-level claim settlement expenses, then the liability for future policy benefits is adjusted at that time, and thereafter, such that all changes, both favorable and unfavorable, in expected benefits resulting from both actual experience deviations and changes in future assumptions are recognized immediately as a gain or loss respectively. In 2025, there was an $85 million charge to net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts, partially offset by an $8 million gain reflecting the impact of ceded reinsurance. The unfavorable impact in 2025 is primarily due to new pension risk transfer business sold in Institutional Retirement Strategies, for which the Present Value of Expected Benefits at the required discount rate exceeds the premium paid. In 2024 and 2023, there was an immaterial impact to net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts. Deferred Profit Liability The balances of and changes in DPL as of and for the period indicated are as follows:
(1)Prior period amounts have been updated to conform to current period presentation. Additional Insurance Reserves AIR represents the additional liability for annuitization, death, or other insurance benefits, including GMDB and GMIB contract features, that are above and beyond the contractholder's account balance. The following table shows a rollforward of AIR balances for variable and universal life products within Individual Life, which is the only line of business that contains a material AIR balance, for the period indicated, along with a reconciliation to the Company’s total AIR balance:
__________ (1)Represents the portion of gross assessments required to fund the future policy benefits.
Future Policy Benefits Reconciliation The following table presents the reconciliation of the ending balances from above rollforwards, Benefit Reserves, DPL, and AIR including other liabilities, gross of related reinsurance recoverable, to the total liability for Future Policy Benefits on the Company's Consolidated Statement of Financial Position as of the periods indicated:
__________ (1)Primarily represents balances for which disaggregated rollforward disclosures are not required, including Closed Block liabilities, unpaid claims and claims expenses, and incurred but not reported and in course of settlement claim liabilities. Revenue and Interest Expense The following tables present revenue and interest expense related to Benefit Reserves, DPL, and AIR as well as related revenue and interest expense not presented in the above supplemental tables, in the Company's Consolidated Statement of Operations as of the periods indicated:
__________ (1)Represents “Gross premiums” for benefit reserves, “Revenue” for DPL and “Gross assessments” for AIR. (2)Prior period amounts have been updated to conform to current period presentation. POLICYHOLDERS’ ACCOUNT BALANCESThe balances of and changes in policyholders' account balances as of and for the periods ended are as follows:
__________ (1)Primarily relates to changes in the value of embedded derivative instruments associated with the indexed options of certain products. (2)Includes $2,738 million, $5,099 million and $5,479 million of the Full Service Retirement business’s account balances reinsured to Empower for December 31, 2025, 2024 and 2023, respectively. (3)The net amount at risk calculation includes both general account and separate account balances. (4)Cash surrender value represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. There are no cash surrender charges for the Institutional Retirement Strategies segment. (5)Prior period amounts have been updated to conform to current period presentation. “Policyholders’ account balances” for Institutional Retirement Strategies, International Businesses and Corporate and Other includes the Company’s Funding Agreement-Backed Notes (“FABN”) and Funding Agreement-Backed Commercial Paper (“FACP”) programs, which totaled $8,674 million, $5,547 million and $5,597 million, at December 31, 2025, 2024 and 2023, respectively. Under these programs, which have maximum authorized amounts of $15 billion of medium-term notes and $6 billion of commercial paper, Delaware statutory trusts issue short-term commercial paper and/or medium-term notes to investors that are secured by funding agreements issued to the trusts by PICA. The outstanding commercial paper and notes have fixed or floating interest rates that range from 0.0% to 5.6% and original maturities ranging from two months to ten years. Included in the amounts at December 31, 2025, 2024 and 2023 are funding agreements which secure the medium-term note liability, which are carried at amortized cost, of $5,694 million, $3,486 million and $3,474 million, respectively, and short-term note liability of $2,500 million, $2,086 million and $2,156 million, respectively, and Retail Note liability of $508 million, $136 million, and $0 million, respectively. “Policyholders’ account balances” for Institutional Retirement Strategies also includes collateralized funding agreements issued to the Federal Home Loan Bank of New York (“FHLBNY”) totaling $2,628 million, $2,628 million, and $2,628 million, as of December 31, 2025, 2024 and 2023, respectively. These obligations, which are carried at amortized cost, have fixed interest rates that range from 1.925% to 4.510% and original maturities of seven years. For additional details regarding the FHLBNY program, see Note 18. The Company issues variable life and universal life insurance contracts which may also include a “no-lapse guarantee” where the Company contractually guarantees to the contractholder a death benefit even when the account value drops to zero, as long as the “no-lapse guarantee” premium is paid. The net amount at risk is generally defined as the current death benefit in excess of the current account balance at the balance sheet date. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including contractholder mortality, contract lapses, and premium pattern, as well as interest rate and equity market returns. The Company also issues annuity contracts that provide certain death benefit and/or living benefit guarantees and are accounted for as MRBs. See Note 14 for additional information, including the net amount at risk associated with these guarantees. The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points (“bps”), between rates being credited to policyholders and the respective guaranteed minimums are as follows:
__________ (1)Excludes contracts without minimum guaranteed crediting rates, such as funds with indexed-linked crediting options and Japan variable products. (2)Prior period amounts have been updated to conform to current period presentation. Unearned Revenue Reserve The balance of and changes in URR as of and for the periods ended are as follows:
The following table shows a rollforward of MRB balances for annuity products within Individual Retirement Strategies, which is the only line of business that contains a material MRB balance, along with a reconciliation to the Company’s total net MRB positions as of the following dates:
__________ (1)Prior period amounts have been updated to conform to current presentation.
__________ (1)Prior period amounts have been updated to conform to current presentation. In 2025, 2024 and 2023, the Company recognized an unfavorable impact to net income attributable to the actuarial assumption update for direct and assumed MRBs, primarily due to updates to policyholder behavior assumptions. The Company issues certain variable annuity insurance contracts where the Company contractually guarantees to the contractholder a return of no less than (1) total deposits made to the contract adjusted for any partial withdrawals plus a minimum return, and/or (2) the highest anniversary contract value on a specified date adjusted for any withdrawals. These guarantees include benefits that are payable in the event of death, annuitization or at specified dates during the accumulation period and withdrawal and income benefits payable during specified periods. The Company also issues indexed annuity contracts for which the return is tied to the return of specific indices where the Company contractually guarantees to the contractholder a return of no less than total deposits made to the contract adjusted for any partial withdrawals upon death. In certain of these indexed annuity contracts, the Company also contractually guarantees to the contractholder withdrawal benefits payable during specific periods. For guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, contract lapses and contractholder mortality. For guarantees of benefits that are payable at annuitization, the net amount at risk is generally defined as the present value of the minimum guaranteed annuity payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, timing of annuitization, contract lapses and contractholder mortality. For guarantees of benefits that are payable at withdrawal, the net amount at risk is generally defined as the present value of the minimum guaranteed withdrawal payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. For guarantees of accumulation balances, the net amount at risk is generally defined as the guaranteed minimum accumulation balance minus the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including equity market returns, interest rates, market volatility and contractholder behavior. The following tables present accompanying information to the rollforward table above.
___________ (1)For contracts with multiple benefit features, the highest net amount at risk for each contract is included. The tables below reconcile MRB asset and liability positions as of the following dates:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholders' Account Balances |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Liability for Future Policy Benefits | LIABILITY FOR FUTURE POLICY BENEFITS Liability for Future Policy Benefits primarily consists of the following sub-components, which are discussed in greater detail below. •Benefit Reserves; •Deferred Profit Liability; and •Additional Insurance Reserves In 2025, the Company recognized a favorable impact to net income attributable to its annual reviews and update of assumptions and other refinements for Liability for Future Policy Benefits. The impact was favorable for direct and assumed Benefit Reserves and DPL, net of the impact of flooring these liabilities at zero for each issue year cohort, primarily due to updates to mortality assumptions in Individual Life Insurance, partially offset by unfavorable updates for morbidity in Long-Term Care and mortality in Institutional Retirement Strategies. Additionally, there was a favorable impact for direct and assumed AIR, primarily due to offsetting impacts from updated policyholder behavior assumptions and mortality assumptions on universal life policies. In 2024, the Company recognized a favorable impact to net income attributable to its annual reviews and update of assumptions and other refinements for Liability for Future Policy Benefits. The impact was favorable for direct and assumed Benefit Reserves and DPL, net of the impact of flooring these liabilities at zero for each issue year cohort, primarily due to updates to mortality assumptions in Institutional Retirement Strategies and Long-Term Care, partially offset by unfavorable updates to policyholder behavior assumptions on certain life policies in International Businesses. Additionally, there was an unfavorable impact for direct and assumed AIR, primarily due to updates to policyholder behavior assumptions on universal life polices with secondary guarantees in Individual Life. In 2023, the Company recognized an unfavorable impact to net income attributable to its annual reviews and update of assumptions and other refinements for Liability for Future Policy Benefits. The impact was unfavorable for direct and assumed Benefit Reserves and DPL, net of the impact of flooring these liabilities at zero for each issue year cohort, primarily due to updates to policyholder behavior and claim assumptions in Long-Term Care. Additionally, there was an unfavorable impact for direct and assumed AIR, primarily due to unfavorable model refinements, partially offset by updates to economic assumptions, including expected future rates of returns on universal life policies with secondary guarantees in Individual Life. Benefit Reserves The balances of and changes in Benefit Reserves as of and for the periods indicated consist of the three tables presented below: Present Value of Expected Net Premiums rollforward, Present Value of Expected Future Policy Benefits rollforward, and Net Liability for Future Policy Benefits.
__________ (1)Reflects balance after reinsurance recoverable of $55 million, $60 million, and $69 million at December 31, 2025, 2024 and 2023, respectively. (2)Prior period amounts have been updated to conform to current period presentation. The following tables provide supplemental information related to the balances of and changes in Benefit Reserves included in the disaggregated tables above, on a gross (direct and assumed) basis, as of and for the period indicated:
(1)Prior period amounts have been updated to conform to current period presentation. For additional information regarding observable market information and the techniques used to determine the interest rate assumptions seen above, see Note 2. For non-participating traditional and limited-payment products, if a cohort is in a loss position where the liability for future policy benefits plus the present value of expected future gross premiums are determined to be insufficient to provide for the present value of expected future policy benefits and non-level claim settlement expenses, then the liability for future policy benefits is adjusted at that time, and thereafter, such that all changes, both favorable and unfavorable, in expected benefits resulting from both actual experience deviations and changes in future assumptions are recognized immediately as a gain or loss respectively. In 2025, there was an $85 million charge to net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts, partially offset by an $8 million gain reflecting the impact of ceded reinsurance. The unfavorable impact in 2025 is primarily due to new pension risk transfer business sold in Institutional Retirement Strategies, for which the Present Value of Expected Benefits at the required discount rate exceeds the premium paid. In 2024 and 2023, there was an immaterial impact to net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts. Deferred Profit Liability The balances of and changes in DPL as of and for the period indicated are as follows:
(1)Prior period amounts have been updated to conform to current period presentation. Additional Insurance Reserves AIR represents the additional liability for annuitization, death, or other insurance benefits, including GMDB and GMIB contract features, that are above and beyond the contractholder's account balance. The following table shows a rollforward of AIR balances for variable and universal life products within Individual Life, which is the only line of business that contains a material AIR balance, for the period indicated, along with a reconciliation to the Company’s total AIR balance:
__________ (1)Represents the portion of gross assessments required to fund the future policy benefits.
Future Policy Benefits Reconciliation The following table presents the reconciliation of the ending balances from above rollforwards, Benefit Reserves, DPL, and AIR including other liabilities, gross of related reinsurance recoverable, to the total liability for Future Policy Benefits on the Company's Consolidated Statement of Financial Position as of the periods indicated:
__________ (1)Primarily represents balances for which disaggregated rollforward disclosures are not required, including Closed Block liabilities, unpaid claims and claims expenses, and incurred but not reported and in course of settlement claim liabilities. Revenue and Interest Expense The following tables present revenue and interest expense related to Benefit Reserves, DPL, and AIR as well as related revenue and interest expense not presented in the above supplemental tables, in the Company's Consolidated Statement of Operations as of the periods indicated:
__________ (1)Represents “Gross premiums” for benefit reserves, “Revenue” for DPL and “Gross assessments” for AIR. (2)Prior period amounts have been updated to conform to current period presentation. POLICYHOLDERS’ ACCOUNT BALANCESThe balances of and changes in policyholders' account balances as of and for the periods ended are as follows:
__________ (1)Primarily relates to changes in the value of embedded derivative instruments associated with the indexed options of certain products. (2)Includes $2,738 million, $5,099 million and $5,479 million of the Full Service Retirement business’s account balances reinsured to Empower for December 31, 2025, 2024 and 2023, respectively. (3)The net amount at risk calculation includes both general account and separate account balances. (4)Cash surrender value represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. There are no cash surrender charges for the Institutional Retirement Strategies segment. (5)Prior period amounts have been updated to conform to current period presentation. “Policyholders’ account balances” for Institutional Retirement Strategies, International Businesses and Corporate and Other includes the Company’s Funding Agreement-Backed Notes (“FABN”) and Funding Agreement-Backed Commercial Paper (“FACP”) programs, which totaled $8,674 million, $5,547 million and $5,597 million, at December 31, 2025, 2024 and 2023, respectively. Under these programs, which have maximum authorized amounts of $15 billion of medium-term notes and $6 billion of commercial paper, Delaware statutory trusts issue short-term commercial paper and/or medium-term notes to investors that are secured by funding agreements issued to the trusts by PICA. The outstanding commercial paper and notes have fixed or floating interest rates that range from 0.0% to 5.6% and original maturities ranging from two months to ten years. Included in the amounts at December 31, 2025, 2024 and 2023 are funding agreements which secure the medium-term note liability, which are carried at amortized cost, of $5,694 million, $3,486 million and $3,474 million, respectively, and short-term note liability of $2,500 million, $2,086 million and $2,156 million, respectively, and Retail Note liability of $508 million, $136 million, and $0 million, respectively. “Policyholders’ account balances” for Institutional Retirement Strategies also includes collateralized funding agreements issued to the Federal Home Loan Bank of New York (“FHLBNY”) totaling $2,628 million, $2,628 million, and $2,628 million, as of December 31, 2025, 2024 and 2023, respectively. These obligations, which are carried at amortized cost, have fixed interest rates that range from 1.925% to 4.510% and original maturities of seven years. For additional details regarding the FHLBNY program, see Note 18. The Company issues variable life and universal life insurance contracts which may also include a “no-lapse guarantee” where the Company contractually guarantees to the contractholder a death benefit even when the account value drops to zero, as long as the “no-lapse guarantee” premium is paid. The net amount at risk is generally defined as the current death benefit in excess of the current account balance at the balance sheet date. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including contractholder mortality, contract lapses, and premium pattern, as well as interest rate and equity market returns. The Company also issues annuity contracts that provide certain death benefit and/or living benefit guarantees and are accounted for as MRBs. See Note 14 for additional information, including the net amount at risk associated with these guarantees. The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points (“bps”), between rates being credited to policyholders and the respective guaranteed minimums are as follows:
__________ (1)Excludes contracts without minimum guaranteed crediting rates, such as funds with indexed-linked crediting options and Japan variable products. (2)Prior period amounts have been updated to conform to current period presentation. Unearned Revenue Reserve The balance of and changes in URR as of and for the periods ended are as follows:
The following table shows a rollforward of MRB balances for annuity products within Individual Retirement Strategies, which is the only line of business that contains a material MRB balance, along with a reconciliation to the Company’s total net MRB positions as of the following dates:
__________ (1)Prior period amounts have been updated to conform to current presentation.
__________ (1)Prior period amounts have been updated to conform to current presentation. In 2025, 2024 and 2023, the Company recognized an unfavorable impact to net income attributable to the actuarial assumption update for direct and assumed MRBs, primarily due to updates to policyholder behavior assumptions. The Company issues certain variable annuity insurance contracts where the Company contractually guarantees to the contractholder a return of no less than (1) total deposits made to the contract adjusted for any partial withdrawals plus a minimum return, and/or (2) the highest anniversary contract value on a specified date adjusted for any withdrawals. These guarantees include benefits that are payable in the event of death, annuitization or at specified dates during the accumulation period and withdrawal and income benefits payable during specified periods. The Company also issues indexed annuity contracts for which the return is tied to the return of specific indices where the Company contractually guarantees to the contractholder a return of no less than total deposits made to the contract adjusted for any partial withdrawals upon death. In certain of these indexed annuity contracts, the Company also contractually guarantees to the contractholder withdrawal benefits payable during specific periods. For guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, contract lapses and contractholder mortality. For guarantees of benefits that are payable at annuitization, the net amount at risk is generally defined as the present value of the minimum guaranteed annuity payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, timing of annuitization, contract lapses and contractholder mortality. For guarantees of benefits that are payable at withdrawal, the net amount at risk is generally defined as the present value of the minimum guaranteed withdrawal payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. For guarantees of accumulation balances, the net amount at risk is generally defined as the guaranteed minimum accumulation balance minus the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including equity market returns, interest rates, market volatility and contractholder behavior. The following tables present accompanying information to the rollforward table above.
___________ (1)For contracts with multiple benefit features, the highest net amount at risk for each contract is included. The tables below reconcile MRB asset and liability positions as of the following dates:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Risk Benefits |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Risk Benefits | LIABILITY FOR FUTURE POLICY BENEFITS Liability for Future Policy Benefits primarily consists of the following sub-components, which are discussed in greater detail below. •Benefit Reserves; •Deferred Profit Liability; and •Additional Insurance Reserves In 2025, the Company recognized a favorable impact to net income attributable to its annual reviews and update of assumptions and other refinements for Liability for Future Policy Benefits. The impact was favorable for direct and assumed Benefit Reserves and DPL, net of the impact of flooring these liabilities at zero for each issue year cohort, primarily due to updates to mortality assumptions in Individual Life Insurance, partially offset by unfavorable updates for morbidity in Long-Term Care and mortality in Institutional Retirement Strategies. Additionally, there was a favorable impact for direct and assumed AIR, primarily due to offsetting impacts from updated policyholder behavior assumptions and mortality assumptions on universal life policies. In 2024, the Company recognized a favorable impact to net income attributable to its annual reviews and update of assumptions and other refinements for Liability for Future Policy Benefits. The impact was favorable for direct and assumed Benefit Reserves and DPL, net of the impact of flooring these liabilities at zero for each issue year cohort, primarily due to updates to mortality assumptions in Institutional Retirement Strategies and Long-Term Care, partially offset by unfavorable updates to policyholder behavior assumptions on certain life policies in International Businesses. Additionally, there was an unfavorable impact for direct and assumed AIR, primarily due to updates to policyholder behavior assumptions on universal life polices with secondary guarantees in Individual Life. In 2023, the Company recognized an unfavorable impact to net income attributable to its annual reviews and update of assumptions and other refinements for Liability for Future Policy Benefits. The impact was unfavorable for direct and assumed Benefit Reserves and DPL, net of the impact of flooring these liabilities at zero for each issue year cohort, primarily due to updates to policyholder behavior and claim assumptions in Long-Term Care. Additionally, there was an unfavorable impact for direct and assumed AIR, primarily due to unfavorable model refinements, partially offset by updates to economic assumptions, including expected future rates of returns on universal life policies with secondary guarantees in Individual Life. Benefit Reserves The balances of and changes in Benefit Reserves as of and for the periods indicated consist of the three tables presented below: Present Value of Expected Net Premiums rollforward, Present Value of Expected Future Policy Benefits rollforward, and Net Liability for Future Policy Benefits.
__________ (1)Reflects balance after reinsurance recoverable of $55 million, $60 million, and $69 million at December 31, 2025, 2024 and 2023, respectively. (2)Prior period amounts have been updated to conform to current period presentation. The following tables provide supplemental information related to the balances of and changes in Benefit Reserves included in the disaggregated tables above, on a gross (direct and assumed) basis, as of and for the period indicated:
(1)Prior period amounts have been updated to conform to current period presentation. For additional information regarding observable market information and the techniques used to determine the interest rate assumptions seen above, see Note 2. For non-participating traditional and limited-payment products, if a cohort is in a loss position where the liability for future policy benefits plus the present value of expected future gross premiums are determined to be insufficient to provide for the present value of expected future policy benefits and non-level claim settlement expenses, then the liability for future policy benefits is adjusted at that time, and thereafter, such that all changes, both favorable and unfavorable, in expected benefits resulting from both actual experience deviations and changes in future assumptions are recognized immediately as a gain or loss respectively. In 2025, there was an $85 million charge to net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts, partially offset by an $8 million gain reflecting the impact of ceded reinsurance. The unfavorable impact in 2025 is primarily due to new pension risk transfer business sold in Institutional Retirement Strategies, for which the Present Value of Expected Benefits at the required discount rate exceeds the premium paid. In 2024 and 2023, there was an immaterial impact to net income for non-participating traditional and limited-payment products, where net premiums exceeded gross premiums for certain issue-year cohorts. Deferred Profit Liability The balances of and changes in DPL as of and for the period indicated are as follows:
(1)Prior period amounts have been updated to conform to current period presentation. Additional Insurance Reserves AIR represents the additional liability for annuitization, death, or other insurance benefits, including GMDB and GMIB contract features, that are above and beyond the contractholder's account balance. The following table shows a rollforward of AIR balances for variable and universal life products within Individual Life, which is the only line of business that contains a material AIR balance, for the period indicated, along with a reconciliation to the Company’s total AIR balance:
__________ (1)Represents the portion of gross assessments required to fund the future policy benefits.
Future Policy Benefits Reconciliation The following table presents the reconciliation of the ending balances from above rollforwards, Benefit Reserves, DPL, and AIR including other liabilities, gross of related reinsurance recoverable, to the total liability for Future Policy Benefits on the Company's Consolidated Statement of Financial Position as of the periods indicated:
__________ (1)Primarily represents balances for which disaggregated rollforward disclosures are not required, including Closed Block liabilities, unpaid claims and claims expenses, and incurred but not reported and in course of settlement claim liabilities. Revenue and Interest Expense The following tables present revenue and interest expense related to Benefit Reserves, DPL, and AIR as well as related revenue and interest expense not presented in the above supplemental tables, in the Company's Consolidated Statement of Operations as of the periods indicated:
__________ (1)Represents “Gross premiums” for benefit reserves, “Revenue” for DPL and “Gross assessments” for AIR. (2)Prior period amounts have been updated to conform to current period presentation. POLICYHOLDERS’ ACCOUNT BALANCESThe balances of and changes in policyholders' account balances as of and for the periods ended are as follows:
__________ (1)Primarily relates to changes in the value of embedded derivative instruments associated with the indexed options of certain products. (2)Includes $2,738 million, $5,099 million and $5,479 million of the Full Service Retirement business’s account balances reinsured to Empower for December 31, 2025, 2024 and 2023, respectively. (3)The net amount at risk calculation includes both general account and separate account balances. (4)Cash surrender value represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. There are no cash surrender charges for the Institutional Retirement Strategies segment. (5)Prior period amounts have been updated to conform to current period presentation. “Policyholders’ account balances” for Institutional Retirement Strategies, International Businesses and Corporate and Other includes the Company’s Funding Agreement-Backed Notes (“FABN”) and Funding Agreement-Backed Commercial Paper (“FACP”) programs, which totaled $8,674 million, $5,547 million and $5,597 million, at December 31, 2025, 2024 and 2023, respectively. Under these programs, which have maximum authorized amounts of $15 billion of medium-term notes and $6 billion of commercial paper, Delaware statutory trusts issue short-term commercial paper and/or medium-term notes to investors that are secured by funding agreements issued to the trusts by PICA. The outstanding commercial paper and notes have fixed or floating interest rates that range from 0.0% to 5.6% and original maturities ranging from two months to ten years. Included in the amounts at December 31, 2025, 2024 and 2023 are funding agreements which secure the medium-term note liability, which are carried at amortized cost, of $5,694 million, $3,486 million and $3,474 million, respectively, and short-term note liability of $2,500 million, $2,086 million and $2,156 million, respectively, and Retail Note liability of $508 million, $136 million, and $0 million, respectively. “Policyholders’ account balances” for Institutional Retirement Strategies also includes collateralized funding agreements issued to the Federal Home Loan Bank of New York (“FHLBNY”) totaling $2,628 million, $2,628 million, and $2,628 million, as of December 31, 2025, 2024 and 2023, respectively. These obligations, which are carried at amortized cost, have fixed interest rates that range from 1.925% to 4.510% and original maturities of seven years. For additional details regarding the FHLBNY program, see Note 18. The Company issues variable life and universal life insurance contracts which may also include a “no-lapse guarantee” where the Company contractually guarantees to the contractholder a death benefit even when the account value drops to zero, as long as the “no-lapse guarantee” premium is paid. The net amount at risk is generally defined as the current death benefit in excess of the current account balance at the balance sheet date. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including contractholder mortality, contract lapses, and premium pattern, as well as interest rate and equity market returns. The Company also issues annuity contracts that provide certain death benefit and/or living benefit guarantees and are accounted for as MRBs. See Note 14 for additional information, including the net amount at risk associated with these guarantees. The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points (“bps”), between rates being credited to policyholders and the respective guaranteed minimums are as follows:
__________ (1)Excludes contracts without minimum guaranteed crediting rates, such as funds with indexed-linked crediting options and Japan variable products. (2)Prior period amounts have been updated to conform to current period presentation. Unearned Revenue Reserve The balance of and changes in URR as of and for the periods ended are as follows:
The following table shows a rollforward of MRB balances for annuity products within Individual Retirement Strategies, which is the only line of business that contains a material MRB balance, along with a reconciliation to the Company’s total net MRB positions as of the following dates:
__________ (1)Prior period amounts have been updated to conform to current presentation.
__________ (1)Prior period amounts have been updated to conform to current presentation. In 2025, 2024 and 2023, the Company recognized an unfavorable impact to net income attributable to the actuarial assumption update for direct and assumed MRBs, primarily due to updates to policyholder behavior assumptions. The Company issues certain variable annuity insurance contracts where the Company contractually guarantees to the contractholder a return of no less than (1) total deposits made to the contract adjusted for any partial withdrawals plus a minimum return, and/or (2) the highest anniversary contract value on a specified date adjusted for any withdrawals. These guarantees include benefits that are payable in the event of death, annuitization or at specified dates during the accumulation period and withdrawal and income benefits payable during specified periods. The Company also issues indexed annuity contracts for which the return is tied to the return of specific indices where the Company contractually guarantees to the contractholder a return of no less than total deposits made to the contract adjusted for any partial withdrawals upon death. In certain of these indexed annuity contracts, the Company also contractually guarantees to the contractholder withdrawal benefits payable during specific periods. For guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, contract lapses and contractholder mortality. For guarantees of benefits that are payable at annuitization, the net amount at risk is generally defined as the present value of the minimum guaranteed annuity payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including fixed income and equity market returns, timing of annuitization, contract lapses and contractholder mortality. For guarantees of benefits that are payable at withdrawal, the net amount at risk is generally defined as the present value of the minimum guaranteed withdrawal payments available to the contractholder determined in accordance with the terms of the contract in excess of the current account balance. For guarantees of accumulation balances, the net amount at risk is generally defined as the guaranteed minimum accumulation balance minus the current account balance. The Company’s primary risk exposures for these contracts relates to actual deviations from, or changes to, the assumptions used in the original pricing of these products, including equity market returns, interest rates, market volatility and contractholder behavior. The following tables present accompanying information to the rollforward table above.
___________ (1)For contracts with multiple benefit features, the highest net amount at risk for each contract is included. The tables below reconcile MRB asset and liability positions as of the following dates:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance | REINSURANCE The Company regularly enters into third-party reinsurance agreements as either the ceding entity or the assuming entity. The Company also enters into affiliated reinsurance agreements as both the ceding and assuming entity for capital management purposes. As a ceding entity, exposure to the risks reinsured is reduced by transferring certain rights and obligations of the underlying insurance product to a counterparty. Conversely, as an assuming entity, exposure to the risks reinsured is increased by assuming certain rights and obligations of the underlying insurance products from a counterparty. The Company enters into reinsurance agreements as the ceding entity for a variety of reasons, but primarily to reduce exposure to loss, reduce risk volatility, provide additional capacity for future growth, facilitate the disposition of a block of business, and for capital management purposes. Under ceded reinsurance, the Company remains liable to the underlying policyholder if a third-party reinsurer is unable to meet its obligations. To mitigate this exposure, the Company evaluates the financial condition of reinsurers, monitors the concentration of counterparty risk and maintains collateral, as appropriate. The Company enters into reinsurance agreements as the assuming entity as part of the normal product offering process (e.g., certain pension risk transfer products in the Institutional Retirement Strategies business) or in order to facilitate an acquisition of a block of business. Effective October 2024, the Company entered into an agreement with Wilton Reassurance Company and Wilton Reinsurance Bermuda Limited (collectively, “Wilton Re”) to reinsure certain guaranteed universal life policies issued by Pruco Life Insurance Company (“Pruco Life”) and Pruco Life Insurance Company of New Jersey (“PLNJ”), both of which are wholly-owned subsidiaries of Prudential Financial. These policies represented approximately 40% of the Company’s remaining statutory reserves on its in-force guaranteed universal life block of business as of September 30, 2024, following the close of the reinsurance transaction with Somerset Reinsurance Ltd. (“Somerset Re”), as discussed below. The transaction is structured on a coinsurance basis and follows reinsurance accounting. As a result of the transaction, the Company recognized a $980 million deferred reinsurance loss at inception that is amortized into income over the estimated remaining life of the reinsured policies. Effective January 2024, the Company entered into an agreement with Somerset Re to reinsure certain guaranteed universal life policies issued by Pruco Life and PLNJ, both of which are wholly-owned subsidiaries of Prudential Financial. These policies represented approximately 30% of the Company’s statutory reserves on its in-force guaranteed universal life block of business as of December 31, 2023. This transaction is structured on a modified coinsurance basis and follows reinsurance accounting. As a result of the transaction, the Company recognized a $363 million deferred reinsurance gain at inception that is amortized into income over the estimated remaining life of the reinsured policies. The reinsurance payables, which represent the Company’s obligations under the modified coinsurance arrangement, are netted with the reinsurance recoverables in the Consolidated Statements of Financial Position. Separately, effective September 2019, Prudential Annuities Life Assurance Corporation (“PALAC”), a previously wholly-owned subsidiary of Prudential Financial, entered into an agreement with Somerset Re, to coinsure business, on a quota share funds withheld basis, related to fixed indexed annuities. This agreement was subsequently novated from PALAC to Pruco Life effective October 2021, in connection with the sale of PALAC effective April 2022. Under this reinsurance agreement, which is accounted for under the deposit method of accounting, the Company cedes to Somerset Re its quota share of the insurance liabilities with respect to the reinsured contracts. Effective September 2023, the Company entered into an agreement with Prismic Life Reinsurance, Ltd. (“Prismic Re”), a wholly-owned subsidiary of Prismic Life Holding Company LP (“Prismic”), to reinsure approximately $9 billion of reserves, representing approximately 70% of the in-force structured settlement annuities business previously issued by PICA, 90% of which is on a coinsurance with funds withheld basis and 10% of which is on a coinsurance basis. The reinsurance of the structured settlement annuities that provide periodic payments for the lifetime of the annuitant follows reinsurance accounting. The reinsurance of structured settlement annuities that provide payments for a guaranteed period of time and do not include life contingency risk follows deposit accounting. Separately, effective March 2025, the Company entered into an agreement with Prismic Life Reinsurance International, Ltd. (“Prismic Re International”), a wholly-owned subsidiary of Prismic, to reinsure approximately $7 billion of reserves for certain USD-denominated Japanese whole life policies originated by the Company’s Japanese affiliates. The transaction is structured on a coinsurance basis and is accounted for under the deposit method of accounting as the reinsured policies do not include life contingency risk and are accounted for as investment contracts. See Note 24 for additional information regarding the Company’s transactions with Prismic. Effective April 2023, the Company entered into an agreement with The Ohio National Life Insurance Company, now known as AuguStar, an affiliate of Constellation Insurance Holdings, Inc., to reinsure approximately $10 billion of account values of PDI traditional variable annuity contracts with guaranteed living benefits issued by Pruco Life, a wholly-owned subsidiary of Prudential Financial. This block represents approximately 10% of the Company’s remaining legacy in-force traditional variable annuity block by account value. The Company ceded 100% of separate account liabilities under modified coinsurance and 100% of general account liabilities under coinsurance of its Pruco Life issued PDI traditional variable annuity contracts. The general account liabilities associated with PDI’s guaranteed living and death benefits and the corresponding reinsurance of those liabilities are accounted for as market risk benefits. Effective April 2022, in connection with the sale of the Full Service Retirement business, the Company entered into separate agreements with external counterparties, Great-West and Great-West Life & Annuity Insurance Company of New York, now known as Empower Annuity Insurance Company of America and Empower Life & Annuity Insurance Company of New York (collectively, “Empower”), respectively, to reinsure a portion of its Full Service Retirement business. The Company ceded 100% of separate account liabilities under modified coinsurance and 100% of general account liabilities under coinsurance of its Full Service Retirement business. The Company’s Full Service Retirement business consists of market value and stable value separate accounts as well as general account products, including stable value accumulation funds and a stable value wrap product known as a synthetic guaranteed investment contract. The majority of these products are considered investment contracts as they do not contain significant insurance risk; therefore, the reinsurance of such products are accounted for under the deposit method of accounting. The reinsurance agreement offers the policyholders the opportunity to novate their contracts from the Company to Empower and any such novated contracts shall cease to be reinsured under this agreement. Effective April 2022, in connection with the sale of the PALAC legal entity, now known as Fortitude Life Insurance and Annuity Company (“FLIAC”), the Company entered into a reinsurance agreement with FLIAC under which the Company assumed all of FLIAC’s indexed variable annuities under modified coinsurance. The reinsurance of the indexed variable annuities transfers all significant risks, including mortality risk, embedded in the reinsured contracts. As a result of the agreement, reinsurance recoverables includes the assumed modified coinsurance receivable, which reflects the value of the invested assets retained by FLIAC and the associated asset returns. The Company also assumed via coinsurance all of FLIAC’s fixed indexed annuities with a guaranteed lifetime withdrawal income feature, which are accounted for under the deposit method of accounting. The reinsurance agreement offers the policyholders the opportunity to novate their contracts from FLIAC to the Company and any such novated contracts shall cease to be reinsured under this agreement. In January 2013, the Company acquired the Hartford Life Business through reinsurance transactions with three subsidiaries of Hartford Financial Services Group, Inc. (“Hartford Financial”). Under the related agreements, the Company provided reinsurance for approximately 700,000 life insurance policies with net retained face amount in force of approximately $141 billion. The Company acquired the general account business through a coinsurance arrangement and, for certain types of general account policies, a modified coinsurance arrangement. The Company acquired the separate account business through a modified coinsurance arrangement. In May 2018, Hartford Financial sold a group of operating subsidiaries, which included two of the Company’s counterparties to these reinsurance arrangements, to Talcott Resolution Life Insurance Company (“Talcott Resolution”). Talcott Resolution was acquired by Sixth Street in July 2021. There was no impact to the terms, rights or obligations of the Company, or operation of these reinsurance arrangements, as a result of these changes in control of such counterparties. Since 2011, the Company has entered into a number of reinsurance agreements to assume pension liabilities in the United Kingdom. Under these arrangements, the Company assumes the longevity risk, and in some arrangements, also the investment risk associated with the pension benefits of certain specified beneficiaries. The Company also obtains collateral from its counterparties to mitigate counterparty default risk. In 2006, the Company acquired the variable annuity business of The Allstate Corporation (“Allstate”) through a reinsurance transaction. The reinsurance arrangements with Allstate include a coinsurance arrangement associated with the general account liabilities assumed and a modified coinsurance arrangement associated with the separate account liabilities assumed. The reinsurance payables, which represent the Company’s obligations under the modified coinsurance arrangement, are netted with the reinsurance recoverables in the Consolidated Statements of Financial Position. During the fourth quarter of 2021, Allstate sold the two counterparties to the aforementioned variable annuity reinsurance transaction to third parties. There was no impact to the terms, rights or obligations of the Company, or operation of these reinsurance arrangements, as a result of this change in control of such counterparties. For the domestic businesses, life and disability reinsurance is accomplished through various types of reinsurance, primarily yearly renewable term, per person excess, excess of loss, and coinsurance. On individual life policies sold since 2000, the Company has reinsured a significant portion of the mortality risk. Placement of reinsurance is accomplished primarily on an automatic basis with some specific risks reinsured on a facultative basis. The Company is authorized and has historically retained up to $30 million per life but reduced its operating retention limit to $20 million per life in 2013 and then down to $10 million per life for new business starting in 2020. Retention in excess of the operating limit is on an exception basis. The Company also uses ceded reinsurance on certain annuity contracts to reduce market sensitivity and mitigate mortality and longevity risks. The international businesses primarily use reinsurance to obtain experience with respect to certain new product offerings and to a lesser extent, to mitigate mortality risk for certain protection products and for capital management purposes. Reinsurance amounts included in the Consolidated Statements of Operations for “Premiums,” “Policy charges and fee income,” “Change in value of market risk benefits, net of related hedging gains (losses),” “Policyholders’ benefits” and “Change in estimates of liability for future policy benefits” for the years ended December 31, are as follows:
Reinsurance recoverables and deposit receivables are as follows:
__________ (1)The Company has also recorded funds withheld and other payables related to the reinsurance agreement with Prismic Re of $7,980 million and $7,796 million as of December 31, 2025 and 2024, respectively. (2)The Company has also recorded reinsurance payables related to the Hartford Life Business acquisition of $1,366 million and $1,387 million as of December 31, 2025 and 2024, respectively. (3)Represents reinsurance recoverables of $8,192 million and $7,979 million as of December 31, 2025 and 2024, respectively, that are netted with reinsurance payables of $6,525 million and $6,388 million as of December 31, 2025 and 2024, respectively, related to the reinsurance agreement with Somerset Re in which the Company reinsured a portion of its in-force guaranteed universal life block of business under modified coinsurance. (4)The Company has also recorded funds withheld and other payables related to the reinsurance agreement with Somerset Re of $2,602 million and $2,595 million as of December 31, 2025 and 2024, respectively. (5)The Company has also recorded funds withheld and other payables related to the reinsurance of annuity contracts in the Individual Retirement Strategies business with Resolution Re, Ltd. (“Resolution Re”) of $851 million as of December 31, 2025. (6)Net of $14 million and $12 million of allowance for credit losses as of December 31, 2025 and 2024, respectively. Excluding the reinsurance recoverables associated with the counterparties separately identified within the reinsurance recoverables table above, four major reinsurance companies account for approximately 61% of the Company’s remaining reinsurance recoverables as of December 31, 2025. The Company periodically reviews the financial condition of its reinsurers, amounts recoverable therefrom, and unearned reinsurance premium, in order to reduce its exposure to loss from reinsurer insolvencies. Any expected credit losses are reflected in the CECL allowance, after considering any collateral the Company obtained in the form of a trust, letter of credit, or funds withheld arrangement. See Note 2 for additional details regarding CECL.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Closed Block |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Closed Block Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Closed Block | CLOSED BLOCK On December 18, 2001, the date of demutualization, PICA established a closed block for certain in-force participating insurance policies and annuity products, along with corresponding assets used for the payment of benefits and policyholders’ dividends on these products, (collectively the “Closed Block”), and ceased offering these participating products. The recorded assets and liabilities were allocated to the Closed Block at their historical carrying amounts. The Closed Block forms the principal component of the Closed Block division. See Note 23 for financial information regarding the Closed Block. The insurance policies and annuity contracts comprising the Closed Block are managed in accordance with the Plan of Reorganization approved by the New Jersey Department of Banking and Insurance (“NJDOBI”) on December 18, 2001, and PICA is directly obligated for the insurance policies and annuity contracts in the Closed Block. The policies included in the Closed Block are specified individual life insurance policies and individual annuity contracts that were in force on the date of demutualization and for which PICA is currently paying or expects to pay experience-based policy dividends. Assets have been allocated to the Closed Block in an amount that has been determined to produce cash flows which, together with revenues from policies included in the Closed Block, are expected to be sufficient to support obligations and liabilities relating to these policies, including provision for payment of benefits, certain expenses and taxes and to provide for continuation of the policyholder dividend scales in effect in 2000, assuming experience underlying such scales continues. To the extent that, over time, cash flows from the assets allocated to the Closed Block and claims and other experience related to the Closed Block are, in the aggregate, more or less favorable than what was assumed when the Closed Block was established, total dividends paid to Closed Block policyholders may be greater than or less than the total dividends that would have been paid to these policyholders if the policyholder dividend scales in effect in 2000 had been continued. Any cash flows in excess of amounts assumed will be available for distribution over time to Closed Block policyholders and will not be available to shareholders. If the Closed Block has insufficient funds to make guaranteed policy benefit payments, such payments will be made from PICA’s assets outside of the Closed Block. The Closed Block will continue in effect as long as any policy in the Closed Block remains in force unless, with the consent of the New Jersey insurance regulator, it is terminated earlier. The excess of Closed Block liabilities over Closed Block assets at the date of the demutualization (adjusted to eliminate the impact of related amounts in AOCI) represented the estimated maximum future earnings at that date from the Closed Block expected to result from operations attributed to the Closed Block after income taxes. In establishing the Closed Block, the Company developed an actuarial calculation of the timing of such maximum future earnings. If actual cumulative earnings of the Closed Block from inception through the end of any given period are greater than the expected cumulative earnings, only the expected earnings will be recognized in income. Any excess of actual cumulative earnings over expected cumulative earnings will represent undistributed accumulated earnings attributable to policyholders, which are recorded as a policyholder dividend obligation. The policyholder dividend obligation represents amounts to be paid to Closed Block policyholders as an additional policyholder dividend unless otherwise offset by future Closed Block performance that is less favorable than originally expected. If the actual cumulative earnings of the Closed Block from its inception through the end of any given period are less than the expected cumulative earnings of the Closed Block, the Company will recognize only the actual earnings in income. As of December 31, 2025, the Company recognized a policyholder dividend obligation of $1,635 million to Closed Block policyholders for the excess of actual cumulative earnings over expected cumulative earnings. Additionally, accumulated net unrealized investment gains (losses) were reflected as a policyholder dividend obligation of $(1,064) million at December 31, 2025, with a corresponding amount reported in AOCI. At December 31, 2024, the Company recognized a policyholder dividend obligation of $2,096 million to Closed Block policyholders for the excess of actual cumulative earnings over the expected cumulative earnings; however, due to accumulated net unrealized investment losses in excess of this amount, the policyholder dividend obligation balance as of December 31, 2024 was reduced to zero. In December of each year, PICA’s Board of Directors takes actions to either increase, continue, or decrease the dividend scale that was in effect on Closed Block policies. As a result of these actions, there was no change, and increases of approximately $109 million and $77 million in the liability for policyholder dividends for the years ended December 31, 2025, 2024 and 2023, respectively. As of December 31, 2025, the Closed Block has sufficient funds to make guaranteed policy benefit payments and there is no expectation that assets outside of the Closed Block will be needed to fund future payments. The excess of Closed Block liabilities over Closed Block assets as of the end of the reporting period shown in the table below is a reasonable measure of the margin in the reported liabilities compared to best estimate liabilities assuming the current dividend scale. Closed Block liabilities and assets designated to the Closed Block, as well as maximum future earnings to be recognized from these liabilities and assets, are as follows:
Information regarding the policyholder dividend obligation is as follows:
Closed Block revenues and benefits and expenses for the years ended December 31, are as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Taxes |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Tax Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Taxes | INCOME TAXES The following schedule discloses significant components of income tax expense (benefit) for each year presented:
__________ (1)The U.S. deferred tax includes a benefit of $318 million, which is fully offset by a corresponding charge in foreign deferred taxes related to one of the Company’s Bermuda operating insurance companies. These amounts are due to changes in Bermuda tax law in 2025. Overall, there is no impact on total taxes, as all earnings of the Bermuda entity are subject to U.S. taxation at a rate of 21% Reconciliation of Expected Tax at Statutory Rates to Reported Income Tax Expense (Benefit) The differences between income taxes expected at the U.S. federal statutory income tax rate of 21% applicable for 2025 and the reported income tax expense (benefit) are summarized as follows:
The following is a description of items that impacted the difference between the Company’s statutory U.S. federal income tax rate of 21% applicable for 2025 and the Company’s effective tax rate: State and Local Income Taxes. State income tax in Illinois represents the majority of the State and local income tax category. Note that in most jurisdictions, the Company’s insurance operations are subject to state premium taxes in lieu of state income taxes. Premium taxes are recorded as a general expense. General Business Credits. These amounts include U.S. tax credits for Low-income Housing. In August 2022, the Inflation Reduction Act was enacted which included provisions that allow for the transfer of certain federal clean energy tax credits (Federal Transferable Tax Credits). During 2025, the Company paid $192 million to purchase $200 million of 2025 Federal Transferable Energy Tax Credits. This amount paid has been included in payments for income taxes, and the difference between tax credits purchased and amounts paid are included as a component of the income tax provision. Non-Taxable Investment Income. The U.S. DRD reduces the amount of dividend income subject to U.S. tax and is included in the non-taxable investment income shown in the table above. More specifically, the U.S. DRD constitutes $54 million of the total $160 million of 2025 non-taxable investment income. The DRD for the current period was estimated using information from 2024, current year investment results, and current year’s equity market performance. The actual current year DRD can vary based on factors such as, but not limited to, changes in the amount of dividends received that are eligible for the DRD, changes in the amount of distributions received from fund investments, changes in the account balances of variable life and annuity contracts, and the Company’s taxable income before the DRD. GILTI. The GILTI provision applies a minimum U.S. tax to earnings of consolidated foreign subsidiaries in excess of a 10% deemed return on tangible assets of foreign subsidiaries by imposing the U.S. tax rate to 50% of earnings of such foreign affiliates and provides for a partial foreign tax credit for foreign income taxes. In years that the PFI consolidated federal income tax return reports a net operating loss or has a loss attributable to U.S. sources of operations, including as a result of loss carrybacks, the GILTI provision would limit the amount of deductions or credits permissible against GILTI. On July 20, 2020, the U.S. Treasury and the Internal Revenue Service issued Final Regulations (Treasury Decision 9902) pursuant to Internal Revenue Code Section 951A which allow an annual election to exclude from the U.S. tax return certain GILTI amounts when the taxes paid by a foreign affiliate exceed 18.9% (90% of U.S. statutory rate of 21%) of the GILTI amount for that foreign affiliate (the “high-tax exception”). These regulations are effective for the 2021 taxable year with an election to apply to any taxable year beginning after 2017. In many of the countries in which the Company operates, including Japan and Brazil, there are differences between local tax rules used to determine the tax base and the U.S. tax principles used to determine GILTI. Also, the Company’s Japan affiliates have a different tax year than the U.S. calendar tax year used to determine GILTI. Therefore, while many of the countries, including Japan and Brazil, have a statutory tax rate above the 18.9% threshold, separate affiliates may not meet the 18.9% threshold each year and, as such, may not qualify for this annual exclusion. Primarily as result of these differences, the Company recorded a $48 million income tax expense in 2025. The Company anticipates making the high-tax exception election for the 2025 tax year for its foreign affiliates that meet the 18.9% threshold. Changes in Tax Law. In December 2023, the Government of Bermuda enacted a corporate income tax, which imposes a 15% income tax, less applicable foreign tax credits, on companies that are organized or operate within Bermuda that are within the scope of the Organization of Economic Cooperation and Development (“OECD”) Pillar Two rules. The Bermuda corporate income tax is effective for tax years beginning on January 1, 2025. The Company intends to make an election to exclude the income of a Bermuda entity that is a controlled foreign corporation within the meaning of the U.S. tax rules from the Bermuda corporate income tax for fiscal years ending prior to January 1, 2027. Certain changes enacted in 2025 to the Bermuda corporate income tax provide for both foreign tax credits for controlled foreign company regime taxes imposed in respect of the income of Bermuda entities which may be claimed against Bermuda income tax liability as well as certain other tax credits. In 2025, the Company recorded an adjustment of $318 million net tax charge as a Change in Tax Laws in Bermuda, which was entirely offset by a corresponding $318 million tax benefit reflected in the Effect of Cross-border Tax Laws. In connection with this change, the Company also decreased the local Bermuda DTA initially recorded in 2023 and the corresponding valuation allowance, which has also been reflected within the Change in Tax Laws in Bermuda. H.R.1, also referred to as the “One Big Beautiful Bill Act” (the “Tax Act of 2025”), was enacted into law on July 4, 2025. The legislation introduces changes to the U.S. international tax regime, including a reduction in the Section 250 deduction for GILTI (now referred to as Net Controlled Foreign Corporation Tested Income (“NCTI”)) from 50% to 40% beginning in 2026, resulting in an increase to the corporate tax rate on NCTI from 10.5% to 12.6%. The legislation also reduces the foreign tax credit limitation related to NCTI from 20% to 10% and makes changes to the related expense allocation. While the Company continues to evaluate the impact of the Tax Act of 2025 on its future consolidated financial statements and related disclosures, the Company does not anticipate that the provisions of the Tax Act of 2025 will have a material impact on its total tax positions in 2026 and forward. In March 2025, Japan enacted a 4% Special Defense Corporation Tax, effective for tax years beginning on or after April 1, 2026, that raises the corporate income tax rate for the Company’s Japan insurance companies from 28.00% to 28.93%. As a result, the Company recorded $37 million income tax expense in 2025 which is included in “other” under the foreign tax effects category for Japan. In November 2025, Brazil enacted Law No. 15,270, effective January 1, 2026, which includes the introduction of a 10% withholding tax on dividends paid to non-residents. The withholding tax applies to dividends declared after December 31, 2025. As a result, a deferred tax expense of approximately $72 million is reflected as Change in Tax Law for Brazil for 2025. Other reconciling items. This line item represents reconciling items that are individually less than 5% of the computed expected federal income tax expense (benefit) and have therefore been aggregated for purposes of this reconciliation in accordance with relevant disclosure guidance. The differences between income taxes expected at the U.S. federal statutory income tax rate of 21% applicable for 2024 and 2023, and the reported income tax expense (benefit) are summarized as follows:
The following is a description of items that had a significant impact on the difference between the Company’s statutory U.S. federal income tax rate of 21% applicable for 2024 and 2023, and the Company’s effective tax rate during the periods presented: Non-Taxable Investment Income. The DRD reduces the amount of dividend income subject to U.S. tax and is included in the non-taxable investment income shown in the table above. More specifically, the U.S. DRD constitutes $55 million of the total $168 million of 2024 non-taxable investment income, and $62 million of the total $162 million of 2023 non-taxable investment income. The DRD for both years was estimated using information from the prior year, the current year investment results, and the current year’s equity market performance. Foreign Taxes at Other Than U.S. Rates. The combined statutory income tax rate in the Company’s largest non-U.S. tax jurisdiction is approximately 28%, plus local taxes in Japan as compared to the U.S. federal income tax rate of 21% applicable for 2024 and 2023. Low-Income Housing and Other Tax Credits. These amounts include U.S. tax credits for Low-income Housing as well as foreign tax credits. Changes in Tax Law. In December 2023, the Government of Bermuda enacted a corporate income tax, which imposes a 15% income tax, less applicable foreign tax credits, on companies that are organized or operate within Bermuda that are within the scope of the OECD Pillar Two rules. The Bermuda corporate income tax will be effective for tax years beginning on January 1, 2025. The Company intends to make an election to exclude the income of a Bermuda entity that is a controlled foreign corporation within the meaning of the U.S. tax rules from the Bermuda corporate income tax for fiscal years ending prior to January 1, 2027. In 2023, the Company reflected a $99 million net tax benefit as a result of the change in Bermuda tax law, which was entirely offset by a corresponding change in valuation allowance. In 2024, the Company recorded an adjustment of $50 million net tax expense, which was entirely offset by a corresponding change in valuation allowance. GILTI. In 2024, the Company received IRS consent to change its tax accounting method for certain products in its Japan operations which resulted in a reduction of the 2022 GILTI tax liability. The Company made the high-tax exception election for the 2023 and 2024 tax years. Other. This line item represents reconciling items that are individually less than 5% of the computed expected federal income tax expense (benefit) and have therefore been aggregated for purposes of this reconciliation in accordance with relevant disclosure guidance. Schedule of Deferred Tax Assets and Deferred Tax Liabilities
__________ (1) As of December 31, 2025, includes net deferred tax assets of $490 million and $0 million related to the Company’s U.S. operations and Bermuda operations, respectively. As of December 31, 2024, includes net deferred tax assets of $840 million and $401 million related to the Company’s U.S. operations and Bermuda operations, respectively. The application of U.S. GAAP requires the Company to evaluate the recoverability of deferred tax assets and establish a valuation allowance if necessary to reduce the deferred tax asset to an amount that is more likely than not expected to be realized. Considerable judgment is required in determining whether a valuation allowance is necessary, and if so, the amount of such valuation allowance. In evaluating the need for a valuation allowance, the Company considers many factors, including: (1) the nature of the deferred tax assets and liabilities; (2) whether they are ordinary or capital; (3) in which tax jurisdictions they were generated and the timing of their reversal; (4) taxable income in prior carryback years as well as projected taxable earnings exclusive of reversing temporary differences and carryforwards; (5) the length of time that carryovers can be utilized in the various taxing jurisdictions; (6) any unique tax rules that would impact the utilization of the deferred tax assets; and (7) any tax planning strategies that the Company would employ to avoid a tax benefit from expiring unused. Although realization is not assured, management believes it is more likely than not that the deferred tax assets, net of valuation allowances, will be realized. Changes in market conditions, including the significant rise in interest rates since the beginning of 2022, resulted in the recording of deferred tax assets related to net unrealized tax capital losses in the Company’s U.S. businesses. When assessing recoverability of these deferred tax assets, the Company considers its ability and intent to hold the underlying securities to recovery in value, if necessary, as well as other factors as noted above. As of December 31, 2025, based on all available evidence, the Company concluded that the deferred tax assets related to the unrealized tax capital losses on the available-for-sale and trading securities portfolios are, more likely than not, expected to be realized. A valuation allowance has been recorded against deferred tax assets related to certain federal, state and local taxes and foreign operations. Adjustments to the valuation allowance are made to reflect changes in management’s assessment of the amount of the deferred tax asset that is realizable and the amount of deferred tax asset actually realized during the year. The valuation allowance includes amounts recorded in connection with deferred tax assets as follows:
The following table sets forth the amount and expiration dates of federal, state and foreign operating, capital loss and tax credit carryforwards for tax purposes, as of the periods indicated:
__________ (1)Certain state net operating loss carryforwards expire between 2026 and 2045, whereas others have an unlimited carryforward. (2)$349 million expires between 2026 and 2042 and $150 million has an unlimited carryforward. (3)Expires between 2028 and 2035. These relate to foreign non-general basket tax credits. Consistent with the U.S. Tax Cuts and Jobs Act of 2017 (“Tax Act of 2017”), the Company provides applicable U.S. income tax for all unremitted earnings of the Company’s foreign affiliates. For certain foreign affiliates organized in withholding tax jurisdictions or that may be subject to other foreign country tax upon a remittance, the Company considers the unremitted foreign earnings of those affiliates to be indefinitely reinvested, and therefore does not provide for the withholding tax when calculating its current and deferred tax obligations. For certain other foreign affiliates organized in withholding tax jurisdictions or that may be subject to other foreign country tax upon a remittance, the Company does not consider unremitted earnings indefinitely reinvested, and therefore provides for foreign withholding tax when calculating its current and deferred tax obligations. The following table summarizes the Company’s indefinite reinvestment assertions for jurisdictions in which the Company operates that impose a withholding tax on dividends that is not eliminated by a tax treaty or may be subject to other foreign country tax upon a remittance:
The Company no longer has a permanent reinvestment assertion related to earnings of affiliates in Italy, France, Germany, and Luxembourg. This change had no net impact to the Company's financial results. The Company made no changes with respect to its repatriation assumptions in 2023 and 2024. The following table sets forth the undistributed earnings of foreign subsidiaries, where the Company assumes indefinite reinvestment of such earnings and for which, in 2025, 2024 and 2023, foreign deferred withholding or other foreign income taxes have not been provided. The net tax liability that may arise if the 2025 earnings were remitted which includes any foreign exchange impacts, is immaterial.
The Company’s “Income (loss) before income taxes and equity in earnings of joint ventures and other operating entities” includes income (loss) from domestic operations of $2,184 million, $2,077 million and $1,341 million and income (loss) from foreign operations of $2,473 million, $1,132 million and $1,731 million for the years ended December 31, 2025, 2024 and 2023, respectively. Income Taxes Paid Income taxes paid during the year are disclosed in the table below and include tax installments made for the current year as well as tax payments and refunds related to prior periods.
__________ (1)Includes $188 million refund related to prior years and $192 million paid for Transferable Energy tax credits.. Tax Audit and Unrecognized Tax Benefits The Company’s liability for income taxes includes the liability for unrecognized tax benefits and interest that relate to tax years still subject to review by the IRS or other taxing authorities. The completion of review or the expiration of the Federal statute of limitations for a given audit period could result in an adjustment to the liability for income taxes. The following table reconciles the total amount of unrecognized tax benefits at the beginning and end of the periods indicated:
The Company classifies all interest and penalties related to tax uncertainties as income tax expense (benefit). The amounts recognized in the consolidated financial statements for tax-related interest and penalties for the years ended December 31 are as follows:
Listed below are the tax years that remain subject to examination, by major tax jurisdiction, as of December 31, 2025:
The Company participates in the IRS’s Compliance Assurance Program. Under this program, the IRS assigns an examination team to review completed transactions as they occur in order to reach agreement with the Company on how they should be reported in the relevant tax returns. If disagreements arise, accelerated resolutions programs are available to resolve the disagreements in a timely manner. The U.S. federal tax law provides that an election may be made pursuant to Internal Revenue Code Section 952 (the “952 election”) to subject earnings from certain insurance operations to tax in the U.S. in the tax year earned, net of related foreign tax credits. The Company made the 952 election effective for the 2017 and later tax years with respect to its affiliates incorporated in Brazil. In October 2019, the IRS issued a legal memorandum applicable to all taxpayers in which the IRS argues that the election became inoperable in 1998. The Company disagrees with the IRS’s position. The Company and the IRS have not been able to resolve this disagreement through the IRS Independent Office of Appeals. The Company is considering all of its options for a resolution of the matter. Some of the Company’s affiliates in Japan file a consolidated tax return, while others file separate tax returns. The Company’s affiliates in Japan are subject to audits by the local taxing authority. The general statute of limitations is five years from when the return is filed. During 2023, the Japanese National Tax Service concluded tax audits of The Gibraltar Life Insurance Company, Ltd. (“Gibraltar Life”) for the three tax years ending March 31, 2022 and The Prudential Gibraltar Financial Life Insurance Company, Ltd. (“PGFL”) for the four tax years ending March 31, 2022. The tax authority also conducted tax audits of some non-insurance companies during the reporting period. The audits had no material impact on the Company’s results. In August 2020, the Company sold an affiliate in South Korea, Prudential of Korea, that was subject to routine tax audits by the local taxing authority for 2017, 2016, and 2015 tax years. In November 2023, the disputed issue on the treatment of foreign tax credits was decided in favor of Prudential of Korea at the Tax Tribunal appeal and therefore had no material impact on the Company’s results.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short-Term and Long-Term Debt |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Short-Term and Long-Term Debt | SHORT-TERM AND LONG-TERM DEBT Short-term Debt The table below presents the Company’s short-term debt at December 31, for the years indicated as follows:
__________ (1)Includes Prudential Financial debt of $561 million and $25 million as of December 31, 2025 and 2024, respectively. At December 31, 2025 and 2024, the Company was in compliance with all covenants related to the above debt. Commercial Paper Prudential Financial has a commercial paper program with an authorized capacity of $3.0 billion. Prudential Financial’s commercial paper borrowings have generally been used to fund the working capital needs of its subsidiaries and provide short-term liquidity at Prudential Financial. Prudential Funding, LLC (“Prudential Funding”), a wholly-owned subsidiary of PICA, has a commercial paper program, with an authorized capacity of $7.0 billion. Prudential Funding commercial paper borrowings generally have served as an additional source of financing to meet the working capital needs of PICA and its subsidiaries. Prudential Funding also lends to other subsidiaries of Prudential Financial up to limits agreed with the NJDOBI. Prudential Funding maintains a support agreement with PICA whereby PICA has agreed to maintain Prudential Funding’s tangible net worth at a positive level. Additionally, Prudential Financial has issued a subordinated guarantee covering Prudential Funding’s $7.0 billion commercial paper program. Federal Home Loan Bank of New York PICA is a member of the FHLBNY. Membership allows PICA access to the FHLBNY’s financial services, including the ability to obtain collateralized loans and to issue collateralized funding agreements. Under applicable law, the funding agreements issued to the FHLBNY have priority claim status above debt holders of PICA. FHLBNY borrowings and funding agreements are collateralized by qualifying mortgage-related assets or U.S. Treasury securities, the fair value of which must be maintained at certain specified levels relative to outstanding borrowings. FHLBNY membership requires PICA to own member stock and borrowings require the purchase of activity-based stock in an amount equal to 4.5% of outstanding borrowings. Under FHLBNY guidelines, if any of PICA’s financial strength ratings decline below A-/A3/A- Negative by S&P/Moody’s/Fitch, respectively, and the FHLBNY does not receive written assurances from the NJDOBI regarding PICA’s solvency, new borrowings from the FHLBNY would be limited to a term of 90 days or less. Currently there are no restrictions on the term of borrowings from the FHLBNY. All FHLBNY stock purchased by PICA is classified as restricted general account investments within “Other invested assets,” and the carrying value of these investments was $141 million and $142 million as of December 31, 2025 and 2024, respectively. NJDOBI permits PICA to pledge collateral to the FHLBNY in an amount of up to 5% of its prior year-end statutory net admitted assets, excluding separate account assets. Based on PICA’s statutory net admitted assets as of December 31, 2024, the 5% limitation equates to a maximum amount of eligible assets of $7.5 billion and an estimated maximum borrowing capacity (after taking into account required collateralization levels) of $6.0 billion. Nevertheless, FHLBNY borrowings are subject to the FHLBNY’s discretion and to the availability of qualifying assets at PICA. As of December 31, 2025, $2.5 billion of funding agreements remain outstanding under this facility, with maturities ranging from February 2027 to November 2029 and rates ranging from 1.925% to 4.510%. These funding agreements are reflected as “Policyholders’ account balances” on the Consolidated Statements of Financial Position and as such are not included in the table above. Federal Agricultural Mortgage Corporation In September 2023, as an additional source of liquidity, the Company entered into an agreement with the Federal Agricultural Mortgage Corporation (“Farmer Mac”), under which the Company can borrow up to $750 million by issuing funding agreements to a subsidiary of Farmer Mac, with borrowings secured by a pledge of certain eligible agricultural property loans. At December 31, 2025, no amounts were drawn from this facility. Credit Facilities As of December 31, 2025, the Company maintained syndicated, unsecured committed credit facilities as described below.
In July 2024, the Company amended and restated its $4.0 billion five-year credit facility that has both Prudential Financial and Prudential Funding as borrowers and a syndicate of financial institutions as lenders, extending the term of the facility to July 2029. The credit facility contains customary representations and warranties, covenants and events of default, and borrowings are not contingent on the borrowers’ credit ratings nor subject to material adverse change clauses. Borrowings under this facility are conditioned on the continued satisfaction of customary conditions, including Prudential Financial’s maintenance of consolidated net worth of at least $22.1 billion. For these purposes, consolidated net worth is calculated as U.S. GAAP equity excluding AOCI, equity of noncontrolling interests, equity attributable to the Closed Block, and certain adjustments related to the Company’s adoption of Targeted Improvements to the Accounting for Long‑Duration Contracts (“ASU 2018‑12”) in the first quarter of 2023. The Company expects that it may borrow under the facility from time to time to fund its working capital needs. In addition, amounts under this credit facility may be drawn in the form of standby letters of credit that can be used to meet the Company’s operating needs. In September 2024, the Company refinanced its ¥100 billion five-year credit facility, on which Prudential Holdings of Japan, Inc. (“PHJ”) is a borrower, extending the term of the facility to September 2029. This facility also contains customary representations and warranties, covenants, and events of default and borrowings are not contingent on the borrower’s credit ratings nor subject to material adverse change clauses. Borrowings under each of these credit facilities may be used for general corporate purposes. As of December 31, 2025, the Company was in compliance with the covenants under each of these credit facilities. In addition to the above credit facilities, the Company had access to $313 million of certain other lines of credit at December 31, 2025, of which $100 million was for the sole use of certain real estate separate accounts. The separate account facilities include loan-to-value ratio requirements and other financial covenants, and recourse on obligations under these facilities is limited to the assets of the applicable separate account. At December 31, 2025, $42 million of these credit facilities were used. The Company also has access to uncommitted lines of credit from financial institutions. Agreements for Senior Notes Issuance In May 2020, Prudential Financial entered into a ten-year facility agreement with a Delaware trust upon the completion of the sale of $1.5 billion of trust securities by that Delaware trust in a Rule 144A private placement. The trust invested the proceeds from the sale of the trust securities in a portfolio of principal and/or interest strips of U.S. Treasury securities. The facility agreement provides Prudential Financial the right to issue and sell to the trust from time to time up to $1.5 billion of 2.850% senior notes due May 15, 2030 and receive in exchange a corresponding amount of the U.S. Treasury securities held by the trust. In return, the Company agreed to pay a semi-annual facility fee to the trust at a rate of 2.175% per annum applied to the maximum amount of senior notes that the Company could issue and sell to the trust. Similar to the Company’s put option agreement, the facility agreement with the trust provides Prudential Financial with a source of liquid assets. The right to issue senior notes described above will be exercised automatically in full upon the Company’s failure to make certain payments to the trust, such as paying the facility fee or reimbursing the trust for its expenses, if the Company’s failure to pay is not cured within 30 days, and upon an event involving its bankruptcy. The Company is also required to exercise this issuance right if its consolidated stockholders’ equity, calculated in accordance with U.S. GAAP but excluding AOCI, falls below $9.0 billion, subject to adjustment in certain cases. Prior to any involuntary exercise of the issuance right, the Company has the right to repurchase any of its senior notes then held by the trust in exchange for a corresponding amount of U.S. Treasury securities. Finally, Prudential Financial may redeem any outstanding senior notes, in whole or in part, prior to February 15, 2030, at a redemption price equal to the greater of par or a make-whole price, or thereafter, at par. In March 2023, Prudential Financial entered into ten-year and thirty-year facility agreements with two Delaware trusts upon the completion of the sale of $1.5 billion of trust securities by the trusts in a Rule 144A private placement. The trusts invested the proceeds from the sale of the trust securities in portfolios of principal and/or interest strips of U.S. Treasury securities. The facility agreements provide Prudential Financial the right to issue and sell to the trusts from time to time up to $800 million of 5.791% senior notes due February 15, 2033 and $700 million of 5.997% senior notes due February 15, 2053, and receive in exchange a corresponding amount of the U.S. Treasury securities held by the trusts. In return, the Company agreed to pay semi-annual facility fees to the trusts at rates of 1.815% and 2.066% per annum for the ten-year and thirty-year facilities, respectively, applied to the maximum amount of senior notes that the Company could issue and sell to the trusts. The right to issue senior notes described above will be exercised automatically in full upon the Company’s failure to make certain payments to the trusts, such as paying the facility fee or reimbursing the trusts for their expenses, if the Company’s failure to pay is not cured within 30 days, and upon an event involving its bankruptcy. The Company is also required to exercise this issuance right if its consolidated stockholders’ equity, calculated in accordance with U.S. GAAP but excluding AOCI, falls below $9.0 billion, subject to adjustment in certain cases. Prior to any involuntary exercise of the issuance right, the Company has the right to repurchase any of its senior notes then held by the trusts in exchange for a corresponding amount of U.S. Treasury securities. Finally, Prudential Financial may redeem any outstanding senior notes, in whole or in part, prior to February 15, 2033 and February 15, 2053 for the ten-year and thirty-year facilities, respectively, at a redemption price equal to the greater of par or a make-whole price, or thereafter, at par. Long-term Debt The table below presents the Company’s long-term debt at December 31, for the years indicated as follows:
__________ (1)Ranges of interest rates are for the year ended December 31, 2025. (2)Amount includes $7.6 billion of surplus notes used to finance Guideline AXXX reserves for business reinsured to Somerset Re in March 2024. See Note 15 for additional information. (3)Includes $184 million and $100 million of debt denominated in foreign currency at December 31, 2025 and 2024, respectively. (4)Includes Prudential Financial debt of $7,555 million and subsidiary debt of $40 million denominated in foreign currency at December 31, 2025. (5)Assets under set-off arrangements represent a reduction in the amount of surplus notes included in long-term debt, resulting from an arrangement where valid rights of set-off exist and it is the intent of both parties to settle on a net basis under legally enforceable arrangements. These assets include available-for-sale securities that are reported at fair value. (6)Includes Prudential Financial debt of $18,378 million and $18,793 million at December 31, 2025 and 2024, respectively. At December 31, 2025 and 2024, the Company was in compliance with all debt covenants related to the borrowings in the table above. The following table presents the contractual maturities of the Company’s long-term debt as of December 31, 2025:
Senior Notes Under its shelf registration statement, the Company has issued Medium-Term Notes and InterNotes® Retail Notes. In addition, the Company completed a debt exchange offer in 2017, pursuant to which it issued two series of Senior Notes. The table below presents the Company’s balances related to these issuances, as well as its mortgage debt balance, as of December 31 for the years indicated as follows:
__________ (1)Includes $569 million of notes from current portion of long-term debt as of December 31, 2025. The weighted average interest rate on outstanding Medium-Term Notes, Senior Notes, and InterNotes® Retail Notes, including the effect of interest rate hedging activity, was 4.48% and 4.43% for the years ended December 31, 2025 and 2024, respectively, excluding the effect of debt issued to consolidated subsidiaries. Funding Agreement-Backed Notes and Commercial Paper Programs The Company maintains FABN and FACP programs in which statutory trusts issue medium-term notes and commercial paper secured by funding agreements issued to the trusts by PICA. These obligations are included in “Policyholders’ account balances” and not included in the foregoing table. See Note 13 for further discussion of these obligations. Surplus Notes Fixed-rate surplus notes are subordinated to other PICA borrowings and policyholder obligations, and the payment of interest and principal may only be made with the prior approval of the NJDOBI. The NJDOBI could prohibit the payment of the interest and principal on the surplus notes if certain statutory capital requirements are not met. As of December 31, 2025 and 2024, PICA had $0 million and $347 million of fixed-rate surplus notes outstanding, respectively. The surplus notes that were outstanding at December 31, 2024, met the statutory capital requirements mentioned above and, based on their July 2025 maturity date, were reclassified to short-term debt. Surplus Notes with Set-Off Arrangements
__________ (1)Amount includes $7.6 billion of surplus notes used to finance Guideline AXXX reserves for business reinsured to Somerset Re in March 2024. See Note 15 for additional information. Surplus Notes Supporting Regulation XXX and Guideline AXXX Reserves As shown in the table above, the Company’s captive reinsurance subsidiaries maintain facilities with external counterparties providing for the issuance of surplus notes by the captive to finance reserves required under Regulation XXX and Guideline AXXX. Under these facilities, the captives receive in exchange for the surplus notes one or more credit-linked notes issued by special-purpose affiliates in aggregate principal amounts equal to the surplus notes issued. The captives hold the credit-linked notes as assets supporting the non-economic portion of the statutory reserves required to be held by the Company’s domestic insurance subsidiaries under Regulation XXX and Guideline AXXX in connection with the reinsurance of term life or universal life insurance policies through the captive. The non-economic portion of the statutory reserve equals the difference between the statutory reserve required under Regulation XXX and Guideline AXXX and the amount the Company considers necessary to maintain solvency for moderately adverse experience. The credit-linked notes are redeemable for cash upon the occurrence of a liquidity stress event affecting the captives and external counterparties have agreed to fund these payments in return for a fee. Under certain of these different transactions, Prudential Financial has agreed to reimburse the captive for investment losses in excess of specified amounts. For each of the above transactions, because valid rights of set-off exist, interest and principal payments on the surplus notes and on the related credit-linked notes are settled on a net basis, and the surplus notes are reflected in the Company’s total consolidated borrowings on a net basis. The surplus notes for the captive reinsurance subsidiaries described above are subordinated to policyholder obligations, and the repayment of principal may only be made with prior approval of the Arizona Department of Insurance and Financial Institutions, the domiciliary insurance regulator of the captives. The payment of interest on the surplus notes has been approved by the Arizona Department of Insurance and Financial Institutions, subject to its ability to withdraw that approval. Other Surplus Notes The surplus note facility listed under “Other Notes” in the table above reflects a financing facility that Prudential Legacy Insurance Company of New Jersey (“PLIC”) has entered into with certain external counterparties and a special-purpose affiliate, pursuant to which PLIC may, at its option, issue and sell to the affiliate up to $4.0 billion in aggregate principal amount of surplus notes, in return for an equal principal amount of credit-linked notes. The credit-linked notes are redeemable for cash upon the occurrence of a liquidity stress event affecting PLIC, and external counterparties have agreed to fund these payments in return for a fee. Upon issuance, PLIC would hold any credit-linked notes as assets to support future statutory surplus needs within PLIC. In December 2025, the Company entered into an agreement with an external counterparty that allows for the issuance by PICA of up to $500 million in principal amount of surplus notes in return for a corresponding amount of credit-linked notes issued by a special-purpose wholly owned subsidiary of the Company. As of December 31, 2025, $287 million in principal amount of these surplus notes and credit-linked notes were outstanding. The surplus notes and credit-linked notes eliminate upon consolidation and are not reflected in the Company’s financial statements. PICA holds these credit-linked notes as assets supporting statutory requirements and can redeem the principal amount of these outstanding credit-linked notes for cash upon the occurrence of specified liquidity stress events affecting PICA. Under the agreement, the external counterparty has agreed to fund any such payments under these credit-linked notes in return for the receipt of fees. To date, no such payments under these credit-linked notes have been required. Junior Subordinated Notes Prudential Financial’s junior subordinated notes outstanding are considered hybrid securities that receive enhanced equity treatment from the rating agencies. These notes outstanding, along with their key terms, are as follows:
. The Company has the right to defer interest payments on these notes for specified periods, typically 5 to 10 years without resulting in a default, during which time interest will be compounded. On or after the optional redemption dates, Prudential Financial may redeem the notes at par plus accrued and unpaid interest. Prior to those optional redemption dates, redemptions generally are subject to a make-whole price; however, the Company may redeem the notes prior to these dates at par upon the occurrence of certain events, such as a future change in the regulatory capital treatment of the notes with respect to the Company. Interest Expense In order to manage exposure to interest rate and currency exchange rate movements, the Company utilizes derivative instruments, primarily interest rate swaps, in conjunction with some of its debt issuances. The impact of these derivative instruments is not reflected in the rates presented in the tables above. For those derivative instruments that qualify for hedge accounting, interest expense was $0 million for the years ended December 31, 2025, 2024 and 2023. See Note 5 for additional information regarding the Company’s use of derivative instruments. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Employee Benefit Plans |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Employee Benefit Plans | EMPLOYEE BENEFIT PLANS Pension and Other Postretirement Plans The Company has funded and non-funded non-contributory defined benefit pension plans (“Pension Benefits”), which cover substantially all of its employees. For some employees, benefits are based on final average earnings and length of service (the “traditional formula”), while benefits for other employees are based on an account balance that takes into consideration age, length of service and earnings during their career (the “cash balance formula”). At December 31, 2025, approximately 81% of the Company’s Pension Benefits relate to its domestic qualified pension plan, which initially determined benefits based on the traditional formula. Effective January 1, 2001, active domestic employees covered under this plan were given the option to convert from the traditional formula to the cash balance formula, and all new domestic employees began accruing benefits under the cash balance formula. As of December 31, 2025, approximately 64% and 36% of the benefit obligation under this plan relates to participants under the traditional formula (including all retirees who are receiving an annuity payment) and cash balance formula, respectively. At December 31, 2025, the vast majority of active employees under this plan are accruing benefits under the cash balance formula. The Company provides certain health care and life insurance benefits for its retired employees, their beneficiaries and covered dependents (“Other Postretirement Benefits”). The health care plan is contributory; the life insurance plan is non-contributory. Substantially all of the Company’s U.S. employees are eligible to receive Other Postretirement Benefits if they retire after age 55 with at least 10 years of service or under certain circumstances after age 50 with at least 20 years of continuous service. Prepaid benefits costs and accrued benefit liabilities are included in “Other assets” and “Other liabilities,” respectively, in the Company’s Consolidated Statements of Financial Position. The status of these plans as of December 31, 2025 and 2024 is summarized below:
__________ (1)For 2025, actuarial losses for pension and other postretirement benefits were primarily driven by a decrease in the discount rate. (2)For 2024, actuarial gains for pension were primarily driven by an increase in the discount rate. For 2024, actuarial losses for other postretirement benefits were primarily driven by an increase in medical trend rate. In addition to the plan assets above, the Company in 2007 established an irrevocable trust, commonly referred to as a “rabbi trust,” for the purpose of holding assets of the Company to be used to satisfy its obligations with respect to certain non-qualified retirement plans ($949 million and $861 million benefit obligation at December 31, 2025 and 2024, respectively). Assets held in the rabbi trust are available to the general creditors of the Company in the event of insolvency or bankruptcy. The Company may from time to time in its discretion make contributions to the trust to fund accrued benefits payable to participants in one or more of the plans, and, in the case of a change in control of the Company, as defined in the trust agreement, the Company will be required to make contributions to the trust to fund the accrued benefits, vested and unvested, payable on a pre-tax basis to participants in the plans. In addition, the Company may from time to time at its discretion make a withdrawal from or request a policy loan through the trust to fund operational or capital needs. The Company did not request policy loans through the trust in 2025 and 2024. The Company did not make any discretionary payments to the trust or receive any withdrawals from the trust in either 2025 or 2024. As of December 31, 2025 and 2024, the assets in the trust had a carrying value of $199 million and $157 million, respectively. The Company also maintains a separate rabbi trust for the purpose of holding assets of the Company to be used to satisfy its obligations with respect to certain other non-qualified retirement plans ($47 million and $51 million benefit obligation at December 31, 2025 and 2024, respectively), as well as certain cash-based deferred compensation arrangements. As of December 31, 2025 and 2024, the assets in the trust had a carrying value of $68 million and $75 million, respectively. Pension benefits for foreign plans comprised 9% and 10% of the ending benefit obligation for 2025 and 2024, respectively. Foreign pension plans comprised 3% of the ending fair value of plan assets for both 2025 and 2024. There are no material foreign postretirement plans. Information for pension plans with a projected benefit obligation in excess of plan assets
Information for pension plans with an accumulated benefit obligation in excess of plan assets
Components of Net Periodic Benefit Cost The Company uses market related value to determine components of net periodic (benefit) cost. Market related value recognizes certain changes in fair value of plan assets over a period of five years. Changes in the fair value of U.S. equities, international equities, real estate and other assets are recognized over a five year period. However, changes in the fair value for fixed maturity assets (including short-term investments) are recognized immediately for the purposes of market related value. Net periodic (benefit) cost included in “General and administrative expenses” in the Company’s Consolidated Statements of Operations for the years ended December 31, includes the following components:
__________ (1)For 2025 and 2024, certain employees were provided special termination benefits under non-qualified plans in the form of unreduced early retirement benefits as a result of their involuntary termination. (2)For 2023, certain employees were provided special termination benefits under non-qualified plans in the form of unreduced early retirement benefits as a result of their involuntary termination while others were provided enhanced benefits due to the Company’s organizational restructuring. Changes in Accumulated Other Comprehensive Income (Loss) The benefit obligation is based upon actuarial assumptions such as discount, termination, retirement, mortality and salary growth rates. Changes at year-end in these actuarial assumptions, along with experience changes based on updated participant census data are deferred in AOCI. Plan assets generate actuarial gains and losses when actual returns on plan assets differ from expected returns on plan assets, and these differences are also deferred in AOCI. The cumulative deferred gain (loss) within AOCI is amortized into earnings if it exceeds 10% of the greater of the benefit obligation or plan assets at the beginning of the year, and the amortization period is based upon the actuarially calculated expected future years of service for a given plan. The amounts recorded in AOCI as of the end of the period, which have not yet been recognized as a component of net periodic (benefit) cost, and the related changes in these items during the period that are recognized in “Other comprehensive income (loss)” are as follows:
__________ (1)For 2023, deferred losses for pension were driven by a decrease in discount rate and unfavorable asset performance. Deferred gains for other postretirement benefits were driven by a change to the Retiree Medical Plan, decrease in discount rate and favorable asset performance. (2)For 2024, deferred losses for pension were driven by unfavorable asset performance offset by an increase in discount rate. Deferred losses for other postretirement benefits were driven by an increase in medical trend experience offset by an increase in discount rate and favorable asset performance. (3)For 2025, deferred losses for pension were driven by a decrease in discount rate and unfavorable asset performance. Deferred gains for other postretirement benefits were driven by favorable asset performance offset by a decrease in discount rate. The Company’s assumptions related to the calculation of the domestic benefit obligation (end of period) and the determination of net periodic (benefit) cost (beginning of period) are presented in the table below:
The domestic discount rate used to value the pension and postretirement obligations at December 31, 2025 and December 31, 2024 is based upon the value of a portfolio of Aa-rated investments whose cash flows would be available to pay the benefit obligation’s cash flows when due. The December 31, 2025 portfolio is selected from a compilation of approximately 980 Aa-rated bonds across the full range of maturities. Since bond ratings and yields can vary widely at each maturity point, the Company uses an average bond rating and excludes bonds with unusually high or low yields, so as to avoid relying on bonds that might be mispriced or misrated. The Aa-rated portfolio is then selected and, accordingly, its value is a measure of the benefit obligation. A single equivalent discount rate is calculated to equate the value of the Aa-rated portfolio to the cash flows for the benefit obligation. The result is rounded to the nearest 5 basis points and the benefit obligation is recalculated using the rounded discount rate. The pension and postretirement expected long-term rates of return on plan assets for 2025 were determined based upon an approach that considered the allocation of plan assets as of December 31, 2024. Expected returns are estimated by asset class as noted in the discussion of investment policies and strategies below. Expected returns on asset classes are developed using a building-block approach that is forward looking and are not strictly based upon historical returns. The building blocks for equity returns include inflation, real return, a term premium, an equity risk premium, capital appreciation, expenses, the effect of active management and the effect of rebalancing. The building blocks for fixed maturity returns include inflation, real return, a term premium, credit spread, capital appreciation, effect of active management, expenses and the effect of rebalancing. The Company applied a similar approach to the determination of the expected rate of return on plan assets in 2026. The expected rate of return for 2026 is 7.75% and 6.25% for pension and postretirement, respectively. The assumptions for foreign pension plans are based on local markets. There are no material foreign postretirement plans. Plan Assets The investment goal of the domestic pension plan is to generate an above benchmark return on a diversified portfolio of stocks, bonds and other investments. The cash requirements of the plan’s pension obligation, which include a traditional defined benefit formula principally representing payments to annuitants and a cash balance formula that allows lump sum payments and annuity payments, are designed to be met by the bonds and short-term investments in the portfolio. The investment goal of the domestic postretirement plan assets is to generate an above benchmark return on a diversified portfolio of stocks, bonds, and other investments, while meeting the cash requirements for the postretirement obligation that includes a medical benefit including prescription drugs, a dental benefit and a life benefit. The pension and postretirement plans risk management practices include guidelines for asset concentration, credit rating, liquidity and tax efficiency. The fiduciaries of the pension and postretirement plans select investment managers to invest the assets of the plans consistent with each manager’s investment mandate. These managers may use derivatives such as futures contracts to reduce transaction costs and change asset concentration and may use interest rate swaps and futures to adjust duration. The plan fiduciaries for the Company’s pension and postretirement plans have developed guidelines for asset allocations reflecting a percentage of total assets by asset class, which are reviewed on a regular basis. Asset allocation targets as of December 31, 2025 are as follows:
To implement the investment strategy, plan assets are invested in funds that primarily invest in securities that correspond to one of the asset categories under the investment guidelines. However, at any point in time, some of the assets in a fund may be of a different nature than the specified asset category. Assets held with PICA are in either pooled separate accounts or single client separate accounts. Assets held with a bank are either in common/collective trusts or single client trusts. Pooled separate accounts and common/collective trusts hold assets for multiple investors. Each investor owns a “unit of account.” The asset allocation targets above include the underlying asset mix in the Pooled Separate Accounts and Common/Collective Trusts. Single client separate accounts or trusts hold assets for only one investor, the domestic qualified pension plan, and each security in the fund is treated as individually owned. There were no investments in Prudential Financial Common Stock as of both December 31, 2025 and 2024 for either the pension or postretirement plans. The authoritative guidance around fair value established a framework for measuring fair value. Fair value is disclosed using a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value, as described in Note 6. The following describes the valuation methodologies used for pension and postretirement plans assets measured at fair value. Insurance Company Pooled Separate Accounts, Common/Collective Trusts, and United Kingdom Insurance Pooled Funds—Insurance company pooled separate accounts are invested via group annuity contracts issued by PICA. Assets are represented by a “unit of account.” The redemption value of those units is based on a per unit value whose value is the result of the accumulated values of underlying investments. The unit of account value is used as a practical expedient to estimate fair value. Equities—See Note 6 for a discussion of the valuation methodologies for equity securities. U.S. Government Securities (both Federal and State & Other), Non–U.S. Government Securities, and Corporate Debt—See Note 6 for a discussion of the valuation methodologies for fixed maturity securities. Interest Rate Swaps—See Note 6 for a discussion of the valuation methodologies for derivative instruments. Registered Investment Companies (Mutual Funds)—Securities are priced at the NAV, which is the closing price published by the registered investment company on the reporting date. Short-term Investments—Securities are valued initially at cost and thereafter adjusted for amortization of any discount or premium (i.e., amortized cost). Amortized cost approximates fair value. Partnerships—The value of interests owned in partnerships is based on valuations of the underlying investments that include private placements, structured debt, real estate, equities, fixed maturities, commodities and other investments. Hedge Funds—The value of interests in hedge funds is based on the underlying investments that include equities, debt and other investments. Variable Life Insurance Policies—These assets are held in group and individual variable life insurance policies issued by PICA. Group policies are invested in Insurance Company Pooled Separate Accounts. Individual policies are invested in Registered Investment Companies (Mutual Funds). The value of interest in these policies is the cash surrender value (contract value) of the policies based on the underlying investments. The variable life insurance policies are valued at contract value which approximates fair value. Pension plan asset allocations in accordance with the investment guidelines are as follows:
__________ (1)Interest rate swaps notional amount is $1,221 million and $1,227 million for the years ended December 31, 2025 and 2024, respectively. (2)This category primarily consists of cash and cash equivalents, short-term investments, payables and receivables, and open future contract positions (including fixed income collateral). (3)The pension plan excludes from the fair value hierarchy investments that are measured at NAV per share (or its equivalent) as a practical expedient to estimate fair value. U.S. equities totaled $54 million and $37 million at December 31, 2025 and 2024, respectively. International equities totaled $166 million and $185 million at December 31, 2025 and 2024, respectively. Fixed maturities totaled $2,418 million and $2,186 million at December 31, 2025 and 2024, respectively. Short-term investments totaled $150 million and $67 million at December 31, 2025 and 2024, respectively. Real estate totaled $511 million and $510 million at December 31, 2025 and 2024, respectively. Changes in Fair Value of Level 3 Pension Assets
Postretirement plan asset allocations in accordance with the investment guidelines are as follows:
__________ (1)The postretirement plan excludes from the fair value hierarchy investments that are measured at NAV per share (or its equivalent) as a practical expedient to estimate fair value and Variable Life Insurance Policies valued at contract value. U.S. equities totaled $215 million and $192 million at December 31, 2025 and 2024, respectively. International equities totaled $119 million and $99 million at December 31, 2025 and 2024, respectively. Fixed maturities totaled $623 million and $652 million at December 31, 2025 and 2024, respectively. (2)There were no changes in the fair value of Level 3 postretirement assets from December 31, 2024 through December 31, 2025. The expected benefit payments for the Company’s pension and postretirement plans for the years indicated are as follows:
The Company anticipates that it will make cash contributions in 2026 of approximately $165 million to the pension plans and approximately $10 million to the postretirement plans. Postemployment Benefits The Company accrues postemployment benefits for income continuance and health and life benefits provided to former or inactive employees who are not retirees. The net accumulated liability for these benefits was $30 million as of both December 31, 2025 and 2024, and is included in “Other liabilities.” Other Employee Benefits The Company sponsors voluntary savings plans for employees (401(k) plans). The plans provide for salary reduction contributions by employees and matching contributions by the Company of up to 4% of annual salary. The matching contributions by the Company included in “General and administrative expenses” were $84 million, $87 million and $79 million for the years ended December 31, 2025, 2024 and 2023, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity | EQUITY Preferred Stock As of December 31, 2025, 2024 and 2023, the Company had 10,000,000 shares of preferred stock authorized but none issued or outstanding. Common Stock On the date of demutualization in December 2001, Prudential Financial completed an initial public offering of its Common Stock. The shares of Common Stock issued were in addition to shares of Common Stock the Company distributed to policyholders as part of the demutualization. The Common Stock is traded on the New York Stock Exchange under the symbol “PRU.” In the event of a liquidation, dissolution or winding-up of the Company, holders of Common Stock would be entitled to receive a proportionate share of the net assets of the Company that remain after paying all liabilities and the liquidation preferences of any preferred stock. The changes in the number of shares of Common Stock issued, held in treasury and outstanding, are as follows for the periods indicated:
__________ (1)Represents net shares issued from treasury pursuant to the Company’s stock-based compensation programs. Additional paid-in capital “Additional paid-in capital” primarily consists of the cumulative excess between: (a) the total cash received by the Company in conjunction with past issuances of Common Stock shares or Common Stock shares reissued from treasury in conjunction with the Company’s stock-based compensation program and (b) the total par value associated with those shares ($.01 per share). Common stock held in treasury Common Stock held in treasury represents the Company’s previously issued shares of stock which have been repurchased by the Company but not retired. These shares are accounted for at the cost at which they were acquired. Common Stock held in treasury is typically impacted by repurchases of shares under the Board of Directors approved share repurchase program and by reissuances of shares associated with the Company’s stock-based compensation programs, or for other purposes, which are accounted for at average cost upon reissuance. Gains resulting from the reissuance of Common Stock held in treasury are credited to “Additional paid-in capital.” Losses resulting from the reissuance of Common Stock held in treasury are charged first to “Additional paid-in capital” to the extent the Company has previously recorded gains on treasury share transactions, then to “Retained earnings.” The Board of Directors may from time to time, at its discretion, authorize management to repurchase shares of Common Stock of the Company. The timing and amount of share repurchases are determined by management based upon market conditions and other considerations, and such repurchases may be executed in the open market, through derivative, accelerated repurchase and other negotiated transactions and through plans complying with Rule 10b5-1(c) under the Securities Exchange Act of 1934 (the “Exchange Act”), as amended. Numerous factors could affect the timing and amount of any future repurchases under the share repurchase authorization, including, but not limited to: compliance with laws, increased capital needs of the Company due to changes in regulatory capital requirements, opportunities for growth and acquisitions, and the effect of adverse market conditions. The following table summarizes share repurchases for each of the past three years as well as the share repurchase authorization for 2026, which was approved by the Board of Directors in December 2025:
__________ * Share repurchase authorization for a future period. Dividends declared per share of Common Stock are as follows for the years indicated:
Accumulated Other Comprehensive Income (Loss) AOCI represents the cumulative OCI items that are reported separate from net income and detailed on the Consolidated Statements of Comprehensive Income. Each of the components that comprise OCI are described in further detail in Note 2 (Foreign Currency Translation Adjustment and Net Unrealized Investment Gains (Losses)), Note 12 (Interest rate remeasurement of Liability for Future Policy Benefits), Note 14 (Gains (losses) from Changes in Nonperformance Risk on Market Risk Benefits) and Note 19 (Pension and Postretirement Unrecognized Net Periodic Benefit (Cost)). The balance of and changes in each component of AOCI as of and for the years ended December 31, are as follows:
__________ (1)Includes cash flow hedges of $(231) million, $1,780 million and $869 million as of December 31, 2025, 2024, and 2023, respectively, and fair value hedges of $(123) million, $(64) million, and $(60) million as of December 31, 2025, 2024, and 2023, respectively. Reclassifications out of Accumulated Other Comprehensive Income (Loss)
__________ (1)All amounts are shown before tax. (2)Positive amounts indicate gains/benefits reclassified out of AOCI. Negative amounts indicate losses/costs reclassified out of AOCI. (3)See Note 5 for additional information regarding cash flow and fair value hedges. (4)See table below for additional information regarding unrealized investment gains (losses), including the impact on future policy benefits and policyholders’ dividends. (5)See Note 19 for information regarding employee benefit plans. Net Unrealized Investment Gains (Losses) Net unrealized investment gains (losses) on available-for-sale fixed maturity securities and certain other invested assets and other assets are included in the Company’s Consolidated Statements of Financial Position as a component of AOCI. Changes in these amounts include reclassification adjustments to exclude from “Other comprehensive income (loss)” those items that are included as part of “Net income (loss)” for a period that had been part of “Other comprehensive income (loss)” in earlier periods. The amounts for the periods indicated below, split between amounts related to available-for-sale fixed maturity securities on which an allowance for credit losses has been recorded, and all other net unrealized investment gains (losses), are as follows:
__________ (1)Includes cash flow and fair value hedges. See Note 5 for additional information. Retained earnings Retained earnings primarily represents the cumulative net income earned by the Company that has been retained by the Company as of the reporting date. Other unique items, included but not limited to the adoption of new accounting standards updates, may also impact retained earnings. In any given period, retained earnings may increase due to net income and may decrease due to net losses or the declaration of dividends. The declaration and payment of dividends on the Common Stock is limited by New Jersey corporate law, pursuant to which Prudential Financial is prohibited from paying a Common Stock dividend if, after giving effect to that dividend, either (a) the Company would be unable to pay its debts as they become due in the usual course of its business or (b) the Company’s total assets would be less than its liabilities. In addition, the terms of the Company’s outstanding junior subordinated debt include a “dividend stopper” provision that restricts the payment of dividends on the Common Stock if interest payments are not made on the junior subordinated debt. Other than the above limitations, the Company’s Retained earnings balance is free of restrictions for the payment of Common Stock dividends; however, Common Stock dividends will be dependent upon financial conditions, results of operations, cash needs, future prospects and other factors, including cash available to Prudential Financial, the parent holding company. The principal sources of funds available to Prudential Financial are dividends and returns of capital from its subsidiaries, loans from its subsidiaries, repayments of operating loans from its subsidiaries, and cash and other highly liquid assets. The primary uses of funds at Prudential Financial include servicing its debt, operating expenses, capital contributions and loans to subsidiaries, the payment of declared shareholder dividends and repurchases of outstanding shares of Common Stock if executed under Board authority. As of December 31, 2025, Prudential Financial had highly liquid assets (excluding amounts held in an intercompany liquidity account) of $3,817 million predominantly including cash, short-term investments, U.S. Treasury securities, obligations of other U.S. government authorities and agencies, and/or foreign government bonds. Future cash available at Prudential Financial to support the payment of future Common Stock dividends is dependent on the receipt of dividends or other funds from its subsidiaries, the majority of which are subject to comprehensive regulation, including limitations on their payment of dividends and other transfers of funds, which are discussed in this Note further below. Noncontrolling interests For certain subsidiaries, the Company owns a controlling interest that is less than 100% ownership of the subsidiary but must consolidate 100% of the subsidiary’s financial statements in accordance with U.S. GAAP. Noncontrolling interests represent the portion of equity ownership in a consolidated subsidiary that is not attributable to the Company. Insurance Subsidiaries - Statutory Financial Information and Restrictions on Payments of Dividends U.S. Insurance Subsidiaries—Statutory Financial Information The Company’s domestic insurance subsidiaries are required to prepare statutory financial statements in accordance with statutory accounting practices prescribed or permitted by the insurance department of the state of domicile. Statutory accounting practices primarily differ from U.S. GAAP by charging policy acquisition costs to expense as incurred, establishing future policy benefit liabilities using different actuarial assumptions as well as valuing investments and certain assets and accounting for deferred taxes on a different basis. The risk-based capital (“RBC”) ratio is a primary measure by which the Company and its insurance regulators evaluate the capital adequacy of PICA and the Company’s other domestic insurance subsidiaries. RBC is determined by NAIC-prescribed formulas that consider, among other things, risks related to the type and quality of the invested assets, insurance-related risks associated with an insurer’s products and liabilities, interest rate risks and general business risks. The RBC ratio is equal to an insurer’s total adjusted capital divided by the minimum amount of statutory capital and surplus needed by the insurer to support its operations, which is referred to as its “company action level RBC.” Insurers that have less statutory capital than required by their company action level RBC are considered to have inadequate capital and are subject to varying degrees of regulatory action depending upon the level of capital inadequacy. The Company expects to report RBC ratios for PICA and its other domestic insurance subsidiaries as of December 31, 2025 above the 100% regulatory required minimum that would require corrective action and above PICA’s target level that would support a “AA” financial strength rating. The following table summarizes certain statutory financial information for the Company’s U.S. insurance subsidiary as of and for the years ended:
__________ (1)Prior period amounts have been updated to conform to finalized statutory filings, where applicable. U.S. Insurance Subsidiaries—Restrictions on Payment of Dividends to Prudential Financial, the Parent Holding Company With respect to PICA, a New Jersey domiciled insurance subsidiary which is also the Company’s primary domestic insurance subsidiary, New Jersey insurance law provides that, except in the case of extraordinary dividends (as described below), all dividends or other distributions paid by PICA may be paid only from unassigned surplus, as determined pursuant to statutory accounting principles, less cumulative unrealized investment gains and losses and revaluation of assets as of the prior calendar year-end. As of December 31, 2025, PICA’s unassigned surplus less applicable adjustments for cumulative unrealized investment gains was $3,687 million. PICA must give prior notification to the NJDOBI of its intent to pay any such dividend or distribution. Also, if any dividend, together with other dividends or distributions made within the preceding twelve months, exceeds the greater of (i) 10% of statutory capital and surplus as of the preceding December 31 or (ii) its statutory net gain from operations excluding realized investment gains and losses for the twelve-month period ending on the preceding December 31, the dividend is considered to be an “extraordinary dividend” and requires the prior approval of the NJDOBI. Under New Jersey insurance law, PICA is permitted to pay an ordinary dividend of up to $1,848 million in 2026, without prior approval of the NJDOBI. Of the $1,848 million, $648 million is permitted to be paid after September 24, 2026, and the remaining $1,200 million is permitted to be paid after December 15, 2026, without prior approval of the NJDOBI. International Insurance Subsidiaries—Statutory Financial Information The Company’s international insurance subsidiaries prepare financial statements in accordance with local regulatory requirements. These statutory accounting practices differ from U.S. GAAP primarily by charging policy acquisition costs to expense as incurred and establishing future policy benefit liabilities using different actuarial assumptions, as well as valuing investments and certain assets and accounting for deferred taxes on a different basis. The Japan Financial Services Agency (“FSA”) utilizes a solvency margin ratio to evaluate the capital adequacy of Japanese insurance companies. The solvency margin ratio considers the level of solvency margin capital to a solvency margin risk amount, which is calculated in a similar manner to RBC. As of December 31, 2025, the Company expects The Prudential Life Insurance Company Ltd. (“Prudential of Japan”) and Gibraltar Life both had solvency margin capital in excess of 3.5 times the regulatory required minimums that would require corrective action. All of the Company’s domestic and international insurance subsidiaries have capital and surplus levels that exceed their respective regulatory minimum requirements, and none utilized prescribed or permitted practices that vary materially from the practices prescribed by the NAIC or equivalent regulatory bodies for results reported as of December 31, 2025 and 2024, respectively, or for the years ended December 31, 2025, 2024 and 2023, respectively. International Insurance Subsidiaries—Restrictions on Payment of Dividends to Prudential Financial, the Parent Holding Company The Company’s international insurance operations are subject to dividend restrictions from the regulatory authorities in the jurisdictions in which they operate. With respect to Prudential of Japan and Gibraltar Life, the Company’s most significant international insurance subsidiaries, both of which are domiciled in Japan, Japan law provides that common stock dividends may be paid in an amount of up to 83% of prior fiscal year statutory after-tax earnings, after certain reserving thresholds are met, including providing for policyholder dividends. If statutory retained earnings exceed 100% of statutory paid-in capital, 100% of prior year statutory after-tax earnings may be paid, after reserving thresholds are met. Dividends in excess of these amounts and other forms of capital distribution may require the prior approval of the FSA. Additionally, Prudential of Japan and Gibraltar Life must give prior notification to the FSA of their intent to pay any dividend or distribution. For the year ended December 31, 2025, Prudential Financial received $1,118 million from its international insurance subsidiaries. In addition to paying Common Stock dividends, the Company’s international insurance operations may return capital to Prudential Financial through, or facilitated by, other means, such as the repayment of Preferred Stock obligations held by Prudential Financial or other affiliates, affiliated lending, affiliated derivatives and reinsurance with U.S.- and Bermuda-based affiliates. The Company’s Japan insurance operations have entered into reinsurance agreements with Gibraltar Reinsurance Company Ltd., the Company’s Bermuda-based reinsurance affiliate, as well as with the Company’s domestic insurance operations to reinsure the mortality and morbidity risk associated with a portion of the in-force contracts as well as newly-issued contracts for certain products. The Company expects these transactions will allow it to more efficiently manage its capital and risk profile. The current regulatory fiscal year end for both Prudential of Japan and Gibraltar Life is March 31, 2026, after which time the common stock dividend amount permitted to be paid without prior approval from the FSA can be determined. In addition, although prior regulatory approval may not be required by law for the payment of dividends up to the limitations described above, in practice, the Company would typically discuss any dividend payments with the applicable regulatory authority prior to payment. Additionally, the payment of dividends by the Company’s subsidiaries is subject to declaration by their Board of Directors and may be affected by market conditions and other factors.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Earnings Per Share | EARNINGS PER SHARE A reconciliation of the numerators and denominators of the basic and diluted per share computations of Common Stock based on the consolidated earnings of Prudential Financial for the years ended December 31, is as follows:
Unvested share-based payment awards that contain nonforfeitable rights to dividends are participating securities and included in the computation of earnings per share pursuant to the two-class method. Under this method, earnings attributable to Prudential Financial are allocated between Common Stock and the participating awards, as if the awards were a second class of stock. During periods of net income available to holders of Common Stock, the calculation of earnings per share excludes the income attributable to participating securities in the numerator and the dilutive impact of these securities from the denominator. In the event of a net loss available to holders of Common Stock, undistributed earnings are not allocated to participating securities and the denominator excludes the dilutive impact of these securities as they do not share in the losses of the Company. Undistributed earnings allocated to participating unvested share-based payment awards for the years ended December 31, 2025, 2024 and 2023, as applicable, were based on 3.8 million, 4.0 million and 4.1 million of such awards, respectively, weighted for the period they were outstanding. Stock options and shares related to deferred and long-term compensation programs that are considered antidilutive are excluded from the computation of diluted earnings per share. Stock options are considered antidilutive based on application of the treasury stock method or in the event of a net loss available to holders of Common Stock. Shares related to deferred and long-term compensation programs are considered antidilutive in the event of a net loss available to holders of Common Stock. For the years ended December 31, the number of stock options and shares related to deferred and long-term compensation programs that were considered antidilutive and were excluded from the computation of diluted earnings per share, weighted for the portion of the period they were outstanding, are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Payments |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-Based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based Payment Arrangement | SHARE-BASED PAYMENTS Omnibus Incentive Plan Prudential Financial, Inc.’s Omnibus Incentive Plan provides stock-based awards including stock options, stock appreciation rights, restricted stock shares, restricted stock units, stock settled performance shares, and cash settled performance units. Dividend equivalents are generally provided on restricted stock shares and restricted stock units outstanding as of the record date. Dividend equivalents are generally accrued on target performance shares and units outstanding as of the record date. These dividend equivalents are paid only on the performance shares and units released up to a maximum of the target number of shares and units awarded. Generally, the requisite service period is the vesting period. There were 12,496,717 authorized shares available for grant under the Omnibus Incentive Plan as of December 31, 2025. Assurance IQ (“AIQ”) Acquisition The Company acquired AIQ on October 10, 2019. The terms of the acquisition included compensation awards that involved share-based payment arrangements that are linked to retention and therefore fall under the reporting requirements of ASC 718, Stock Compensation. These compensation awards include stock options, restricted stock units and performance shares. Compensation Costs Compensation cost for restricted stock units and performance shares granted to employees is measured by the share price of the underlying Common Stock at the date of grant. Compensation cost for employee stock options is based on the fair values estimated on the grant date. Under the Omnibus Incentive Plan, the fair value of each stock option award is estimated using a binomial option pricing model on the date of grant for stock options issued to employees. For the awards related to the AIQ acquisition, the fair value of each stock option award is based on its intrinsic value on the date of grant. There were no stock options granted in 2025, 2024 and 2023. Expected volatility is based on historical volatility of Prudential Financial’s Common Stock and implied volatility from traded options on Prudential Financial’s Common Stock. The Company uses historical data and expectations of future exercise patterns to estimate option exercises and employee terminations within the valuation model. The expected term of options granted represents the period of time that options granted are expected to be outstanding. The risk-free rate for periods associated with the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The following table summarizes the compensation cost recognized and the related income tax benefit for stock options, restricted stock units, performance shares and performance units for the years ended December 31:
__________ (1) Compensation costs related to retirement eligible participants are recorded on the grant date (typically in the first quarter of every year). On January 10, 2024, the Board of Directors of Prudential Financial, Inc. adopted certain modifications to the terms and conditions of performance shares granted in 2021, 2022 and 2023. These modifications 1) mitigate the impact of outsized interest rate volatility, both positive and negative, as it relates to achieving adjusted book value per share growth goals, and 2) reduce certain book value per share goals and maximum payout opportunities. The impact from these modifications increased shares to be delivered to 161 employees across all three performance plans by a total of approximately 600,000 shares. In addition, total compensation costs resulting from these modifications increased by approximately $62 million.
Compensation costs related to stock-based compensation plans capitalized in deferred acquisition costs for the years ended December 31, 2025, 2024 and 2023 were de minimis. Stock Options Each stock option granted under the Omnibus Incentive Plan has an exercise price at the fair market value of Prudential Financial’s Common Stock on the date of grant and has a maximum term of 10 years. Generally, one third of the option grant vests in each of the first three years. Options granted related to the AIQ acquisition have an exercise price based on the original strike price of the AIQ options that they replaced and have a maximum term of 10 years from the date the AIQ options were originally granted. Options granted related to the AIQ acquisition generally vest quarterly over three years. A summary of the status of the Company’s stock option grants is as follows:
There were no stock options granted for the years 2025, 2024 or 2023. The total intrinsic value (i.e., market price of the stock less the option exercise price) of employee stock options exercised during the years ended December 31, 2025, 2024 and 2023 was $2 million, $26 million, and $8 million, respectively. For the AIQ acquisition related awards, the total intrinsic value of employee stock options exercised during the years ended December 31, 2025, 2024 and 2023 was less than $1 million, $2 million and $3 million, respectively. The weighted average remaining contractual term and the aggregate intrinsic value of stock options outstanding and exercisable as of December 31, 2025 is as follows:
There were no AIQ Acquisition options remaining as of December 31, 2025. Restricted Stock Units and Performance Share Awards A restricted stock unit is an unfunded, unsecured right to receive a share of Prudential Financial’s Common Stock at the end of a specified period of time, which is subject to forfeiture and transfer restrictions. Generally, the restrictions will lapse one third annually over 3 years. Performance shares are awards denominated in Prudential Financial’s Common Stock. The number of units is determined over the performance period and may be adjusted based on the satisfaction of certain performance goals for the Company. Performance share awards are payable in Prudential Financial’s Common Stock. Generally, the awards will be released following the 3-year performance period. A summary of the Company’s restricted stock unit and performance share awards under the Omnibus Incentive Plan is as follows:
__________ (1)Performance share awards reflect the target units awarded, reduced for forfeitures and releases to date. The actual number of units to be awarded at the end of each performance period will range between 0% and 150% of the target number of units granted, based upon a measure of the reported performance for the Company relative to stated goals. (2)Represents the difference between the target units granted and the actual units awarded based upon the attainment of performance goals for the Company. The fair market value of restricted stock units and performance shares released under the Omnibus Incentive Plan for the years ended December 31, 2025, 2024 and 2023 was $269 million, $302 million and $360 million, respectively. The fair market value of restricted stock units released for the AIQ acquisition related awards under the Omnibus Incentive Plan for the years ended December 31, 2025, 2024 and 2023 was $0, less than $1 million and $1 million, respectively. The weighted average grant date fair value for restricted stock units granted under the Omnibus Incentive Plan during the years ended December 31, 2025, 2024 and 2023 was $108.42, $102.66 and $102.64, respectively. The weighted average grant date fair value for performance shares granted under the Omnibus Incentive Plan during the years ended December 31, 2025, 2024 and 2023 was $104.93, $97.67 and $103.27, respectively. There were no restricted stock units granted for the AIQ acquisition during the year ended December 31, 2025, 2024 and 2023. Unrecognized Compensation Cost There was no unrecognized compensation cost for stock options under the Omnibus Incentive Plan as of December 31, 2025. Unrecognized compensation cost for restricted stock units and performance shares under the Omnibus Incentive Plan as of December 31, 2025 was $169 million with a weighted average recognition period of 1.76 years. There was no unrecognized compensation cost for stock options or restricted units related to the AIQ acquisition as of December 31, 2025. Tax Benefits Realized The Company’s tax benefit realized for exercises of stock options under the Omnibus Incentive Plan during the years ended December 31, 2025, 2024 and 2023 was less than $1 million, $3 million and $2 million, respectively. The tax benefit realized for exercises of stock options related to the AIQ acquisition during the years ended December 31, 2025, 2024 and 2023 was less than $1 million for each period. The Company’s tax benefit realized upon vesting of restricted stock units, performance shares and performance units under the Omnibus Incentive Plan for the years ended December 31, 2025, 2024 and 2023 was $54 million, $60 million and $77 million, respectively. The tax benefit realized upon vesting of restricted stock units related to the AIQ acquisition during the years ended December 31, 2025, 2024 and 2023 was $0, less than $1 million and less than $1 million, respectively. Settlement of Awards |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Information |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Information | SEGMENT INFORMATION Segments The Company’s principal operations consist of PGIM (the Company’s global investment management business), the U.S. Businesses (consisting of the Retirement Strategies, Group Insurance, and Individual Life businesses), the International Businesses, the Closed Block division, and the Company’s Corporate and Other operations. The Closed Block division is accounted for as a divested business that is reported separately from the Divested and Run-off Businesses that are included in Corporate and Other operations. Divested and Run-off Businesses consist of businesses that have been, or will be, sold or exited, including businesses that have been placed in wind-down status that do not qualify for “discontinued operations” accounting treatment under U.S. GAAP. The Company’s Corporate and Other operations include corporate items and initiatives that are not allocated to business segments as well as the Divested and Run-off Businesses described above. The PGIM segment provides a comprehensive array of investment management solutions across a variety of asset classes, including public fixed income, public equity, real estate, private credit and other alternatives, and multi-asset class strategies, to institutional and retail clients, as well as the Company’s affiliated insurance and retirement businesses. The U.S. Businesses offer a broad range of products and solutions that cover protection, retirement, savings, income and investment needs. The U.S. Businesses are organized into the following segments: •The Retirement Strategies segment, which includes the Institutional and Individual Retirement Strategies businesses, provides a broad range of retirement investment and income products and services to retirement plan sponsors in the public, private and not-for-profit sectors, and develops and distributes individual variable and fixed annuity products, primarily to the U.S. mass affluent and affluent markets. •The Group Insurance segment provides and distributes a full range of group life, long-term and short-term group disability, and group corporate-, bank- and trust-owned life insurance. In addition, the segment sells supplemental health solutions including accident, critical illness, and hospital indemnity. •The Individual Life segment develops and distributes variable life, universal life and term life insurance products primarily to the U.S. mass middle, mass affluent and affluent markets. The International Businesses segment develops and distributes life insurance, retirement products, investment products and certain accident and health products with fixed benefits to affluent, mass affluent and broad middle income customers predominantly in Japan, Brazil and Mexico, as well as through joint ventures in Chile, China, India and Indonesia, and through strategic investments in Ghana and South Africa. Effective in the first quarter of 2025, consistent with changes to the Company’s internal management structure, the Company’s International Businesses are reflected as a single operating and reportable segment, which is how the chief operating decision maker (“CODM”) now assesses its performance and allocates resources. Prior to the first quarter of 2025, International Businesses consisted of the Life Planner and Gibraltar Life and Other operating segments, each of which was a reportable segment under U.S. GAAP. The change has been applied retrospectively and did not have any impact on the Company’s Consolidated Financial Statements contained herein or to any previously issued financial statements. The Closed Block division includes certain in-force participating insurance and annuity products and corresponding assets that are used for the payment of benefits, expenses and policyholders’ dividends related to these products, as well as certain related assets and liabilities. In connection with demutualization, the Company ceased offering these participating products. The Closed Block division is accounted for as a divested business that is reported separately from the Divested and Run-off Businesses that are included in the Company’s Corporate and Other operations. See Note 16 for additional information regarding the Closed Block. Corporate and Other Operations consists primarily of: (1) capital that is not deployed in any business segment; (2) investments not allocated to business segments; (3) capital debt; (4) the Company’s qualified and non-qualified pension and other employee benefit plans, after allocations to business segments; (5) corporate-level activities, after allocations to business segments, primarily including strategic expenditures, acquisition and disposition costs, corporate governance, corporate advertising, philanthropic activities, deferred compensation, and costs related to certain contingencies and legal matters; (6) expenses associated with the multi-year plan of programs that span across the Company’s businesses and the functional areas that support those businesses; (7) certain retained obligations relating to pre-demutualization policyholders; (8) impacts of risk management activities pursuant to the Company’s Risk Appetite Framework; (9) the foreign currency income hedging program used to hedge certain non-U.S. dollar denominated earnings in the International Businesses segment; (10) intercompany arrangements with the Company’s International Businesses and PGIM segments to translate certain non-U.S. dollar-denominated earnings at fixed currency exchange rates; (11) certain funding agreement issuances used in a spread lending capacity; (12) the consolidation of certain entities, including investment funds managed by the Company’s PGIM business, where the Company’s segments have collectively obtained controlling financial interest; (13) Prudential Advisors, Prudential’s proprietary nationwide advice organization; (14) the Company’s share of earnings in Prismic as well as the invested assets supporting the contracts reinsured with Prismic Re via coinsurance with funds withheld arrangements and the offsetting funds withheld payable; and (15) transactions with and between other segments, including the elimination of intercompany transactions for consolidation purposes. Segment Accounting Policies. The accounting policies of the segments are the same as those described in Note 2. Results for each segment include earnings on attributed equity established at a level which management considers necessary to support each segment’s risks. Operating expenses specifically identifiable to a particular segment are allocated to that segment as incurred. Following an annual review of its internal expense allocations, the Company implemented an allocation update that will impact segment results; however, there will be no impact to the Company’s consolidated results. Effective in 2025, operating expenses not identifiable to a specific segment that are incurred in connection with the generation of segment revenues are generally allocated using a proportional allocation measure such as headcount, segment-level support or other financial measures. Prior to 2025, these expenses were generally allocated based upon the segment’s historical percentage of general and administrative expenses. For information related to the adoption of new accounting pronouncements, see Note 2. The segments’ results in prior years have been revised for these items, as applicable, to conform to current year presentation. Adjusted Operating Income The Company analyzes the operating performance of each segment using “adjusted operating income.” Adjusted operating income does not equate to “Income (loss) before income taxes and equity in earnings of joint ventures and other operating entities” or “Net income (loss)” as determined in accordance with U.S. GAAP but is the measure of segment profit or loss used by the chief executive officer, who is the Company’s CODM, and is the measure of segment performance presented below. The CODM uses adjusted operating income to (1) evaluate segment performance; (2) allocate resources and capital, predominantly during the annual budgeting and planning processes; and (3) consider variances to pre-established targets during the compensation process. Adjusted operating income is not a substitute for income determined in accordance with U.S. GAAP, and the Company’s definition of adjusted operating income may differ from that used by other companies. The Company, however, believes that the presentation of adjusted operating income as measured for management purposes enhances the understanding of results of operations by highlighting the results from ongoing operations and the underlying profitability factors of its businesses. Adjusted operating income is calculated by adjusting each segment’s “Income (loss) before income taxes and equity in earnings of joint ventures and other operating entities” for the following items which are important to an understanding of overall results of operations, and are described in greater detail below: •Realized investment gains (losses), net, and related charges and adjustments; •Change in value of market risk benefits, net of related hedging gains (losses); •Market experience updates; •Divested and Run-off Businesses; •Equity in earnings of joint ventures and other operating entities and earnings attributable to noncontrolling interests; and •Other adjustments. Realized investment gains (losses), net, and related charges and adjustments Realized investment gains (losses), net Adjusted operating income excludes “Realized investment gains (losses), net,” except for certain items described below. Significant activity excluded from adjusted operating income includes impairments and credit-related gains (losses) from sales of securities, the timing of which depends largely on market credit cycles and can vary considerably across periods, and interest rate-related gains (losses) from sales of securities, which are largely subject to the Company’s discretion and influenced by market opportunities, as well as the Company’s tax and capital profile. Additionally, adjusted operating income excludes realized investment gains (losses) from products that contain embedded derivatives, and from associated derivative portfolios that are part of an asset/liability management program related to the risk of those products, as well as from investment performance of invested assets and embedded derivatives associated with certain coinsurance with funds withheld and modified coinsurance reinsurance arrangements. The following table sets forth the significant components of “Realized investment gains (losses), net” that are included in adjusted operating income and, as a result, are reflected as adjustments to “Realized investment gains (losses), net” for purposes of calculating adjusted operating income:
__________ (1)In addition to the items in the table above, “Realized investment gains (losses), net, and related charges and adjustments” also includes an adjustment to reflect “Realized investment gains (losses), net” related to Divested and Run-off Businesses. See “Divested and Run-off Businesses” discussed below. Terminated Hedges of Foreign Currency Earnings. The amounts shown in the table above primarily reflect the impact of an intercompany arrangement between Corporate and Other operations and the International Businesses segment, pursuant to which the non-U.S. dollar-denominated earnings in all countries for a particular year, including its interim reporting periods, are translated at fixed currency exchange rates. The fixed rates are determined in connection with a currency hedging program designed to mitigate the risk that unfavorable rate changes will reduce the segment’s U.S. dollar-equivalent earnings. Pursuant to this program, the Company’s Corporate and Other operations may execute forward currency contracts with third parties to sell the net exposure of projected earnings from the hedged currency in exchange for U.S. dollars at a specified exchange rate. The maturities of these contracts correspond with the future periods in which the identified non-U.S. dollar-denominated earnings are expected to be generated. These contracts do not qualify for hedge accounting under U.S. GAAP, so the resulting profits or losses are recorded in “Realized investment gains (losses), net.” When the contracts are terminated in the same period that the expected earnings emerge, the resulting positive or negative cash flow effect is included in adjusted operating income. Current Period Yield Adjustments. The Company uses interest rate and currency swaps and other derivatives to manage interest and currency exchange rate exposures arising from mismatches between assets and liabilities, including duration mismatches. For derivative contracts that do not qualify for hedge accounting treatment, the periodic swap settlements, as well as certain other derivative related yield adjustments are recorded in “Realized investment gains (losses), net,” and are included in adjusted operating income to reflect the after-hedge yield of the underlying instruments. In certain instances, when these derivative contracts are terminated or offset before their final maturity, the resulting realized gains or losses are recognized in adjusted operating income over periods that generally approximate the expected terms of the derivatives or underlying instruments in order for adjusted operating income to reflect the after-hedge yield of the underlying instruments. Included in the amounts shown in the table above are gains (losses) on certain derivative contracts that were terminated or offset before their final maturity of $123 million, $140 million and $178 million for the years ended 2025, 2024 and 2023, respectively. As of December 31, 2025, there was a $711 million deferred net gain related to certain derivative contracts that were terminated or offset before their final maturity, primarily within the Individual Retirement Strategies business and International Businesses. Also included in the amounts shown in the table above are fees related to synthetic GICs of $97 million, $100 million and $107 million for the years ended 2025, 2024 and 2023, respectively. Synthetic GICs are accounted for as derivatives under U.S. GAAP and, therefore, these fees are recorded in “Realized investment gains (losses), net.” See Note 5 for additional information regarding synthetic GICs. Principal Source of Earnings. The Company conducts certain activities for which realized investment gains (losses) are a principal source of earnings for its businesses and are therefore included in adjusted operating income, particularly within the Company’s PGIM segment. For example, PGIM’s strategic investing business makes investments for sale or syndication to other investors or for placement or co-investment in the Company’s managed funds and structured products. The realized investment gains (losses) associated with the sale of these strategic investments, as well as the majority of derivative results, are a principal activity for this business and included in adjusted operating income. In addition, the realized investment gains (losses) associated with loans originated by the Company’s commercial mortgage operations, as well as related derivative results and retained mortgage servicing rights, are a principal activity for this business and are therefore included in adjusted operating income. Adjustments related to Realized investment gains (losses), net The following table sets forth certain other items excluded from adjusted operating income and reflected as an adjustment to “Realized investment gains (losses), net” for purposes of calculating adjusted operating income:
Investments carried at fair value through net income. The Company has certain investments in its general account portfolios that are carried at fair value with changes in fair value reported in “Other income (loss).” Examples include the Company’s investments in equity securities and fixed maturities designated as trading. Consistent with the exclusion of realized investment gains (losses) with respect to other investments managed on a consistent basis, the net gains or losses on these investments are excluded from adjusted operating income. Foreign Currency Exchange Movements. The Company has certain assets and liabilities for which, under U.S. GAAP, the changes in value, including those associated with changes in foreign currency exchange rates during the period, are recorded in “Other income (loss).” To the extent the foreign currency exposure on these assets and liabilities is economically hedged or considered part of the Company’s capital funding strategies for its international subsidiaries, the change in value included in “Other income (loss)” is excluded from adjusted operating income. The insurance liabilities are supported by investments denominated in corresponding currencies, including a significant portion designated as available-for-sale. While these non-yen denominated assets and liabilities are economically hedged, unrealized gains (losses) on available-for-sale investments, including those arising from foreign currency exchange rate movements, are recorded in AOCI under U.S. GAAP, while the non-yen denominated liabilities are remeasured for foreign currency exchange rate movements, with the related change in value recorded in earnings within “Other income (loss).” Due to this non-economic volatility that has been reflected in U.S. GAAP earnings, the change in value recorded within “Other income (loss)” is excluded from adjusted operating income. Other Activities. The Company excludes certain other items from adjusted operating income that are consistent with similar adjustments described above. Charges related to realized investment gains (losses), net Charges that relate to realized investment gains (losses) are also excluded from adjusted operating income, and include the following: •Policyholder dividends and interest credited to policyholders’ account balances that relate to certain life policies that pass back certain realized investment gains (losses) to the policyholder, and reserves for future policy benefits for certain policies that are affected by net realized investment gains (losses); and •Market value adjustments paid or received upon a contractholder’s surrender of certain of the Company’s annuity products as these amounts mitigate the net realized investment gains or losses incurred upon the disposition of the underlying invested assets. Change in value of market risk benefits, net of related hedging gains (losses) The Company is required to measure all market risk benefits (e.g., living benefit and death benefit guarantees associated with variable annuities) at fair value. In order to enhance the understanding of underlying performance trends, the Company excludes from adjusted operating income “Change in value of market risk benefits, net of related hedging gains (losses),” which reflects the impact from changes in current market conditions. See Note 2 for additional information regarding market risk benefits. Market experience updates “Market experience updates” represent the immediate impacts from changes in current market conditions on estimates of profitability and the impact of those changes on reserves, primarily related to variable and universal life products. These amounts are excluded from adjusted operating income, which the Company believes enhances the understanding of underlying performance trends. Divested and Run-off Businesses The contribution to income (loss) of Divested and Run-off Businesses that have been or will be sold or exited, including businesses that have been placed in wind down, but that did not qualify for “discontinued operations” accounting treatment under U.S. GAAP, are excluded from adjusted operating income as the results of Divested and Run-off Businesses are not considered relevant to understanding the Company’s ongoing operating results. The Closed Block division is accounted for as a divested business because it consists primarily of certain participating insurance and annuity products that the Company ceased selling at demutualization in 2001. See Note 16 for additional information regarding the Closed Block. Equity in earnings of joint ventures and other operating entities and earnings attributable to noncontrolling interests Equity in earnings of joint ventures and other operating entities, on a pre-tax basis, are included in adjusted operating income as these results are a principal source of earnings. These earnings are reflected on a U.S. GAAP basis on an after-tax basis as a separate line on the Company’s Consolidated Statements of Operations. Earnings attributable to noncontrolling interests are excluded from adjusted operating income. Earnings attributable to noncontrolling interests represents the portion of earnings from consolidated entities that relates to the equity interests of minority investors, and are reflected on a U.S. GAAP basis as a separate line on the Company’s Consolidated Statements of Operations. Other adjustments “Other adjustments” represents all other adjustments that are excluded from adjusted operating income. These primarily include certain components of the consideration for business acquisitions, which are recognized as compensation expense over the requisite service periods. Reconciliation of select financial information The tables below present certain financial information that is regularly provided to the CODM for the Company’s segments, including revenues and significant benefits and expenses, on an adjusted operating income basis, as well as assets by segment, and the reconciliation of the segment totals to amounts reported in the Consolidated Financial Statements.
__________ (1)The Individual Retirement Strategies and Individual Life segments’ results reflect DAC as if the business is a stand-alone operation. The elimination of intersegment costs capitalized in accordance with this policy is included in consolidating adjustments within Corporate and Other operations. (2)Corporate and Other operations, through Prudential Advisors, generates fee revenues from the sale and distribution of certain insurance, annuity and investment products offered by Prudential and third parties. (3)“Operating expenses” includes amounts related to salaries, employee benefits, occupancy, technology, consulting, external and contracted services, legal, corporate charges, costs for initiatives, and other miscellaneous expenses. “Variable expenses” includes commissions, certain compensation related to levels of investment performance, premium taxes and other fees related to sales of certain insurance and investment products. (4)“Other benefits and expenses” primarily includes: (i) the change in estimates of liability for future policy benefits, which can be either positive or negative, for Retirement Strategies, Individual Life and International Businesses; (ii) dividends to policyholders for Individual Life and International Businesses, which are included in adjusted operating income; and (iii) dividends to policyholders in the Closed Block Division, which are not included in adjusted operating income. (5)Reflects “Income (loss) before income taxes and equity in earnings of joint ventures and other operating entities”.
Revenues, calculated in accordance with U.S. GAAP, for the years ended December 31, include the following by geographic location that are 10 percent or more of the Company’s total consolidated revenue:
Intersegment revenues Management has determined the intersegment revenues with reference to market rates. Intersegment revenues are eliminated in consolidation in the Company’s Corporate and Other operations. The PGIM segment revenues include intersegment revenues, primarily consisting of asset-based management and administration fees, for the years ended December 31, as follows:
Segments may also enter into internal derivative contracts with other segments. For adjusted operating income, each segment accounts for the internal derivative results consistent with the manner in which that segment accounts for other similar external derivatives. Asset management and service fees The table below presents asset management and service fees, predominantly related to investment management activities, for the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Related Party Transactions [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Related Party Transactions | RELATED PARTY TRANSACTIONS In September 2023, the Company invested approximately $200 million in Prismic, a Bermuda-exempted limited partnership that owns all of the outstanding capital stock of Prismic Re, a licensed Bermuda-based life and annuity reinsurance company. Also in September 2023, the Company entered into an agreement with Prismic Re, to reinsure approximately $9 billion of reserves for certain structured settlement annuity contracts issued by PICA, a wholly-owned subsidiary of Prudential Financial. Separately, the Company, through PGIM, entered into an investment management agreement with Prismic to manage a large portion of Prismic Re's assets. In March 2025, the Company entered into an agreement with Prismic Re International, a wholly-owned subsidiary of Prismic, to reinsure approximately $7 billion of reserves for certain USD-denominated Japanese whole life policies originated by the Company’s Japanese affiliates. In connection with this transaction, the Company invested an additional $103 million in Prismic. PGIM also provides investment management services on a large portion of Prismic Re International’s assets. In October 2025, the Company entered into an agreement with Prismic Re, to reinsure certain fixed annuity new business contracts issued by Pruco Life, a wholly-owned subsidiary of Prudential Financial, on or after October 1, 2025. As of December 31, 2025 and 2024, the Company’s ownership in Prismic is approximately 20% and the carrying value of the Company’s investment is approximately $200 million. As the investment in Prismic is accounted for under the equity method, Prismic, Prismic Re and Prismic Re International are considered related parties. The following tables summarize the impacts to the Company’s financial statements related to the agreements that the Company entered with Prismic, Prismic Re and Prismic Re International. The related party balances with Prismic, Prismic Re and Prismic Re International impacted the Company’s balance sheet as of the periods indicated as follows:
The Company has agreed to guarantee Prismic Re's reimbursement obligations on letters of credit that may be obtained by Prismic Re from third-party financial institutions to support Prismic Re’s obligations under the reinsurance agreement with the Company for a total amount up to $2.0 billion as of both December 31, 2025 and 2024. As part of the transaction with Prismic Re International, the Company provided an $80 million, 10-year contingent debt facility, where the Company may be required to purchase subordinated debt from certain subsidiaries of Prismic in the event their capital ratio falls below a predetermined level. In November 2025, the Company committed to Prismic Re $320 million of additional capital, intended to fund future transactions executed by Prismic, that is required to be fully funded by the end of the second quarter of 2027. This commitment is part of a broader capital commitment, involving third-party investors in Prismic, and will allow the Company to retain its approximately 20% equity ownership in Prismic. See Note 25 for additional information on the Company’s guarantees and commitments. The related party activity with Prismic, Prismic Re and Prismic Re International impacted the Company’s results of operations and cash flows for the periods indicated as follows:
See the Consolidated Statements of Cash Flows for information regarding significant non-cash transactions with Prismic Re and Prismic Re International.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingent Liabilities |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commitments and Contingent Liabilities | COMMITMENTS AND CONTINGENT LIABILITIES Commitments and Guarantees Commercial Mortgage Loan Commitments
The Company originates commercial mortgage loans as part of its commercial mortgage operations. Commitments for loans that will be held for sale are recognized as derivatives and recorded at fair value. In certain of these transactions, the Company prearranges that it will sell the loan to an investor, including to government sponsored entities as discussed below, after the Company funds the loan. The above amount includes unfunded commitments that are not unconditionally cancellable. For related credit exposure, there was an allowance for credit losses of $5 million and $2 million as of December 31, 2025 and 2024, respectively. The change in allowance is $3 million and $1 million for the years ended December 31, 2025 and 2024, respectively. Commitments to Purchase Investments (excluding Commercial Mortgage Loans)
The Company has other commitments to purchase or fund investments, some of which are contingent upon events or circumstances not under the Company’s control, including those at the discretion of the Company’s counterparties. The Company anticipates a portion of these commitments will ultimately be funded from its separate accounts. The above amount includes unfunded commitments that are not unconditionally cancellable. There were no related charges for credit losses for the years ended December 31, 2025 or 2024. Additionally, the above amount includes an unfunded commitment of $320 million to Prismic Re, intended to fund future transactions executed by Prismic, that is required to be fully funded by the end of the second quarter of 2027. See Note 24 for additional information regarding the related party relationship between the Company and Prismic Re. Indemnification of Securities Lending and Securities Repurchase Transactions
__________ (1)Includes $0 million and $240 million related to securities repurchase transactions as of December 31, 2025 and December 31, 2024, respectively. In the normal course of business, the Company may facilitate securities lending or securities repurchase transactions on behalf of certain client accounts (collectively, “the accounts”). In certain of these arrangements, the Company has provided an indemnification to the accounts to hold them harmless against losses caused by counterparty (i.e., borrower) defaults associated with such transactions facilitated by the Company. In securities lending transactions, collateral is provided by the counterparty to the accounts at the inception of the transaction in an amount at least equal to 102% of the fair value of the loaned securities and the collateral is maintained daily to equal at least 102% of the fair value of the loaned securities. In securities repurchase transactions, collateral is provided by the counterparty to the accounts at the inception of the transaction in an amount at least equal to 95% of the fair value of the securities subject to repurchase and the collateral is maintained daily to equal at least 95% of the fair value of the securities subject to repurchase. The Company is only at risk if the counterparty to the transaction defaults and the value of the collateral held is less than the value of the securities loaned to, or subject to repurchase from, such counterparty. The Company believes the possibility of any payments under these indemnities is remote. Credit Derivatives Written As discussed further in Note 5, the Company writes credit derivatives under which the Company is obligated to pay the counterparty the referenced amount of the contract and receive in return the defaulted security or similar security. Guarantees of Asset Values
Certain contracts underwritten by the Retirement Strategies segment include guarantees related to financial assets owned by the guaranteed party. These contracts are accounted for as derivatives and carried at fair value. The collateral supporting these guarantees is not reflected on the Consolidated Statements of Financial Position. Indemnification of Serviced Mortgage Loans
__________ (1)The accrued liability associated with guarantees includes an allowance for credit losses of $11 million and $12 million as of December 31, 2025 and 2024, respectively. The change in allowance is a reduction of $1 million and $2 million for the years ended December 31, 2025 and 2024, respectively. As part of the commercial mortgage activities of the Company’s PGIM segment, the Company provides commercial mortgage origination, underwriting and servicing for certain government sponsored entities, such as Fannie Mae and Freddie Mac. The Company has agreed to indemnify the government sponsored entities for a portion of the credit risk associated with certain of the mortgages it services through a delegated authority arrangement. Under these arrangements, the Company originates multi-family mortgages for sale to the government sponsored entities based on underwriting standards they specify, and makes payments to them for a specified percentage share of losses they incur on certain loans serviced by the Company. The Company’s percentage share of losses incurred generally varies from 4% to 20% of the loan balance, and is typically based on a first-loss exposure for a stated percentage of the loan balance, plus a shared exposure with the government sponsored entity for any losses in excess of the stated first-loss percentage, subject to a contractually specified maximum percentage. The Company determines the liability related to this exposure using historical loss experience, and the size and remaining life of the asset. The Company serviced $28,275 million and $25,763 million of mortgages subject to these loss-sharing arrangements as of December 31, 2025 and 2024, respectively, all of which are collateralized by first priority liens on the underlying multi-family residential properties. As of December 31, 2025, these mortgages had a weighted-average debt service coverage ratio of 1.93 times and a weighted-average loan-to-value ratio of 62%. As of December 31, 2024, these mortgages had a weighted-average debt service coverage ratio of 1.95 times and a weighted-average loan-to-value ratio of 62%. The Company had no losses related to indemnifications that were settled during the years ended December 31, 2025 and 2024. Other Guarantees
The Company is also subject to other financial guarantees and indemnity arrangements. The Company has provided indemnities and guarantees related to acquisitions, dispositions, investments and other transactions that are triggered by, among other things, breaches of representations, warranties or covenants provided by the Company. These obligations are typically subject to various time limitations, defined by the contract or by operation of law, such as statutes of limitation. In some cases, the maximum potential obligation is subject to contractual limitations, while in other cases such limitations are not specified or applicable. This includes guarantees issued on $1.5 billion of standby committed letters of credit and $0.5 billion of standby uncommitted letters of credit that may be obtained by Prismic Re from third-party financial institutions, for the benefit of PICA as beneficiary, to support U.S. statutory reserve credit related to a reinsurance agreement with PICA. As of December 31, 2025, no letters of credit have been issued to PICA under the facility, and the likelihood of PICA drawing upon them is remote. The guarantees are renewable on an annual basis. The current value of the guarantees is estimated to be immaterial. See Note 24 for additional information regarding the related party relationship between the Company and Prismic Re and Note 15 for additional information regarding the Company’s reinsurance transactions. Since certain of these obligations are not subject to limitations, it is not possible to determine the maximum potential amount due under these guarantees. The accrued liability identified above relates to the sale of The Prudential Life Insurance Company of Taiwan Inc. (“POT”) and represents a financial guarantee of certain insurance obligations of POT. Insolvency Assessments Most of the jurisdictions in which the Company is admitted to transact business require insurers doing business within the jurisdiction to participate in guarantee associations, which are organized to pay contractual benefits owed pursuant to insurance policies issued by impaired, insolvent or failed insurers. These associations levy assessments, up to prescribed limits, on all member insurers in a particular state on the basis of the proportionate share of the premiums written by member insurers in the lines of business in which the impaired, insolvent or failed insurer engaged. Some states permit member insurers to recover assessments paid through full or partial premium tax offsets. In addition, Japan has established the Japan Policyholders Protection Corporation as a contingency to protect policyholders against the insolvency of life insurance companies in Japan through assessments to companies licensed to provide life insurance. Assets and liabilities held for insolvency assessments were as follows:
Contingent Liabilities On an ongoing basis, the Company and its regulators review its operations including, but not limited to, sales and other customer interface procedures and practices, and procedures for meeting obligations to its customers and other parties. These reviews may result in the modification or enhancement of processes or the imposition of other action plans, including concerning management oversight, sales and other customer interface procedures and practices, and the timing or computation of payments to customers and other parties. In certain cases, if appropriate, the Company may offer customers or other parties remediation and may incur charges, including the cost of such remediation, administrative costs and regulatory fines. The Company is subject to the laws and regulations of states and other jurisdictions concerning the identification, reporting and escheatment of unclaimed or abandoned funds, and is subject to audit and examination for compliance with these requirements. It is possible that the results of operations or the cash flow of the Company in a particular quarterly or annual period could be materially affected as a result of payments in connection with the matters discussed above or other matters depending, in part, upon the results of operations or cash flow for such period. Management believes, however, that ultimate payments in connection with these matters, after consideration of applicable reserves and rights to indemnification, should not have a material adverse effect on the Company’s financial position. Litigation and Regulatory Matters The Company is subject to legal and regulatory actions in the ordinary course of its businesses. Pending legal and regulatory actions include proceedings relating to aspects of the Company’s businesses and operations that are specific to it and proceedings that are typical of the businesses in which it operates, including in both cases businesses that have been either divested or placed in wind-down status. Some of these proceedings have been brought on behalf of various alleged classes of complainants. In certain of these matters, the plaintiffs are seeking large and/or indeterminate amounts, including punitive or exemplary damages. The outcome of litigation or a regulatory matter, and the amount or range of potential loss at any particular time, is often inherently uncertain. The Company establishes accruals for litigation and regulatory matters when it is probable that a loss has been incurred and the amount of that loss can be reasonably estimated. For litigation and regulatory matters where a loss may be reasonably possible, but not probable, or is probable but not reasonably estimable, no accrual is established but the matter, if potentially material, is disclosed, including matters discussed below. The Company estimates that as of December 31, 2025, the aggregate range of reasonably possible losses in excess of accruals established for those litigation and regulatory matters for which such an estimate currently can be made is less than $250 million. Any estimate is not an indication of expected loss, if any, or the Company’s maximum possible loss exposure on such matters. The Company reviews relevant information with respect to its litigation and regulatory matters on a quarterly and annual basis and updates its accruals, disclosures and estimates of reasonably possible loss based on such reviews. Labor and Employment Matters Prudential of Brazil Labor and Employment Matters Prudential of Brazil (“POB”) sells insurance products to consumers through life planner franchisees (“Life Planners”), who are engaged as independent life insurance brokers and not as employees. When a Life Planner’s contractual relationship with POB is terminated, in many cases the Life Planner commences a labor suit against POB alleging entitlement to employment related benefits. POB is a defendant in numerous such lawsuits in Brazil brought by former Life Planners and has been subject to regulatory actions challenging the validity of POB’s franchise model. POB has continued to receive additional labor suits and regulatory actions involving the operation of its franchise model notwithstanding steps that POB has taken to attempt to mitigate the labor risk by modifying its franchise model. POB continues to modify its franchise model to further mitigate this risk. Individual Annuities, Individual Life and Group Insurance California Advocates for Nursing Home Reform v. The Prudential Insurance Company of America and Pruco Life Insurance Company, et al. In January 2024, a putative class action complaint entitled California Advocates for Nursing Home Reform v. The Prudential Insurance Company of America and Pruco Life Insurance Company, et al., was filed in California Superior Court, Alameda County, alleging that the Company has failed to comply with California laws requiring that life insurance policies issued or delivered in California: (i) provide for a contractual 60-day grace period pre-lapse during which a policy must stay in force; (ii) provide policyholders and designees with notice of payment default within 30 days and a 30-day advance written notice of pending lapse; and (iii) notify policyholders annually of their right to designate additional recipients for lapse notices. The complaint asserts claims for violation of California’s Unfair Competition law (“UCL”) and seeks unspecified damages along with declaratory and injunctive relief. In February 2024, defendants removed the action from California state court to the United States District Court for the Northern District of California. Plaintiff filed a motion to remand the action to the California Superior Court, Alameda County, and in December 2024, the motion was granted. In April 2025, Plaintiff filed a First Amended Complaint removing allegations related to the Unclaimed Life Insurance and Annuities Act, and the Defendant filed a demurrer seeking to dismiss the Amended Complaint. In October 2025, the court issued an Order: (i) sustaining Defendant’s demurrer as to Plaintiff’s declaratory relief claim, and (ii) denying the demurrer as to the UCL claim. Escheatment Litigation Total Asset Recovery Services, LLC v. MetLife, Inc., et al., Prudential Financial, Inc., The Prudential Insurance Company of America, and Prudential Insurance Agency, LLC In December 2017, Total Asset Recovery Services, LLC, on behalf of the State of New York, filed a Second Amended Complaint in the Supreme Court of the State of New York, County of New York, against, among other 19 defendants, Prudential Financial, Inc., The Prudential Insurance Company of America and Prudential Insurance Agency, LLC, alleging that the Company failed to escheat life insurance proceeds in violation of the New York False Claims Act. The second amended complaint seeks injunctive relief, compensatory damages, civil penalties, treble damages, prejudgment interest, attorneys’ fees and costs. In May 2018, defendants filed a motion to dismiss the Second Amended Complaint. In April 2019, defendants’ motion to dismiss the Second Amended Complaint was granted and plaintiff subsequently filed a Notice of Appeal with the New York State Supreme Court, First Department. In December 2020, the New York Supreme Court, First Department, reversed and vacated the judgment of the trial court and granted leave to plaintiff to file a third amended complaint. In March 2021, the plaintiff filed a third amended complaint asserting claims against all defendants for violation of the New York False Claims Act, and seeking injunctive relief, compensatory and treble damages, attorneys’ fees and costs. In January 2023, the plaintiff filed a Fourth Amended Complaint. In March 2023, defendants filed a motion to dismiss the Fourth Amended Complaint. In October 2024, defendants’ motion to dismiss the Fourth Amended Complaint was denied. In December 2024, defendants filed an Answer to the Fourth Amended Complaint. Securities Litigation Donel Davidson v. Charles F. Lowrey, et al. In September 2020, a shareholder derivative complaint entitled Pekin Police Pension Fund, Derivatively on Behalf of Prudential Financial, Inc. v. Charles F. Lowrey, et al., was filed in the United States District Court for the District of New Jersey (the “Derivative Complaint”) against PFI as a “nominal” defendant, PFI’s chairman and chief executive officer, vice chairman, chief financial officer, certain former officers of PFI, and all of the current outside directors of PFI’s Board. The Derivative Complaint asserts claims for federal securities law violations, breach of fiduciary duty, waste of corporate assets, and unjust enrichment, and alleges that: (i) the Company's reserve assumptions failed to account for adversely developing mortality experience in the Individual Life business segment; (ii) the Company's reserves were insufficient to satisfy its future policy benefit liabilities; (iii) the Company materially understated its liabilities and overstated net income due to flawed assumptions in calculating mortality experience; and (iv) the individual defendants breached their duty of care and loyalty to the Company by allowing the alleged improper activity. In December 2020, the court issued an order substituting Donel Davidson for Pekin Police Pension Fund as the named plaintiff. In March 2021, the court issued an order consolidating this action with Robert Lalor, Derivatively on behalf of Prudential Financial, Inc. v. Charles F. Lowrey, et al. under the caption In re Prudential Financial, Inc. Derivative Litigation. In May 2021, the Company filed a motion to dismiss the complaint. In March 2025, plaintiffs filed a motion seeking preliminary approval of the settlement notice and preliminary approval of the proposed settlement of the derivative litigation (“the Settlement”). In April 2025, the court issued an order granting the motion for preliminary approval of the Settlement. In June 2025, the court granted final approval of the Settlement and issued a final judgment dismissing the action with prejudice. This matter is now closed. Daniel Plaut v. Prudential Financial, Inc. In October 2020, a shareholder derivative complaint entitled Daniel Plaut, Derivatively on Behalf of Prudential Financial, Inc. v. Charles F. Lowrey, et al., was filed in the Superior Court of New Jersey, Law Division, Essex County (the “Derivative Complaint”) against PFI as a “nominal” defendant, PFI’s chairman and chief executive officer, vice chairman, and all of the current outside directors of PFI’s Board. The Derivative Complaint asserts claims for breach of fiduciary duty, unjust enrichment, and abuse of control and alleges that: (i) the Company's reserve assumptions failed to account for adversely developing mortality experience in the Individual Life business segment; (ii) the Company's reserves were insufficient to satisfy its future policy benefit liabilities; (iii) the Company materially understated its liabilities and overstated net income due to flawed assumptions in calculating mortality experience; and (iv) the individual defendants engaged in corporate misconduct, mismanagement and waste through their participation in the alleged wrongdoing. In September 2024, the court issued an order consolidating this action with Kevin M. Frost et al. v. Prudential Financial, Inc., under the caption In re Prudential Financial, Inc. Derivative Litigation. In July 2025, the parties entered into a Stipulation of Dismissal with Prejudice. This matter is now closed. Shareholder Demands In January 2020, the Board of Directors received a shareholder demand letter containing allegations: (i) of wrongdoing similar to those alleged in the City of Warren and Crawford complaints; and (ii) that certain of the Company’s current and former directors and executive officers breached their fiduciary duties of loyalty, due care and candor. The demand letter requests that the Board of Directors investigate and commence legal proceedings against the named individuals to recover for the Company’s benefit the damages purportedly sustained by the Company as a result of the alleged breaches. In February 2020, the Board of Directors authorized the creation of a special committee to investigate the allegations set forth in the shareholder demand letter. In April 2020, the Company received additional shareholder demands raising allegations similar to those contained in the January 2020 demand, and may be subject prospectively to additional activity relating to these matters. In January 2021, the special committee completed its investigation, and in February 2021, the Board provided notice rejecting the shareholder demands and dissolved the special committee. This matter is now closed. Other Matters Cho v. PICA, et al. In November 2019, a putative class action complaint entitled Cho v. The Prudential Insurance Company of America, et. al., was filed in the United States District Court for the District of New Jersey. The Complaint purports to be brought on behalf of participants in the Prudential Employee Savings Plan (the “Plan”) and (i) alleges that defendants failed to fulfill their fiduciary obligations under the Employee Retirement Income Security Act of 1974, in the administration, management and operation of the Plan, including engaging in prohibited transactions; and (ii) seeks declaratory, injunctive and equitable relief, and unspecified damages including interest, attorneys’ fees and costs. In January 2020, defendants filed a motion to dismiss the complaint. In September 2020, plaintiff filed an amended complaint and added as individual defendants certain PFI officers and current and former members of the Company’s Administrative Committee and Investment Oversight Committee. In December 2020, defendants filed a motion to dismiss the amended complaint. In September 2021, the court granted defendants’ motion to dismiss the amended complaint without prejudice. In October 2021, plaintiff filed a second amended complaint asserting claims against defendants under the Employee Retirement Income Security Act of 1974 for breach of fiduciary duty, prohibited transactions and failure to monitor fiduciaries. The second amended complaint seeks declaratory, injunctive and equitable relief, unspecified damages, attorneys’ fees and costs. In December 2021, defendants filed a motion to dismiss the second amended complaint. In August 2022, the court: (i) dismissed, with prejudice, the breach of the fiduciary duty of loyalty and prohibited transaction claims based on the inclusion of Prudential-affiliated funds in the Plan’s investment options; (ii) dismissed, without prejudice, the breach of fiduciary duty claims based on certain alleged underperforming Plan funds; and (iii) denied the motion to dismiss plaintiffs’ claims for breach of the fiduciary duties of prudence and to monitor other fiduciaries, based on alleged delays in removing other alleged underperforming funds. In September 2022, plaintiff filed a third amended complaint asserting claims for breach of duty of prudence and to monitor fiduciaries, and in October 2022, defendants filed their answer to the third amended complaint. In May 2023, plaintiff filed a motion for class certification. In August 2023, the court issued an Order granting plaintiff’s class certification motion. In January 2024, by an October 2023 court Order, defendants submitted to plaintiffs their summary judgment brief. In December 2024, the court issued an order granting Prudential’s motion for summary judgment. In January 2025, plaintiff filed a Notice of Appeal to the Third Circuit. In January 2026, the Third Circuit Court of Appeals affirmed the District Court's order granting defendant’s summary judgment motion. Optimum Communications, Inc., et al. v. Apollo Capital Management, L.P., et al. In November 2025, a complaint entitled Optimum Communications, Inc., et al. v. Apollo Capital Management, L.P., et al. was filed in the United States District Court for the Southern District of New York. The Complaint alleges that defendant asset managers, including PGIM, Inc., seven other unaffiliated asset managers, and “Doe Entities” that are currently unknown to plaintiffs, violated federal and New York state antitrust laws by entering into a cooperation agreement and collectively negotiating with Optimum Communications, Inc. (“Optimum”) concerning the terms for any future restructurings or financings. Optimum alleges this same conduct also breached the credit agreement and indentures governing its debt and breached the implied covenant of good faith and fair dealing. The complaint seeks declaratory and injunctive relief, unspecified compensatory, treble, and punitive damages, attorneys’ fees, and costs. In February 2026, defendants filed a motion to dismiss the complaint. Regulatory Prudential of Japan Matter In January 2026, Prudential of Japan, a Japanese insurance subsidiary of the Company, reported the findings of its internal investigation into sales practice misconduct involving certain employees. In February 2026, in consultation with the Japanese insurance regulator, the Company voluntarily suspended new sales activity at Prudential of Japan for a 90-day period commencing February 9, 2026. The matter remains ongoing and the Company is continuing to engage with the Japanese insurance regulator. Civil Investigative Demand The Company has received a civil investigative demand and other inquiries related to the appropriateness of Assurance IQ’s supplemental health product sales and marketing activity. The Company is cooperating with regulators and may become subject to additional regulatory inquiries and other investigations and actions related to this matter. In August 2025, the Company settled this matter with the Federal Trade Commission (“FTC”), and agreed, as Assurance’s guarantor, to: (1) pay the FTC for consumer redress; and (2) certain restrictions regarding practices and compliance reporting involving Assurance, if Assurance commences any prospective operation as an insurance provider. In reaching the settlement, the Company neither admitted nor denied any wrongdoing. This matter is now closed. Summary The Company’s litigation and regulatory matters are subject to many uncertainties, and given their complexity and scope, their outcome cannot be predicted. It is possible that the Company’s results of operations or cash flow in a particular quarterly or annual period could be materially affected by an ultimate unfavorable resolution of pending litigation and regulatory matters depending, in part, upon the results of operations or cash flow for such period. In light of the unpredictability of the Company’s litigation and regulatory matters, it is also possible that in certain cases an ultimate unfavorable resolution of one or more pending litigation or regulatory matters could have a material adverse effect on the Company’s financial statements. Management believes, however, that, based on information currently known to it, the ultimate outcome of all pending litigation and regulatory matters, after consideration of applicable reserves and rights to indemnification, is not likely to have a material adverse effect on the Company’s financial statements.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Subsequent Events |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Subsequent Events [Abstract] | |
| Subsequent Events | SUBSEQUENT EVENTS Common Stock Dividend On February 3, 2026, Prudential Financial’s Board of Directors declared a cash dividend of $1.40 per share of Common Stock, payable on March 12, 2026 to shareholders of record as of February 17, 2026.
|
Schedule I - Summary of Investments Other Than investments in Related Parties Schedule I - Summary of Investments Other Than Investments In Related Parties |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule I - Summary of Investments Other Than Investments In Related Parties | PRUDENTIAL FINANCIAL, INC. Schedule I Summary of Investments Other Than Investments in Related Parties As of December 31, 2025 (in millions)
__________ (1)See Note 3 to the Consolidated Financial Statements for the composition of the Company’s “Assets supporting experience-rated contractholder liabilities, at fair value.” (2)Includes collateralized commercial mortgage and other loans of $64,544 million and uncollateralized loans of $171 million.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule II - Condensed Financial Information of Registrant |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Condensed Financial Information Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule II - Condensed Financial Information of Registrant | PRUDENTIAL FINANCIAL, INC. Schedule II Condensed Financial Information of Registrant Condensed Statements of Financial Positions as of December 31, 2025 and 2024 (in millions)
See Notes to Condensed Financial Information of Registrant PRUDENTIAL FINANCIAL, INC. Schedule II Condensed Financial Information of Registrant Condensed Statements of Operations for the Years Ended December 31, 2025, 2024 and 2023 (in millions)
See Notes to Condensed Financial Information of Registrant PRUDENTIAL FINANCIAL, INC. Schedule II Condensed Financial Information of Registrant Condensed Statements of Cash Flows for the Years Ended December 31, 2025, 2024 and 2023 (in millions)
See Notes to Condensed Financial Information of Registrant PRUDENTIAL FINANCIAL, INC. Schedule II Condensed Financial Information of Registrant Notes to Condensed Financial Information of Registrant ORGANIZATION AND PRESENTATIONPrudential Financial, Inc. (“Prudential Financial”) was incorporated on December 28, 1999, as a wholly-owned subsidiary of The Prudential Insurance Company of America (“PICA”). On December 18, 2001, PICA converted from a mutual life insurance company to a stock life insurance company and became an indirect, wholly-owned subsidiary of Prudential Financial. The condensed financial information of Prudential Financial, Inc. (the “Parent Company”) should be read in conjunction with the consolidated financial statements of Prudential Financial, Inc. and its subsidiaries and the notes thereto (the “Consolidated Financial Statements”). The condensed financial statements of Prudential Financial reflect its direct wholly-owned subsidiaries using the equity method of accounting. In September 2023, Prudential Financial invested approximately $200 million, and acquired a 20% equity interest as a limited partner, in Prismic Life Holding Company LP (“Prismic”), a Bermuda-exempted limited partnership that owns all of the outstanding capital stock of Prismic Life Reinsurance, Ltd. (“Prismic Re”) and Prismic Life Reinsurance International, Ltd. (“Prismic Re International”), which are licensed Bermuda-based life and annuity reinsurance companies. Beginning with the fourth quarter of 2023, the operating results of Prudential Financial reflect our share of earnings in Prismic on a quarter lag. As this investment is accounted for under the equity method, Prismic, Prismic Re, and Prismic Re International are considered related parties. 2. OTHER INVESTMENTS Prudential Financial’s other investments as of December 31, 2025 and 2024 consisted primarily of highly liquid debt investments and intercompany enterprise liquidity account funds. 3. DEBT A summary of Prudential Financial’s short- and long-term debt is as follows:
__________ (1)Ranges of interest rates are for the year ended December 31, 2025. (2)The weighted average interest rate on outstanding commercial paper was 3.85% and 4.38% at December 31, 2025 and December 31, 2024, respectively. Long-term Debt In order to manage exposure to interest rate movements, Prudential Financial utilizes derivative instruments, primarily interest rate swaps, in conjunction with some of its debt issuances. The impact of these derivative instruments is not reflected in the rates presented in the table above. Interest expense was $0 million for the years ended December 31, 2025, 2024 and 2023, as there were no such derivatives that qualified for hedge accounting treatment. Schedule of Long-term Debt Maturities The following table presents Prudential Financial’s contractual maturities for long-term debt as of December 31, 2025:
For the years ended December 31, Prudential Financial received cash dividends and/or returns of capital from the following subsidiaries:
__________ (1)2023 includes $900 million of dividends and returns of capital from a rabbi trust. 5. COMMITMENTS AND GUARANTEES Prudential Financial has issued a subordinated guarantee covering a subsidiary’s domestic commercial paper program. As of December 31, 2025, there was $850 million outstanding under this commercial paper program. Prudential Financial has provided guarantees of the payment of principal and interest on intercompany loans between affiliates. As of December 31, 2025, Prudential Financial had issued guarantees of outstanding loans totaling $5.0 billion between international insurance subsidiaries and other affiliates. In 2013, Prudential Financial entered into a $500 million indemnity and guarantee agreement with Wells Fargo Bank Northwest, N.A. Under this agreement, Prudential Financial guaranteed obligations with respect to an affiliated loan from PICA to an affiliate. The loan proceeds were utilized to construct the Prudential Tower home office in Newark, New Jersey. Prudential Financial is also subject to other financial guarantees, net worth maintenance agreements and indemnity arrangements, including those made in the normal course of business guaranteeing the performance of, or representations made by, Prudential Financial subsidiaries. Prudential Financial has provided indemnities and guarantees related to acquisitions and dispositions, investments, debt issuances and other transactions, including those provided as part of its ongoing operations that are triggered by, among other things, breaches of representations, warranties or covenants provided by Prudential Financial or its subsidiaries. These obligations are typically subject to various time limitations, defined by the contract or by operation of law, such as statutes of limitation. In some cases, the maximum potential obligation is subject to contractual limitations, while in other cases such limitations are not specified or applicable. This includes guarantees issued on $2.3 billion of letters of credit obtained by the Lotus Reinsurance Company Ltd. from a third-party financial institution, for the benefit of PICA and Pruco Life as beneficiaries, to support U.S. statutory reserve credit related to reinsurance agreements with PICA and Pruco Life. As of December 31, 2025, $2.3 billion of letters of credit have been issued to PICA and Pruco Life under the facility, and the likelihood of PICA and Pruco Life drawing upon them is remote. The guarantees are automatically renewed annually unless notice of termination is given by either party. The current value of the guarantees is estimated to be immaterial. This also includes guarantees issued on $1.5 billion of standby committed letters of credit and $0.5 billion of standby uncommitted letters of credit obtained by Prismic Re from third-party financial institutions, for the benefit of PICA as beneficiary, to support U.S. statutory reserve credit related to a reinsurance agreement with PICA. As of December 31, 2025, no letters of credit have been issued to PICA under the facility, and the likelihood of PICA drawing upon them is remote. The guarantees are renewable on an annual basis. The current value of the guarantees is estimated to be immaterial.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule III - Supplementary Insurance Information |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule III - Supplementary Insurance Information | PRUDENTIAL FINANCIAL, INC. Schedule III Supplementary Insurance Information As of and for the Year Ended December 31, 2025 (in millions)
PRUDENTIAL FINANCIAL, INC. Schedule III Supplementary Insurance Information As of and for the Year Ended December 31, 2024 (in millions)
PRUDENTIAL FINANCIAL, INC. Schedule III Supplementary Insurance Information As of and for the Year Ended December 31, 2023 (in millions)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule IV - Reinsurance |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule IV - Reinsurance | PRUDENTIAL FINANCIAL, INC. Schedule IV Reinsurance As of and For the Years Ended December 31, 2025, 2024 and 2023 ($ in millions)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insider Trading Arrangements |
3 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Trading Arrangements, by Individual | |
| Rule 10b5-1 Arrangement Adopted | false |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
Insider Trading Policies and Procedures |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Insider Trading Policies and Procedures [Line Items] | |
| Insider Trading Policies and Procedures Adopted | true |
Cybersecurity Risk Management and Strategy Disclosure |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Cybersecurity Risk Management, Strategy, and Governance [Line Items] | |
| Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] | Because of the size and scope of our business, we are subject to numerous and evolving cybersecurity risks, any of which, if it materializes, could affect our business strategy, results of operations, or financial condition. See “Item 1A. Risk Factors—Operational Risk” for a discussion of such risks. Cybersecurity risk management is integrated within our risk management framework. See “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Risk Management” for additional information regarding our risk management processes. We conduct risk identification through several processes at the business unit, corporate, senior management, and Board levels. This framework includes escalation points to Prudential’s risk committees, allowing cyber risk and control matters to be elevated to the Board of Directors or its Audit Committee for oversight. In order to respond to the threat of security breaches and cyber-attacks, we have developed an information security program designed to protect and preserve the confidentiality, integrity, and continued availability of information owned by, or in the care of, the Company. This information security program provides for the coordination of various corporate functions and governance groups, including global technology, risk, legal, compliance and corporate audit, and serves as a framework for the execution of responsibilities across businesses and operational roles. Among other things, the information security program establishes security standards for our technological resources and includes training for employees, contractors and third parties. Employees with access to our Company’s systems are subject to comprehensive annual training on responsible information security, data security, and cybersecurity practices and how to protect data against cyber threats. As part of the information security program, we routinely engage independent outside advisors to assess the effectiveness of our program and our internal response preparedness. We also regularly engage with the broader cybersecurity community and monitor cyber threat information. To address risks associated with third parties, Prudential has established an enterprise-wide Third-Party Risk Management Program. This program’s features include, among other things, identifying, assessing and managing cybersecurity risks throughout the life of our third-party relationships. We also maintain an incident response plan, which specifies escalation and evaluation processes for cyber events. This plan is executed in close coordination with our corporate functions, including a dedicated cyber and privacy law function, external affairs, and risk management, and is designed to ensure, among other things, appropriate and timely reporting and disclosure. When we do experience cybersecurity incidents, like the cybersecurity incident we disclosed in February 2024, we aim to utilize that experience to inform and strengthen our information security program. During the period covered by this Report, we did not identify any cybersecurity threats that have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or financial condition. See “Item 1A. Risk Factors—Operational Risk” for a discussion of risks related to cybersecurity.
|
| Cybersecurity Risk Management Processes Integrated [Flag] | true |
| Cybersecurity Risk Management Processes Integrated [Text Block] | Cybersecurity risk management is integrated within our risk management framework. See “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Risk Management” for additional information regarding our risk management processes. We conduct risk identification through several processes at the business unit, corporate, senior management, and Board levels. This framework includes escalation points to Prudential’s risk committees, allowing cyber risk and control matters to be elevated to the Board of Directors or its Audit Committee for oversight.
|
| Cybersecurity Risk Management Third Party Engaged [Flag] | true |
| Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] | true |
| Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] | false |
| Cybersecurity Risk Board of Directors Oversight [Text Block] | The Audit Committee of the Board of Directors, which is responsible for oversight of certain risk issues, including cybersecurity, receives reports from the CISO, the HGTO and Operational Risk Management throughout the year. At least annually, the Board and the Audit Committee also receive updates about the results of program reviews, including assessments led by outside advisors who provide a third-party independent assessment of our technical program and internal response preparedness. To the extent cybersecurity controls are related to internal control over financial reporting, such controls are considered in the context of Prudential’s annual external integrated audit. The Audit Committee regularly briefs the full Board of Directors on these matters, and the full Board of Directors also receives periodic briefings on cyber threats in order to enhance our directors’ literacy on cyber issues.
|
| Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] | The Audit Committee of the Board of Directors, which is responsible for oversight of certain risk issues, including cybersecurity, receives reports from the CISO, the HGTO and Operational Risk Management throughout the year. |
| Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] | The Audit Committee of the Board of Directors, which is responsible for oversight of certain risk issues, including cybersecurity, receives reports from the CISO, the HGTO and Operational Risk Management throughout the year. At least annually, the Board and the Audit Committee also receive updates about the results of program reviews, including assessments led by outside advisors who provide a third-party independent assessment of our technical program and internal response preparedness. To the extent cybersecurity controls are related to internal control over financial reporting, such controls are considered in the context of Prudential’s annual external integrated audit. |
| Cybersecurity Risk Role of Management [Text Block] | The Company’s information security program is overseen by the Chief Information Security Officer (“CISO”) and Information Security Office, as well as the Head of Global Technology and Operations (“HGTO”). The CISO and Information Security Office are responsible for monitoring for cybersecurity incidents impacting Prudential’s systems, and ensuring appropriate processes are maintained to inform management of the prevention, detection, mitigation, and remediation of such cybersecurity incidents.The Audit Committee of the Board of Directors, which is responsible for oversight of certain risk issues, including cybersecurity, receives reports from the CISO, the HGTO and Operational Risk Management throughout the year. |
| Cybersecurity Risk Management Positions or Committees Responsible [Flag] | true |
| Cybersecurity Risk Management Positions or Committees Responsible [Text Block] | The Company’s information security program is overseen by the Chief Information Security Officer (“CISO”) and Information Security Office, as well as the Head of Global Technology and Operations (“HGTO”). |
| Cybersecurity Risk Management Expertise of Management Responsible [Text Block] | The current CISO, who is serving in an interim capacity, has served in various roles in information security for over 20 years, including as Deputy CISO and roles overseeing cyber defense, investigations, and incident response. The interim CISO holds a law degree and has attained numerous Global Information Assurance Certifications.. |
| Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] | The Audit Committee of the Board of Directors, which is responsible for oversight of certain risk issues, including cybersecurity, receives reports from the CISO, the HGTO and Operational Risk Management throughout the year. At least annually, the Board and the Audit Committee also receive updates about the results of program reviews, including assessments led by outside advisors who provide a third-party independent assessment of our technical program and internal response preparedness. The Audit Committee regularly briefs the full Board of Directors on these matters, and the full Board of Directors also receives periodic briefings on cyber threats in order to enhance our directors’ literacy on cyber issues.
|
| Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] | true |
Significant Accounting Policies and Pronouncements (Policies) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounting Policies [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Basis of Presentation | The Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). The Consolidated Financial Statements include the accounts of Prudential Financial, entities over which the Company exercises control, including majority-owned subsidiaries and minority-owned entities such as limited partnerships in which the Company is the general partner and variable interest entities (“VIEs”) in which the Company is considered the primary beneficiary. See Note 4 for additional information regarding the Company’s consolidated variable interest entities. Intercompany balances and transactions have been eliminated.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Use of Estimates | Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The most significant estimates include those used in determining future policy benefits; policyholders’ account balances related to the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products; market risk benefits; the measurement of goodwill and any related impairment; the valuation of investments including derivatives, the measurement of allowance for credit losses, and the recognition of other-than-temporary impairments (“OTTI”); pension and other postretirement benefits; any provision for income taxes and valuation of deferred tax assets; and accruals for contingent liabilities, including estimates for losses in connection with unresolved legal and regulatory matters. Out of Period Adjustments In the first quarter of 2025, the Company recorded out of period adjustments resulting in a net charge of $150 million to “Income (loss) from operations before income taxes and equity in earnings of joint ventures and other operating entities” for the year ended 2025. The adjustments included an overstatement of “Reinsurance recoverables and deposit receivables” and an understatement of “Deferred policy acquisition costs.” The impact of these adjustments, individually and in the aggregate, was not material to any previously reported annual financial statements and is not material to the 2025 annual financial statements.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments and Investment-Related Liabilities | Fixed maturities, available-for-sale, at fair value (“AFS debt securities”) includes bonds, notes and redeemable preferred stock that are carried at fair value. See Note 6 for additional information regarding the determination of fair value. The purchased cost of fixed maturities is adjusted for amortization of premiums and accretion of discounts to maturity or, if applicable, call date. AFS debt securities, where fair value is below amortized cost, are reviewed quarterly to determine whether the amortized cost basis of the security is recoverable. For mortgage-backed and asset-backed AFS debt securities, a credit impairment will be recognized in earnings as an allowance for credit losses and reported in “Realized investment gains (losses), net,” to the extent the amortized cost exceeds the net present value of projected future cash flows (the “net present value”) for the security. For all other AFS debt securities, qualitative factors are first considered including, but not limited to, the extent of the decline and the reasons for the decline in value (e.g., credit events, currency or interest-rate related, including general credit spread widening), and the financial condition of the issuer. If analysis of these qualitative factors results in the security needing to be impaired, a credit impairment will be recognized in earnings as an allowance for credit losses and reported in “Realized investment gains (losses), net,” to the extent the amortized cost exceeds the net present value of projected future cash flows (the “net present value”) for the security. A credit impairment recorded cannot exceed the difference between the amortized cost and fair value of the respective security. The net present value used to measure a credit impairment is calculated by discounting the Company’s best estimate of projected future cash flows at the effective interest rate implicit in the AFS debt security at the date of acquisition. Once the Company has deemed all or a portion of the amortized cost uncollectible, the allowance is removed from the balance sheet by writing down the amortized cost basis of the AFS debt security. Any amount of an AFS debt security’s change in fair value not recorded as an allowance for credit losses will be recorded in Other Comprehensive Income (loss) (“OCI”). When an AFS debt security’s fair value is below amortized cost and the Company has the intent to sell the AFS debt security, or it is more likely than not the Company will be required to sell the AFS debt security before its anticipated recovery, the amortized cost basis of the AFS debt security is written down to fair value and any previously recognized allowance is reversed. The write-down is reported in “Realized investment gains (losses), net.” Interest income, including amortization of premium and accretion of discount, are included in “Net investment income” under the effective yield method. Prepayment premiums are also included in “Net investment income.” For high credit quality mortgage-backed and asset-backed AFS debt securities (those rated AA or above), the amortized cost and effective yield of the securities are adjusted as necessary to reflect historical prepayment experience and changes in estimated future prepayments. The adjustments to amortized cost are recorded as a charge or credit to “Net investment income” in accordance with the retrospective method. For mortgage-backed and asset-backed AFS debt securities rated below AA, the effective yield is adjusted prospectively for any changes in the estimated timing and amount of cash flows unless the investment is purchased with credit deterioration or an allowance is currently recorded for the respective security. If an investment is impaired, any changes in the estimated timing and amount of cash flows will be recorded as the credit impairment, as opposed to a yield adjustment. If the asset is purchased with credit deterioration (or previously impaired), the effective yield will be adjusted if there are favorable changes in cash flows subsequent to the allowance being reduced to zero. For mortgage-backed and asset-backed AFS debt securities, cash flow estimates consider the payment terms of the underlying assets backing a particular security, including interest rate and prepayment assumptions based on data from widely accepted third-party data sources or internal estimates. In addition to interest rate and prepayment assumptions, cash flow estimates also include other assumptions regarding the underlying collateral including default rates and recoveries, which vary based on the asset type and geographic location, as well as the vintage year of the security. These assumptions can significantly impact income recognition, unrealized gains and loss recorded in OCI, and the amount of impairment recognized in earnings. The payment priority of the respective security is also considered. For all other AFS debt securities, cash flow estimates are driven by assumptions regarding probability of default and estimates regarding timing and amount of recoveries associated with a default. The Company has developed these estimates using information based on its historical experience as well as using market observable data, such as industry analyst reports and forecasts, sector credit ratings and other data relevant to the collectability of a security, such as the general payment terms of the security and the security’s position within the capital structure of the issuer. Fixed maturities, trading, at fair value (“Trading debt securities”) includes debt securities that are carried at fair value, such as fixed maturities with embedded features that are considered derivatives and assets contained within consolidated variable interest entities. See Note 6 for additional information regarding the determination of fair value. Realized and unrealized gains and losses for these investments are reported in “Other income (loss),” and interest income from these investments is reported in “Net investment income.” Assets supporting experience-rated contractholder liabilities, at fair value includes invested assets that consist of fixed maturities, equity securities, short-term investments and cash equivalents, that support certain products which are experience-rated, meaning that the investment results associated with these products are expected to ultimately accrue to contractholders. Realized and unrealized gains and losses for these investments are reported in “Other income (loss).” Interest and dividend income from these investments is reported in “Net investment income.” Equity securities, at fair value consists of common stock, mutual fund shares and non-redeemable preferred stock carried at fair value. Realized and unrealized gains and losses on these investments are reported in “Other income (loss),” and dividend income is reported in “Net investment income” on the ex-dividend date. Commercial mortgage and other loans consists of commercial mortgage loans, agricultural property loans, residential mortgage loans, as well as certain other collateralized and uncollateralized loans. Uncollateralized loans primarily represent reverse dual currency loans and corporate loans held by the Company’s international insurance operations. Commercial mortgage and other loans originated and held for investment are generally carried at unpaid principal balance, net of unamortized deferred loan origination fees and expenses, and net of any current expected credit loss (“CECL”) allowance. Certain off-balance sheet credit exposures (e.g., indemnification of serviced mortgage loans, and certain unfunded mortgage loan commitments where the Company cannot unconditionally cancel the commitment) are also subject to a CECL allowance. See Note 25 for additional information. The Company carries certain commercial mortgage loans originated within the Company’s commercial mortgage operations at fair value where the fair value option has been elected. Loans held for sale where the Company has not elected the fair value option are carried at the lower of cost or fair value. Commercial mortgage and other loans acquired, including those related to the acquisition of a business, are recorded at fair value when purchased, reflecting any premiums or discounts to unpaid principal balances. Interest income, and the amortization of the related premiums or discounts, are included in “Net investment income” under the effective yield method. Prepayment fees are also included in “Net investment income.” The CECL allowance represents the Company’s best estimate of expected credit losses over the remaining life of the assets or off-balance sheet credit exposures. The determination of the allowance considers historical credit loss experience, current conditions, and reasonable and supportable forecasts. The allowance is calculated separately for commercial mortgage loans, agricultural property loans, residential mortgage loans, and other collateralized and uncollateralized loans. For commercial mortgage and agricultural property loans, the allowance is calculated using an internally developed CECL model that pools together loans that share similar risk characteristics. Similar risk characteristics used to create the pools include, but are not limited to, vintage, maturity, credit rating, and collateral type. Key inputs to the CECL model include unpaid principal balances, internal credit ratings, annual expected loss factors, average lives of the loans adjusted for prepayment considerations, current and historical interest rate assumptions, and other factors influencing the Company’s view of the current stage of the economic cycle and future economic conditions. Subjective considerations include a review of whether historical loss experience is representative of current market conditions and the Company’s view of the credit cycle. Model assumptions and factors are reviewed and updated as appropriate. Information about certain key inputs is detailed below. Key factors in determining the internal credit ratings for commercial mortgage and agricultural property loans include loan-to-value and debt-service-coverage ratios. Other factors include amortization, loan term, and estimated market value growth rate and volatility for the property type and region. The loan-to-value ratio compares the carrying amount of the loan to the fair value of the underlying property or properties collateralizing the loan, and is commonly expressed as a percentage. Loan-to-value ratios greater than 100% indicate that the carrying amount of the loan exceeds the collateral value. A loan-to-value ratio less than 100% indicates an excess of collateral value over the carrying amount of the loan. The debt service coverage ratio is a property’s net operating income as a percentage of its debt service payments. Debt service coverage ratios less than 1.0 indicates that property operations do not generate enough income to cover the loan’s current debt payments. A debt service coverage ratio greater than 1.0 indicates an excess of net operating income over the debt service payments. The values utilized in calculating these ratios are developed as part of the Company’s periodic review of the commercial mortgage loan and agricultural property loan portfolios, which includes an internal appraisal of the underlying collateral value. The Company’s periodic review also includes a quality re-rating process, whereby the internal quality rating originally assigned at underwriting is updated based on current loan, property and market information using a proprietary quality rating system. See Note 3 for additional information related to the loan-to-value ratios and debt service coverage ratios related to the Company’s commercial mortgage and agricultural property loan portfolios. Annual expected loss rates are based on historical default and loss experience factors. Using average lives, the annual expected loss rates are converted into life-of-loan loss expectations. When individual loans no longer have the credit risk characteristics of the commercial mortgage or agricultural property loan pools, they are removed from the pools and are evaluated individually for an allowance. The allowance is determined based on the outstanding loan balance less the present value of expected future cash flows discounted at the loan’s effective interest rate or the fair value of the collateral if the loan is collateral dependent. For residential mortgage loans, the allowance is calculated using an internally developed CECL model that pools together loans that share similar risk characteristics. The estimated lifetime loss of the pool is calculated from the risk profiles of the loans, including borrower credit score, loan-to-value ratio, property type, and several key attributes of the loan and property including: loan type, loan age, loan performance history, and current performing or nonperforming status. Estimated lifetime loss rates are calculated by weighting projected losses in multiple economic scenarios based on the Company’s view of the current stage of the economic cycle and future economic conditions. The scenario losses are calibrated to industry historical experience of defaults, loss severities, and prepayment rates in multiple economic cycles, reflective of similar loan characteristics. When individual loans become nonperforming, the allowance is determined based on annual expected loss rates for nonperforming loans or the fair value of the collateral if the loan is collateral dependent. The Company defines nonperforming residential mortgage loans as those that are 90 days or more past due and/or in nonaccrual status. The CECL allowance for other collateralized and uncollateralized loans (e.g., corporate loans) carried at amortized cost is determined based on probability of default and loss given default assumptions by sector, credit quality and average lives of the loans. The CECL allowance on commercial mortgage and other loans can increase or decrease from period to period based on the factors noted above. The change in allowance is reported in “Realized investment gains (losses), net.” As it relates to unfunded commitments that are in scope of this guidance, the CECL allowance is reported in “Other liabilities,” and the change in the allowance is reported in “Realized investment gains (losses), net.” Once the Company has deemed a portion of the amortized cost to be uncollectible, the uncollectible portion of allowance is removed from the balance sheet by writing down the amortized cost basis of the loan. The carrying amount of the loan is not adjusted for subsequent recoveries in value. Interest received on loans that are past due is either applied against the principal or reported as net investment income based on the Company’s assessment as to the collectability of the principal. The Company defines “past due” as principal or interest not collected at least 30 days past the scheduled contractual due date. See Note 3 for additional information about the Company’s past due loans. The Company discontinues accruing interest on loans after the loans become 90 days delinquent as to principal or interest payments, or earlier when the Company has doubts about collectability. When the Company discontinues accruing interest on a loan, any accrued but uncollectible interest on the loan and other loans backed by the same collateral, if any, is charged against interest income in the same period. Generally, a loan is restored to accrual status only after all delinquent interest and principal are brought current and, in the case of loans where the payment of interest has been interrupted for a substantial period, or the loan has been modified, a regular payment performance has been established. Commercial mortgage and other loans are occasionally restructured. These restructurings generally include one or more of the following: full or partial payoffs outside of the original contract terms; changes to interest rates; extensions of maturity; or additions or modifications to covenants. Additionally, the Company may accept assets in full or partial satisfaction of the debt. All restructurings are evaluated under the modification guidance in ASC 310-20. When a loan is modified, the Company evaluates whether the restructuring results in a continuation of the existing loan or a new loan. For modifications that result in a continuation of the existing loan, the CECL allowance of the loan is remeasured using the modified terms, including the loan’s post-modification effective yield, and the allowance is adjusted accordingly. For modifications that result in a new loan, any CECL allowance is reversed and a direct write-down of the loan is recorded for the amount of the allowance, and any additional loss, net of recoveries, or any gain is recorded for the difference between the fair value of the new loan and the recorded investment in the loan. The new loan is evaluated prospectively for credit impairment based on the CECL allowance process noted above. The Company’s PGIM business provides commercial mortgage origination, underwriting and servicing for certain government sponsored entities (“GSEs”). The Company has agreed to indemnify the GSEs for a portion of the credit risk associated with certain of the mortgages it services. Management has established a CECL allowance that factors in historical loss information, current conditions and reasonable and supportable forecasts. The allowance also considers the remaining lives of the loans subject to the indemnification. The CECL allowance is included in “Other liabilities” and changes in the CECL allowance are reported in “Realized investment gains (losses), net.” See Note 25 for additional information. Policy loans represents funds loaned to policyholders up to the cash surrender value of the associated insurance policies and are carried at the unpaid principal balances due to the Company from the policyholders. Interest income on policy loans is recognized in “Net investment income” at the contract interest rate when earned. Policy loans are fully collateralized by the cash surrender value of the associated insurance policies. Other invested assets consists of the Company’s non-coupon investments in limited partnerships and limited liability companies (“LPs/LLCs”), other than joint ventures and other operating entities, as well as wholly-owned investment real estate, derivative assets and other investments. LPs/LLCs interests are accounted for using either the equity method of accounting, or at fair value with changes in fair value reported in “Other income (loss).” The Company’s income from investments in LPs/LLCs accounted for using the equity method, other than the Company’s investments in joint ventures and other operating entities, is included in “Net investment income.” The carrying value of these investments is written down, or impaired, to fair value when a decline in value is considered to be other-than-temporary. In applying the equity method (including assessment for OTTI), the Company uses financial information provided by the investee, generally on a one to three-month lag. The Company consolidates LPs/LLCs in certain other instances where it is deemed to exercise control, or is considered the primary beneficiary of a variable interest entity. See Note 4 for additional information about VIEs. The Company’s wholly-owned investment real estate consists of real estate which the Company has the intent to hold for the production of income as well as real estate held for sale. Real estate which the Company has the intent to hold for the production of income is carried at depreciated cost less any write-downs to fair value for impairment losses and is reviewed for impairment whenever events or circumstances indicate that the carrying value may not be recoverable. Real estate held for sale is carried at the lower of depreciated cost or fair value less estimated selling costs and is not further depreciated once classified as such. An impairment loss is recognized when the carrying value of the investment real estate exceeds the estimated undiscounted future cash flows (excluding interest charges) from the investment. At that time, the carrying value of the investment real estate is written down to fair value. Decreases in the carrying value of investment real estate held for the production of income due to OTTI are recorded in “Realized investment gains (losses), net.” Depreciation on real estate held for the production of income is computed using the straight-line method over the estimated useful lives of the properties and is included in “Net investment income.” Short-term investments primarily consists of highly liquid debt instruments with a maturity of twelve months or less and greater than three months when purchased, other than those debt instruments meeting this definition that are included in “Assets supporting experience-rated contractholder liabilities, at fair value.” These investments are generally carried at fair value or amortized cost that approximates fair value and include certain money market investments, funds managed similar to regulated money market funds, short-term debt securities issued by government-sponsored entities and other highly liquid debt instruments. Accrued investment income primarily includes accruals of interest and dividend income from investments that have been earned but not yet received. Notes issued by consolidated variable interest entities represents notes issued by certain asset-backed investment vehicles, primarily collateralized loan obligations (“CLOs”) and rated feeder funds, which the Company is required to consolidate. The creditors of these VIEs do not have recourse to the Company in excess of the assets contained within the VIEs. The Company has elected the fair value option for certain of these notes. Changes in fair value are reported in “Other income (loss).” Realized investment gains (losses), net includes realized gains or losses from sales and maturities of investments, changes to the allowance for credit losses, other impairments, fair value changes on mortgage loans where the fair value option has been elected, and derivative gains or losses. The derivative gains or losses include the impact of maturities, terminations and changes in fair value of the derivative instruments, including embedded derivatives, and other hedging instruments. Realized investment gains (losses) from the sales of securities are generally calculated using the specific identification method, with the exception of some of the Company’s International Businesses portfolios where the average cost method is used.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash and Cash Equivalents | Cash and cash equivalents includes cash on hand, amounts due from banks, certain money market investments, funds managed similar to regulated money market funds, other debt instruments with maturities of three months or less when purchased, other than cash equivalents that are included in “Assets supporting experience-rated contractholder liabilities, at fair value,” and receivables related to securities purchased under agreements to resell (see also “Securities sold under agreements to repurchase” below). These assets are generally carried at fair value or amortized cost which approximates fair value.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DAC | Deferred policy acquisition costs (“DAC”) represents costs directly related to the successful acquisition of new and renewal insurance and annuity business. Such DAC primarily includes commissions, costs of policy issuance and underwriting, and certain other expenses that are directly related to successfully acquired contracts. In each reporting period, previously capitalized DAC is amortized and included in “Amortization of deferred policy acquisition costs.” DAC for most long-duration contracts is amortized on a constant-level basis at a grouped contract level over the expected life of the underlying insurance contracts. Contracts are grouped consistent with the groupings used to estimate the liability for future policy benefits (or other related balances) for the corresponding contracts. Since contracts within a grouping may be of different sizes, contracts within a group are weighted to achieve appropriate amortization and to ensure that DAC is derecognized when a policy is no longer in force. The constant-level basis used to weight contracts within a grouping and amortize DAC is generally defined as follows: •Life insurance contracts – DAC associated with life insurance contracts is generally amortized in proportion to the initial face amount of life insurance in force. This is applicable to traditional and universal life insurance products in the Individual Life and International Businesses segments and Closed Block division, and group corporate- and bank-owned life insurance contracts in the Group Insurance segment. •Payout annuity contracts – DAC associated with payout annuity contracts in the Retirement Strategies segment is amortized in proportion to annual benefit payments. •Deferred annuity contracts – DAC associated with fixed and variable deferred annuity contracts in the Retirement Strategies and International Businesses segments is amortized in proportion to deposits. •Health contracts – DAC associated with health contracts in the International Businesses segment is generally amortized in proportion to maximum lifetime benefits. For funding agreement note contracts, single premium structured settlement contracts without life contingencies, and single premium immediate annuities without life contingencies, acquisition expenses are deferred and amortized over the expected life of the contracts using the interest method. For other group life and disability insurance contracts and guaranteed investment contracts (“GICs”), acquisition costs are expensed as incurred. Current period DAC amortization reflects the impact of changes in actual insurance in force during the period and changes in future assumptions effected as of the end of the quarter, where applicable. The Company typically updates actuarial assumptions annually in the second quarter, unless a material change is observed in an interim period that is indicative of a long-term trend. Generally, the Company does not expect trends to change significantly in the short-term and, to the extent these trends may change, the Company expects such changes to be gradual over the long-term. Assumptions used for DAC are consistent with those used in estimating the liability for future policy benefits (or any other related balance) for the corresponding contract. Determining the level of aggregation and actuarial assumptions used in projecting in-force terminations requires judgment. Internal criteria are developed to determine the level of aggregation by considering both qualitative and quantitative materiality thresholds. The assumptions used in projecting in-force terminations are mortality, mortality improvement, and lapse assumptions. These assumptions are generally based on the Company’s experience, industry experience and/or other factors, as applicable. For variable deferred annuity contracts, lapse rates are adjusted at the contract level based on the in-the-moneyness of the living benefits and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. For some products, policyholders can elect to modify product benefits, features, rights or coverages by exchanging a contract for a new contract or by amendment, endorsement, or rider to a contract, or by the election of a feature or coverage within a contract. These transactions are known as internal replacements. If policyholders surrender traditional life insurance policies in exchange for life insurance policies that do not have fixed and guaranteed terms, the Company immediately charges to expense the remaining unamortized DAC on the surrendered policies. For other internal replacement transactions, except those that involve the addition of a non-integrated contract feature that does not change the existing base contract, the unamortized DAC is immediately charged to expense if the terms of the new policies are not substantially similar to those of the former policies. If the new terms are substantially similar to those of the earlier policies, the DAC is retained with respect to the new policies and amortized over the expected life of the new policies. See Note 7 for additional information regarding DAC.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| VOBA | Value of business acquired (“VOBA”) represents identifiable intangible assets to which a portion of the purchase price in a business acquisition is attributed under the application of purchase accounting. VOBA represents an adjustment to the stated value of in-force insurance contract liabilities to present them at fair value, determined as of the acquisition date. VOBA balances are subject to recoverability testing in the manner in which they were acquired. The Company has established a VOBA asset primarily for its acquired life insurance products and accident and health products with fixed benefits. As of December 31, 2025, the majority of the VOBA balance relates to the 2011 acquisition of AIG Star Life Insurance Co., Ltd, AIG Edison Life Insurance Company, AIG Financial Assurance Japan K.K. and AIG Edison Service Co., Ltd. (collectively, the “Star and Edison Businesses”). The Company records amortization of VOBA in “General and administrative expenses” and amortizes it over the anticipated life of the acquired contracts using the same methodology, factors, and assumptions used to amortize DAC and deferred sales inducements (“DSI”). See Note 7 for additional information regarding VOBA.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Risk Benefit | Market risk benefit assets represents market risk benefits (“MRBs”) in an asset position and are presented separately from MRBs in a liability position. See “Market risk benefit liabilities” below. MRB assets also reflect ceded MRBs resulting from reinsurance of the Company’s Prudential Defined Income (“PDI”) traditional variable annuity contracts. See Note 15 for additional information regarding the reinsurance of PDI. Market risk benefit liabilities represents contracts or contract features that provide protection to the contractholder and exposes the Company to other than nominal capital market risk, primarily related to deferred annuities with guaranteed minimum benefits in the Retirement Strategies segment including guaranteed minimum death benefits (“GMDB”), guaranteed minimum income benefits (“GMIB”), guaranteed minimum accumulation benefits (“GMAB”), guaranteed minimum withdrawal benefits (“GMWB”) and guaranteed minimum income and withdrawal benefits (“GMIWB”). The benefits are accounted for using a fair value measurement framework. If a contract contains multiple market risk benefits, the benefits are bundled together and accounted for as a single compound market risk benefit. Market risk benefits in an asset position are presented separately from those in a liability position as there is no legal right of offset between contracts. The fair value of market risk benefits is calculated as the present value of expected future benefit payments to contractholders less the present value of expected future rider fees attributable to the market risk benefits. The fair value of market risk benefits is based on assumptions a market participant would use in valuing market risk benefits. For additional information regarding the valuation of market risk benefits, see Note 6. On a quarterly basis, changes in the fair value of market risk benefits are recorded in net income, net of related hedges, in “Change in value of market risk benefits, net of related hedging gains (losses),” except for the portion of the change attributable to changes in the Company’s non-performance risk (“NPR”) which is recorded in OCI. See Note 14 for additional information regarding market risk benefits. See “Reinsurance” below for information regarding the reinsurance of MRBs.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance | Reinsurance recoverables and deposit receivables includes amounts recoverable under reinsurance agreements and receivables that follow the deposit method of accounting (see “Reinsurance” below). Reinsurance and funds withheld payables represents amounts payable under reinsurance agreements (see “Reinsurance” below). Reinsurance For each of its reinsurance contracts, the Company determines if the contract provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. The Company reviews all contractual features, particularly those that may limit the amount of insurance risk to which the reinsurer is subject, or features that delay the timely reimbursement of claims. The Company participates in reinsurance arrangements in various capacities as either the ceding entity or as the reinsurer (i.e., assuming entity). See Note 15 for additional information regarding the Company’s reinsurance arrangements. Reinsurance assumed business is generally accounted for consistent with direct business. Amounts currently recoverable under reinsurance agreements are included in “Reinsurance recoverables and deposit receivables” and amounts payable are included in “Reinsurance and funds withheld payables.” “Reinsurance recoverables and deposit receivables” also includes (1) an embedded derivative on deposit receivables where the Company has ceded fixed indexed annuities; and (2) embedded derivatives associated with receivables from modified coinsurance arrangements where the Company is the reinsurer, and net receivables from modified coinsurance arrangements where the Company is the cedant, and generally reflect the fair value of the invested assets retained by the cedant. “Reinsurance and funds withheld payables” also includes amounts payable to the reinsurer under coinsurance with funds withheld or net payables from modified coinsurance arrangements where the Company is the cedant, and generally reflect the fair value of the invested assets retained by the Company and contain an embedded derivative that is bifurcated and accounted for at fair value separately from the host contract, with changes in fair value recorded through “Realized investment gains (losses), net.” Revenues and benefits and expenses include amounts assumed under reinsurance agreements and are reflected net of reinsurance ceded. Reinsurance ceded arrangements do not discharge the Company as the primary insurer. Ceded balances would represent a liability of the Company in the event the reinsurers were unable to meet their obligations to the Company under the terms of the reinsurance agreements. Reinsurance recoverables are reported net of the CECL allowance. The CECL allowance considers the credit quality of the reinsurance counterparty and is generally determined based on the probability of default and loss given default assumptions, after considering any applicable collateral arrangements. Additions to or releases of the allowance are reported in “Policyholders’ benefits.” Reinsurance premiums, commissions, expense reimbursements, benefits and reserves related to reinsured long-duration contracts under coinsurance arrangements are accounted for over the life of the underlying reinsured contracts using assumptions consistent with those used to account for the underlying contracts. For reinsurance of in- force blocks of non-participating traditional and limited-payment contracts, the current value of the direct liability as of inception of the reinsurance agreement is used to calculate the reinsurance recoverable and cost of reinsurance such that there is no immediate other comprehensive income or loss from recognition of the reinsurance recoverable at inception. Consistent with the direct liability, the reinsurance recoverable for non-participating traditional and limited-payment contracts is remeasured each period using current single A rates with the effect on the reinsurance recoverable resulting from such updates recorded in “Interest rate remeasurement of future policy benefits” in OCI. For reinsurance of limited-payment contracts, the Company establishes a cost of reinsurance asset relating to the direct DPL and amortizes this balance through “Premiums” using the same methodology and assumptions used to amortize the direct DPL. For reinsurance of existing in-force blocks of long-duration contracts that transfer significant insurance risk, the difference between the fair value of the net consideration exchanged and the net liabilities ceded related to the underlying reinsured contracts is considered the net cost of reinsurance at the inception of the reinsurance agreement. This initial net cost of reinsurance is deferred and amortized into income over the remaining life of the reinsured policies on a basis consistent with the methodologies and assumptions used for amortizing DAC. This initial net cost of reinsurance may result in a deferred reinsurance gain which is recorded in “Other liabilities” and amortized through “Other income (loss),” or a deferred reinsurance loss which is recorded in “Other assets” and amortized through “General and administrative expenses.” Consistent with direct contracts, reinsurance arrangements may also include features that meet the definition of MRBs and, if so, are accounted for at fair value. The fair value of direct or assumed MRBs reflects the Company’s NPR, while the fair value of ceded MRBs reflects the counterparty credit risk of the reinsurer. Changes in the fair value of ceded MRBs, including the impact of changes in counterparty credit risk, are recorded in net income in “Change in value of market risk benefits, net of related hedging gains (losses).” Coinsurance arrangements contrast with the Company’s yearly renewable term arrangements, where only mortality risk is transferred to the reinsurer and premiums are paid to the reinsurer to reinsure that risk. The mortality risk that is reinsured under yearly renewable term arrangements represents the difference between the stated death benefits in the underlying reinsured contracts and the corresponding reserves or account value carried by the Company on those same contracts. The premiums paid to the reinsurer are based upon negotiated amounts, not on the actual premiums paid by the underlying contractholders to the Company. As yearly renewable term arrangements are usually entered into by the Company with the expectation that the contracts will be in force for the lives of the underlying policies, they are considered to be long-duration reinsurance contracts. The cost of reinsurance for universal life products is generally recognized based on the gross assessments of the underlying direct policies. The cost of reinsurance for term insurance products is generally recognized in proportion to direct premiums over the life of the underlying policies. The cost of reinsurance related to short-duration reinsurance contracts is accounted for over the reinsurance contract period. If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in “Reinsurance and funds withheld payables” and deposits made are included in “Reinsurance recoverables and deposit receivables.” As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as “Other income (loss)” or “General and administrative expenses,” as appropriate.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Assets and Other Liabilities | Other assets consists primarily of prepaid pension benefit costs (see Note 19), certain restricted assets (e.g., cash and cash equivalents), trade receivables, goodwill and other intangible assets, “right-of-use” lease assets (see “Other liabilities” below), DSI, the Company’s investments in joint ventures and other operating entities, property and equipment, deferred reinsurance losses (“DRL”) (see “Reinsurance” below) and receivables resulting from sales of securities that had not yet settled at the balance sheet date. Property and equipment are carried at cost less accumulated depreciation. Depreciation is determined using the straight-line method over the estimated useful lives of the related assets, which generally range from 3 to 40 years. As a result of certain acquisitions, the Company recognizes an asset for goodwill representing the excess of cost over the net fair value of the assets acquired and liabilities assumed. Goodwill is assigned to reporting units at the date the goodwill is initially recorded. A reporting unit is an operating segment, or a unit one level below the operating segment if discrete financial information is prepared and regularly reviewed by management at that level. Once goodwill has been assigned to reporting units, it no longer retains its association with a particular acquisition, and all of the activities within a reporting unit, whether acquired or organically grown, are available to support the value of the goodwill. The Company tests goodwill for impairment annually as of December 31 and more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Accounting guidance provides for an optional qualitative assessment for testing goodwill impairment that may allow companies to skip the quantitative test. As part of the annual goodwill impairment test, the Company estimates the fair value of the reporting units by applying the quantitative test, which involves comparing each reporting unit’s fair value to its carrying value including goodwill. If the fair value of a reporting unit exceeds its carrying value, the applicable goodwill is considered not to be impaired. If the carrying value exceeds fair value, goodwill is reduced and an impairment charge to income is recognized for the excess. The measurement of a goodwill impairment loss includes the related income tax effect from any tax deductible goodwill. The impairment loss cannot exceed the amount of goodwill assigned to a reporting unit, and the loss establishes a new basis in the goodwill. Subsequent reversal of goodwill impairment losses is not permitted. Management is required to make significant estimates in determining the fair value of a reporting unit including, but not limited to: projected revenues and operating margins, applicable discount and growth rates, and comparative market multiples. See Note 10 for additional information regarding goodwill. Deferred Sales Inducements are amounts that are credited to a policyholders’ account balance primarily as an inducement to purchase fixed and/or variable deferred annuity contracts. The Company defers sales inducements and amortizes them over the expected life of the policy using the same methodology, factors and assumptions used to amortize DAC. The Company records amortization of DSI in “Interest credited to policyholders’ account balances.” Unlike DAC, DSI are considered contractual cash flows and, as a result, are subject to periodic recoverability testing. See Note 7 for additional information regarding DSI. Identifiable intangible assets primarily include customer relationships and mortgage servicing rights and are recorded net of accumulated amortization. The Company tests identifiable intangible assets for impairment on an annual basis as of December 31 of each year or whenever events or circumstances suggest that the carrying value of an identifiable intangible asset may exceed the sum of the undiscounted cash flows expected to result from its use and eventual disposition. If this condition exists and the carrying value of an identifiable intangible asset exceeds its fair value, the excess is recognized as an impairment and is recorded as a charge against net income. Measuring intangible assets requires the use of estimates. Significant estimates include the projected net cash flow attributable to the intangible asset and the rate at which future net cash flows are discounted for purposes of estimating fair value, as applicable. See Note 10 for additional information regarding identifiable intangible assets. Investments in joint ventures and other operating entities are generally accounted for under the equity method. The carrying value of these investments is written down, or impaired, to fair value when a decline in value is considered to be other-than-temporary. See Note 9 for additional information regarding investments in joint ventures and other operating entities. Other liabilities consists primarily of trade payables, lease liabilities (see “Other assets” above), pension and other employee benefit liabilities (see Note 19), derivative liabilities (see “Derivative Financial Instruments” below), deferred reinsurance gains (“DRG”) (see “Reinsurance” below) and payables resulting from purchases of securities that had not yet settled at the balance sheet date.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Lessor, Leases | Leases are recorded on the balance sheet as “right-of-use” assets and lease liabilities within “Other assets” and “Other liabilities” respectively. Leases are classified as either operating or finance leases and lease expense is recognized within “General and administrative expenses.” As a lessee, for operating leases, total lease expense is recognized using a straight-line method. Finance leases are treated as the purchase of an asset on a financing basis. Additionally, as a lessor, for sales-type and direct financing leases, the Company derecognizes the carrying value of the leased asset that is considered to have been transferred to a lessee and records a lease receivable and residual asset (“receivable and residual” approach). See Note 11 for additional information regarding leases.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Lessee, Leases | Leases are recorded on the balance sheet as “right-of-use” assets and lease liabilities within “Other assets” and “Other liabilities” respectively. Leases are classified as either operating or finance leases and lease expense is recognized within “General and administrative expenses.” As a lessee, for operating leases, total lease expense is recognized using a straight-line method. Finance leases are treated as the purchase of an asset on a financing basis. Additionally, as a lessor, for sales-type and direct financing leases, the Company derecognizes the carrying value of the leased asset that is considered to have been transferred to a lessee and records a lease receivable and residual asset (“receivable and residual” approach). See Note 11 for additional information regarding leases.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Future Policy Benefits | Future policy benefits primarily consists of the present value of expected future payments to or on behalf of policyholders, where the timing and amount of such payments depend on policyholder mortality or morbidity, less the present value of expected future net premiums (where net premiums are gross premiums multiplied by the Net-To-Gross (“NTG”) ratio discussed below). The liability for future policy benefits is accrued over time as premium revenue is recognized. See Note 12 for additional information regarding future policy benefits. The reserving methodology used for non-participating traditional and limited-payment contracts include the following: •Cash Flow Assumptions. In measuring the liability for future policy benefits, the net premium valuation methodology is utilized. Under this methodology, a liability for future policy benefits is established using current best estimate insurance assumptions and interest rate assumptions locked-in at contract issuance date. The NTG ratio is calculated as the ratio of the present value of expected policy benefits and non-level claim settlement expenses divided by the present value of expected gross premiums. The NTG ratio is applied to gross premiums, as premium revenue is recognized, to determine net premiums. The liability is then determined as the present value of expected future policy benefits and non-level claim settlement expenses less the present value of expected future net premiums. The result of the net premium valuation methodology is that the liability at any point in time represents an accumulation of the portion of premiums received to date expected to fund future benefits (i.e., net premiums received to date), less any benefits and expenses already paid. The liability does not necessarily reflect the full policyholder obligation the Company expects to pay at the conclusion of the contract since a portion of that obligation would be funded by net premiums received in the future and would be recognized in the liability at that time. For purposes of liability measurement, contracts are grouped into cohorts based primarily on issue year, reportable segment and major product line. The NTG ratio is generally updated quarterly for actual experience and annually in the second quarter of each year for future cash flow assumption updates during the Company’s annual assumptions review process unless a material change is observed in an interim period that is indicative of a long-term trend, with the exception of claim settlement expense assumptions which the Company has made an entity-wide election to lock-in as of contract issuance. The NTG ratio is subject to a retrospective unlocking method whereby the Company updates its best estimate of cash flows expected over the life of the cohort using actual historical experience and updated future cash flow assumptions. These updated cash flows are used to calculate the revised NTG ratio, which is used to derive an updated liability for future policy benefits as of the beginning of the current reporting period, discounted at the original contract issuance discount rate. The updated liability for future policy benefit amount as of the beginning of the quarter is then compared to the carrying amount of the liability as of that same date, before the updates for actual experience or future cash flow assumptions, to determine the current period change in liability estimate. This current period change in the liability is the liability remeasurement gain or loss that is recorded through current period earnings in “Change in estimates of liability for future policy benefits.” In subsequent periods, the revised NTG ratio is used to measure the liability for future policy benefits, subject to future revisions. If a cohort is in a loss position where the liability for future policy benefits plus the present value of expected future gross premiums are determined to be insufficient to provide for expected future policy benefits and non-level claim settlement expenses, the NTG ratio is capped at 100%. In these instances, all changes in expected benefits resulting from both actual experience deviations and changes in future assumptions are recognized immediately. While the liability for future policy benefits cannot be less than zero (i.e., a contra-liability) at the cohort level and thus the balance is floored at zero (i.e., “flooring”), the NTG ratio may be negative. This would be the case whereby conditions have improved such that the present value of future net premiums plus the existing liability for future policy benefits as of the valuation date exceed the present value of expected future policy benefits and non-level claim settlement expenses. In this case, the negative NTG ratio would be applied going forward to gross premiums received, effectively amortizing the gain into income and reducing the liability over time. In addition, for limited-payment contracts, the liability for future policy benefits also includes a Deferred Profit Liability (“DPL”) representing gross premiums received in excess of net premiums and is generally recognized in revenue in a constant relationship with insurance in force for life contracts or with the amount of expected future benefit payments for annuity contracts. The DPL is subject to a retrospective unlocking adjustment consistent with the liability for future policy benefits discussed above. The DPL cannot be less than zero (i.e., a contra-liability) at the cohort level and thus the balance is floored at zero (i.e., “flooring”). •Discount Rate Assumption. The locked-in discount rate is generally based on expected investment returns at contract inception for contracts issued prior to January 1, 2021 and the upper-medium grade fixed income corporate instrument yield (i.e., global single A) at contract inception for contracts issued on or after January 1, 2021. The discount rate in effect at contract inception is locked-in for the calculation of the NTG ratio and accretion of interest cost on the liability through net income. However, for balance sheet remeasurement purposes, the discount rate is updated using the current single A rate at each reporting period, with the effect on the liability resulting from such update recorded in “Interest rate remeasurement of future policy benefits” in OCI. The methodology used in constructing the single A discount rate curve for discounting cash flows used to calculate the liability for future policy benefits is intended to be reflective of the characteristics of the applicable insurance liabilities. The single A discount rate curve is developed by reference to upper-medium grade (low credit risk) fixed- income instrument yields that reflect the duration characteristics of the applicable insurance liabilities. The single A discount curve for the United States and foreign economies, such as Japan, with observable corporate A spreads, is developed using government bond rates, plus globally equivalent public corporate A spreads in the observable periods. The definition of upper medium grade is based on Moody's Investor Service, Inc. (“Moody’s”) definition which includes the spectrum of A (i.e., A- to A+). The rate used in foreign operations (with the exception of certain emerging markets, as discussed below) is based on the equivalent of a single A rate from a global rating agency for corporate bonds issued in the same currency and country in which the insurance contract is written. Liquidity is considered in defining the observable period and linear extrapolation is performed to the Company’s ultimate long-term economic assumptions. Annually, the Company performs a comprehensive review of the economic assumptions, including long-term interest rate assumptions and equity return assumptions, generally utilizing relevant economic outlook information and industry surveys as the primary basis. The Company has foreign currency denominated insurance obligations to policyholders in certain emerging markets where there is limited or no observable market data on upper-medium grade (low credit risk) fixed-income instrument yields. As a proxy for the upper-medium grade fixed-income instrument yield, the Company estimates an equivalent global single A yield in the currency of the emerging economy by converting a global single A U.S. dollar bond yield curve based on the relationship between market observable U.S. Treasury and foreign sovereign yield curves of similar duration as the insurance liability cash flows. The derived global single A curves in the foreign currency are evaluated against available evidence of observable global single A corporate bond rates in similar emerging economies. The Company uses interpolation and extrapolation techniques to complete the discount rate construction for the duration of the insurance liabilities to calculate the liability for future policy benefits denominated in the local currencies. The Company’s liability for future policy benefits also includes net liabilities for guaranteed benefits related to certain long-duration life contracts, such as no-lapse guarantee contract features (Additional Insurance Reserves or “AIR” liability), for which a liability is established when associated assessments are recognized (which include investment margin on policyholders’ account balances deposited to fixed and indexed funds and all policy charges including charges for administration, mortality, expense, surrender and other charges). This liability is established using current best estimate assumptions and is based on the ratio of the present value of total expected excess payments (i.e., payments in excess of account value) over the life of the contract divided by the present value of total expected assessments (i.e., benefit ratio). The liability equals the current benefit ratio multiplied by cumulative assessments recognized to date, plus interest, less cumulative excess payments to date. The liability does not necessarily reflect the full policyholder obligation the Company expects to pay at the conclusion of the contract since a portion of that excess payment would be funded by assessments received in the future and would be recognized in the liability at that time. The reserves are subject to adjustments based on annual reviews of assumptions and quarterly adjustments for experience as described below, including market performance. These adjustments reflect the impact on the benefit ratio of using actual historical experience from the issuance date to the balance sheet date plus updated estimates of future experience. The updated benefit ratio is then applied to all prior periods’ assessments to derive an adjustment to the reserve recognized through a benefit or charge to current period earnings. Any adjustments to this liability related to net unrealized gains (losses) on securities classified as available-for-sale are included in AOCI. For universal life type contracts and participating contracts, the Company performs premium deficiency tests using best estimate assumptions as of the testing date, at a minimum, on an annual basis, and on a quarterly basis for business whose profitability is closely tied to equity market performance. If the liabilities determined based on these best estimate assumptions are greater than the net reserves (i.e., GAAP reserves including unearned revenue reserves (“URR”), net of reinsurance, and any DSI or VOBA asset), the existing net reserves are adjusted by first reducing assets such as DSI, VOBA or deferred reinsurance loss by the amount of the deficiency or to zero through a charge to current period earnings. If the deficiency is more than these asset balances for insurance contracts, the net reserves are increased by the excess through a charge to current period earnings included in “Policyholders’ benefits.” Since investment yields are used as the discount rate, the premium deficiency test is also performed using a discount rate based on the market yield (i.e., assuming what would be the impact if any unrealized gains (losses) were realized as of the testing date). In the event that by using the market yield a deficiency occurs, an adjustment is established for the deficiency and is included in AOCI. The Company’s liability for future policy benefits also includes a liability for unpaid claims and claim adjustment expenses. The Company does not establish claim liabilities until a loss has been incurred. However, unpaid claims and claim adjustment expenses include estimates of claims that the Company believes have been incurred but have not yet been reported as of the balance sheet date. Expense assumptions included in the liability only include claim related expenses and exclude acquisition costs and non-claim related costs such as costs relating to investments, general administration, policy maintenance, product development, market research, and general overhead.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholders' Account Balances | Separate account assets represents segregated funds that are invested for certain policyholders, pension funds and other customers. The assets consist primarily of equity securities, fixed maturities, real estate-related investments, real estate mortgage loans, short-term investments and derivative instruments and are reported at fair value. The assets of each account are legally segregated and are not subject to claims that arise out of any other business of the Company. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. The investment income and realized investment gains or losses from separate account assets generally accrue to the policyholders and are not included in the Company’s results of operations. Mortality, policy administration and surrender charges assessed against the accounts are included in “Policy charges and fee income.” Asset management fees charged to the accounts are included in “Asset management and service fees.” Seed money that the Company invests in separate accounts is reported in the appropriate general account asset line. Investment income and realized investment gains or losses from seed money invested in separate accounts accrue to the Company and are included in the Company’s results of operations. See Note 8 for additional information regarding separate account arrangements with contractual guarantees. See also “Separate account liabilities” below. Policyholders’ account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date. This liability is primarily associated with the accumulated account deposits, plus interest credited, less policyholder withdrawals and other charges assessed against the account balance, as applicable. These policyholders’ account balances also include provision for benefits under non-life contingent payout annuities and certain unearned revenues. The unearned revenue liability represents policy charges for services to be provided in future periods. The charges are deferred as incurred and are generally amortized over the expected life of the contract using the same methodology, factors, and assumption used to amortize DAC. See Note 13 for additional information regarding policyholders’ account balances. Policyholders’ account balances also include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products. The changes in the fair value of the embedded derivatives are recorded in net income. For additional information regarding the valuation of these embedded derivatives, see Note 6. Separate account liabilities primarily represents the contractholders’ account balances in separate account assets and to a lesser extent borrowings of the separate account, and will be equal and offsetting to total separate account assets. See also “Separate account assets” above.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholders' Dividends | Policyholders’ dividends includes dividends payable to policyholders and the policyholder dividend obligation associated with the participating policies included in the Closed Block. The dividends payable for participating policies included in the Closed Block are determined at the end of each year for the following year by the Board of Directors of The Prudential Insurance Company of America (“PICA”) based on its statutory results, capital position, ratings, and the emerging experience of the Closed Block. The policyholder dividend obligation represents amounts expected to be paid to Closed Block policyholders as an additional policyholder dividend unless otherwise offset by future Closed Block performance. Any adjustments to the policyholder dividend obligation related to net unrealized gains (losses) on securities classified as available- for-sale are included in AOCI. For additional information regarding the policyholder dividend obligation, see Note 16. The dividends payable for policies other than the participating policies included in the Closed Block include dividends payable in accordance with certain group and individual insurance policies.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Securities repurchase and resale agreements and securities loaned transactions | Securities sold under agreements to repurchase represents liabilities associated with securities repurchase agreements that are used primarily to earn spread income. As part of securities repurchase agreements, the Company transfers U.S. government and government agency securities to a third party and receives cash as collateral. For securities repurchase agreements, the cash received is typically invested in cash equivalents, short-term investments or fixed maturities. Receivables associated with securities purchased under agreements to resell are generally reflected as cash equivalents. As part of securities resale agreements, the Company invests cash and receives as collateral U.S. government securities or other debt securities. Securities repurchase and resale agreements that satisfy certain criteria are treated as secured borrowing or secured lending arrangements. These agreements are carried at the amounts at which the securities will be subsequently resold or reacquired, as specified in the respective transactions. For securities purchased under agreements to resell, the Company’s policy is to take possession or control of the securities either directly or through a third-party custodian. These securities are valued daily, and additional securities or cash collateral is received, or returned, when appropriate to protect against credit exposure. Securities to be resold are the same, or substantially the same, as the securities received. The majority of these transactions are with large brokerage firms and large banks. For securities sold under agreements to repurchase, the market value of the securities to be repurchased is monitored, and additional collateral is obtained where appropriate, to protect against credit exposure. The Company obtains collateral in an amount at least equal to 95% of the fair value of the securities sold. Securities to be repurchased are the same, or substantially the same, as those sold. The majority of these transactions are with highly rated money market funds. Income and expenses related to these transactions executed within the insurance companies used to earn spread income are reported as “Net investment income.” Cash collateral for loaned securities represents liabilities to return cash proceeds from security lending transactions. Securities lending transactions are used primarily to earn spread income. As part of securities lending transactions, the Company transfers U.S. and foreign debt and equity securities, as well as U.S. government and government agency securities, and receives cash as collateral. Cash proceeds from securities lending transactions are primarily used to earn spread income, and are typically invested in cash equivalents, short-term investments or fixed maturities. Securities lending transactions are treated as financing arrangements and are recorded at the amount of cash received. The Company obtains collateral in an amount equal to 102% and 105% of the fair value of the domestic and foreign securities, respectively. The Company monitors the market value of the securities loaned on a daily basis with additional collateral obtained as necessary. Substantially all of the Company’s securities lending transactions are with large brokerage firms and large banks. Income and expenses associated with securities lending transactions used to earn spread income are reported as “Net investment income.” The Company also enters into securities lending transactions where non-cash collateral, typically U.S. government, Japanese government, or other sovereign bonds are received. The collateral received is not reported on the Company’s Consolidated Statements of Financial Position. In these transactions, the Company receives a fee and obtains collateral in an amount equal to 102% to 105% of the fair value of the loaned securities. The Company monitors the market value of the securities loaned on a daily basis with additional collateral obtained as necessary. Substantially all of these transactions are with large brokerage firms and large banks. Income is reported as “Net investment income.”
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Short-Term and Long-Term Debt | Short-term and long-term debt liabilities are primarily carried at an amount equal to unpaid principal balance, net of unamortized discount or premium and debt issuance costs. Original-issue discount or premium and debt-issue costs are recognized as a component of interest expense over the period the debt is expected to be outstanding, using the interest method of amortization. Interest expense is generally presented within “General and administrative expenses” in the Company’s Consolidated Statements of Operations. Interest expense may also be reported within “Net investment income” for certain activity, as prescribed by specialized industry guidance. Short-term debt is debt coming due in the next twelve months, including that portion of debt otherwise classified as long-term. The short-term debt caption may exclude short-term debt items for which the Company has the intent and ability to refinance on a long-term basis in the near-term. See Note 18 for additional information regarding short-term and long-term debt.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Contingent Liabilities | Commitments and contingent liabilities are accrued if it is probable that a liability has been incurred and an amount is reasonably estimable. Management evaluates whether there are incremental legal or other costs directly associated with the ultimate resolution of the matter that are reasonably estimable and, if so, they are included in the accrual. These accruals are generally reported in “Other liabilities.”
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Redeemable Noncontrolling Interest | Redeemable noncontrolling interests includes redeemable noncontrolling interests associated with certain consolidated PGIM-managed entities. These redeemable noncontrolling interests are classified as “Mezzanine equity” because their redemption is at the option of the holder and not within the control of the Company. Income (loss) attributable to redeemable noncontrolling interests is reported in “Income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests.”
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance Revenue and Expense Recognition | Insurance Revenue and Expense Recognition Premiums from individual life products, other than universal and variable life contracts, and health insurance and long-term care products are recognized when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any gross premium in excess of the net premium (i.e., the portion of the gross premium required to provide for all expected future policy benefits and non-level claim settlement expenses) is generally deferred and recognized into revenue in a constant relationship to insurance in force. Benefits are recorded as an expense when they are incurred. A liability for future policy benefits is recorded when premiums are recognized as described in “Future policy benefits” above. Premiums from non-participating group annuities with life contingencies, single premium structured settlements with life contingencies and single premium immediate annuities with life contingencies are recognized when due. When premiums are due over a significantly shorter period than the period over which benefits are provided, any gross premium in excess of the net premium is generally deferred and recognized into revenue based on expected future benefit payments. Benefits are recorded as an expense when they are incurred. A liability for future policy benefits is recorded when premiums are recognized as described in “Future policy benefits” above. Certain individual annuity contracts provide the contractholder a guarantee that the benefit received upon death or annuitization will be no less than a minimum prescribed amount. These benefits are generally accounted for as market risk benefits (see “Market risk benefits” above). Amounts received from policyholders as payment for universal or variable group and individual life contracts, deferred fixed or variable annuities, structured settlements and other contracts without life contingencies, and participating group annuities are reported as deposits to “Policyholders’ account balances” and/or “Separate account liabilities.” Revenues from these contracts are reflected in “Policy charges and fee income” consisting primarily of fees assessed during the period against the policyholders’ account balances for mortality and other benefit charges, policy administration charges and surrender charges. In addition to fees, the Company earns investment income from the investment of deposits in the Company’s general account portfolio. Fees assessed that represent compensation to the Company for services to be provided in future periods and certain other fees are generally deferred and amortized into revenue over the life of the related contracts using the same methodology, factors, and assumption used to amortize DAC as described above. Benefits and expenses for these products include claims in excess of related account balances, expenses of contract administration, interest credited to policyholders’ account balances and amortization of DAC, DSI and VOBA. Policyholders’ account balances also include amounts representing the fair value of embedded derivative instruments associated with the index-linked features of certain universal life and annuity products where changes in the value of the embedded derivatives are recorded through “Realized investment gains (losses), net.” For additional information regarding the valuation of these embedded derivatives, see Note 6. For group life, other than universal and variable group life contracts, and disability insurance, premiums are generally recognized over the period to which the premiums relate in proportion to the amount of insurance protection provided. Claim and claim adjustment expenses are recognized when incurred.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Asset Management and Service Fees | Asset management and service fees principally includes asset-based asset management fees, which are recognized in the period in which the services are performed. In certain asset management fee arrangements, the Company is entitled to receive performance-based incentive fees when the return on assets under management exceeds certain benchmark returns or other performance targets. The Company may be required to return all, or part, of such performance-based incentive fees depending on future performance of these assets relative to performance benchmarks. The Company records performance-based incentive fee revenue when the contractual terms of the asset management fee arrangement have been satisfied and it is probable that a significant reversal in the amount of the fee will not occur. Under this principle, the Company records a deferred performance-based incentive fee liability to the extent it receives cash related to the performance-based incentive fee prior to meeting the revenue recognition criteria delineated above.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Income | Other income (loss) includes realized and unrealized gains or losses from investments classified “Fixed maturities, trading, at fair value,” “Assets supporting experience-rated contractholder liabilities, at fair value,” “Equity securities, at fair value,” and “Other invested assets” that are measured at fair value and consolidated entities that follow specialized investment company fair value accounting. “Other income (loss)” also includes gains and losses primarily related to the remeasurement of foreign currency denominated assets and liabilities, as discussed in more detail under “Foreign Currency” below, as well as gains and losses related to business dispositions.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Taxes | Income taxes receivable (payable) primarily represents the net deferred tax asset or liability and the Company’s estimated taxes receivable or payable for the current year and open audit years. The Company and its includable domestic subsidiaries file a consolidated federal income tax return that includes both life insurance companies and non-life insurance companies. Subsidiaries operating outside the U.S. are taxed, and income tax expense is recorded, based on applicable foreign statutes. See Note 17 for a discussion of certain non-U.S. jurisdictions for which the Company assumes repatriation of earnings. The application of U.S. GAAP requires the Company to evaluate the recoverability of the Company’s deferred tax assets and establish a valuation allowance if necessary to reduce the Company’s deferred tax assets to an amount that is more likely than not expected to be realized. Considerable judgment is required in determining whether a valuation allowance is necessary, and if so, the amount of such valuation allowance. See Note 17 for a discussion of factors considered when evaluating the need for a valuation allowance. The Company has elected to treat taxes related to Global Intangible Low-Taxed Income (“GILTI”) as a period cost and records such amounts in income tax expense in the period incurred. U.S. GAAP prescribes a comprehensive model for how a company should recognize, measure, present, and disclose in its financial statements uncertain tax positions that a company has taken or expects to take on tax returns. The application of this guidance is a two-step process. First, the Company determines whether it is more likely than not, based on the technical merits, that the tax position will be sustained upon examination. If a tax position does not meet the more likely than not recognition threshold, the benefit of that position is not recognized in the financial statements. The second step is measurement. The Company measures the tax position as the largest amount of benefit that is greater than 50% likely to be realized upon ultimate resolution with a taxing authority that has full knowledge of all relevant information. This measurement considers the amounts and probabilities of the outcomes that could be realized upon ultimate settlement using the facts, circumstances, and information available at the reporting date. The Company accrues a liability for unrecognized tax benefits, interest and penalties which relate to tax years still subject to review by the Internal Revenue Service (“IRS”) or other taxing jurisdictions. Audit periods remain open for review until the statute of limitations has passed. Generally, for tax years which produce net operating losses, capital losses or tax credit carryforwards (“tax attributes”), the statute of limitations does not close, to the extent of these tax attributes, until the expiration of the statute of limitations for the tax year in which they are fully utilized. The completion of review or the expiration of the statute of limitations for a given audit period could result in an adjustment to the liability for income taxes. The Company classifies all interest and penalties related to tax uncertainties as income tax expense. See Note 17 for additional information regarding income taxes.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-Based Payments | Share-Based Payments The Company applies the fair value-based measurement method in accounting for share-based payment transactions with employees except for equity instruments held by employee share ownership plans. Excess tax benefits (deficits) are recorded in earnings and represent the cumulative difference between the actual tax benefit realized and the amount of deferred tax assets recorded attributable to shared-based payment transactions. The Company accounts for non-employee stock options using the fair value method in accordance with authoritative guidance and related interpretations on accounting for equity instruments that are issued to other than employees for acquiring, or in conjunction with selling, goods or services.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Earnings Per Share | Earnings Per Share Earnings per share of Common Stock reflects the consolidated earnings of Prudential Financial. Basic earnings per share is computed by dividing available income attributable to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share includes the effect of all dilutive potential common shares that were outstanding during the period. See Note 21 for additional information.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign Currency | Foreign Currency The currency in which the Company prepares its financial statements (the “reporting currency”) is the U.S. dollar. Assets, liabilities and results of foreign operations are recorded based on the functional currency of each foreign operation. The determination of the functional currency is based on economic facts and circumstances pertaining to each foreign operation. The local currencies of the Company’s foreign operations are typically their functional currencies with the most significant exception being the Company’s Japanese operations where multiple functional currencies exist. There are two distinct processes for expressing these foreign transactions and balances in the Company’s financial statements: foreign currency measurement and foreign currency translation. Foreign currency measurement is the process by which transactions in foreign currencies are expressed in the functional currency. Gains and losses resulting from foreign currency measurement are reported in current earnings in “Other income (loss).” Foreign currency translation is the process of expressing a foreign entity’s functional currency financial statements in the reporting currency. Assets and liabilities of foreign operations and subsidiaries reported in currencies other than U.S. dollars are translated at the exchange rate in effect at the end of the period. Revenues, benefits and other expenses are translated at the average rate prevailing during the period. The effects of translating the statements of operations and financial position of non-U.S. entities with functional currencies other than the U.S. dollar are included, net of related qualifying hedge gains and losses and income taxes, in “Foreign currency translation adjustment,” a component of AOCI.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Financial Instruments | Derivative Financial Instruments Derivatives are financial instruments whose values are derived from interest rates, foreign exchange rates, financial indices, values of securities or commodities, credit spreads, market volatility, expected returns, and liquidity. Values can also be affected by changes in estimates and assumptions, including those related to counterparty behavior and NPR used in valuation models. Derivative financial instruments generally used by the Company include swaps, futures, forwards and options and may be exchange-traded or contracted in the over-the-counter (“OTC”) market. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (OTC-cleared), while others are bilateral contracts between two counterparties (OTC-bilateral). Derivative positions are carried at fair value, generally by obtaining quoted market prices or through the use of valuation models. Derivatives are used to manage the interest rate and currency characteristics of assets or liabilities and to mitigate volatility of expected non-functional currency earnings and net investments in foreign operations resulting from changes in currency exchange rates. Additionally, derivatives may be used to reduce exposure to risks such as interest rate, credit, foreign currency and equity associated with assets held or expected to be purchased or sold, and liabilities incurred or expected to be incurred. As discussed in detail below, and in Note 5, all realized and unrealized changes in fair value of derivatives are recorded in current earnings, with the exception of cash flow hedges and hedges of net investments in foreign operations. The Company may also enter into intercompany derivatives, the results of which ultimately eliminate in consolidation over the term of the instrument. Cash flows from derivatives are reported in the operating, investing, or financing activities sections in the Consolidated Statements of Cash Flows based on the nature and purpose of the derivative. Derivatives are recorded either as assets, within “Other invested assets,” or as liabilities, within “Other liabilities,” except for embedded derivatives which are recorded with the associated host contract. The Company nets the fair value of all derivative financial instruments with counterparties for which a master netting arrangement has been executed. The Company designates derivatives as either (1) a hedge of the fair value of a recognized asset or liability or unrecognized firm commitment (“fair value” hedge); (2) a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability (“cash flow” hedge); (3) a foreign currency fair value or cash flow hedge (“foreign currency” hedge); (4) a hedge of a net investment in a foreign operation; or (5) a derivative that does not qualify for hedge accounting. To qualify for hedge accounting treatment, a derivative must be highly effective in mitigating the designated risk of the hedged item. Effectiveness of the hedge is formally assessed at inception and throughout the life of the hedging relationship. The Company formally documents at inception all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking various hedge transactions. This process includes linking all derivatives designated as fair value, cash flow, or foreign currency hedges to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. Hedges of a net investment in a foreign operation are linked to the specific foreign operation. When a derivative is designated as a fair value hedge and is determined to be highly effective, changes in its fair value, along with changes in the fair value of the hedged asset or liability (including losses or gains on firm commitments), are reported on a net basis in the Consolidated Statements of Operations, generally in “Realized investment gains (losses), net.” When swaps are used in hedge accounting relationships, periodic settlements are recorded in the same Consolidated Statements of Operations line as the related settlements of the hedged items. When a derivative is designated as a cash flow hedge and is determined to be highly effective, changes in its fair value are recorded in AOCI until earnings are affected by the variability of cash flows being hedged (e.g., when periodic settlements on a variable-rate asset or liability are recorded in earnings). At that time, the related portion of deferred gains or losses on the derivative instrument is reclassified and reported in the Consolidated Statements of Operations line item associated with the hedged item. When a derivative is designated as a foreign currency hedge and is determined to be highly effective, changes in its fair value are recorded either in current period earnings if the hedge transaction is a fair value hedge (e.g., a hedge of a recognized foreign currency asset or liability) or in AOCI if the hedge transaction is a cash flow hedge (e.g., a foreign currency denominated forecasted transaction). When a derivative is used as a hedge of a net investment in a foreign operation, its change in fair value is accounted for in the same manner as a translation adjustment (i.e., reported in the cumulative translation adjustment account within AOCI). If it is determined that a derivative no longer qualifies as an effective fair value or cash flow hedge or management removes the hedge designation, the derivative will continue to be carried on the balance sheet at its fair value, with changes in fair value recognized currently in “Realized investment gains (losses), net.” In this scenario, the hedged asset or liability under a fair value hedge will no longer be adjusted for changes in fair value associated with the hedged risk and the existing basis adjustment is amortized to the Consolidated Statements of Operations line associated with the asset or liability. The component of AOCI related to discontinued cash flow hedges is reclassified to the Consolidated Statements of Operations line associated with the hedged cash flows consistent with the earnings impact of the original hedged cash flows. When hedge accounting is discontinued because the hedged item no longer meets the definition of a firm commitment, or because it is probable that the forecasted transaction will not occur by the end of the specified time period, the derivative will continue to be carried on the balance sheet at its fair value, with changes in fair value recognized currently in “Realized investment gains (losses), net.” Any asset or liability that was recorded pursuant to recognition of the firm commitment is removed from the balance sheet and recognized currently in “Realized investment gains (losses), net.” Gains and losses that were in AOCI pursuant to the cash flow hedge of a forecasted transaction are recognized immediately in “Realized investment gains (losses), net.” If a derivative does not qualify for hedge accounting, all changes in its fair value, including net receipts and payments, are included in “Realized investment gains (losses), net” without considering changes in the fair value of the economically associated assets or liabilities. The Company is a party to financial instruments that contain derivative instruments that are “embedded” in the financial instruments. At inception, the Company assesses whether the economic characteristics of the embedded instrument are clearly and closely related to the economic characteristics of the remaining component of the financial instrument (i.e., the host contract) and whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. When it is determined that (1) the embedded instrument possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract and (2) a separate instrument with the same terms would qualify as a derivative instrument, the embedded instrument qualifies as an embedded derivative that is separated from the host contract, carried at fair value, and changes in its fair value are included in “Realized investment gains (losses), net.” For certain financial instruments that contain an embedded derivative that otherwise would need to be bifurcated and reported at fair value, the Company may elect to carry the entire instrument at fair value and report it within “Other invested assets” or “Other liabilities.”
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Recent Accounting Pronouncements | Changes to U.S. GAAP are established by the Financial Accounting Standards Board (“FASB”) in the form of Accounting Standards Updates (“ASUs”) to the FASB Accounting Standards Codification (“ASC”). The Company considers the applicability and impact of all ASUs. ASUs listed below include those that have been adopted during the current fiscal year and/or those that have been issued but not yet adopted as of December 31, 2025, and as of the date of this filing. ASUs not listed below were assessed and determined to be either not applicable or not material.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ASUs adopted during the year | ASUs adopted during the year ended December 31, 2025
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Future Adoption Of New Accounting Pronouncements | ASUs issued but not yet adopted as of December 31, 2025
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Maturities, Available-for-sale, Debt Securities | The following tables set forth the composition of fixed maturity securities (excluding investments classified as trading), as of the dates indicated:
(1)Excludes notes with amortized cost of $15,744 million (fair value, $15,744 million), which have been offset with the associated debt under a netting agreement. (2)Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans, education loans and other asset types. (3)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.
__________ (1)Excludes notes with amortized cost of $14,748 million (fair value, $14,748 million), which have been offset with the associated debt under a netting agreement. (2)Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans, education loans and other asset types. (3)Includes publicly-traded agency pass-through securities and collateralized mortgage obligations.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value | The following tables set forth the fair value and gross unrealized losses on available-for-sale fixed maturity securities without an allowance for credit losses aggregated by investment category and length of time that individual fixed maturity securities had been in a continuous unrealized loss position, as of the dates indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fixed Maturities Classified by Contractual Maturity Date | The following table sets forth the amortized cost and fair value of fixed maturities by contractual maturities, as of the date indicated:
__________ (1)Excludes notes with amortized cost of $15,744 million (fair value, $15,744 million), which have been offset with the associated debt under a netting agreement.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Sources of Fixed Maturity Proceeds and Related Investment Gains (Losses) as well as Losses on Impairments | The following table sets forth the sources of fixed maturity proceeds and related investment gains (losses), as well as losses on write-downs and the allowance for credit losses of fixed maturities, for the periods indicated:
__________ (1)Excludes activity from non-cash related proceeds due to the timing of trade settlements of $104 million, $(100) million and $(74) million for the years ended December 31, 2025, 2024 and 2023, respectively. (2)Amounts represent securities actively marketed for sale, securities where it is more likely than not the Company will be required to sell prior to the recovery of the amortized cost basis and write-downs on credit adverse securities. (3)Excludes activity from non-cash related proceeds due to the timing of trade settlements of $1 million for the year ended December 31, 2023. There were no fixed maturities, held-to-maturity assets during 2025 and 2024.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Allowance for Credit Losses for Fixed Maturity Securities | The following tables set forth the balance of and changes in the allowance for credit losses for fixed maturity securities, as of and for the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assets Supporting Experience-Rated Contractholder Liabilities | The following table sets forth the composition of “Assets supporting experience-rated contractholder liabilities,” as of the dates indicated:
(1)As a percentage of amortized cost, 99% of the portfolio was considered high or highest quality based on NAIC or equivalent ratings, as of both December 31, 2025 and 2024. (2)As a percentage of amortized cost, 100% of the portfolio consisted of public securities as of both December 31, 2025 and 2024.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Securities Concentrations of Credit Risk | As of the dates indicated, the Company’s exposure to concentrations of credit risk of single issuers greater than 10% of the Company’s equity included securities of the U.S. government and certain U.S. government agencies and securities guaranteed by the U.S. government, as well as the securities disclosed below:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commercial Mortgage and Other Loans | The following table sets forth the composition of “Commercial mortgage and other loans,” as of the dates indicated:
__________ (1)Prior period amounts have been updated to conform to current period presentation. (2)Includes loans which are carried at fair value under the fair value option and are collateralized primarily by apartment complexes. As of December 31, 2025 and 2024, the net carrying value of these loans was $1,056 million and $702 million, respectively. Commercial Mortgage Loan Commitments
Indemnification of Serviced Mortgage Loans
__________ (1)The accrued liability associated with guarantees includes an allowance for credit losses of $11 million and $12 million as of December 31, 2025 and 2024, respectively. The change in allowance is a reduction of $1 million and $2 million for the years ended December 31, 2025 and 2024, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Allowance for Credit Losses | The following table sets forth the balance of and changes in the allowance for credit losses for commercial mortgage and other loans, as of and for the periods ended:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Write-downs of Loans by Origination Year | The following table sets forth the write-downs of commercial mortgage and agricultural property loans by origination year for the year ended December 31, 2025:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financing Receivable Credit Quality Indicators | The following tables set forth key credit quality indicators based upon the recorded investment gross of allowance for credit losses, as of the dates indicated:
Residential mortgage loans primarily include fixed-rate, amortizing mortgage loans on rental properties owned by borrowers with FICO scores typically considered prime or above. The primary credit quality indicator is whether a loan is performing or nonperforming. The Company defines nonperforming residential mortgage loans as those that are 90 days or more past due and/or in nonaccrual status.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Amortized Cost Basis of Loan Modifications made to Borrowers Experiencing Financial Difficulties | The following tables set forth the amortized cost basis of loan modifications made to borrowers experiencing financial difficulties during the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Aging of Past Due Commercial Mortgage and Other Loans and Nonaccrual Status | The following tables set forth an aging of past due commercial mortgage and other loans based upon the recorded investment gross of allowance for credit losses, as well as the amount of commercial mortgage and other loans on non-accrual status, as of the dates indicated:
__________ (1)As of December 31, 2025, there were no loans in this category accruing interest. (2)Includes loans for which no credit losses are expected due to U.S. agency guarantees. (3)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2.
__________ (1)As of December 31, 2024, there were no loans in this category accruing interest. (2)Includes loans for which no credit losses are expected due to U.S. agency guarantees. (3)For additional information regarding the Company’s policies for accruing interest on loans, see Note 2.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Invested Assets | The following table sets forth the composition of “Other invested assets,” as of the dates indicated:
__________ (1)As of December 31, 2025 and 2024, real estate held through direct ownership had mortgage debt of $217 million and $185 million, respectively. (2)Includes structured debt investments in feeder funds that are consolidated, resulting in the Company reporting the consolidated feeder funds’ proportionate share of the net assets of the master fund within Other invested assets. (3)Primarily includes equity investments accounted for under the measurement alternative, tax advantaged investments, strategic investments made by investment management operations, leveraged leases and member and activity stock held in the Federal Home Loan Bank of New York. For additional information regarding the Company’s holdings in the Federal Home Loan Bank of New York, see Note 18.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Method Investments | The following tables set forth summarized combined financial information for significant LP/LLC interests accounted for under the equity method, including the Company’s investments in joint ventures and other operating entities that are described in more detail in Note 9. Changes between periods in the tables below reflect changes in the activities within the joint ventures and other operating entities and LPs/LLCs, as well as changes in the Company’s level of investment in such entities:
__________ (1)Amount represents gross assets of each fund where the Company has a significant investment. These assets consist primarily of investments in real estate, investments in securities and other miscellaneous assets. (2)Amount represents gross liabilities of each fund where the Company has a significant investment. These liabilities consist primarily of third-party borrowed funds, securities repurchase agreements and other miscellaneous liabilities.
__________ (1)Amount represents gross revenue of each fund where the Company has a significant investment. This revenue consists of income from investments in real estate, investments in securities and other income. (2)Amount represents gross expenses of each fund where the Company has a significant investment. These expenses consist primarily of interest expense, investment management fees, salary expenses and other expenses. The following table sets forth information related to the Company’s investments in joint ventures and other operating entities as of and for the years ended December 31:
__________ (1)In September of 2023, the Company acquired a 20% equity interest as a limited partner in Prismic. See Note 1 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accrued Investment Income | The following table sets forth the composition of “Accrued investment income,” as of the dates indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Investment Income | The following table sets forth “Net investment income” by investment type, for the periods indicated:
__________ (1)Includes income on credit-linked notes which are reported on the same financial statement line as related surplus notes, as conditions are met for right to offset.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Realized Investment Gains (Losses), Net | The following table sets forth “Realized investment gains (losses), net” by investment type, for the periods indicated:
__________ (1)Excludes fixed maturity securities classified as trading. (2)Prior period amounts have been updated to conform to current period presentation. (3)Includes changes in the value of reinsurance and funds withheld payables, primarily reflecting the impact of net investment income on withheld assets that are ceded to certain reinsurance counterparties.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Unrealized Gains (Losses) on Investment | The following table sets forth net unrealized gains (losses) on investments, as of the dates indicated:
(1)For additional information regarding cash flow and fair value hedges, see Note 5. (2)Includes net unrealized gains (losses) on certain joint ventures that are strategic in nature and are included in “Other assets.”
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Repurchase Agreements and Securities Lending | The following table sets forth the composition of “Securities sold under agreements to repurchase,” as of the dates indicated:
The following table sets forth the composition of “Cash collateral for loaned securities” which represents the liability to return cash collateral received for the following types of securities loaned, as of the dates indicated:
__________ (1)The Company did not have any agreements with remaining contractual maturities greater than thirty days, as of the dates indicated.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Securities Pledged | The following table sets forth the carrying value of investments pledged to third parties, as of the dates indicated:
__________ (1)These assets are reported on the Company's Consolidated Statements of Financial Position. The following table sets forth the carrying amount of the associated liabilities supported by the pledged collateral, as of the dates indicated:
__________ (1)Includes funding agreements issued to the Federal Home Loan Bank of New York. (2)Primarily includes liabilities associated with derivative counterparties. The following table provides assets on deposit, assets held in trust, and securities restricted as to sale, as of the dates indicated:
__________ (1)Represents assets held in voluntary trusts established primarily to fund guaranteed dividends to certain policyholders and to fund certain employee benefits. (2)Represents assets held in trust related to reinsurance agreements excluding reinsurance agreements between wholly-owned subsidiaries. Assets valued at $15.0 billion and $16.0 billion were held in trust related to reinsurance agreements between wholly-owned subsidiaries as of December 31, 2025 and 2024, respectively. (3)Includes member and activity stock associated with membership in the Federal Home Loan Bank of New York.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Variable Interest Entities (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Variable Interest Entity, Measure of Activity [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Consolidated Variable Interest Entities | The table below reflects the carrying amount and balance sheet caption in which the assets and liabilities of consolidated VIEs are reported. The liabilities primarily comprise obligations under debt instruments issued by the VIEs. The creditors of these VIEs do not have recourse to the Company in excess of the assets contained within the VIEs.
__________ (1)Total assets of consolidated VIEs reflect $4,801 million and $3,835 million as of December 31, 2025 and 2024, respectively, related to VIEs whose beneficial interests are wholly-owned by consolidated subsidiaries. (2)Recourse is limited to the assets of the respective VIE and does not extend to the general credit of the Company. As of December 31, 2025, the maturities of these obligations were between 0 and 14 years.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | The table below provides a summary of the gross notional amount and fair value of derivative contracts by the primary underlying risks they are utilized to manage, excluding embedded derivatives. Many derivative instruments contain multiple underlying risks. The fair value amounts below represent the value of derivative contracts prior to taking into account the netting effects of master netting agreements and cash collateral. These netting impacts resulted in total derivative assets of $1,671 million and $1,601 million as of December 31, 2025 and 2024, respectively, and total derivative liabilities of $6,215 million and $4,751 million as of December 31, 2025 and 2024, respectively, reflected in the Consolidated Statements of Financial Position.
__________ (1)“Other” primarily includes derivative contracts used to improve the balance of the Company’s tail longevity and mortality risk. Under these contracts, the Company’s gains (losses) are capped at the notional amount. (2)Excludes embedded derivatives which contain multiple underlying risks. The fair value of these embedded derivatives was a net liability of $18,404 million (including the Prismic funds withheld-related embedded derivative net liability of $194 million) and $11,783 million (including the Prismic funds withheld-related embedded derivative net liability of $(91) million) as of December 31, 2025, and 2024, respectively, primarily included in “Policyholders’ account balances” and “Reinsurance and funds withheld payables.” (3)Recorded in “Other invested assets” and “Other liabilities” on the Consolidated Statements of Financial Position.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of financial instruments in a fair value hedge accounting relationship | As of December 31, 2025, the following amounts were recorded on the Consolidated Statements of Financial Position related to the carrying amount of the hedged assets (liabilities) and cumulative basis adjustments included in the carrying amount for fair value hedges:
__________ (1)There were no material fair value hedging adjustments for hedged assets and liabilities for which hedge accounting has been discontinued.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Offsetting Assets | The following tables present recognized derivative instruments (excluding embedded derivatives), and repurchase and reverse repurchase agreements that are offset in the Consolidated Statements of Financial Position, and/or are subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in the Consolidated Statements of Financial Position:
__________ (1)Amounts exclude the excess of collateral received/pledged from/to the counterparty.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Offsetting Liabilities | The following tables present recognized derivative instruments (excluding embedded derivatives), and repurchase and reverse repurchase agreements that are offset in the Consolidated Statements of Financial Position, and/or are subject to an enforceable master netting arrangement or similar agreement, irrespective of whether they are offset in the Consolidated Statements of Financial Position:
__________ (1)Amounts exclude the excess of collateral received/pledged from/to the counterparty.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance | The following tables provide the financial statement classification and impact of derivatives used in qualifying and non-qualifying hedge relationships, including the offset of the hedged item in fair value hedge relationships.
(2)Includes the Prismic funds withheld-related embedded derivative realized gain (loss) of $(284) million, $598 million, and $(508) million for the years ended December 31, 2025, 2024, and 2023 respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Derivative Instruments Recognized in Accumulated Other Comprehensive Income(Loss) Before Taxes | Presented below is a rollforward of current period cash flow hedges in AOCI before taxes:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of Credit Derivatives | The following tables provide a summary of the notional and fair value of written credit protection, presented as assets (liabilities). The Company’s maximum amount at risk under these credit derivatives, assuming the value of the underlying referenced securities become worthless, is equal to the notional amounts. These credit derivatives have maturities of less than 10 years for index reference.
__________ (1)The NAIC rating designations are based on availability and the lowest ratings among “Moody's, Standard & Poor’s Rating Services (“S&P”) and Fitch Ratings Inc. (“Fitch”). If no rating is available from a rating agency, an NAIC 6 rating is used. (2)The NAIC rating designation is due to approximately 3% and 4% of the index reference name rated as NAIC 6 as of December 31, 2025, and 2024, respectively. (3)Single name credit default swaps may make reference to the credit of corporate debt, sovereign debt, and structured finance. Index reference NAIC designations are based on the lowest rated single name reference included in the index.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Assets and Liabilities (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value, Assets and Liabilities Measured on Recurring Basis | The tables below present the balances of assets and liabilities reported at fair value on a recurring basis, as of the dates indicated:
__________ (1)“Netting” amounts represent cash collateral of $(8,496) million and $(8,049) million as of December 31, 2025 and 2024, respectively, and the impact of offsetting asset and liability positions held with the same counterparty, subject to master netting agreements. (2)Excludes notes with fair value of $15,744 million (carrying amount of $15,744 million) and $14,748 million (carrying amount of $14,748 million) as of December 31, 2025 and 2024, respectively, which have been offset with the associated debt under a netting agreement. (3)Includes credit-tranched securities collateralized by loan obligations, home equity loans, auto loans, education loans and other asset types. (4)Other invested assets excluded from the fair value hierarchy include certain hedge funds, private equity funds and other funds for which fair value is measured at net asset value (“NAV”) per share (or its equivalent) as a practical expedient. As of December 31, 2025 and 2024, the fair value of such investments was $5,526 million and $5,021 million, respectively. (5)Separate account assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate, hedge funds and other invested assets. As of December 31, 2025 and 2024, the fair value of such investments was $27,506 million and $26,700 million, respectively. (6)Separate account assets represent segregated funds that are invested for certain customers. Investment risks associated with market value changes are borne by the customers, except to the extent of minimum guarantees made by the Company with respect to certain accounts. Separate account liabilities are not included in the above table as they are reported at contract value and not fair value in the Company’s Consolidated Statements of Financial Position.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information | The tables below present quantitative information regarding significant internally-priced Level 3 assets and liabilities:
__________ (1)Conversely, the impact of a decrease in input would have the opposite impact on fair value as that presented in the table. (2)Includes assets classified as fixed maturities available-for-sale, assets supporting experience-rated contractholder liabilities and fixed maturities, trading. (3)Excludes notes which have been offset with the associated debt under a netting agreement. (4)Represents multiple of earnings before interest, taxes, depreciation and amortization (“EBITDA”), and are amounts used when the Company has determined that market participants would use such multiples when valuing the investments. (5)For these investments, a range of discount rates is typically used and is therefore a more meaningful representation of the unobservable inputs used in the valuation rather than a weighted average. (6)Market risk benefits primarily represent fair value for all living benefit guarantees including accumulation, withdrawal and income benefits. Since the valuation methodology for these assets and liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (7)Policyholders’ account balances primarily represent general account liabilities for the index-linked interest credited on certain of the Company’s life and annuity products that are accounted for as embedded derivatives. Since the valuation methodology for these liabilities uses a range of inputs that vary at the contract level over the cash flow projection period, presenting a range, rather than a weighted average, is a more meaningful representation of the unobservable inputs used in the valuation. (8)Lapse rates for contracts with living benefit guarantees are adjusted at the contract level based on the in-the-moneyness of the living benefit and reflect other factors, such as the applicability of any surrender charges. Lapse rates are reduced when contracts are more in-the-money. Lapse rates for contracts with index-linked crediting guarantees may be adjusted at the contract level based on the applicability of any surrender charges, product type, and market related factors such as interest rates. Lapse rates are also generally assumed to be lower for the period where surrender charges apply. For any given contract, lapse rates vary throughout the period over which cash flows are projected for the purposes of valuing these balances. (9)The spread over the SOFR swap curve represents the premium added to the proxy for the risk-free rate (SOFR) to reflect the Company’s estimates of rates that a market participant would use to value the living benefits in both the accumulation and payout phases and index-linked interest crediting guarantees as of December 31, 2025 and 2024, respectively. This spread includes an estimate of NPR, which is the risk that the obligation will not be fulfilled by the Company. NPR is primarily estimated by utilizing the credit spreads associated with issuing funding agreements, adjusted for any illiquidity risk premium. In order to reflect the financial strength ratings of the Company, credit spreads associated with funding agreements, as opposed to credit spread associated with debt, are utilized in developing this estimate because funding agreements are insurance liabilities and are therefore senior to debt. Effective April 2023, the Company entered into an agreement with The Ohio National Life Insurance Company, now known as AuguStar Life Insurance Company (“AuguStar”), an affiliate of Constellation Insurance Holdings, Inc., to reinsure approximately $10 billion of account values of PDI traditional variable annuity contracts with guaranteed living benefits. See Note 15 for additional information regarding this transaction. As a result of this transaction, a ceded MRB asset balance was established to fair value the reinsurance reimbursements to the Company. The establishment of the fair value also required an estimate of NPR for AuguStar, which may differ from the Company’s; however, the NPR spreads for AuguStar were developed using a methodology similar to that of the Company. (10)The utilization rate assumption estimates the percentage of contracts that will utilize the benefit during the contract duration, and begin lifetime withdrawals at various time intervals from contract inception. The remaining contractholders are assumed to either begin lifetime withdrawals immediately or never utilize the benefit. Utilization assumptions may vary by product type, tax status and age. The impact of changes in these assumptions is highly dependent on the product type, the age of the contractholder at the time of the sale, and the timing of the first lifetime income withdrawal. Range reflects the utilization rate for the vast majority of business with living benefits. (11)The withdrawal rate assumption estimates the magnitude of annual contractholder withdrawals relative to the maximum allowable amount under the contract. These assumptions vary based on the age of the contractholder, the tax status of the contract and the duration since the contractholder began lifetime withdrawals. As of both December 31, 2025 and 2024, the minimum withdrawal rate assumption is 78% and the maximum withdrawal rate assumption may be greater than 100%. The fair value of the liability will generally increase the closer the withdrawal rate is to 100% and decrease as the withdrawal rate moves further away from 100%. (12)The range reflects the mortality rates for the vast majority of business with living benefits and other contracts, with policyholders ranging from 50 to 90 years old. While the majority of living benefits have a minimum age requirement, certain other contracts do not have an age restriction. This results in contractholders with mortality rates approaching 0% for certain benefits. Mortality rates may vary by product, age and duration. A mortality improvement assumption is also incorporated into the overall mortality table. (13)Option budget estimates the expected long-term cost of options used to hedge exposures associated with equity price and interest rate changes. The level of option budget determines future costs of the options, which impacts the growth in account value and the valuation of embedded derivatives.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation | Transfers out of Level 3 are generally due to the use of observable inputs in valuation methodologies as well as the availability of pricing service information for certain assets that the Company can validate.
__________ (1)“Other” includes additional activity not allocated to the specific categories within the rollforward of Level 3 Assets and Liabilities. (2)Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts. (3)Includes U.S. corporate public, U.S. corporate private, foreign corporate public and foreign corporate private securities. (4)Includes asset-backed, commercial mortgage-backed and residential mortgage-backed securities. (5)Issuances and settlements for Policyholders’ account balances are presented net in the rollforward. (6)Excludes MRB assets of $2,330 million and $2,331 million and MRB liabilities of $4,623 million and $4,455 million as of December 31, 2025 and 2024, respectively. See Note 14 for additional information. (7)Transfers into or out of Level 3 are generally reported at the value as of the beginning of the quarter in which the transfers occur for any such positions still held at the end of the quarter.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation | Transfers out of Level 3 are generally due to the use of observable inputs in valuation methodologies as well as the availability of pricing service information for certain assets that the Company can validate.
__________ (1)“Other” includes additional activity not allocated to the specific categories within the rollforward of Level 3 Assets and Liabilities. (2)Unrealized gains or losses related to assets still held at the end of the period do not include amortization or accretion of premiums and discounts. (3)Includes U.S. corporate public, U.S. corporate private, foreign corporate public and foreign corporate private securities. (4)Includes asset-backed, commercial mortgage-backed and residential mortgage-backed securities. (5)Issuances and settlements for Policyholders’ account balances are presented net in the rollforward. (6)Excludes MRB assets of $2,330 million and $2,331 million and MRB liabilities of $4,623 million and $4,455 million as of December 31, 2025 and 2024, respectively. See Note 14 for additional information. (7)Transfers into or out of Level 3 are generally reported at the value as of the beginning of the quarter in which the transfers occur for any such positions still held at the end of the quarter.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Assets and Liabilities Measured on Recurring Basis, Derivatives | The following tables present the balances of certain derivative assets and liabilities measured at fair value on a recurring basis, as of the dates indicated, by the primary underlying risks they are used to manage. These tables include NPR and exclude embedded derivatives. The derivative assets and liabilities shown below are included in “Other invested assets” or “Other liabilities” in the tables contained within the sections “—Assets and Liabilities by Hierarchy Level” and “—Changes in Level 3 Assets and Liabilities,” above.
__________ (1)“Netting” amounts represent cash collateral and the impact of offsetting asset and liability positions held with the same counterparty, subject to master netting agreements.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Assets and Liabilities Measured on Recurring Basis Unobservable Input Reconciliation, Derivatives | The following tables provide a summary of the changes in fair value of Level 3 derivative assets and liabilities as of the dates indicated, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at the end of their respective periods:
__________ (1)Total realized and unrealized gains (losses) as well as unrealized gains (losses) for assets still held at the end of the period are recorded in “Realized investment gains (losses), net.” (2)Transfers into or out of Level 3 are generally reported at the value as of the beginning of the quarter in which the transfers occur for any such positions still held at the end of the quarter.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Measurements, Nonrecurring | The estimated fair values for these amounts were determined using significant unobservable inputs (Level 3).
__________ (1)Commercial mortgage loans are valued based on discounted cash flows utilizing market rates or the fair value of the underlying real estate collateral. (2)Reported carrying values for 2025 include values as of the measurement periods of March 31, 2025 for “Investment real estate,” December 31, 2025 for “Investment in JV/LP and Other” and September 30, 2025 and December 31, 2025 for “Equity securities.” Reported carrying values for 2024 include values as of the measurement periods of March 31, 2024 for “Investment in JV/LP and Other” and June 30, 2024 and September 30, 2024 for “Investment real estate.” (3)The Company recognized a goodwill impairment charge for Assurance IQ (“AIQ”) in 2023. The fair value was determined using weighting of an income approach, based on discounted cash flow valuation techniques and a market valuation approach based on a forward sales multiple.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value, Option | The following tables present information regarding assets and liabilities where the fair value option has been elected:
__________ (1)As of December 31, 2025, for loans for which the fair value option has been elected, none of the loans were 90 days or more past due.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosure Financial Instruments Not Carried at Fair Value | In some cases, as described below, the carrying amount equals or approximates fair value.
__________ (1)Carrying values presented herein differ from those in the Company’s Consolidated Statements of Financial Position because certain items within the respective financial statement captions are not considered financial instruments or are out of scope under authoritative guidance relating to disclosures of the fair value of financial instruments. (2)Includes contracts reinsured through coinsurance with funds withheld agreement with Prismic Re with a fair value of $7,513 million (carrying amount of $7,513 million) and $7,887 million (carrying amount of $7,887 million), a portion of which relates to insurance contracts as of December 31, 2025 and December 31, 2024, respectively. See Note 15 for additional information regarding the reinsurance arrangement with Prismic Re. (3)Excludes debt with fair value of $15,744 million (carrying amount of $15,744 million) and $14,748 million (carrying amount of $14,748 million) as of December 31, 2025 and December 31, 2024, respectively, which have been offset with the associated notes under a netting agreement.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Separate Accounts (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Separate Accounts Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Separate Account Assets | The aggregate fair value of assets, by major investment asset category, supporting separate accounts is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Separate Account Liability | The balances of and changes in separate account liabilities as of and for the periods ended are as follows:
__________ (1)Primarily represents activity from the Company’s intercompany eliminations as well as Divested and Run-off Businesses. There are no associated cash surrender charges. (2)“Cash surrender value” represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. There are no cash surrender charges for the PGIM and Institutional Retirement Strategies segments.
__________ (1)Primarily represents activity from the Company’s intercompany eliminations as well as Divested and Run-off Businesses. There are no associated cash surrender charges. (2)“Cash surrender value” represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. There are no cash surrender charges for the PGIM and Institutional Retirement Strategies segments.
__________ (1)Primarily represents activity from the Company’s intercompany eliminations as well as Divested and Run-off Businesses. There are no associated cash surrender charges. (2)“Cash surrender value” represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. There are no cash surrender charges for the PGIM and Institutional Retirement Strategies segments.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Policy Acquisition Costs, Deferred Reinsurance, Deferred Sales Inducements and Value of Business Acquired (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Charges, Insurers [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Deferred Policy Acquisition Costs | The following tables show a rollforward for the lines of business that contain material DAC balances, along with a reconciliation to the Company’s total DAC balance:
__________ (1)Includes the impact of the reinsurance transaction with Prismic Re International in International Businesses. See Note 15 for additional information.
__________ (1)Prior period amounts have been updated to conform to current presentation. (2)Includes the impacts of the reinsurance transactions with Wilton Re and Somerset Re in Individual Life (Universal Life). See Note 15 for additional information
__________ (1)Prior period amounts have been updated to conform to current presentation. (2)Includes the impact of the reinsurance transaction with AuguStar in Individual Retirement Strategies. See Note 15 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Reinsurance Losses | Deferred Reinsurance Losses The following tables show a rollforward for the lines of business that contain DRL balances, along with a reconciliation to the Company's total DRL balance:
__________ (1)Includes the impacts of the reinsurance transaction with Wilton Re. See Note 15 for additional information.
__________ (1)Includes the impacts of the reinsurance transaction with Prismic Re. See Note 15 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Reinsurance Gains | Deferred Reinsurance Gains The following tables show a rollforward for the lines of business that contain DRG balances, along with a reconciliation to the Company's total DRG balance:
__________ (1)Includes the impacts of the reinsurance transaction with Somerset Re. See Note 15 for additional information.
__________ (1)Includes the impacts of the reinsurance transaction with AuguStar. See Note 15 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Sales Inducements | The following table shows a rollforward of DSI balances for variable annuity products within Individual Retirement Strategies, which is the only line of business that contains a material DSI balance, along with a reconciliation to the Company’s total DSI balance:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Value of Business Acquired | The following table shows a rollforward of VOBA balances for the acquisition of the Star and Edison Businesses for International Businesses, along with a reconciliation to the Company’s total VOBA balance:
__________ (1)Represents Aoba Life business.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Estimated Future VOBA Amortization, Net of Interest | The following table provides estimated future amortization for the periods indicated:
The following table provides estimated future amortization for the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments in Operating Joint Ventures (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Method Investments and Joint Ventures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity Method Investments | The following tables set forth summarized combined financial information for significant LP/LLC interests accounted for under the equity method, including the Company’s investments in joint ventures and other operating entities that are described in more detail in Note 9. Changes between periods in the tables below reflect changes in the activities within the joint ventures and other operating entities and LPs/LLCs, as well as changes in the Company’s level of investment in such entities:
__________ (1)Amount represents gross assets of each fund where the Company has a significant investment. These assets consist primarily of investments in real estate, investments in securities and other miscellaneous assets. (2)Amount represents gross liabilities of each fund where the Company has a significant investment. These liabilities consist primarily of third-party borrowed funds, securities repurchase agreements and other miscellaneous liabilities.
__________ (1)Amount represents gross revenue of each fund where the Company has a significant investment. This revenue consists of income from investments in real estate, investments in securities and other income. (2)Amount represents gross expenses of each fund where the Company has a significant investment. These expenses consist primarily of interest expense, investment management fees, salary expenses and other expenses. The following table sets forth information related to the Company’s investments in joint ventures and other operating entities as of and for the years ended December 31:
__________ (1)In September of 2023, the Company acquired a 20% equity interest as a limited partner in Prismic. See Note 1 for additional information.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Other Intangibles (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Goodwill | The changes in the carrying value of goodwill by reportable segment are as follows:
__________ (1)During 2023, PGIM acquired a majority stake in Deerpath Capital Management, LP, a leading U.S.-based private credit and direct lending manager. The goodwill associated with that acquisition includes a measurement period adjustment made during 2024. (2)Corporate and Other includes the impairment of the remaining goodwill allocated with Assurance IQ. (3)Corporate and Other includes a sale of a foreign operation classified as a divested business.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Finite-Lived Intangible Assets | Other intangible balances at December 31, are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Indefinite-Lived Intangible Assets | Other intangible balances at December 31, are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Estimated Future Amortization Expense of Other Intangibles | The following table provides estimated future amortization for the periods indicated:
The following table provides estimated future amortization for the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Leases (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Leases [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Lessee Supplemental Balance Sheet Information Related to Operating Leases | Supplemental balance sheet information related to leases where the Company is the lessee is included below. Right-of-use assets and lease liabilities are included within “Other assets” and “Other liabilities” respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Lessee Maturities of Operating Lease Liabilities | Maturities of operating lease liabilities are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Liability for Future Policy Benefits (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Liability for Future Policy Benefit | The balances of and changes in Benefit Reserves as of and for the periods indicated consist of the three tables presented below: Present Value of Expected Net Premiums rollforward, Present Value of Expected Future Policy Benefits rollforward, and Net Liability for Future Policy Benefits.
__________ (1)Reflects balance after reinsurance recoverable of $55 million, $60 million, and $69 million at December 31, 2025, 2024 and 2023, respectively. (2)Prior period amounts have been updated to conform to current period presentation. The following tables provide supplemental information related to the balances of and changes in Benefit Reserves included in the disaggregated tables above, on a gross (direct and assumed) basis, as of and for the period indicated:
(1)Prior period amounts have been updated to conform to current period presentation. The balances of and changes in DPL as of and for the period indicated are as follows:
(1)Prior period amounts have been updated to conform to current period presentation. The following table shows a rollforward of AIR balances for variable and universal life products within Individual Life, which is the only line of business that contains a material AIR balance, for the period indicated, along with a reconciliation to the Company’s total AIR balance:
__________ (1)Represents the portion of gross assessments required to fund the future policy benefits.
The following table presents the reconciliation of the ending balances from above rollforwards, Benefit Reserves, DPL, and AIR including other liabilities, gross of related reinsurance recoverable, to the total liability for Future Policy Benefits on the Company's Consolidated Statement of Financial Position as of the periods indicated:
__________ (1)Primarily represents balances for which disaggregated rollforward disclosures are not required, including Closed Block liabilities, unpaid claims and claims expenses, and incurred but not reported and in course of settlement claim liabilities. The following tables present revenue and interest expense related to Benefit Reserves, DPL, and AIR as well as related revenue and interest expense not presented in the above supplemental tables, in the Company's Consolidated Statement of Operations as of the periods indicated:
__________ (1)Represents “Gross premiums” for benefit reserves, “Revenue” for DPL and “Gross assessments” for AIR. (2)Prior period amounts have been updated to conform to current period presentation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Policyholders' Account Balances (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholder Account Balance | The balances of and changes in policyholders' account balances as of and for the periods ended are as follows:
__________ (1)Primarily relates to changes in the value of embedded derivative instruments associated with the indexed options of certain products. (2)Includes $2,738 million, $5,099 million and $5,479 million of the Full Service Retirement business’s account balances reinsured to Empower for December 31, 2025, 2024 and 2023, respectively. (3)The net amount at risk calculation includes both general account and separate account balances. (4)Cash surrender value represents the amount of the contractholder's account balances distributable at the balance sheet date less certain surrender charges. There are no cash surrender charges for the Institutional Retirement Strategies segment. (5)Prior period amounts have been updated to conform to current period presentation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Policyholder Account Balance, Guaranteed Minimum Crediting Rate | The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points (“bps”), between rates being credited to policyholders and the respective guaranteed minimums are as follows:
__________ (1)Excludes contracts without minimum guaranteed crediting rates, such as funds with indexed-linked crediting options and Japan variable products. (2)Prior period amounts have been updated to conform to current period presentation.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Additional Liability, Long-Duration Insurance | The balance of and changes in URR as of and for the periods ended are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Risk Benefits (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Risk Benefits In Asset and Liability Positions | The following table shows a rollforward of MRB balances for annuity products within Individual Retirement Strategies, which is the only line of business that contains a material MRB balance, along with a reconciliation to the Company’s total net MRB positions as of the following dates:
__________ (1)Prior period amounts have been updated to conform to current presentation.
__________ (1)Prior period amounts have been updated to conform to current presentation. The following tables present accompanying information to the rollforward table above.
___________ (1)For contracts with multiple benefit features, the highest net amount at risk for each contract is included. The tables below reconcile MRB asset and liability positions as of the following dates:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reinsurance (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance amounts included in the Consolidated Statement of Operations | Reinsurance amounts included in the Consolidated Statements of Operations for “Premiums,” “Policy charges and fee income,” “Change in value of market risk benefits, net of related hedging gains (losses),” “Policyholders’ benefits” and “Change in estimates of liability for future policy benefits” for the years ended December 31, are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance Recoverables | Reinsurance recoverables and deposit receivables are as follows:
__________ (1)The Company has also recorded funds withheld and other payables related to the reinsurance agreement with Prismic Re of $7,980 million and $7,796 million as of December 31, 2025 and 2024, respectively. (2)The Company has also recorded reinsurance payables related to the Hartford Life Business acquisition of $1,366 million and $1,387 million as of December 31, 2025 and 2024, respectively. (3)Represents reinsurance recoverables of $8,192 million and $7,979 million as of December 31, 2025 and 2024, respectively, that are netted with reinsurance payables of $6,525 million and $6,388 million as of December 31, 2025 and 2024, respectively, related to the reinsurance agreement with Somerset Re in which the Company reinsured a portion of its in-force guaranteed universal life block of business under modified coinsurance. (4)The Company has also recorded funds withheld and other payables related to the reinsurance agreement with Somerset Re of $2,602 million and $2,595 million as of December 31, 2025 and 2024, respectively. (5)The Company has also recorded funds withheld and other payables related to the reinsurance of annuity contracts in the Individual Retirement Strategies business with Resolution Re, Ltd. (“Resolution Re”) of $851 million as of December 31, 2025. (6)Net of $14 million and $12 million of allowance for credit losses as of December 31, 2025 and 2024, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Closed Block (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Closed Block Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Closed Block Liabilities and Assets | Closed Block liabilities and assets designated to the Closed Block, as well as maximum future earnings to be recognized from these liabilities and assets, are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Closed Block Dividend Obligation | Information regarding the policyholder dividend obligation is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Closed Block Revenues Benefits Expenses | Closed Block revenues and benefits and expenses for the years ended December 31, are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income Taxes (Tables) |
12 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Income Tax Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Components of Income Tax Expense (Benefit) | The following schedule discloses significant components of income tax expense (benefit) for each year presented:
__________ (1)The U.S. deferred tax includes a benefit of $318 million, which is fully offset by a corresponding charge in foreign deferred taxes related to one of the Company’s Bermuda operating insurance companies. These amounts are due to changes in Bermuda tax law in 2025. Overall, there is no impact on total taxes, as all earnings of the Bermuda entity are subject to U.S. taxation at a rate of 21%
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Effective Income Tax Rate Reconciliation | The differences between income taxes expected at the U.S. federal statutory income tax rate of 21% applicable for 2025 and the reported income tax expense (benefit) are summarized as follows:
The differences between income taxes expected at the U.S. federal statutory income tax rate of 21% applicable for 2024 and 2023, and the reported income tax expense (benefit) are summarized as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Deferred Tax Assets and Liabilities |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Operating And Capital Loss Carryforwards | The valuation allowance includes amounts recorded in connection with deferred tax assets as follows:
The following table sets forth the amount and expiration dates of federal, state and foreign operating, capital loss and tax credit carryforwards for tax purposes, as of the periods indicated:
__________ (1)Certain state net operating loss carryforwards expire between 2026 and 2045, whereas others have an unlimited carryforward. (2)$349 million expires between 2026 and 2042 and $150 million has an unlimited carryforward. (3)Expires between 2028 and 2035. These relate to foreign non-general basket tax credits.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Undistributed Earnings Of Foreign Subsidiaries Assuming Permanent Reinvestment | The following table sets forth the undistributed earnings of foreign subsidiaries, where the Company assumes indefinite reinvestment of such earnings and for which, in 2025, 2024 and 2023, foreign deferred withholding or other foreign income taxes have not been provided. The net tax liability that may arise if the 2025 earnings were remitted which includes any foreign exchange impacts, is immaterial.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Income Taxes Paid | Income taxes paid during the year are disclosed in the table below and include tax installments made for the current year as well as tax payments and refunds related to prior periods.
__________ (1)Includes $188 million refund related to prior years and $192 million paid for Transferable Energy tax credits.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Unrecognized Tax Benefits Reconciliation | The following table reconciles the total amount of unrecognized tax benefits at the beginning and end of the periods indicated:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Amounts Recognized In Consolidated Financial Statements For Tax Related Interest And Penalties | The amounts recognized in the consolidated financial statements for tax-related interest and penalties for the years ended December 31 are as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Open Tax Years By Major Tax Jurisdictions | Listed below are the tax years that remain subject to examination, by major tax jurisdiction, as of December 31, 2025:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Short-Term and Long-Term Debt (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Short-term Debt | The table below presents the Company’s short-term debt at December 31, for the years indicated as follows:
__________ (1)Includes Prudential Financial debt of $561 million and $25 million as of December 31, 2025 and 2024, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Line of Credit Facilities | As of December 31, 2025, the Company maintained syndicated, unsecured committed credit facilities as described below.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Long-term Debt Instruments |
__________ (1)Ranges of interest rates are for the year ended December 31, 2025. (2)Amount includes $7.6 billion of surplus notes used to finance Guideline AXXX reserves for business reinsured to Somerset Re in March 2024. See Note 15 for additional information. (3)Includes $184 million and $100 million of debt denominated in foreign currency at December 31, 2025 and 2024, respectively. (4)Includes Prudential Financial debt of $7,555 million and subsidiary debt of $40 million denominated in foreign currency at December 31, 2025. (5)Assets under set-off arrangements represent a reduction in the amount of surplus notes included in long-term debt, resulting from an arrangement where valid rights of set-off exist and it is the intent of both parties to settle on a net basis under legally enforceable arrangements. These assets include available-for-sale securities that are reported at fair value. (6)Includes Prudential Financial debt of $18,378 million and $18,793 million at December 31, 2025 and 2024, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Maturities of Long-term Debt | The following table presents the contractual maturities of the Company’s long-term debt as of December 31, 2025:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Senior Notes | The table below presents the Company’s balances related to these issuances, as well as its mortgage debt balance, as of December 31 for the years indicated as follows:
__________ (1)Includes $569 million of notes from current portion of long-term debt as of December 31, 2025.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Surplus Notes with Set-Off Arrangements |
__________ (1)Amount includes $7.6 billion of surplus notes used to finance Guideline AXXX reserves for business reinsured to Somerset Re in March 2024. See Note 15 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Junior Subordinated Notes | Prudential Financial’s junior subordinated notes outstanding are considered hybrid securities that receive enhanced equity treatment from the rating agencies. These notes outstanding, along with their key terms, are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Employee Benefit Plans (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Status of Employee Benefit Plans | The status of these plans as of December 31, 2025 and 2024 is summarized below:
__________ (1)For 2025, actuarial losses for pension and other postretirement benefits were primarily driven by a decrease in the discount rate. (2)For 2024, actuarial gains for pension were primarily driven by an increase in the discount rate. For 2024, actuarial losses for other postretirement benefits were primarily driven by an increase in medical trend rate.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Benefit Obligations in Excess of Fair Value of Plan Assets |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Net Benefit Costs | Net periodic (benefit) cost included in “General and administrative expenses” in the Company’s Consolidated Statements of Operations for the years ended December 31, includes the following components:
__________ (1)For 2025 and 2024, certain employees were provided special termination benefits under non-qualified plans in the form of unreduced early retirement benefits as a result of their involuntary termination. (2)For 2023, certain employees were provided special termination benefits under non-qualified plans in the form of unreduced early retirement benefits as a result of their involuntary termination while others were provided enhanced benefits due to the Company’s organizational restructuring.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Changes in Accumulated Other Comprehensive Income | The amounts recorded in AOCI as of the end of the period, which have not yet been recognized as a component of net periodic (benefit) cost, and the related changes in these items during the period that are recognized in “Other comprehensive income (loss)” are as follows:
__________ (1)For 2023, deferred losses for pension were driven by a decrease in discount rate and unfavorable asset performance. Deferred gains for other postretirement benefits were driven by a change to the Retiree Medical Plan, decrease in discount rate and favorable asset performance. (2)For 2024, deferred losses for pension were driven by unfavorable asset performance offset by an increase in discount rate. Deferred losses for other postretirement benefits were driven by an increase in medical trend experience offset by an increase in discount rate and favorable asset performance. (3)For 2025, deferred losses for pension were driven by a decrease in discount rate and unfavorable asset performance. Deferred gains for other postretirement benefits were driven by favorable asset performance offset by a decrease in discount rate.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Assumptions Used | The Company’s assumptions related to the calculation of the domestic benefit obligation (end of period) and the determination of net periodic (benefit) cost (beginning of period) are presented in the table below:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Plans Assets-Fair Value and Allocation % (Target/Actual) | Asset allocation targets as of December 31, 2025 are as follows:
Postretirement plan asset allocations in accordance with the investment guidelines are as follows:
__________ (1)The postretirement plan excludes from the fair value hierarchy investments that are measured at NAV per share (or its equivalent) as a practical expedient to estimate fair value and Variable Life Insurance Policies valued at contract value. U.S. equities totaled $215 million and $192 million at December 31, 2025 and 2024, respectively. International equities totaled $119 million and $99 million at December 31, 2025 and 2024, respectively. Fixed maturities totaled $623 million and $652 million at December 31, 2025 and 2024, respectively. (2)There were no changes in the fair value of Level 3 postretirement assets from December 31, 2024 through December 31, 2025.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Effect of Significant Unobservable Inputs, Changes in Plan Assets |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Expected Benefit Payments | The expected benefit payments for the Company’s pension and postretirement plans for the years indicated are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Common Stock Disclosure | The changes in the number of shares of Common Stock issued, held in treasury and outstanding, are as follows for the periods indicated:
__________ (1)Represents net shares issued from treasury pursuant to the Company’s stock-based compensation programs.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share Repurchases Authorizations | The following table summarizes share repurchases for each of the past three years as well as the share repurchase authorization for 2026, which was approved by the Board of Directors in December 2025:
__________ * Share repurchase authorization for a future period.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends Declared | Dividends declared per share of Common Stock are as follows for the years indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Components of Accumulated Other Comprehensive Income (Loss) | The balance of and changes in each component of AOCI as of and for the years ended December 31, are as follows:
__________ (1)Includes cash flow hedges of $(231) million, $1,780 million and $869 million as of December 31, 2025, 2024, and 2023, respectively, and fair value hedges of $(123) million, $(64) million, and $(60) million as of December 31, 2025, 2024, and 2023, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reclassification Out Of Accumulated Other Comprehensive Income (Loss) | Reclassifications out of Accumulated Other Comprehensive Income (Loss)
__________ (1)All amounts are shown before tax. (2)Positive amounts indicate gains/benefits reclassified out of AOCI. Negative amounts indicate losses/costs reclassified out of AOCI. (3)See Note 5 for additional information regarding cash flow and fair value hedges. (4)See table below for additional information regarding unrealized investment gains (losses), including the impact on future policy benefits and policyholders’ dividends. (5)See Note 19 for information regarding employee benefit plans.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| OTTI, Allowance and All Other Net Unrealized Investment Gain Loss AOCI Rollforward |
__________ (1)Includes cash flow and fair value hedges. See Note 5 for additional information.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Statutory Financial Information | The following table summarizes certain statutory financial information for the Company’s U.S. insurance subsidiary as of and for the years ended:
__________ (1)Prior period amounts have been updated to conform to finalized statutory filings, where applicable.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reconciliation of Earnings Per Share | A reconciliation of the numerators and denominators of the basic and diluted per share computations of Common Stock based on the consolidated earnings of Prudential Financial for the years ended December 31, is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Earnings Per Share Computation | For the years ended December 31, the number of stock options and shares related to deferred and long-term compensation programs that were considered antidilutive and were excluded from the computation of diluted earnings per share, weighted for the portion of the period they were outstanding, are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-Based Payments (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-Based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan | The following table summarizes the compensation cost recognized and the related income tax benefit for stock options, restricted stock units, performance shares and performance units for the years ended December 31:
__________ (1) Compensation costs related to retirement eligible participants are recorded on the grant date (typically in the first quarter of every year). On January 10, 2024, the Board of Directors of Prudential Financial, Inc. adopted certain modifications to the terms and conditions of performance shares granted in 2021, 2022 and 2023. These modifications 1) mitigate the impact of outsized interest rate volatility, both positive and negative, as it relates to achieving adjusted book value per share growth goals, and 2) reduce certain book value per share goals and maximum payout opportunities. The impact from these modifications increased shares to be delivered to 161 employees across all three performance plans by a total of approximately 600,000 shares. In addition, total compensation costs resulting from these modifications increased by approximately $62 million.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Share Based Compensation Stock Options Activity | A summary of the status of the Company’s stock option grants is as follows:
The weighted average remaining contractual term and the aggregate intrinsic value of stock options outstanding and exercisable as of December 31, 2025 is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Nonvested Share Activity | A summary of the Company’s restricted stock unit and performance share awards under the Omnibus Incentive Plan is as follows:
__________ (1)Performance share awards reflect the target units awarded, reduced for forfeitures and releases to date. The actual number of units to be awarded at the end of each performance period will range between 0% and 150% of the target number of units granted, based upon a measure of the reported performance for the Company relative to stated goals. (2)Represents the difference between the target units granted and the actual units awarded based upon the attainment of performance goals for the Company.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Information (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reconciliation of Operating Profit (Loss) from Segments to Consolidated | The following table sets forth the significant components of “Realized investment gains (losses), net” that are included in adjusted operating income and, as a result, are reflected as adjustments to “Realized investment gains (losses), net” for purposes of calculating adjusted operating income:
__________ (1)In addition to the items in the table above, “Realized investment gains (losses), net, and related charges and adjustments” also includes an adjustment to reflect “Realized investment gains (losses), net” related to Divested and Run-off Businesses. See “Divested and Run-off Businesses” discussed below. The following table sets forth certain other items excluded from adjusted operating income and reflected as an adjustment to “Realized investment gains (losses), net” for purposes of calculating adjusted operating income:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Segment Reporting Information, by Segment | Reconciliation of select financial information The tables below present certain financial information that is regularly provided to the CODM for the Company’s segments, including revenues and significant benefits and expenses, on an adjusted operating income basis, as well as assets by segment, and the reconciliation of the segment totals to amounts reported in the Consolidated Financial Statements.
__________ (1)The Individual Retirement Strategies and Individual Life segments’ results reflect DAC as if the business is a stand-alone operation. The elimination of intersegment costs capitalized in accordance with this policy is included in consolidating adjustments within Corporate and Other operations. (2)Corporate and Other operations, through Prudential Advisors, generates fee revenues from the sale and distribution of certain insurance, annuity and investment products offered by Prudential and third parties. (3)“Operating expenses” includes amounts related to salaries, employee benefits, occupancy, technology, consulting, external and contracted services, legal, corporate charges, costs for initiatives, and other miscellaneous expenses. “Variable expenses” includes commissions, certain compensation related to levels of investment performance, premium taxes and other fees related to sales of certain insurance and investment products. (4)“Other benefits and expenses” primarily includes: (i) the change in estimates of liability for future policy benefits, which can be either positive or negative, for Retirement Strategies, Individual Life and International Businesses; (ii) dividends to policyholders for Individual Life and International Businesses, which are included in adjusted operating income; and (iii) dividends to policyholders in the Closed Block Division, which are not included in adjusted operating income. (5)Reflects “Income (loss) before income taxes and equity in earnings of joint ventures and other operating entities”.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Revenues From Domestic And Foreign Operations | Revenues, calculated in accordance with U.S. GAAP, for the years ended December 31, include the following by geographic location that are 10 percent or more of the Company’s total consolidated revenue:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule Of Intersegment Revenues | The PGIM segment revenues include intersegment revenues, primarily consisting of asset-based management and administration fees, for the years ended December 31, as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Asset Mgmt and Service Fees | The table below presents asset management and service fees, predominantly related to investment management activities, for the periods indicated:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Related Party Transactions (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Related Party Transactions [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Related Party Transactions | The related party balances with Prismic, Prismic Re and Prismic Re International impacted the Company’s balance sheet as of the periods indicated as follows:
The related party activity with Prismic, Prismic Re and Prismic Re International impacted the Company’s results of operations and cash flows for the periods indicated as follows:
See the Consolidated Statements of Cash Flows for information regarding significant non-cash transactions with Prismic Re and Prismic Re International.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Commitments and Contingent Liabilities (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commitments and Contingencies Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mortgage Loans | The following table sets forth the composition of “Commercial mortgage and other loans,” as of the dates indicated:
__________ (1)Prior period amounts have been updated to conform to current period presentation. (2)Includes loans which are carried at fair value under the fair value option and are collateralized primarily by apartment complexes. As of December 31, 2025 and 2024, the net carrying value of these loans was $1,056 million and $702 million, respectively. Commercial Mortgage Loan Commitments
Indemnification of Serviced Mortgage Loans
__________ (1)The accrued liability associated with guarantees includes an allowance for credit losses of $11 million and $12 million as of December 31, 2025 and 2024, respectively. The change in allowance is a reduction of $1 million and $2 million for the years ended December 31, 2025 and 2024, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Commitments to Purchase Investments (excluding Commercial Mortgage Loans) | Commitments to Purchase Investments (excluding Commercial Mortgage Loans)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Indemnification of Securities Lending and Securities Repurchase Transactions | Indemnification of Securities Lending and Securities Repurchase Transactions
__________ (1)Includes $0 million and $240 million related to securities repurchase transactions as of December 31, 2025 and December 31, 2024, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Guarantees | Guarantees of Asset Values
Other Guarantees
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insolvency Assessment | Assets and liabilities held for insolvency assessments were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business and Basis of Presentation (Dispositions Narratives) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | $ 4,656 | $ 3,209 | $ 3,072 | ||
| Other Income | [1] | 4,426 | 3,037 | $ 4,065 | |
| Fixed Maturities, AFS, allowance for credit losses | 183 | 331 | |||
| Other Guarantees | |||||
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||
| Accrued Liability associated with guarantee | $ 31 | $ 32 | |||
| |||||
Business and Basis of Presentation (Held-For-Sale Table) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||||||
| Fixed maturities, available-for-sale, at fair value | $ 357,996 | $ 341,004 | ||||||||
| Fixed Maturities, Trading, amortized cost | 15,536 | 13,631 | ||||||||
| Assets supporting experience-rated contractholder liabilities, at fair value | 4,842 | 3,707 | ||||||||
| Equity securities | [1] | 10,972 | 9,417 | |||||||
| Commercial mortgage and other loans | [1] | 64,715 | 62,341 | |||||||
| Policy loans | 9,958 | 9,795 | ||||||||
| Other invested assets | [1] | 27,294 | 26,351 | |||||||
| Cash and cash equivalents | 19,712 | [1] | 18,497 | [1] | $ 19,419 | |||||
| Accrued investment income | [1] | 3,636 | 3,441 | |||||||
| Balance, BOP | 21,530 | 20,448 | 20,856 | |||||||
| Value of business acquired | 397 | 435 | ||||||||
| Other assets | [1],[2] | 15,009 | 13,737 | |||||||
| Separate account assets | 196,251 | 193,372 | ||||||||
| Future policy benefits | 266,914 | 268,912 | 273,281 | |||||||
| Cash collateral for loaned securities | 8,700 | 9,621 | ||||||||
| Other Liabilities | [1] | 17,692 | 16,679 | |||||||
| Separate account liabilities | 196,251 | 193,372 | 198,888 | |||||||
| Goodwill | 1,090 | 1,053 | $ 1,071 | $ 876 | ||||||
| Fixed Maturities, AFS, allowance for credit losses | 183 | 331 | ||||||||
| Fixed Maturities | ||||||||||
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | ||||||||||
| Assets supporting experience-rated contractholder liabilities, at fair value | 896 | 826 | ||||||||
| Accrued investment income | $ 3,089 | $ 2,892 | ||||||||
| ||||||||||
Business and Basis of Presentation Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
May 09, 2026 |
Dec. 31, 2025 |
Mar. 31, 2025 |
Dec. 31, 2023 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|||
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | $ 4,656 | $ 3,209 | $ 3,072 | ||||||||
| General and administrative expenses | [1] | 13,012 | 13,342 | 12,951 | |||||||
| Restructuring Charges | $ 135 | $ 200 | |||||||||
| Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration] | General and administrative expenses | General and administrative expenses | |||||||||
| Retained Earnings | $ 34,831 | 34,831 | 33,187 | ||||||||
| Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 4,656 | 3,209 | 3,072 | ||||||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 4,656 | 3,209 | 3,072 | ||||||||
| Operating Segments | |||||||||||
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 6,637 | 5,926 | 5,599 | ||||||||
| Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 6,637 | 5,926 | 5,599 | ||||||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 6,637 | 5,926 | 5,599 | ||||||||
| Prismic HoldCo | |||||||||||
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
| Equity Method Investment, Ownership Percentage | 20.00% | 20.00% | |||||||||
| Individual Retirement Strategies | U.S. Businesses Division | Operating Segments | Retirement Strategies | |||||||||||
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 1,732 | 1,763 | 1,818 | ||||||||
| Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 1,732 | 1,763 | 1,818 | ||||||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | $ 1,732 | $ 1,763 | $ 1,818 | ||||||||
| POJ | Subsequent Event | |||||||||||
| Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||
| Voluntarily suspension of new sales activity at Prudential of Japan | 90 days | ||||||||||
| Revision of Prior Period, Adjustment | |||||||||||
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | $ (150) | ||||||||||
| Error Corrections and Prior Period Adjustments Restatement [Line Items] | |||||||||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | (150) | ||||||||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | $ (150) | ||||||||||
| |||||||||||
Business and Basis of Presentation (Deferred Sales Inducements) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Movement in Deferred Sales Inducements [Roll Forward] | ||
| Balance, BOP | $ 406 | $ 443 |
| Balance, EOP | 375 | 406 |
| Other businesses | ||
| Movement in Deferred Sales Inducements [Roll Forward] | ||
| Balance, BOP | 30 | 33 |
| Balance, EOP | $ 28 | $ 30 |
Business and Basis of Presentation (Value of Business Acquired) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|---|
| Value of Business Acquired [Line Items] | |||
| Balance, BOP | $ 435 | ||
| Balance, EOP | 397 | $ 435 | |
| Other businesses | |||
| Value of Business Acquired [Line Items] | |||
| Balance, BOP | 14 | 19 | |
| Balance, EOP | 13 | 14 | $ 19 |
| Gibraltar Life and Other | |||
| Value of Business Acquired [Line Items] | |||
| Balance, BOP | 421 | 511 | 597 |
| Balance, EOP | $ 384 | $ 421 | $ 511 |
Business and Basis of Presentation (Summary of Adoption of New Guidance on Consolidated Statements of Financial Position) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
||||
|---|---|---|---|---|---|---|---|---|
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
| Balance, BOP | $ 21,530 | $ 20,448 | $ 20,856 | |||||
| Balance, BOP | 397 | 435 | ||||||
| Income Tax Assets | 279 | 866 | ||||||
| Total MRB assets | 2,330 | 2,331 | ||||||
| Other assets | [1],[2] | 15,009 | 13,737 | |||||
| Total assets | 773,740 | 735,587 | ||||||
| Future policy benefits | 266,914 | 268,912 | 273,281 | |||||
| Policyholder Contract Deposit | 191,307 | 166,254 | ||||||
| Other Liabilities | [2] | 17,692 | 16,679 | |||||
| Total liabilities | 738,159 | 705,461 | ||||||
| Accumulated other comprehensive income (loss) | [1] | (3,077) | (6,711) | |||||
| Retained Earnings | 34,831 | 33,187 | ||||||
| Partner's Capital | 32,438 | 27,872 | ||||||
| Noncontrolling Interests | 349 | 315 | ||||||
| Total equity | 32,787 | 28,187 | $ 28,110 | $ 30,934 | ||||
| TOTAL LIABILITIES AND EQUITY | 773,740 | 735,587 | ||||||
| Reinsurance Recoverable And Deposit Receivables, Including Reinsurance Premium Paid | [1] | 44,077 | 37,680 | |||||
| Reinsurance and funds withheld payables | [1] | $ 18,844 | $ 17,084 | |||||
| ||||||||
Business and Basis of Presentation (Summary of Adoption of New Guidance on Consolidated Statement of Operations) (Details) - USD ($) $ / shares in Units, $ in Millions |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||
| Net income (loss) attributable to Prudential Financial available to holders of Common Stock, Diluted Per Share Amount | $ 9.99 | $ 7.50 | $ 6.74 | ||||
| Net income (loss) attributable to Prudential Financial available to holders of Common Stock, Basic Per Share Amount | $ 10.05 | $ 7.54 | $ 6.76 | ||||
| Net Income (Loss) | $ 3,576 | $ 2,727 | $ 2,488 | ||||
| Net income (loss) | 3,732 | 2,846 | 2,508 | ||||
| Equity in earnings of joint ventures and other operating entities, net of taxes | 129 | 144 | 49 | ||||
| Total income tax expense (benefit) | 1,053 | 507 | 613 | ||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 4,656 | 3,209 | 3,072 | ||||
| Benefits, Losses and Expenses | 56,118 | 67,196 | 50,907 | ||||
| General and administrative expenses | [1] | 13,012 | 13,342 | 12,951 | |||
| Amortization expense | [1] | 1,635 | 1,492 | 1,459 | |||
| Policyholder Account Balance, Interest Expense | 5,068 | 4,582 | 3,983 | ||||
| Change in estimates of liability for future policy benefits | [1] | 103 | (37) | 337 | |||
| Policyholders’ benefits | [1] | 35,224 | 47,119 | 30,931 | |||
| Revenues | 60,774 | 70,405 | 53,979 | ||||
| Change in value of market risk benefits, net of related hedging gains (losses) | (475) | (397) | 56 | ||||
| Realized Investment Gains (Losses) | [1],[2] | (4,132) | (3,429) | (3,615) | |||
| Other income (loss) | [1] | 4,426 | 3,037 | 4,065 | |||
| Insurance Commissions and Fees | 4,666 | 4,298 | 4,527 | ||||
| Premiums | [1] | $ 30,797 | $ 42,897 | $ 27,364 | |||
| |||||||
Business and Basis of Presentation (Summary of Adoption of New Guidance on Consolidated Statements of Comprehensive Income) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $ 7,210 | $ 2,520 | $ (210) | ||
| Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | 7,366 | 2,639 | (190) | ||
| Other Comprehensive Income (Loss), Net of Tax | 3,634 | (207) | (2,698) | ||
| Less: Income tax expense (benefit) related to other comprehensive income (loss) | 1,003 | 364 | (837) | ||
| Other Comprehensive Income (Loss), before Tax | 4,637 | 157 | (3,535) | ||
| Gain (loss) from changes in non-performance risk on market risk benefits | (195) | (466) | (693) | ||
| Interest rate remeasurement of future policy benefits | [1] | 5,385 | 11,804 | (8,770) | |
| Net unrealized investment gains (losses) | (653) | (10,125) | 6,219 | ||
| Net income (loss) | 3,732 | 2,846 | 2,508 | ||
| Foreign currency translation adjustments for the period | $ 446 | $ (852) | $ (264) | ||
| |||||
Business and Basis of Presentation (Summary of Adoption of New Guidance on Consolidated Statement of Cash Flows) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||||||
| Net income (loss) | $ 3,732 | $ 2,846 | $ 2,508 | ||||
| Realized investment gains(losses), net | [1],[2] | 4,132 | 3,429 | 3,615 | |||
| Change in value of market risk benefits, net of related hedging (gains) losses | 475 | 397 | (56) | ||||
| Policy charges and fee income | (2,028) | (2,128) | (2,186) | ||||
| Interest credited to policyholders' account balances | 5,068 | 4,582 | 3,983 | ||||
| Depreciation and amortization | 128 | 383 | |||||
| Deferred policy acquisition costs | [2] | (1,215) | (1,111) | (869) | |||
| Future policy benefits and other insurance liabilities | 3,493 | 4,803 | 5,489 | ||||
| Income Taxes | (493) | (146) | (442) | ||||
| Derivatives, net | 377 | 897 | (746) | ||||
| Other, net | [2] | (4,487) | (2,124) | (3,707) | |||
| Cash flows from (used in) operating activities | $ 6,271 | $ 8,502 | $ 6,510 | ||||
| |||||||
Significant Accounting Policies and Pronouncements (Narratives) (Details) |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
| Loan-to-value ratios (greater than) | 100.00% |
| Loan-to-value ratio (less than) | 100.00% |
| Debt service coverage ratios (less than) | 1.0 |
| Debt Service Coverage Ratios (greater than) | 1.0 |
| Repurchase and Resale Agreements, Collateral, Percentage | 95.00% |
| Uncertain Tax Positions Measurement Percentage (greater than) | 50.00% |
| United States | Securities Lending and Securities Repurchase Transactions | |
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
| Guarantor obligations, liquidation proceeds, percentage | 102.00% |
| Other Countries | Securities Lending and Securities Repurchase Transactions | |
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
| Guarantor obligations, liquidation proceeds, percentage | 105.00% |
| Minimum | |
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
| Estimated useful life | 3 years |
| Maximum | |
| New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |
| Estimated useful life | 40 years |
Investments (Fixed Maturities Securities Excluding Investments Classified as Trading) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
||
|---|---|---|---|---|
| Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | $ 357,996 | $ 341,004 | ||
| Gross Unrealized Gains | 6,864 | 5,517 | ||
| Gross Unrealized Losses | 33,222 | 34,620 | ||
| Fixed Maturities, AFS, allowance for credit losses | 183 | 331 | ||
| Fixed Maturities, available-for-sale, at fair value | [1] | 331,455 | 311,570 | |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||||
| Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 26,334 | 24,869 | ||
| Gross Unrealized Gains | 668 | 584 | ||
| Gross Unrealized Losses | 4,823 | 5,105 | ||
| Fixed Maturities, AFS, allowance for credit losses | 0 | 0 | ||
| Fixed Maturities, available-for-sale, at fair value | 22,179 | 20,348 | ||
| Obligations of U.S. states and their political subdivisions | ||||
| Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 5,881 | 6,590 | ||
| Gross Unrealized Gains | 138 | 132 | ||
| Gross Unrealized Losses | 554 | 618 | ||
| Fixed Maturities, AFS, allowance for credit losses | 0 | 0 | ||
| Fixed Maturities, available-for-sale, at fair value | 5,465 | 6,104 | ||
| Foreign government securities | ||||
| Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 62,469 | 63,523 | ||
| Gross Unrealized Gains | 497 | 1,837 | ||
| Gross Unrealized Losses | 12,352 | 7,881 | ||
| Fixed Maturities, AFS, allowance for credit losses | 0 | 0 | ||
| Fixed Maturities, available-for-sale, at fair value | 50,614 | 57,479 | ||
| U.S. public corporate securities | ||||
| Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 115,160 | 108,883 | ||
| Gross Unrealized Gains | 1,977 | 1,226 | ||
| Gross Unrealized Losses | 9,345 | 11,529 | ||
| Fixed Maturities, AFS, allowance for credit losses | 11 | 72 | ||
| Fixed Maturities, available-for-sale, at fair value | 107,781 | 98,508 | ||
| U.S. private corporate securities | ||||
| Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 47,976 | 45,854 | ||
| Gross Unrealized Gains | 1,177 | 918 | ||
| Gross Unrealized Losses | 1,964 | 2,926 | ||
| Fixed Maturities, AFS, allowance for credit losses | 88 | 57 | ||
| Fixed Maturities, available-for-sale, at fair value | 47,101 | 43,789 | ||
| Foreign public corporate securities | ||||
| Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 24,496 | 23,165 | ||
| Gross Unrealized Gains | 413 | 248 | ||
| Gross Unrealized Losses | 1,178 | 1,421 | ||
| Fixed Maturities, AFS, allowance for credit losses | 28 | 10 | ||
| Fixed Maturities, available-for-sale, at fair value | 23,703 | 21,982 | ||
| Foreign private corporate securities | ||||
| Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 41,099 | 38,652 | ||
| Gross Unrealized Gains | 1,638 | 314 | ||
| Gross Unrealized Losses | 2,523 | 4,311 | ||
| Fixed Maturities, AFS, allowance for credit losses | 55 | 192 | ||
| Fixed Maturities, available-for-sale, at fair value | 40,159 | 34,463 | ||
| Asset-backed securities | ||||
| Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 19,130 | 16,979 | ||
| Gross Unrealized Gains | 226 | 214 | ||
| Gross Unrealized Losses | 26 | 59 | ||
| Fixed Maturities, AFS, allowance for credit losses | 1 | 0 | ||
| Fixed Maturities, available-for-sale, at fair value | 19,329 | 17,134 | ||
| Commercial mortgage-backed securities | ||||
| Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 9,958 | 9,791 | ||
| Gross Unrealized Gains | 87 | 29 | ||
| Gross Unrealized Losses | 302 | 547 | ||
| Fixed Maturities, AFS, allowance for credit losses | 0 | 0 | ||
| Fixed Maturities, available-for-sale, at fair value | 9,743 | 9,273 | ||
| Residential mortgage-backed securities | ||||
| Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 5,493 | 2,698 | ||
| Gross Unrealized Gains | 43 | 15 | ||
| Gross Unrealized Losses | 155 | 223 | ||
| Fixed Maturities, AFS, allowance for credit losses | 0 | 0 | ||
| Fixed Maturities, available-for-sale, at fair value | 5,381 | 2,490 | ||
| Prudential Netting Agreement | U.S. private corporate securities | ||||
| Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 15,744 | 14,748 | ||
| Fixed Maturities, available-for-sale, at fair value | 15,744 | $ 14,748 | ||
| Prudential Netting Agreement | Fixed Maturities | U.S. private corporate securities | ||||
| Summary Of Investments Other Than Investments In Related Parties Reportable Data [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 15,744 | |||
| Fixed Maturities, available-for-sale, at fair value | $ 15,744 | |||
| ||||
Investments (Fair Value and Losses by Investment Category and Length of Time in a Loss Position) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Debt Securities[Line Items] | ||
| Less than Twelve Months, Fair Value | $ 33,698 | $ 66,934 |
| Less than Twelve Months, Unrealized Losses | 976 | 2,430 |
| Twelve Months or More, Fair Value | 147,942 | 142,997 |
| Twelve Months or More, Unrealized Losses | 32,225 | 32,158 |
| Fair Value | 181,640 | 209,931 |
| Unrealized Losses | 33,201 | 34,588 |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||
| Debt Securities[Line Items] | ||
| Less than Twelve Months, Fair Value | 3,644 | 6,667 |
| Less than Twelve Months, Unrealized Losses | 83 | 334 |
| Twelve Months or More, Fair Value | 12,075 | 10,161 |
| Twelve Months or More, Unrealized Losses | 4,740 | 4,771 |
| Fair Value | 15,719 | 16,828 |
| Unrealized Losses | 4,823 | 5,105 |
| Obligations of U.S. states and their political subdivisions | ||
| Debt Securities[Line Items] | ||
| Less than Twelve Months, Fair Value | 399 | 1,592 |
| Less than Twelve Months, Unrealized Losses | 9 | 53 |
| Twelve Months or More, Fair Value | 3,631 | 3,288 |
| Twelve Months or More, Unrealized Losses | 545 | 565 |
| Fair Value | 4,030 | 4,880 |
| Unrealized Losses | 554 | 618 |
| Foreign government securities | ||
| Debt Securities[Line Items] | ||
| Less than Twelve Months, Fair Value | 9,886 | 8,280 |
| Less than Twelve Months, Unrealized Losses | 510 | 349 |
| Twelve Months or More, Fair Value | 23,570 | 20,780 |
| Twelve Months or More, Unrealized Losses | 11,842 | 7,532 |
| Fair Value | 33,456 | 29,060 |
| Unrealized Losses | 12,352 | 7,881 |
| U.S. public corporate securities | ||
| Debt Securities[Line Items] | ||
| Less than Twelve Months, Fair Value | 9,789 | 25,420 |
| Less than Twelve Months, Unrealized Losses | 218 | 1,036 |
| Twelve Months or More, Fair Value | 52,459 | 48,152 |
| Twelve Months or More, Unrealized Losses | 9,114 | 10,485 |
| Fair Value | 62,248 | 73,572 |
| Unrealized Losses | 9,332 | 11,521 |
| U.S. private corporate securities | ||
| Debt Securities[Line Items] | ||
| Less than Twelve Months, Fair Value | 3,297 | 7,581 |
| Less than Twelve Months, Unrealized Losses | 68 | 183 |
| Twelve Months or More, Fair Value | 24,064 | 24,846 |
| Twelve Months or More, Unrealized Losses | 1,895 | 2,743 |
| Fair Value | 27,361 | 32,427 |
| Unrealized Losses | 1,963 | 2,926 |
| Foreign public corporate securities | ||
| Debt Securities[Line Items] | ||
| Less than Twelve Months, Fair Value | 2,253 | 5,751 |
| Less than Twelve Months, Unrealized Losses | 35 | 170 |
| Twelve Months or More, Fair Value | 8,586 | 8,084 |
| Twelve Months or More, Unrealized Losses | 1,142 | 1,246 |
| Fair Value | 10,839 | 13,835 |
| Unrealized Losses | 1,177 | 1,416 |
| Foreign private corporate securities | ||
| Debt Securities[Line Items] | ||
| Less than Twelve Months, Fair Value | 849 | 8,702 |
| Less than Twelve Months, Unrealized Losses | 44 | 282 |
| Twelve Months or More, Fair Value | 16,286 | 18,862 |
| Twelve Months or More, Unrealized Losses | 2,473 | 4,010 |
| Fair Value | 17,135 | 27,564 |
| Unrealized Losses | 2,517 | 4,292 |
| Asset-backed securities | ||
| Debt Securities[Line Items] | ||
| Less than Twelve Months, Fair Value | 2,979 | 1,488 |
| Less than Twelve Months, Unrealized Losses | 6 | 11 |
| Twelve Months or More, Fair Value | 626 | 1,015 |
| Twelve Months or More, Unrealized Losses | 20 | 48 |
| Fair Value | 3,605 | 2,503 |
| Unrealized Losses | 26 | 59 |
| Commercial mortgage-backed securities | ||
| Debt Securities[Line Items] | ||
| Less than Twelve Months, Fair Value | 249 | 1,092 |
| Less than Twelve Months, Unrealized Losses | 1 | 8 |
| Twelve Months or More, Fair Value | 5,435 | 6,432 |
| Twelve Months or More, Unrealized Losses | 301 | 539 |
| Fair Value | 5,684 | 7,524 |
| Unrealized Losses | 302 | 547 |
| Residential mortgage-backed securities | ||
| Debt Securities[Line Items] | ||
| Less than Twelve Months, Fair Value | 353 | 361 |
| Less than Twelve Months, Unrealized Losses | 2 | 4 |
| Twelve Months or More, Fair Value | 1,210 | 1,377 |
| Twelve Months or More, Unrealized Losses | 153 | 219 |
| Fair Value | 1,563 | 1,738 |
| Unrealized Losses | $ 155 | $ 223 |
Investments (Amortized Cost and Fair Value of Fixed Maturities by Contractual Maturities) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
||
|---|---|---|---|---|
| Available-for-sale, Amortized Cost | ||||
| Due in one year or less | $ 12,343 | |||
| Due after one year through five years | 65,698 | |||
| Due after five years through ten years | 63,307 | |||
| Due after ten years | 182,067 | |||
| Fixed Maturities, available-for-sale, Amortized Cost | 357,996 | $ 341,004 | ||
| Available-for-sale, Fair Value | ||||
| Due in one year or less | 12,446 | |||
| Due after one year through five years | 66,518 | |||
| Due after five years through ten years | 63,669 | |||
| Due after ten years | 154,369 | |||
| Fixed Maturities, available-for-sale, at fair value | [1] | 331,455 | 311,570 | |
| U.S. private corporate securities | ||||
| Available-for-sale, Amortized Cost | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 47,976 | 45,854 | ||
| Available-for-sale, Fair Value | ||||
| Fixed Maturities, available-for-sale, at fair value | 47,101 | 43,789 | ||
| Asset-backed securities | ||||
| Available-for-sale, Amortized Cost | ||||
| Debt Maturities, without single maturity date | 19,130 | |||
| Fixed Maturities, available-for-sale, Amortized Cost | 19,130 | 16,979 | ||
| Available-for-sale, Fair Value | ||||
| Debt Maturities, without single maturity date | 19,329 | |||
| Fixed Maturities, available-for-sale, at fair value | 19,329 | 17,134 | ||
| Commercial mortgage-backed securities | ||||
| Available-for-sale, Amortized Cost | ||||
| Debt Maturities, without single maturity date | 9,958 | |||
| Fixed Maturities, available-for-sale, Amortized Cost | 9,958 | 9,791 | ||
| Available-for-sale, Fair Value | ||||
| Debt Maturities, without single maturity date | 9,743 | |||
| Fixed Maturities, available-for-sale, at fair value | 9,743 | 9,273 | ||
| Residential mortgage-backed securities | ||||
| Available-for-sale, Amortized Cost | ||||
| Debt Maturities, without single maturity date | 5,493 | |||
| Fixed Maturities, available-for-sale, Amortized Cost | 5,493 | 2,698 | ||
| Available-for-sale, Fair Value | ||||
| Debt Maturities, without single maturity date | 5,381 | |||
| Fixed Maturities, available-for-sale, at fair value | 5,381 | 2,490 | ||
| Prudential Netting Agreement | U.S. private corporate securities | ||||
| Available-for-sale, Amortized Cost | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 15,744 | 14,748 | ||
| Available-for-sale, Fair Value | ||||
| Fixed Maturities, available-for-sale, at fair value | 15,744 | $ 14,748 | ||
| Fixed maturities | Prudential Netting Agreement | U.S. private corporate securities | ||||
| Available-for-sale, Amortized Cost | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 15,744 | |||
| Available-for-sale, Fair Value | ||||
| Fixed Maturities, available-for-sale, at fair value | $ 15,744 | |||
| ||||
Investments (Fixed Maturity Proceeds) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Debt Securities[Line Items] | |||
| Proceeds from maturities/prepayments | $ 45,218 | $ 59,059 | $ 44,097 |
| Proceeds from maturities/prepayments - HTM | 0 | 0 | 22 |
| Available-for-sale-Securities Netting | |||
| Debt Securities[Line Items] | |||
| Non cash Or Part Non cash Divestitures Amount Of Consideration Received | 104 | (100) | (74) |
| Held-to-Maturity Securities Netting | |||
| Debt Securities[Line Items] | |||
| Non cash Or Part Non cash Divestitures Amount Of Consideration Received | 0 | 0 | 1 |
| Fixed maturities | Available-for-sale | |||
| Debt Securities[Line Items] | |||
| Proceeds from sales | 19,029 | 36,727 | 27,161 |
| Proceeds from maturities/prepayments | 26,085 | 22,432 | 17,010 |
| Gross investment gains from sales and maturities | 727 | 1,400 | 973 |
| Gross investment losses from sales and maturities | (1,367) | (3,553) | (2,183) |
| Write-downs recognized in earnings | (408) | (924) | (81) |
| (Addition to) release of allowance for credit losses | 148 | (195) | (22) |
| Fixed maturities | Held-to-maturity | |||
| Debt Securities[Line Items] | |||
| Proceeds from maturities/prepayments - HTM | 0 | 0 | 21 |
| (Addition to) release of allowance for credit Losses | $ 0 | $ 0 | $ 2 |
Investments (Credit Losses Recognized In Earnings on Fixed Maturity Securities Held by the Company) (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | $ 331 | |
| Balance, ending of period | 183 | $ 331 |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | |
| Balance, ending of period | 0 | 0 |
| Foreign government securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | |
| Balance, ending of period | 0 | 0 |
| Asset-backed securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | |
| Balance, ending of period | 1 | 0 |
| Commercial mortgage-backed securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | |
| Balance, ending of period | 0 | 0 |
| Residential mortgage-backed securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | |
| Balance, ending of period | 0 | 0 |
| Available-for-sale | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 331 | 160 |
| Additions to allowance for credit losses not previously recorded | 114 | 235 |
| Reductions for securities sold during the period | (30) | (85) |
| Additions (reductions) on securities with previous allowance | 29 | 21 |
| Write-offs charged against the allowance | (261) | 0 |
| Balance, ending of period | 183 | 331 |
| Available-for-sale | U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | 0 |
| Additions to allowance for credit losses not previously recorded | 0 | 0 |
| Reductions for securities sold during the period | 0 | 0 |
| Additions (reductions) on securities with previous allowance | 0 | 0 |
| Write-offs charged against the allowance | 0 | 0 |
| Balance, ending of period | 0 | 0 |
| Available-for-sale | Foreign government securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | 53 |
| Additions to allowance for credit losses not previously recorded | 0 | 0 |
| Reductions for securities sold during the period | 0 | (30) |
| Additions (reductions) on securities with previous allowance | 0 | (23) |
| Write-offs charged against the allowance | 0 | 0 |
| Balance, ending of period | 0 | 0 |
| Available-for-sale | Corporate securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 331 | 105 |
| Additions to allowance for credit losses not previously recorded | 113 | 235 |
| Reductions for securities sold during the period | (30) | (55) |
| Additions (reductions) on securities with previous allowance | 29 | 46 |
| Write-offs charged against the allowance | (261) | 0 |
| Balance, ending of period | 182 | 331 |
| Available-for-sale | Asset-backed securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | 2 |
| Additions to allowance for credit losses not previously recorded | 1 | 0 |
| Reductions for securities sold during the period | 0 | 0 |
| Additions (reductions) on securities with previous allowance | 0 | (2) |
| Write-offs charged against the allowance | 0 | 0 |
| Balance, ending of period | 1 | 0 |
| Available-for-sale | Commercial mortgage-backed securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | 0 |
| Additions to allowance for credit losses not previously recorded | 0 | 0 |
| Reductions for securities sold during the period | 0 | 0 |
| Additions (reductions) on securities with previous allowance | 0 | 0 |
| Write-offs charged against the allowance | 0 | 0 |
| Balance, ending of period | 0 | 0 |
| Available-for-sale | Residential mortgage-backed securities | ||
| Debt Securities, Available-for-Sale, Allowance for Credit Loss [Roll Forward] | ||
| Balance, beginning of period | 0 | 0 |
| Additions to allowance for credit losses not previously recorded | 0 | 0 |
| Reductions for securities sold during the period | 0 | 0 |
| Additions (reductions) on securities with previous allowance | 0 | 0 |
| Write-offs charged against the allowance | 0 | 0 |
| Balance, ending of period | $ 0 | $ 0 |
Investments (Assets Supporting Experience-Rated Contractholder Liabilities) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
| Assets supporting experience-rated contractholder liabilities, at amortized cost or cost | $ 3,129 | $ 2,582 |
| Assets supporting experience-rated contractholder liabilities, at fair value | 4,842 | 3,707 |
| Fixed maturities | ||
| Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
| Assets supporting experience-rated contractholder liabilities, at amortized cost or cost | 895 | 819 |
| Assets supporting experience-rated contractholder liabilities, at fair value | 896 | 826 |
| Equity securities | ||
| Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
| Assets supporting experience-rated contractholder liabilities, at amortized cost or cost | 2,234 | 1,763 |
| Assets supporting experience-rated contractholder liabilities, at fair value | 3,946 | 2,881 |
| Corporate securities | ||
| Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
| Assets supporting experience-rated contractholder liabilities, at amortized cost or cost | 57 | 68 |
| Assets supporting experience-rated contractholder liabilities, at fair value | 55 | 67 |
| Foreign government securities | ||
| Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
| Assets supporting experience-rated contractholder liabilities, at amortized cost or cost | 611 | 544 |
| Assets supporting experience-rated contractholder liabilities, at fair value | 596 | 539 |
| Obligations of U.S. government authorities and agencies and obligations of U.S. states | ||
| Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
| Assets supporting experience-rated contractholder liabilities, at amortized cost or cost | 227 | 207 |
| Assets supporting experience-rated contractholder liabilities, at fair value | $ 245 | $ 220 |
| NAIC High or Highest Quality Rating | Fixed maturities | ||
| Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
| Assets supporting experience-rated contractholder liabilities, at amortized cost percentage | 99.00% | 99.00% |
| Public Securities | Fixed maturities | ||
| Assets Supporting Experience-Rated Contractholder Liabilities [Line Items] | ||
| Assets supporting experience-rated contractholder liabilities, at amortized cost percentage | 100.00% | 100.00% |
Investments (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||
| Schedule of Investments [Line Items] | |||||
| Master funds gross assets | $ 44,434 | $ 43,004 | |||
| Master funds gross liabilities | 42,644 | 41,370 | |||
| Unaffiliated interest | 500 | 450 | |||
| Consolidated feeder funds’ investments | 781 | 788 | |||
| Total Unrealized Losses | 33,201 | 34,588 | |||
| Twelve Months or More, Unrealized Losses | 32,225 | 32,158 | |||
| Fixed Maturities, available-for-sale, at fair value | [1] | 331,455 | 311,570 | ||
| Write-downs charged against the allowance | 272 | 137 | $ 29 | ||
| Fixed maturities, trading | [1] | 14,869 | 12,530 | ||
| Total commercial mortgage and other loans | 64,715 | 62,341 | |||
| Write-down on accrued investment income receivable | 1 | 2 | |||
| Fixed maturity securities purchased with credit deterioration | 0 | 0 | |||
| Loans on non-accrual status recognized in interest income | 5 | 16 | |||
| Loans on non-accrual status do not have allowance for credit losses | 442 | 207 | |||
| Commercial mortgage and other loans purchased with credit deterioration | 0 | 0 | |||
| Fair value of collateral | 1,532 | 1,920 | |||
| Fixed maturities | Fixed maturities, trading | |||||
| Schedule of Investments [Line Items] | |||||
| Fixed maturities, trading | 14,869 | ||||
| Corporate securities | |||||
| Schedule of Investments [Line Items] | |||||
| Twelve Months or More, Unrealized Losses | 32,225 | 32,158 | |||
| Other income (loss) | Fixed maturities | Fixed maturities, trading | |||||
| Schedule of Investments [Line Items] | |||||
| Unrealized Gain (Loss) on Investments | 461 | (551) | 518 | ||
| Other income (loss) | Equity securities | |||||
| Schedule of Investments [Line Items] | |||||
| Unrealized Gain (Loss) on Investments | 750 | 735 | 612 | ||
| Other income (loss) | Assets supporting experience-rated contractholder liabilities | Held-for-sale | |||||
| Schedule of Investments [Line Items] | |||||
| Unrealized Gain (Loss) on Investments | 613 | $ 495 | 440 | ||
| Commercial Mortgage Loans | Extended Maturity | |||||
| Schedule of Investments [Line Items] | |||||
| Financing Receivable, Modified, Weighted Average Term Increase from Modification | 1 year | ||||
| Commercial Mortgage Loans | |||||
| Schedule of Investments [Line Items] | |||||
| Write-downs charged against the allowance | 122 | $ 132 | 29 | ||
| Agricultural Property Loans | |||||
| Schedule of Investments [Line Items] | |||||
| Write-downs charged against the allowance | 150 | $ 5 | 0 | ||
| Agricultural Property Loans | Extended Maturity | |||||
| Schedule of Investments [Line Items] | |||||
| Financing Receivable, Modified, Weighted Average Term Increase from Modification | 1 year | ||||
| Investments | |||||
| Schedule of Investments [Line Items] | |||||
| Fair value of collateral | 637 | $ 265 | |||
| Cash | |||||
| Schedule of Investments [Line Items] | |||||
| Fair value of collateral | 895 | 1,655 | |||
| Residential property loans | |||||
| Schedule of Investments [Line Items] | |||||
| Write-downs charged against the allowance | 0 | 0 | 0 | ||
| Loans acquired | 1,618 | 0 | |||
| Loans sold | 0 | 0 | |||
| Collateralized loan obligations | |||||
| Schedule of Investments [Line Items] | |||||
| Write-downs charged against the allowance | 0 | 0 | 0 | ||
| Uncollateralized loans | |||||
| Schedule of Investments [Line Items] | |||||
| Write-downs charged against the allowance | 0 | 0 | $ 0 | ||
| Carrying value of non-income producing assets | |||||
| Schedule of Investments [Line Items] | |||||
| Fixed Maturities, available-for-sale, at fair value | 82 | ||||
| Fixed maturities, trading | 8 | ||||
| Total commercial mortgage and other loans | $ 7 | ||||
| California | |||||
| Schedule of Investments [Line Items] | |||||
| Commercial mortgage loan, concentration percentage | 28.00% | ||||
| Residential mortgage loan, Concentration Percentage | 10.00% | ||||
| Texas | |||||
| Schedule of Investments [Line Items] | |||||
| Commercial mortgage loan, concentration percentage | 6.00% | ||||
| Florida | |||||
| Schedule of Investments [Line Items] | |||||
| Commercial mortgage loan, concentration percentage | 6.00% | ||||
| Residential mortgage loan, Concentration Percentage | 13.00% | ||||
| Europe | |||||
| Schedule of Investments [Line Items] | |||||
| Commercial mortgage loan, concentration percentage | 6.00% | ||||
| Mexico | |||||
| Schedule of Investments [Line Items] | |||||
| Commercial mortgage loan, concentration percentage | 2.00% | ||||
| Japan | |||||
| Schedule of Investments [Line Items] | |||||
| Commercial mortgage loan, concentration percentage | 1.00% | ||||
| Australia | |||||
| Schedule of Investments [Line Items] | |||||
| Commercial mortgage loan, concentration percentage | 1.00% | ||||
| New York | |||||
| Schedule of Investments [Line Items] | |||||
| Residential mortgage loan, Concentration Percentage | 9.00% | ||||
| NAIC High or Highest Quality Rating | Fixed maturities | |||||
| Schedule of Investments [Line Items] | |||||
| Total Unrealized Losses | $ 32,392 | 33,437 | |||
| NAIC Other Than High or Highest Quality Rating | Fixed maturities | |||||
| Schedule of Investments [Line Items] | |||||
| Total Unrealized Losses | $ 809 | $ 1,151 | |||
| |||||
Investments (Concentrations of Credit Risk) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Investments in Japanese government and government agency securities: | ||
| Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
| Concentrations of credit risk at amortized cost | $ 55,418 | $ 56,947 |
| Concentrations of credit risk at fair value | 44,082 | 51,657 |
| Investments in Brazil government and government agencies securities | ||
| Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
| Concentrations of credit risk at amortized cost | 3,912 | 3,027 |
| Concentrations of credit risk at fair value | 3,413 | 2,521 |
| Assets supporting experience-rated contractholder liabilities | Investments in Japanese government and government agency securities: | ||
| Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
| Concentrations of credit risk at amortized cost | 536 | 472 |
| Concentrations of credit risk at fair value | 510 | 462 |
| Short-term Investments | Investments in Brazil government and government agencies securities | ||
| Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
| Concentrations of credit risk at amortized cost | 1 | 2 |
| Concentrations of credit risk at fair value | 1 | 2 |
| Cash equivalents | Investments in Brazil government and government agencies securities | ||
| Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
| Concentrations of credit risk at amortized cost | 260 | 228 |
| Concentrations of credit risk at fair value | 260 | 228 |
| Fixed maturities, available-for-sale | Fixed maturities | Investments in Japanese government and government agency securities: | ||
| Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
| Concentrations of credit risk at amortized cost | 54,863 | 56,457 |
| Concentrations of credit risk at fair value | 43,554 | 51,177 |
| Fixed maturities, available-for-sale | Fixed maturities | Investments in Brazil government and government agencies securities | ||
| Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
| Concentrations of credit risk at amortized cost | 3,651 | 2,753 |
| Concentrations of credit risk at fair value | 3,152 | 2,251 |
| Fixed maturities, trading | Fixed maturities | Investments in Japanese government and government agency securities: | ||
| Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
| Concentrations of credit risk at amortized cost | 19 | 18 |
| Concentrations of credit risk at fair value | 18 | 18 |
| Fixed maturities, trading | Fixed maturities | Investments in Brazil government and government agencies securities | ||
| Fair Value, Concentration of Risk, Financial Statement Captions [Line Items] | ||
| Concentrations of credit risk at amortized cost | 0 | 44 |
| Concentrations of credit risk at fair value | $ 0 | $ 40 |
Investments (Commercial Mortgage and Other Loans) (Details) - USD ($) $ in Millions |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||
| Commercial Mortgage and Other Loans [Line Items] | ||||||
| Commercial mortgage and agricultural property loans by property type | $ 62,778 | $ 61,833 | ||||
| Total net loans | [1] | 64,715 | 62,341 | |||
| Other loans | 2,406 | 1,082 | ||||
| Allowance for credit losses, Other loans | (469) | (574) | $ (460) | $ (203) | ||
| Total commercial mortgage and other loans | $ 64,715 | $ 62,341 | ||||
| % of Total | 100.00% | 100.00% | ||||
| Net carrying value of commercial loans held for sale | $ 1,056 | $ 702 | ||||
| Commercial Mortgage Loans | ||||||
| Commercial Mortgage and Other Loans [Line Items] | ||||||
| Commercial mortgage and agricultural property loans by property type | 54,503 | 54,058 | ||||
| Allowance for credit losses, Other loans | $ (366) | $ (407) | (443) | (188) | ||
| % of Total | 86.80% | 87.40% | ||||
| Commercial mortgage and agricultural property loans | ||||||
| Commercial Mortgage and Other Loans [Line Items] | ||||||
| Allowance for credit losses | $ (414) | $ (528) | ||||
| Total net loans | 62,364 | 61,305 | ||||
| Residential mortgage loans | ||||||
| Commercial Mortgage and Other Loans [Line Items] | ||||||
| Other loans | 1,632 | 19 | ||||
| Allowance for credit losses, Other loans | (15) | 0 | 0 | 0 | ||
| Uncollateralized loans | ||||||
| Commercial Mortgage and Other Loans [Line Items] | ||||||
| Other loans | 171 | 595 | ||||
| Allowance for credit losses, Other loans | 0 | (14) | (1) | (2) | ||
| Other collateralized loans | ||||||
| Commercial Mortgage and Other Loans [Line Items] | ||||||
| Other loans | 603 | 468 | ||||
| Allowance for credit losses, Other loans | (40) | (32) | $ 0 | $ 0 | ||
| Other loans | ||||||
| Commercial Mortgage and Other Loans [Line Items] | ||||||
| Total net loans | 2,351 | 1,036 | ||||
| Allowance for credit losses, Other loans | (55) | (46) | ||||
| Office | ||||||
| Commercial Mortgage and Other Loans [Line Items] | ||||||
| Commercial mortgage and agricultural property loans by property type | $ 6,517 | $ 7,867 | ||||
| % of Total | 10.40% | 12.70% | ||||
| Retail | ||||||
| Commercial Mortgage and Other Loans [Line Items] | ||||||
| Commercial mortgage and agricultural property loans by property type | $ 5,680 | $ 5,552 | ||||
| % of Total | 9.00% | 9.00% | ||||
| Apartments/Multi-Family | ||||||
| Commercial Mortgage and Other Loans [Line Items] | ||||||
| Commercial mortgage and agricultural property loans by property type | $ 18,522 | $ 17,522 | ||||
| % of Total | 29.50% | 28.30% | ||||
| Industrial | ||||||
| Commercial Mortgage and Other Loans [Line Items] | ||||||
| Commercial mortgage and agricultural property loans by property type | $ 17,280 | $ 16,900 | ||||
| % of Total | 27.50% | 27.30% | ||||
| Hospitality | ||||||
| Commercial Mortgage and Other Loans [Line Items] | ||||||
| Commercial mortgage and agricultural property loans by property type | $ 1,738 | $ 1,831 | ||||
| % of Total | 2.80% | 3.00% | ||||
| Self-Storage | ||||||
| Commercial Mortgage and Other Loans [Line Items] | ||||||
| Commercial mortgage and agricultural property loans by property type | $ 2,245 | $ 2,194 | ||||
| % of Total | 3.60% | 3.50% | ||||
| Health Care Senior Living | ||||||
| Commercial Mortgage and Other Loans [Line Items] | ||||||
| Commercial mortgage and agricultural property loans by property type | $ 1,832 | $ 1,858 | ||||
| % of Total | 2.90% | 3.00% | ||||
| Other | ||||||
| Commercial Mortgage and Other Loans [Line Items] | ||||||
| Commercial mortgage and agricultural property loans by property type | $ 689 | $ 334 | ||||
| % of Total | 1.10% | 0.60% | ||||
| Agricultural property loans | ||||||
| Commercial Mortgage and Other Loans [Line Items] | ||||||
| Commercial mortgage and agricultural property loans by property type | $ 8,275 | $ 7,775 | ||||
| % of Total | 13.20% | 12.60% | ||||
| ||||||
Investments (Allowance for Credit Losses) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, beginning of year | $ 574 | $ 460 | $ 203 |
| Addition to (release of) allowance for expected losses | 166 | 255 | 284 |
| Write-downs charged against the allowance | (272) | (137) | (29) |
| Other | 1 | (4) | 2 |
| Total ending balance | 469 | 574 | 460 |
| Commercial Mortgage Loans | |||
| Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, beginning of year | 407 | 443 | 188 |
| Addition to (release of) allowance for expected losses | 80 | 100 | 282 |
| Write-downs charged against the allowance | (122) | (132) | (29) |
| Other | 1 | (4) | 2 |
| Total ending balance | 366 | 407 | 443 |
| Agricultural Property Loans | |||
| Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, beginning of year | 121 | 16 | 13 |
| Addition to (release of) allowance for expected losses | 77 | 110 | 3 |
| Write-downs charged against the allowance | (150) | (5) | 0 |
| Other | 0 | 0 | 0 |
| Total ending balance | 48 | 121 | 16 |
| Residential property loans | |||
| Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, beginning of year | 0 | 0 | 0 |
| Addition to (release of) allowance for expected losses | 15 | 0 | 0 |
| Write-downs charged against the allowance | 0 | 0 | 0 |
| Other | 0 | 0 | 0 |
| Total ending balance | 15 | 0 | 0 |
| Other collateralized loans | |||
| Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, beginning of year | 32 | 0 | 0 |
| Addition to (release of) allowance for expected losses | 8 | 32 | 0 |
| Write-downs charged against the allowance | 0 | 0 | 0 |
| Other | 0 | 0 | 0 |
| Total ending balance | 40 | 32 | 0 |
| Uncollateralized loans | |||
| Financing Receivable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, beginning of year | 14 | 1 | 2 |
| Addition to (release of) allowance for expected losses | (14) | 13 | (1) |
| Write-downs charged against the allowance | 0 | 0 | 0 |
| Other | 0 | 0 | 0 |
| Total ending balance | $ 0 | $ 14 | $ 1 |
Investments (Write-downs of Loans by Origination Year) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Current Fiscal Year | $ 0 | ||
| One Years Prior | 0 | ||
| Two Years Prior | 13 | ||
| Three Years Prior | 117 | ||
| Four Years Prior | 1 | ||
| Prior | 141 | ||
| Write-downs of loans by origination year | 272 | $ 137 | $ 29 |
| Commercial Mortgage Loans | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Current Fiscal Year | 0 | ||
| One Years Prior | 0 | ||
| Two Years Prior | 0 | ||
| Three Years Prior | 0 | ||
| Four Years Prior | 0 | ||
| Prior | 122 | ||
| Write-downs of loans by origination year | 122 | $ 132 | $ 29 |
| Agricultural property loans | |||
| Financing Receivable, Credit Quality Indicator [Line Items] | |||
| Current Fiscal Year | 0 | ||
| One Years Prior | 0 | ||
| Two Years Prior | 13 | ||
| Three Years Prior | 117 | ||
| Four Years Prior | 1 | ||
| Prior | 19 | ||
| Write-downs of loans by origination year | $ 150 | ||
Investments (Credit Quality Indicators) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Recording investment gross of allowance for credit losses | $ 65,184 | $ 62,915 |
| Commercial Mortgage Loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 7,163 | 7,705 |
| One Years Prior | 7,341 | 5,240 |
| Two Years Prior | 5,172 | 3,631 |
| Three Years Prior | 3,284 | 6,030 |
| Four Years Prior | 5,506 | 2,951 |
| Prior | 25,975 | 28,465 |
| Revolving Loans | 62 | 36 |
| Recording investment gross of allowance for credit losses | 54,503 | 54,058 |
| Commercial Mortgage Loans | ≥ 1.2X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 6,602 | 6,771 |
| One Years Prior | 6,779 | 4,563 |
| Two Years Prior | 4,673 | 3,283 |
| Three Years Prior | 2,963 | 5,929 |
| Four Years Prior | 5,333 | 2,795 |
| Prior | 23,384 | 25,790 |
| Revolving Loans | 45 | 0 |
| Recording investment gross of allowance for credit losses | 49,779 | 49,131 |
| Commercial Mortgage Loans | 1.0X to 1.2X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 463 | 745 |
| One Years Prior | 534 | 527 |
| Two Years Prior | 499 | 313 |
| Three Years Prior | 238 | 43 |
| Four Years Prior | 82 | 102 |
| Prior | 885 | 1,279 |
| Revolving Loans | 17 | 36 |
| Recording investment gross of allowance for credit losses | 2,718 | 3,045 |
| Commercial Mortgage Loans | Less than 1.0X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 98 | 189 |
| One Years Prior | 28 | 150 |
| Two Years Prior | 0 | 35 |
| Three Years Prior | 83 | 58 |
| Four Years Prior | 91 | 54 |
| Prior | 1,706 | 1,396 |
| Revolving Loans | 0 | 0 |
| Recording investment gross of allowance for credit losses | 2,006 | 1,882 |
| Agricultural property loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 893 | 744 |
| One Years Prior | 764 | 932 |
| Two Years Prior | 855 | 1,523 |
| Three Years Prior | 1,418 | 2,020 |
| Four Years Prior | 1,969 | 803 |
| Prior | 2,132 | 1,579 |
| Revolving Loans | 244 | 174 |
| Recording investment gross of allowance for credit losses | 8,275 | 7,775 |
| Agricultural property loans | ≥ 1.2X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 893 | 688 |
| One Years Prior | 741 | 864 |
| Two Years Prior | 799 | 932 |
| Three Years Prior | 741 | 1,967 |
| Four Years Prior | 1,849 | 739 |
| Prior | 1,756 | 1,384 |
| Revolving Loans | 201 | 122 |
| Recording investment gross of allowance for credit losses | 6,980 | 6,696 |
| Agricultural property loans | 1.0X to 1.2X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 56 |
| One Years Prior | 19 | 63 |
| Two Years Prior | 40 | 530 |
| Three Years Prior | 65 | 45 |
| Four Years Prior | 62 | 23 |
| Prior | 148 | 98 |
| Revolving Loans | 0 | 52 |
| Recording investment gross of allowance for credit losses | 334 | 867 |
| Agricultural property loans | Less than 1.0X | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 0 |
| One Years Prior | 4 | 5 |
| Two Years Prior | 16 | 61 |
| Three Years Prior | 612 | 8 |
| Four Years Prior | 58 | 41 |
| Prior | 228 | 97 |
| Revolving Loans | 43 | 0 |
| Recording investment gross of allowance for credit losses | 961 | 212 |
| Residential mortgage loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 1,561 | 0 |
| One Years Prior | 57 | 0 |
| Two Years Prior | 0 | 0 |
| Three Years Prior | 0 | 0 |
| Four Years Prior | 0 | 0 |
| Prior | 14 | 19 |
| Recording investment gross of allowance for credit losses | 1,632 | 19 |
| Performing | Residential mortgage loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 1,561 | 0 |
| One Years Prior | 57 | 0 |
| Two Years Prior | 0 | 0 |
| Three Years Prior | 0 | 0 |
| Four Years Prior | 0 | 0 |
| Prior | 14 | 19 |
| Recording investment gross of allowance for credit losses | 1,632 | 19 |
| Nonperforming | Residential mortgage loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 0 |
| One Years Prior | 0 | 0 |
| Two Years Prior | 0 | 0 |
| Three Years Prior | 0 | 0 |
| Four Years Prior | 0 | 0 |
| Prior | 0 | 0 |
| Recording investment gross of allowance for credit losses | 0 | 0 |
| 0%-59.99% | Commercial Mortgage Loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 2,816 | 2,122 |
| One Years Prior | 2,088 | 1,492 |
| Two Years Prior | 2,057 | 1,183 |
| Three Years Prior | 1,270 | 2,295 |
| Four Years Prior | 2,570 | 1,378 |
| Prior | 16,546 | 16,652 |
| Revolving Loans | 62 | 36 |
| Recording investment gross of allowance for credit losses | 27,409 | 25,158 |
| 0%-59.99% | Agricultural property loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 813 | 657 |
| One Years Prior | 624 | 371 |
| Two Years Prior | 296 | 877 |
| Three Years Prior | 977 | 2,004 |
| Four Years Prior | 1,944 | 679 |
| Prior | 1,927 | 1,491 |
| Revolving Loans | 143 | 122 |
| Recording investment gross of allowance for credit losses | 6,724 | 6,201 |
| 60%-69.99% | Commercial Mortgage Loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 3,670 | 4,726 |
| One Years Prior | 4,506 | 2,287 |
| Two Years Prior | 1,873 | 1,013 |
| Three Years Prior | 1,250 | 2,192 |
| Four Years Prior | 1,581 | 846 |
| Prior | 3,048 | 5,113 |
| Revolving Loans | 0 | 0 |
| Recording investment gross of allowance for credit losses | 15,928 | 16,177 |
| 60%-69.99% | Agricultural property loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 76 | 87 |
| One Years Prior | 140 | 555 |
| Two Years Prior | 554 | 125 |
| Three Years Prior | 8 | 10 |
| Four Years Prior | 15 | 53 |
| Prior | 85 | 43 |
| Revolving Loans | 58 | 0 |
| Recording investment gross of allowance for credit losses | 936 | 873 |
| 70%-79.99% | Commercial Mortgage Loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 677 | 809 |
| One Years Prior | 711 | 1,326 |
| Two Years Prior | 1,242 | 953 |
| Three Years Prior | 506 | 1,327 |
| Four Years Prior | 901 | 446 |
| Prior | 1,948 | 2,293 |
| Revolving Loans | 0 | 0 |
| Recording investment gross of allowance for credit losses | 5,985 | 7,154 |
| 70%-79.99% | Agricultural property loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 0 |
| One Years Prior | 0 | 0 |
| Two Years Prior | 0 | 0 |
| Three Years Prior | 0 | 6 |
| Four Years Prior | 0 | 0 |
| Prior | 16 | 3 |
| Revolving Loans | 0 | 0 |
| Recording investment gross of allowance for credit losses | 16 | 9 |
| 80% or greater | Commercial Mortgage Loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 0 | 48 |
| One Years Prior | 36 | 135 |
| Two Years Prior | 0 | 482 |
| Three Years Prior | 258 | 216 |
| Four Years Prior | 454 | 281 |
| Prior | 4,433 | 4,407 |
| Revolving Loans | 0 | 0 |
| Recording investment gross of allowance for credit losses | 5,181 | 5,569 |
| 80% or greater | Agricultural property loans | ||
| Financing Receivable, Credit Quality Indicator [Line Items] | ||
| Current Year | 4 | 0 |
| One Years Prior | 0 | 6 |
| Two Years Prior | 5 | 521 |
| Three Years Prior | 433 | 0 |
| Four Years Prior | 10 | 71 |
| Prior | 104 | 42 |
| Revolving Loans | 43 | 52 |
| Recording investment gross of allowance for credit losses | $ 599 | $ 692 |
Investments (Amortized Cost Basis of Loan Modifications made to Borrowers Experiencing Financial Difficulties) (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Term Extension | Commercial mortgage loans | ||
| Financing Receivable, Modified, Subsequent Default [Line Items] | ||
| Amortized cost basis | $ 0 | $ 337 |
| % of Amortized Cost | 0.00% | 0.10% |
| Term Extension | Agricultural property loans | ||
| Financing Receivable, Modified, Subsequent Default [Line Items] | ||
| Amortized cost basis | $ 0 | $ 3 |
| % of Amortized Cost | 0.00% | 0.00% |
| Other Than Insignificant Delay in Payment | Commercial mortgage loans | ||
| Financing Receivable, Modified, Subsequent Default [Line Items] | ||
| Amortized cost basis | $ 0 | $ 63 |
| Other Than Insignificant Delay in Payment | Agricultural property loans | ||
| Financing Receivable, Modified, Subsequent Default [Line Items] | ||
| Amortized cost basis | $ 0 | $ 0 |
Investments (Analysis of Past Due Commercial Mortgage and Other Loans) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Financing Receivable, Past Due [Line Items] | ||
| Total | $ 65,184 | $ 62,915 |
| Non-Accrual Status | 1,090 | 1,012 |
| Current | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 64,196 | 61,967 |
| 30-59 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 10 | 0 |
| 60-89 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 0 | 24 |
| 90 days or more past due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 978 | 924 |
| Total Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 988 | 948 |
| Commercial Mortgage Loans | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 54,503 | 54,058 |
| Non-Accrual Status | 190 | 220 |
| Commercial Mortgage Loans | Current | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 54,349 | 53,873 |
| Commercial Mortgage Loans | 30-59 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 0 | 0 |
| Commercial Mortgage Loans | 60-89 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 0 | 3 |
| Commercial Mortgage Loans | 90 days or more past due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 154 | 182 |
| Commercial Mortgage Loans | Total Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 154 | 185 |
| Agricultural property loans | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 8,275 | 7,775 |
| Non-Accrual Status | 875 | 767 |
| Agricultural property loans | Current | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 7,443 | 7,012 |
| Agricultural property loans | 30-59 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 8 | 0 |
| Agricultural property loans | 60-89 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 0 | 21 |
| Agricultural property loans | 90 days or more past due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 824 | 742 |
| Agricultural property loans | Total Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 832 | 763 |
| Residential property loans | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 1,632 | 19 |
| Non-Accrual Status | 0 | 0 |
| Residential property loans | Current | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 1,630 | 19 |
| Residential property loans | 30-59 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 2 | 0 |
| Residential property loans | 60-89 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 0 | 0 |
| Residential property loans | 90 days or more past due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 0 | 0 |
| Residential property loans | Total Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 2 | 0 |
| Other collateralized loans | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 603 | 468 |
| Non-Accrual Status | 0 | 0 |
| Other collateralized loans | Current | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 603 | 468 |
| Other collateralized loans | 30-59 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 0 | 0 |
| Other collateralized loans | 60-89 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 0 | 0 |
| Other collateralized loans | 90 days or more past due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 0 | 0 |
| Other collateralized loans | Total Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 0 | 0 |
| Uncollateralized loans | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 171 | 595 |
| Non-Accrual Status | 25 | 25 |
| Uncollateralized loans | Current | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 171 | 595 |
| Uncollateralized loans | 30-59 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 0 | 0 |
| Uncollateralized loans | 60-89 Days Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 0 | 0 |
| Uncollateralized loans | 90 days or more past due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 0 | 0 |
| Uncollateralized loans | Total Past Due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Total | 0 | 0 |
| Loans | 90 days or more past due | ||
| Financing Receivable, Past Due [Line Items] | ||
| Accruing Interest | $ 0 | $ 0 |
Investments (Other Invested Assets) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
||
|---|---|---|---|---|
| Other Invested Assets [Line Items] | ||||
| Other invested assets | [1] | $ 27,294 | $ 26,351 | |
| LPs/LLCs | ||||
| Other Invested Assets [Line Items] | ||||
| Other invested assets | 20,124 | 20,526 | ||
| Real estate held through direct ownership | ||||
| Other Invested Assets [Line Items] | ||||
| Other invested assets | 1,888 | 1,743 | ||
| Alternative assets | ||||
| Other Invested Assets [Line Items] | ||||
| Other invested assets | 22,012 | 22,269 | ||
| Credit-like instruments | ||||
| Other Invested Assets [Line Items] | ||||
| Other invested assets | 1,929 | 933 | ||
| Derivative instruments | ||||
| Other Invested Assets [Line Items] | ||||
| Other invested assets | 1,667 | 1,597 | ||
| Other invested assets | ||||
| Other Invested Assets [Line Items] | ||||
| Other invested assets | 1,686 | 1,552 | ||
| Mortgage Debt | Real estate-related | ||||
| Other Invested Assets [Line Items] | ||||
| Other invested assets | 217 | 185 | ||
| Equity method | LPs/LLCs | ||||
| Other Invested Assets [Line Items] | ||||
| Other invested assets | 16,502 | 16,419 | ||
| Equity method | Private equity | LPs/LLCs | ||||
| Other Invested Assets [Line Items] | ||||
| Other invested assets | 10,832 | 10,615 | ||
| Equity method | Hedge funds | LPs/LLCs | ||||
| Other Invested Assets [Line Items] | ||||
| Other invested assets | 2,909 | 3,143 | ||
| Equity method | Real estate-related | LPs/LLCs | ||||
| Other Invested Assets [Line Items] | ||||
| Other invested assets | 2,761 | 2,661 | ||
| Fair Value | ||||
| Other Invested Assets [Line Items] | ||||
| Other invested assets | 93 | 95 | ||
| Fair Value | LPs/LLCs | ||||
| Other Invested Assets [Line Items] | ||||
| Other invested assets | 3,622 | 4,107 | ||
| Fair Value | Private equity | LPs/LLCs | ||||
| Other Invested Assets [Line Items] | ||||
| Other invested assets | 848 | 1,076 | ||
| Fair Value | Hedge funds | LPs/LLCs | ||||
| Other Invested Assets [Line Items] | ||||
| Other invested assets | 1,964 | 2,080 | ||
| Fair Value | Real estate-related | LPs/LLCs | ||||
| Other Invested Assets [Line Items] | ||||
| Other invested assets | $ 810 | $ 951 | ||
| ||||
Investments (Equity Method Investments, Statement of Financial Position) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Schedule of Equity Method Investments [Line Items] | ||
| Total assets | $ 773,740 | $ 735,587 |
| Total liabilities | 738,159 | 705,461 |
| Partner's Capital | 32,438 | 27,872 |
| Total liabilities and partner's capital | 773,740 | 735,587 |
| LP/LLC Interests | ||
| Schedule of Equity Method Investments [Line Items] | ||
| Total liabilities and partners’ capital included above | 17,131 | 16,586 |
| Equity in LP/LLC interests not included above | 787 | 1,003 |
| Carrying value | 17,918 | 17,589 |
| Equity Method Investment | ||
| Schedule of Equity Method Investments [Line Items] | ||
| Total assets | 1,056,789 | 803,096 |
| Total liabilities | 102,261 | 59,358 |
| Partner's Capital | 954,528 | 743,738 |
| Total liabilities and partner's capital | $ 1,056,789 | $ 803,096 |
Investments (Equity Method Investments, Statement of Operations) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Investments [Abstract] | |||
| Total revenues | $ 118,643 | $ 86,249 | $ 43,325 |
| Total expenses | (35,549) | (22,327) | (14,551) |
| Net earnings (losses) | 83,094 | 63,922 | 28,774 |
| Equity in net earnings (losses) of LP/LLC interests included above | 1,460 | 1,112 | 620 |
| Equity in net earnings (losses) of LP/LLC interests not included above | (132) | (245) | 22 |
| Total equity in net earnings (loss) | $ 1,328 | $ 867 | $ 642 |
Investments (Accrued Investment Income) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
||
|---|---|---|---|---|
| Net Investment Income [Line Items] | ||||
| Accrued investment income | [1] | $ 3,636 | $ 3,441 | |
| Fixed maturities | ||||
| Net Investment Income [Line Items] | ||||
| Accrued investment income | 3,089 | 2,892 | ||
| Equity securities | ||||
| Net Investment Income [Line Items] | ||||
| Accrued investment income | 11 | 8 | ||
| Commercial mortgage and other loans | ||||
| Net Investment Income [Line Items] | ||||
| Accrued investment income | 250 | 228 | ||
| Policy loans | ||||
| Net Investment Income [Line Items] | ||||
| Accrued investment income | 230 | 236 | ||
| Other invested assets | ||||
| Net Investment Income [Line Items] | ||||
| Accrued investment income | 10 | 12 | ||
| Short-term investments and cash equivalents | ||||
| Net Investment Income [Line Items] | ||||
| Accrued investment income | $ 46 | $ 65 | ||
| ||||
Investments (Net Investment Income) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | $ 22,948 | $ 21,345 | $ 19,066 |
| Less: investment expenses | (1,475) | (1,436) | (1,201) |
| Net investment income | 21,473 | 19,909 | 17,865 |
| Assets supporting experience-rated contractholder liabilities | |||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | 60 | 56 | 45 |
| Equity securities | |||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | 200 | 206 | 197 |
| Commercial mortgage and other loans | |||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | 2,842 | 2,591 | 2,279 |
| Policy loans | |||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | 484 | 492 | 499 |
| Other invested assets | |||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | 1,968 | 1,326 | 1,347 |
| Short-term investments and cash equivalents | |||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | 958 | 1,171 | 954 |
| Available-for-sale | Fixed maturities | |||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | 15,700 | 14,948 | 13,305 |
| Held-to-maturity | Fixed maturities | |||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | 0 | 0 | 148 |
| Trading | Fixed maturities | |||
| Schedule of Investment Income, Reported Amounts, by Category [Line Items] | |||
| Gross investment income | $ 736 | $ 555 | $ 292 |
Investments (Realized Investment Gains Losses Net) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||
| Gain (Loss) on Securities [Line Items] | |||||||
| Realized investment gains (losses), net | [1],[2] | $ (4,132) | $ (3,429) | $ (3,615) | |||
| Fixed maturities | |||||||
| Gain (Loss) on Securities [Line Items] | |||||||
| Realized investment gains (losses), net | (900) | (3,272) | (1,311) | ||||
| Commercial mortgage and other loans | |||||||
| Gain (Loss) on Securities [Line Items] | |||||||
| Realized investment gains (losses), net | (151) | (236) | (255) | ||||
| Investment real estate | |||||||
| Gain (Loss) on Securities [Line Items] | |||||||
| Realized investment gains (losses), net | (10) | 0 | 45 | ||||
| LPs/LLCs | |||||||
| Gain (Loss) on Securities [Line Items] | |||||||
| Realized investment gains (losses), net | 25 | 57 | 72 | ||||
| Derivatives | |||||||
| Gain (Loss) on Securities [Line Items] | |||||||
| Realized investment gains (losses), net | (2,513) | 678 | (2,234) | ||||
| Ceded income on modified coinsurance assets | |||||||
| Gain (Loss) on Securities [Line Items] | |||||||
| Realized investment gains (losses), net | (597) | (654) | 54 | ||||
| Other | |||||||
| Gain (Loss) on Securities [Line Items] | |||||||
| Realized investment gains (losses), net | $ 14 | $ (2) | $ 14 | ||||
| |||||||
Investments (Net Unrealized Gains Losses on Investments) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|---|
| Gain (Loss) on Securities [Line Items] | |||
| Net unrealized gains (losses) on investments | $ (26,645) | $ (27,281) | $ (17,251) |
| Fixed maturities | Available-for-sale | With an allowance | |||
| Gain (Loss) on Securities [Line Items] | |||
| Net unrealized gains (losses) on investments | (4) | 6 | (72) |
| Fixed maturities | Available-for-sale | Without an allowance | |||
| Gain (Loss) on Securities [Line Items] | |||
| Net unrealized gains (losses) on investments | (26,354) | (29,109) | (18,045) |
| Derivatives designated as cash flow hedges | |||
| Gain (Loss) on Securities [Line Items] | |||
| Net unrealized gains (losses) on investments | (231) | 1,780 | 869 |
| Derivatives designated as fair value hedges | |||
| Gain (Loss) on Securities [Line Items] | |||
| Net unrealized gains (losses) on investments | (123) | (64) | (60) |
| Other investments | |||
| Gain (Loss) on Securities [Line Items] | |||
| Net unrealized gains (losses) on investments | $ 67 | $ 106 | $ 57 |
Investments (Repurchase Agreements and Securities Lending Transactions) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | $ 9,598 | $ 6,796 |
| Total cash collateral for loaned securities | 8,700 | 9,621 |
| Overnight & Continuous | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 7,352 | 6,450 |
| Total cash collateral for loaned securities | 8,532 | 9,094 |
| Up to 30 Days | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 2,246 | 346 |
| Total cash collateral for loaned securities | 168 | 527 |
| 30 to 90 Days | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 0 | 0 |
| Total cash collateral for loaned securities | 0 | 0 |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 8,978 | 6,450 |
| Total cash collateral for loaned securities | 0 | 1 |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | Overnight & Continuous | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 7,277 | 6,450 |
| Total cash collateral for loaned securities | 0 | 1 |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | Up to 30 Days | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 1,701 | 0 |
| Total cash collateral for loaned securities | 0 | 0 |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | 30 to 90 Days | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 0 | 0 |
| Obligations of U.S. states and their political subdivisions | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 45 | 46 |
| Obligations of U.S. states and their political subdivisions | Overnight & Continuous | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 45 | 46 |
| Obligations of U.S. states and their political subdivisions | Up to 30 Days | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 0 |
| Foreign government securities | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 226 | 128 |
| Foreign government securities | Overnight & Continuous | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 226 | 122 |
| Foreign government securities | Up to 30 Days | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 0 | 6 |
| U.S. public corporate securities | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 527 | 327 |
| Total cash collateral for loaned securities | 7,220 | 7,909 |
| U.S. public corporate securities | Overnight & Continuous | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 0 | 0 |
| Total cash collateral for loaned securities | 7,068 | 7,506 |
| U.S. public corporate securities | Up to 30 Days | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 527 | 327 |
| Total cash collateral for loaned securities | 152 | 403 |
| U.S. public corporate securities | 30 to 90 Days | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 0 | 0 |
| Foreign public corporate securities | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 18 | 19 |
| Total cash collateral for loaned securities | 1,173 | 1,299 |
| Foreign public corporate securities | Overnight & Continuous | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 0 | 0 |
| Total cash collateral for loaned securities | 1,157 | 1,181 |
| Foreign public corporate securities | Up to 30 Days | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 18 | 19 |
| Total cash collateral for loaned securities | 16 | 118 |
| Foreign public corporate securities | 30 to 90 Days | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 0 | 0 |
| Commercial mortgage-backed securities | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 75 | 0 |
| Commercial mortgage-backed securities | Overnight & Continuous | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 75 | 0 |
| Commercial mortgage-backed securities | Up to 30 Days | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 0 | 0 |
| Commercial mortgage-backed securities | 30 to 90 Days | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total securities sold under agreements to repurchase | 0 | 0 |
| Equity securities | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 36 | 238 |
| Equity securities | Overnight & Continuous | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | 36 | 238 |
| Equity securities | Up to 30 Days | ||
| Transfer Of Certain Financial Assets Accounted For As Secured Borrowings [Line Items] | ||
| Total cash collateral for loaned securities | $ 0 | $ 0 |
Investments (Securities Pledged) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total securities pledged | $ 31,116 | $ 24,718 |
| Total liabilities supported by the pledged collateral | 27,482 | 24,234 |
| Separate account assets | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total securities pledged | 275 | 442 |
| Equity securities | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total securities pledged | 244 | 476 |
| Short-term Investments | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total securities pledged | 0 | 351 |
| Other | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total securities pledged | 319 | 357 |
| Total liabilities supported by the pledged collateral | 6,215 | 4,762 |
| Securities sold under agreements to repurchase | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total liabilities supported by the pledged collateral | 9,598 | 6,796 |
| Cash collateral for loaned securities | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total liabilities supported by the pledged collateral | 8,700 | 9,621 |
| Policyholders’ account balances | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total liabilities supported by the pledged collateral | 2,501 | 2,501 |
| Separate account liabilities | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total liabilities supported by the pledged collateral | 284 | 454 |
| Short-term Debt | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total liabilities supported by the pledged collateral | 0 | 1 |
| Long-term Debt | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total liabilities supported by the pledged collateral | 184 | 99 |
| Trading | Fixed maturities | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total securities pledged | 231 | 201 |
| Available-for-sale | Fixed maturities | ||
| Financial Instruments Owned and Pledged as Collateral [Line Items] | ||
| Total securities pledged | $ 30,047 | $ 22,891 |
Investments (Assets on Deposit, Held in Trust and Restricted as to Sale) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Assets on Deposit, Held in Trust and Restricted as to Sale [Line Items] | ||
| Assets on deposit with governmental authorities or trustees | $ 11 | $ 10 |
| Assets held in voluntary trusts | 548 | 533 |
| Assets held in trust related to reinsurance and other agreements | 13,564 | 13,236 |
| Securities restricted as to sale | 141 | 142 |
| Total assets on deposit, assets held in trust and securities restricted as to sale | 14,264 | 13,921 |
| Wholly-owned subsidiaries | ||
| Assets on Deposit, Held in Trust and Restricted as to Sale [Line Items] | ||
| Assets held in trust related to reinsurance and other agreements | $ 15,000 | $ 16,000 |
Variable Interest Entities (Assets and Liabilities of Consolidated VIEs) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||||
| Variable Interest Entity [Line Items] | |||||||||
| Fixed Maturities, available-for-sale, at fair value | [1] | $ 331,455 | $ 311,570 | ||||||
| Fixed maturities, trading | [1] | 14,869 | 12,530 | ||||||
| Equity securities | [1] | 10,972 | 9,417 | ||||||
| Commercial mortgage and other loans | [1] | 64,715 | 62,341 | ||||||
| Other invested assets | [1] | 27,294 | 26,351 | ||||||
| Cash and cash equivalents | 19,712 | [1] | 18,497 | [1] | $ 19,419 | ||||
| Accrued investment income | [1] | 3,636 | 3,441 | ||||||
| Other assets | [1],[2] | 15,009 | 13,737 | ||||||
| Total assets | 773,740 | 735,587 | |||||||
| Other Liabilities | [1] | 17,692 | 16,679 | ||||||
| Notes Issued by Consolidated Variable Interest Entities | [1] | 2,659 | 1,430 | ||||||
| Total liabilities | 738,159 | 705,461 | |||||||
| Consolidated VIEs for Which the Company is the Investment Manager | |||||||||
| Variable Interest Entity [Line Items] | |||||||||
| Fixed Maturities, available-for-sale, at fair value | 1,870 | 1,250 | |||||||
| Fixed maturities, trading | 442 | 166 | |||||||
| Equity securities | 106 | 80 | |||||||
| Commercial mortgage and other loans | 583 | 681 | |||||||
| Other invested assets | 8,227 | 6,379 | |||||||
| Cash and cash equivalents | 654 | 308 | |||||||
| Accrued investment income | 12 | 6 | |||||||
| Other assets | 1,594 | 644 | |||||||
| Total assets | 13,488 | 9,514 | |||||||
| Other Liabilities | 603 | 218 | |||||||
| Notes Issued by Consolidated Variable Interest Entities | 2,644 | 1,392 | |||||||
| Total liabilities | 3,247 | 1,610 | |||||||
| Consolidated VIEs for Which the Company is the Investment Manager | Wholly-owned Beneficial Interests | |||||||||
| Variable Interest Entity [Line Items] | |||||||||
| Total assets | 4,801 | 3,835 | |||||||
| Other Consolidated VIEs | |||||||||
| Variable Interest Entity [Line Items] | |||||||||
| Fixed Maturities, available-for-sale, at fair value | 663 | 716 | |||||||
| Fixed maturities, trading | 0 | 0 | |||||||
| Equity securities | 0 | 0 | |||||||
| Commercial mortgage and other loans | 244 | 490 | |||||||
| Other invested assets | 477 | 500 | |||||||
| Cash and cash equivalents | 0 | 0 | |||||||
| Accrued investment income | 1 | 3 | |||||||
| Other assets | 716 | 613 | |||||||
| Total assets | 2,101 | 2,322 | |||||||
| Other Liabilities | 3 | 1 | |||||||
| Notes Issued by Consolidated Variable Interest Entities | 15 | 38 | |||||||
| Total liabilities | $ 18 | $ 39 | |||||||
| Minimum | Consolidated VIEs for Which the Company is the Investment Manager | Notes issued by consolidated VIEs | |||||||||
| Variable Interest Entity [Line Items] | |||||||||
| VIE Liabilities, maturities obligations (between) | 0 years | ||||||||
| Maximum | Consolidated VIEs for Which the Company is the Investment Manager | Notes issued by consolidated VIEs | |||||||||
| Variable Interest Entity [Line Items] | |||||||||
| VIE Liabilities, maturities obligations (between) | 14 years | ||||||||
| |||||||||
Variable Interest Entities (Narrative) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Variable Interest Entity [Line Items] | ||
| Liabilities | $ 738,159 | $ 705,461 |
| Unconsolidated VIEs | ||
| Variable Interest Entity [Line Items] | ||
| Liabilities | 102,261 | 59,358 |
| Unconsolidated VIEs | Company may or may not be the investment manager of certain VIEs | ||
| Variable Interest Entity [Line Items] | ||
| Liabilities | 0 | |
| Fixed maturities, available-for-sale, Fixed maturities, trading, Equity securities and Other invested assets | Unconsolidated VIEs | Company may or may not be the investment manager of certain VIEs | ||
| Variable Interest Entity [Line Items] | ||
| Maximum exposure to loss resulting from investment in unconsolidated VIEs | 1,484 | 1,529 |
| Other invested assets | Unconsolidated VIEs | ||
| Variable Interest Entity [Line Items] | ||
| Maximum exposure to loss resulting from investment in unconsolidated VIEs | $ 20,509 | $ 21,847 |
Derivative Instruments (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||
| Total derivative assets | $ 1,671 | $ 1,601 | |
| Total derivative liabilities | 6,215 | 4,751 | |
| Anticipated pre-tax loss reclassified from accumulated other comprehensive income (loss) to earnings | $ 281 | ||
| Maximum Length of Time Hedged in Cash Flow Hedge (future cash flows) | 26 years | ||
| Net investment hedges income (loss) before taxes | $ (49) | $ 104 | $ 39 |
Derivative Instruments (Gross Notional Amount and Fair Value of Derivatives Contracts) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Derivative [Line Items] | ||
| Gross Notional | $ 676,411 | $ 548,831 |
| Assets | 26,116 | 21,694 |
| Liabilities | (39,157) | (32,892) |
| Embedded Derivative, Fair Value of Embedded Derivative, Net | (18,404) | (11,783) |
| PRISMIC Embedded Derivative, Fair Value of Embedded Derivative | (194) | 91 |
| Derivatives Designated as Hedge Accounting Instruments: | ||
| Derivative [Line Items] | ||
| Gross Notional | 43,828 | 40,342 |
| Assets | 1,337 | 2,755 |
| Liabilities | (1,992) | (969) |
| Derivatives Designated as Hedge Accounting Instruments: | Interest Rate Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 5,083 | 4,260 |
| Assets | 23 | 11 |
| Liabilities | (344) | (404) |
| Derivatives Designated as Hedge Accounting Instruments: | Interest Rate Forwards | ||
| Derivative [Line Items] | ||
| Gross Notional | 10 | 10 |
| Assets | 0 | 0 |
| Liabilities | 0 | 0 |
| Derivatives Designated as Hedge Accounting Instruments: | Foreign Currency Forwards | ||
| Derivative [Line Items] | ||
| Gross Notional | 4,912 | 4,771 |
| Assets | 28 | 92 |
| Liabilities | (208) | (197) |
| Derivatives Designated as Hedge Accounting Instruments: | Foreign Currency Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 33,823 | 31,301 |
| Assets | 1,286 | 2,652 |
| Liabilities | (1,440) | (368) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | ||
| Derivative [Line Items] | ||
| Gross Notional | 632,583 | 508,489 |
| Assets | 24,779 | 18,939 |
| Liabilities | (37,165) | (31,923) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 244,336 | 228,392 |
| Assets | 10,825 | 11,272 |
| Liabilities | (23,617) | (24,802) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Forwards | ||
| Derivative [Line Items] | ||
| Gross Notional | 3,658 | 2,544 |
| Assets | 11 | 9 |
| Liabilities | (7) | (80) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Total Return Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 1,434 | 485 |
| Assets | 217 | 4 |
| Liabilities | (221) | (2) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Foreign Currency Forwards | ||
| Derivative [Line Items] | ||
| Gross Notional | 34,149 | 27,819 |
| Assets | 1,356 | 1,625 |
| Liabilities | (1,383) | (1,181) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Foreign Currency Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 7,318 | 7,525 |
| Assets | 370 | 658 |
| Liabilities | (179) | (129) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Futures | ||
| Derivative [Line Items] | ||
| Gross Notional | 12,079 | 9,773 |
| Assets | 7 | 6 |
| Liabilities | (22) | (21) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Interest Rate Options | ||
| Derivative [Line Items] | ||
| Gross Notional | 30,025 | 34,005 |
| Assets | 134 | 430 |
| Liabilities | (1,382) | (1,583) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Credit Default Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 5,784 | 4,027 |
| Assets | 112 | 90 |
| Liabilities | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity Futures | ||
| Derivative [Line Items] | ||
| Gross Notional | 1,033 | 2,019 |
| Assets | 3 | 6 |
| Liabilities | (6) | (7) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity Options | ||
| Derivative [Line Items] | ||
| Gross Notional | 200,661 | 104,438 |
| Assets | 10,378 | 4,507 |
| Liabilities | (9,189) | (3,790) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Equity Total Return Swaps | ||
| Derivative [Line Items] | ||
| Gross Notional | 14,973 | 9,796 |
| Assets | 1,366 | 331 |
| Liabilities | (1,159) | (327) |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Other | ||
| Derivative [Line Items] | ||
| Gross Notional | 1,250 | 1,250 |
| Assets | 0 | 0 |
| Liabilities | 0 | 0 |
| Derivatives Not Qualifying as Hedge Accounting Instruments: | Synthetic GICs | ||
| Derivative [Line Items] | ||
| Gross Notional | 75,883 | 76,416 |
| Assets | 0 | 1 |
| Liabilities | $ 0 | $ (1) |
Derivative Instruments Derivative Instruments (Hedged Item Offset By Derivatives Achieving Fair Value Hedge Accounting) (Details) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
||
|---|---|---|---|---|---|
| Derivative [Line Items] | |||||
| Fixed Maturities, available-for-sale, at fair value | [1] | $ 331,455 | $ 311,570 | ||
| Commercial mortgage and other loans | [1] | 64,715 | 62,341 | ||
| Policyholders’ account balances | (191,307) | (166,254) | |||
| Future policy benefits | (266,914) | (268,912) | $ (273,281) | ||
| Carrying Amount of the Hedged Assets (Liabilities) | |||||
| Derivative [Line Items] | |||||
| Fixed Maturities, available-for-sale, at fair value | 594 | 216 | |||
| Policyholders’ account balances | (1,588) | (1,510) | |||
| Future policy benefits | (2,405) | (2,280) | |||
| Cumulative Adjustment Included in Carrying Amount | |||||
| Derivative [Line Items] | |||||
| Fixed Maturities, available-for-sale, at fair value | 11 | 11 | |||
| Policyholders’ account balances | 299 | 327 | |||
| Future policy benefits | $ 300 | $ 423 | |||
| |||||
Derivative Instruments (Offsetting Assets and Liabilities) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Derivative Assets | ||
| Gross Amounts of Recognized Financial Instruments | $ 25,990 | $ 21,574 |
| Gross Amounts Offset in the Statements of Financial Position | (24,445) | (20,093) |
| Net Amounts Presented in the Statements of Financial Position | 1,545 | 1,481 |
| Financial Instruments/Collateral | (637) | (696) |
| Net Amount | 908 | 785 |
| Securities purchased under agreement to resell | ||
| Gross Amounts of Recognized Financial Instruments | 0 | 277 |
| Gross Amounts Offset in the Statements of Financial Position | 0 | 0 |
| Net Amounts Presented in the Statements of Financial Position | 0 | 277 |
| Financial Instruments/Collateral | 0 | (277) |
| Net Amount | 0 | 0 |
| Total Assets | ||
| Gross Amounts of Recognized Financial Instruments | 25,990 | 21,851 |
| Gross Amounts Offset in the Statements of Financial Position | (24,445) | (20,093) |
| Net Amounts Presented in the Statements of Financial Position | 1,545 | 1,758 |
| Financial Instruments/Collateral | (637) | (973) |
| Net Amount | 908 | 785 |
| Derivative Liabilities | ||
| Gross Amounts of Recognized Financial Instruments | 39,157 | 32,891 |
| Gross Amounts Offset in the Statements of Financial Position | (32,942) | (28,141) |
| Net Amounts Presented in the Statements of Financial Position | 6,215 | 4,750 |
| Financial Instruments/Collateral | (6,011) | (4,403) |
| Net Amount | 204 | 347 |
| Securities sold under agreement to repurchase | ||
| Gross Amounts of Recognized Financial Instruments | 9,598 | 6,796 |
| Gross Amounts Offset in the Statements of Financial Position | 0 | 0 |
| Net Amounts Presented in the Statements of Financial Position | 9,598 | 6,796 |
| Financial Instruments/Collateral | (9,523) | (6,796) |
| Net Amount | 75 | 0 |
| Total Liabilities | ||
| Gross Amounts of Recognized Financial Instruments | 48,755 | 39,687 |
| Gross Amounts Offset in the Statements of Financial Position | (32,942) | (28,141) |
| Net Amounts Presented in the Statements of Financial Position | 15,813 | 11,546 |
| Financial Instruments/Collateral | (15,534) | (11,199) |
| Net Amount | $ 279 | $ 347 |
Derivative Instruments (Financial Statement Classification and Impact of Derivatives Used in Qualifying and Non-qualifying Hedge Relationships) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Derivative Instruments Gain Loss [Line Items] | |||
| Non-derivative AOCI Net Investment Hedge Before Tax | $ (3) | $ 78 | $ 28 |
| PRISMIC Embedded Derivative, Gain (Loss) on Derivative, Net | (284) | 598 | (508) |
| Gain (Loss) on Investments | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ (2,291) | $ 678 | $ (2,220) |
| Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Realized Investment Gains (Losses) | Realized Investment Gains (Losses) | Realized Investment Gains (Losses) |
| Gain (Loss) on Investments | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ (2,295) | $ 615 | $ (2,281) |
| Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ (1,645) | $ (3,165) | $ (2,586) |
| Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Change in value of market risk benefits, net of related hedging gains (losses) | Change in value of market risk benefits, net of related hedging gains (losses) | Change in value of market risk benefits, net of related hedging gains (losses) |
| Market Risk Benefit, Increase (Decrease) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ (1,645) | $ (3,165) | $ (2,586) |
| Investment Income | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ 355 | $ 324 | $ 312 |
| Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Net Investment Income | Net Investment Income | Net Investment Income |
| Investment Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ 0 | $ 0 | $ 0 |
| Other Income | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ (468) | $ 209 | $ (189) |
| Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Other income (loss) | Other income (loss) | Other income (loss) |
| Other Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ (8) | $ 2 | $ 0 |
| Interest Expense | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ 0 | $ 0 | $ 0 |
| Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | General and Administrative Expense | General and Administrative Expense | General and Administrative Expense |
| Interest Expense | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ 0 | $ 0 | $ 0 |
| Interest Credited To Policyholder Account Balances | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ (8) | $ (10) | $ (29) |
| Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Policyholder Account Balance, Interest Expense | Policyholder Account Balance, Interest Expense | Policyholder Account Balance, Interest Expense |
| Interest Credited To Policyholder Account Balances | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ 0 | $ 0 | $ 0 |
| Policyholder Benefts | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ (19) | $ (40) | $ (35) |
| Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Policyholders’ benefits | Policyholders’ benefits | Policyholders’ benefits |
| Policyholder Benefts | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ 0 | $ 0 | $ 0 |
| Accumulated Other Comprehensive Income (Loss) | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ (2,117) | $ 934 | $ (1,741) |
| Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Other Comprehensive Income (Loss), Net of Tax | Other Comprehensive Income (Loss), Net of Tax | Other Comprehensive Income (Loss), Net of Tax |
| Accumulated Other Comprehensive Income (Loss) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ 0 | $ 0 | $ 0 |
| Fair value hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (5) | 8 | 1 |
| Fair value hedges | Market Risk Benefit, Increase (Decrease) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Fair value hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 1 | 0 | (1) |
| Fair value hedges | Other Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Fair value hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Fair value hedges | Interest Credited To Policyholder Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 20 | (119) | (31) |
| Fair value hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 127 | (156) | 65 |
| Fair value hedges | Accumulated Other Comprehensive Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Fair Value Hedged Item | Gain (Loss) on Investments | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 2 | (8) | (1) |
| Change In Unrealized Gain (Loss) On Hedged Item In Fair Value Net Of Hedging Instrument | (3) | 0 | 0 |
| Fair Value Hedged Item | Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
| Change In Unrealized Gain (Loss) On Hedged Item In Fair Value Net Of Hedging Instrument | 0 | 0 | 0 |
| Fair Value Hedged Item | Investment Income | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 21 | 12 | 14 |
| Change In Unrealized Gain (Loss) On Hedged Item In Fair Value Net Of Hedging Instrument | 22 | 12 | 13 |
| Fair Value Hedged Item | Other Income | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
| Change In Unrealized Gain (Loss) On Hedged Item In Fair Value Net Of Hedging Instrument | 0 | 0 | 0 |
| Fair Value Hedged Item | Interest Expense | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
| Change In Unrealized Gain (Loss) On Hedged Item In Fair Value Net Of Hedging Instrument | 0 | 0 | 0 |
| Fair Value Hedged Item | Interest Credited To Policyholder Account Balances | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | (28) | 109 | 2 |
| Change In Unrealized Gain (Loss) On Hedged Item In Fair Value Net Of Hedging Instrument | (8) | (10) | (29) |
| Fair Value Hedged Item | Policyholder Benefts | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | (132) | 126 | (92) |
| Change In Unrealized Gain (Loss) On Hedged Item In Fair Value Net Of Hedging Instrument | (19) | (40) | (35) |
| Fair Value Hedged Item | Accumulated Other Comprehensive Income (Loss) | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
| Change In Unrealized Gain (Loss) On Hedged Item In Fair Value Net Of Hedging Instrument | (59) | (4) | (6) |
| Amortization of Gain(loss) excluded from assessment of effectiveness | Gain (Loss) on Investments | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Amortization of Gain(loss) excluded from assessment of effectiveness | Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Amortization of Gain(loss) excluded from assessment of effectiveness | Investment Income | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Amortization of Gain(loss) excluded from assessment of effectiveness | Other Income | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Amortization of Gain(loss) excluded from assessment of effectiveness | Interest Expense | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Amortization of Gain(loss) excluded from assessment of effectiveness | Interest Credited To Policyholder Account Balances | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Amortization of Gain(loss) excluded from assessment of effectiveness | Policyholder Benefts | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (14) | (10) | (8) |
| Amortization of Gain(loss) excluded from assessment of effectiveness | Accumulated Other Comprehensive Income (Loss) | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (59) | (4) | (6) |
| Cash flow hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 7 | 63 | 61 |
| Cash flow hedges | Market Risk Benefit, Increase (Decrease) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Cash flow hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 333 | 312 | 299 |
| Cash flow hedges | Other Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (460) | 207 | (189) |
| Cash flow hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Cash flow hedges | Interest Credited To Policyholder Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Cash flow hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Cash flow hedges | Accumulated Other Comprehensive Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (2,011) | 911 | (1,747) |
| Net investment hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Net investment hedges | Market Risk Benefit, Increase (Decrease) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Net investment hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Net investment hedges | Other Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Net investment hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Net investment hedges | Interest Credited To Policyholder Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Net investment hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Net investment hedges | Accumulated Other Comprehensive Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (47) | 27 | 12 |
| Interest Rate | Gain (Loss) on Investments | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (47) | (1,554) | (285) |
| Interest Rate | Market Risk Benefit, Increase (Decrease) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (810) | (2,313) | (1,657) |
| Interest Rate | Investment Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Interest Rate | Other Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Interest Rate | Interest Expense | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Interest Rate | Interest Credited To Policyholder Account Balances | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Interest Rate | Policyholder Benefts | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Interest Rate | Accumulated Other Comprehensive Income (Loss) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Interest Rate | Fair value hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (5) | 8 | 2 |
| Interest Rate | Fair value hedges | Market Risk Benefit, Increase (Decrease) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Interest Rate | Fair value hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 1 | 0 | 0 |
| Interest Rate | Fair value hedges | Other Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Interest Rate | Fair value hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Interest Rate | Fair value hedges | Interest Credited To Policyholder Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 20 | (119) | (31) |
| Interest Rate | Fair value hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (1) | (125) | (39) |
| Interest Rate | Fair value hedges | Accumulated Other Comprehensive Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Interest Rate | Fair Value Hedged Item | Gain (Loss) on Investments | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 2 | (8) | (2) |
| Interest Rate | Fair Value Hedged Item | Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
| Interest Rate | Fair Value Hedged Item | Investment Income | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 21 | 12 | 13 |
| Interest Rate | Fair Value Hedged Item | Other Income | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
| Interest Rate | Fair Value Hedged Item | Interest Expense | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
| Interest Rate | Fair Value Hedged Item | Interest Credited To Policyholder Account Balances | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | (28) | 109 | 2 |
| Interest Rate | Fair Value Hedged Item | Policyholder Benefts | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | (5) | 95 | 10 |
| Interest Rate | Fair Value Hedged Item | Accumulated Other Comprehensive Income (Loss) | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
| Interest Rate | Cash flow hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | (15) | (21) |
| Interest Rate | Cash flow hedges | Market Risk Benefit, Increase (Decrease) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Interest Rate | Cash flow hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (13) | (16) | (16) |
| Interest Rate | Cash flow hedges | Other Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Interest Rate | Cash flow hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Interest Rate | Cash flow hedges | Interest Credited To Policyholder Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Interest Rate | Cash flow hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Interest Rate | Cash flow hedges | Accumulated Other Comprehensive Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 9 | 2 | 23 |
| Currency | Gain (Loss) on Investments | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (684) | 263 | (567) |
| Currency | Market Risk Benefit, Increase (Decrease) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Investment Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Other Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (1) | 0 | 3 |
| Currency | Interest Expense | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Interest Credited To Policyholder Account Balances | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Policyholder Benefts | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Accumulated Other Comprehensive Income (Loss) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Fair value hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | (1) |
| Currency | Fair value hedges | Market Risk Benefit, Increase (Decrease) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Fair value hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | (1) |
| Currency | Fair value hedges | Other Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Fair value hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Fair value hedges | Interest Credited To Policyholder Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Fair value hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 128 | (31) | 104 |
| Currency | Fair value hedges | Accumulated Other Comprehensive Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Fair Value Hedged Item | Gain (Loss) on Investments | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 1 |
| Currency | Fair Value Hedged Item | Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
| Currency | Fair Value Hedged Item | Investment Income | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 1 |
| Currency | Fair Value Hedged Item | Other Income | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
| Currency | Fair Value Hedged Item | Interest Expense | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
| Currency | Fair Value Hedged Item | Interest Credited To Policyholder Account Balances | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
| Currency | Fair Value Hedged Item | Policyholder Benefts | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | (127) | 31 | (102) |
| Currency | Fair Value Hedged Item | Accumulated Other Comprehensive Income (Loss) | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | 0 | 0 | 0 |
| Currency | Amortization of Gain(loss) excluded from assessment of effectiveness | Gain (Loss) on Investments | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Amortization of Gain(loss) excluded from assessment of effectiveness | Market Risk Benefit, Increase (Decrease) | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Amortization of Gain(loss) excluded from assessment of effectiveness | Investment Income | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Amortization of Gain(loss) excluded from assessment of effectiveness | Other Income | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Amortization of Gain(loss) excluded from assessment of effectiveness | Interest Expense | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Amortization of Gain(loss) excluded from assessment of effectiveness | Interest Credited To Policyholder Account Balances | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Amortization of Gain(loss) excluded from assessment of effectiveness | Policyholder Benefts | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (14) | (10) | (8) |
| Currency | Amortization of Gain(loss) excluded from assessment of effectiveness | Accumulated Other Comprehensive Income (Loss) | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (59) | (4) | (6) |
| Currency | Cash flow hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 8 |
| Currency | Cash flow hedges | Market Risk Benefit, Increase (Decrease) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Cash flow hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Cash flow hedges | Other Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Cash flow hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Cash flow hedges | Interest Credited To Policyholder Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Cash flow hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Cash flow hedges | Accumulated Other Comprehensive Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (107) | 52 | (122) |
| Currency | Net investment hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Net investment hedges | Market Risk Benefit, Increase (Decrease) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Net investment hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Net investment hedges | Other Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Net investment hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Net investment hedges | Interest Credited To Policyholder Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Net investment hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency | Net investment hedges | Accumulated Other Comprehensive Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (47) | 27 | 12 |
| Currency/Interest Rate | Gain (Loss) on Investments | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (267) | 292 | (211) |
| Currency/Interest Rate | Market Risk Benefit, Increase (Decrease) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Investment Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Other Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (7) | 2 | (3) |
| Currency/Interest Rate | Interest Expense | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Interest Credited To Policyholder Account Balances | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Policyholder Benefts | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Accumulated Other Comprehensive Income (Loss) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Cash flow hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 7 | 78 | 74 |
| Currency/Interest Rate | Cash flow hedges | Market Risk Benefit, Increase (Decrease) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Cash flow hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 346 | 328 | 315 |
| Currency/Interest Rate | Cash flow hedges | Other Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (460) | 207 | (189) |
| Currency/Interest Rate | Cash flow hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Cash flow hedges | Interest Credited To Policyholder Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Cash flow hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Cash flow hedges | Accumulated Other Comprehensive Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (1,913) | 857 | (1,648) |
| Currency/Interest Rate | Net investment hedges | Gain (Loss) on Investments | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Net investment hedges | Market Risk Benefit, Increase (Decrease) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Net investment hedges | Investment Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Net investment hedges | Other Income | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Net investment hedges | Interest Expense | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Net investment hedges | Interest Credited To Policyholder Account Balances | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Net investment hedges | Policyholder Benefts | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Currency/Interest Rate | Net investment hedges | Accumulated Other Comprehensive Income (Loss) | Derivatives Designated as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Credit | Gain (Loss) on Investments | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 96 | 109 | 164 |
| Credit | Market Risk Benefit, Increase (Decrease) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Credit | Investment Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Credit | Other Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Credit | Interest Expense | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Credit | Interest Credited To Policyholder Account Balances | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Credit | Policyholder Benefts | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Credit | Accumulated Other Comprehensive Income (Loss) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Equity | Gain (Loss) on Investments | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 3,441 | 3,257 | 1,751 |
| Equity | Market Risk Benefit, Increase (Decrease) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (835) | (852) | (929) |
| Equity | Investment Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Equity | Other Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Equity | Interest Expense | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Equity | Interest Credited To Policyholder Account Balances | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Equity | Policyholder Benefts | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Equity | Accumulated Other Comprehensive Income (Loss) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Embedded Derivative Financial Instruments | Gain (Loss) on Investments | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | (4,834) | (1,752) | (3,133) |
| Embedded Derivative Financial Instruments | Market Risk Benefit, Increase (Decrease) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Embedded Derivative Financial Instruments | Investment Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Embedded Derivative Financial Instruments | Other Income | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Embedded Derivative Financial Instruments | Interest Expense | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Embedded Derivative Financial Instruments | Interest Credited To Policyholder Account Balances | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Embedded Derivative Financial Instruments | Policyholder Benefts | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | 0 | 0 | 0 |
| Embedded Derivative Financial Instruments | Accumulated Other Comprehensive Income (Loss) | Derivatives Not Qualifying as Hedge Accounting Instruments: | |||
| Derivative Instruments Gain Loss [Line Items] | |||
| Derivative Instruments Gain (Loss) Recognized In Income Net | $ 0 | $ 0 | $ 0 |
Derivative Instruments (Current Period Cash Flow Hedges in AOCI (loss) before Taxes) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
| Beginning Balance | $ 28,187 | $ 28,110 | $ 30,934 |
| Ending Balance | 32,787 | 28,187 | 28,110 |
| Derivatives designated as cash flow hedges | |||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
| Beginning Balance | 1,780 | 869 | 2,616 |
| Total amount recorded in AOCI | (2,139) | 1,496 | (1,571) |
| Total amount reclassified from AOCI to income | 128 | (585) | (176) |
| Ending Balance | (231) | 1,780 | 869 |
| Interest Rate | Derivatives designated as cash flow hedges | |||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
| Total amount recorded in AOCI | (4) | (28) | (15) |
| Total amount reclassified from AOCI to income | 13 | 30 | 38 |
| Currency | Derivatives designated as cash flow hedges | |||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
| Total amount recorded in AOCI | (115) | 55 | (108) |
| Total amount reclassified from AOCI to income | 8 | (3) | (14) |
| Currency/Interest Rate | Derivatives designated as cash flow hedges | |||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | |||
| Total amount recorded in AOCI | (2,020) | 1,469 | (1,448) |
| Total amount reclassified from AOCI to income | $ 107 | $ (612) | $ (200) |
Derivative Instruments (Credit Derivatives) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | $ 5,784 | $ 4,027 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 112 | 90 |
| Single Name | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
| Credit Default Index | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 5,784 | 4,027 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | $ 112 | 90 |
| Credit Index Product | ||
| Derivative [Line Items] | ||
| Credit Derivatives Written Max Length Of Maturities | 10 years | |
| NAIC 1 | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | $ 0 | 0 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
| NAIC 1 | Single Name | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
| NAIC 1 | Credit Default Index | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
| NAIC 2 | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
| NAIC 2 | Single Name | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
| NAIC 2 | Credit Default Index | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
| NAIC 3 | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 5,043 | 3,365 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 61 | 40 |
| NAIC 3 | Single Name | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
| NAIC 3 | Credit Default Index | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 5,043 | 3,365 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 61 | 40 |
| NAIC 4 | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
| NAIC 4 | Single Name | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
| NAIC 4 | Credit Default Index | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
| NAIC 5 | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
| NAIC 5 | Single Name | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
| NAIC 5 | Credit Default Index | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 0 | 0 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
| NAIC 6 | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 741 | 662 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | $ 51 | $ 50 |
| Credit Derivative, Maximum Exposure, Undiscounted Percentage | 3.00% | 4.00% |
| NAIC 6 | Single Name | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | $ 0 | $ 0 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | 0 | 0 |
| NAIC 6 | Credit Default Index | ||
| Derivative [Line Items] | ||
| Credit Derivative, Maximum Exposure, Undiscounted | 741 | 662 |
| Credit Risk Derivatives, at Fair Value, Asset Net (Liability) | $ 51 | $ 50 |
Fair Value of Assets and Liabilities (Balances of Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
||||
|---|---|---|---|---|---|---|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | [1] | $ 331,455 | $ 311,570 | |||
| Assets supporting experience-rated contractholder liabilities | 4,842 | 3,707 | ||||
| Market risk benefit assets | 2,330 | 2,331 | ||||
| Fixed maturities, trading | [1] | 14,869 | 12,530 | |||
| Equity securities | [1] | 10,972 | 9,417 | |||
| Commercial mortgage and other loans | [1] | 64,715 | 62,341 | |||
| Other invested assets | [1] | 27,294 | 26,351 | |||
| Reinsurance recoverables and deposit receivables | [2] | 44,077 | 37,680 | |||
| Separate account assets | 196,251 | 193,372 | ||||
| TOTAL ASSETS | 773,740 | 735,587 | ||||
| Market risk benefit liabilities | 4,623 | 4,455 | ||||
| Reinsurance and funds withheld payables | [2] | 18,844 | 17,084 | |||
| Other Liabilities | [1] | 17,692 | 16,679 | |||
| Total liabilities | 738,159 | 705,461 | ||||
| Netting | (24,445) | (20,093) | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 357,996 | 341,004 | ||||
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 22,179 | 20,348 | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 26,334 | 24,869 | ||||
| Obligations of U.S. states and their political subdivisions | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 5,465 | 6,104 | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 5,881 | 6,590 | ||||
| Foreign government securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 50,614 | 57,479 | ||||
| Assets supporting experience-rated contractholder liabilities | 596 | 539 | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 62,469 | 63,523 | ||||
| U.S. public corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 107,781 | 98,508 | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 115,160 | 108,883 | ||||
| U.S. private corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 47,101 | 43,789 | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 47,976 | 45,854 | ||||
| Foreign public corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 23,703 | 21,982 | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 24,496 | 23,165 | ||||
| Foreign private corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 40,159 | 34,463 | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 41,099 | 38,652 | ||||
| Corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Assets supporting experience-rated contractholder liabilities | 55 | 67 | ||||
| Asset-backed securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 19,329 | 17,134 | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 19,130 | 16,979 | ||||
| Commercial mortgage-backed securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 9,743 | 9,273 | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 9,958 | 9,791 | ||||
| Residential mortgage-backed securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 5,381 | 2,490 | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 5,493 | 2,698 | ||||
| Fair Value, Measurements, Recurring | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 331,455 | 311,570 | ||||
| Assets supporting experience-rated contractholder liabilities | 4,842 | 3,707 | ||||
| Market risk benefit assets | 2,330 | 2,331 | ||||
| Fixed maturities, trading | 14,869 | 12,530 | ||||
| Equity securities | 10,972 | 9,417 | ||||
| Commercial mortgage and other loans | 1,056 | 702 | ||||
| Other invested assets | 2,760 | 2,553 | ||||
| Short-term investments | 5,781 | 8,595 | ||||
| Cash equivalents | 12,838 | 10,691 | ||||
| Reinsurance recoverables and deposit receivables | 573 | 849 | ||||
| Separate account assets | 168,745 | 166,672 | ||||
| TOTAL ASSETS | 556,221 | 529,617 | ||||
| Market risk benefit liabilities | 4,623 | 4,455 | ||||
| Policyholders' account balances | 18,799 | 12,746 | ||||
| Reinsurance and funds withheld payables | 174 | (118) | ||||
| Other Liabilities | 6,215 | 4,751 | ||||
| Notes issued by consolidated VIEs | 767 | 60 | ||||
| Total liabilities | 30,578 | 21,894 | ||||
| Assets Netting | (24,445) | (20,093) | ||||
| Liabilities Netting | (32,942) | (28,141) | ||||
| Netting | (8,496) | (8,049) | ||||
| Fair Value, Measurements, Recurring | U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 22,179 | 20,348 | ||||
| Assets supporting experience-rated contractholder liabilities | 245 | 220 | ||||
| Fair Value, Measurements, Recurring | Obligations of U.S. states and their political subdivisions | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 5,465 | 6,104 | ||||
| Fair Value, Measurements, Recurring | Foreign government securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 50,614 | 57,479 | ||||
| Assets supporting experience-rated contractholder liabilities | 596 | 539 | ||||
| Fair Value, Measurements, Recurring | U.S. public corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 107,781 | 98,508 | ||||
| Fair Value, Measurements, Recurring | U.S. private corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 47,101 | 43,789 | ||||
| Fair Value, Measurements, Recurring | Foreign public corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 23,703 | 21,982 | ||||
| Fair Value, Measurements, Recurring | Foreign private corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 40,159 | 34,463 | ||||
| Fair Value, Measurements, Recurring | Corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Assets supporting experience-rated contractholder liabilities | 55 | 67 | ||||
| Fair Value, Measurements, Recurring | Asset-backed securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 19,329 | 17,134 | ||||
| Fair Value, Measurements, Recurring | Commercial mortgage-backed securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 9,743 | 9,273 | ||||
| Fair Value, Measurements, Recurring | Residential mortgage-backed securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 5,381 | 2,490 | ||||
| Fair Value, Measurements, Recurring | Equity securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Assets supporting experience-rated contractholder liabilities | 3,946 | 2,881 | ||||
| Fair Value, Measurements, Recurring | Level 1 | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 0 | 0 | ||||
| Assets supporting experience-rated contractholder liabilities | 2,225 | 1,522 | ||||
| Market risk benefit assets | 0 | 0 | ||||
| Fixed maturities, trading | 0 | 0 | ||||
| Equity securities | 8,052 | 7,154 | ||||
| Commercial mortgage and other loans | 0 | 0 | ||||
| Other invested assets | 301 | 10 | ||||
| Short-term investments | 116 | 1,896 | ||||
| Cash equivalents | 1,466 | 326 | ||||
| Reinsurance recoverables and deposit receivables | 0 | 0 | ||||
| Separate account assets | 9,419 | 8,441 | ||||
| TOTAL ASSETS | 21,579 | 19,349 | ||||
| Market risk benefit liabilities | 0 | 0 | ||||
| Policyholders' account balances | 0 | 0 | ||||
| Reinsurance and funds withheld payables | 0 | 0 | ||||
| Other Liabilities | 280 | 28 | ||||
| Notes issued by consolidated VIEs | 0 | 0 | ||||
| Total liabilities | 280 | 28 | ||||
| Fair Value, Measurements, Recurring | Level 1 | U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 0 | 0 | ||||
| Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||||
| Fair Value, Measurements, Recurring | Level 1 | Obligations of U.S. states and their political subdivisions | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 0 | 0 | ||||
| Fair Value, Measurements, Recurring | Level 1 | Foreign government securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 0 | 0 | ||||
| Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||||
| Fair Value, Measurements, Recurring | Level 1 | U.S. public corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 0 | 0 | ||||
| Fair Value, Measurements, Recurring | Level 1 | U.S. private corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 0 | 0 | ||||
| Fair Value, Measurements, Recurring | Level 1 | Foreign public corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 0 | 0 | ||||
| Fair Value, Measurements, Recurring | Level 1 | Foreign private corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 0 | 0 | ||||
| Fair Value, Measurements, Recurring | Level 1 | Corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||||
| Fair Value, Measurements, Recurring | Level 1 | Asset-backed securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 0 | 0 | ||||
| Fair Value, Measurements, Recurring | Level 1 | Commercial mortgage-backed securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 0 | 0 | ||||
| Fair Value, Measurements, Recurring | Level 1 | Residential mortgage-backed securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 0 | 0 | ||||
| Fair Value, Measurements, Recurring | Level 1 | Equity securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Assets supporting experience-rated contractholder liabilities | 2,225 | 1,522 | ||||
| Fair Value, Measurements, Recurring | Level 2 | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 319,457 | 303,393 | ||||
| Assets supporting experience-rated contractholder liabilities | 2,617 | 2,185 | ||||
| Market risk benefit assets | 0 | 0 | ||||
| Fixed maturities, trading | 12,556 | 10,544 | ||||
| Equity securities | 2,294 | 1,745 | ||||
| Commercial mortgage and other loans | 793 | 469 | ||||
| Other invested assets | 25,816 | 21,683 | ||||
| Short-term investments | 5,664 | 6,238 | ||||
| Cash equivalents | 11,372 | 10,365 | ||||
| Reinsurance recoverables and deposit receivables | 206 | 236 | ||||
| Separate account assets | 159,115 | 157,999 | ||||
| TOTAL ASSETS | 539,890 | 514,857 | ||||
| Market risk benefit liabilities | 0 | 0 | ||||
| Policyholders' account balances | 0 | 0 | ||||
| Reinsurance and funds withheld payables | 174 | (118) | ||||
| Other Liabilities | 38,877 | 32,863 | ||||
| Notes issued by consolidated VIEs | 0 | 0 | ||||
| Total liabilities | 39,051 | 32,745 | ||||
| Fair Value, Measurements, Recurring | Level 2 | U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 22,179 | 20,348 | ||||
| Assets supporting experience-rated contractholder liabilities | 245 | 220 | ||||
| Fair Value, Measurements, Recurring | Level 2 | Obligations of U.S. states and their political subdivisions | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 5,460 | 6,098 | ||||
| Fair Value, Measurements, Recurring | Level 2 | Foreign government securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 50,609 | 57,472 | ||||
| Assets supporting experience-rated contractholder liabilities | 596 | 539 | ||||
| Fair Value, Measurements, Recurring | Level 2 | U.S. public corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 107,718 | 98,442 | ||||
| Fair Value, Measurements, Recurring | Level 2 | U.S. private corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 42,007 | 39,848 | ||||
| Fair Value, Measurements, Recurring | Level 2 | Foreign public corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 23,661 | 21,946 | ||||
| Fair Value, Measurements, Recurring | Level 2 | Foreign private corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 38,425 | 32,675 | ||||
| Fair Value, Measurements, Recurring | Level 2 | Corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Assets supporting experience-rated contractholder liabilities | 55 | 67 | ||||
| Fair Value, Measurements, Recurring | Level 2 | Asset-backed securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 15,227 | 15,654 | ||||
| Fair Value, Measurements, Recurring | Level 2 | Commercial mortgage-backed securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 8,890 | 8,420 | ||||
| Fair Value, Measurements, Recurring | Level 2 | Residential mortgage-backed securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 5,281 | 2,490 | ||||
| Fair Value, Measurements, Recurring | Level 2 | Equity securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Assets supporting experience-rated contractholder liabilities | 1,721 | 1,359 | ||||
| Fair Value, Measurements, Recurring | Level 3 | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 11,998 | 8,177 | ||||
| Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||||
| Market risk benefit assets | 2,330 | 2,331 | ||||
| Fixed maturities, trading | 2,313 | 1,986 | ||||
| Equity securities | 626 | 518 | ||||
| Commercial mortgage and other loans | 263 | 233 | ||||
| Other invested assets | 1,088 | 953 | ||||
| Short-term investments | 1 | 461 | ||||
| Cash equivalents | 0 | 0 | ||||
| Reinsurance recoverables and deposit receivables | 367 | 613 | ||||
| Separate account assets | 211 | 232 | ||||
| TOTAL ASSETS | 19,197 | 15,504 | ||||
| Market risk benefit liabilities | 4,623 | 4,455 | ||||
| Policyholders' account balances | 18,799 | 12,746 | ||||
| Reinsurance and funds withheld payables | 0 | 0 | ||||
| Other Liabilities | 0 | 1 | ||||
| Notes issued by consolidated VIEs | 767 | 60 | ||||
| Total liabilities | 24,189 | 17,262 | ||||
| Fair Value, Measurements, Recurring | Level 3 | U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 0 | 0 | ||||
| Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||||
| Fair Value, Measurements, Recurring | Level 3 | Obligations of U.S. states and their political subdivisions | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 5 | 6 | ||||
| Fair Value, Measurements, Recurring | Level 3 | Foreign government securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 5 | 7 | ||||
| Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||||
| Fair Value, Measurements, Recurring | Level 3 | U.S. public corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 63 | 66 | ||||
| Fair Value, Measurements, Recurring | Level 3 | U.S. private corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 5,094 | 3,941 | ||||
| Fair Value, Measurements, Recurring | Level 3 | Foreign public corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 42 | 36 | ||||
| Fair Value, Measurements, Recurring | Level 3 | Foreign private corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 1,734 | 1,788 | ||||
| Fair Value, Measurements, Recurring | Level 3 | Corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||||
| Fair Value, Measurements, Recurring | Level 3 | Asset-backed securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 4,102 | 1,480 | ||||
| Fair Value, Measurements, Recurring | Level 3 | Commercial mortgage-backed securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 853 | 853 | ||||
| Fair Value, Measurements, Recurring | Level 3 | Residential mortgage-backed securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 100 | 0 | ||||
| Fair Value, Measurements, Recurring | Level 3 | Equity securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Assets supporting experience-rated contractholder liabilities | 0 | 0 | ||||
| Prudential Netting Agreement | U.S. private corporate securities | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fixed maturities, available-for-sale, at fair value | 15,744 | 14,748 | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 15,744 | 14,748 | ||||
| Other invested assets | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fair value investment measured at NAV per share | 5,526 | 5,021 | ||||
| Separate account assets | ||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||
| Fair value investment measured at NAV per share | $ 27,506 | $ 26,700 | ||||
| ||||||
Fair Value of Assets and Liabilities (Quantitative Info for Level 3 Inputs) (Details) - USD ($) $ in Millions |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Market risk benefit assets | $ 2,330 | $ 2,331 | ||||
| Commercial mortgage and other loans | [1] | 64,715 | 62,341 | |||
| Reinsurance recoverables and deposit receivables | [2] | 44,077 | 37,680 | |||
| Market risk benefit liabilities | 4,623 | 4,455 | ||||
| Fair Value, Measurements, Recurring | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Market risk benefit assets | 2,330 | 2,331 | ||||
| Notes issued by consolidated VIEs | 767 | 60 | ||||
| Commercial mortgage and other loans | 1,056 | 702 | ||||
| Reinsurance recoverables and deposit receivables | 573 | 849 | ||||
| Market risk benefit liabilities | 4,623 | 4,455 | ||||
| Policyholders' account balances | 18,799 | 12,746 | ||||
| Level 3 | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Funds held under reinsurance agreements | $ 10,000 | |||||
| Level 3 | Minimum | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Fair value inputs, policyholder age | 50 years | |||||
| Level 3 | Minimum | Market risk benefit liabilities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Mortality rate | 0.00% | |||||
| Level 3 | Maximum | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Fair value inputs, policyholder age | 90 years | |||||
| Level 3 | Fair Value, Measurements, Recurring | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Market risk benefit assets | $ 2,330 | 2,331 | ||||
| Notes issued by consolidated VIEs | 767 | 60 | ||||
| Commercial mortgage and other loans | 263 | 233 | ||||
| Reinsurance recoverables and deposit receivables | 367 | 613 | ||||
| Market risk benefit liabilities | 4,623 | 4,455 | ||||
| Policyholders' account balances | $ 18,799 | $ 12,746 | ||||
| Level 3 | Internal | Minimum | Discounted cash flow | Market risk benefit liabilities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Lapse rate | 1.00% | 1.00% | ||||
| Spread over SOFR | 0.38% | 0.29% | ||||
| Utilization rate | 37.00% | 37.00% | ||||
| Withdrawal rate (greater than maximum range) | 78.00% | 78.00% | ||||
| Mortality rate | 0.00% | 0.00% | ||||
| Equity volatility curve | 15.00% | 16.00% | ||||
| Level 3 | Internal | Minimum | Discounted cash flow | Policyholders’ account balances | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Lapse rate | 0.00% | 0.00% | ||||
| Spread over SOFR | 0.38% | 0.29% | ||||
| Mortality rate | 0.00% | 0.00% | ||||
| Option budget | (2.00%) | (1.00%) | ||||
| Level 3 | Internal | Minimum | Discounted cash flow | Corporate securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Discount rate | 1.10% | 0.95% | ||||
| Level 3 | Internal | Minimum | Discounted cash flow | Asset-backed securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Discount rate | 2.10% | 2.30% | ||||
| Liquidity premium | 1.50% | |||||
| Level 3 | Internal | Minimum | Discounted cash flow | Commercial mortgage-backed securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Liquidity premium | 0.90% | 1.00% | ||||
| Level 3 | Internal | Minimum | Discounted cash flow | Market risk benefit assets | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Lapse rate | 1.00% | 1.00% | ||||
| Spread over SOFR | 0.38% | 0.29% | ||||
| Utilization rate | 37.00% | 37.00% | ||||
| Withdrawal rate (greater than maximum range) | 78.00% | 78.00% | ||||
| Mortality rate | 0.00% | 0.00% | ||||
| Equity volatility curve | 15.00% | 16.00% | ||||
| Level 3 | Internal | Minimum | Discounted cash flow | Equity securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Discount rate | 40.00% | 0.16% | ||||
| Level 3 | Internal | Minimum | Discounted cash flow | Commercial mortgage and other loans | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Spread | 2.15% | |||||
| Level 3 | Internal | Minimum | Discounted cash flow | Reinsurance recoverables and deposit receivables | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Lapse rate | 1.00% | 1.00% | ||||
| Spread over SOFR | 0.38% | 0.29% | ||||
| Option budget | 0.00% | 0.00% | ||||
| Level 3 | Internal | Minimum | Market comparables | Corporate securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| EBITDA multiples | 5.5 | 3.0 | ||||
| Level 3 | Internal | Minimum | Market comparables | Equity securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| EBITDA multiples | 7.0 | 5.5 | ||||
| Level 3 | Internal | Minimum | Liquidation | Notes issued by consolidated VIEs | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Liquidation value | 100.00% | |||||
| Level 3 | Internal | Minimum | Liquidation | Corporate securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Liquidation value | 12.01% | 75.00% | ||||
| Level 3 | Internal | Minimum | Net asset value | Equity securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Share price | 3 | 3 | ||||
| Level 3 | Internal | Maximum | Discounted cash flow | Market risk benefit liabilities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Lapse rate | 20.00% | 20.00% | ||||
| Spread over SOFR | 1.61% | 1.71% | ||||
| Utilization rate | 94.00% | 94.00% | ||||
| Withdrawal rate (greater than maximum range) | 100.00% | 100.00% | ||||
| Mortality rate | 16.00% | 16.00% | ||||
| Equity volatility curve | 25.00% | 25.00% | ||||
| Level 3 | Internal | Maximum | Discounted cash flow | Policyholders’ account balances | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Lapse rate | 80.00% | 80.00% | ||||
| Spread over SOFR | 1.61% | 1.73% | ||||
| Mortality rate | 23.00% | 23.00% | ||||
| Option budget | 9.00% | 7.00% | ||||
| Level 3 | Internal | Maximum | Discounted cash flow | Corporate securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Discount rate | 25.50% | 20.00% | ||||
| Level 3 | Internal | Maximum | Discounted cash flow | Asset-backed securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Discount rate | 10.05% | 10.70% | ||||
| Liquidity premium | 2.60% | |||||
| Level 3 | Internal | Maximum | Discounted cash flow | Commercial mortgage-backed securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Liquidity premium | 0.90% | 1.00% | ||||
| Level 3 | Internal | Maximum | Discounted cash flow | Market risk benefit assets | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Lapse rate | 20.00% | 20.00% | ||||
| Spread over SOFR | 1.61% | 1.71% | ||||
| Utilization rate | 94.00% | 94.00% | ||||
| Withdrawal rate (greater than maximum range) | 100.00% | 100.00% | ||||
| Mortality rate | 16.00% | 16.00% | ||||
| Equity volatility curve | 25.00% | 25.00% | ||||
| Level 3 | Internal | Maximum | Discounted cash flow | Equity securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Discount rate | 40.00% | 40.00% | ||||
| Level 3 | Internal | Maximum | Discounted cash flow | Commercial mortgage and other loans | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Spread | 3.10% | |||||
| Level 3 | Internal | Maximum | Discounted cash flow | Reinsurance recoverables and deposit receivables | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Lapse rate | 50.00% | 50.00% | ||||
| Spread over SOFR | 1.61% | 1.71% | ||||
| Option budget | 6.00% | 6.00% | ||||
| Level 3 | Internal | Maximum | Market comparables | Corporate securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| EBITDA multiples | 8.5 | 8.8 | ||||
| Level 3 | Internal | Maximum | Market comparables | Equity securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| EBITDA multiples | 7.0 | 12.2 | ||||
| Level 3 | Internal | Maximum | Liquidation | Notes issued by consolidated VIEs | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Liquidation value | 100.00% | |||||
| Level 3 | Internal | Maximum | Liquidation | Corporate securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Liquidation value | 39.00% | 75.00% | ||||
| Level 3 | Internal | Maximum | Net asset value | Equity securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Share price | 1,809 | 1,810 | ||||
| Level 3 | Internal | Weighted Average | Discounted cash flow | Corporate securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Discount rate | 8.47% | 10.36% | ||||
| Level 3 | Internal | Weighted Average | Discounted cash flow | Asset-backed securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Discount rate | 6.10% | 6.08% | ||||
| Liquidity premium | 1.89% | |||||
| Level 3 | Internal | Weighted Average | Discounted cash flow | Commercial mortgage-backed securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Liquidity premium | 0.90% | 1.00% | ||||
| Level 3 | Internal | Weighted Average | Discounted cash flow | Commercial mortgage and other loans | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Spread | 2.63% | |||||
| Level 3 | Internal | Weighted Average | Market comparables | Corporate securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| EBITDA multiples | 7.5 | 7.6 | ||||
| Level 3 | Internal | Weighted Average | Market comparables | Equity securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| EBITDA multiples | 7.0 | 6.0 | ||||
| Level 3 | Internal | Weighted Average | Liquidation | Notes issued by consolidated VIEs | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Liquidation value | 100.00% | |||||
| Level 3 | Internal | Weighted Average | Liquidation | Corporate securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Liquidation value | 30.18% | 75.00% | ||||
| Level 3 | Internal | Weighted Average | Net asset value | Equity securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Share price | 778 | 779 | ||||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Market risk benefit liabilities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Market risk benefit liabilities | $ 4,623 | $ 4,455 | ||||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Policyholders’ account balances | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Policyholders' account balances | 18,716 | 12,741 | ||||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Notes issued by consolidated VIEs | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Notes issued by consolidated VIEs | 382 | |||||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Corporate securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Corporate securities | 7,702 | 6,763 | ||||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Asset-backed securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Asset backed securities | 1,767 | 529 | ||||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Commercial mortgage-backed securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Commercial mortgage-backed securities | 853 | 853 | ||||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Market risk benefit assets | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Market risk benefit assets | 2,330 | 2,331 | ||||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Equity securities | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Equity securities | 214 | 209 | ||||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Commercial mortgage and other loans | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Commercial mortgage and other loans | 263 | |||||
| Level 3 | Internal | Fair Value, Measurements, Recurring | Reinsurance recoverables and deposit receivables | ||||||
| Fair Value Inputs, Assets and Liabilities, Quantitative Information [Line Items] | ||||||
| Reinsurance recoverables and deposit receivables | $ 367 | $ 613 | ||||
| ||||||
Fair Value of Assets and Liabilities (Changes in Level 3 Assets and Liabilities) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Market risk benefit assets | $ 2,330 | $ 2,331 | |
| Market risk benefit liabilities | 4,623 | 4,455 | |
| Fair Value, Measurements, Recurring | |||
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Market risk benefit assets | 2,330 | 2,331 | |
| Market risk benefit liabilities | 4,623 | 4,455 | |
| Equity securities | |||
| Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 518 | 512 | |
| Purchases | 246 | 153 | |
| Sales | (82) | (55) | |
| Issuances | 0 | 0 | |
| Settlements | (3) | (67) | |
| Other | (8) | 5 | |
| Transfers into Level 3 | 131 | 2 | |
| Transfers out of Level 3 | (181) | (10) | |
| Fair Value, end of period | 626 | 518 | $ 512 |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 5 | (22) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (7) | (6) | |
| Equity securities | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | (1) |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Equity securities | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 5 | (22) | 27 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (7) | (6) | 12 |
| Equity securities | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Equity securities | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Equity securities | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Commercial mortgage and other loans | |||
| Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 233 | 0 | |
| Purchases | 0 | 0 | |
| Sales | 0 | 0 | |
| Issuances | 31 | 210 | |
| Settlements | 0 | 0 | |
| Other | 0 | 23 | |
| Transfers into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | 263 | 233 | 0 |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (1) | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Commercial mortgage and other loans | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (1) | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Commercial mortgage and other loans | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Commercial mortgage and other loans | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Commercial mortgage and other loans | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Commercial mortgage and other loans | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Other invested assets | |||
| Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 953 | 846 | |
| Purchases | 196 | 175 | |
| Sales | (46) | (2) | |
| Issuances | 0 | 0 | |
| Settlements | (2) | 0 | |
| Other | 1 | 19 | |
| Transfers into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | 1,088 | 953 | 846 |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (14) | (85) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (15) | (85) | |
| Other invested assets | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (1) | (1) | (4) |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (1) | (1) | (4) |
| Other invested assets | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (14) | (84) | (34) |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (14) | (84) | (34) |
| Other invested assets | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Other invested assets | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Other invested assets | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 1 | 0 | 0 |
| Short-term investments | |||
| Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 461 | 29 | |
| Purchases | 39 | 488 | |
| Sales | (453) | (25) | |
| Issuances | 0 | 0 | |
| Settlements | (62) | (6) | |
| Other | (5) | (25) | |
| Transfers into Level 3 | 22 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | 1 | 461 | 29 |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (1) | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 1 | |
| Short-term investments | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | (1) | 3 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Short-term investments | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Short-term investments | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Short-term investments | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (1) | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 1 | 0 |
| Short-term investments | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 1 | 2 |
| Cash equivalents | |||
| Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 0 | 4 | |
| Purchases | 12 | 5 | |
| Sales | 0 | 0 | |
| Issuances | 0 | 0 | |
| Settlements | (10) | 0 | |
| Other | (2) | (9) | |
| Transfers into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | 0 | 0 | 4 |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Cash equivalents | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Cash equivalents | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Cash equivalents | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Cash equivalents | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Cash equivalents | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Reinsurance recoverables and deposit receivables | |||
| Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 613 | 224 | |
| Purchases | 94 | 223 | |
| Sales | 0 | 0 | |
| Issuances | 0 | 0 | |
| Settlements | (75) | (66) | |
| Other | (236) | 88 | |
| Transfers into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | 367 | 613 | 224 |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (29) | 144 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (104) | 78 | |
| Reinsurance recoverables and deposit receivables | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (29) | 144 | (40) |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (104) | 78 | (63) |
| Reinsurance recoverables and deposit receivables | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Reinsurance recoverables and deposit receivables | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Reinsurance recoverables and deposit receivables | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Reinsurance recoverables and deposit receivables | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Other assets | |||
| Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 0 | 11 | |
| Purchases | 0 | 8 | |
| Sales | 0 | 0 | |
| Issuances | 0 | 0 | |
| Settlements | 0 | 0 | |
| Other | 0 | (19) | |
| Transfers into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | 0 | 0 | 11 |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Other assets | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Other assets | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Other assets | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Other assets | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Other assets | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Separate accounts assets | |||
| Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 232 | 1,094 | |
| Purchases | 99 | 322 | |
| Sales | (51) | (1,061) | |
| Issuances | 0 | 0 | |
| Settlements | (68) | (14) | |
| Other | 0 | 0 | |
| Transfers into Level 3 | 4 | 12 | |
| Transfers out of Level 3 | (25) | (60) | |
| Fair Value, end of period | 211 | 232 | 1,094 |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 20 | (61) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 13 | (24) | |
| Separate accounts assets | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Separate accounts assets | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Separate accounts assets | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 20 | (61) | 55 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 13 | (24) | 42 |
| Separate accounts assets | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Separate accounts assets | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Policyholders’ account balances | |||
| Fair Value, Assets And Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | (12,746) | (7,752) | |
| Purchases | 0 | 0 | |
| Sales | 0 | 0 | |
| Issuances | (1,570) | (2,254) | |
| Settlements | 0 | 0 | |
| Other | (8) | 45 | |
| Transfers Into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | (18,799) | (12,746) | (7,752) |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (4,475) | (2,785) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 616 | 1,165 | |
| Policyholders’ account balances | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (4,475) | (2,785) | (2,601) |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 616 | 1,165 | (322) |
| Policyholders’ account balances | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Policyholders’ account balances | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Policyholders’ account balances | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Policyholders’ account balances | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Other liabilities | |||
| Fair Value, Assets And Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | (1) | (1) | |
| Purchases | 0 | 0 | |
| Sales | 0 | 0 | |
| Issuances | 0 | 0 | |
| Settlements | 0 | 0 | |
| Other | 0 | 0 | |
| Transfers Into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | 0 | (1) | (1) |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 1 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 1 | 0 | |
| Other liabilities | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 1 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 1 | 0 | 0 |
| Other liabilities | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Other liabilities | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Other liabilities | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Other liabilities | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Notes issued by consolidated VIEs | |||
| Fair Value, Assets And Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | (60) | (778) | |
| Purchases | 0 | 0 | |
| Sales | 0 | 0 | |
| Issuances | (507) | (60) | |
| Settlements | 193 | 0 | |
| Other | (398) | 783 | |
| Transfers Into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | (767) | (60) | (778) |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 5 | (5) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 2 | 0 | |
| Notes issued by consolidated VIEs | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Notes issued by consolidated VIEs | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 5 | (5) | 9 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 2 | 0 | 9 |
| Notes issued by consolidated VIEs | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Notes issued by consolidated VIEs | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Notes issued by consolidated VIEs | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Fixed maturities, available-for-sale | Fixed maturities | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (162) | (269) | (25) |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (190) | (240) | (7) |
| Fixed maturities, available-for-sale | Fixed maturities | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Fixed maturities, available-for-sale | Fixed maturities | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Fixed maturities, available-for-sale | Fixed maturities | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 80 | 22 | (5) |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 75 | 10 | (30) |
| Fixed maturities, available-for-sale | Fixed maturities | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (5) | (1) | 9 |
| Fixed maturities, available-for-sale | Fixed maturities | U.S. states | |||
| Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 6 | 7 | |
| Purchases | 0 | 0 | |
| Sales | 0 | 0 | |
| Issuances | 0 | 0 | |
| Settlements | (1) | 0 | |
| Other | 0 | (1) | |
| Transfers into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | 5 | 6 | 7 |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | (1) | |
| Fixed maturities, available-for-sale | Fixed maturities | Foreign government securities | |||
| Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 7 | 8 | |
| Purchases | 0 | 0 | |
| Sales | 0 | 0 | |
| Issuances | 0 | 0 | |
| Settlements | (2) | (1) | |
| Other | 0 | 0 | |
| Transfers into Level 3 | 0 | 0 | |
| Transfers out of Level 3 | 0 | 0 | |
| Fair Value, end of period | 5 | 7 | 8 |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | |
| Fixed maturities, available-for-sale | Fixed maturities | Corporate securities | |||
| Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 5,831 | 4,806 | |
| Purchases | 2,682 | 2,181 | |
| Sales | (547) | (145) | |
| Issuances | 0 | 0 | |
| Settlements | (1,210) | (806) | |
| Other | (42) | (144) | |
| Transfers into Level 3 | 413 | 250 | |
| Transfers out of Level 3 | (63) | (58) | |
| Fair Value, end of period | 6,933 | 5,831 | 4,806 |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (131) | (253) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (165) | (227) | |
| Fixed maturities, available-for-sale | Fixed maturities | Structured securities | |||
| Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 2,333 | 1,297 | |
| Purchases | 2,902 | 2,764 | |
| Sales | (169) | (244) | |
| Issuances | 0 | 0 | |
| Settlements | (513) | (125) | |
| Other | (174) | (494) | |
| Transfers into Level 3 | 1,220 | 67 | |
| Transfers out of Level 3 | (588) | (937) | |
| Fair Value, end of period | 5,055 | 2,333 | 1,297 |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 44 | 5 | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 50 | (2) | |
| Fixed maturities, trading | Fixed maturities | |||
| Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |||
| Fair Value, beginning of period | 1,986 | 429 | |
| Purchases | 1,725 | 1,826 | |
| Sales | (324) | (56) | |
| Issuances | 0 | 0 | |
| Settlements | (542) | (218) | |
| Other | 181 | 1 | |
| Transfers into Level 3 | 30 | 466 | |
| Transfers out of Level 3 | (689) | (395) | |
| Fair Value, end of period | 2,313 | 1,986 | 429 |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (54) | (67) | |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (86) | (64) | |
| Fixed maturities, trading | Fixed maturities | Realized investment gains (losses), net | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Fixed maturities, trading | Fixed maturities | Other income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | (54) | (69) | 9 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | (86) | (64) | 5 |
| Fixed maturities, trading | Fixed maturities | Interest credited to policyholders’ account balances | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Fixed maturities, trading | Fixed maturities | Included in other comprehensive income (loss) | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Unrealized gains (losses) for assets/liabilities still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Fixed maturities, trading | Fixed maturities | Net investment income | |||
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | $ 0 | $ 2 | $ 2 |
Fair Value of Assets and Liabilities (Derivative Assets and Liabilities Measured at Fair Value on a Recurring Basis) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | $ 1,671 | $ 1,601 |
| Netting | $ (24,445) | $ (20,093) |
| Derivative Asset, Statement of Financial Position [Extensible Enumeration] | Other invested assets | Other invested assets |
| Total derivative liabilities | $ 6,215 | $ 4,751 |
| Netting | $ (32,942) | $ (28,141) |
| Derivative Liability, Statement of Financial Position [Extensible Enumeration] | Other Liabilities | Other Liabilities |
| Interest Rate | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | $ 11,217 | $ 11,733 |
| Total derivative liabilities | 25,593 | 26,893 |
| Currency | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 1,384 | 1,717 |
| Total derivative liabilities | 1,591 | 1,378 |
| Credit | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 112 | 90 |
| Total derivative liabilities | 0 | 0 |
| Currency/Interest Rate | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 1,656 | 3,310 |
| Total derivative liabilities | 1,619 | 497 |
| Equity | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 11,747 | 4,844 |
| Total derivative liabilities | 10,354 | 4,124 |
| Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 300 | 10 |
| Total derivative liabilities | 280 | 28 |
| Level 1 | Interest Rate | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 7 | 7 |
| Total derivative liabilities | 22 | 21 |
| Level 1 | Currency | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 0 | 0 |
| Total derivative liabilities | 0 | 0 |
| Level 1 | Credit | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 0 | 0 |
| Total derivative liabilities | 0 | 0 |
| Level 1 | Currency/Interest Rate | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 0 | 0 |
| Total derivative liabilities | 0 | 0 |
| Level 1 | Equity | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 293 | 3 |
| Total derivative liabilities | 258 | 7 |
| Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 25,816 | 21,683 |
| Total derivative liabilities | 38,877 | 32,863 |
| Level 2 | Interest Rate | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 11,210 | 11,725 |
| Total derivative liabilities | 25,571 | 26,871 |
| Level 2 | Currency | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 1,384 | 1,717 |
| Total derivative liabilities | 1,591 | 1,378 |
| Level 2 | Credit | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 112 | 90 |
| Total derivative liabilities | 0 | 0 |
| Level 2 | Currency/Interest Rate | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 1,656 | 3,310 |
| Total derivative liabilities | 1,619 | 497 |
| Level 2 | Equity | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 11,454 | 4,841 |
| Total derivative liabilities | 10,096 | 4,117 |
| Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 0 | 1 |
| Total derivative liabilities | 0 | 1 |
| Level 3 | Interest Rate | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 0 | 1 |
| Total derivative liabilities | 0 | 1 |
| Level 3 | Currency | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 0 | 0 |
| Total derivative liabilities | 0 | 0 |
| Level 3 | Credit | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 0 | 0 |
| Total derivative liabilities | 0 | 0 |
| Level 3 | Currency/Interest Rate | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 0 | 0 |
| Total derivative liabilities | 0 | 0 |
| Level 3 | Equity | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Total derivative assets | 0 | 0 |
| Total derivative liabilities | $ 0 | $ 0 |
Fair Value of Assets and Liabilities (Changes in Level 3 Derivative Assets and Liabilities) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Equity | |||
| Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] | |||
| Fair Value, beginning of period | $ 0 | $ 0 | $ 0 |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Purchases | 0 | 0 | 0 |
| Sales | 0 | 0 | 0 |
| Issuances | 0 | 0 | 0 |
| Settlements | 0 | 0 | 0 |
| Other | 0 | 0 | 0 |
| Transfers into Level 3 | 0 | 0 | 0 |
| Transfers out of Level 3 | 0 | 0 | 0 |
| Fair Value, end of period | 0 | 0 | 0 |
| Unrealized gains (losses) for assets still held: | |||
| Included in earnings | 0 | 0 | 0 |
| Interest Rate | |||
| Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] | |||
| Fair Value, beginning of period | 0 | 0 | 0 |
| Total gains (losses) (realized/unrealized): | |||
| Included in earnings | 0 | 0 | 0 |
| Purchases | 0 | 0 | 0 |
| Sales | 0 | 0 | 0 |
| Issuances | 0 | 0 | 0 |
| Settlements | 0 | 0 | 0 |
| Other | 0 | 0 | 0 |
| Transfers into Level 3 | 0 | 0 | 0 |
| Transfers out of Level 3 | 0 | 0 | 0 |
| Fair Value, end of period | 0 | 0 | 0 |
| Unrealized gains (losses) for assets still held: | |||
| Included in earnings | $ 0 | $ 0 | $ 0 |
Fair Value of Assets and Liabilities (Nonrecurring Fair Value Measurements) (Details) - Fair Value, Measurements, Nonrecurring - Level 3 - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Commercial mortgage loans | |||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Realized investment gains (losses) net | $ 0 | $ 0 | $ (29) |
| Carrying value after measurement as of period end | 0 | 0 | |
| Investment real estate | |||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Realized investment gains (losses) net | (12) | (12) | (17) |
| Carrying value after measurement as of period end | 45 | 73 | |
| Investment in JV/LP and Other | |||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Realized investment gains (losses) net | (70) | (7) | (76) |
| Carrying value after measurement as of period end | 61 | 128 | |
| Equity Securities | |||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Realized investment gains (losses) net | 56 | 0 | 0 |
| Carrying value after measurement as of period end | 92 | 0 | |
| Goodwill | |||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
| Realized investment gains (losses) net | 0 | 0 | $ (177) |
| Carrying value after measurement as of period end | $ 0 | $ 0 | |
Fair Value of Assets and Liabilities (Changes in Fair Values Recorded in Earnings for FVO Assets-Liabilities) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||
| Fair Value, Option, Quantitative Disclosures [Line Items] | |||||
| Commercial mortgage and other loans | [1] | $ 64,715 | $ 62,341 | ||
| Other invested assets | [1] | 27,294 | 26,351 | ||
| Commercial mortgage and other loans | |||||
| Fair Value, Option, Quantitative Disclosures [Line Items] | |||||
| Changes in fair value | (1) | 0 | $ 0 | ||
| Interest income | 46 | 26 | 9 | ||
| Fair value option loans in more than 90 days past due and still accruing | 0 | ||||
| Notes issued by consolidated VIEs | |||||
| Fair Value, Option, Quantitative Disclosures [Line Items] | |||||
| Changes in fair value | (5) | 5 | (9) | ||
| Interest expense | 13 | 14 | $ 11 | ||
| Fair value option | |||||
| Fair Value, Option, Quantitative Disclosures [Line Items] | |||||
| Commercial mortgage and other loans | 1,056 | 702 | |||
| Other invested assets | 26 | 19 | |||
| Notes issued by consolidated VIEs | 767 | 60 | |||
| Fair value option, aggregate contractual principal | |||||
| Fair Value, Option, Quantitative Disclosures [Line Items] | |||||
| Commercial mortgage and other loans | 1,048 | 697 | |||
| Notes issued by consolidated VIEs | $ 767 | $ 60 | |||
| |||||
Fair Value of Assets and Liabilities (Financial Instruments where Carrying Amounts and Fair Values May Differ) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Commercial mortgage and other loans | [1] | $ 64,715 | $ 62,341 | ||||||
| Policy loans | 9,958 | 9,795 | |||||||
| Other invested assets | [1] | 27,294 | 26,351 | ||||||
| Cash and cash equivalents | 19,712 | [1] | 18,497 | [1] | $ 19,419 | ||||
| Accrued investment income | [1] | 3,636 | 3,441 | ||||||
| Reinsurance recoverables and deposit receivables | [2] | 44,077 | 37,680 | ||||||
| Other assets, assets at fair value | 0 | 0 | |||||||
| Liabilities: | |||||||||
| Securities sold under agreements to repurchase | 9,598 | 6,796 | |||||||
| Cash collateral for loaned securities | 8,700 | 9,621 | |||||||
| Reinsurance and funds withheld payables | [2] | 18,844 | 17,084 | ||||||
| Short-term debt | 1,443 | 953 | |||||||
| Long-term debt | 18,856 | 19,187 | |||||||
| Other Liabilities, derivatives at fair value | 6,215 | 4,751 | |||||||
| Fair Value | |||||||||
| Assets: | |||||||||
| Commercial mortgage and other loans | 63,178 | 58,463 | |||||||
| Policy loans | 9,958 | 9,795 | |||||||
| Other invested assets | 93 | 95 | |||||||
| Short-term investments | 633 | 474 | |||||||
| Cash and cash equivalents | 6,874 | 7,806 | |||||||
| Accrued investment income | 3,636 | 3,441 | |||||||
| Reinsurance recoverables and deposit receivables | 6,718 | 5,790 | |||||||
| Other assets, assets at fair value | 3,181 | 3,086 | |||||||
| Total assets | 94,271 | 88,950 | |||||||
| Liabilities: | |||||||||
| Policyholders’ account balances—investment contracts | 85,106 | 74,871 | |||||||
| Securities sold under agreements to repurchase | 9,598 | 6,796 | |||||||
| Cash collateral for loaned securities | 8,700 | 9,621 | |||||||
| Reinsurance and funds withheld payables | 10,607 | 10,454 | |||||||
| Short-term debt | 1,441 | 960 | |||||||
| Long-term debt | 18,353 | 18,132 | |||||||
| Notes issued by consolidated VIEs | 1,892 | 1,370 | |||||||
| Other Liabilities, derivatives at fair value | 7,024 | 6,918 | |||||||
| Separate account liabilities—investment contracts | 40,211 | 39,821 | |||||||
| Total liabilities | 182,932 | 168,943 | |||||||
| Carrying Amount | |||||||||
| Assets: | |||||||||
| Commercial mortgage and other loans | 63,659 | 61,639 | |||||||
| Policy loans | 9,958 | 9,795 | |||||||
| Other invested assets | 93 | 95 | |||||||
| Short-term investments | 633 | 474 | |||||||
| Cash and cash equivalents | 6,874 | 7,806 | |||||||
| Accrued investment income | 3,636 | 3,441 | |||||||
| Reinsurance recoverables and deposit receivables | 6,718 | 5,790 | |||||||
| Other assets, assets at fair value | 3,181 | 3,086 | |||||||
| Total assets | 94,752 | 92,126 | |||||||
| Liabilities: | |||||||||
| Policyholders’ account balances—investment contracts | 89,970 | 79,571 | |||||||
| Securities sold under agreements to repurchase | 9,598 | 6,796 | |||||||
| Cash collateral for loaned securities | 8,700 | 9,621 | |||||||
| Reinsurance and funds withheld payables | 10,607 | 10,454 | |||||||
| Short-term debt | 1,443 | 953 | |||||||
| Long-term debt | 18,856 | 19,187 | |||||||
| Notes issued by consolidated VIEs | 1,892 | 1,370 | |||||||
| Other Liabilities, derivatives at fair value | 7,024 | 6,918 | |||||||
| Separate account liabilities—investment contracts | 40,211 | 39,821 | |||||||
| Total liabilities | 188,301 | 174,691 | |||||||
| Level 1 | Fair Value | |||||||||
| Assets: | |||||||||
| Commercial mortgage and other loans | 0 | 0 | |||||||
| Policy loans | 12 | 8 | |||||||
| Other invested assets | 0 | 0 | |||||||
| Short-term investments | 632 | 453 | |||||||
| Cash and cash equivalents | 6,652 | 7,352 | |||||||
| Accrued investment income | 0 | 0 | |||||||
| Reinsurance recoverables and deposit receivables | 0 | 0 | |||||||
| Other assets, assets at fair value | 37 | 23 | |||||||
| Total assets | 7,333 | 7,836 | |||||||
| Liabilities: | |||||||||
| Policyholders’ account balances—investment contracts | 0 | 0 | |||||||
| Securities sold under agreements to repurchase | 0 | 0 | |||||||
| Cash collateral for loaned securities | 0 | 0 | |||||||
| Reinsurance and funds withheld payables | 0 | 0 | |||||||
| Short-term debt | 0 | 0 | |||||||
| Long-term debt | 7,507 | 524 | |||||||
| Notes issued by consolidated VIEs | 0 | 0 | |||||||
| Other Liabilities, derivatives at fair value | 0 | 0 | |||||||
| Separate account liabilities—investment contracts | 0 | 0 | |||||||
| Total liabilities | 7,507 | 524 | |||||||
| Level 2 | Fair Value | |||||||||
| Assets: | |||||||||
| Commercial mortgage and other loans | 14 | 17 | |||||||
| Policy loans | 0 | 0 | |||||||
| Other invested assets | 93 | 95 | |||||||
| Short-term investments | 1 | 21 | |||||||
| Cash and cash equivalents | 222 | 454 | |||||||
| Accrued investment income | 3,636 | 3,441 | |||||||
| Reinsurance recoverables and deposit receivables | 8 | 8 | |||||||
| Other assets, assets at fair value | 3,142 | 3,062 | |||||||
| Total assets | 7,116 | 7,098 | |||||||
| Liabilities: | |||||||||
| Policyholders’ account balances—investment contracts | 35,175 | 31,405 | |||||||
| Securities sold under agreements to repurchase | 9,598 | 6,796 | |||||||
| Cash collateral for loaned securities | 8,700 | 9,621 | |||||||
| Reinsurance and funds withheld payables | 10,639 | 10,489 | |||||||
| Short-term debt | 1,408 | 521 | |||||||
| Long-term debt | 10,324 | 17,185 | |||||||
| Notes issued by consolidated VIEs | 0 | 0 | |||||||
| Other Liabilities, derivatives at fair value | 6,993 | 6,886 | |||||||
| Separate account liabilities—investment contracts | 22,548 | 21,144 | |||||||
| Total liabilities | 105,385 | 104,047 | |||||||
| Level 3 | Fair Value | |||||||||
| Assets: | |||||||||
| Commercial mortgage and other loans | 63,164 | 58,446 | |||||||
| Policy loans | 9,946 | 9,787 | |||||||
| Other invested assets | 0 | 0 | |||||||
| Short-term investments | 0 | 0 | |||||||
| Cash and cash equivalents | 0 | 0 | |||||||
| Accrued investment income | 0 | 0 | |||||||
| Reinsurance recoverables and deposit receivables | 6,710 | 5,782 | |||||||
| Other assets, assets at fair value | 2 | 1 | |||||||
| Total assets | 79,822 | 74,016 | |||||||
| Liabilities: | |||||||||
| Policyholders’ account balances—investment contracts | 49,931 | 43,466 | |||||||
| Securities sold under agreements to repurchase | 0 | 0 | |||||||
| Cash collateral for loaned securities | 0 | 0 | |||||||
| Reinsurance and funds withheld payables | (32) | (35) | |||||||
| Short-term debt | 33 | 439 | |||||||
| Long-term debt | 522 | 423 | |||||||
| Notes issued by consolidated VIEs | 1,892 | 1,370 | |||||||
| Other Liabilities, derivatives at fair value | 31 | 32 | |||||||
| Separate account liabilities—investment contracts | 17,663 | 18,677 | |||||||
| Total liabilities | 70,040 | 64,372 | |||||||
| Prudential Netting Agreement | Fair Value | |||||||||
| Liabilities: | |||||||||
| Long-term debt | 15,744 | 14,748 | |||||||
| Prudential Netting Agreement | Carrying Amount | |||||||||
| Liabilities: | |||||||||
| Long-term debt | 15,744 | 14,748 | |||||||
| Prismic Life Reinsurance, Ltd | Fair Value | |||||||||
| Liabilities: | |||||||||
| Reinsurance and funds withheld payables | 7,513 | 7,887 | |||||||
| Prismic Life Reinsurance, Ltd | Carrying Amount | |||||||||
| Liabilities: | |||||||||
| Reinsurance and funds withheld payables | $ 7,513 | $ 7,887 | |||||||
| |||||||||
Separate Accounts (Separate Account Assets) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | $ 196,251 | $ 193,372 |
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 4,753 | 4,674 |
| Obligations of U.S. states and their political subdivisions | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 2,514 | 2,224 |
| Foreign government bonds | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 109 | 93 |
| U.S. corporate securities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 13,783 | 11,440 |
| Foreign corporate securities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 4,282 | 3,010 |
| Asset-backed securities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 3,445 | 1,283 |
| Mortgage-backed securities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 10,154 | 14,144 |
| Equity | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 92,137 | 90,180 |
| Fixed Income | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 30,602 | 33,828 |
| Other | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 6,315 | 5,439 |
| Equity securities | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 5,459 | 4,845 |
| Commercial mortgage and other loans | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 53 | 54 |
| Other invested assets | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 19,749 | 19,352 |
| Short-term investments | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | 1,276 | 1,137 |
| Cash and cash equivalents | ||
| Fair Value, Separate Account Investment [Line Items] | ||
| Separate account assets | $ 1,620 | $ 1,669 |
Separate Accounts (Narratives) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Separate Accounts Disclosure [Abstract] | |||
| Assets Transferred, Other Than Cash, From General Account to Separate Account | $ 0 | $ 0 | $ 0 |
| Gain (Loss) Recognized on Assets Transferred to Separate Account | $ 0 | $ 0 | $ 0 |
Separate Accounts (Separate Account Liabilities) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Separate Account, Liability [Roll Forward] | |||
| Separate account liabilities, BOP | $ 193,372 | $ 198,888 | |
| Separate account liabilities, EOP | 196,251 | 193,372 | $ 198,888 |
| Cash surrender value | 198,019 | 192,395 | 197,418 |
| Total | |||
| Separate Account, Liability [Roll Forward] | |||
| Separate account liabilities, BOP | 196,944 | 202,033 | 201,322 |
| Deposits | 15,009 | 20,585 | 10,628 |
| Investment performance | 21,663 | 16,868 | 20,953 |
| Policy charges | (3,659) | (3,796) | (3,821) |
| Surrenders and withdrawals | (23,344) | (31,242) | (19,477) |
| Benefit payments | (5,313) | (4,930) | (4,766) |
| Net transfers (to) from general account | (916) | (933) | (1,892) |
| Other | (84) | (1,641) | (914) |
| Separate account liabilities, EOP | 200,300 | 196,944 | 202,033 |
| Total Corporate and Other | |||
| Separate Account, Liability [Roll Forward] | |||
| Separate account liabilities, BOP | (3,572) | (3,145) | |
| Separate account liabilities, EOP | (4,049) | (3,572) | (3,145) |
| Cash Surrender Charges | 0 | 0 | 0 |
| PGIM | |||
| Separate Account, Liability [Roll Forward] | |||
| Separate account liabilities, BOP | 28,645 | 32,648 | 40,056 |
| Deposits | 9,597 | 15,374 | 6,848 |
| Investment performance | 1,930 | (45) | (1,045) |
| Policy charges | (64) | (69) | (81) |
| Surrenders and withdrawals | (6,871) | (14,766) | (8,109) |
| Benefit payments | (3,706) | (3,550) | (3,477) |
| Net transfers (to) from general account | (36) | (184) | (501) |
| Other | (217) | (763) | (1,043) |
| Separate account liabilities, EOP | 29,278 | 28,645 | 32,648 |
| Cash surrender value | 29,278 | 28,645 | 32,648 |
| Institutional Retirement Strategies | Retirement Strategies | |||
| Separate Account, Liability [Roll Forward] | |||
| Separate account liabilities, BOP | 9,308 | 11,011 | 11,428 |
| Deposits | 397 | 143 | 259 |
| Investment performance | 698 | 146 | 830 |
| Policy charges | (11) | (11) | (12) |
| Surrenders and withdrawals | (604) | (1,050) | (660) |
| Benefit payments | (544) | (541) | (562) |
| Net transfers (to) from general account | (174) | (76) | (74) |
| Other | (93) | (314) | (198) |
| Separate account liabilities, EOP | 8,977 | 9,308 | 11,011 |
| Cash surrender value | 8,977 | 9,308 | 11,011 |
| Individual Retirement Strategies | Retirement Strategies | |||
| Separate Account, Liability [Roll Forward] | |||
| Separate account liabilities, BOP | 86,974 | 94,130 | 93,395 |
| Deposits | 560 | 606 | 446 |
| Investment performance | 9,914 | 8,722 | 12,598 |
| Policy charges | (1,994) | (2,231) | (2,316) |
| Surrenders and withdrawals | (14,305) | (14,070) | (9,891) |
| Benefit payments | (102) | (87) | (95) |
| Net transfers (to) from general account | 8 | (102) | (17) |
| Other | 2 | 6 | 10 |
| Separate account liabilities, EOP | 81,057 | 86,974 | 94,130 |
| Cash surrender value | 80,384 | 86,081 | 92,927 |
| Group Insurance | |||
| Separate Account, Liability [Roll Forward] | |||
| Separate account liabilities, BOP | 25,126 | 25,021 | 23,513 |
| Deposits | 157 | 734 | 103 |
| Investment performance | 2,359 | 1,013 | 1,828 |
| Policy charges | (340) | (317) | (337) |
| Surrenders and withdrawals | (119) | (370) | (52) |
| Benefit payments | (400) | (303) | (290) |
| Net transfers (to) from general account | 49 | 6 | 44 |
| Other | 84 | (658) | 212 |
| Separate account liabilities, EOP | 26,916 | 25,126 | 25,021 |
| Cash surrender value | 26,828 | 25,028 | 24,911 |
| Individual Life | |||
| Separate Account, Liability [Roll Forward] | |||
| Separate account liabilities, BOP | 46,891 | 39,223 | 32,930 |
| Deposits | 4,298 | 3,728 | 2,972 |
| Investment performance | 6,762 | 7,032 | 6,742 |
| Policy charges | (1,250) | (1,168) | (1,075) |
| Surrenders and withdrawals | (1,445) | (986) | (765) |
| Benefit payments | (561) | (449) | (342) |
| Net transfers (to) from general account | (763) | (577) | (1,344) |
| Other | 140 | 88 | 105 |
| Separate account liabilities, EOP | 54,072 | 46,891 | 39,223 |
| Cash surrender value | 52,552 | 43,333 | 35,921 |
| PGIM and Institutional Retirement Strategy | |||
| Separate Account, Liability [Roll Forward] | |||
| Cash Surrender Charges | $ 0 | $ 0 | $ 0 |
Deferred Policy Acquisition Costs, Deferred Reinsurance, Deferred Sales Inducements and Value of Business Acquired - Balance of and Changes in DAC (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||
| Balance, BOP | $ 20,448 | $ 20,856 | |||
| Amortization expense | [1] | 1,635 | 1,492 | $ 1,459 | |
| Balance, EOP | 21,530 | 20,448 | 20,856 | ||
| Retirement Strategies | Individual Variable | |||||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||
| Balance, BOP | 3,713 | 3,676 | 4,171 | ||
| Capitalization | 531 | 423 | 261 | ||
| Amortization expense | (465) | (386) | (366) | ||
| Other Adjustments | 17 | 0 | (390) | ||
| Foreign currency adjustment | 0 | 0 | 0 | ||
| Balance, EOP | 3,796 | 3,713 | 3,676 | ||
| Individual Life | Term Life Insurance | |||||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||
| Balance, BOP | 2,215 | 2,237 | 2,288 | ||
| Capitalization | 195 | 186 | 160 | ||
| Amortization expense | (207) | (208) | (212) | ||
| Other Adjustments | 0 | 0 | 1 | ||
| Foreign currency adjustment | 0 | 0 | 0 | ||
| Balance, EOP | 2,203 | 2,215 | 2,237 | ||
| Individual Life | Variable/ Universal Life | |||||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||
| Balance, BOP | 4,878 | 5,364 | 5,000 | ||
| Capitalization | 740 | 734 | 608 | ||
| Amortization expense | (235) | (241) | (244) | ||
| Other Adjustments | 7 | (979) | 0 | ||
| Foreign currency adjustment | 0 | 0 | 0 | ||
| Balance, EOP | 5,390 | 4,878 | 5,364 | ||
| International Businesses | International Businesses | |||||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||
| Balance, BOP | 9,304 | 9,351 | 8,941 | ||
| Capitalization | 1,197 | 1,139 | 1,196 | ||
| Amortization expense | (697) | (670) | (641) | ||
| Other Adjustments | (214) | (40) | 20 | ||
| Foreign currency adjustment | 88 | (476) | (165) | ||
| Balance, EOP | 9,678 | 9,304 | 9,351 | ||
| Total | |||||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||
| Balance, BOP | 20,110 | 20,628 | 20,400 | ||
| Capitalization | 2,663 | 2,482 | 2,225 | ||
| Amortization expense | (1,604) | (1,505) | (1,463) | ||
| Other Adjustments | (190) | (1,019) | (369) | ||
| Foreign currency adjustment | 88 | (476) | (165) | ||
| Balance, EOP | 21,067 | 20,110 | 20,628 | ||
| Other businesses | |||||
| Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward] | |||||
| Balance, BOP | 338 | 228 | |||
| Balance, EOP | $ 463 | $ 338 | $ 228 | ||
| |||||
Deferred Policy Acquisition Costs, Deferred Reinsurance, Deferred Sales Inducements and Value of Business Acquired (DRL) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, BOP | $ 1,336 | $ 310 | |
| Balance, EOP | 1,244 | 1,336 | $ 310 |
| Total | |||
| Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, BOP | 1,249 | 310 | 206 |
| Deferred reinsurance Loss | 979 | 224 | |
| Amortization | (69) | (40) | (29) |
| Other adjustments | (91) | ||
| Balance, EOP | 1,180 | 1,249 | 310 |
| Other businesses | |||
| Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, BOP | 87 | 0 | |
| Balance, EOP | 64 | 87 | 0 |
| Individual Variable | Retirement Strategies | |||
| Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, BOP | 150 | 178 | 206 |
| Deferred reinsurance Loss | 0 | 0 | |
| Amortization | (29) | (28) | (28) |
| Other adjustments | 0 | ||
| Balance, EOP | 121 | 150 | 178 |
| Institutional | Retirement Strategies | |||
| Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, BOP | 130 | 132 | 0 |
| Deferred reinsurance Loss | 0 | 224 | |
| Amortization | (3) | (2) | (1) |
| Other adjustments | (91) | ||
| Balance, EOP | 127 | 130 | 132 |
| Variable/ Universal Life | Individual Life | |||
| Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward] | |||
| Balance, BOP | 969 | 0 | 0 |
| Deferred reinsurance Loss | 979 | 0 | |
| Amortization | (37) | (10) | 0 |
| Other adjustments | 0 | ||
| Balance, EOP | $ 932 | $ 969 | $ 0 |
Deferred Policy Acquisition Costs, Deferred Reinsurance, Deferred Sales Inducements and Value of Business Acquired (DRG) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | |||
| Balance, BOP | $ 739 | $ 424 | |
| Balance, EOP | 703 | 739 | $ 424 |
| Total | |||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | |||
| Balance, BOP | 697 | 376 | 117 |
| Deferred reinsurance gain | 6 | 364 | 280 |
| Amortization | (42) | (42) | (24) |
| Foreign currency adjustment | 2 | (1) | 3 |
| Balance, EOP | 663 | 697 | 376 |
| Other businesses | |||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | |||
| Balance, BOP | 42 | 48 | |
| Balance, EOP | 40 | 42 | 48 |
| Individual Variable | Retirement Strategies | |||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | |||
| Balance, BOP | 287 | 311 | 55 |
| Deferred reinsurance gain | 0 | 0 | 277 |
| Amortization | (24) | (24) | (21) |
| Foreign currency adjustment | 0 | 0 | 0 |
| Balance, EOP | 263 | 287 | 311 |
| Institutional | Retirement Strategies | |||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | |||
| Balance, BOP | 62 | 65 | 62 |
| Deferred reinsurance gain | 6 | 1 | 3 |
| Amortization | (3) | (3) | (3) |
| Foreign currency adjustment | 2 | (1) | 3 |
| Balance, EOP | 67 | 62 | 65 |
| Variable/ Universal Life | Individual Life | |||
| Reinsurance Recoverable, Allowance for Credit Gain [Roll Forward] | |||
| Balance, BOP | 348 | 0 | 0 |
| Deferred reinsurance gain | 0 | 363 | 0 |
| Amortization | (15) | (15) | 0 |
| Foreign currency adjustment | 0 | 0 | 0 |
| Balance, EOP | $ 333 | $ 348 | $ 0 |
Deferred Policy Acquisition Costs, Deferred Reinsurance, Deferred Sales Inducements and Value of Business Acquired - Balance of and Changes in DSI (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Movement in Deferred Sales Inducements [Roll Forward] | |||
| Balance, BOP | $ 406 | $ 443 | |
| Balance, EOP | 375 | 406 | $ 443 |
| Individual Retirement Strategies | Individual Variable | |||
| Movement in Deferred Sales Inducements [Roll Forward] | |||
| Balance, BOP | 376 | 410 | 446 |
| Capitalization | 5 | 1 | 2 |
| Amortization expense | (34) | (35) | (38) |
| Balance, EOP | 347 | 376 | 410 |
| Other businesses | |||
| Movement in Deferred Sales Inducements [Roll Forward] | |||
| Balance, BOP | 30 | 33 | |
| Balance, EOP | $ 28 | $ 30 | $ 33 |
Deferred Policy Acquisition Costs, Deferred Reinsurance, Deferred Sales Inducements and Value of Business Acquired - Balance of and Changes in VOBA (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Movement Analysis of Value of Business Acquired [Roll Forward] | |||
| Balance, BOP | $ 435 | ||
| Balance, EOP | 397 | $ 435 | |
| Gibraltar Life and Other | |||
| Movement Analysis of Value of Business Acquired [Roll Forward] | |||
| Balance, BOP | 421 | 511 | $ 597 |
| Amortization expense | (40) | (42) | (49) |
| Foreign currency adjustment | 3 | (48) | (37) |
| Balance, EOP | 384 | 421 | 511 |
| Other businesses | |||
| Movement Analysis of Value of Business Acquired [Roll Forward] | |||
| Balance, BOP | 14 | 19 | |
| Balance, EOP | 13 | 14 | 19 |
| Gibraltar Life and Other And Other Businesses | |||
| Movement Analysis of Value of Business Acquired [Roll Forward] | |||
| Balance, BOP | 435 | 530 | |
| Balance, EOP | $ 397 | $ 435 | $ 530 |
Deferred Policy Acquisition Costs, Deferred Reinsurance, Deferred Sales Inducements and Value of Business Acquired - Estimated Future VOBA Amort, Net of Interest (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Deferred Charges, Insurers [Abstract] | ||
| Estimated future VOBA amortization - 2026 | $ 37 | |
| Estimated future VOBA amortization - 2027 | 33 | |
| Estimated future VOBA amortization - 2028 | 30 | |
| Estimated future VOBA amortization - 2029 | 27 | |
| Estimated future VOBA amortization - 2030 | 25 | |
| Estimated future VOBA amortization - Thereafter | 245 | |
| Value of business acquired | $ 397 | $ 435 |
Investments in Operating Joint Ventures (Investments in Operating Joint Ventures) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|
| Schedule of Equity Method Investments [Line Items] | |||||
| Investment in joint ventures and other operating entities | $ 1,030 | $ 782 | $ 1,192 | ||
| Dividends received from joint ventures and other operating entities | 107 | 95 | 66 | ||
| After-tax equity in earnings of joint ventures and other operating entities | $ 129 | $ 144 | $ 49 | ||
| Prismic HoldCo | |||||
| Schedule of Equity Method Investments [Line Items] | |||||
| Equity Method Investment, Ownership Percentage | 20.00% | 20.00% | |||
Investments in Operating Joint Ventures (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Equity Method Investments and Joint Ventures [Abstract] | |||
| Asset management fee income | $ 61 | $ 31 | $ 10 |
Goodwill and Other Intangibles (Changes in the Book Value of Goodwill by Segment) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Goodwill [Roll Forward] | |||
| Goodwill balance, Beginning of the year | $ 1,053 | $ 1,071 | $ 876 |
| Acquisitions | 373 | ||
| Goodwill impairment | 0 | 0 | (177) |
| Divestitures | (23) | ||
| Effect of foreign currency translation | 22 | ||
| Effect of foreign currency translation and other | 37 | (18) | |
| Goodwill balance, End of the year | 1,090 | 1,053 | 1,071 |
| PGIM | |||
| Goodwill [Roll Forward] | |||
| Goodwill balance, Beginning of the year | 946 | 952 | 549 |
| Acquisitions | 373 | ||
| Goodwill impairment | 0 | ||
| Divestitures | 0 | ||
| Effect of foreign currency translation | 30 | ||
| Effect of foreign currency translation and other | 47 | (6) | |
| Goodwill balance, End of the year | 993 | 946 | 952 |
| Total International Businesses | |||
| Goodwill [Roll Forward] | |||
| Goodwill balance, Beginning of the year | 96 | 108 | 115 |
| Acquisitions | 0 | ||
| Goodwill impairment | 0 | ||
| Divestitures | 0 | ||
| Effect of foreign currency translation | (7) | ||
| Effect of foreign currency translation and other | 1 | (12) | |
| Goodwill balance, End of the year | 97 | 96 | 108 |
| Corporate and Other | |||
| Goodwill [Roll Forward] | |||
| Goodwill balance, Beginning of the year | 1 | 1 | 202 |
| Acquisitions | 0 | ||
| Goodwill impairment | (177) | ||
| Divestitures | (23) | ||
| Effect of foreign currency translation | (1) | ||
| Effect of foreign currency translation and other | (1) | 0 | |
| Goodwill balance, End of the year | 0 | 1 | 1 |
| Other | |||
| Goodwill [Roll Forward] | |||
| Goodwill balance, Beginning of the year | 10 | 10 | 10 |
| Acquisitions | 0 | ||
| Goodwill impairment | 0 | ||
| Divestitures | 0 | ||
| Effect of foreign currency translation | 0 | ||
| Effect of foreign currency translation and other | (10) | 0 | |
| Goodwill balance, End of the year | $ 0 | $ 10 | $ 10 |
Goodwill and Other Intangibles (Goodwill Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Goodwill and Intangible Assets Disclosure [Abstract] | |||
| Goodwill impairment | $ 0 | $ 0 | $ 177 |
Goodwill and Other Intangibles (Other Intangibles) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Finite and Indefinite-Lived Intangible Assets [Line Items] | ||
| Not subject to amortization | $ 39 | $ 41 |
| Total | 390 | 406 |
| Mortgage servicing rights | ||
| Finite and Indefinite-Lived Intangible Assets [Line Items] | ||
| Gross Carrying Amount | 918 | 897 |
| Accumulated Amortization | (650) | (630) |
| Net Carrying Amount | 268 | 267 |
| Customer relationships | ||
| Finite and Indefinite-Lived Intangible Assets [Line Items] | ||
| Gross Carrying Amount | 271 | 260 |
| Accumulated Amortization | (197) | (173) |
| Net Carrying Amount | 74 | 87 |
| Software and other | ||
| Finite and Indefinite-Lived Intangible Assets [Line Items] | ||
| Gross Carrying Amount | 35 | 41 |
| Accumulated Amortization | (26) | (30) |
| Net Carrying Amount | $ 9 | $ 11 |
Goodwill and Other Intangibles (Other Intangibles Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Finite and Indefinite-Lived Intangible Assets [Line Items] | |||
| Amortization expense for other intangibles | $ 73 | $ 80 | $ 89 |
| Mortgage servicing rights | |||
| Finite and Indefinite-Lived Intangible Assets [Line Items] | |||
| Net Carrying Amount | 268 | 267 | |
| Fair Value | Mortgage servicing rights | |||
| Finite and Indefinite-Lived Intangible Assets [Line Items] | |||
| Net Carrying Amount | $ 271 | $ 269 | |
Goodwill and Other Intangibles (Future Amortization Expense) (Details) $ in Millions |
Dec. 31, 2025
USD ($)
|
|---|---|
| Goodwill and Intangible Assets Disclosure [Abstract] | |
| Estimated future amortization expense - 2026 | $ 69 |
| Estimated future amortization expense - 2027 | 62 |
| Estimated future amortization expense - 2028 | 56 |
| Estimated future amortization expense - 2029 | 40 |
| Estimated future amortization expense - 2030 | $ 32 |
Leases (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Lessee, Lease, Description [Line Items] | |||
| Leases with options to extend | 15 years | ||
| Leases with options to terminate | 12 years | ||
| Operating lease costs | $ 121 | $ 123 | $ 121 |
| Short-term lease costs | 70 | 68 | 74 |
| Net investment income | |||
| Income and Expenses, Lessor [Abstract] | |||
| Lease Income | 64 | 69 | 79 |
| Other income (loss) | |||
| Income and Expenses, Lessor [Abstract] | |||
| Lease Income | $ 12 | $ 11 | $ 11 |
| Minimum | |||
| Lessee, Lease, Description [Line Items] | |||
| Remaining lease terms | 1 year | ||
| Maximum | |||
| Lessee, Lease, Description [Line Items] | |||
| Remaining lease terms | 23 years | ||
Leases (Lessee Right-of-Use Assets and Lease Liabilities) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Leases [Abstract] | ||
| Right-of-use assets | $ 366 | $ 373 |
| Lease liabilities | $ 408 | $ 408 |
| Weighted average remaining lease term | 8 years | 9 years |
| Weighted average discount rate | 2.82% | 2.58% |
| Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] | Other assets | Other assets |
| Operating Lease, Liability, Statement of Financial Position [Extensible List] | Other Liabilities | Other Liabilities |
Leases (Maturities of Operating Lease Liabilities) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Leases [Abstract] | ||
| 2026 | $ 92 | |
| 2027 | 81 | |
| 2028 | 56 | |
| 2029 | 46 | |
| 2030 | 41 | |
| Thereafter | 189 | |
| Total lease payments | 505 | |
| Less imputed interest | (97) | |
| Total | $ 408 | $ 408 |
Liability for Future Policy Benefits (Benefit Reserves) (Details) - USD ($) $ in Millions |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Other adjustments | [1] | $ (103) | $ 37 | $ (337) | ||
| Balance, EOP, post-flooring | 266,914 | 268,912 | ||||
| Retirement Strategies | Institutional | ||||||
| Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||||
| Balance, BOP | 72,526 | 71,407 | 52,620 | |||
| Effect of cumulative changes in discount rate assumptions, BOP | 14,545 | 11,869 | 14,349 | |||
| Balance at original discount rate, BOP | 87,071 | 83,276 | 66,969 | |||
| Effect of assumption update | 169 | 41 | $ (1,117) | |||
| Effect of actual variances from expected experience and other activity | (49) | 568 | 540 | |||
| Adjusted balance, BOP | 87,191 | 83,885 | 66,392 | |||
| Issuances | 13,848 | 24,498 | 20,914 | |||
| Net premiums / considerations collected | (10,223) | (22,206) | (10,389) | |||
| Interest accrual | 3,638 | 2,896 | 2,233 | |||
| Foreign currency adjustment | 7,155 | (2,002) | 4,126 | |||
| Other adjustments | 0 | 0 | 0 | |||
| Balance at original discount rate, EOP | 101,609 | 87,071 | 83,276 | |||
| Effect of cumulative changes in discount rate assumptions, EOP | (14,178) | (14,545) | (11,869) | |||
| Balance, EOP | 87,431 | 72,526 | 71,407 | |||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Balance, BOP | 151,484 | 141,135 | 117,754 | |||
| Effect of cumulative changes in discount rate assumptions, BOP | 20,182 | 14,751 | 20,170 | |||
| Balance at original discount rate, BOP | 171,666 | 155,886 | 137,924 | |||
| Effect of assumption update | 322 | (481) | (1,289) | |||
| Effect of actual variances from expected experience and other activity | 71 | 716 | 514 | |||
| Adjusted balance, BOP | 172,059 | 156,121 | 137,149 | |||
| Issuances | 13,848 | 24,498 | 20,914 | |||
| Interest accrual | 7,238 | 6,290 | 5,109 | |||
| Benefit payments | (15,095) | (13,131) | (11,477) | |||
| Foreign currency adjustment | 7,219 | (2,017) | 4,209 | |||
| Other adjustments | 5 | (95) | (18) | |||
| Balance at original discount rate, EOP | 185,274 | 171,666 | 155,886 | |||
| Effect of cumulative changes in discount rate assumptions, EOP | (17,758) | (20,182) | (14,751) | |||
| Balance, EOP | 167,516 | 151,484 | 141,135 | |||
| Balance, EOP, pre-flooring | 80,086 | 78,958 | 69,728 | |||
| Flooring impact, EOP | 183 | 68 | 61 | |||
| Balance, EOP, post-flooring | 80,269 | 79,026 | 69,789 | |||
| Less: Reinsurance recoverable | 5,189 | 5,057 | 5,539 | |||
| Total balance after reinsurance recoverable, EOP | 75,080 | 73,969 | 64,250 | |||
| Retirement Strategies | Institutional | Gross Basis | ||||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Undiscounted expected future gross premiums | 175,170 | 145,442 | 134,192 | |||
| Discounted expected future gross premiums (at original discount rate) | 109,368 | 94,222 | 90,606 | |||
| Discounted expected future gross premiums (at current discount rate) | 93,833 | 78,237 | 77,520 | |||
| Undiscounted expected future benefits and expenses | $ 301,899 | $ 274,071 | $ 242,617 | |||
| Weighted-average duration of the liability in years (at original discount rate) | 8 years | 8 years | 9 years | |||
| Weighted-average duration of the liability in years (at current discount rate) | 8 years | 8 years | 8 years | |||
| Weighted-average interest rate (at original discount rate) | 4.81% | 4.74% | 4.62% | |||
| Weighted-average interest rate (at current discount rate) | 5.37% | 5.59% | 5.03% | |||
| Individual Life | Term Life | ||||||
| Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||||
| Balance, BOP | $ 10,724 | $ 11,274 | $ 11,282 | |||
| Effect of cumulative changes in discount rate assumptions, BOP | 578 | 228 | 572 | |||
| Balance at original discount rate, BOP | 11,302 | 11,502 | 11,854 | |||
| Effect of assumption update | (241) | 21 | (1) | |||
| Effect of actual variances from expected experience and other activity | (179) | (228) | (223) | |||
| Adjusted balance, BOP | 10,882 | 11,295 | 11,630 | |||
| Issuances | 813 | 857 | 750 | |||
| Net premiums / considerations collected | (1,365) | (1,379) | (1,413) | |||
| Interest accrual | 527 | 530 | 538 | |||
| Foreign currency adjustment | 0 | 0 | 0 | |||
| Other adjustments | 60 | (1) | (3) | |||
| Balance at original discount rate, EOP | 10,917 | 11,302 | 11,502 | |||
| Effect of cumulative changes in discount rate assumptions, EOP | (280) | (578) | (228) | |||
| Balance, EOP | 10,637 | 10,724 | 11,274 | |||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Balance, BOP | 18,996 | 19,852 | 19,288 | |||
| Effect of cumulative changes in discount rate assumptions, BOP | 1,134 | 334 | 1,012 | |||
| Balance at original discount rate, BOP | 20,130 | 20,186 | 20,300 | |||
| Effect of assumption update | (392) | 21 | (1) | |||
| Effect of actual variances from expected experience and other activity | (230) | (252) | (269) | |||
| Adjusted balance, BOP | 19,508 | 19,955 | 20,030 | |||
| Issuances | 813 | 857 | 750 | |||
| Interest accrual | 943 | 945 | 944 | |||
| Benefit payments | (1,526) | (1,615) | (1,522) | |||
| Foreign currency adjustment | 0 | 0 | 0 | |||
| Other adjustments | 30 | (12) | (16) | |||
| Balance at original discount rate, EOP | 19,768 | 20,130 | 20,186 | |||
| Effect of cumulative changes in discount rate assumptions, EOP | (602) | (1,134) | (334) | |||
| Balance, EOP | 19,166 | 18,996 | 19,852 | |||
| Balance, EOP, pre-flooring | 8,529 | 8,272 | 8,578 | |||
| Flooring impact, EOP | 1 | 0 | 0 | |||
| Balance, EOP, post-flooring | 8,530 | 8,272 | 8,578 | |||
| Less: Reinsurance recoverable | 613 | 654 | 744 | |||
| Total balance after reinsurance recoverable, EOP | 7,917 | 7,618 | 7,834 | |||
| Individual Life | Term Life | Gross Basis | ||||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Undiscounted expected future gross premiums | 23,101 | 22,947 | 23,083 | |||
| Discounted expected future gross premiums (at original discount rate) | 15,594 | 15,662 | 15,322 | |||
| Discounted expected future gross premiums (at current discount rate) | 15,249 | 14,901 | 15,044 | |||
| Undiscounted expected future benefits and expenses | $ 30,574 | $ 31,068 | $ 31,114 | |||
| Weighted-average duration of the liability in years (at original discount rate) | 9 years | 10 years | 10 years | |||
| Weighted-average duration of the liability in years (at current discount rate) | 9 years | 9 years | 10 years | |||
| Weighted-average interest rate (at original discount rate) | 5.11% | 5.30% | 5.17% | |||
| Weighted-average interest rate (at current discount rate) | 5.27% | 5.78% | 4.99% | |||
| International Businesses | ||||||
| Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||||
| Balance, BOP | $ 45,851 | $ 55,431 | $ 59,640 | |||
| Effect of cumulative changes in discount rate assumptions, BOP | 2,599 | 1,218 | 2,680 | |||
| Balance at original discount rate, BOP | 48,450 | 56,649 | 62,320 | |||
| Effect of assumption update | (1,072) | (863) | (97) | |||
| Effect of actual variances from expected experience and other activity | (803) | (2,160) | (1,937) | |||
| Adjusted balance, BOP | 46,575 | 53,626 | 60,286 | |||
| Issuances | 2,880 | 3,354 | 3,875 | |||
| Net premiums / considerations collected | (6,656) | (6,969) | (7,637) | |||
| Interest accrual | 1,449 | 1,527 | 1,669 | |||
| Foreign currency adjustment | 451 | (3,209) | (1,663) | |||
| Other adjustments | 91 | 121 | 119 | |||
| Balance at original discount rate, EOP | 44,790 | 48,450 | 56,649 | |||
| Effect of cumulative changes in discount rate assumptions, EOP | (3,431) | (2,599) | (1,218) | |||
| Balance, EOP | 41,359 | 45,851 | 55,431 | |||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Balance, BOP | 135,485 | 158,858 | 158,970 | |||
| Effect of cumulative changes in discount rate assumptions, BOP | 17,834 | 7,918 | 14,985 | |||
| Balance at original discount rate, BOP | 153,319 | 166,776 | 173,955 | |||
| Effect of assumption update | (1,013) | (513) | 189 | |||
| Effect of actual variances from expected experience and other activity | (928) | (2,184) | (1,836) | |||
| Adjusted balance, BOP | 151,378 | 164,079 | 172,308 | |||
| Issuances | 2,880 | 3,354 | 3,875 | |||
| Interest accrual | 4,738 | 4,717 | 4,902 | |||
| Benefit payments | (8,430) | (9,163) | (9,022) | |||
| Foreign currency adjustment | 997 | (9,953) | (5,515) | |||
| Other adjustments | 247 | 285 | 228 | |||
| Balance at original discount rate, EOP | 151,810 | 153,319 | 166,776 | |||
| Effect of cumulative changes in discount rate assumptions, EOP | (26,267) | (17,834) | (7,918) | |||
| Balance, EOP | 125,543 | 135,485 | 158,858 | |||
| Balance, EOP, pre-flooring | 84,184 | 89,634 | 103,426 | |||
| Flooring impact, EOP | 77 | 37 | 25 | |||
| Balance, EOP, post-flooring | 84,261 | 89,671 | 103,451 | |||
| Less: Reinsurance recoverable | 307 | 349 | 304 | |||
| Total balance after reinsurance recoverable, EOP | 83,954 | 89,322 | 103,147 | |||
| International Businesses | Gross Basis | ||||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Undiscounted expected future gross premiums | 102,250 | 107,844 | 125,636 | |||
| Discounted expected future gross premiums (at original discount rate) | 79,537 | 84,715 | 98,959 | |||
| Discounted expected future gross premiums (at current discount rate) | 73,788 | 80,616 | 97,522 | |||
| Undiscounted expected future benefits and expenses | $ 250,822 | $ 254,008 | $ 280,791 | |||
| Weighted-average duration of the liability in years (at original discount rate) | 17 years | 18 years | 19 years | |||
| Weighted-average duration of the liability in years (at current discount rate) | 14 years | 16 years | 18 years | |||
| Weighted-average interest rate (at original discount rate) | 3.05% | 3.02% | 2.95% | |||
| Weighted-average interest rate (at current discount rate) | 4.46% | 3.70% | 3.01% | |||
| Total Corporate and Other | Long - Term Care | ||||||
| Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||||
| Balance, BOP | $ 2,854 | $ 3,286 | $ 2,932 | |||
| Effect of cumulative changes in discount rate assumptions, BOP | 132 | 16 | 103 | |||
| Balance at original discount rate, BOP | 2,986 | 3,302 | 3,035 | |||
| Effect of assumption update | 8 | (276) | 266 | |||
| Effect of actual variances from expected experience and other activity | 106 | 122 | 161 | |||
| Adjusted balance, BOP | 3,100 | 3,148 | 3,462 | |||
| Issuances | 0 | 0 | 0 | |||
| Net premiums / considerations collected | (310) | (311) | (317) | |||
| Interest accrual | 142 | 149 | 157 | |||
| Foreign currency adjustment | 0 | 0 | 0 | |||
| Other adjustments | 0 | 0 | 0 | |||
| Balance at original discount rate, EOP | 2,932 | 2,986 | 3,302 | |||
| Effect of cumulative changes in discount rate assumptions, EOP | (64) | (132) | (16) | |||
| Balance, EOP | 2,868 | 2,854 | 3,286 | |||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Balance, BOP | 11,178 | 12,139 | 10,685 | |||
| Effect of cumulative changes in discount rate assumptions, BOP | 1,548 | 603 | 1,216 | |||
| Balance at original discount rate, BOP | 12,726 | 12,742 | 11,901 | |||
| Effect of assumption update | 14 | (394) | 357 | |||
| Effect of actual variances from expected experience and other activity | 105 | 99 | 160 | |||
| Adjusted balance, BOP | 12,845 | 12,447 | 12,418 | |||
| Issuances | 0 | 0 | 0 | |||
| Interest accrual | 617 | 606 | 594 | |||
| Benefit payments | (367) | (327) | (270) | |||
| Foreign currency adjustment | 0 | 0 | 0 | |||
| Other adjustments | 0 | 0 | 0 | |||
| Balance at original discount rate, EOP | 13,095 | 12,726 | 12,742 | |||
| Effect of cumulative changes in discount rate assumptions, EOP | (1,435) | (1,548) | (603) | |||
| Balance, EOP | 11,660 | 11,178 | 12,139 | |||
| Balance, EOP, pre-flooring | 8,792 | 8,324 | 8,852 | |||
| Flooring impact, EOP | 0 | 0 | 0 | |||
| Balance, EOP, post-flooring | 8,792 | 8,324 | 8,852 | |||
| Less: Reinsurance recoverable | 0 | 0 | 0 | |||
| Total balance after reinsurance recoverable, EOP | 8,792 | 8,324 | 8,852 | |||
| Total Corporate and Other | Long - Term Care | Gross Basis | ||||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Undiscounted expected future gross premiums | 6,397 | 6,817 | 6,852 | |||
| Discounted expected future gross premiums (at original discount rate) | 4,325 | 4,542 | 4,509 | |||
| Discounted expected future gross premiums (at current discount rate) | 4,240 | 4,350 | 4,491 | |||
| Undiscounted expected future benefits and expenses | $ 29,483 | $ 29,661 | $ 30,761 | |||
| Weighted-average duration of the liability in years (at original discount rate) | 16 years | 17 years | 18 years | |||
| Weighted-average duration of the liability in years (at current discount rate) | 15 years | 16 years | 17 years | |||
| Weighted-average interest rate (at original discount rate) | 4.91% | 4.91% | 4.91% | |||
| Weighted-average interest rate (at current discount rate) | 5.78% | 5.85% | 5.25% | |||
| Total | ||||||
| Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||||
| Balance, BOP | $ 131,955 | $ 141,398 | $ 126,474 | |||
| Effect of cumulative changes in discount rate assumptions, BOP | 17,854 | 13,331 | 17,704 | |||
| Balance at original discount rate, BOP | 149,809 | 154,729 | 144,178 | |||
| Effect of assumption update | (1,136) | (1,077) | (949) | |||
| Effect of actual variances from expected experience and other activity | (925) | (1,698) | (1,459) | |||
| Adjusted balance, BOP | 147,748 | 151,954 | 141,770 | |||
| Issuances | 17,541 | 28,709 | 25,539 | |||
| Net premiums / considerations collected | (18,554) | (30,865) | (19,756) | |||
| Interest accrual | 5,756 | 5,102 | 4,597 | |||
| Foreign currency adjustment | 7,606 | (5,211) | 2,463 | |||
| Other adjustments | 151 | 120 | 116 | |||
| Balance at original discount rate, EOP | 160,248 | 149,809 | 154,729 | |||
| Effect of cumulative changes in discount rate assumptions, EOP | (17,953) | (17,854) | (13,331) | |||
| Balance, EOP | 142,295 | 131,955 | 141,398 | |||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Balance, BOP | 317,143 | 331,984 | 306,697 | |||
| Effect of cumulative changes in discount rate assumptions, BOP | 40,698 | 23,606 | 37,383 | |||
| Balance at original discount rate, BOP | 357,841 | 355,590 | 344,080 | |||
| Effect of assumption update | (1,069) | (1,367) | (744) | |||
| Effect of actual variances from expected experience and other activity | (982) | (1,621) | (1,431) | |||
| Adjusted balance, BOP | 355,790 | 352,602 | $ 341,905 | |||
| Issuances | 17,541 | 28,709 | 25,539 | |||
| Interest accrual | 13,536 | 12,558 | 11,549 | |||
| Benefit payments | (25,418) | (24,236) | (22,291) | |||
| Foreign currency adjustment | 8,216 | (11,970) | (1,306) | |||
| Other adjustments | 282 | 178 | 194 | |||
| Balance at original discount rate, EOP | 369,947 | 357,841 | 355,590 | |||
| Effect of cumulative changes in discount rate assumptions, EOP | (46,062) | (40,698) | (23,606) | |||
| Balance, EOP | 323,885 | 317,143 | 331,984 | |||
| Balance, EOP, pre-flooring | 181,591 | 185,188 | 190,584 | |||
| Flooring impact, EOP | 261 | 105 | 86 | |||
| Balance, EOP, post-flooring | 181,852 | 185,293 | 190,670 | |||
| Less: Reinsurance recoverable | 6,109 | 6,060 | 6,587 | |||
| Total balance after reinsurance recoverable, EOP | 175,743 | 179,233 | 184,083 | |||
| Other businesses | ||||||
| Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||||
| Balance, BOP | 93 | 86 | ||||
| Balance, EOP | 111 | 93 | 86 | |||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Balance, BOP | 1,646 | 1,716 | ||||
| Balance, EOP | 1,689 | 1,646 | 1,716 | |||
| Less: Reinsurance recoverable | 55 | 60 | 69 | |||
| Total balance after reinsurance recoverable, EOP | 1,522 | 1,493 | 1,563 | |||
| Total balance | ||||||
| Liability for Future Policy Benefit, Expected Net Premium [Roll Forward] | ||||||
| Balance, BOP | 132,048 | 141,484 | ||||
| Balance, EOP | 142,406 | 132,048 | 141,484 | |||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Balance, BOP | 318,789 | 333,700 | ||||
| Balance, EOP | 325,574 | 318,789 | 333,700 | |||
| Total balance after reinsurance recoverable, EOP | 177,265 | $ 180,726 | $ 185,646 | |||
| Nonparticipating Traditional and Limited-Pay Business | ||||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Loss in net income | 85 | |||||
| Gain in net income | $ 8 | |||||
| ||||||
Liability for Future Policy Benefits (Deferred Profit Liability) (Details) - USD ($) $ in Millions |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Balance, BOP | $ 268,912 | |||||
| Other adjustments | [1] | (103) | $ 37 | $ (337) | ||
| Balance, EOP | 266,914 | 268,912 | ||||
| Retirement Strategies | Institutional | ||||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Balance, BOP | 79,026 | 69,789 | ||||
| Flooring impact, BOP | 68 | 61 | ||||
| Balance, BOP, pre-flooring | 78,958 | 69,728 | ||||
| Effect of assumption update | 322 | (481) | $ (1,289) | |||
| Effect of actual variances from expected experience and other activity | 71 | 716 | 514 | |||
| Adjusted balance, BOP | 172,059 | 156,121 | 137,149 | |||
| Interest accrual | 7,238 | 6,290 | 5,109 | |||
| Foreign currency adjustment | 7,219 | (2,017) | 4,209 | |||
| Other adjustments | 5 | (95) | (18) | |||
| Balance, EOP, pre-flooring | 80,086 | 78,958 | 69,728 | |||
| Flooring impact, EOP | 183 | 68 | 61 | |||
| Balance, EOP | 80,269 | 79,026 | 69,789 | |||
| Less: Reinsurance recoverable | 5,189 | 5,057 | 5,539 | |||
| Total balance after reinsurance recoverable | 75,080 | 73,969 | 64,250 | |||
| International Businesses | ||||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Balance, BOP | 89,671 | 103,451 | ||||
| Flooring impact, BOP | 37 | 25 | ||||
| Balance, BOP, pre-flooring | 89,634 | 103,426 | ||||
| Effect of assumption update | (1,013) | (513) | 189 | |||
| Effect of actual variances from expected experience and other activity | (928) | (2,184) | (1,836) | |||
| Adjusted balance, BOP | 151,378 | 164,079 | 172,308 | |||
| Interest accrual | 4,738 | 4,717 | 4,902 | |||
| Foreign currency adjustment | 997 | (9,953) | (5,515) | |||
| Other adjustments | 247 | 285 | 228 | |||
| Balance, EOP, pre-flooring | 84,184 | 89,634 | 103,426 | |||
| Flooring impact, EOP | 77 | 37 | 25 | |||
| Balance, EOP | 84,261 | 89,671 | 103,451 | |||
| Less: Reinsurance recoverable | 307 | 349 | 304 | |||
| Total balance after reinsurance recoverable | 83,954 | 89,322 | 103,147 | |||
| Total | ||||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Balance, BOP | 185,293 | 190,670 | ||||
| Flooring impact, BOP | 105 | 86 | ||||
| Balance, BOP, pre-flooring | 185,188 | 190,584 | ||||
| Effect of assumption update | (1,069) | (1,367) | (744) | |||
| Effect of actual variances from expected experience and other activity | (982) | (1,621) | (1,431) | |||
| Adjusted balance, BOP | 355,790 | 352,602 | 341,905 | |||
| Interest accrual | 13,536 | 12,558 | 11,549 | |||
| Foreign currency adjustment | 8,216 | (11,970) | (1,306) | |||
| Other adjustments | 282 | 178 | 194 | |||
| Balance, EOP, pre-flooring | 181,591 | 185,188 | 190,584 | |||
| Flooring impact, EOP | 261 | 105 | 86 | |||
| Balance, EOP | 181,852 | 185,293 | 190,670 | |||
| Less: Reinsurance recoverable | 6,109 | 6,060 | 6,587 | |||
| Total balance after reinsurance recoverable | 175,743 | 179,233 | 184,083 | |||
| Other businesses | ||||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Less: Reinsurance recoverable | 55 | 60 | 69 | |||
| Total balance after reinsurance recoverable | 1,522 | 1,493 | 1,563 | |||
| Total balance | ||||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Total balance after reinsurance recoverable | 177,265 | 180,726 | 185,646 | |||
| Deferred Profit Liability | Retirement Strategies | Institutional | ||||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Balance, BOP | 5,670 | 5,615 | 5,532 | |||
| Flooring impact, BOP | 0 | 0 | 0 | |||
| Balance, BOP, pre-flooring | 5,670 | 5,615 | 5,532 | |||
| Effect of assumption update | (73) | 370 | 35 | |||
| Effect of actual variances from expected experience and other activity | 0 | (99) | 21 | |||
| Adjusted balance, BOP | 5,597 | 5,886 | 5,588 | |||
| Profits deferred | 131 | 142 | 342 | |||
| Interest accrual | 230 | 236 | 227 | |||
| Amortization | (570) | (588) | (565) | |||
| Foreign currency adjustment | 19 | (6) | 15 | |||
| Other adjustments | 0 | 0 | 8 | |||
| Balance, EOP, pre-flooring | 5,407 | 5,670 | 5,615 | |||
| Flooring impact, EOP | 0 | 0 | 0 | |||
| Balance, EOP | 5,407 | 5,670 | 5,615 | |||
| Less: Reinsurance recoverable | 391 | 391 | 386 | |||
| Total balance after reinsurance recoverable | 5,016 | 5,279 | 5,229 | |||
| Deferred Profit Liability | International Businesses | ||||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Balance, BOP | 9,354 | 9,259 | 8,640 | |||
| Flooring impact, BOP | 2 | 2 | 1 | |||
| Balance, BOP, pre-flooring | 9,352 | 9,257 | 8,639 | |||
| Effect of assumption update | (58) | (288) | (295) | |||
| Effect of actual variances from expected experience and other activity | 9 | (59) | (75) | |||
| Adjusted balance, BOP | 9,303 | 8,910 | 8,269 | |||
| Profits deferred | 2,565 | 2,679 | 3,005 | |||
| Interest accrual | 353 | 320 | 300 | |||
| Amortization | (2,128) | (2,109) | (2,173) | |||
| Foreign currency adjustment | 90 | (480) | (176) | |||
| Other adjustments | 40 | 32 | 32 | |||
| Balance, EOP, pre-flooring | 10,223 | 9,352 | 9,257 | |||
| Flooring impact, EOP | 2 | 2 | 2 | |||
| Balance, EOP | 10,225 | 9,354 | 9,259 | |||
| Less: Reinsurance recoverable | 44 | 40 | 19 | |||
| Total balance after reinsurance recoverable | 10,181 | 9,314 | 9,240 | |||
| Deferred Profit Liability | Total | ||||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Balance, BOP | 15,024 | 14,874 | 14,172 | |||
| Flooring impact, BOP | 2 | 2 | 1 | |||
| Balance, BOP, pre-flooring | 15,022 | 14,872 | 14,171 | |||
| Effect of assumption update | (131) | 82 | (260) | |||
| Effect of actual variances from expected experience and other activity | 9 | (158) | (54) | |||
| Adjusted balance, BOP | 14,900 | 14,796 | $ 13,857 | |||
| Profits deferred | 2,696 | 2,821 | 3,347 | |||
| Interest accrual | 583 | 556 | 527 | |||
| Amortization | (2,698) | (2,697) | (2,738) | |||
| Foreign currency adjustment | 109 | (486) | (161) | |||
| Other adjustments | 40 | 32 | 40 | |||
| Balance, EOP, pre-flooring | 15,630 | 15,022 | 14,872 | |||
| Flooring impact, EOP | 2 | 2 | 2 | |||
| Balance, EOP | 15,632 | 15,024 | 14,874 | |||
| Less: Reinsurance recoverable | 435 | 431 | 405 | |||
| Total balance after reinsurance recoverable | 15,197 | 14,593 | 14,469 | |||
| Deferred Profit Liability | Other businesses | ||||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Total balance after reinsurance recoverable | 166 | 161 | 148 | |||
| Deferred Profit Liability | Total balance | ||||||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | ||||||
| Total balance after reinsurance recoverable | $ 15,363 | $ 14,754 | $ 14,617 | |||
| ||||||
Liability for Future Policy Benefits (Additional Insurance Reserves) (Details) - USD ($) $ in Millions |
12 Months Ended | |||
|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Additional Liability, Long-Duration Insurance [Line Items] | ||||
| Balance, including amounts in AOCI, BOP, post-flooring | $ 16,439 | $ 14,439 | ||
| Balance, including amounts in AOCI, EOP, post-flooring | $ 18,293 | $ 16,439 | $ 14,439 | |
| Individual Life | Gross Basis | ||||
| Additional Liability, Long-Duration Insurance [Line Items] | ||||
| Weighted-average duration of the liability in years (at original discount rate) | 21 years | 21 years | 22 years | |
| Weighted-average interest rate (at original discount rate) | 3.36% | 3.36% | 3.40% | |
| Total | Individual Life | ||||
| Additional Liability, Long-Duration Insurance [Line Items] | ||||
| Balance, including amounts in AOCI, BOP, post-flooring | $ 16,376 | $ 14,308 | $ 12,684 | |
| Flooring impact and amounts in AOCI | 632 | 843 | 1,285 | |
| Balance, excluding amounts in AOCI, BOP, pre-flooring | 17,008 | 15,151 | 13,969 | |
| Effect of assumption update | (39) | 153 | $ 23 | |
| Effect of actual variances from expected experience and other activity | 147 | 266 | 32 | |
| Adjusted balance, BOP | 17,116 | 15,570 | $ 14,024 | |
| Assessment collected | 1,203 | 1,251 | 938 | |
| Interest accrual | 592 | 539 | 488 | |
| Benefits paid | (394) | (353) | (301) | |
| Other adjustments | 37 | 1 | 2 | |
| Balance, excluding amounts in AOCI, EOP, pre-flooring | 18,554 | 17,008 | 15,151 | |
| Flooring impact and amounts in AOCI | (440) | (632) | (843) | |
| Balance, including amounts in AOCI, EOP, post-flooring | 18,114 | 16,376 | 14,308 | |
| Less: Reinsurance recoverable | 10,726 | 9,543 | 5,852 | |
| Total balance after reinsurance recoverable | 7,388 | 6,833 | 8,456 | |
| Other businesses | ||||
| Additional Liability, Long-Duration Insurance [Line Items] | ||||
| Total balance after reinsurance recoverable | 179 | 63 | 131 | |
| Total balance | ||||
| Additional Liability, Long-Duration Insurance [Line Items] | ||||
| Total balance after reinsurance recoverable | $ 7,567 | $ 6,896 | $ 8,587 | |
Liability for Future Policy Benefits (Future Policy Benefits Reconciliations) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|---|
| Insurance [Abstract] | |||
| Benefit reserves, EOP, post-flooring | $ 183,429 | $ 186,846 | $ 192,302 |
| Deferred profit liability, EOP, post-flooring | 15,798 | 15,185 | 15,022 |
| Additional insurance reserves, including amounts in AOCI, EOP, post-flooring | 18,293 | 16,439 | 14,439 |
| Subtotal of amounts disclosed above | 217,520 | 218,470 | 221,763 |
| Other Future Policy Benefits reserves | 49,394 | 50,442 | 51,518 |
| Future policy benefits | $ 266,914 | $ 268,912 | $ 273,281 |
Liability for Future Policy Benefits (Revenue and Interest Expense) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Benefit reserves | Retirement Strategies | Institutional | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | $ 10,803 | $ 22,814 | $ 11,156 |
| Interest Expense | 3,600 | 3,394 | 2,876 |
| Benefit reserves | Individual Life | Term Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 1,919 | 1,892 | 1,848 |
| Interest Expense | 416 | 415 | 406 |
| Benefit reserves | Individual Life | Variable/ Universal Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 |
| Benefit reserves | International Businesses | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 10,489 | 11,061 | 12,353 |
| Interest Expense | 3,289 | 3,191 | 3,233 |
| Benefit reserves | Other businesses | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 547 | 557 | 540 |
| Interest Expense | 525 | 505 | 490 |
| Benefit reserves | Total | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 23,758 | 36,324 | 25,897 |
| Interest Expense | 7,830 | 7,505 | 7,005 |
| Deferred Profit Liability | Retirement Strategies | Institutional | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 282 | (61) | (68) |
| Interest Expense | 230 | 236 | 227 |
| Deferred Profit Liability | Individual Life | Term Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 |
| Deferred Profit Liability | Individual Life | Variable/ Universal Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 |
| Deferred Profit Liability | International Businesses | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | (781) | (576) | (794) |
| Interest Expense | 353 | 320 | 300 |
| Deferred Profit Liability | Other businesses | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | (4) | (12) | 34 |
| Interest Expense | 4 | 4 | 4 |
| Deferred Profit Liability | Total | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | (503) | (649) | (828) |
| Interest Expense | 587 | 560 | 531 |
| Additional insurance reserves | Retirement Strategies | Institutional | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 |
| Additional insurance reserves | Individual Life | Term Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 |
| Additional insurance reserves | Individual Life | Variable/ Universal Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 3,219 | 3,458 | 2,947 |
| Interest Expense | 592 | 539 | 488 |
| Additional insurance reserves | International Businesses | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 92 | 0 | 0 |
| Interest Expense | 2 | 1 | 2 |
| Additional insurance reserves | Other businesses | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 44 | 0 | 0 |
| Interest Expense | 1 | 0 | 0 |
| Additional insurance reserves | Total | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 3,355 | 3,458 | 2,947 |
| Interest Expense | 595 | 540 | 490 |
| Revenues | Retirement Strategies | Institutional | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 11,085 | 22,753 | 11,088 |
| Revenues | Individual Life | Term Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 1,919 | 1,892 | 1,848 |
| Revenues | Individual Life | Variable/ Universal Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 3,219 | 3,458 | 2,947 |
| Revenues | International Businesses | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 9,800 | 10,485 | 11,559 |
| Revenues | Other businesses | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 587 | 545 | 574 |
| Revenues | Total | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Revenue | 26,610 | 39,133 | 28,016 |
| Interest Expense | Retirement Strategies | Institutional | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Interest Expense | 3,830 | 3,630 | 3,103 |
| Interest Expense | Individual Life | Term Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Interest Expense | 416 | 415 | 406 |
| Interest Expense | Individual Life | Variable/ Universal Life | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Interest Expense | 592 | 539 | 488 |
| Interest Expense | International Businesses | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Interest Expense | 3,644 | 3,512 | 3,535 |
| Interest Expense | Other businesses | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Interest Expense | 530 | 509 | 494 |
| Interest Expense | Total | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Interest Expense | $ 9,012 | $ 8,605 | $ 8,026 |
Policyholders' Account Balances (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||
| Balance, beginning of period | $ 166,254 | $ 147,018 | |
| Policyholder Account Balance, Interest Expense | 5,068 | 4,582 | $ 3,983 |
| Total Policyholders' account balance | 191,307 | 166,254 | 147,018 |
| Closed Block Division | 4,273 | 4,359 | 4,500 |
| Policyholder Account Balance, Unearned Revenue Reserve, Unearned Expense Credit, And Additional Interest Reserve | 6,782 | 6,009 | 5,326 |
| Other | $ 1,585 | $ 3,853 | $ 4,463 |
| Weighted-average crediting rate | 2.97% | 2.99% | 2.78% |
| Net amount at risk | $ 521,117 | $ 500,684 | $ 480,986 |
| Cash surrender value | 163,407 | 138,670 | 117,561 |
| International Businesses | |||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||
| Balance, beginning of period | 54,270 | 51,399 | 46,493 |
| Deposits | 9,159 | 8,862 | 9,028 |
| Policyholder Account Balance, Interest Expense | 2,169 | 1,810 | 1,445 |
| Acquisitions and dispositions | 0 | (336) | 0 |
| Policy charges | (618) | (570) | (529) |
| Surrenders and withdrawals | (1,902) | (2,373) | (1,705) |
| Benefit payments | (2,295) | (2,348) | (2,185) |
| Net transfers (to) from separate account | 0 | 0 | 0 |
| Change in market value and other adjustments | (12) | (30) | 22 |
| Foreign currency adjustment | 175 | (2,144) | (1,170) |
| Balance, end of period | $ 60,946 | 54,270 | 51,399 |
| Total Policyholders' account balance | $ 54,270 | $ 51,399 | |
| Weighted-average crediting rate | 3.76% | 3.43% | 2.95% |
| Net amount at risk | $ 29,906 | $ 26,435 | $ 25,729 |
| Cash surrender value | 55,511 | 49,028 | 45,101 |
| Total | |||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||
| Balance, beginning of period | 152,033 | 132,729 | 118,377 |
| Deposits | 36,269 | 33,370 | 25,641 |
| Policyholder Account Balance, Interest Expense | 4,916 | 4,252 | 3,494 |
| Acquisitions and dispositions | 0 | (336) | 0 |
| Policy charges | (3,142) | (2,992) | (2,955) |
| Surrenders and withdrawals | (13,155) | (13,012) | (11,485) |
| Benefit payments | (3,272) | (3,256) | (3,150) |
| Net transfers (to) from separate account | 752 | 729 | 1,379 |
| Change in market value and other adjustments | 4,091 | 2,693 | 2,598 |
| Foreign currency adjustment | 175 | (2,144) | (1,170) |
| Balance, end of period | 178,667 | 152,033 | 132,729 |
| Total Policyholders' account balance | 152,033 | 132,729 | |
| Institutional | |||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||
| Balance, beginning of period | 9,262 | 9,684 | |
| Total Policyholders' account balance | 12,162 | 9,262 | 9,684 |
| Institutional | Retirement Strategies | |||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||
| Balance, beginning of period | 19,088 | 17,738 | 17,376 |
| Deposits | 9,706 | 7,106 | 5,657 |
| Policyholder Account Balance, Interest Expense | 884 | 757 | 677 |
| Acquisitions and dispositions | 0 | 0 | 0 |
| Policy charges | (10) | (11) | (23) |
| Surrenders and withdrawals | (5,639) | (5,895) | (5,290) |
| Benefit payments | (664) | (607) | (659) |
| Net transfers (to) from separate account | 0 | 0 | 0 |
| Change in market value and other adjustments | 1 | 0 | 0 |
| Foreign currency adjustment | 0 | 0 | 0 |
| Balance, end of period | $ 23,366 | 19,088 | 17,738 |
| Total Policyholders' account balance | $ 19,088 | $ 17,738 | |
| Weighted-average crediting rate | 4.16% | 4.11% | 3.85% |
| Net amount at risk | $ 0 | $ 0 | $ 0 |
| Cash surrender value | 23,366 | 19,058 | 17,738 |
| Individual Variable | |||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||
| Balance, beginning of period | 3,531 | 4,051 | |
| Total Policyholders' account balance | 3,002 | 3,531 | 4,051 |
| Individual Variable | Retirement Strategies | |||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||
| Balance, beginning of period | 34,085 | 23,765 | 17,524 |
| Deposits | 7,232 | 8,318 | 4,638 |
| Policyholder Account Balance, Interest Expense | 729 | 511 | 305 |
| Acquisitions and dispositions | 0 | 0 | 0 |
| Policy charges | (75) | (33) | (24) |
| Surrenders and withdrawals | (1,238) | (919) | (704) |
| Benefit payments | (57) | (85) | (76) |
| Net transfers (to) from separate account | 15 | 122 | 34 |
| Change in market value and other adjustments | 3,301 | 2,406 | 2,068 |
| Foreign currency adjustment | 0 | 0 | 0 |
| Balance, end of period | $ 43,992 | 34,085 | 23,765 |
| Total Policyholders' account balance | $ 34,085 | $ 23,765 | |
| Weighted-average crediting rate | 1.87% | 1.77% | 1.48% |
| Net amount at risk | $ 0 | $ 0 | $ 0 |
| Cash surrender value | 42,831 | 32,501 | 21,640 |
| Individual Fixed | |||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||
| Balance, beginning of period | 5,690 | 3,121 | |
| Total Policyholders' account balance | 8,240 | 5,690 | 3,121 |
| Individual Fixed | Retirement Strategies | |||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||
| Balance, beginning of period | 12,020 | 7,095 | 4,643 |
| Deposits | 5,922 | 5,266 | 2,659 |
| Policyholder Account Balance, Interest Expense | 392 | 252 | 129 |
| Acquisitions and dispositions | 0 | 0 | 0 |
| Policy charges | (54) | (5) | (9) |
| Surrenders and withdrawals | (1,079) | (719) | (414) |
| Benefit payments | (135) | (79) | (76) |
| Net transfers (to) from separate account | 0 | 0 | 0 |
| Change in market value and other adjustments | 266 | 210 | 163 |
| Foreign currency adjustment | 0 | 0 | 0 |
| Balance, end of period | $ 17,332 | 12,020 | 7,095 |
| Total Policyholders' account balance | $ 12,020 | $ 7,095 | |
| Weighted-average crediting rate | 2.67% | 2.64% | 2.21% |
| Net amount at risk | $ 0 | $ 0 | $ 0 |
| Cash surrender value | 15,442 | 10,305 | 5,827 |
| Life/Disability | Group Insurance | |||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||
| Balance, beginning of period | 4,974 | 5,293 | 5,839 |
| Deposits | 1,363 | 1,313 | 1,212 |
| Policyholder Account Balance, Interest Expense | 137 | 148 | 165 |
| Acquisitions and dispositions | 0 | 0 | 0 |
| Policy charges | (325) | (322) | (323) |
| Surrenders and withdrawals | (1,337) | (1,452) | (1,552) |
| Benefit payments | 0 | 0 | 0 |
| Net transfers (to) from separate account | (49) | (6) | (48) |
| Change in market value and other adjustments | 0 | 0 | 0 |
| Foreign currency adjustment | 0 | 0 | 0 |
| Balance, end of period | $ 4,763 | 4,974 | 5,293 |
| Total Policyholders' account balance | $ 4,974 | $ 5,293 | |
| Weighted-average crediting rate | 2.82% | 2.88% | 2.96% |
| Net amount at risk | $ 72,850 | $ 73,259 | $ 72,858 |
| Cash surrender value | 3,871 | 3,892 | 4,021 |
| Variable/ Universal Life | |||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||
| Balance, beginning of period | 23,801 | 24,064 | |
| Total Policyholders' account balance | 23,531 | 23,801 | 24,064 |
| Variable/ Universal Life | Individual Life | |||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||
| Balance, beginning of period | 27,596 | 27,439 | 26,502 |
| Deposits | 2,887 | 2,505 | 2,447 |
| Policyholder Account Balance, Interest Expense | 605 | 774 | 773 |
| Acquisitions and dispositions | 0 | 0 | 0 |
| Policy charges | (2,060) | (2,051) | (2,047) |
| Surrenders and withdrawals | (1,960) | (1,654) | (1,820) |
| Benefit payments | (121) | (137) | (154) |
| Net transfers (to) from separate account | 786 | 613 | 1,393 |
| Change in market value and other adjustments | 535 | 107 | 345 |
| Foreign currency adjustment | 0 | 0 | 0 |
| Balance, end of period | $ 28,268 | 27,596 | 27,439 |
| Total Policyholders' account balance | $ 27,596 | $ 27,439 | |
| Weighted-average crediting rate | 2.16% | 2.81% | 2.87% |
| Net amount at risk | $ 418,361 | $ 400,990 | $ 382,399 |
| Cash surrender value | 22,386 | 23,886 | 23,234 |
| Full Service | Corporate and Other | |||
| Additional Liability, Long-Duration Insurance [Roll Forward] | |||
| Policyholder Account Balance, Reinsurance Recoverable, after Allowance | $ 2,738 | $ 5,099 | $ 5,479 |
Policyholders' Account Balances (Guaranteed Minimum Crediting Rate) (Details) $ in Millions |
Dec. 31, 2025
USD ($)
|
Dec. 31, 2024
USD ($)
Rate
|
Dec. 31, 2023
USD ($)
Rate
|
|---|---|---|---|
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 191,307 | $ 166,254 | $ 147,018 |
| 1 - 50 bps above guaranteed minimum | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, above Guaranteed Minimum Crediting Rate | 1 | 1 | 1 |
| 1 - 50 bps above guaranteed minimum | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, above Guaranteed Minimum Crediting Rate | 50 | 50 | 50 |
| 51 - 150 bps above guaranteed minimum | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, above Guaranteed Minimum Crediting Rate | 51 | 51 | 51 |
| 51 - 150 bps above guaranteed minimum | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, above Guaranteed Minimum Crediting Rate | 150 | 150 | 150 |
| Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, above Guaranteed Minimum Crediting Rate | 150 | 150 | 150 |
| Institutional | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 12,162 | $ 9,262 | $ 9,684 |
| Institutional | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 12,162 | 9,262 | 9,684 |
| Institutional | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Institutional | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Institutional | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Individual Variable | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 3,002 | 3,531 | 4,051 |
| Individual Variable | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 2,091 | 2,065 | 3,192 |
| Individual Variable | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 565 | 805 | 826 |
| Individual Variable | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 346 | 661 | 33 |
| Individual Variable | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Individual Fixed | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 8,240 | 5,690 | 3,121 |
| Individual Fixed | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 4,115 | 3,157 | 1,492 |
| Individual Fixed | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 1,528 | 635 | 602 |
| Individual Fixed | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 790 | 788 | 813 |
| Individual Fixed | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 1,807 | 1,110 | 214 |
| Group Insurance | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 2,317 | 2,548 | 2,842 |
| Group Insurance | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 1,464 | 1,509 | 1,645 |
| Group Insurance | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 7 | 15 | 0 |
| Group Insurance | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 69 | 41 | 0 |
| Group Insurance | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 777 | 983 | 1,197 |
| Variable/ Universal Life | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 23,531 | 23,801 | 24,064 |
| Variable/ Universal Life | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 11,091 | 11,812 | 10,144 |
| Variable/ Universal Life | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 3,556 | 3,395 | 5,537 |
| Variable/ Universal Life | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 6,143 | 6,309 | 6,843 |
| Variable/ Universal Life | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 2,741 | 2,285 | 1,540 |
| International Businesses | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 55,479 | 49,784 | 46,645 |
| International Businesses | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 55,124 | 46,304 | 44,080 |
| International Businesses | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 331 | 387 | 444 |
| International Businesses | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 24 | 109 | 125 |
| International Businesses | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 2,984 | 1,996 |
| Less than 1.00% | Institutional | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 208 | $ 401 | $ 589 |
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.00% | 1.00% | 1.00% |
| Less than 1.00% | Institutional | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 208 | $ 401 | $ 589 |
| Less than 1.00% | Institutional | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Less than 1.00% | Institutional | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Less than 1.00% | Institutional | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Less than 1.00% | Individual Variable | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 874 | $ 1,279 | $ 1,733 |
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.00% | 1.00% | 1.00% |
| Less than 1.00% | Individual Variable | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 422 | $ 129 | $ 908 |
| Less than 1.00% | Individual Variable | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 120 | 503 | 807 |
| Less than 1.00% | Individual Variable | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 332 | 647 | 18 |
| Less than 1.00% | Individual Variable | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Less than 1.00% | Individual Fixed | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 1,781 | $ 1,037 | $ 118 |
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.00% | 1.00% | 1.00% |
| Less than 1.00% | Individual Fixed | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 3 | $ 0 | $ 0 |
| Less than 1.00% | Individual Fixed | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 7 | 3 | 0 |
| Less than 1.00% | Individual Fixed | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 28 | 12 | 1 |
| Less than 1.00% | Individual Fixed | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 1,743 | 1,022 | 117 |
| Less than 1.00% | Group Insurance | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 771 | $ 959 | $ 1,147 |
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.00% | 1.00% | 1.00% |
| Less than 1.00% | Group Insurance | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 0 | $ 0 | $ 0 |
| Less than 1.00% | Group Insurance | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Less than 1.00% | Group Insurance | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Less than 1.00% | Group Insurance | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 771 | 959 | 1,147 |
| Less than 1.00% | Variable/ Universal Life | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 373 | $ 324 | $ 368 |
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.00% | 1.00% | 1.00% |
| Less than 1.00% | Variable/ Universal Life | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 0 | $ 7 | $ 0 |
| Less than 1.00% | Variable/ Universal Life | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Less than 1.00% | Variable/ Universal Life | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Less than 1.00% | Variable/ Universal Life | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 373 | 317 | 368 |
| Less than 1.00% | International Businesses | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 3,675 | $ 18,661 | $ 18,434 |
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.00% | 1.00% | 1.00% |
| Less than 1.00% | International Businesses | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 3,652 | $ 15,556 | $ 16,306 |
| Less than 1.00% | International Businesses | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 23 | 41 | 43 |
| Less than 1.00% | International Businesses | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 80 | 89 |
| Less than 1.00% | International Businesses | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 2,984 | 1,996 |
| 1.00% - 1.99% | Institutional | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 1,552 | $ 1,552 | $ 1,552 |
| 1.00% - 1.99% | Institutional | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.00% | 1.00% | 1.00% |
| 1.00% - 1.99% | Institutional | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.99% | 1.99% | 1.99% |
| 1.00% - 1.99% | Institutional | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 1,552 | $ 1,552 | $ 1,552 |
| 1.00% - 1.99% | Institutional | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 1.00% - 1.99% | Institutional | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 1.00% - 1.99% | Institutional | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 1.00% - 1.99% | Individual Variable | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 515 | $ 421 | $ 221 |
| 1.00% - 1.99% | Individual Variable | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.00% | 1.00% | 1.00% |
| 1.00% - 1.99% | Individual Variable | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.99% | 1.99% | 1.99% |
| 1.00% - 1.99% | Individual Variable | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 82 | $ 124 | $ 218 |
| 1.00% - 1.99% | Individual Variable | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 432 | 295 | 2 |
| 1.00% - 1.99% | Individual Variable | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 1 | 2 | 1 |
| 1.00% - 1.99% | Individual Variable | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 1.00% - 1.99% | Individual Fixed | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 695 | $ 821 | $ 978 |
| 1.00% - 1.99% | Individual Fixed | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.00% | 1.00% | 1.00% |
| 1.00% - 1.99% | Individual Fixed | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.99% | 1.99% | 1.99% |
| 1.00% - 1.99% | Individual Fixed | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 395 | $ 461 | $ 526 |
| 1.00% - 1.99% | Individual Fixed | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 46 | 83 | 122 |
| 1.00% - 1.99% | Individual Fixed | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 208 | 208 | 250 |
| 1.00% - 1.99% | Individual Fixed | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 46 | 69 | 80 |
| 1.00% - 1.99% | Group Insurance | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 5 | $ 5 | $ 0 |
| 1.00% - 1.99% | Group Insurance | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.00% | 1.00% | 1.00% |
| 1.00% - 1.99% | Group Insurance | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.99% | 1.99% | 1.99% |
| 1.00% - 1.99% | Group Insurance | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 3 | $ 0 | $ 0 |
| 1.00% - 1.99% | Group Insurance | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 1.00% - 1.99% | Group Insurance | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 3 | 0 |
| 1.00% - 1.99% | Group Insurance | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 2 | 2 | 0 |
| 1.00% - 1.99% | Variable/ Universal Life | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 4,197 | $ 4,041 | $ 3,602 |
| 1.00% - 1.99% | Variable/ Universal Life | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.00% | 1.00% | 1.00% |
| 1.00% - 1.99% | Variable/ Universal Life | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.99% | 1.99% | 1.99% |
| 1.00% - 1.99% | Variable/ Universal Life | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 387 | $ 290 | $ 201 |
| 1.00% - 1.99% | Variable/ Universal Life | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 1.00% - 1.99% | Variable/ Universal Life | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 2,063 | 2,238 | 2,588 |
| 1.00% - 1.99% | Variable/ Universal Life | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 1,747 | 1,513 | 813 |
| 1.00% - 1.99% | International Businesses | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 14,838 | $ 10,510 | $ 12,076 |
| 1.00% - 1.99% | International Businesses | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.00% | 1.00% | 1.00% |
| 1.00% - 1.99% | International Businesses | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 1.99% | 1.99% | 1.99% |
| 1.00% - 1.99% | International Businesses | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 14,806 | $ 10,431 | $ 11,985 |
| 1.00% - 1.99% | International Businesses | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 32 | 79 | 91 |
| 1.00% - 1.99% | International Businesses | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 1.00% - 1.99% | International Businesses | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 2.00% - 2.99% | Institutional | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 71 | $ 79 | $ 596 |
| 2.00% - 2.99% | Institutional | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 2.00% | 2.00% | 2.00% |
| 2.00% - 2.99% | Institutional | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 2.99% | 2.99% | 2.99% |
| 2.00% - 2.99% | Institutional | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 71 | $ 79 | $ 596 |
| 2.00% - 2.99% | Institutional | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 2.00% - 2.99% | Institutional | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 2.00% - 2.99% | Institutional | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 2.00% - 2.99% | Individual Variable | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 30 | $ 29 | $ 37 |
| 2.00% - 2.99% | Individual Variable | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 2.00% | 2.00% | 2.00% |
| 2.00% - 2.99% | Individual Variable | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 2.99% | 2.99% | 2.99% |
| 2.00% - 2.99% | Individual Variable | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 19 | $ 21 | $ 29 |
| 2.00% - 2.99% | Individual Variable | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 7 | 4 | 4 |
| 2.00% - 2.99% | Individual Variable | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 4 | 4 | 4 |
| 2.00% - 2.99% | Individual Variable | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 2.00% - 2.99% | Individual Fixed | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 2,593 | $ 1,576 | $ 1,598 |
| 2.00% - 2.99% | Individual Fixed | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 2.00% | 2.00% | 2.00% |
| 2.00% - 2.99% | Individual Fixed | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 2.99% | 2.99% | 2.99% |
| 2.00% - 2.99% | Individual Fixed | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 572 | $ 538 | $ 550 |
| 2.00% - 2.99% | Individual Fixed | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 1,463 | 465 | 469 |
| 2.00% - 2.99% | Individual Fixed | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 543 | 557 | 562 |
| 2.00% - 2.99% | Individual Fixed | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 15 | 16 | 17 |
| 2.00% - 2.99% | Group Insurance | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 40 | $ 39 | $ 29 |
| 2.00% - 2.99% | Group Insurance | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 2.00% | 2.00% | 2.00% |
| 2.00% - 2.99% | Group Insurance | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 2.99% | 2.99% | 2.99% |
| 2.00% - 2.99% | Group Insurance | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 40 | $ 24 | $ 29 |
| 2.00% - 2.99% | Group Insurance | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 15 | 0 |
| 2.00% - 2.99% | Group Insurance | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 2.00% - 2.99% | Group Insurance | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 2.00% - 2.99% | Variable/ Universal Life | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 5,169 | $ 4,870 | $ 4,759 |
| 2.00% - 2.99% | Variable/ Universal Life | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 2.00% | 2.00% | 2.00% |
| 2.00% - 2.99% | Variable/ Universal Life | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 2.99% | 2.99% | 2.99% |
| 2.00% - 2.99% | Variable/ Universal Life | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 267 | $ 33 | $ 30 |
| 2.00% - 2.99% | Variable/ Universal Life | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 1,604 | 1,668 | 1,445 |
| 2.00% - 2.99% | Variable/ Universal Life | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 2,731 | 2,750 | 2,944 |
| 2.00% - 2.99% | Variable/ Universal Life | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 567 | 419 | 340 |
| 2.00% - 2.99% | International Businesses | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 8,025 | $ 4,842 | $ 5,584 |
| 2.00% - 2.99% | International Businesses | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 2.00% | 2.00% | 2.00% |
| 2.00% - 2.99% | International Businesses | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 2.99% | 2.99% | 2.99% |
| 2.00% - 2.99% | International Businesses | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 7,725 | $ 4,546 | $ 5,238 |
| 2.00% - 2.99% | International Businesses | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 276 | 267 | 310 |
| 2.00% - 2.99% | International Businesses | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 24 | 29 | 36 |
| 2.00% - 2.99% | International Businesses | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 3.00% - 4.00% | Institutional | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 4,015 | $ 3,889 | $ 5,041 |
| 3.00% - 4.00% | Institutional | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 3.00% | 3.00% | 3.00% |
| 3.00% - 4.00% | Institutional | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 4.00% | 4.00% | 4.00% |
| 3.00% - 4.00% | Institutional | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 4,015 | $ 3,889 | $ 5,041 |
| 3.00% - 4.00% | Institutional | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 3.00% - 4.00% | Institutional | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 3.00% - 4.00% | Institutional | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 3.00% - 4.00% | Individual Variable | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 1,510 | $ 1,719 | $ 1,965 |
| 3.00% - 4.00% | Individual Variable | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 3.00% | 3.00% | 3.00% |
| 3.00% - 4.00% | Individual Variable | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 4.00% | 4.00% | 4.00% |
| 3.00% - 4.00% | Individual Variable | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 1,495 | $ 1,708 | $ 1,942 |
| 3.00% - 4.00% | Individual Variable | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 6 | 3 | 13 |
| 3.00% - 4.00% | Individual Variable | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 9 | 8 | 10 |
| 3.00% - 4.00% | Individual Variable | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 3.00% - 4.00% | Individual Fixed | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 3,098 | $ 2,172 | $ 332 |
| 3.00% - 4.00% | Individual Fixed | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 3.00% | 3.00% | 3.00% |
| 3.00% - 4.00% | Individual Fixed | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 4.00% | 4.00% | 4.00% |
| 3.00% - 4.00% | Individual Fixed | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 3,072 | $ 2,074 | $ 321 |
| 3.00% - 4.00% | Individual Fixed | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 12 | 84 | 11 |
| 3.00% - 4.00% | Individual Fixed | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 11 | 11 | 0 |
| 3.00% - 4.00% | Individual Fixed | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 3 | 3 | 0 |
| 3.00% - 4.00% | Group Insurance | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 1,498 | $ 1,542 | $ 1,593 |
| 3.00% - 4.00% | Group Insurance | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 3.00% | 3.00% | 3.00% |
| 3.00% - 4.00% | Group Insurance | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 4.00% | 4.00% | 4.00% |
| 3.00% - 4.00% | Group Insurance | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 1,418 | $ 1,482 | $ 1,543 |
| 3.00% - 4.00% | Group Insurance | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 7 | 0 | 0 |
| 3.00% - 4.00% | Group Insurance | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 69 | 38 | 0 |
| 3.00% - 4.00% | Group Insurance | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 4 | 22 | 50 |
| 3.00% - 4.00% | Variable/ Universal Life | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 8,521 | $ 9,182 | $ 9,844 |
| 3.00% - 4.00% | Variable/ Universal Life | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 3.00% | 3.00% | 3.00% |
| 3.00% - 4.00% | Variable/ Universal Life | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 4.00% | 4.00% | 4.00% |
| 3.00% - 4.00% | Variable/ Universal Life | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 5,166 | $ 6,098 | $ 4,422 |
| 3.00% - 4.00% | Variable/ Universal Life | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 1,952 | 1,727 | 4,092 |
| 3.00% - 4.00% | Variable/ Universal Life | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 1,349 | 1,321 | 1,311 |
| 3.00% - 4.00% | Variable/ Universal Life | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 54 | 36 | 19 |
| 3.00% - 4.00% | International Businesses | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 10,265 | $ 6,699 | $ 4,732 |
| 3.00% - 4.00% | International Businesses | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 3.00% | 3.00% | 3.00% |
| 3.00% - 4.00% | International Businesses | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 4.00% | 4.00% | 4.00% |
| 3.00% - 4.00% | International Businesses | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 10,265 | $ 6,699 | $ 4,732 |
| 3.00% - 4.00% | International Businesses | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 3.00% - 4.00% | International Businesses | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| 3.00% - 4.00% | International Businesses | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | Institutional | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 6,316 | $ 3,341 | $ 1,906 |
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 4.00% | 4.00% | 4.00% |
| Greater than 4.00% | Institutional | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 6,316 | $ 3,341 | $ 1,906 |
| Greater than 4.00% | Institutional | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | Institutional | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | Institutional | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | Individual Variable | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 73 | $ 83 | $ 95 |
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 4.00% | 4.00% | 4.00% |
| Greater than 4.00% | Individual Variable | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 73 | $ 83 | $ 95 |
| Greater than 4.00% | Individual Variable | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | Individual Variable | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | Individual Variable | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | Individual Fixed | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 73 | $ 84 | $ 95 |
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 4.00% | 4.00% | 4.00% |
| Greater than 4.00% | Individual Fixed | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 73 | $ 84 | $ 95 |
| Greater than 4.00% | Individual Fixed | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | Individual Fixed | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | Individual Fixed | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | Group Insurance | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 3 | $ 3 | $ 73 |
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 4.00% | 4.00% | 4.00% |
| Greater than 4.00% | Group Insurance | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 3 | $ 3 | $ 73 |
| Greater than 4.00% | Group Insurance | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | Group Insurance | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | Group Insurance | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | Variable/ Universal Life | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 5,271 | $ 5,384 | $ 5,491 |
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 4.00% | 4.00% | 4.00% |
| Greater than 4.00% | Variable/ Universal Life | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 5,271 | $ 5,384 | $ 5,491 |
| Greater than 4.00% | Variable/ Universal Life | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | Variable/ Universal Life | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | Variable/ Universal Life | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | International Businesses | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 18,676 | $ 9,072 | $ 5,819 |
| Policyholder Account Balance, Guaranteed Minimum Credit Rating | 4.00% | 4.00% | 4.00% |
| Greater than 4.00% | International Businesses | At guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 18,676 | $ 9,072 | $ 5,819 |
| Greater than 4.00% | International Businesses | 1 - 50 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | International Businesses | 51 - 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | 0 | 0 | 0 |
| Greater than 4.00% | International Businesses | Greater Than 150 bps above guaranteed minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 0 | $ 0 | $ 0 |
Policyholders' Liabilities (Additional Insurance Reserves) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Individual Life | Variable/ Universal Life | |||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | |||
| Balance, beginning of period | $ 5,245 | $ 4,613 | $ 3,983 |
| Unearned revenue | 866 | 872 | 841 |
| Amortization expense | (255) | (240) | (211) |
| Other adjustments | 0 | 0 | 0 |
| Foreign currency adjustment | 0 | 0 | 0 |
| Balance, end of period | 5,856 | 5,245 | 4,613 |
| International Businesses | |||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | |||
| Balance, beginning of period | 505 | 454 | 312 |
| Unearned revenue | 195 | 161 | 169 |
| Amortization expense | (30) | (22) | (15) |
| Other adjustments | 0 | (58) | 3 |
| Foreign currency adjustment | (4) | (30) | (15) |
| Balance, end of period | 666 | 505 | 454 |
| Total | |||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | |||
| Balance, beginning of period | 5,750 | 5,067 | 4,295 |
| Unearned revenue | 1,061 | 1,033 | 1,010 |
| Amortization expense | (285) | (262) | (226) |
| Other adjustments | 0 | (58) | 3 |
| Foreign currency adjustment | (4) | (30) | (15) |
| Balance, end of period | 6,522 | 5,750 | 5,067 |
| Other Businesses | |||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | |||
| Balance, beginning of period | 59 | 49 | |
| Balance, end of period | 69 | 59 | 49 |
| Total balance | |||
| Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward] | |||
| Balance, beginning of period | 5,809 | 5,116 | |
| Balance, end of period | $ 6,591 | $ 5,809 | $ 5,116 |
Policyholders' Account Balances - Narrative (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|---|
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 191,307 | $ 166,254 | $ 147,018 |
| FABN | Medium-Term Note | |||
| Policyholder Account Balance [Line Items] | |||
| Capacity | 15,000 | ||
| Debt Instrument, Face Amount | $ 5,694 | 3,486 | 3,474 |
| FABN | Medium-Term Note | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Interest Rate | 0.00% | ||
| Maturities | 2 months | ||
| FABN | Medium-Term Note | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Interest Rate | 5.60% | ||
| Maturities | 10 years | ||
| FABN | Commercial paper | |||
| Policyholder Account Balance [Line Items] | |||
| Capacity | $ 6,000 | ||
| Debt Instrument, Face Amount | $ 2,500 | 2,086 | 2,156 |
| FABN | Commercial paper | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Interest Rate | 0.00% | ||
| Maturities | 2 months | ||
| FABN | Commercial paper | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Interest Rate | 5.60% | ||
| Maturities | 10 years | ||
| FABN | Retail Note Liability | |||
| Policyholder Account Balance [Line Items] | |||
| Debt Instrument, Face Amount | $ 508 | 136 | 0 |
| FHLBNY | Secured debt | |||
| Policyholder Account Balance [Line Items] | |||
| Debt Instrument, Face Amount | $ 2,628 | 2,628 | 2,628 |
| FHLBNY | Secured debt | Minimum | |||
| Policyholder Account Balance [Line Items] | |||
| Interest Rate | 1.925% | ||
| FHLBNY | Secured debt | Maximum | |||
| Policyholder Account Balance [Line Items] | |||
| Interest Rate | 4.51% | ||
| Maturities | 7 years | ||
| Institutional Retirement Strategies, C&O and Life Planner | FABN | |||
| Policyholder Account Balance [Line Items] | |||
| Policyholder Account Balance | $ 8,674 | $ 5,547 | $ 5,597 |
Market Risk Benefits (Rollforward of Balances for Individual Retirement Products) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Market Risk Benefit [Line Items] | |||
| Market risk benefit, beginning balance | $ 2,124 | $ 3,486 | |
| Balance, EOP | 2,293 | 2,124 | $ 3,486 |
| Individual Retirement Strategies | Variable Annuity | |||
| Market Risk Benefit [Line Items] | |||
| Market risk benefit, beginning balance | 2,740 | 4,038 | 4,987 |
| Effect of cumulative changes in NPR | 672 | 1,137 | 1,828 |
| Balance, BOP, before effect of changes in NPR | 3,412 | 5,175 | 6,815 |
| Attributed fees collected | 1,033 | 1,122 | 1,186 |
| Claims paid | (76) | (79) | (114) |
| Interest accrual | 182 | 246 | 317 |
| Actual in force different from expected | 64 | 47 | 80 |
| Effect of changes in interest rates | (268) | (1,493) | (1,480) |
| Effect of changes in equity markets | (1,183) | (1,745) | (1,952) |
| Effect of assumption update and other refinements | 112 | 88 | 276 |
| Issuances | 59 | 72 | 23 |
| Other Adjustments | 38 | (21) | 24 |
| Balance, EOP, before effect of changes in NPR | 3,373 | 3,412 | 5,175 |
| Effect of cumulative changes in NPR | (487) | (672) | (1,137) |
| Less: Reinsured MRBs | 804 | 654 | 616 |
| Balance, EOP, net of reinsurance | 2,082 | 2,086 | 3,422 |
| Balance, EOP | 2,886 | 2,740 | 4,038 |
| Net amount at risk | $ 8,075 | $ 9,285 | $ 9,753 |
| Weighted-average attained age of contractholders (in years) | 72 years | 71 years | 70 years |
| Individual Retirement Strategies | Individual Fixed | |||
| Market Risk Benefit [Line Items] | |||
| Market risk benefit, beginning balance | $ 0 | $ 0 | $ 0 |
| Effect of cumulative changes in NPR | 0 | 0 | 0 |
| Balance, BOP, before effect of changes in NPR | 0 | 0 | 0 |
| Attributed fees collected | 20 | 0 | 0 |
| Claims paid | 0 | 0 | 0 |
| Interest accrual | 5 | 0 | 0 |
| Actual in force different from expected | (2) | 0 | 0 |
| Effect of changes in interest rates | (35) | 0 | 0 |
| Effect of changes in equity markets | (13) | 0 | 0 |
| Effect of assumption update and other refinements | 151 | 0 | 0 |
| Issuances | 37 | 0 | 0 |
| Other Adjustments | 3 | 0 | 0 |
| Balance, EOP, before effect of changes in NPR | 166 | 0 | 0 |
| Effect of cumulative changes in NPR | 10 | 0 | 0 |
| Less: Reinsured MRBs | 0 | 0 | 0 |
| Balance, EOP, net of reinsurance | 176 | 0 | 0 |
| Balance, EOP | 176 | 0 | 0 |
| Net amount at risk | $ 513 | ||
| Weighted-average attained age of contractholders (in years) | 68 years | ||
| Total | |||
| Market Risk Benefit [Line Items] | |||
| Balance, EOP, net of reinsurance | $ 2,293 | 2,124 | 3,486 |
| Total | Total | |||
| Market Risk Benefit [Line Items] | |||
| Market risk benefit, beginning balance | 2,740 | 4,038 | 4,987 |
| Effect of cumulative changes in NPR | 672 | 1,137 | 1,828 |
| Balance, BOP, before effect of changes in NPR | 3,412 | 5,175 | 6,815 |
| Attributed fees collected | 1,053 | 1,122 | 1,186 |
| Claims paid | (76) | (79) | (114) |
| Interest accrual | 187 | 246 | 317 |
| Actual in force different from expected | 62 | 47 | 80 |
| Effect of changes in interest rates | (303) | (1,493) | (1,480) |
| Effect of changes in equity markets | (1,196) | (1,745) | (1,952) |
| Effect of assumption update and other refinements | 263 | 88 | 276 |
| Issuances | 96 | 72 | 23 |
| Other Adjustments | 41 | (21) | 24 |
| Balance, EOP, before effect of changes in NPR | 3,539 | 3,412 | 5,175 |
| Effect of cumulative changes in NPR | (477) | (672) | (1,137) |
| Less: Reinsured MRBs | 804 | 654 | 616 |
| Balance, EOP, net of reinsurance | 2,258 | 2,086 | 3,422 |
| Balance, EOP | 3,062 | 2,740 | 4,038 |
| Other businesses | |||
| Market Risk Benefit [Line Items] | |||
| Balance, EOP, net of reinsurance | $ 35 | $ 38 | $ 64 |
Market Risk Benefits - Market Risk Benefits In Asset and Liability Positions (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|---|
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Total MRB assets | $ 2,330 | $ 2,331 | |
| Total MRB liabilities | 4,623 | 4,455 | |
| Total | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Direct and assumed | 1,402 | 1,525 | $ 1,232 |
| Ceded | 928 | 806 | 749 |
| Total MRB assets | 2,330 | 2,331 | 1,981 |
| Direct and assumed | 4,499 | 4,305 | 5,337 |
| Ceded | 124 | 150 | 130 |
| Total MRB liabilities | 4,623 | 4,455 | 5,467 |
| Individual Retirement Strategies | Variable Annuity | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Direct and assumed | 1,399 | 1,516 | 1,221 |
| Ceded | 928 | 804 | 746 |
| Total MRB assets | 2,327 | 2,320 | 1,967 |
| Direct and assumed | 4,285 | 4,256 | 5,259 |
| Ceded | 124 | 150 | 130 |
| Total MRB liabilities | 4,409 | 4,406 | 5,389 |
| Balance, EOP, net of reinsurance | 2,082 | 2,086 | 3,422 |
| Individual Retirement Strategies | Individual Fixed | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Direct and assumed | 3 | 0 | 0 |
| Ceded | 0 | 0 | 0 |
| Total MRB assets | 3 | 0 | 0 |
| Direct and assumed | 179 | 0 | 0 |
| Ceded | 0 | 0 | 0 |
| Total MRB liabilities | 179 | 0 | 0 |
| Balance, EOP, net of reinsurance | 176 | 0 | 0 |
| Total | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Balance, EOP, net of reinsurance | 2,293 | 2,124 | 3,486 |
| Total | Total | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Balance, EOP, net of reinsurance | 2,258 | 2,086 | 3,422 |
| Other businesses | |||
| Liability for Future Policy Benefit, Activity [Line Items] | |||
| Direct and assumed | 0 | 9 | 11 |
| Ceded | 0 | 2 | 3 |
| Total MRB assets | 0 | 11 | 14 |
| Direct and assumed | 35 | 49 | 78 |
| Ceded | 0 | 0 | 0 |
| Total MRB liabilities | 35 | 49 | 78 |
| Balance, EOP, net of reinsurance | $ 35 | $ 38 | $ 64 |
Reinsurance (Narrative) (Details) $ in Millions |
3 Months Ended | 12 Months Ended | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Mar. 01, 2025
USD ($)
|
Oct. 01, 2024
USD ($)
|
Jan. 01, 2024
USD ($)
|
Sep. 01, 2023
USD ($)
|
Apr. 01, 2023
USD ($)
|
Apr. 01, 2022 |
Jan. 02, 2013
USD ($)
subsidiary
policy
|
Mar. 31, 2013
USD ($)
|
Mar. 31, 2000
USD ($)
|
Dec. 31, 2025
USD ($)
defendant
|
Dec. 31, 2020
USD ($)
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
Dec. 31, 2021
counterparty
|
May 31, 2018
counterparty
|
|
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Reinsurance retention policy, reinsured risk percentage | 61.00% | ||||||||||||||
| Deferred reinsurance gain | $ 703 | $ 739 | $ 424 | ||||||||||||
| Number of Reinsurance companies | defendant | 4 | ||||||||||||||
| Geographic Distribution, Domestic | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Reinsurance, retention policy, amount retained per life | $ 20 | $ 30 | $ 10 | ||||||||||||
| Hartford Life Business | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Reinsurance retention policy, amount retained per event | $ 141,000 | ||||||||||||||
| Business acquisition through reinsurance transactions, number of subsidiaries of acquiree | subsidiary | 3 | ||||||||||||||
| Business acquisition number of life insurance policies acquired reinsurance | policy | 700,000 | ||||||||||||||
| Number Of Counterparties | counterparty | 2 | ||||||||||||||
| Wilton Re | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Deferred reinsurance loss | $ (980) | ||||||||||||||
| Wilton Re | Universal Life | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Reinsurance retention policy, reinsured risk percentage | 40.00% | ||||||||||||||
| Somerset Re | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Deferred reinsurance gain | $ 363 | ||||||||||||||
| Somerset Re | Universal Life | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Reinsurance retention policy, reinsured risk percentage | 30.00% | ||||||||||||||
| Prismic Re | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Reinsured Amount | $ 9,000 | ||||||||||||||
| Prismic Re | Structured Settlement Annuity | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Reinsurance retention policy, reinsured risk percentage | 70.00% | ||||||||||||||
| Prismic Re | Coinsurance with funds witheld | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Reinsurance retention policy, reinsured risk percentage | 90.00% | ||||||||||||||
| Prismic Re | Coinsurance | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Reinsurance retention policy, reinsured risk percentage | 10.00% | ||||||||||||||
| Prismic Re International | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Reinsured Amount | $ 7,000 | ||||||||||||||
| AuguStar | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Reinsured Amount | $ 10,000 | ||||||||||||||
| AuguStar | Variable Annuity | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Reinsurance retention policy, reinsured risk percentage | 10.00% | ||||||||||||||
| AuguStar | Separate account liabilities under MODCO | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Reinsurance retention policy, reinsured risk percentage | 100.00% | ||||||||||||||
| AuguStar | General account liabilities under MODCO | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Reinsurance retention policy, reinsured risk percentage | 100.00% | ||||||||||||||
| Empower | Separate account liabilities under MODCO | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Reinsurance retention policy, reinsured risk percentage | 100.00% | ||||||||||||||
| Empower | General account liabilities under MODCO | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Reinsurance retention policy, reinsured risk percentage | 100.00% | ||||||||||||||
| Allstate | |||||||||||||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | |||||||||||||||
| Number Of Counterparties | counterparty | 2 | ||||||||||||||
Reinsurance (Reinsurance Amounts Included in the Consolidated Statements of Operations) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||
| Reinsurance Disclosures [Abstract] | |||||
| Direct premiums | $ 26,371 | $ 39,222 | $ 29,475 | ||
| Reinsurance assumed | 6,990 | 6,167 | 5,005 | ||
| Reinsurance ceded | (2,564) | (2,492) | (7,116) | ||
| Premiums | [1] | 30,797 | 42,897 | 27,364 | |
| Direct policy charges and fee income | 4,719 | 4,629 | 3,933 | ||
| Reinsurance assumed | 1,163 | 1,188 | 1,228 | ||
| Reinsurance ceded | (1,216) | (1,519) | (634) | ||
| Policy charges and fee income | 4,666 | 4,298 | 4,527 | ||
| Direct change in value of market risk benefits, net of related hedging gains (losses) | (545) | (405) | 123 | ||
| Reinsurance assumed | 64 | 134 | 120 | ||
| Reinsurance ceded | 6 | (126) | (187) | ||
| Change in value of market risk benefits, net of related hedging gains (losses) | (475) | (397) | 56 | ||
| Direct policyholders’ benefits | 31,577 | 43,743 | 32,044 | ||
| Reinsurance assumed | 8,320 | 7,722 | 7,128 | ||
| Reinsurance ceded | (4,673) | (4,346) | (8,241) | ||
| Policyholders’ benefits | [1] | 35,224 | 47,119 | 30,931 | |
| Direct change in estimates of liability for future policy benefits | 113 | 112 | 447 | ||
| Reinsurance assumed | 4 | 78 | (147) | ||
| Reinsurance ceded | (14) | (227) | 37 | ||
| Change in estimates of liability for future policy benefits | [1] | $ 103 | $ (37) | $ 337 | |
| |||||
Reinsurance (Reinsurance Recoverable and Deposit Receivables) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
||
|---|---|---|---|---|
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Reinsurance recoverables and deposit receivables | [1] | $ 44,077 | $ 37,680 | |
| Reinsurance recoverables | 28,031 | 26,486 | ||
| Deposit receivables | 16,046 | 11,194 | ||
| Reinsurance recoverables net of loss allowance | 14 | 12 | ||
| Individual and group annuities | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Reinsurance recoverables | 7,027 | 6,987 | ||
| Life insurance | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Reinsurance recoverables | 20,589 | 19,098 | ||
| Other reinsurance | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Reinsurance recoverables | 415 | 401 | ||
| FLIAC | Individual and group annuities | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Reinsurance recoverables | 1,381 | 1,442 | ||
| Prismic Re | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Deposit receivables | 3,684 | 3,578 | ||
| Prismic Re | Individual and group annuities | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Reinsurance recoverables | 5,475 | 5,506 | ||
| Funds withheld and other payables | 7,980 | 7,796 | ||
| Other | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Deposit receivables | 129 | 0 | ||
| Other | Individual and group annuities | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Reinsurance recoverables | 171 | 39 | ||
| Other | Life insurance | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Reinsurance recoverables | 8,887 | 7,996 | ||
| Hartford Life Business | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Reinsurance Payables | 1,366 | 1,387 | ||
| Hartford Life Business | Life insurance | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Reinsurance recoverables | 2,022 | 2,033 | ||
| Somerset Re | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Deposit receivables | 2,491 | 2,795 | ||
| Funds withheld and other payables | 2,602 | 2,595 | ||
| Somerset Re | Life insurance | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Reinsurance recoverables | 1,667 | 1,591 | ||
| Reinsurance Payables | 6,525 | 6,388 | ||
| Reinsurance recoverables before reins payables | 8,192 | 7,979 | ||
| Wilton Re | Life insurance | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Reinsurance recoverables | 8,013 | 7,478 | ||
| Empower | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Deposit receivables | 2,471 | 4,821 | ||
| Prismic Re International | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Deposit receivables | 6,422 | 0 | ||
| Resolution Re | ||||
| SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items] | ||||
| Deposit receivables | 849 | $ 0 | ||
| Funds withheld and other payables | $ 851 | |||
| ||||
Closed Block (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Jan. 01, 2023 |
Jan. 01, 2022 |
|
| Closed Block Policyholder Dividend Obligation [Line Items] | |||||
| Policyholders’ dividend obligation | $ 571 | $ 0 | $ 0 | $ 792 | |
| Increase (decrease) in liability | 0 | (109) | $ (77) | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 4,656 | 3,209 | $ 3,072 | ||
| Excess Of Actual Cumulative Earnings Over Expected Cumulative Earnings | |||||
| Closed Block Policyholder Dividend Obligation [Line Items] | |||||
| Policyholders’ dividend obligation | 1,635 | $ 2,096 | |||
| Accumulated Net Unrealized Investment Gain (Loss) Pre Tax | |||||
| Closed Block Policyholder Dividend Obligation [Line Items] | |||||
| Policyholder dividend obligation, net | $ (1,064) | ||||
Closed Block (Closed Block Liabilities and Assets Designated to Closed Block; Maximum Future Earnings to be Recognized) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Jan. 01, 2023 |
Jan. 01, 2022 |
|
| Closed Block liabilities | |||||
| Future policy benefits | $ 41,484 | $ 42,464 | |||
| Policyholders’ dividends payable | 669 | 688 | |||
| Policyholders’ dividend obligation | 571 | 0 | $ 0 | $ 792 | |
| Policyholders’ account balances | 4,273 | 4,359 | $ 4,500 | ||
| Other Closed Block liabilities | 3,030 | 3,346 | |||
| Total Closed Block liabilities | 50,027 | 50,857 | |||
| Closed Block assets | |||||
| Fixed maturities, available-for-sale, at fair value | 28,721 | 28,570 | |||
| Fixed maturities, trading, at fair value | 581 | 647 | |||
| Equity securities, at fair value | 1,593 | 1,642 | |||
| Commercial mortgage and other loans | 7,464 | 7,652 | |||
| Policy loans | 3,217 | 3,348 | |||
| Other invested assets | 4,538 | 4,929 | |||
| Short-term investments | 255 | 520 | |||
| Total investments | 46,369 | 47,308 | |||
| Cash and cash equivalents | 726 | 400 | |||
| Accrued investment income | 388 | 403 | |||
| Other Closed Block assets | 279 | 367 | |||
| Total Closed Block assets | 47,762 | 48,478 | |||
| Cumulative-effect adjustment from the adoption of ASU 2016-01 | 0 | 109 | $ 77 | ||
| Excess of reported Closed Block liabilities over Closed Block assets | 2,265 | 2,379 | |||
| Portion of above representing accumulated other comprehensive income (loss): | |||||
| Net unrealized investment gains (losses) | (1,230) | (2,299) | |||
| Allocated to policyholder dividend obligation | 1,064 | 2,096 | |||
| Future earnings to be recognized from Closed Block assets and Closed Block liabilities | $ 2,099 | $ 2,176 | |||
Closed Block (Information Regarding Policyholder Dividend Obligation) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Movement in Closed Block Dividend Obligation [Roll Forward] | |||
| Cumulative-effect adjustment from the adoption of ASU 2016-01 | $ 0 | $ 109 | $ 77 |
| Impact from earnings allocable to policyholder dividend obligation | (461) | (777) | |
| Change in net unrealized investment gains (losses) allocated to policyholder dividend obligation | 1,032 | (15) | |
| Balance, December 31 | $ 571 | $ 0 | |
Closed Block (Closed Block Revenues and Benefits and Expenses) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Revenues | |||
| Premiums | $ 1,719 | $ 1,689 | $ 1,675 |
| Net investment income | 2,056 | 2,041 | 1,949 |
| Realized investment gains (losses), net | (373) | (769) | (380) |
| Other income (loss) | 347 | 319 | 411 |
| Total Closed Block revenues | 3,749 | 3,280 | 3,655 |
| Benefits and Expenses | |||
| Policyholders’ benefits | 2,392 | 2,343 | 2,354 |
| Interest credited to policyholders’ account balances | 113 | 117 | 118 |
| Dividends to policyholders | 1,015 | 641 | 1,008 |
| General and administrative expenses | 261 | 266 | 280 |
| Total Closed Block benefits and expenses | 3,781 | 3,367 | 3,760 |
| Closed Block revenues, net of Closed Block benefits and expenses, before income taxes | (32) | (87) | (105) |
| Income tax expense (benefit) | (111) | (166) | (176) |
| Closed Block revenues, net of Closed Block benefits and expenses and income taxes | $ 79 | $ 79 | $ 71 |
Income Taxes (Components of Income Tax Expense (Benefit)) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Current tax expense (benefit): | |||
| U.S. | $ 60 | $ 495 | $ (4) |
| State and local | 16 | 35 | 25 |
| Foreign | 579 | 755 | 667 |
| Total current tax expense (benefit) | 655 | 1,285 | 688 |
| Deferred tax expense (benefit): | |||
| U.S. | (125) | (545) | 323 |
| State and local | 2 | (1) | 0 |
| Foreign | 521 | (232) | (398) |
| Total deferred tax expense (benefit) | 398 | (778) | (75) |
| Total | 1,053 | 507 | 613 |
| Income tax expense (benefit) on equity in earnings of joint ventures and other operating entities | 40 | 41 | 34 |
| Income tax expense (benefit) on discontinued operations | 0 | 0 | 0 |
| Income tax expense (benefit) reported in equity related to: | |||
| Other comprehensive income (loss) | 1,003 | 364 | (837) |
| Total income taxes | $ 2,096 | $ 912 | $ (190) |
Income Taxes (Effective Income Tax Rate Reconciliation) (Details) - USD ($) $ in Millions |
1 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract] | ||||
| Expected federal income tax expense (benefit) | $ 978 | $ 674 | $ 645 | |
| State taxes (net of federal benefit) | 11 | |||
| Tax credits | (125) | |||
| Foreign tax credits | (52) | |||
| General business credits | (73) | |||
| Effect of cross-border tax laws | (143) | |||
| GILTI | 48 | (24) | 5 | |
| Change in tax law—Bermuda | (318) | |||
| Full inclusion—Bermuda | 112 | |||
| Other | 15 | |||
| Nontaxable or nondeductible items | (137) | |||
| Nontaxable investment income | (160) | |||
| Nondeductible expenses | 23 | |||
| Other reconciling items | (122) | |||
| Foreign tax effects | 585 | |||
| National & local tax rate difference than U.S. | 189 | 191 | ||
| Other | (130) | (21) | ||
| Changes in unrecognized tax benefits | 6 | |||
| Total | $ 1,053 | $ 507 | $ 613 | |
| Effective Income Tax Rate Reconciliation, Percent [Abstract] | ||||
| Expected federal income tax expense/(benefit) | 21.00% | 21.00% | 21.00% | |
| State taxes (net of federal benefit) | 0.20% | |||
| Tax credits | (2.70%) | |||
| Foreign tax credits | (1.10%) | |||
| General business credits | (1.60%) | |||
| Effect of cross-border tax laws | (3.10%) | |||
| GILTI | 1.00% | |||
| Change in tax law—Bermuda | (6.80%) | |||
| Full inclusion—Bermuda | 2.40% | |||
| Other | 0.30% | |||
| Nontaxable or nondeductible items | (2.90%) | |||
| Effective Income Tax Rate Reconciliation, Tax Exempt Income, Percent | (3.40%) | |||
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | 0.50% | |||
| Other reconciling items | (2.60%) | |||
| Foreign tax effects | 12.60% | |||
| Changes in unrecognized tax benefits | 0.10% | |||
| Effective tax rate | 22.60% | 15.80% | 20.00% | |
| Japan | ||||
| Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract] | ||||
| Foreign tax effects | $ 210 | |||
| National & local tax rate difference than U.S. | 143 | |||
| Other | $ 67 | |||
| Effective Income Tax Rate Reconciliation, Percent [Abstract] | ||||
| Foreign tax effects | 4.50% | |||
| National & local tax rate difference than U.S. | 3.10% | |||
| Other | 1.40% | |||
| Effective tax rate | 28.00% | |||
| Brazil | ||||
| Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract] | ||||
| Foreign tax effects | $ 169 | |||
| National & local tax rate difference than U.S. | 80 | |||
| Change in tax law | 72 | |||
| Other | $ 17 | |||
| Effective Income Tax Rate Reconciliation, Percent [Abstract] | ||||
| Foreign tax effects | 3.60% | |||
| National & local tax rate difference than U.S. | 1.70% | |||
| Change in tax law | 1.50% | |||
| Other | 0.40% | |||
| Bermuda | ||||
| Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract] | ||||
| Foreign tax effects | $ 194 | |||
| National & local tax rate difference than U.S. | (112) | |||
| Change in tax law | 318 | |||
| Other | $ (12) | |||
| Effective Income Tax Rate Reconciliation, Percent [Abstract] | ||||
| Foreign tax effects | 4.20% | |||
| National & local tax rate difference than U.S. | (2.40%) | |||
| Change in tax law | 6.80% | |||
| Other | (0.30%) | |||
| Effective tax rate | 15.00% | |||
| Other Foreign Jurisdictions | ||||
| Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract] | ||||
| Foreign tax effects | $ 12 | |||
| Effective Income Tax Rate Reconciliation, Percent [Abstract] | ||||
| Foreign tax effects | 0.30% | |||
Income Taxes (Narrative) (Details) - USD ($) $ in Millions |
1 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Change in Accounting Estimate [Line Items] | ||||
| Payments for energy-related tax credits | $ 192 | |||
| Energy-related tax credits, purchased, value | 200 | |||
| Total income tax expense (benefit) | $ 1,053 | $ 507 | $ 613 | |
| Effective tax rate | 22.60% | 15.80% | 20.00% | |
| Expected federal income tax expense/(benefit) | 21.00% | 21.00% | 21.00% | |
| Income tax expense (benefit), adjustment of deferred tax (asset) liability | $ 50 | $ 99 | ||
| DRD constituting non-taxable investment income | $ 54 | 55 | 62 | |
| Non-taxable investment income | 160 | 168 | 162 | |
| Income (loss) from foreign operations | 2,473 | 1,132 | 1,731 | |
| Expected federal income tax expense (benefit) | 978 | 674 | 645 | |
| Income (loss) from domestic operations | 2,184 | 2,077 | 1,341 | |
| GILTI | $ 48 | $ (24) | $ 5 | |
| Other reconciling items | (2.60%) | |||
| Japan Statutory Tax Rate | ||||
| Change in Accounting Estimate [Line Items] | ||||
| Effective tax rate | 28.00% | |||
| Brazil Statutory Tax Rate | ||||
| Change in Accounting Estimate [Line Items] | ||||
| Effective tax rate | 10.00% | |||
| Office of the Tax Commissioner, Bermuda | ||||
| Change in Accounting Estimate [Line Items] | ||||
| Effective tax rate | 15.00% | |||
| Bermuda | ||||
| Change in Accounting Estimate [Line Items] | ||||
| Effective tax rate | 15.00% | |||
| Deferred Tax Assets, Tax Deferred Expense | $ 0 | $ 401 | ||
| Bermuda | Change In Enacted Tax Rate | ||||
| Change in Accounting Estimate [Line Items] | ||||
| Income tax expense (benefit), adjustment of deferred tax (asset) liability | 318 | |||
| Bermuda | Change In Enacted Tax Rate, Cross-Border | ||||
| Change in Accounting Estimate [Line Items] | ||||
| Income tax expense (benefit), adjustment of deferred tax (asset) liability | (318) | |||
| Japan | ||||
| Change in Accounting Estimate [Line Items] | ||||
| Effective tax rate | 28.00% | |||
| Income tax expense (benefit), adjustment of deferred tax (asset) liability | $ 37 | |||
| Corporate income tax rate, expected | 28.93% | |||
| Brazil | ||||
| Change in Accounting Estimate [Line Items] | ||||
| Income tax expense (benefit), adjustment of deferred tax (asset) liability | $ 72 | |||
Income Taxes (Reconciliation To Effective Rate) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Income Tax Disclosure [Abstract] | |||
| Expected federal income tax expense (benefit) | $ 978 | $ 674 | $ 645 |
| Non-taxable investment income | (168) | (162) | |
| Foreign taxes at other than U.S. rate | 189 | 191 | |
| Low-income housing and other tax credits | (94) | (106) | |
| Changes in tax law | 50 | (99) | |
| GILTI | 48 | (24) | 5 |
| Sale of subsidiary | (10) | 0 | |
| Non-deductible expenses | 39 | 29 | |
| Change in valuation allowance | (45) | 111 | |
| State taxes (net of federal benefit) | 26 | 20 | |
| Other | (130) | (21) | |
| Total | $ 1,053 | $ 507 | $ 613 |
| Effective tax rate | 22.60% | 15.80% | 20.00% |
| Expected federal income tax expense/(benefit) | 21.00% | 21.00% | 21.00% |
Income Taxes (Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|---|
| Deferred tax assets: | |||
| Deferred Tax Asset, Debt Securities, Trading, Unrealized Loss | $ 6,938 | $ 6,987 | |
| Policyholders’ dividends | 171 | 55 | |
| Net operating and capital loss carryforwards | 269 | 360 | |
| Employee benefits | 360 | 271 | |
| Investments | 2,862 | 2,448 | |
| Goodwill and other intangibles | 287 | 313 | |
| Deferred tax assets before valuation allowance | 10,887 | 10,434 | |
| Valuation allowance | (212) | (238) | $ (290) |
| Deferred tax assets after valuation allowance | 10,675 | 10,196 | |
| Deferred tax liabilities: | |||
| Insurance reserves | 6,991 | 4,629 | |
| Deferred policy acquisition costs | 3,951 | 3,851 | |
| Value of business acquired | 142 | 147 | |
| Other | 687 | 1,261 | |
| Deferred tax liabilities | 11,771 | 9,888 | |
| Net Deferred tax asset (liabilities) | (1,096) | 308 | |
| Bermuda | |||
| Change in Accounting Estimate [Line Items] | |||
| Deferred Tax Assets, Tax Deferred Expense | 0 | 401 | |
| U.S Operations | |||
| Change in Accounting Estimate [Line Items] | |||
| Deferred Tax Assets, Tax Deferred Expense | $ 490 | $ 840 |
Income Taxes (Valuation Allowance on Deferred Tax Assets) (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Valuation Allowance, Deferred Tax Asset [Roll Forward] | ||
| Balance, beginning of year | $ 238 | $ 290 |
| Charged to costs and expenses | 19 | 5 |
| Other adjustments | (45) | (57) |
| Balance, ending of year | 212 | 238 |
| Federal | ||
| Valuation Allowance, Deferred Tax Asset [Roll Forward] | ||
| Balance, beginning of year | 23 | 25 |
| Charged to costs and expenses | (1) | (2) |
| Other adjustments | 0 | 0 |
| Balance, ending of year | 22 | 23 |
| State | ||
| Valuation Allowance, Deferred Tax Asset [Roll Forward] | ||
| Balance, beginning of year | 128 | 132 |
| Charged to costs and expenses | 4 | 0 |
| Other adjustments | 0 | (4) |
| Balance, ending of year | 132 | 128 |
| Foreign operations | ||
| Valuation Allowance, Deferred Tax Asset [Roll Forward] | ||
| Balance, beginning of year | 87 | 133 |
| Charged to costs and expenses | 16 | 7 |
| Other adjustments | (45) | (53) |
| Balance, ending of year | $ 58 | $ 87 |
Income Taxes (Operating and Capital Loss Carryforwards) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Federal | ||
| Operating Loss Carryforwards [Line Items] | ||
| Operating loss carryforwards | $ 0 | $ 23 |
| State and local | ||
| Operating Loss Carryforwards [Line Items] | ||
| Operating loss carryforwards | 1,993 | 1,888 |
| Foreign operations | ||
| Operating Loss Carryforwards [Line Items] | ||
| Operating loss carryforwards | 926 | 907 |
| Operating loss carryforwards, subject to expiration | 349 | |
| Operating loss carryforwards, not subject to expiration | 150 | |
| Federal foreign | ||
| Operating Loss Carryforwards [Line Items] | ||
| Tax credit carryforwards | $ 16 | $ 15 |
Income Taxes (Undistributed Earnings) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|---|
| Income Tax Disclosure [Abstract] | |||
| Undistributed earnings of foreign subsidiaries | $ 417 | $ 351 | $ 291 |
Income Taxes (Income Taxes Paid) (Details) - USD ($) $ in Millions |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
||||
| Income Tax Paid, by Individual Jurisdiction [Line Items] | ||||||
| Federal | $ 808 | |||||
| State | 32 | |||||
| Foreign | ||||||
| Foreign | 558 | |||||
| Total taxes paid, net of refunds | 1,398 | [1] | $ 756 | $ 895 | ||
| Refund received related to prior years | 188 | |||||
| Income taxes paid for transferable energy tax credits | 192 | |||||
| Japan | ||||||
| Foreign | ||||||
| Foreign | 423 | |||||
| Brazil | ||||||
| Foreign | ||||||
| Foreign | 79 | |||||
| Other Foreign Jurisdictions | ||||||
| Foreign | ||||||
| Foreign | $ 56 | |||||
| ||||||
Income Taxes (Unrecognized Tax Benefits) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Unrecognized Tax Benefits [Roll Forward] | |||
| Amount | $ 132 | $ 133 | $ 84 |
| Increases in unrecognized tax benefits—prior years | 1 | 4 | 13 |
| (Decreases) in unrecognized tax benefits—prior years | (3) | (5) | 0 |
| Increases in unrecognized tax benefits—current year | 0 | 0 | 36 |
| (Decreases) in unrecognized tax benefits—current year | 0 | 0 | 0 |
| Settlements with taxing authorities | (5) | 0 | 0 |
| Amount | 125 | 132 | 133 |
| Unrecognized tax benefits that, if recognized, would favorably impact the effective rate | $ 125 | $ 132 | $ 133 |
Income Taxes (Amounts Recognized for Tax Related Interest and Penalties) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Income Tax Disclosure [Abstract] | |||
| Interest and penalties recognized in the Consolidated Statements of Operations | $ 1 | $ 10 | $ 7 |
| Interest and penalties recognized in liabilities in the Consolidated Statements of Financial Position | $ 33 | $ 33 | |
Short-Term and Long-Term Debt (Short-Term Debt) (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Short Term Debt [Line Items] | ||
| Short-term debt | $ 1,443 | $ 953 |
| Less: assets under set-off arrangements | $ 15,744 | $ 14,748 |
| Weighted average interest rate on outstanding short-term debt | 3.72% | 4.61% |
| Commercial paper | ||
| Short Term Debt [Line Items] | ||
| Debt maturity | 11 days | 15 days |
| Short-term Debt | $ 874 | $ 521 |
| Current portion of long-term debt | ||
| Short Term Debt [Line Items] | ||
| Short-term Debt | 569 | 432 |
| Short-term Debt | ||
| Short Term Debt [Line Items] | ||
| Less: assets under set-off arrangements | 0 | 0 |
| Short-term Debt | 1,443 | 953 |
| Borrowings due overnight | Commercial paper | ||
| Short Term Debt [Line Items] | ||
| Short-term debt | 175 | 310 |
| Daily average outstanding | Commercial paper | ||
| Short Term Debt [Line Items] | ||
| Short-term debt | 2,389 | 1,823 |
| Prudential Financial | ||
| Short Term Debt [Line Items] | ||
| Short-term debt | 561 | 25 |
| Short-term Debt | 561 | 25 |
| Prudential Financial | Commercial paper | ||
| Short Term Debt [Line Items] | ||
| Short-term debt | $ 25 | $ 25 |
| Weighted average interest rate on outstanding short-term debt | 3.85% | 4.38% |
| Short-term Debt | $ 25 | $ 25 |
| Prudential Financial | Current portion of long-term debt | ||
| Short Term Debt [Line Items] | ||
| Short-term debt | 536 | 0 |
| Prudential Funding, LLC | Commercial paper | ||
| Short Term Debt [Line Items] | ||
| Short-term Debt | 849 | 496 |
| Mortgage Debt | ||
| Short Term Debt [Line Items] | ||
| Short-term Debt | 33 | 85 |
| Surplus notes | ||
| Short Term Debt [Line Items] | ||
| Short-term Debt | 0 | 347 |
| Senior notes | ||
| Short Term Debt [Line Items] | ||
| Short-term Debt | $ 536 | $ 0 |
Short-Term and Long-Term Debt (Narrative) (Details) ¥ in Millions, $ in Millions |
1 Months Ended | 12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2024 |
Mar. 31, 2023
lender
|
May 31, 2020 |
Dec. 31, 2025
USD ($)
Rate
|
Dec. 31, 2025
JPY (¥)
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
Dec. 31, 2017
debtInstrument
|
Dec. 31, 2025
JPY (¥)
Rate
|
May 15, 2020
USD ($)
Rate
|
|
| Debt Instrument [Line Items] | ||||||||||
| Long-term debt | $ 18,856 | $ 19,187 | ||||||||
| Assets Under Set Off Arrangements | 15,744 | 14,748 | ||||||||
| Line of Credit, Current | 0 | |||||||||
| Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Long-term debt | 18,378 | 18,793 | ||||||||
| Interest expense | 1,360 | 1,322 | $ 1,282 | |||||||
| Outstanding amount of notes | 18,378 | 18,793 | ||||||||
| Minimum statutory consolidated net worth | $ 22,100 | |||||||||
| Prudential Insurance | Federal Home Loan Bank of New York | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Purchase requirement activity-based stock of the outstanding borrowings | 4.50% | 4.50% | ||||||||
| Debt Instrument, Term Upon Certain Events | 90 days | 90 days | ||||||||
| Other long-term investments | $ 141 | $ 142 | ||||||||
| Pledge collateral of prior year-end statutory net admitted assets | 5.00% | 5.00% | ||||||||
| Maximum amount of pledged asset | $ 7,500 | |||||||||
| Debt Instrument, Unused Borrowing Capacity, Amount | 6,000 | |||||||||
| Prudential Financial and Prudential Funding | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Capacity | $ 4,000 | |||||||||
| Line of Credit Facility, Expiration Period | 5 years | 5 years | ||||||||
| Proceeds from Lines of Credit | $ 0 | |||||||||
| Prudential Holdings of Japan | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Capacity | ¥ | ¥ 100,000 | |||||||||
| Line of Credit Facility, Expiration Period | 5 years | 5 years | 5 years | |||||||
| Proceeds from Lines of Credit | ¥ | ¥ 0 | |||||||||
| Other Subsidiaries | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Capacity | $ 313 | |||||||||
| PLIC | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Future Debt Instrument Authorized | 4,000 | |||||||||
| Podiatry Insurance Company of America | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Future Debt Instrument Authorized | 500 | |||||||||
| Future Debt Instrument Outstanding | $ 287 | |||||||||
| Minimum | Prudential Insurance | Federal Home Loan Bank of New York | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument, Interest Rate, Stated Percentage | 1.925% | 1.925% | ||||||||
| Maximum | Prudential Insurance | Federal Home Loan Bank of New York | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument, Interest Rate, Stated Percentage | 4.51% | 4.51% | ||||||||
| Commercial paper | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt maturity | 11 days | 11 days | 15 days | |||||||
| Commercial paper | Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument Authorized | $ 3,000 | |||||||||
| Commercial paper | Prudential Funding, LLC | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument Authorized | 7,000 | |||||||||
| Real estate separate accounts | Other Subsidiaries | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Capacity | 100 | |||||||||
| Proceeds from Lines of Credit | 42 | |||||||||
| Put Option | Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Minimum Equity Less AOCI For Automatic Exercise | 9,000 | |||||||||
| Private Placement | Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument, Face Amount | $ 1,500 | |||||||||
| Debt Instrument, Interest Rate, Stated Percentage | Rate | 2.85% | |||||||||
| Debt Instrument, Interest Rate | Rate | 2.175% | |||||||||
| Proceeds from sales | $ 1,500 | |||||||||
| Senior notes | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Long-term Debt, Weighted Average Interest Rate, at Point in Time | 4.48% | 4.43% | 4.48% | |||||||
| Derivative Financial Instruments, Liabilities | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Interest expense | $ 0 | $ 0 | 0 | |||||||
| Current And Long Term Debt | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Interest Expense, Debt | 1,967 | 1,956 | $ 1,749 | |||||||
| Junior subordinated debt | Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Long-term debt | $ 7,555 | 8,548 | ||||||||
| Junior subordinated debt | Minimum | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument, Deferral Period | 5 years | 5 years | ||||||||
| Junior subordinated debt | Minimum | Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument, Interest Rate, Stated Percentage | 3.70% | 3.70% | ||||||||
| Junior subordinated debt | Maximum | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument, Deferral Period | 10 years | 10 years | ||||||||
| Junior subordinated debt | Maximum | Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument, Interest Rate, Stated Percentage | 6.75% | 6.75% | ||||||||
| Long-term Debt | Prudential Insurance | Federal Home Loan Bank of New York | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Issuance Costs, Net | $ 2,500 | |||||||||
| Retail Medium Term Note | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Outstanding amount of notes | 727 | 370 | ||||||||
| Surplus notes subject to set-off arrangements | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Outstanding amount of notes | 15,744 | 14,748 | ||||||||
| Future Debt Instrument Authorized | 21,500 | |||||||||
| Surplus notes subject to set-off arrangements | Captive Reinsurance Subsidiary | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Estimated maximum borrowing capacity, after taking into account applicable required collateralization levels and required purchases of activity based stock | 500 | 300 | ||||||||
| Fixed rate | Senior notes | Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Long-term debt | $ 10,823 | 10,245 | ||||||||
| Fixed rate | Senior notes | Minimum | Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument, Interest Rate, Stated Percentage | 1.50% | 1.50% | ||||||||
| Fixed rate | Senior notes | Maximum | Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument, Interest Rate, Stated Percentage | 6.63% | 6.63% | ||||||||
| Floating rate debt | Fixed-Rate Surplus Notes | Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Long-term debt | $ 0 | 347 | ||||||||
| Maturity in February 2033 | Private Placement | Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt maturity | 10 years | |||||||||
| Debt Instrument, Face Amount | $ 800 | |||||||||
| Debt Instrument, Interest Rate, Stated Percentage | Rate | 5.791% | 5.791% | ||||||||
| Debt Instrument, Interest Rate | Rate | 1.815% | 1.815% | ||||||||
| Maturity in February 2053 | Private Placement | Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt maturity | 30 years | |||||||||
| Debt Instrument, Face Amount | $ 700 | |||||||||
| Debt Instrument, Interest Rate, Stated Percentage | Rate | 5.997% | 5.997% | ||||||||
| Debt Instrument, Interest Rate | Rate | 2.066% | 2.066% | ||||||||
| Subordinated Debt | Fixed rate | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Outstanding amount of notes | $ 0 | 0 | ||||||||
| Senior notes | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Number of debt instruments issued | debtInstrument | 2 | |||||||||
| Senior notes | Private Placement | Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt maturity | 10 years | |||||||||
| Debt Instrument, Face Amount | $ 1,500 | |||||||||
| Cure period | 30 days | 30 days | ||||||||
| Debt instrument, number of lenders | lender | 2 | |||||||||
| Senior notes | Mortgage Debt | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Long-term Debt | 217 | 185 | ||||||||
| Senior notes | Fixed rate | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Outstanding amount of notes | $ 10,823 | 10,245 | ||||||||
| Senior notes | Fixed rate | Minimum | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument, Interest Rate, Stated Percentage | 1.50% | 1.50% | ||||||||
| Senior notes | Fixed rate | Maximum | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument, Interest Rate, Stated Percentage | 6.63% | 6.63% | ||||||||
| Senior notes | Maturity in February 2033 | Private Placement | Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt maturity | 10 years | |||||||||
| Senior notes | Maturity in February 2053 | Private Placement | Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt maturity | 30 years | |||||||||
| Mortgage Debt | Prudential Financial | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument, Face Amount | $ 750 | |||||||||
| Mortgage Debt | Fixed rate | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Outstanding amount of notes | $ 134 | 69 | ||||||||
| Mortgage Debt | Fixed rate | Minimum | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument, Interest Rate, Stated Percentage | 1.28% | 1.28% | ||||||||
| Mortgage Debt | Fixed rate | Maximum | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument, Interest Rate, Stated Percentage | 2.21% | 2.21% | ||||||||
| Mortgage Debt | Floating rate debt | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Outstanding amount of notes | $ 49 | 31 | ||||||||
| Mortgage Debt | Floating rate debt | Minimum | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument, Interest Rate, Stated Percentage | 0.95% | 0.95% | ||||||||
| Mortgage Debt | Floating rate debt | Maximum | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Debt Instrument, Interest Rate, Stated Percentage | 1.74% | 1.74% | ||||||||
| Mortgage Debt | Floating rate debt | Foreign public corporate securities | ||||||||||
| Debt Instrument [Line Items] | ||||||||||
| Outstanding amount of notes | $ 184 | $ 100 | ||||||||
Short-Term and Long-Term Debt (Credit Facilities) (Details) ¥ in Millions, $ in Millions |
1 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2024 |
Dec. 31, 2025
USD ($)
|
Dec. 31, 2025
JPY (¥)
|
Dec. 31, 2025
JPY (¥)
|
|
| Prudential Financial and Prudential Funding | ||||
| CreditFacility [Line Items] | ||||
| Original Term | 5 years | 5 years | ||
| Capacity | $ | $ 4,000 | |||
| Amount Outstanding | $ | $ 0 | |||
| Prudential Holdings of Japan | ||||
| CreditFacility [Line Items] | ||||
| Original Term | 5 years | 5 years | 5 years | |
| Capacity | ¥ | ¥ 100,000 | |||
| Amount Outstanding | ¥ | ¥ 0 | |||
Short-Term and Long-Term Debt (Long-Term Debt) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Debt Instrument [Line Items] | ||
| Less: assets under set-off arrangements | $ 15,744 | $ 14,748 |
| Total long-term debt | 18,856 | 19,187 |
| Surplus notes subject to set-off arrangements | ||
| Debt Instrument [Line Items] | ||
| Long-term debt | 15,744 | 14,748 |
| Retail Medium Term Note | ||
| Debt Instrument [Line Items] | ||
| Long-term debt | 727 | 370 |
| Surplus notes | Fixed-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Long-term debt | 0 | 0 |
| Surplus notes subject to set-off arrangements | Fixed-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Long-term debt | 15,744 | 14,748 |
| Senior notes | Fixed-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Long-term debt | 10,823 | 10,245 |
| Mortgage Debt | Fixed-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Long-term debt | 134 | 69 |
| Mortgage Debt | Floating-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Long-term debt | 49 | 31 |
| Mortgage Debt | Debt denominated in foreign currency | Floating-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Long-term debt | 184 | 100 |
| Junior subordinated debt | ||
| Debt Instrument [Line Items] | ||
| Long-term debt | 7,595 | 8,587 |
| Subtotal | ||
| Debt Instrument [Line Items] | ||
| Long-term debt | 34,600 | 33,935 |
| Line of Credit | Floating-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Long-term debt | 255 | 255 |
| Somerset Re surplus notes subject to set off arrangements | ||
| Debt Instrument [Line Items] | ||
| Long-term debt | 7,600 | |
| Prudential Financial | ||
| Debt Instrument [Line Items] | ||
| Long-term debt | 18,378 | 18,793 |
| Total long-term debt | 18,378 | 18,793 |
| Prudential Financial | Senior notes | Fixed-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Total long-term debt | 10,823 | $ 10,245 |
| Prudential Financial | Junior subordinated debt | ||
| Debt Instrument [Line Items] | ||
| Long-term debt | 7,555 | |
| Subsidiaries | Junior subordinated debt | ||
| Debt Instrument [Line Items] | ||
| Long-term debt | $ 40 | |
| Minimum | Surplus notes subject to set-off arrangements | Fixed-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Interest Rate | 3.66% | |
| Minimum | Senior notes | Fixed-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Interest Rate | 1.50% | |
| Minimum | Mortgage Debt | Fixed-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Interest Rate | 1.28% | |
| Minimum | Mortgage Debt | Floating-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Interest Rate | 0.95% | |
| Minimum | Junior subordinated debt | ||
| Debt Instrument [Line Items] | ||
| Interest Rate | 1.72% | |
| Minimum | Line of Credit | Fixed-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Interest Rate | 5.62% | |
| Minimum | Prudential Financial | Senior notes | Fixed-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Interest Rate | 1.50% | |
| Maximum | Surplus notes subject to set-off arrangements | Fixed-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Interest Rate | 5.48% | |
| Maximum | Senior notes | Fixed-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Interest Rate | 6.63% | |
| Maximum | Mortgage Debt | Fixed-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Interest Rate | 2.21% | |
| Maximum | Mortgage Debt | Floating-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Interest Rate | 1.74% | |
| Maximum | Junior subordinated debt | ||
| Debt Instrument [Line Items] | ||
| Interest Rate | 6.75% | |
| Maximum | Line of Credit | Fixed-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Interest Rate | 5.98% | |
| Maximum | Prudential Financial | Senior notes | Fixed-rate notes: | ||
| Debt Instrument [Line Items] | ||
| Interest Rate | 6.63% |
Short-Term and Long-Term Debt (Contractual Maturities for Long-Term Debt) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Debt Disclosure [Abstract] | ||
| 2027 | $ 63 | |
| 2028 | 667 | |
| 2029 | 95 | |
| 2030 | 750 | |
| 2031 and thereafter | 17,281 | |
| Long-term debt | $ 18,856 | $ 19,187 |
Short-Term and Long-Term Debt (Senior Notes and Mortgage Debt) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Senior notes | ||
| Debt Instrument [Line Items] | ||
| Short-term Debt | $ 536 | $ 0 |
| Medium-Term Notes | ||
| Debt Instrument [Line Items] | ||
| Debt, Long-term and Short-term, Combined Amount | 9,130 | 8,382 |
| Medium-Term Notes | Senior notes | ||
| Debt Instrument [Line Items] | ||
| Debt, Long-term and Short-term, Combined Amount | 11,576 | 10,430 |
| Senior notes | ||
| Debt Instrument [Line Items] | ||
| Debt, Long-term and Short-term, Combined Amount | 1,502 | 1,493 |
| Retail Medium Term Note | ||
| Debt Instrument [Line Items] | ||
| Outstanding amount of notes | 727 | 370 |
| Mortgage Debt | Senior notes | ||
| Debt Instrument [Line Items] | ||
| Long-term Debt | 217 | $ 185 |
| Short-term Debt | $ 569 |
Short-Term and Long-Term Debt (Surplus Notes with Set-Off Arrangements) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Debt Instrument [Line Items] | ||
| Assets Under Set Off Arrangements | $ 15,744 | $ 14,748 |
| PLIC | ||
| Debt Instrument [Line Items] | ||
| Future Debt Instrument Authorized | 4,000 | |
| Surplus notes subject to set-off arrangements | ||
| Debt Instrument [Line Items] | ||
| Outstanding amount of notes | 15,744 | 14,748 |
| Future Debt Instrument Authorized | 21,500 | |
| Surplus notes subject to set-off arrangements | Captive Reinsurance Subsidiary | ||
| Debt Instrument [Line Items] | ||
| Estimated maximum borrowing capacity, after taking into account applicable required collateralization levels and required purchases of activity based stock | 500 | 300 |
| Regulation XXX | Surplus notes subject to set-off arrangements due 2044 | Captive Reinsurance Subsidiary | ||
| Debt Instrument [Line Items] | ||
| Debt Instrument Authorized | 8,000 | |
| Outstanding amount of notes | 7,660 | 7,560 |
| Guideline AXXX | Somerset Re surplus notes subject to set off arrangements | Captive Reinsurance Subsidiary | ||
| Debt Instrument [Line Items] | ||
| Debt Instrument Authorized | 9,500 | |
| Outstanding amount of notes | $ 7,584 | $ 6,888 |
Short-Term and Long-Term Debt (Schedule of Junior Subordinated Notes) (Details) $ in Millions |
12 Months Ended |
|---|---|
|
Dec. 31, 2025
USD ($)
Rate
| |
| Junior Subordinated Institutional Notes September 2017 | |
| Debt Instrument [Line Items] | |
| Principal Amount | $ 750 |
| Interest Rate | 4.50% |
| Junior Subordinated Institutional Notes September 2017 | SOFR | |
| Debt Instrument [Line Items] | |
| Interest Rate Subsequent to Optional Redemption Date | Rate | 4.50% |
| Junior Subordinated Institutional Notes August 2018 | |
| Debt Instrument [Line Items] | |
| Principal Amount | $ 565 |
| Interest Rate | 5.63% |
| Junior Subordinated Institutional Notes September 2018 | |
| Debt Instrument [Line Items] | |
| Principal Amount | $ 1,000 |
| Interest Rate | 5.70% |
| Junior Subordinated Institutional Notes September 2018 | SOFR | |
| Debt Instrument [Line Items] | |
| Interest Rate Subsequent to Optional Redemption Date | Rate | 2.93% |
| Junior Subordinated Retail Notes August 2020 4.13% | |
| Debt Instrument [Line Items] | |
| Principal Amount | $ 500 |
| Interest Rate | 4.13% |
| Junior Subordinated Institutional Notes August 2020 3.70% | |
| Debt Instrument [Line Items] | |
| Principal Amount | $ 800 |
| Interest Rate | 3.70% |
| Junior Subordinated Institutional Notes August 2020 3.70% | US Treasury | |
| Debt Instrument [Line Items] | |
| Interest Rate Subsequent to Optional Redemption Date | Rate | 3.04% |
| Junior Subordinated Institutional Notes February 2022 | |
| Debt Instrument [Line Items] | |
| Principal Amount | $ 1,000 |
| Interest Rate | 5.13% |
| Junior Subordinated Institutional Notes February 2022 | US Treasury | |
| Debt Instrument [Line Items] | |
| Interest Rate Subsequent to Optional Redemption Date | Rate | 3.16% |
| Junior Subordinated Institutional Notes August 2022 5.95% | |
| Debt Instrument [Line Items] | |
| Principal Amount | $ 300 |
| Interest Rate | 5.95% |
| Junior Subordinated Institutional Notes August 2022 6.00% | |
| Debt Instrument [Line Items] | |
| Principal Amount | $ 1,200 |
| Interest Rate | 6.00% |
| Junior Subordinated Institutional Notes August 2022 6.00% | US Treasury | |
| Debt Instrument [Line Items] | |
| Interest Rate Subsequent to Optional Redemption Date | Rate | 3.23% |
| Junior Subordinated Institutional Notes February 2023 | |
| Debt Instrument [Line Items] | |
| Principal Amount | $ 500 |
| Interest Rate | 6.75% |
| Junior Subordinated Institutional Notes February 2023 | US Treasury | |
| Debt Instrument [Line Items] | |
| Interest Rate Subsequent to Optional Redemption Date | Rate | 2.85% |
| Junior Subordinated Institutional Notes March 2024 | |
| Debt Instrument [Line Items] | |
| Principal Amount | $ 1,000 |
| Interest Rate | 6.50% |
| Junior Subordinated Institutional Notes March 2024 | US Treasury | |
| Debt Instrument [Line Items] | |
| Interest Rate Subsequent to Optional Redemption Date | Rate | 2.40% |
Employee Benefit Plans (Narrative) (Details) - USD ($) $ in Millions |
12 Months Ended | |||
|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Defined Benefit Plan Disclosure [Line Items] | ||||
| Qualified Pension Plan | 81.00% | |||
| Pension Benefit Percent Allocation Traditional | 64.00% | |||
| Pension Benefit Percent Allocation Cash Balance | 36.00% | |||
| Percentage of annual salary Contributed by the Company for employees (401(k) plans) | 4.00% | |||
| General And Administrative Expense | ||||
| Defined Benefit Plan Disclosure [Line Items] | ||||
| Defined Contribution Plan, Cost | $ 84 | $ 87 | $ 79 | |
| Other liabilities | ||||
| Defined Benefit Plan Disclosure [Line Items] | ||||
| Net accumulated liability for non-retiree postemployment benefits provided to former or inactive employee | 30 | |||
| Rabbi Trust | ||||
| Defined Benefit Plan Disclosure [Line Items] | ||||
| Defined Benefit Plan Obligation | 949 | 861 | ||
| Fair value of plan assets | 199 | 157 | ||
| Defined Benefit Plan, Plan Assets, Amount | 199 | 157 | ||
| Rabbi Trust | Discontinued Operations | ||||
| Defined Benefit Plan Disclosure [Line Items] | ||||
| Defined Benefit Plan Obligation | 47 | 51 | ||
| Fair value of plan assets | 68 | 75 | ||
| Defined Benefit Plan, Plan Assets, Amount | 68 | 75 | ||
| Pension Benefits | ||||
| Defined Benefit Plan Disclosure [Line Items] | ||||
| Defined Benefit Plan Obligation | 10,804 | 10,629 | 11,238 | |
| Fair value of plan assets | $ 12,490 | $ 12,293 | $ 12,649 | |
| Bond Yield rate used in determining Discount rate | 5.55% | 5.85% | 5.30% | 5.45% |
| Expected long-term rate of return on plan assets | 7.75% | 8.00% | 7.50% | 7.50% |
| Defined Benefit Plans Estimated Future Employer Contributions in Next Fiscal Year | $ 165 | |||
| Defined Benefit Plan, Plan Assets, Amount | 12,490 | $ 12,293 | $ 12,649 | |
| Postretirement | ||||
| Defined Benefit Plan Disclosure [Line Items] | ||||
| Defined Benefit Plan Obligation | 1,038 | 1,026 | 1,032 | |
| Fair value of plan assets | $ 1,239 | $ 1,187 | $ 1,186 | |
| Bond Yield rate used in determining Discount rate | 5.25% | 5.70% | 5.20% | 5.55% |
| Expected long-term rate of return on plan assets | 6.25% | 6.50% | 6.75% | 7.75% |
| Defined Benefit Plans Estimated Future Employer Contributions in Next Fiscal Year | $ 10 | |||
| Defined Benefit Plan, Plan Assets, Amount | $ 1,239 | $ 1,187 | $ 1,186 | |
| Maximum | Postretirement | ||||
| Defined Benefit Plan Disclosure [Line Items] | ||||
| Deferred Compensation Arrangement with Individual, Requisite Age | 55 years | |||
| Deferred Compensation Arrangement with Individual, Requisite Service Period | 20 years | |||
| Minimum | Postretirement | ||||
| Defined Benefit Plan Disclosure [Line Items] | ||||
| Deferred Compensation Arrangement with Individual, Requisite Age | 50 years | |||
| Deferred Compensation Arrangement with Individual, Requisite Service Period | 10 years | |||
| Foreign plans | ||||
| Defined Benefit Plan Disclosure [Line Items] | ||||
| Defined Benefit Plan Weighted Average Asset Allocations | 3.00% | |||
| Foreign plans | Pension Benefits | ||||
| Defined Benefit Plan Disclosure [Line Items] | ||||
| Pension benefits for foreign plans percentage of the ending benefit obligation | 9.00% | 10.00% | ||
Employee Benefit Plans (Status of Prepaid Benefits Costs and Accrued Benefit Liabilities Included in Other Assets and Other Liabilities) (Details) - USD ($) $ in Millions |
12 Months Ended | |||
|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Pension Benefits | ||||
| Change in benefit obligation | ||||
| Benefit obligation at the beginning of period | $ (10,629) | $ (11,238) | ||
| Service cost | (187) | (206) | $ (204) | |
| Interest cost | (565) | (539) | (551) | |
| Plan participants’ contributions | 0 | 0 | ||
| Amendments | (6) | 0 | ||
| Actuarial gains (losses), net | (333) | 360 | ||
| Settlements | 58 | 62 | ||
| Special termination benefits | 0 | (1) | ||
| Benefits paid | 872 | 823 | ||
| Foreign currency changes and other | (15) | 110 | ||
| Benefit obligation at end of period | (10,804) | (10,629) | (11,238) | |
| Change in plan assets | ||||
| Plan assets at beginning of period | 12,293 | 12,649 | ||
| Actual return on plan assets | 944 | 366 | ||
| Employer contributions | 168 | 177 | ||
| Plan participants’ contributions | 0 | 0 | ||
| Disbursement for settlements | (58) | (62) | ||
| Benefits paid | (872) | (823) | ||
| Foreign currency changes and other | 16 | (14) | ||
| Plan assets at end of period | 12,490 | 12,293 | 12,649 | |
| Funded status at end of period | 1,686 | 1,664 | ||
| Acquisition/Divestiture | 1 | 0 | ||
| Amounts recognized in the Statements of Financial Position | ||||
| Prepaid benefit cost | 3,503 | 3,451 | ||
| Accrued benefit liability | (1,817) | (1,787) | ||
| Net amount recognized | 1,686 | 1,664 | ||
| Items recorded in “Accumulated other comprehensive income (loss)” not yet recognized as a component of net periodic (benefit) cost: | ||||
| Prior service cost | 6 | (1) | (2) | $ (2) |
| Net actuarial loss | 3,228 | 2,924 | 2,797 | 2,466 |
| Net amount not recognized | 3,234 | 2,923 | ||
| Accumulated benefit obligation | (9,973) | (9,925) | ||
| Acquisition/Divestiture | 1 | 0 | ||
| Other Postretirement Benefits | ||||
| Change in benefit obligation | ||||
| Benefit obligation at the beginning of period | (1,026) | (1,032) | ||
| Service cost | (6) | (7) | (9) | |
| Interest cost | (55) | (51) | (71) | |
| Plan participants’ contributions | (18) | (21) | ||
| Amendments | 0 | 0 | ||
| Actuarial gains (losses), net | (42) | (29) | ||
| Settlements | 0 | 0 | ||
| Special termination benefits | 0 | 0 | ||
| Benefits paid | 110 | 113 | ||
| Foreign currency changes and other | (1) | 1 | ||
| Benefit obligation at end of period | (1,038) | (1,026) | (1,032) | |
| Change in plan assets | ||||
| Plan assets at beginning of period | 1,187 | 1,186 | ||
| Actual return on plan assets | 136 | 88 | ||
| Employer contributions | 8 | 5 | ||
| Plan participants’ contributions | 18 | 21 | ||
| Disbursement for settlements | 0 | 0 | ||
| Benefits paid | (110) | (113) | ||
| Foreign currency changes and other | 0 | 0 | ||
| Plan assets at end of period | 1,239 | 1,187 | 1,186 | |
| Funded status at end of period | 201 | 161 | ||
| Acquisition/Divestiture | 0 | 0 | ||
| Amounts recognized in the Statements of Financial Position | ||||
| Prepaid benefit cost | 282 | 232 | ||
| Accrued benefit liability | (81) | (71) | ||
| Net amount recognized | 201 | 161 | ||
| Items recorded in “Accumulated other comprehensive income (loss)” not yet recognized as a component of net periodic (benefit) cost: | ||||
| Prior service cost | (211) | (278) | (345) | (54) |
| Net actuarial loss | 186 | 218 | $ 209 | $ 222 |
| Net amount not recognized | (25) | (60) | ||
| Accumulated benefit obligation | (1,038) | (1,026) | ||
| Acquisition/Divestiture | $ 0 | $ 0 | ||
Employee Benefit Plans (Information for Pension Plans with a Projected and Accumulated Benefit Obligation in Excess of Plan Assets) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Defined Benefit Plan, Pension Plan with Project Benefit Obligation in Excess of Plan Assets [Abstract] | ||
| Projected benefit obligation | $ 1,817 | $ 1,787 |
| Fair value of plan assets | 0 | 0 |
| Information On Pension Plans With Accumulated Benefit Obligation In Excess Of Plan Assets [Abstract] | ||
| Accumulated benefit obligation | 1,617 | 1,625 |
| Fair value of plan assets | $ 0 | $ 0 |
Employee Benefit Plans (Components of Net Periodic Benefit Cost Included in General and Administrative Expenses) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Pension Benefits | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Service cost | $ 187 | $ 206 | $ 204 |
| Interest cost | 565 | 539 | 551 |
| Expected return on plan assets | (996) | (953) | (926) |
| Amortization of prior service cost | (1) | (1) | (1) |
| Amortization of actuarial (gain) loss, net | 84 | 90 | 69 |
| Settlements | (3) | 1 | 3 |
| Special termination benefits | 0 | 1 | 25 |
| Net periodic (benefit) cost | (164) | (117) | (75) |
| Other Postretirement Benefits | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Service cost | 6 | 7 | 9 |
| Interest cost | 55 | 51 | 71 |
| Expected return on plan assets | (73) | (76) | (86) |
| Amortization of prior service cost | (67) | (67) | (7) |
| Amortization of actuarial (gain) loss, net | 10 | 8 | 10 |
| Settlements | 0 | 0 | 0 |
| Special termination benefits | 0 | 0 | 5 |
| Net periodic (benefit) cost | $ (69) | $ (77) | $ 2 |
Employee Benefit Plans (Amounts Recorded in Accumulated Other Comprehensive Income not yet Recognized) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Pension Benefits | |||
| Pension And Other Post Retirement Benefits Plans, Net Prior Service Cost Credit [Roll Forward] | |||
| Beginning balance | $ (1) | $ (2) | $ (2) |
| Amortization for the period | 1 | 1 | 1 |
| Deferrals for the period | 6 | 0 | (2) |
| Impact of foreign currency changes and other | 0 | 0 | 1 |
| Ending balance | 6 | (1) | (2) |
| Pension And Other Postretirement Benefit Plans, Accumulated Net Gains (Losses) [Roll Forward] | |||
| Balance, beginning of year | 2,924 | 2,797 | 2,466 |
| Amortization for the period | (84) | (90) | (69) |
| Deferrals for the period | 385 | 227 | 411 |
| Impact of foreign currency changes and other | 3 | (10) | (11) |
| Balance, end of period | 3,228 | 2,924 | 2,797 |
| Other Postretirement Benefits | |||
| Pension And Other Post Retirement Benefits Plans, Net Prior Service Cost Credit [Roll Forward] | |||
| Beginning balance | (278) | (345) | (54) |
| Amortization for the period | 67 | 67 | 7 |
| Deferrals for the period | 0 | 0 | (298) |
| Impact of foreign currency changes and other | 0 | 0 | 0 |
| Ending balance | (211) | (278) | (345) |
| Pension And Other Postretirement Benefit Plans, Accumulated Net Gains (Losses) [Roll Forward] | |||
| Balance, beginning of year | 218 | 209 | 222 |
| Amortization for the period | (10) | (8) | (10) |
| Deferrals for the period | (21) | 17 | (3) |
| Impact of foreign currency changes and other | (1) | 0 | 0 |
| Balance, end of period | $ 186 | $ 218 | $ 209 |
Employee Benefit Plans (Assumptions Related to Calculation of Domestic Benefit Obligation (End of Period) and Determination of Net Periodic (Benefit) Cost (Beginning of Period)) (Details) |
12 Months Ended | |||
|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
|
| Pension Benefits | ||||
| Defined Benefit Plan Disclosure [Line Items] | ||||
| Discount rate | 5.55% | 5.85% | 5.30% | 5.45% |
| Rate of increase in compensation levels | 6.25% | 6.25% | 6.25% | 4.50% |
| Expected return on plan assets | 7.75% | 8.00% | 7.50% | 7.50% |
| Interest Crediting Rate | 4.85% | 4.35% | 4.95% | 4.25% |
| Other Postretirement Benefits | ||||
| Defined Benefit Plan Disclosure [Line Items] | ||||
| Discount rate | 5.25% | 5.70% | 5.20% | 5.55% |
| Expected return on plan assets | 6.25% | 6.50% | 6.75% | 7.75% |
| Health care cost trend rates | 8.00% | 7.90% | 7.35% | 6.50% |
| Ultimate health care cost trend rate | 4.75% | 4.75% | 4.75% | 4.75% |
Employee Benefit Plans (Asset Allocation Targets Reflecting a Percentage of Total Assets by Asset Class) (Details) |
Dec. 31, 2025 |
|---|---|
| Minimum | Pension Benefits | U.S. Equities | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 0.00% |
| Minimum | Pension Benefits | International Equities | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 0.00% |
| Minimum | Pension Benefits | Fixed maturities | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 51.00% |
| Minimum | Pension Benefits | Short-term Investments | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 0.00% |
| Minimum | Pension Benefits | Real Estate | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 3.00% |
| Minimum | Pension Benefits | Other invested assets | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 8.00% |
| Minimum | Postretirement | U.S. Equities | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 11.00% |
| Minimum | Postretirement | International Equities | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 4.00% |
| Minimum | Postretirement | Fixed maturities | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 5.00% |
| Minimum | Postretirement | Short-term Investments | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 0.00% |
| Minimum | Postretirement | Real Estate | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 0.00% |
| Minimum | Postretirement | Other invested assets | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 0.00% |
| Maximum | Pension Benefits | U.S. Equities | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 3.00% |
| Maximum | Pension Benefits | International Equities | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 8.00% |
| Maximum | Pension Benefits | Fixed maturities | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 70.00% |
| Maximum | Pension Benefits | Short-term Investments | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 11.00% |
| Maximum | Pension Benefits | Real Estate | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 16.00% |
| Maximum | Pension Benefits | Other invested assets | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 40.00% |
| Maximum | Postretirement | U.S. Equities | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 32.00% |
| Maximum | Postretirement | International Equities | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 22.00% |
| Maximum | Postretirement | Fixed maturities | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 72.00% |
| Maximum | Postretirement | Short-term Investments | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 26.00% |
| Maximum | Postretirement | Real Estate | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 0.00% |
| Maximum | Postretirement | Other invested assets | |
| Defined Benefit Plan Disclosure [Line Items] | |
| Asset allocation targets | 0.00% |
Employee Benefit Plans (Pension and Post Retirement Asset Allocations in Accordance with Investment Guidelines) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|---|
| Defined Benefit Plan Disclosure [Line Items] | |||
| Gross Notional | $ 676,411 | $ 548,831 | |
| Pension Benefits | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 12,490 | 12,293 | $ 12,649 |
| Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 4,285 | 4,416 | |
| Pension Benefits | Other invested assets | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 4,198 | 4,122 | |
| Pension Benefits | Net assets in the fair value hierarchy | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 9,191 | 9,308 | |
| Postretirement | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 1,239 | 1,187 | 1,186 |
| Postretirement | Equities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 55 | 48 | |
| Postretirement | Defined Benefit Plan, Debt Security | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 2 | |
| Postretirement | Net assets in the fair value hierarchy | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 133 | 96 | |
| Postretirement | Variable Life Insurance Policies at contract value | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 957 | 943 | |
| Level 1 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 52 | 86 | |
| Level 1 | Pension Benefits | Other invested assets | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Level 1 | Pension Benefits | Net assets in the fair value hierarchy | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 52 | 86 | |
| Level 1 | Postretirement | Equities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Level 1 | Postretirement | Defined Benefit Plan, Debt Security | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Level 1 | Postretirement | Net assets in the fair value hierarchy | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 78 | 46 | |
| Level 2 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 4,210 | 4,295 | |
| Level 2 | Pension Benefits | Other invested assets | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Level 2 | Pension Benefits | Net assets in the fair value hierarchy | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 4,210 | 4,295 | |
| Level 2 | Postretirement | Equities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 55 | 48 | |
| Level 2 | Postretirement | Defined Benefit Plan, Debt Security | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 2 | |
| Level 2 | Postretirement | Net assets in the fair value hierarchy | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 55 | 50 | |
| Level 3 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 23 | 35 | |
| Level 3 | Pension Benefits | Other invested assets | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 4,198 | 4,122 | |
| Level 3 | Pension Benefits | Net assets in the fair value hierarchy | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 4,929 | 4,927 | |
| Level 3 | Postretirement | Equities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Level 3 | Postretirement | Defined Benefit Plan, Debt Security | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Level 3 | Postretirement | Net assets in the fair value hierarchy | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Investment Measure at Net Asset Value as a practical expedient | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 2,418 | 2,186 | |
| Investment Measure at Net Asset Value as a practical expedient | Pension Benefits | Real Estate | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 511 | 510 | |
| Investment Measure at Net Asset Value as a practical expedient | Pension Benefits | Short-term Investments | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 150 | 67 | |
| Investment Measure at Net Asset Value as a practical expedient | Pension Benefits | Equity Securities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 54 | 37 | |
| Investment Measure at Net Asset Value as a practical expedient | Pension Benefits | Equity Securities | International | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 166 | 185 | |
| Investment Measure at Net Asset Value as a practical expedient | Postretirement | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 149 | 148 | |
| Investment Measure at Net Asset Value as a practical expedient | Postretirement | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 623 | 652 | |
| Investment Measure at Net Asset Value as a practical expedient | Postretirement | Equity Securities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 215 | 192 | |
| Investment Measure at Net Asset Value as a practical expedient | Postretirement | Equity Securities | International | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 119 | 99 | |
| U.S. Equities | Postretirement | Equities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 43 | 38 | |
| U.S. Equities | Level 1 | Postretirement | Equities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| U.S. Equities | Level 2 | Postretirement | Equities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 43 | 38 | |
| U.S. Equities | Level 3 | Postretirement | Equities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| International Equities | Postretirement | Equities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 12 | 10 | |
| International Equities | Level 1 | Postretirement | Equities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| International Equities | Level 2 | Postretirement | Equities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 12 | 10 | |
| International Equities | Level 3 | Postretirement | Equities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Other U.S. government securities | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 919 | 919 | |
| Other U.S. government securities | Level 1 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Other U.S. government securities | Level 2 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 919 | 919 | |
| Other U.S. government securities | Level 3 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| U.S. government securities (state & other) | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 259 | 273 | |
| U.S. government securities (state & other) | Level 1 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| U.S. government securities (state & other) | Level 2 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 259 | 273 | |
| U.S. government securities (state & other) | Level 3 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Non-U.S. government securities | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 47 | 42 | |
| Non-U.S. government securities | Level 1 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Non-U.S. government securities | Level 2 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 47 | 42 | |
| Non-U.S. government securities | Level 3 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Corporate bonds | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 2,181 | 2,041 | |
| Corporate bonds | Level 1 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Corporate bonds | Level 2 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 2,171 | 2,035 | |
| Corporate bonds | Level 3 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 10 | 6 | |
| Asset-backed | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 486 | 560 | |
| Asset-backed | Level 1 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Asset-backed | Level 2 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 486 | 560 | |
| Asset-backed | Level 3 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Collateralized mortgage obligations | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 304 | 453 | |
| Collateralized mortgage obligations | Level 1 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Collateralized mortgage obligations | Level 2 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 304 | 453 | |
| Collateralized mortgage obligations | Level 3 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Collateralized loan obligations | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 24 | |
| Collateralized loan obligations | Level 1 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Collateralized loan obligations | Level 2 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 24 | |
| Collateralized loan obligations | Level 3 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Interest Rate Swaps | Pension Benefits | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Gross Notional | 1,221 | 1,227 | |
| Interest Rate Swaps | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 24 | (12) | |
| Interest Rate Swaps | Level 1 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Interest Rate Swaps | Level 2 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 24 | (12) | |
| Interest Rate Swaps | Level 3 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Registered investment companies | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 21 | 44 | |
| Registered investment companies | Postretirement | Defined Benefit Plan, Debt Security | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 2 | |
| Registered investment companies | Postretirement | Short-term Investments | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 78 | 46 | |
| Registered investment companies | Level 1 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 21 | 44 | |
| Registered investment companies | Level 1 | Postretirement | Defined Benefit Plan, Debt Security | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Registered investment companies | Level 1 | Postretirement | Short-term Investments | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 78 | 46 | |
| Registered investment companies | Level 2 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Registered investment companies | Level 2 | Postretirement | Defined Benefit Plan, Debt Security | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 2 | |
| Registered investment companies | Level 2 | Postretirement | Short-term Investments | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Registered investment companies | Level 3 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Registered investment companies | Level 3 | Postretirement | Defined Benefit Plan, Debt Security | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Registered investment companies | Level 3 | Postretirement | Short-term Investments | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Other | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 36 | 52 | |
| Other | Level 1 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 23 | 22 | |
| Other | Level 2 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 1 | |
| Other | Level 3 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 13 | 29 | |
| Partnerships | Pension Benefits | Real Estate | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 708 | 770 | |
| Partnerships | Pension Benefits | Other invested assets | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 2,550 | 2,437 | |
| Partnerships | Level 1 | Pension Benefits | Real Estate | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Partnerships | Level 1 | Pension Benefits | Other invested assets | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Partnerships | Level 2 | Pension Benefits | Real Estate | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Partnerships | Level 2 | Pension Benefits | Other invested assets | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Partnerships | Level 3 | Real Estate | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 708 | 770 | 942 |
| Partnerships | Level 3 | Other invested assets | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 2,550 | 2,437 | 2,142 |
| Partnerships | Level 3 | Pension Benefits | Real Estate | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 708 | 770 | |
| Partnerships | Level 3 | Pension Benefits | Other invested assets | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 2,550 | 2,437 | |
| Hedge Fund | Pension Benefits | Other invested assets | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 1,648 | 1,685 | |
| Hedge Fund | Level 1 | Pension Benefits | Other invested assets | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Hedge Fund | Level 2 | Pension Benefits | Other invested assets | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Hedge Fund | Level 3 | Other invested assets | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 1,648 | 1,685 | $ 1,495 |
| Hedge Fund | Level 3 | Pension Benefits | Other invested assets | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 1,648 | 1,685 | |
| Pooled separate accounts | Investment Measure at Net Asset Value as a practical expedient | Pension Benefits | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 2,265 | 2,090 | |
| Common/collective trusts | Investment Measure at Net Asset Value as a practical expedient | Pension Benefits | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 940 | 802 | |
| Other countries | Investment Measure at Net Asset Value as a practical expedient | Pension Benefits | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 94 | 93 | |
| Other common stocks | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 8 | 20 | |
| Other common stocks | Level 1 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 8 | 20 | |
| Other common stocks | Level 2 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Other common stocks | Level 3 | Pension Benefits | Fixed maturities | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | 0 | 0 | |
| Net assets at fair value | Postretirement | |||
| Defined Benefit Plan Disclosure [Line Items] | |||
| Defined Benefit Plan, Plan Assets, Amount | $ 282 | $ 244 |
Employee Benefit Plans (Changes in Fair Value of Level 3 Pension and Post Retirement Assets) (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Level 3 | Corporate Bond Securities | ||
| Fair Value, Assets And Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
| Plan assets at beginning of period | $ 6 | $ 9 |
| Actual return on assets: | ||
| Relating to assets still held at the reporting date | 0 | 0 |
| Relating to assets sold during the period | 0 | 0 |
| Purchases | 4 | 0 |
| Sales | 0 | (3) |
| Issuances | 0 | 0 |
| Settlements | 0 | 0 |
| Transfers in and/or out of Level 3 | 0 | 0 |
| Plan assets at end of period | 10 | 6 |
| Postretirement | ||
| Fair Value, Assets And Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
| Plan assets at beginning of period | 1,187 | 1,186 |
| Actual return on assets: | ||
| Plan assets at end of period | 1,239 | 1,187 |
| Other | Level 3 | Fixed Maturities | ||
| Fair Value, Assets And Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
| Plan assets at beginning of period | 29 | 82 |
| Actual return on assets: | ||
| Relating to assets still held at the reporting date | 0 | 0 |
| Relating to assets sold during the period | 0 | 0 |
| Purchases | 0 | 0 |
| Sales | 0 | 0 |
| Issuances | 14 | 29 |
| Settlements | (30) | (82) |
| Transfers in and/or out of Level 3 | 0 | 0 |
| Plan assets at end of period | 13 | 29 |
| Partnerships | Level 3 | Real Estate | ||
| Fair Value, Assets And Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
| Plan assets at beginning of period | 770 | 942 |
| Actual return on assets: | ||
| Relating to assets still held at the reporting date | 2 | (95) |
| Relating to assets sold during the period | 0 | 0 |
| Purchases | 8 | (18) |
| Sales | (72) | (59) |
| Issuances | 0 | 0 |
| Settlements | 0 | 0 |
| Transfers in and/or out of Level 3 | 0 | 0 |
| Plan assets at end of period | 708 | 770 |
| Partnerships | Level 3 | Other invested assets | ||
| Fair Value, Assets And Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
| Plan assets at beginning of period | 2,437 | 2,142 |
| Actual return on assets: | ||
| Relating to assets still held at the reporting date | 254 | 219 |
| Relating to assets sold during the period | 0 | 0 |
| Purchases | 127 | 76 |
| Sales | (268) | 0 |
| Issuances | 0 | 0 |
| Settlements | 0 | 0 |
| Transfers in and/or out of Level 3 | 0 | 0 |
| Plan assets at end of period | 2,550 | 2,437 |
| Hedge Fund | Level 3 | Other invested assets | ||
| Fair Value, Assets And Liabilities Measured On Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||
| Plan assets at beginning of period | 1,685 | 1,495 |
| Actual return on assets: | ||
| Relating to assets still held at the reporting date | 146 | 158 |
| Relating to assets sold during the period | 0 | 0 |
| Purchases | 75 | 32 |
| Sales | (258) | 0 |
| Issuances | 0 | 0 |
| Settlements | 0 | 0 |
| Transfers in and/or out of Level 3 | 0 | 0 |
| Plan assets at end of period | $ 1,648 | $ 1,685 |
Employee Benefit Plans (Expected Benefit Payments for Company's Pension and Postretirement Plans as well as Expected Medicare Part D Subsidy Receipts Related to Postretirement Plan) (Details) $ in Millions |
Dec. 31, 2025
USD ($)
|
|---|---|
| Pension Benefits | |
| Defined Benefit Plan Disclosure [Line Items] | |
| 2026 | $ 1,056 |
| 2027 | 900 |
| 2028 | 914 |
| 2029 | 933 |
| 2030 | 962 |
| 2031-2035 | 4,594 |
| Total | 9,359 |
| Postretirement | |
| Defined Benefit Plan Disclosure [Line Items] | |
| 2026 | 92 |
| 2027 | 96 |
| 2028 | 99 |
| 2029 | 105 |
| 2030 | 107 |
| 2031-2035 | 469 |
| Total | $ 968 |
Equity (Common Stock Changes in Number of Shares Issued, Held in Treasury and Outstanding) (Details) - shares |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||
| Balance, beginning (in shares) | 666,305,189 | ||
| Balance, ending (in shares) | 666,305,189 | 666,305,189 | |
| Issued | |||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||
| Balance, beginning (in shares) | 666,300,000 | 666,300,000 | 666,300,000 |
| Common Stock issued (in shares) | 0.0 | 0.0 | 0.0 |
| Common Stock acquired | 0.0 | 0.0 | 0.0 |
| Stock-based compensation programs (in shares) | 0.0 | 0.0 | 0.0 |
| Balance, ending (in shares) | 666,300,000 | 666,300,000 | 666,300,000 |
| Held In Treasury | |||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||
| Balance, beginning (in shares) | 311,700,000 | 307,100,000 | 300,300,000 |
| Common Stock issued (in shares) | 0.0 | 0.0 | 0.0 |
| Common Stock acquired | 9,300,000 | 8,600,000 | 10,900,000 |
| Stock-based compensation programs (in shares) | (2,700,000) | (4,000,000.0) | (4,100,000) |
| Balance, ending (in shares) | 318,300,000 | 311,700,000 | 307,100,000 |
| Outstanding | |||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||
| Balance, beginning (in shares) | 354,600,000 | 359,200,000 | 366,000,000.0 |
| Common Stock issued (in shares) | 0.0 | 0.0 | 0.0 |
| Common Stock acquired | 9,300,000 | 8,600,000 | 10,900,000 |
| Stock-based compensation programs (in shares) | 2,700,000 | 4,000,000.0 | 4,100,000 |
| Balance, ending (in shares) | 348,000,000.0 | 354,600,000 | 359,200,000 |
Equity (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|---|
| Class of Stock [Line Items] | |||
| Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | 10,000,000 |
| Preferred Stock, Shares Outstanding | 0 | 0 | 0 |
| Common Stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | |
| Prudential Financial | |||
| Class of Stock [Line Items] | |||
| Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | |
| Common Stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | |
| Cash and short-term investments at carrying value excluding intercompany liquidity account | $ 3,817 | ||
| Cash and short-term investments at carrying value excluding intercompany liquidity account | 3,817 | ||
| Prudential Insurance | |||
| Class of Stock [Line Items] | |||
| Unassigned Surplus | $ 3,687 | ||
| Percentage exceed the greater/lesser of statutory surplus | 10.00% | ||
| POJ | |||
| Class of Stock [Line Items] | |||
| Japan Permitted Percentage of Statutory Earnings w/o approval | 83.00% | ||
| Japan-Retained Earnings Level- Permitted Percentage of Prior Year Statutory Earnings | 100.00% | ||
| RBC or solvency margin capital in excess of the regulatory required minimums | 3.5 | ||
| Permitted to be paid, after September 24, 2026 | Prudential Insurance | |||
| Class of Stock [Line Items] | |||
| Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval | $ 648 | ||
| Permitted to be paid in 2026 | Prudential Insurance | |||
| Class of Stock [Line Items] | |||
| Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval | 1,848 | ||
| Permitted to be paid, after December 25, 2026 | Prudential Insurance | |||
| Class of Stock [Line Items] | |||
| Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval | $ 1,200 |
Equity (Share Repurchases Authorizations) (Details) - USD ($) shares in Millions, $ in Billions |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 10, 2025 |
Dec. 10, 2024 |
Dec. 11, 2023 |
|
| Under February 2023 Board Of Directors Authorization | ||||||
| Equity, Class of Treasury Stock [Line Items] | ||||||
| Share Repurchase Program, Authorized, Amount | $ 1.0 | |||||
| Under November 2025 Board Of Directors Authorization | ||||||
| Equity, Class of Treasury Stock [Line Items] | ||||||
| Share Repurchase Program, Authorized, Amount | $ 1.0 | |||||
| Under December 2023 Board Of Directors Authorization | ||||||
| Equity, Class of Treasury Stock [Line Items] | ||||||
| Share Repurchase Program, Authorized, Amount | $ 1.0 | |||||
| Under December 2024 Board Of Directors Authorization | ||||||
| Equity, Class of Treasury Stock [Line Items] | ||||||
| Share Repurchase Program, Authorized, Amount | $ 1.0 | |||||
| Other common stocks | Under February 2023 Board Of Directors Authorization | ||||||
| Equity, Class of Treasury Stock [Line Items] | ||||||
| Number of Treasury Stock Shares Acquired | 10.9 | |||||
| Other common stocks | Under December 2023 Board Of Directors Authorization | ||||||
| Equity, Class of Treasury Stock [Line Items] | ||||||
| Number of Treasury Stock Shares Acquired | 8.6 | |||||
| Other common stocks | Under December 2024 Board Of Directors Authorization | ||||||
| Equity, Class of Treasury Stock [Line Items] | ||||||
| Number of Treasury Stock Shares Acquired | 9.3 | |||||
Equity (Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | $ 28,187 | $ 28,110 | $ 30,934 |
| Income tax benefit (expense) | (1,003) | (364) | 837 |
| Ending Balance | 32,787 | 28,187 | 28,110 |
| Foreign Currency Translation Adjustment | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | (3,615) | (2,686) | (2,274) |
| Total amount recorded in AOCI | 499 | (811) | (246) |
| Amounts reclassified from AOCI | (53) | (41) | (18) |
| Income tax benefit (expense) | (14) | (77) | (148) |
| Ending Balance | (3,183) | (3,615) | (2,686) |
| Net Unrealized Investment Gains (Losses) | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | (18,687) | (11,213) | (16,194) |
| Total amount recorded in AOCI | (1,695) | (12,822) | 5,076 |
| Amounts reclassified from AOCI | 1,042 | 2,697 | 1,143 |
| Income tax benefit (expense) | 551 | 2,651 | (1,238) |
| Ending Balance | (18,789) | (18,687) | (11,213) |
| Interest rate remeasurement of Liability for Future Policy Benefits | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | 17,306 | 8,547 | 15,242 |
| Total amount recorded in AOCI | 5,385 | 11,804 | (8,770) |
| Amounts reclassified from AOCI | 0 | 0 | 0 |
| Income tax benefit (expense) | (1,652) | (3,045) | 2,075 |
| Ending Balance | 21,039 | 17,306 | 8,547 |
| Gains (losses) from Changes in Non-performance Risk on Market Risk Benefits | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | 532 | 900 | 1,448 |
| Total amount recorded in AOCI | (195) | (466) | (693) |
| Amounts reclassified from AOCI | 0 | 0 | 0 |
| Income tax benefit (expense) | 41 | 98 | 145 |
| Ending Balance | 378 | 532 | 900 |
| Pension and Postretirement Unrecognized Net Periodic Benefit (Cost) | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | (2,247) | (2,052) | (2,028) |
| Total amount recorded in AOCI | (372) | (234) | (98) |
| Amounts reclassified from AOCI | 26 | 30 | 71 |
| Income tax benefit (expense) | 71 | 9 | 3 |
| Ending Balance | (2,522) | (2,247) | (2,052) |
| Accumulated Other Comprehensive Income (Loss) | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | (6,711) | (6,504) | (3,806) |
| Total amount recorded in AOCI | 3,622 | (2,529) | (4,731) |
| Amounts reclassified from AOCI | 1,015 | 2,686 | 1,196 |
| Income tax benefit (expense) | (1,003) | (364) | 837 |
| Ending Balance | (3,077) | (6,711) | (6,504) |
| Net unrealized gains (losses) on all other investments | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | (27,287) | (17,179) | (24,959) |
| Ending Balance | (26,641) | (27,287) | (17,179) |
| Cash flow hedges | Net Unrealized Investment Gains (Losses) | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | 1,780 | 869 | |
| Ending Balance | (231) | 1,780 | 869 |
| Fair value hedges | Net Unrealized Investment Gains (Losses) | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | (64) | (60) | |
| Ending Balance | $ (123) | $ (64) | $ (60) |
Equity (Reclassifications out of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||
| Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||||||
| Realized investment gains (losses), net | [1],[2] | $ (4,132) | $ (3,429) | $ (3,615) | |||
| Other income (loss) | [1] | 4,426 | 3,037 | 4,065 | |||
| Total Foreign Currency Translation Adjustment | |||||||
| Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||||||
| Total amount reclassified from AOCI to income | 53 | 41 | 18 | ||||
| Net Unrealized Investment Gains (Losses) | |||||||
| Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||||||
| Total amount reclassified from AOCI to income | (1,042) | (2,697) | (1,143) | ||||
| Total amortization of defined benefit pension items | |||||||
| Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||||||
| Total amount reclassified from AOCI to income | (26) | (30) | (71) | ||||
| Accumulated Other Comprehensive Income (Loss) | |||||||
| Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||||||
| Total amount reclassified from AOCI to income | (1,015) | (2,686) | (1,196) | ||||
| Amounts reclassified from AOCI | |||||||
| Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||||||
| Realized investment gains (losses), net | 44 | 41 | 18 | ||||
| Other income (loss) | $ 9 | $ 0 | $ 0 | ||||
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Amortization of Prior Service Cost (Credit), Statement of Income or Comprehensive Income [Extensible Enumeration] | General and Administrative Expense | General and Administrative Expense | General and Administrative Expense | ||||
| Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] | General and Administrative Expense | General and Administrative Expense | General and Administrative Expense | ||||
| Amortization of defined benefit items: | |||||||
| Prior service cost | $ 68 | $ 68 | $ 8 | ||||
| Actuarial gain (loss) | (94) | (98) | (79) | ||||
| Amounts reclassified from AOCI | Total Foreign Currency Translation Adjustment | |||||||
| Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||||||
| Total amount reclassified from AOCI to income | 53 | 41 | 18 | ||||
| Amounts reclassified from AOCI | Net Unrealized Investment Gains (Losses) | |||||||
| Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||||||
| Total amount reclassified from AOCI to income | (1,042) | (2,697) | (1,143) | ||||
| Amounts reclassified from AOCI | Total amortization of defined benefit pension items | |||||||
| Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||||||
| Total amount reclassified from AOCI to income | (26) | (30) | (71) | ||||
| Amounts reclassified from AOCI | Accumulated Other Comprehensive Income (Loss) | |||||||
| Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||||||
| Total amount reclassified from AOCI to income | (1,015) | (2,686) | (1,196) | ||||
| Amounts reclassified from AOCI | Net unrealized investment gains (losses) on available-for-sale securities | |||||||
| Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||||||
| Net unrealized investment gains (losses) | (900) | (3,272) | (1,311) | ||||
| Amounts reclassified from AOCI | Interest Rate | Cash Flow Hedges | |||||||
| Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||||||
| Net unrealized investment gains (losses) | (13) | (30) | (38) | ||||
| Amounts reclassified from AOCI | Currency | Cash Flow Hedges | |||||||
| Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||||||
| Net unrealized investment gains (losses) | (8) | 3 | 14 | ||||
| Amounts reclassified from AOCI | Currency | Fair value hedges | |||||||
| Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||||||
| Net unrealized investment gains (losses) | (14) | (10) | (8) | ||||
| Amounts reclassified from AOCI | Currency/Interest Rate | Cash Flow Hedges | |||||||
| Reclassification Adjustment Out Of Accumulated Other Comprehensive Income [Line Items] | |||||||
| Net unrealized investment gains (losses) | $ (107) | $ 612 | $ 200 | ||||
| |||||||
Equity (Net Unrealized Investment Gains (Losses) in AOCI on AFS Fixed Maturity Securities with OTTI, Allowance for Credit Losses and All Other Investments) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | $ 28,187 | $ 28,110 | $ 30,934 |
| Ending Balance | 32,787 | 28,187 | 28,110 |
| Net Unrealized Investment Gain (Loss) on AFS Fixed Maturity Securities With AllowancePre Tax | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | 6 | (72) | (45) |
| Net investment gains (losses) on investments arising during the period | (6) | (24) | 15 |
| Reclassification adjustment for (gains) losses included in net income | (4) | 97 | (3) |
| Reclassification due to allowance for credit losses recorded during the period | (39) | ||
| Reclassification due to allowance for credit losses recorded during the period | 5 | ||
| Ending Balance | (4) | 6 | (72) |
| Net unrealized gains (losses) on all other investments | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | (27,287) | (17,179) | (24,959) |
| Net investment gains (losses) on investments arising during the period | (400) | (12,703) | 6,595 |
| Reclassification adjustment for (gains) losses included in net income | 1,046 | 2,600 | 1,146 |
| Reclassification due to allowance for credit losses recorded during the period | 39 | ||
| Reclassification due to allowance for credit losses recorded during the period | (5) | ||
| Ending Balance | (26,641) | (27,287) | (17,179) |
| Reinsurance Recoverables | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | (269) | (484) | (703) |
| Impact of net unrealized investment (gains) losses | 101 | 215 | 219 |
| Ending Balance | (168) | (269) | (484) |
| Future Policy Benefits, Policyholders’ Account Balances and Reinsurance Payables | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | 981 | 1,306 | 1,946 |
| Impact of net unrealized investment (gains) losses | (358) | (325) | (640) |
| Ending Balance | 623 | 981 | 1,306 |
| Policyholders' Dividends | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | 2,096 | 2,081 | 3,194 |
| Impact of net unrealized investment (gains) losses | (1,032) | 15 | (1,113) |
| Ending Balance | 1,064 | 2,096 | 2,081 |
| Income Tax Benefit (Expense) | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | 5,786 | 3,135 | 4,373 |
| Net investment gains (losses) on investments arising during the period | (179) | 3,339 | (1,327) |
| Reclassification adjustment for (gains) losses included in net income | 459 | (708) | (229) |
| Reclassification due to allowance for credit losses recorded during the period | 0 | ||
| Reclassification due to allowance for credit losses recorded during the period | 0 | ||
| Impact of net unrealized investment (gains) losses | 271 | 20 | 318 |
| Ending Balance | 6,337 | 5,786 | 3,135 |
| Accumulated Other Comprehensive Income (Loss) Related to Net Unrealized Investment Gains (Losses) | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | (18,687) | (11,213) | (16,194) |
| Net investment gains (losses) on investments arising during the period | (585) | (9,388) | 5,283 |
| Reclassification adjustment for (gains) losses included in net income | 1,501 | 1,989 | 914 |
| Reclassification due to allowance for credit losses recorded during the period | 0 | ||
| Reclassification due to allowance for credit losses recorded during the period | 0 | ||
| Impact of net unrealized investment (gains) losses | (1,018) | (75) | (1,216) |
| Ending Balance | (18,789) | (18,687) | (11,213) |
| Additional Paid-in Capital | |||
| Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward] | |||
| Beginning Balance | 25,901 | 25,746 | 25,747 |
| Ending Balance | $ 26,013 | $ 25,901 | $ 25,746 |
Equity (Statutory Financial Information) (Details) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2025
USD ($)
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
|
| Prudential Insurance | |||
| Statutory Accounting Practices [Line Items] | |||
| Statutory net income (loss) | $ 1,951 | $ 1,245 | $ 1,732 |
| Statutory capital and surplus | $ 15,907 | $ 15,790 | $ 16,085 |
| Gibraltar Life [Member] | |||
| Statutory Accounting Practices [Line Items] | |||
| Statutory Accounting Practices Risk Based Capital Requirements Compliance Ratio Multiple | 3.5 | ||
| Japan Permitted Percentage of Statutory Earnings w/o approval | 83.00% | ||
| POJ | |||
| Statutory Accounting Practices [Line Items] | |||
| Statutory Accounting Practices Risk Based Capital Requirements Compliance Ratio Multiple | 3.5 | ||
| Japan Permitted Percentage of Statutory Earnings w/o approval | 83.00% | ||
| Permitted to be paid in 2026 | Prudential Insurance | |||
| Statutory Accounting Practices [Line Items] | |||
| Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval | $ 1,848 | ||
| Permitted to be paid, after September 24, 2026 | Prudential Insurance | |||
| Statutory Accounting Practices [Line Items] | |||
| Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval | 648 | ||
| Permitted to be paid, after December 25, 2026 | Prudential Insurance | |||
| Statutory Accounting Practices [Line Items] | |||
| Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval | $ 1,200 | ||
Equity (Dividends Declared) (Details) - $ / shares |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Equity [Abstract] | |||
| Dividends declared per share of Common Stock (in dollars per share) | $ 5.40 | $ 5.20 | $ 5.00 |
Earnings Per Share (Narrative) (Details) - shares shares in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Debt Instrument [Line Items] | |||
| Undistributed earnings allocated to participating unvested share-based payment awards, weighted outstanding shares | 3.8 | 4.0 | 4.1 |
Earnings Per Share (Reconciliation of the Numerators and Denominators of the Basic and Diluted Per Share) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Basic earnings per share | |||
| Net income (loss) | $ 3,732 | $ 2,846 | $ 2,508 |
| Less: Dividends and undistributed earnings allocated to participating unvested share-based payment awards | 41 | 32 | 29 |
| Net income (loss) attributable to Prudential Financial available to holders of Common Stock, Basic Income | $ 3,535 | $ 2,695 | $ 2,459 |
| Net income (loss) attributable to Prudential Financial available to holders of Common Stock, Basic Weighted Average Shares | 351.8 | 357.5 | 363.5 |
| Net income (loss) attributable to Prudential Financial available to holders of Common Stock, Basic Per Share Amount | $ 10.05 | $ 7.54 | $ 6.76 |
| Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] | |||
| Add: Dividends and undistributed earnings allocated to participating unvested share-based payment awards—Basic | $ 41 | $ 32 | $ 29 |
| Less: Dividends and undistributed earnings allocated to participating unvested share-based payment awards—Diluted | $ 41 | $ 32 | $ 29 |
| Stock options, Weighted Average Shares | 0.1 | 0.3 | 0.2 |
| Deferred and long-term compensation programs (in shares) | 1.8 | 1.5 | 0.9 |
| Diluted earnings per share | |||
| Net income (loss) attributable to Prudential Financial available to holders of Common Stock, Diluted Income | $ 3,535 | $ 2,695 | $ 2,459 |
| Net income (loss) attributable to Prudential Financial available to holders of Common Stock, Diluted Weighted Average Shares | 353.7 | 359.3 | 364.6 |
| Net income (loss) attributable to Prudential Financial available to holders of Common Stock, Diluted Per Share Amount | $ 9.99 | $ 7.50 | $ 6.74 |
| Less: Income (loss) attributable to noncontrolling interests and redeemable noncontrolling interests | $ 156 | $ 119 | $ 20 |
Earnings Per Share (Antidilutive Securities Excluded From the Computation of Diluted Earnings Per Share) (Details) - $ / shares shares in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
| Weighted average shares of antidilutive security excluded from computation of diluted earnings per share (in shares) | 0.1 | 0.1 | 1.3 |
| Antidilutive stock options based on application of the treasury stock method | |||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
| Weighted average shares of antidilutive security excluded from computation of diluted earnings per share (in shares) | 0.1 | 0.1 | 1.2 |
| Weighted average exercise price of options excluded from computation of diluted earnings per share (in dollars per share) | $ 109.02 | $ 110.42 | $ 102.63 |
| Antidilutive stock options due to net loss available to holders of Common Stock | |||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
| Weighted average shares of antidilutive security excluded from computation of diluted earnings per share (in shares) | 0.0 | 0.0 | 0.0 |
| Antidilutive shares based on application of the treasury stock method | |||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
| Weighted average shares of antidilutive security excluded from computation of diluted earnings per share (in shares) | 0.0 | 0.0 | 0.1 |
| Antidilutive shares due to net loss available to holders of Common Stock | |||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | |||
| Weighted average shares of antidilutive security excluded from computation of diluted earnings per share (in shares) | 0.0 | 0.0 | 0.0 |
Share-Based Payments (Narrative) (Details) $ / shares in Units, $ in Millions |
12 Months Ended | |||
|---|---|---|---|---|
|
Jan. 10, 2024
USD ($)
employee
plan
shares
|
Dec. 31, 2025
USD ($)
$ / shares
Rate
shares
|
Dec. 31, 2024
USD ($)
$ / shares
shares
|
Dec. 31, 2023
USD ($)
$ / shares
shares
|
|
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Tax benefit realized for exercises of stock options | $ 1 | $ 3 | $ 2 | |
| Tax benefit realized upon vesting of restricted stock shares, restricted stock units, and performance shares | 54 | 60 | 77 | |
| Total Compensation Cost Recognized | 257 | 314 | 254 | |
| Omnibus Incentive Plan | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Unrecognized compensation cost for stock options | 0 | |||
| Assurance IQ | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Tax benefit realized for exercises of stock options | 1 | 1 | 1 | |
| Unrecognized compensation cost for stock options | 0 | |||
| Total Compensation Cost Recognized | $ 0 | 0 | 3 | |
| Omnibus Incentive Plan | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Authorized shares remain available for grant including previously authorized but unissued shares under the Option Plan | shares | 12,496,717 | |||
| Employee stock options | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Maximum term of stock option granted (in years) | 10 years | |||
| Vesting period | 3 years | |||
| The total intrinsic value of stock options exercised | $ 2 | $ 26 | $ 8 | |
| Granted (in shares) | shares | 0 | 0 | 0 | |
| Total Compensation Cost Recognized | $ 0 | $ 0 | $ 0 | |
| Employee stock options | Share-Based Payment Arrangement, Tranche One | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Award vesting rights, percentage | Rate | 33.00% | |||
| Employee stock options | Share-Based Payment Arrangement, Tranche Two | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Award vesting rights, percentage | Rate | 33.00% | |||
| Employee stock options | Share-Based Payment Arrangement, Tranche Three | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Award vesting rights, percentage | Rate | 33.00% | |||
| Employee stock options | Assurance IQ | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Maximum term of stock option granted (in years) | 10 years | |||
| Vesting period | 3 years | |||
| The total intrinsic value of stock options exercised | $ 1 | 2 | 3 | |
| Granted (in shares) | shares | 0 | |||
| Total Compensation Cost Recognized | $ 0 | 0 | 2 | |
| Employee Restricted Stock Restricted Units And Performance Shares | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| The fair market value of share awards released | 269 | 302 | 360 | |
| Unrecognized Compensation Cost | $ 169 | |||
| Weighted Average Recognition Period (in years) | 1 year 9 months 3 days | |||
| Employee Restricted Stock Restricted Units And Performance Shares | Assurance IQ | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| The fair market value of share awards released | $ 0 | $ 1 | $ 1 | |
| Employee restricted stock units | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Granted (in dollars per share) | $ / shares | $ 108.42 | $ 102.66 | $ 102.64 | |
| Award restriction period | 3 years | |||
| Granted (in shares) | shares | 1,952,680 | |||
| Total Compensation Cost Recognized | $ 200 | $ 200 | $ 200 | |
| Employee restricted stock units | Share-Based Payment Arrangement, Tranche One | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Award restrictions, percentage | 33.00% | |||
| Employee restricted stock units | Share-Based Payment Arrangement, Tranche Two | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Award restrictions, percentage | 33.00% | |||
| Employee restricted stock units | Share-Based Payment Arrangement, Tranche Three | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Award restrictions, percentage | Rate | 33.00% | |||
| Employee restricted stock units | Assurance IQ | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Granted (in dollars per share) | $ / shares | $ 0 | $ 0 | $ 0 | |
| Unrecognized compensation cost not including stock options | $ 0 | |||
| Total Compensation Cost Recognized | $ 0 | $ 0 | $ 1 | |
| Employee performance shares and performance units | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Granted (in dollars per share) | $ / shares | $ 104.93 | $ 97.67 | $ 103.27 | |
| Number of employees to receive shares from plan modifications | employee | 161 | |||
| Number of performance plans affected by plan modifications | plan | 3 | |||
| Granted (in shares) | shares | 734,808 | |||
| Total Compensation Cost Recognized | $ 62 | $ 57 | $ 114 | $ 54 |
| Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period | shares | 600,000 | |||
| Employee performance shares and performance units | Assurance IQ | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Tax benefit realized upon vesting of restricted stock shares, restricted stock units, and performance shares | 0 | 1 | 1 | |
| Total Compensation Cost Recognized | $ 0 | $ 0 | $ 0 | |
Share-Based Payments (Compensation Cost Recognized and Related Income Tax Benefit for Stock Options, Restricted Stock Shares, Restricted Stock Units, and Performance Share Awards) (Details) - USD ($) $ in Millions |
12 Months Ended | |||
|---|---|---|---|---|
Jan. 10, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Total Compensation Cost Recognized | $ 257 | $ 314 | $ 254 | |
| Income Tax Benefit | 59 | 74 | 59 | |
| Assurance IQ | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Total Compensation Cost Recognized | 0 | 0 | 3 | |
| Income Tax Benefit | 0 | 0 | 1 | |
| Employee stock options | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Total Compensation Cost Recognized | 0 | 0 | 0 | |
| Income Tax Benefit | 0 | 0 | 0 | |
| Employee stock options | Assurance IQ | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Total Compensation Cost Recognized | 0 | 0 | 2 | |
| Income Tax Benefit | 0 | 0 | 1 | |
| Employee restricted stock units | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Total Compensation Cost Recognized | 200 | 200 | 200 | |
| Income Tax Benefit | 46 | 47 | 47 | |
| Employee restricted stock units | Assurance IQ | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Total Compensation Cost Recognized | 0 | 0 | 1 | |
| Income Tax Benefit | 0 | 0 | 0 | |
| Employee performance shares and performance units | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Total Compensation Cost Recognized | $ 62 | 57 | 114 | 54 |
| Income Tax Benefit | 13 | 27 | 12 | |
| Employee performance shares and performance units | Assurance IQ | ||||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | ||||
| Total Compensation Cost Recognized | 0 | 0 | 0 | |
| Income Tax Benefit | $ 0 | $ 0 | $ 0 | |
Share-Based Payments (Summary of the Status of the Company's Employee Stock Option Grants) (Details) - Employee stock options - $ / shares |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Shares | |||
| Outstanding (in shares) | 661,895 | ||
| Granted (in shares) | 0 | 0 | 0 |
| Exercised (in shares) | (56,141) | ||
| Forfeited (in shares) | 0 | ||
| Expired (in shares) | (1,314) | ||
| Outstanding (in shares) | 604,440 | 661,895 | |
| Exercisable (in shares) | 604,440 | ||
| Weighted Average Exercise Price | |||
| Outstanding (in dollars per share) | $ 96.00 | ||
| Granted (in dollars per share) | 0.00 | ||
| Exercised (in dollars per share) | 78.42 | ||
| Forfeited (in dollars per share) | 0.00 | ||
| Expired (in dollars per share) | 78.08 | ||
| Outstanding (in dollars per share) | 97.67 | $ 96.00 | |
| Exercisable (in dollars per share) | $ 97.67 | ||
| Assurance IQ | |||
| Shares | |||
| Outstanding (in shares) | 2,171 | ||
| Granted (in shares) | 0 | ||
| Exercised (in shares) | (2,171) | ||
| Forfeited (in shares) | 0 | ||
| Expired (in shares) | 0 | ||
| Outstanding (in shares) | 0 | 2,171 | |
| Exercisable (in shares) | 0 | ||
| Weighted Average Exercise Price | |||
| Outstanding (in dollars per share) | $ 0.09 | ||
| Granted (in dollars per share) | 0.00 | ||
| Exercised (in dollars per share) | 0.09 | ||
| Forfeited (in dollars per share) | 0.00 | ||
| Expired (in dollars per share) | 0.00 | ||
| Outstanding (in dollars per share) | 0.00 | $ 0.09 | |
| Exercisable (in dollars per share) | $ 0.00 | ||
Share-Based Payments (Weighted Average Remaining Contractual Term and Aggregate Intrinsic Value of Stock Options Outstanding, Vested and Expected to Vest, and Exercisable) (Details) - Employee stock options $ in Millions |
12 Months Ended |
|---|---|
|
Dec. 31, 2025
USD ($)
| |
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |
| Outstanding, Weighted Average Remaining Contractual Term | 2 years 6 months 3 days |
| Exercisable, Weighted Average Remaining Contractual Term | 2 years 6 months 3 days |
| Outstanding, Aggregate Intrinsic Value | $ 9 |
| Exercisable, Aggregate Intrinsic Value | $ 9 |
Share-Based Payments (Summary of the Company's Employee Restricted Stock Shares, Restricted Stock Units and Performance Shares (Details) - $ / shares |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Minimum | |||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
| Number of shares to be awarded at the end of each performance period | 0.00% | ||
| Maximum | |||
| Share Based Compensation Arrangement By Share Based Payment Award [Line Items] | |||
| Number of shares to be awarded at the end of each performance period | 150.00% | ||
| Employee restricted stock units | |||
| Restricted Awards | |||
| Restricted (in shares) | 3,919,337 | ||
| Granted (in shares) | 1,952,680 | ||
| Forfeited (in shares) | (229,277) | ||
| Performance adjustment (in shares) | 0 | ||
| Released (in shares) | (1,893,017) | ||
| Restricted (in shares) | 3,749,723 | 3,919,337 | |
| Weighted Average Grant Date Fair Value | |||
| Restricted (in dollars per share) | $ 104.53 | ||
| Granted (in dollars per share) | 108.42 | $ 102.66 | $ 102.64 |
| Forfeited (in dollars per share) | 107.07 | ||
| Performance adjustment (in dollars per share) | 0.00 | ||
| Released (in dollars per share) | 107.52 | ||
| Restricted (in dollars per share) | $ 104.90 | $ 104.53 | |
| Employee performance shares and performance units | |||
| Restricted Awards | |||
| Restricted (in shares) | 1,923,149 | ||
| Granted (in shares) | 734,808 | ||
| Forfeited (in shares) | (53,342) | ||
| Performance adjustment (in shares) | (100,878) | ||
| Released (in shares) | (468,344) | ||
| Restricted (in shares) | 2,035,393 | 1,923,149 | |
| Weighted Average Grant Date Fair Value | |||
| Restricted (in dollars per share) | $ 101.50 | ||
| Granted (in dollars per share) | 104.93 | $ 97.67 | 103.27 |
| Forfeited (in dollars per share) | 107.21 | ||
| Performance adjustment (in dollars per share) | 103.72 | ||
| Released (in dollars per share) | 103.74 | ||
| Restricted (in dollars per share) | 101.96 | 101.50 | |
| Assurance IQ | Employee restricted stock units | |||
| Weighted Average Grant Date Fair Value | |||
| Granted (in dollars per share) | $ 0 | $ 0 | $ 0 |
Segment Information (Narrative) (Details) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Mar. 31, 2025 |
Dec. 31, 2023 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Segment Reporting Information [Line Items] | ||||||
| Total deferred gain (loss) | $ 711 | $ 711 | ||||
| Synthetic Gic Fees | 97 | $ 100 | $ 107 | |||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 4,656 | 3,209 | 3,072 | |||
| Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration] | General and Administrative Expense | General and Administrative Expense | ||||
| Revision of Prior Period, Adjustment | ||||||
| Segment Reporting Information [Line Items] | ||||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | $ (150) | |||||
| Segment Reconciling Items | ||||||
| Segment Reporting Information [Line Items] | ||||||
| Derivative, Gain (Loss) on Derivative, Net, Terminated Or Offset Before Maturity | 123 | 140 | 178 | |||
| Operating Segments | ||||||
| Segment Reporting Information [Line Items] | ||||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 6,637 | 5,926 | 5,599 | |||
| Retirement Strategies | Operating Segments | Individual Retirement Strategies | U.S. Businesses | ||||||
| Segment Reporting Information [Line Items] | ||||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | $ 1,732 | $ 1,763 | $ 1,818 | |||
Segment Information (Operating Income of Reportable Segments) (Reconciling Items) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||
| Segment Reporting Information [Line Items] | |||||
| Premiums | [1] | $ 30,797 | $ 42,897 | $ 27,364 | |
| Insurance Commissions and Fees | 4,666 | 4,298 | 4,527 | ||
| Net Investment Income | 21,473 | 19,909 | 17,865 | ||
| Asset management fees, commissions and other income | 3,838 | 3,301 | 4,223 | ||
| Revenues | 60,774 | 70,405 | 53,979 | ||
| Policyholders’ benefits | [1] | 35,224 | 47,119 | 30,931 | |
| Policyholder Account Balance, Interest Expense | 5,068 | 4,582 | 3,983 | ||
| Amortization expense | [1] | 1,635 | 1,492 | 1,459 | |
| Total Expenses | 35,549 | 22,327 | 14,551 | ||
| Benefits, Losses and Expenses | 56,118 | 67,196 | 50,907 | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 4,656 | 3,209 | 3,072 | ||
| Total Reconciling Items | |||||
| Segment Reporting Information [Line Items] | |||||
| Premiums | 2,206 | 2,152 | 2,140 | ||
| Insurance Commissions and Fees | 256 | 21 | 303 | ||
| Net Investment Income | 2,535 | 2,534 | 2,572 | ||
| Asset management fees, commissions and other income | (1,900) | (2,355) | (1,526) | ||
| Revenues | 3,097 | 2,352 | 3,489 | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | (1,981) | (2,717) | (2,527) | ||
| Realized investment gains (losses), net, and related charges and adjustments | |||||
| Segment Reporting Information [Line Items] | |||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | (1,618) | (2,150) | (2,510) | ||
| Segment Reconciling Items, Change In Value Of Market Risk Benefits, Net Of Related Hedging Gains (Losses) | |||||
| Segment Reporting Information [Line Items] | |||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | (475) | (397) | 56 | ||
| Segment Reconciling Items, Market Experience Updates | |||||
| Segment Reporting Information [Line Items] | |||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 68 | (52) | 110 | ||
| Segment Reconciling Items, Closed Block Division | |||||
| Segment Reporting Information [Line Items] | |||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | (68) | (113) | (100) | ||
| Segment Reconciling Items, Other Divested And Run-Off Business | |||||
| Segment Reporting Information [Line Items] | |||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 107 | 30 | 21 | ||
| Equity in earnings of operating joint ventures and earnings attributable to noncontrolling interests | |||||
| Segment Reporting Information [Line Items] | |||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | (20) | (16) | (68) | ||
| Segment Reconciling Items, Other Adjustments | |||||
| Segment Reporting Information [Line Items] | |||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 25 | (19) | (36) | ||
| International Businesses | |||||
| Segment Reporting Information [Line Items] | |||||
| Policyholder Account Balance, Interest Expense | 2,169 | 1,810 | 1,445 | ||
| Segment Reconciling Items | |||||
| Segment Reporting Information [Line Items] | |||||
| Terminated hedges of foreign currency earnings | 9 | (11) | (32) | ||
| Current period yield adjustments | 199 | 216 | 467 | ||
| Principal source of earnings | 17 | 50 | 1 | ||
| Investments carried at fair value through net income | 692 | (337) | 754 | ||
| Foreign currency exchange movements | 12 | (76) | (123) | ||
| Other Activities | (1) | (1) | (10) | ||
| Operating Segments | |||||
| Segment Reporting Information [Line Items] | |||||
| Premiums | 28,591 | 40,745 | 25,224 | ||
| Insurance Commissions and Fees | 4,410 | 4,277 | 4,224 | ||
| Net Investment Income | 18,938 | 17,375 | 15,293 | ||
| Asset management fees, commissions and other income | 5,738 | 5,656 | 5,749 | ||
| Revenues | 57,677 | 68,053 | 50,490 | ||
| Policyholders’ benefits | 31,899 | 44,018 | 27,937 | ||
| Policyholder Account Balance, Interest Expense | 4,704 | 3,949 | 3,246 | ||
| Interest expense | 2,112 | 2,019 | 1,754 | ||
| Deferred Policy Acquisition Cost, Capitalization | (2,753) | (2,601) | (2,328) | ||
| Amortization expense | 1,571 | 1,445 | 1,417 | ||
| Total Expenses | 6,773 | 6,870 | 7,035 | ||
| Variable Expenses | 6,441 | 6,262 | 5,520 | ||
| Other Expenses | 293 | 165 | 310 | ||
| Benefits, Losses and Expenses | 51,040 | 62,127 | 44,891 | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 6,637 | 5,926 | 5,599 | ||
| Operating Segments | Total Corporate and Other | |||||
| Segment Reporting Information [Line Items] | |||||
| Premiums | (22) | (20) | (16) | ||
| Insurance Commissions and Fees | (60) | (57) | (53) | ||
| Net Investment Income | 1,338 | 1,234 | 730 | ||
| Asset management fees, commissions and other income | (1,060) | (1,063) | (612) | ||
| Revenues | 196 | 94 | 49 | ||
| Policyholders’ benefits | (6) | (19) | (11) | ||
| Policyholder Account Balance, Interest Expense | 54 | 84 | 113 | ||
| Interest expense | 840 | 677 | 639 | ||
| Deferred Policy Acquisition Cost, Capitalization | 144 | 188 | 97 | ||
| Amortization expense | (60) | (56) | (37) | ||
| Total Expenses | 799 | 1,102 | 1,354 | ||
| Variable Expenses | (1) | (99) | (72) | ||
| Other Expenses | 0 | 0 | 0 | ||
| Benefits, Losses and Expenses | 1,770 | 1,877 | 2,083 | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | (1,574) | (1,783) | (2,034) | ||
| Operating Segments | PGIM | PGIM | |||||
| Segment Reporting Information [Line Items] | |||||
| Premiums | 0 | 0 | 0 | ||
| Insurance Commissions and Fees | 0 | 0 | 0 | ||
| Net Investment Income | 181 | 15 | 268 | ||
| Asset management fees, commissions and other income | 4,050 | 4,077 | 3,370 | ||
| Revenues | 4,231 | 4,092 | 3,638 | ||
| Policyholders’ benefits | 0 | 0 | 0 | ||
| Policyholder Account Balance, Interest Expense | 0 | 0 | 0 | ||
| Interest expense | 100 | 105 | 113 | ||
| Deferred Policy Acquisition Cost, Capitalization | 0 | (1) | (2) | ||
| Amortization expense | 0 | 2 | 2 | ||
| Total Expenses | 1,973 | 1,841 | 1,771 | ||
| Variable Expenses | 1,280 | 1,270 | 1,041 | ||
| Other Expenses | 0 | 0 | 0 | ||
| Benefits, Losses and Expenses | 3,353 | 3,217 | 2,925 | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 878 | 875 | 713 | ||
| Operating Segments | U.S. Businesses Division | Retirement Strategies | Institutional Retirement Strategies | |||||
| Segment Reporting Information [Line Items] | |||||
| Premiums | 10,987 | 22,947 | 6,342 | ||
| Insurance Commissions and Fees | 30 | 33 | 33 | ||
| Net Investment Income | 5,150 | 4,674 | 4,180 | ||
| Asset management fees, commissions and other income | 490 | 541 | 475 | ||
| Revenues | 16,657 | 28,195 | 11,030 | ||
| Policyholders’ benefits | 13,501 | 25,752 | 8,759 | ||
| Policyholder Account Balance, Interest Expense | 817 | 664 | 552 | ||
| Interest expense | 60 | 31 | 1 | ||
| Deferred Policy Acquisition Cost, Capitalization | (95) | (80) | (75) | ||
| Amortization expense | 24 | 11 | 16 | ||
| Total Expenses | 273 | 231 | 199 | ||
| Variable Expenses | 106 | 106 | 84 | ||
| Other Expenses | 258 | (376) | (201) | ||
| Benefits, Losses and Expenses | 14,944 | 26,339 | 9,335 | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 1,713 | 1,856 | 1,695 | ||
| Operating Segments | U.S. Businesses Division | Retirement Strategies | Individual Retirement Strategies | |||||
| Segment Reporting Information [Line Items] | |||||
| Premiums | 78 | 76 | 86 | ||
| Insurance Commissions and Fees | 1,125 | 1,234 | 1,247 | ||
| Net Investment Income | 2,855 | 2,110 | 1,454 | ||
| Asset management fees, commissions and other income | 1,483 | 1,705 | 1,745 | ||
| Revenues | 5,541 | 5,125 | 4,532 | ||
| Policyholders’ benefits | 264 | 141 | 134 | ||
| Policyholder Account Balance, Interest Expense | 1,455 | 1,039 | 560 | ||
| Interest expense | 52 | 84 | 72 | ||
| Deferred Policy Acquisition Cost, Capitalization | (668) | (641) | (379) | ||
| Amortization expense | 472 | 394 | 349 | ||
| Total Expenses | 580 | 578 | 552 | ||
| Variable Expenses | 1,635 | 1,759 | 1,418 | ||
| Other Expenses | 19 | 8 | 8 | ||
| Benefits, Losses and Expenses | 3,809 | 3,362 | 2,714 | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 1,732 | 1,763 | 1,818 | ||
| Operating Segments | U.S. Businesses Division | Group Insurance | |||||
| Segment Reporting Information [Line Items] | |||||
| Premiums | 5,419 | 5,129 | 5,024 | ||
| Insurance Commissions and Fees | 728 | 678 | 674 | ||
| Net Investment Income | 543 | 530 | 512 | ||
| Asset management fees, commissions and other income | 84 | 90 | 75 | ||
| Revenues | 6,774 | 6,427 | 6,285 | ||
| Policyholders’ benefits | 5,022 | 4,801 | 4,703 | ||
| Policyholder Account Balance, Interest Expense | 137 | 149 | 166 | ||
| Interest expense | 21 | 11 | 8 | ||
| Deferred Policy Acquisition Cost, Capitalization | (4) | (28) | (3) | ||
| Amortization expense | 9 | 6 | 9 | ||
| Total Expenses | 751 | 734 | 743 | ||
| Variable Expenses | 457 | 440 | 340 | ||
| Other Expenses | 0 | 0 | 0 | ||
| Benefits, Losses and Expenses | 6,393 | 6,113 | 5,966 | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 381 | 314 | 319 | ||
| Operating Segments | U.S. Businesses Division | Individual Life | |||||
| Segment Reporting Information [Line Items] | |||||
| Premiums | 936 | 957 | 969 | ||
| Insurance Commissions and Fees | 2,207 | 2,065 | 2,015 | ||
| Net Investment Income | 2,842 | 3,089 | 2,860 | ||
| Asset management fees, commissions and other income | 145 | 84 | 430 | ||
| Revenues | 6,130 | 6,195 | 6,274 | ||
| Policyholders’ benefits | 2,920 | 3,095 | 3,295 | ||
| Policyholder Account Balance, Interest Expense | 733 | 803 | 912 | ||
| Interest expense | 1,036 | 1,113 | 898 | ||
| Deferred Policy Acquisition Cost, Capitalization | (933) | (901) | (768) | ||
| Amortization expense | 433 | 442 | 456 | ||
| Total Expenses | 529 | 591 | 481 | ||
| Variable Expenses | 1,173 | 1,125 | 981 | ||
| Other Expenses | (21) | 132 | 114 | ||
| Benefits, Losses and Expenses | 5,870 | 6,400 | 6,369 | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 260 | (205) | (95) | ||
| Operating Segments | International Businesses | International Businesses | |||||
| Segment Reporting Information [Line Items] | |||||
| Premiums | 11,193 | 11,656 | 12,819 | ||
| Insurance Commissions and Fees | 380 | 324 | 308 | ||
| Net Investment Income | 6,029 | 5,723 | 5,289 | ||
| Asset management fees, commissions and other income | 546 | 222 | 266 | ||
| Revenues | 18,148 | 17,925 | 18,682 | ||
| Policyholders’ benefits | 10,198 | 10,248 | 11,057 | ||
| Policyholder Account Balance, Interest Expense | 1,508 | 1,210 | 943 | ||
| Interest expense | 3 | (2) | 23 | ||
| Deferred Policy Acquisition Cost, Capitalization | (1,197) | (1,138) | (1,198) | ||
| Amortization expense | 693 | 646 | 622 | ||
| Total Expenses | 1,868 | 1,793 | 1,935 | ||
| Variable Expenses | 1,791 | 1,661 | 1,728 | ||
| Other Expenses | 37 | 401 | 389 | ||
| Benefits, Losses and Expenses | 14,901 | 14,819 | 15,499 | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | $ 3,247 | $ 3,106 | $ 3,183 | ||
| |||||
Segment Information (Certain Financial Information for the Reportable Segments) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||
| Segment Reporting Information [Line Items] | |||||
| Number Of Reportable Segments Not Disclosed Flag | segments | ||||
| Total assets | $ 773,740 | $ 735,587 | |||
| Revenues | 60,774 | 70,405 | $ 53,979 | ||
| Net Investment Income | 21,473 | 19,909 | 17,865 | ||
| Total Benefits and Expenses | 56,118 | 67,196 | 50,907 | ||
| Policyholders’ Benefits | [1] | 35,224 | 47,119 | 30,931 | |
| Interest credited to policyholders’ account balances | 5,068 | 4,582 | 3,983 | ||
| Amortization of deferred policy acquisition costs | [1] | 1,635 | 1,492 | 1,459 | |
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 4,656 | 3,209 | 3,072 | ||
| International Businesses | |||||
| Segment Reporting Information [Line Items] | |||||
| Interest credited to policyholders’ account balances | 2,169 | 1,810 | 1,445 | ||
| Operating Segments | |||||
| Segment Reporting Information [Line Items] | |||||
| Revenues | 57,677 | 68,053 | 50,490 | ||
| Net Investment Income | 18,938 | 17,375 | 15,293 | ||
| Total Benefits and Expenses | 51,040 | 62,127 | 44,891 | ||
| Policyholders’ Benefits | 31,899 | 44,018 | 27,937 | ||
| Interest credited to policyholders’ account balances | 4,704 | 3,949 | 3,246 | ||
| Interest expense | 2,112 | 2,019 | 1,754 | ||
| Amortization of deferred policy acquisition costs | 1,571 | 1,445 | 1,417 | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 6,637 | 5,926 | 5,599 | ||
| Operating Segments | Total U.S. Businesses | |||||
| Segment Reporting Information [Line Items] | |||||
| Total assets | 468,873 | 438,923 | |||
| Operating Segments | International Businesses | International Businesses | |||||
| Segment Reporting Information [Line Items] | |||||
| Total assets | 187,770 | 180,038 | |||
| Operating Segments | PGIM | PGIM | |||||
| Segment Reporting Information [Line Items] | |||||
| Total assets | 39,103 | 36,044 | |||
| Operating Segments | Retirement Strategies | U.S. Businesses Division | |||||
| Segment Reporting Information [Line Items] | |||||
| Total assets | 296,440 | 276,993 | |||
| Operating Segments | Retirement Strategies | U.S. Businesses Division | Individual Retirement Strategies | |||||
| Segment Reporting Information [Line Items] | |||||
| Total assets | 161,309 | 150,151 | |||
| Revenues | 5,541 | 5,125 | 4,532 | ||
| Net Investment Income | 2,855 | 2,110 | 1,454 | ||
| Total Benefits and Expenses | 3,809 | 3,362 | 2,714 | ||
| Policyholders’ Benefits | 264 | 141 | 134 | ||
| Interest credited to policyholders’ account balances | 1,455 | 1,039 | 560 | ||
| Interest expense | 52 | 84 | 72 | ||
| Amortization of deferred policy acquisition costs | 472 | 394 | 349 | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 1,732 | 1,763 | 1,818 | ||
| Operating Segments | Retirement Strategies | U.S. Businesses Division | Institutional Retirement Strategies | |||||
| Segment Reporting Information [Line Items] | |||||
| Total assets | 135,131 | 126,842 | |||
| Revenues | 16,657 | 28,195 | 11,030 | ||
| Net Investment Income | 5,150 | 4,674 | 4,180 | ||
| Total Benefits and Expenses | 14,944 | 26,339 | 9,335 | ||
| Policyholders’ Benefits | 13,501 | 25,752 | 8,759 | ||
| Interest credited to policyholders’ account balances | 817 | 664 | 552 | ||
| Interest expense | 60 | 31 | 1 | ||
| Amortization of deferred policy acquisition costs | 24 | 11 | 16 | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 1,713 | 1,856 | 1,695 | ||
| Operating Segments | Group Insurance | U.S. Businesses Division | |||||
| Segment Reporting Information [Line Items] | |||||
| Total assets | 41,292 | 39,340 | |||
| Revenues | 6,774 | 6,427 | 6,285 | ||
| Net Investment Income | 543 | 530 | 512 | ||
| Total Benefits and Expenses | 6,393 | 6,113 | 5,966 | ||
| Policyholders’ Benefits | 5,022 | 4,801 | 4,703 | ||
| Interest credited to policyholders’ account balances | 137 | 149 | 166 | ||
| Interest expense | 21 | 11 | 8 | ||
| Amortization of deferred policy acquisition costs | 9 | 6 | 9 | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 381 | 314 | 319 | ||
| Operating Segments | Individual Life | U.S. Businesses Division | |||||
| Segment Reporting Information [Line Items] | |||||
| Total assets | 131,141 | 122,590 | |||
| Revenues | 6,130 | 6,195 | 6,274 | ||
| Net Investment Income | 2,842 | 3,089 | 2,860 | ||
| Total Benefits and Expenses | 5,870 | 6,400 | 6,369 | ||
| Policyholders’ Benefits | 2,920 | 3,095 | 3,295 | ||
| Interest credited to policyholders’ account balances | 733 | 803 | 912 | ||
| Interest expense | 1,036 | 1,113 | 898 | ||
| Amortization of deferred policy acquisition costs | 433 | 442 | 456 | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 260 | (205) | (95) | ||
| Operating Segments | International Businesses | International Businesses | |||||
| Segment Reporting Information [Line Items] | |||||
| Revenues | 18,148 | 17,925 | 18,682 | ||
| Net Investment Income | 6,029 | 5,723 | 5,289 | ||
| Total Benefits and Expenses | 14,901 | 14,819 | 15,499 | ||
| Policyholders’ Benefits | 10,198 | 10,248 | 11,057 | ||
| Interest credited to policyholders’ account balances | 1,508 | 1,210 | 943 | ||
| Interest expense | 3 | (2) | 23 | ||
| Amortization of deferred policy acquisition costs | 693 | 646 | 622 | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 3,247 | 3,106 | 3,183 | ||
| Operating Segments | Total Corporate and Other | |||||
| Segment Reporting Information [Line Items] | |||||
| Revenues | 196 | 94 | 49 | ||
| Net Investment Income | 1,338 | 1,234 | 730 | ||
| Total Benefits and Expenses | 1,770 | 1,877 | 2,083 | ||
| Policyholders’ Benefits | (6) | (19) | (11) | ||
| Interest credited to policyholders’ account balances | 54 | 84 | 113 | ||
| Interest expense | 840 | 677 | 639 | ||
| Amortization of deferred policy acquisition costs | (60) | (56) | (37) | ||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | (1,574) | (1,783) | $ (2,034) | ||
| Segment Reconciling Items | Total Corporate and Other | |||||
| Segment Reporting Information [Line Items] | |||||
| Total assets | 29,899 | 31,767 | |||
| Segment Reporting, Reconciling Item, Corporate Nonsegment | Closed Block division | |||||
| Segment Reporting Information [Line Items] | |||||
| Total assets | $ 48,095 | $ 48,815 | |||
| |||||
Segment Information (Revenues and Asset Management Revenues) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||
| Segment Reporting Information [Line Items] | |||||
| Asset management and service fees | [1] | $ 4,019 | $ 4,090 | $ 3,717 | |
| Revenues | 60,774 | 70,405 | 53,979 | ||
| PGIM | Intersegment Eliminations | |||||
| Segment Reporting Information [Line Items] | |||||
| Revenues | 905 | 837 | 796 | ||
| United States | |||||
| Segment Reporting Information [Line Items] | |||||
| Revenues | 36,801 | 48,568 | 31,031 | ||
| Japan | |||||
| Segment Reporting Information [Line Items] | |||||
| Revenues | 13,487 | 13,760 | 15,538 | ||
| Other Countries | |||||
| Segment Reporting Information [Line Items] | |||||
| Revenues | 10,486 | 8,077 | 7,410 | ||
| Management Service, Base | |||||
| Segment Reporting Information [Line Items] | |||||
| Asset management and service fees | 3,440 | 3,386 | 3,169 | ||
| Management Service, Incentive | |||||
| Segment Reporting Information [Line Items] | |||||
| Asset management and service fees | 94 | 198 | 45 | ||
| Financial Service, Other | |||||
| Segment Reporting Information [Line Items] | |||||
| Asset management and service fees | $ 485 | $ 506 | $ 503 | ||
| |||||
Related Party Transactions - Narrative (Details) - USD ($) $ in Millions |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Nov. 30, 2025 |
Mar. 31, 2025 |
Dec. 31, 2024 |
Sep. 30, 2024 |
Dec. 31, 2023 |
Sep. 30, 2023 |
|
| Related Party Transaction [Line Items] | |||||||
| Future policy benefits | $ 266,914 | $ 268,912 | $ 273,281 | ||||
| Guarantee on letters of credit | 2,300 | ||||||
| Prismic Re International | |||||||
| Related Party Transaction [Line Items] | |||||||
| Future policy benefits | $ 7,000 | ||||||
| Contingent debt facility | $ 80 | ||||||
| Contingent Debt Facility | |||||||
| Related Party Transaction [Line Items] | |||||||
| Related Party Transaction, Term | 10 years | ||||||
| Related Party | |||||||
| Related Party Transaction [Line Items] | |||||||
| Future policy benefits | $ 9,000 | ||||||
| Guarantee on letters of credit | $ 2,000 | $ 2,000 | |||||
| Prismic Re Unfunded Commitment | $ 320 | ||||||
| Prismic HoldCo | |||||||
| Related Party Transaction [Line Items] | |||||||
| Equity Method Investment, Ownership Percentage | 20.00% | 20.00% | |||||
| Prismic HoldCo | Prismic Re International | |||||||
| Related Party Transaction [Line Items] | |||||||
| Carrying value | $ 103 | ||||||
| Prismic HoldCo | Related Party | |||||||
| Related Party Transaction [Line Items] | |||||||
| Equity Method Investment, Ownership Percentage | 20.00% | 20.00% | 20.00% | 20.00% | |||
| Prismic HoldCo | Related Party | |||||||
| Related Party Transaction [Line Items] | |||||||
| Carrying value | $ 200 | $ 200 | $ 200 |
Related Party Transactions - The Company’s Related Party Balances with Prismic (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
||||
|---|---|---|---|---|---|---|
| Related Party Transaction [Line Items] | ||||||
| Other assets | [1],[2] | $ 15,009 | $ 13,737 | |||
| Accumulated other comprehensive income (loss) | [1] | (3,077) | (6,711) | |||
| Reinsurance and funds withheld payables, embedded derivatives at fair value | 174 | (118) | ||||
| Related Party | ||||||
| Related Party Transaction [Line Items] | ||||||
| Reinsurance Recoverables, Gross | 15,581 | 9,084 | ||||
| Other assets | 162 | 187 | ||||
| Reinsurance and funds withheld payables (includes $194 and $(91) of embedded derivatives at fair value at December 31, 2024 and 2023, respectively) | 7,980 | 7,796 | ||||
| Accumulated other comprehensive income (loss) | (128) | (139) | ||||
| Reinsurance and funds withheld payables, embedded derivatives at fair value | $ 194 | $ (91) | ||||
| ||||||
Related Party Transactions - The Initial and Ongoing Reinsurance Activity with Prismic Re of Operations (Details) - USD ($) $ in Millions |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||
| Related Party Transaction [Line Items] | |||||||
| Premiums | [1] | $ 30,797 | $ 42,897 | $ 27,364 | |||
| Asset management and service fees | [1] | 4,019 | 4,090 | 3,717 | |||
| Other income (loss) | [1] | 4,426 | 3,037 | 4,065 | |||
| Realized Investment Gains (Losses) | [1],[2] | (4,132) | (3,429) | (3,615) | |||
| Policyholders’ benefits | [1] | (35,224) | (47,119) | (30,931) | |||
| Change in estimates of liability for future policy benefits | [1] | (103) | 37 | (337) | |||
| Amortization of deferred policy acquisition costs | [1] | 1,635 | 1,492 | 1,459 | |||
| General and administrative expenses | [1] | 13,012 | 13,342 | 12,951 | |||
| Income (loss) from related parties, before income taxes | 4,656 | 3,209 | 3,072 | ||||
| Other Comprehensive Income (Loss), before tax | 3,634 | (207) | (2,698) | ||||
| Prudential Financial | |||||||
| Related Party Transaction [Line Items] | |||||||
| Other income (loss) | 20 | 17 | 14 | ||||
| Realized Investment Gains (Losses) | 7 | (2) | (4) | ||||
| Income (loss) from related parties, before income taxes | (784) | (703) | (692) | ||||
| Related Party | |||||||
| Related Party Transaction [Line Items] | |||||||
| Premiums | (19) | 6 | (4,811) | ||||
| Asset management and service fees | 61 | 38 | 10 | ||||
| Other income (loss) | 353 | 150 | 52 | ||||
| Realized Investment Gains (Losses) | (509) | 255 | (491) | ||||
| Policyholders’ benefits | (281) | (281) | (4,915) | ||||
| Change in estimates of liability for future policy benefits | (20) | 7 | 5 | ||||
| Amortization of deferred policy acquisition costs | (9) | 0 | 0 | ||||
| General and administrative expenses | 40 | 48 | 3 | ||||
| Income (loss) from related parties, before income taxes | 156 | 675 | (333) | ||||
| Other Comprehensive Income (Loss), before tax | 11 | (473) | 335 | ||||
| Total comprehensive income (loss), before tax | $ 167 | $ 202 | $ 2 | ||||
| |||||||
Related Party Transactions - The Initial and Ongoing Reinsurance Activity with Prismic Re of Cash Flows (Details) - USD ($) $ in Millions |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||||
| Realized investment gains(losses), net | [1],[2] | $ 4,132 | $ 3,429 | $ 3,615 | |||
| Deferred policy acquisition costs | [2] | (1,215) | (1,111) | (869) | |||
| Reinsurance related-balances | [2] | 2,263 | 2,731 | 683 | |||
| Other, net | [2] | (4,487) | (2,124) | (3,707) | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Other. net | [2] | (207) | (50) | (676) | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Other, net | [2] | 848 | 830 | 645 | |||
| Related Party | |||||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||||
| Realized investment gains(losses), net | 509 | (255) | 491 | ||||
| Deferred policy acquisition costs | (9) | 0 | 0 | ||||
| Reinsurance related-balances | (843) | (743) | (235) | ||||
| Other, net | (26) | (16) | (29) | ||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Other. net | (64) | 0 | 0 | ||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Other, net | $ 336 | $ 374 | $ 3 | ||||
| |||||||
Commitments and Contingent Liabilities (Details) - USD ($) $ in Millions |
12 Months Ended | |
|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Commitments and Contingent Liabilities [Line Items] | ||
| Guarantee on letters of credit | $ 2,300 | |
| Other assets: | ||
| Premium tax offset for future undiscounted assessments | 5 | $ 25 |
| Premium tax offset currently available for paid assessments | 69 | 62 |
| Total | 74 | 87 |
| Other liabilities: | ||
| Insolvency assessments | 5 | 29 |
| Standby Letters of Credit | ||
| Commitments and Contingent Liabilities [Line Items] | ||
| Guarantee on letters of credit | 1,500 | |
| Standby Uncommitted Letters Of Credit | ||
| Commitments and Contingent Liabilities [Line Items] | ||
| Guarantee on letters of credit | 500 | |
| Commitments | Commercial Mortgage Loans | ||
| Commitments and Contingent Liabilities [Line Items] | ||
| Total outstanding mortgage loan commitments | 1,851 | 2,552 |
| Portion of commitment where prearrangement to sell to investor exists | 352 | 578 |
| Allowance for credit losses | 5 | 2 |
| Change in allowance for credit losses | 3 | 1 |
| Expected to be funded from the GA and other operations outside the SA | ||
| Commitments and Contingent Liabilities [Line Items] | ||
| Commitments to Purchase Investment (excluding Commercial Mortgage Loans) | 13,205 | 11,664 |
| Expected to be funded from separate accounts | ||
| Commitments and Contingent Liabilities [Line Items] | ||
| Commitments to Purchase Investment (excluding Commercial Mortgage Loans) | 339 | 0 |
| Indemnification | Securities Lending and Securities Repurchase Transactions | ||
| Commitments and Contingent Liabilities [Line Items] | ||
| Indemnification provided to certain clients for securities lending and securities repurchase transactions | 4,459 | 5,015 |
| Fair value of related collateral associated with above indemnifications | 4,558 | 5,119 |
| Accrued Liability associated with guarantee | 0 | 0 |
| Indemnification | Securities Repurchase Transactions | ||
| Commitments and Contingent Liabilities [Line Items] | ||
| Indemnification provided to certain clients for securities lending and securities repurchase transactions | 0 | 240 |
| Indemnification | Serviced Mortgage Loans | ||
| Commitments and Contingent Liabilities [Line Items] | ||
| Maximum exposure under indemnification agreements for mortgage loans serviced by the Company | 3,717 | 3,272 |
| First-loss exposure portion of above | 1,068 | 942 |
| Accrued Liability associated with guarantee | 24 | 25 |
| Allowance for credit losses | 11 | 12 |
| Change in allowance for credit losses | (1) | (2) |
| Guarantee of Asset Values | ||
| Commitments and Contingent Liabilities [Line Items] | ||
| Guaranteed value of third parties’ assets | 75,883 | 76,416 |
| Fair value of collateral supporting these assets | 73,511 | 71,423 |
| Guarantees, Liabilities, Fair Value Disclosure | 0 | (1) |
| Other Guarantees | ||
| Commitments and Contingent Liabilities [Line Items] | ||
| Other guarantees where amount can be determined | 290 | 289 |
| Accrued Liability associated with guarantee | 31 | 32 |
| Purchase Investments | ||
| Commitments and Contingent Liabilities [Line Items] | ||
| Change in allowance for credit losses | $ 0 | $ 0 |
Commitments and Contingent Liabilities (Narrative Excluding Litigation) (Details) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
|
Dec. 31, 2025
USD ($)
|
Dec. 31, 2024
USD ($)
|
Nov. 30, 2025
USD ($)
|
|
| Related Party | |||
| Commitments and Contingent Liabilities [Line Items] | |||
| Prismic Re Unfunded Commitment | $ 320 | ||
| Commitments | Commercial Mortgage Loans | |||
| Commitments and Contingent Liabilities [Line Items] | |||
| Allowance for credit losses | $ 5 | $ 2 | |
| Change in allowance for credit losses | 3 | 1 | |
| Purchase Investments | |||
| Commitments and Contingent Liabilities [Line Items] | |||
| Change in allowance for credit losses | $ 0 | 0 | |
| Indemnification | Securities Lending and Securities Repurchase Transactions | |||
| Commitments and Contingent Liabilities [Line Items] | |||
| Guarantor obligations, liquidation proceeds, percentage | 102.00% | ||
| Indemnification | Securities Repurchase Transactions | |||
| Commitments and Contingent Liabilities [Line Items] | |||
| Guarantor obligations, liquidation proceeds, percentage | 95.00% | ||
| Indemnification | Serviced Mortgage Loans | |||
| Commitments and Contingent Liabilities [Line Items] | |||
| Allowance for credit losses | $ 11 | 12 | |
| Change in allowance for credit losses | (1) | (2) | |
| Mortgages subject to loss-sharing arrangements | $ 28,275 | $ 25,763 | |
| Weighted-average debt service coverage ratio of mortgages subject to loss-sharing arrangements | 1.93 | 1.95 | |
| Weighted-average loan-to-value ratio of mortgages subject to loss-sharing arrangements | 62.00% | 62.00% | |
| Losses related to indemnifications that were settled | $ 0 | $ 0 | |
| Indemnification | Minimum | Serviced Mortgage Loans | |||
| Commitments and Contingent Liabilities [Line Items] | |||
| Percentage share of losses incurred on certain loans serviced | 4.00% | ||
| Indemnification | Maximum | Serviced Mortgage Loans | |||
| Commitments and Contingent Liabilities [Line Items] | |||
| Percentage share of losses incurred on certain loans serviced | 20.00% | ||
Commitments and Contingent Liabilities (Litigation Narrative) (Details) $ in Millions |
1 Months Ended | 3 Months Ended | ||
|---|---|---|---|---|
|
Nov. 30, 2025
assetManagers
|
Dec. 31, 2017
defendant
|
May 09, 2026 |
Dec. 31, 2025
USD ($)
|
|
| POJ | Subsequent Event | ||||
| Loss Contingencies [Line Items] | ||||
| Voluntarily suspension of new sales activity at Prudential of Japan | 90 days | |||
| Maximum | ||||
| Loss Contingencies [Line Items] | ||||
| Estimate of possible losses in excess of accruals (less than) for litigation and regulatory matters | $ | $ 250 | |||
| Total Asset Recovery Services, LLC v. MetLife, Inc., and Prudential | Pending Litigation | ||||
| Loss Contingencies [Line Items] | ||||
| Loss Contingency, Number of Defendants | defendant | 19 | |||
| Optimum Communications, Inc., et al. v. Apollo Capital Management, L.P. | Pending Litigation | ||||
| Loss Contingencies [Line Items] | ||||
| Loss contingency, number of unaffiliated asset managers | assetManagers | 7 | |||
Subsequent Events (Narrative) (Details) - USD ($) $ / shares in Units, $ in Billions |
12 Months Ended | |||
|---|---|---|---|---|
Feb. 03, 2026 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Subsequent Event [Line Items] | ||||
| Dividends declared per share of Common Stock (in dollars per share) | $ 5.40 | $ 5.20 | $ 5.00 | |
| Under February 2023 Board Of Directors Authorization | ||||
| Subsequent Event [Line Items] | ||||
| Share Repurchase Program, Authorized, Amount | $ 1.0 | |||
| Subsequent Event | ||||
| Subsequent Event [Line Items] | ||||
| Dividends declared per share of Common Stock (in dollars per share) | $ 1.40 | |||
Schedule I - Summary of Investments Other Than investments in Related Parties (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
||
|---|---|---|---|---|
| Schedule of Investments [Line Items] | ||||
| Commercial mortgage and other loans | [1] | $ 64,715 | $ 62,341 | |
| Fixed Maturities, available-for-sale, Amortized Cost | 357,996 | 341,004 | ||
| Fixed Maturities, available-for-sale, at fair value | [1] | 331,455 | 311,570 | |
| Equity securities, Fair Value | [1] | 10,972 | 9,417 | |
| Fixed Maturities, Trading, amortized cost | 15,536 | 13,631 | ||
| Fixed maturities, trading | [1] | 14,869 | 12,530 | |
| Assets supporting experience-rated contractholder liabilities, at amortized cost | 3,129 | 2,582 | ||
| Assets supporting experience-rated contractholder liabilities, at fair value | 4,842 | 3,707 | ||
| Commercial mortgage and other loans | 64,715 | 62,341 | ||
| Policy loans | 9,958 | 9,795 | ||
| Short-term investments | 6,414 | 9,069 | ||
| Other invested assets | [1] | 27,294 | 26,351 | |
| Total Investment at Cost | 493,345 | |||
| Total investment | 470,519 | 444,780 | ||
| Fixed Maturities | ||||
| Schedule of Investments [Line Items] | ||||
| Assets supporting experience-rated contractholder liabilities, at amortized cost | 895 | 819 | ||
| Assets supporting experience-rated contractholder liabilities, at fair value | 896 | 826 | ||
| Equity securities | ||||
| Schedule of Investments [Line Items] | ||||
| Equity securities, at cost | 8,303 | |||
| Equity securities, Fair Value | 10,972 | |||
| Assets supporting experience-rated contractholder liabilities, at amortized cost | 2,234 | 1,763 | ||
| Assets supporting experience-rated contractholder liabilities, at fair value | 3,946 | 2,881 | ||
| Available-for-sale | Fixed Maturities | ||||
| Schedule of Investments [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 357,996 | |||
| Fixed Maturities, available-for-sale, at fair value | 331,455 | |||
| Trading | Fixed Maturities | ||||
| Schedule of Investments [Line Items] | ||||
| Fixed Maturities, Trading, amortized cost | 15,536 | |||
| Fixed maturities, trading | 14,869 | |||
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | ||||
| Schedule of Investments [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 26,334 | 24,869 | ||
| Fixed Maturities, available-for-sale, at fair value | 22,179 | 20,348 | ||
| U.S. Treasury securities and obligations of U.S. government authorities and agencies | Available-for-sale | Fixed Maturities | ||||
| Schedule of Investments [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 26,334 | |||
| Fixed Maturities, available-for-sale, at fair value | 22,179 | |||
| Obligations of U.S. states and their political subdivisions | ||||
| Schedule of Investments [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 5,881 | 6,590 | ||
| Fixed Maturities, available-for-sale, at fair value | 5,465 | 6,104 | ||
| Obligations of U.S. states and their political subdivisions | Available-for-sale | Fixed Maturities | ||||
| Schedule of Investments [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 5,881 | |||
| Fixed Maturities, available-for-sale, at fair value | 5,465 | |||
| Foreign governments | Available-for-sale | Fixed Maturities | ||||
| Schedule of Investments [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 62,469 | |||
| Fixed Maturities, available-for-sale, at fair value | 50,614 | |||
| Asset-backed securities | ||||
| Schedule of Investments [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 19,130 | 16,979 | ||
| Fixed Maturities, available-for-sale, at fair value | 19,329 | 17,134 | ||
| Asset-backed securities | Available-for-sale | Fixed Maturities | ||||
| Schedule of Investments [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 19,130 | |||
| Fixed Maturities, available-for-sale, at fair value | 19,329 | |||
| Residential mortgage-backed securities | ||||
| Schedule of Investments [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 5,493 | 2,698 | ||
| Fixed Maturities, available-for-sale, at fair value | 5,381 | 2,490 | ||
| Residential mortgage-backed securities | Available-for-sale | Fixed Maturities | ||||
| Schedule of Investments [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 5,493 | |||
| Fixed Maturities, available-for-sale, at fair value | 5,381 | |||
| Commercial Mortgage Backed Securities | ||||
| Schedule of Investments [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 9,958 | 9,791 | ||
| Fixed Maturities, available-for-sale, at fair value | 9,743 | $ 9,273 | ||
| Commercial Mortgage Backed Securities | Available-for-sale | Fixed Maturities | ||||
| Schedule of Investments [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 9,958 | |||
| Fixed Maturities, available-for-sale, at fair value | 9,743 | |||
| Public utilities | Available-for-sale | Fixed Maturities | ||||
| Schedule of Investments [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 37,064 | |||
| Fixed Maturities, available-for-sale, at fair value | 35,090 | |||
| All other corporate bonds | Available-for-sale | Fixed Maturities | ||||
| Schedule of Investments [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 191,338 | |||
| Fixed Maturities, available-for-sale, at fair value | 183,273 | |||
| Redeemable preferred stock | Available-for-sale | Fixed Maturities | ||||
| Schedule of Investments [Line Items] | ||||
| Fixed Maturities, available-for-sale, Amortized Cost | 329 | |||
| Fixed Maturities, available-for-sale, at fair value | 381 | |||
| Other common stocks | Equity securities | ||||
| Schedule of Investments [Line Items] | ||||
| Equity securities, at cost | 6,245 | |||
| Equity securities, Fair Value | 7,645 | |||
| Mutual funds | Equity securities | ||||
| Schedule of Investments [Line Items] | ||||
| Equity securities, at cost | 1,509 | |||
| Equity securities, Fair Value | 2,755 | |||
| Nonredeemable preferred stock | Equity securities | ||||
| Schedule of Investments [Line Items] | ||||
| Equity securities, at cost | 85 | |||
| Equity securities, Fair Value | 103 | |||
| Perpetual preferred stock | Equity securities | ||||
| Schedule of Investments [Line Items] | ||||
| Equity securities, at cost | 464 | |||
| Equity securities, Fair Value | 469 | |||
| Commercial mortgage and agricultural properties loans and other collateralized loans | ||||
| Schedule of Investments [Line Items] | ||||
| Commercial mortgage and other loans | 64,544 | |||
| Uncollateralized loans | ||||
| Schedule of Investments [Line Items] | ||||
| Commercial mortgage and other loans | $ 171 | |||
| ||||
Schedule II - Condensed Financial Information of Registrant (Condensed Statements of Financial Position) (Details) - USD ($) $ / shares in Units, $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| Fixed maturities, available-for-sale, at fair value | [1] | $ 331,455 | $ 311,570 | |||||||
| Equity securities | [1] | 10,972 | 9,417 | |||||||
| Other invested assets | [1] | 27,294 | 26,351 | |||||||
| Total investment | 470,519 | 444,780 | ||||||||
| Cash and cash equivalents | 19,712 | [1] | 18,497 | [1] | $ 19,419 | |||||
| Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures | 1,030 | 782 | $ 1,192 | |||||||
| Other assets | [1],[2] | 15,009 | 13,737 | |||||||
| TOTAL ASSETS | 773,740 | 735,587 | ||||||||
| LIABILITIES | ||||||||||
| Short-term debt | 1,443 | 953 | ||||||||
| Long-term debt | 18,856 | 19,187 | ||||||||
| Other Liabilities | [1] | 17,692 | 16,679 | |||||||
| Total liabilities | 738,159 | 705,461 | ||||||||
| EQUITY | ||||||||||
| Preferred Stock ($0.01 par value; 10,000,000 shares authorized; none issued) | 0 | 0 | ||||||||
| Common Stock ($0.01 par value; 1,500,000,000 shares authorized; 666,305,189 shares issued as of December 31, 2025 and December 31, 2024) | 6 | 6 | ||||||||
| Additional paid-in capital | 26,013 | 25,901 | ||||||||
| Common Stock held in treasury, at cost (318,361,498 and 311,738,187 shares as of December 31, 2025 and 2024, respectively) | (25,335) | (24,511) | ||||||||
| Accumulated Other Comprehensive Income (Loss) | [2] | (3,077) | (6,711) | |||||||
| Retained earnings | 34,831 | 33,187 | ||||||||
| Total equity | 32,438 | 27,872 | ||||||||
| Total liabilities and equity | 773,740 | 735,587 | ||||||||
| Fixed Maturities, available-for-sale, Amortized Cost | $ 357,996 | $ 341,004 | ||||||||
| Preferred Stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||||||||
| Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | 10,000,000 | |||||||
| Preferred Stock, Shares Issued | 0 | 0 | ||||||||
| Common Stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||||||||
| Common Stock, Shares Authorized | 1,500,000,000 | 1,500,000,000 | ||||||||
| Common Stock, Shares, Issued | 666,305,189 | 666,305,189 | ||||||||
| Treasury Stock, Shares | 318,361,498 | 311,738,187 | ||||||||
| Prudential Financial | ||||||||||
| ASSETS | ||||||||||
| Fixed maturities, available-for-sale, at fair value | $ 1,335 | $ 1,335 | ||||||||
| Equity securities | 174 | 25 | ||||||||
| Other invested assets | 2,051 | 3,361 | ||||||||
| Total investment | 3,560 | 4,721 | ||||||||
| Cash and cash equivalents | 1,204 | 1,051 | $ 971 | $ 1,396 | ||||||
| Due from subsidiaries | 3,327 | 3,460 | ||||||||
| Loans receivable from subsidiaries | 5,393 | 5,251 | ||||||||
| Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures | 47,056 | 41,054 | ||||||||
| Property, plant and equipment | 363 | 381 | ||||||||
| Income taxes receivable | 491 | 418 | ||||||||
| Other assets | 445 | 475 | ||||||||
| TOTAL ASSETS | 61,839 | 56,811 | ||||||||
| LIABILITIES | ||||||||||
| Due to subsidiaries | 4,139 | 3,800 | ||||||||
| Loans payable to subsidiaries | 5,684 | 5,602 | ||||||||
| Short-term debt | 561 | 25 | ||||||||
| Long-term debt | 18,378 | 18,793 | ||||||||
| Income Taxes Payable | 128 | 167 | ||||||||
| Other Liabilities | 511 | 552 | ||||||||
| Total liabilities | 29,401 | 28,939 | ||||||||
| EQUITY | ||||||||||
| Preferred Stock ($0.01 par value; 10,000,000 shares authorized; none issued) | 0 | 0 | ||||||||
| Common Stock ($0.01 par value; 1,500,000,000 shares authorized; 666,305,189 shares issued as of December 31, 2025 and December 31, 2024) | 6 | 6 | ||||||||
| Additional paid-in capital | 26,013 | 25,901 | ||||||||
| Common Stock held in treasury, at cost (318,361,498 and 311,738,187 shares as of December 31, 2025 and 2024, respectively) | (25,335) | (24,511) | ||||||||
| Accumulated Other Comprehensive Income (Loss) | (3,077) | (6,711) | ||||||||
| Retained earnings | 34,831 | 33,187 | ||||||||
| Total equity | 32,438 | 27,872 | ||||||||
| Total liabilities and equity | 61,839 | 56,811 | ||||||||
| Fixed Maturities, available-for-sale, Amortized Cost | 1,425 | 1,477 | ||||||||
| Equity securities, at cost | $ 174 | $ 25 | ||||||||
| Preferred Stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||||||||
| Preferred Stock, Shares Authorized | 10,000,000 | 10,000,000 | ||||||||
| Preferred Stock, Shares Issued | 0 | 0 | ||||||||
| Common Stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||||||||
| Common Stock, Shares Authorized | 1,500,000,000 | 1,500,000,000 | ||||||||
| Common Stock, Shares, Issued | 666,305,189 | 666,305,189 | ||||||||
| Treasury Stock, Shares | 318,361,498 | 311,738,187 | ||||||||
| ||||||||||
Schedule II - Condensed Financial Information of Registrant (Condensed Statements of Operations) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||
| REVENUES | |||||||
| Net Investment Income | $ 21,473 | $ 19,909 | $ 17,865 | ||||
| Realized investment gains (losses), net | [1],[2] | (4,132) | (3,429) | (3,615) | |||
| Other income (loss) | [1] | 4,426 | 3,037 | 4,065 | |||
| Total revenues | 60,774 | 70,405 | 53,979 | ||||
| EXPENSES | |||||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | 4,656 | 3,209 | 3,072 | ||||
| Total income tax expense (benefit) | 1,053 | 507 | 613 | ||||
| INCOME (LOSS) BEFORE EQUITY IN EARNINGS OF OPERATING JOINT VENTURES | 3,603 | 2,702 | 2,459 | ||||
| Equity in earnings of joint ventures and other operating entities, net of taxes | 129 | 144 | 49 | ||||
| Net income (loss) | 3,732 | 2,846 | 2,508 | ||||
| Comprehensive income (loss) attributable to Prudential Financial, Inc. | 7,210 | 2,520 | (210) | ||||
| Prudential Financial | |||||||
| REVENUES | |||||||
| Net Investment Income | 360 | 376 | 345 | ||||
| Realized investment gains (losses), net | 7 | (2) | (4) | ||||
| Affiliated interest revenue | 317 | 392 | 408 | ||||
| Other income (loss) | 20 | 17 | 14 | ||||
| Total revenues | 704 | 783 | 763 | ||||
| EXPENSES | |||||||
| General and administrative expenses | 128 | 164 | 173 | ||||
| Interest expense | 1,360 | 1,322 | 1,282 | ||||
| Total expenses | 1,488 | 1,486 | 1,455 | ||||
| Income (loss) before income taxes and equity in earnings of operating joint ventures | (784) | (703) | (692) | ||||
| Total income tax expense (benefit) | (214) | (192) | (152) | ||||
| INCOME (LOSS) BEFORE EQUITY IN EARNINGS OF OPERATING JOINT VENTURES | (570) | (511) | (540) | ||||
| Equity In Earnings Of Subsidiaries | 4,117 | 3,191 | 3,023 | ||||
| Equity in earnings of joint ventures and other operating entities, net of taxes | 29 | 47 | 5 | ||||
| Net income (loss) | 3,576 | 2,727 | 2,488 | ||||
| Other Comprehensive Income (loss) | 3,634 | (207) | (2,698) | ||||
| Comprehensive income (loss) attributable to Prudential Financial, Inc. | $ 7,210 | $ 2,520 | $ (210) | ||||
| |||||||
Schedule II - Condensed Financial Information of Registrant (Condensed Statements of Cash Flow) (Details) - USD ($) $ in Millions |
12 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||||||||
| Net income (loss) | $ 3,732 | $ 2,846 | $ 2,508 | ||||||||||
| Adjustments to reconcile net income to cash provided by operating activities: | |||||||||||||
| Equity in earnings of joint ventures and other operating entities, net of taxes | (129) | (144) | (49) | ||||||||||
| Realized investment gains (losses), net | [1],[2] | 4,132 | 3,429 | 3,615 | |||||||||
| Dividends received from subsidiaries | 107 | 95 | 66 | ||||||||||
| Change in: | |||||||||||||
| Other, net | [2] | (4,487) | (2,124) | (3,707) | |||||||||
| Cash flows from (used in) operating activities | 6,271 | 8,502 | 6,510 | ||||||||||
| Proceeds from the sale/maturity of: | |||||||||||||
| Fixed maturities, available-for-sale | 45,218 | 59,059 | 44,097 | ||||||||||
| Short-term investments | 33,226 | 33,316 | 32,684 | ||||||||||
| Payments for the purchase of: | |||||||||||||
| Equity securities, at fair value | 8,473 | 6,576 | 4,296 | ||||||||||
| Fixed maturities, available-for-sale | (67,592) | (72,997) | (47,580) | ||||||||||
| Short-term investments | (31,039) | (37,244) | (32,872) | ||||||||||
| Other. net | [2] | (207) | (50) | (676) | |||||||||
| Cash flows from (used in) investing activities | (25,892) | (28,585) | (12,122) | ||||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||||||||
| Cash dividends paid on Common Stock | (1,926) | (1,891) | (1,846) | ||||||||||
| Common Stock acquired | (1,000) | (1,000) | (1,012) | ||||||||||
| Common Stock reissued for exercise of stock options | 109 | 201 | 126 | ||||||||||
| Proceeds from the issuance of debt (maturities longer than 90 days) | 1,195 | 1,423 | 716 | ||||||||||
| Repayments of debt (maturities longer than 90 days) | (1,546) | (814) | (1,982) | ||||||||||
| Net change in financing arrangements (maturities 90 days or less) | 449 | (583) | 10 | ||||||||||
| Other, net | [2] | 848 | 830 | 645 | |||||||||
| Cash flows from (used in) financing activities | 20,773 | 19,394 | 7,739 | ||||||||||
| CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | 18,497 | [3] | 19,419 | ||||||||||
| CASH AND CASH EQUIVALENTS, END OF YEAR | 19,712 | [3] | 18,497 | [3] | 19,419 | ||||||||
| SUPPLEMENTAL CASH FLOW INFORMATION | |||||||||||||
| Cash paid (refunds received) during the period for taxes | 1,398 | [4] | 756 | 895 | |||||||||
| Prudential Financial | |||||||||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||||||||
| Net income (loss) | 3,576 | 2,727 | 2,488 | ||||||||||
| Adjustments to reconcile net income to cash provided by operating activities: | |||||||||||||
| Equity in earnings of subsidiaries | (4,117) | (3,191) | (3,023) | ||||||||||
| Equity in earnings of joint ventures and other operating entities, net of taxes | (29) | (47) | (5) | ||||||||||
| Realized investment gains (losses), net | (7) | 2 | 4 | ||||||||||
| Dividends received from subsidiaries | 2,232 | 3,032 | 3,705 | ||||||||||
| Property, plant and equipment | (1) | (3) | (15) | ||||||||||
| Change in: | |||||||||||||
| Due to/from subsidiaries, net | 753 | (106) | 212 | ||||||||||
| Other, net | 46 | 145 | (487) | ||||||||||
| Cash flows from (used in) operating activities | 2,453 | 2,559 | 2,879 | ||||||||||
| Proceeds from the sale/maturity of: | |||||||||||||
| Fixed maturities, available-for-sale | 617 | 212 | 372 | ||||||||||
| Short-term investments | 15,206 | 15,502 | 19,196 | ||||||||||
| Payments for the purchase of: | |||||||||||||
| Equity securities, at fair value | (149) | 0 | 0 | ||||||||||
| Fixed maturities, available-for-sale | (565) | (171) | (171) | ||||||||||
| Short-term investments | (13,896) | (16,627) | (18,938) | ||||||||||
| Capital contributions to subsidiaries | (430) | (384) | (1,651) | ||||||||||
| Returns of capital contributions from subsidiaries | 0 | 300 | 599 | ||||||||||
| Loans to subsidiaries, net of maturities | (142) | 197 | 584 | ||||||||||
| Other. net | (114) | 0 | 0 | ||||||||||
| Cash flows from (used in) investing activities | 527 | (971) | (9) | ||||||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||||||||
| Cash dividends paid on Common Stock | (1,926) | (1,891) | (1,846) | ||||||||||
| Common Stock acquired | (1,000) | (1,000) | (1,012) | ||||||||||
| Common Stock reissued for exercise of stock options | 109 | 201 | 126 | ||||||||||
| Proceeds from the issuance of debt (maturities longer than 90 days) | 1,108 | 1,123 | 495 | ||||||||||
| Repayments of debt (maturities longer than 90 days) | (1,008) | (512) | (1,514) | ||||||||||
| Repayments of loans from subsidiaries | (530) | (9) | (660) | ||||||||||
| Proceeds from loans payable to subsidiaries | 524 | 702 | 1,256 | ||||||||||
| Net change in financing arrangements (maturities 90 days or less) | 0 | (1) | 1 | ||||||||||
| Other, net | (104) | (121) | (141) | ||||||||||
| Cash flows from (used in) financing activities | (2,827) | (1,508) | (3,295) | ||||||||||
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | 153 | 80 | (425) | ||||||||||
| CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR | 1,051 | 971 | 1,396 | ||||||||||
| CASH AND CASH EQUIVALENTS, END OF YEAR | 1,204 | 1,051 | 971 | ||||||||||
| SUPPLEMENTAL CASH FLOW INFORMATION | |||||||||||||
| Cash paid during the period for interest | 1,257 | 1,231 | 1,224 | ||||||||||
| Cash paid (refunds received) during the period for taxes | (289) | (448) | 554 | ||||||||||
| NON-CASH TRANSACTIONS DURING THE YEAR | |||||||||||||
| Non-cash capital contributions to subsidiaries | (63) | (2,919) | (753) | ||||||||||
| Non-cash dividends/returns of capital from subsidiaries | 0 | 83 | 1,067 | ||||||||||
| Treasury Stock shares issued for stock-based compensation programs | $ 186 | $ 216 | $ 275 | ||||||||||
| |||||||||||||
Schedule II - Condensed Financial Information of Registrant (Short and Long-Term Debt) (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Debt Instrument [Line Items] | |||
| Short-term debt | $ 1,443,000 | $ 953,000 | |
| Long-term debt | $ 18,856,000 | $ 19,187,000 | |
| Commercial Paper, Weighted Average Interest Rate | 3.72% | 4.61% | |
| Prudential Financial | |||
| Debt Instrument [Line Items] | |||
| Short-term debt | $ 561,000 | $ 25,000 | |
| Long-term debt | 18,378,000 | 18,793,000 | |
| Interest expense | 1,360,000 | 1,322,000 | $ 1,282,000 |
| Prudential Financial | Derivatives | |||
| Debt Instrument [Line Items] | |||
| Interest expense | 0 | 0 | $ 0 |
| Prudential Financial | Commercial Paper | |||
| Debt Instrument [Line Items] | |||
| Short-term debt | $ 25,000 | $ 25,000 | |
| Commercial Paper, Weighted Average Interest Rate | 3.85% | 4.38% | |
| Prudential Financial | Current portion of long-term debt | |||
| Debt Instrument [Line Items] | |||
| Short-term debt | $ 536,000 | $ 0 | |
| Prudential Financial | Junior subordinated debt | |||
| Debt Instrument [Line Items] | |||
| Long-term debt | $ 7,555,000 | 8,548,000 | |
| Prudential Financial | Minimum | Junior subordinated debt | |||
| Debt Instrument [Line Items] | |||
| Interest Rate | 3.70% | ||
| Prudential Financial | Maximum | Junior subordinated debt | |||
| Debt Instrument [Line Items] | |||
| Interest Rate | 6.75% | ||
| Fixed rate | Prudential Financial | Senior notes | |||
| Debt Instrument [Line Items] | |||
| Long-term debt | $ 10,823,000 | $ 10,245,000 | |
| Fixed rate | Prudential Financial | Minimum | Senior notes | |||
| Debt Instrument [Line Items] | |||
| Interest Rate | 1.50% | ||
| Fixed rate | Prudential Financial | Maximum | Senior notes | |||
| Debt Instrument [Line Items] | |||
| Interest Rate | 6.63% | ||
Schedule II - Condensed Financial Information of Registrant (Contractual Maturities for Long-Term Debt) (Details) - USD ($) $ in Millions |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Debt Instrument [Line Items] | ||
| 2027 | $ 63 | |
| 2028 | 667 | |
| 2029 | 95 | |
| 2030 | 750 | |
| 2031 and thereafter | 17,281 | |
| Long-term debt | 18,856 | $ 19,187 |
| Prudential Financial | ||
| Debt Instrument [Line Items] | ||
| 2027 | 63 | |
| 2028 | 412 | |
| 2029 | 71 | |
| 2030 | 665 | |
| 2031 and thereafter | 17,167 | |
| Long-term debt | $ 18,378 | $ 18,793 |
Schedule II - Condensed Financial Information of Registrant (Dividends and Returns of Capital) (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Rabbi Trust | |||
| Condensed Financial Statements, Captions [Line Items] | |||
| Dividends or Returns of Capital received by Parent Company from Subsidiaries | $ 900 | ||
| Prudential Financial | |||
| Condensed Financial Statements, Captions [Line Items] | |||
| Dividends or Returns of Capital received by Parent Company from Subsidiaries | $ 2,232 | 3,332 | $ 4,304 |
| International Insurance and Investments Holding Companies | Prudential Financial | |||
| Condensed Financial Statements, Captions [Line Items] | |||
| Dividends or Returns of Capital received by Parent Company from Subsidiaries | 1,118 | 1,385 | 216 |
| Prudential Insurance Company of America | Prudential Financial | |||
| Condensed Financial Statements, Captions [Line Items] | |||
| Dividends or Returns of Capital received by Parent Company from Subsidiaries | 900 | 1,550 | 3,100 |
| PGIM Holding Company | Prudential Financial | |||
| Condensed Financial Statements, Captions [Line Items] | |||
| Dividends or Returns of Capital received by Parent Company from Subsidiaries | 202 | 61 | 84 |
| Other Companies | Prudential Financial | |||
| Condensed Financial Statements, Captions [Line Items] | |||
| Dividends or Returns of Capital received by Parent Company from Subsidiaries | $ 12 | $ 336 | $ 904 |
Schedule II - Condensed Financial Information of Registrant (Narratives) (Details) - USD ($) $ in Thousands |
12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Nov. 30, 2025 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|||
| Schedule II Narrative [Line Items] | ||||||||
| Guarantee on letters of credit | $ 2,300,000 | |||||||
| Other Income | [1] | (4,426,000) | $ (3,037,000) | $ (4,065,000) | ||||
| Related Party | ||||||||
| Schedule II Narrative [Line Items] | ||||||||
| Guarantee on letters of credit | 2,000,000 | 2,000,000 | ||||||
| Other Income | $ (353,000) | $ (150,000) | (52,000) | |||||
| Prismic HoldCo | ||||||||
| Schedule II Narrative [Line Items] | ||||||||
| Equity Method Investment, Ownership Percentage | 20.00% | 20.00% | ||||||
| Prismic HoldCo | Related Party | ||||||||
| Schedule II Narrative [Line Items] | ||||||||
| Equity Method Investment, Ownership Percentage | 20.00% | 20.00% | 20.00% | 20.00% | ||||
| Prismic HoldCo | Related Party | ||||||||
| Schedule II Narrative [Line Items] | ||||||||
| Carrying value | $ 200,000 | $ 200,000 | $ 200,000 | |||||
| Prudential Financial | ||||||||
| Schedule II Narrative [Line Items] | ||||||||
| Increase (Decrease) In Interest Expense, Derivative Instruments | 1,360,000 | 1,322,000 | 1,282,000 | |||||
| Other Income | (20,000) | (17,000) | (14,000) | |||||
| Derivatives | Prudential Financial | ||||||||
| Schedule II Narrative [Line Items] | ||||||||
| Increase (Decrease) In Interest Expense, Derivative Instruments | 0 | $ 0 | 0 | |||||
| Standby Letters of Credit | ||||||||
| Schedule II Narrative [Line Items] | ||||||||
| Guarantee on letters of credit | 1,500,000 | |||||||
| Standby Uncommitted Letters Of Credit | ||||||||
| Schedule II Narrative [Line Items] | ||||||||
| Guarantee on letters of credit | 500,000 | |||||||
| Commercial Paper | Prudential Financial | ||||||||
| Schedule II Narrative [Line Items] | ||||||||
| Guarantee obligation | 850,000 | |||||||
| Investee Debt | Prudential Financial | ||||||||
| Schedule II Narrative [Line Items] | ||||||||
| Guarantee obligation | $ 5,000,000 | |||||||
| Commitments to Extend Credit | Prudential Financial | ||||||||
| Schedule II Narrative [Line Items] | ||||||||
| Guarantee obligation | $ 500,000 | |||||||
| ||||||||
Schedule III - Supplementary Insurance Information (Details) - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
| Deferred Policy Acquisition Costs | $ 21,530 | $ 20,448 | $ 20,856 |
| Future Policy Benefits, Losses, Claims Expenses | 266,750 | 268,600 | 272,957 |
| Unearned Premiums | 164 | 312 | 324 |
| Other Policy Claims and Benefits Payable | 192,579 | 166,972 | 148,493 |
| Premiums, Policy Charges and Fee Income | 35,463 | 47,195 | 31,891 |
| Net Investment Income | 21,473 | 19,909 | 17,865 |
| Benefits, Claims, Losses and Settlement Expenses | 41,368 | 52,399 | 35,983 |
| Amortization of DAC | 1,635 | 1,492 | 1,459 |
| Other Operating Expenses | 13,012 | 13,342 | 13,128 |
| U.S. Businesses Division | |||
| SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
| Deferred Policy Acquisition Costs | 12,359 | 11,551 | 11,757 |
| Future Policy Benefits, Losses, Claims Expenses | 120,974 | 117,864 | 106,756 |
| Unearned Premiums | 94 | 246 | 251 |
| Other Policy Claims and Benefits Payable | 123,543 | 102,944 | 85,988 |
| Premiums, Policy Charges and Fee Income | 21,679 | 33,008 | 16,589 |
| Net Investment Income | 11,380 | 10,405 | 9,010 |
| Benefits, Claims, Losses and Settlement Expenses | 24,546 | 36,245 | 18,943 |
| Amortization of DAC | 993 | 889 | 862 |
| Other Operating Expenses | 4,904 | 5,148 | 4,551 |
| International Businesses | |||
| SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
| Deferred Policy Acquisition Costs | 9,678 | 9,304 | 9,351 |
| Future Policy Benefits, Losses, Claims Expenses | 95,165 | 99,633 | 113,428 |
| Unearned Premiums | 70 | 66 | 73 |
| Other Policy Claims and Benefits Payable | 61,715 | 54,881 | 51,971 |
| Premiums, Policy Charges and Fee Income | 11,660 | 12,103 | 13,231 |
| Net Investment Income | 6,040 | 5,715 | 5,281 |
| Benefits, Claims, Losses and Settlement Expenses | 12,322 | 12,059 | 12,525 |
| Amortization of DAC | 692 | 646 | 622 |
| Other Operating Expenses | 2,463 | 2,314 | 2,488 |
| Total PFI excluding Closed Block division | |||
| SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
| Deferred Policy Acquisition Costs | 21,386 | 20,292 | 20,688 |
| Future Policy Benefits, Losses, Claims Expenses | 225,266 | 226,136 | 229,370 |
| Unearned Premiums | 164 | 312 | 324 |
| Other Policy Claims and Benefits Payable | 187,067 | 161,925 | 142,553 |
| Premiums, Policy Charges and Fee Income | 33,744 | 45,505 | 30,216 |
| Net Investment Income | 19,416 | 17,861 | 15,906 |
| Benefits, Claims, Losses and Settlement Expenses | 37,848 | 49,299 | 32,503 |
| Amortization of DAC | 1,623 | 1,480 | 1,446 |
| Other Operating Expenses | 12,725 | 13,054 | 12,856 |
| PGIM | PGIM | |||
| SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
| Deferred Policy Acquisition Costs | 0 | 0 | 0 |
| Future Policy Benefits, Losses, Claims Expenses | 0 | 0 | 0 |
| Unearned Premiums | 0 | 0 | 0 |
| Other Policy Claims and Benefits Payable | 0 | 0 | 0 |
| Premiums, Policy Charges and Fee Income | 0 | 0 | 0 |
| Net Investment Income | 181 | 15 | 268 |
| Benefits, Claims, Losses and Settlement Expenses | 0 | 0 | 0 |
| Amortization of DAC | 0 | 2 | 2 |
| Other Operating Expenses | 3,215 | 3,097 | 2,937 |
| Institutional Retirement Strategies | U.S. Businesses Division | |||
| SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
| Deferred Policy Acquisition Costs | 283 | 208 | 139 |
| Future Policy Benefits, Losses, Claims Expenses | 85,693 | 84,717 | 75,431 |
| Unearned Premiums | 0 | 0 | 0 |
| Other Policy Claims and Benefits Payable | 23,067 | 18,761 | 17,520 |
| Premiums, Policy Charges and Fee Income | 11,017 | 22,979 | 6,375 |
| Net Investment Income | 5,055 | 4,603 | 4,161 |
| Benefits, Claims, Losses and Settlement Expenses | 14,383 | 26,392 | 9,209 |
| Amortization of DAC | 23 | 10 | 10 |
| Other Operating Expenses | 354 | 286 | 210 |
| Individual Retirement Strategies | U.S. Businesses Division | |||
| SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
| Deferred Policy Acquisition Costs | 4,329 | 4,091 | 3,881 |
| Future Policy Benefits, Losses, Claims Expenses | 1,321 | 1,181 | 1,229 |
| Unearned Premiums | 0 | 0 | 0 |
| Other Policy Claims and Benefits Payable | 61,324 | 46,105 | 30,860 |
| Premiums, Policy Charges and Fee Income | 1,205 | 1,312 | 1,335 |
| Net Investment Income | 2,891 | 2,124 | 1,453 |
| Benefits, Claims, Losses and Settlement Expenses | 1,505 | 1,042 | 713 |
| Amortization of DAC | 528 | 430 | 387 |
| Other Operating Expenses | 1,511 | 1,779 | 1,663 |
| Retirement Strategies | U.S. Businesses Division | |||
| SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
| Deferred Policy Acquisition Costs | 4,612 | 4,299 | 4,020 |
| Future Policy Benefits, Losses, Claims Expenses | 87,014 | 85,898 | 76,660 |
| Unearned Premiums | 0 | 0 | 0 |
| Other Policy Claims and Benefits Payable | 84,391 | 64,866 | 48,380 |
| Premiums, Policy Charges and Fee Income | 12,222 | 24,291 | 7,710 |
| Net Investment Income | 7,946 | 6,727 | 5,614 |
| Benefits, Claims, Losses and Settlement Expenses | 15,888 | 27,434 | 9,922 |
| Amortization of DAC | 551 | 440 | 397 |
| Other Operating Expenses | 1,865 | 2,065 | 1,873 |
| Group Insurance | U.S. Businesses Division | |||
| SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
| Deferred Policy Acquisition Costs | 154 | 159 | 137 |
| Future Policy Benefits, Losses, Claims Expenses | 5,609 | 5,425 | 5,348 |
| Unearned Premiums | 94 | 246 | 251 |
| Other Policy Claims and Benefits Payable | 4,832 | 5,032 | 5,342 |
| Premiums, Policy Charges and Fee Income | 6,147 | 5,807 | 5,699 |
| Net Investment Income | 543 | 531 | 517 |
| Benefits, Claims, Losses and Settlement Expenses | 5,160 | 4,949 | 4,869 |
| Amortization of DAC | 9 | 6 | 9 |
| Other Operating Expenses | 1,226 | 1,157 | 1,088 |
| Individual Life | U.S. Businesses Division | |||
| SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
| Deferred Policy Acquisition Costs | 7,593 | 7,093 | 7,600 |
| Future Policy Benefits, Losses, Claims Expenses | 28,351 | 26,541 | 24,748 |
| Unearned Premiums | 0 | 0 | 0 |
| Other Policy Claims and Benefits Payable | 34,320 | 33,046 | 32,266 |
| Premiums, Policy Charges and Fee Income | 3,310 | 2,910 | 3,180 |
| Net Investment Income | 2,891 | 3,147 | 2,879 |
| Benefits, Claims, Losses and Settlement Expenses | 3,498 | 3,862 | 4,152 |
| Amortization of DAC | 433 | 443 | 456 |
| Other Operating Expenses | 1,813 | 1,926 | 1,590 |
| Corporate and Other | |||
| SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
| Deferred Policy Acquisition Costs | (651) | (563) | (420) |
| Future Policy Benefits, Losses, Claims Expenses | 9,127 | 8,639 | 9,186 |
| Unearned Premiums | 0 | 0 | 0 |
| Other Policy Claims and Benefits Payable | 1,809 | 4,100 | 4,594 |
| Premiums, Policy Charges and Fee Income | 405 | 394 | 396 |
| Net Investment Income | 1,815 | 1,726 | 1,347 |
| Benefits, Claims, Losses and Settlement Expenses | 980 | 995 | 1,035 |
| Amortization of DAC | (62) | (57) | (40) |
| Other Operating Expenses | 2,143 | 2,495 | 2,880 |
| Closed Block division | |||
| SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Line Items] | |||
| Deferred Policy Acquisition Costs | 144 | 156 | 168 |
| Future Policy Benefits, Losses, Claims Expenses | 41,484 | 42,464 | 43,587 |
| Unearned Premiums | 0 | 0 | 0 |
| Other Policy Claims and Benefits Payable | 5,512 | 5,047 | 5,940 |
| Premiums, Policy Charges and Fee Income | 1,719 | 1,690 | 1,675 |
| Net Investment Income | 2,057 | 2,048 | 1,959 |
| Benefits, Claims, Losses and Settlement Expenses | 3,520 | 3,100 | 3,480 |
| Amortization of DAC | 12 | 12 | 13 |
| Other Operating Expenses | $ 287 | $ 288 | $ 272 |
Schedule IV - Reinsurance (Details) - USD ($) $ in Millions |
12 Months Ended | ||||
|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||
| Reinsurance Face Amount/Premiums for Insurance Companies, by Product Segment [Line Items] | |||||
| Gross Amount | $ 4,227,621 | $ 4,125,517 | $ 4,173,524 | ||
| Ceded to Other Companies | 1,022,549 | 979,667 | 891,770 | ||
| Assumed from Other Companies | 154,535 | 159,355 | 165,988 | ||
| Net Amount | $ 3,359,607 | $ 3,305,205 | $ 3,447,742 | ||
| Percentage of Amount Assumed to Net | 4.60% | 4.80% | 4.80% | ||
| Gross Amount | $ 26,371 | $ 39,222 | $ 29,475 | ||
| Ceded to Other Companies | 2,564 | 2,492 | 7,116 | ||
| Assumed from Other Companies | 6,990 | 6,167 | 5,005 | ||
| Premiums | [1] | $ 30,797 | $ 42,897 | $ 27,364 | |
| Percentage of Amount Assumed to Net | 22.70% | 14.40% | 18.30% | ||
| Life Insurance | |||||
| Reinsurance Face Amount/Premiums for Insurance Companies, by Product Segment [Line Items] | |||||
| Gross Amount | $ 23,367 | $ 36,320 | $ 26,585 | ||
| Ceded to Other Companies | 2,447 | 2,384 | 7,028 | ||
| Assumed from Other Companies | 6,990 | 6,167 | 5,005 | ||
| Premiums | $ 27,910 | $ 40,103 | $ 24,562 | ||
| Percentage of Amount Assumed to Net | 25.00% | 15.40% | 20.40% | ||
| Accident and Health Insurance | |||||
| Reinsurance Face Amount/Premiums for Insurance Companies, by Product Segment [Line Items] | |||||
| Gross Amount | $ 3,004 | $ 2,902 | $ 2,890 | ||
| Ceded to Other Companies | 117 | 108 | 88 | ||
| Assumed from Other Companies | 0 | 0 | 0 | ||
| Premiums | $ 2,887 | $ 2,794 | $ 2,802 | ||
| Percentage of Amount Assumed to Net | 0.00% | 0.00% | 0.00% | ||
| |||||